<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32025286</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>F1000Research</Title><ISOAbbreviation>F1000Res</ISOAbbreviation></Journal><ArticleTitle>BOSC 2019, the 20th annual Bioinformatics Open Source Conference.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ISCB Comm J-2132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.21568.1</ELocationID><Abstract><AbstractText>The Bioinformatics Open Source Conference is a volunteer-organized meeting that covers open source software development and open science in bioinformatics. Launched in 2000, BOSC has been held every year since. BOSC 2019, the 20th annual BOSC, took place as one of the Communities of Special Interest (COSIs) at the Intelligent Systems for Molecular Biology meeting (ISMB/ECCB 2019). The two-day meeting included a total of 46 talks and 55 posters, as well as eight Birds of a Feather interest groups. The keynote speaker was University of Cape Town professor Dr. Nicola Mulder, who spoke on "Building infrastructure for responsible open science in Africa". Immediately after BOSC 2019, about 50 people participated in the two-day CollaborationFest (CoFest for short), an open and free community-driven event at which participants work together to contribute to bioinformatics software, documentation, training materials, and use cases.</AbstractText><CopyrightInformation>Copyright: © 2019 Harris NL et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Nomi L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0001-6315-3707</Identifier><AffiliationInfo><Affiliation>Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cock</LastName><ForeName>Peter J A</ForeName><Initials>PJA</Initials><Identifier Source="ORCID">0000-0001-9513-9993</Identifier><AffiliationInfo><Affiliation>Information and Computational Sciences, James Hutton Institute, Dundee, DD2 5DA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fields</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-7749-5844</Identifier><AffiliationInfo><Affiliation>Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greshake Tzovaras</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9925-9623</Identifier><AffiliationInfo><Affiliation>Center for Research &amp; Interdisciplinarity, Université de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9052-6000</Identifier><AffiliationInfo><Affiliation>University of California, Berkeley, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hokamp</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7464-2370</Identifier><AffiliationInfo><Affiliation>Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz-Torres</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, 97331, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peltzer</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6503-2180</Identifier><AffiliationInfo><Affiliation>Quantitative Biology Center, University of Tübingen, Tübingen, 72074, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rieck</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4335-0302</Identifier><AffiliationInfo><Affiliation>Machine Learning &amp; Computational Biology Lab, ETH Zürich, Zürich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiencko</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Open Bioinformatics Foundation, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yehudi</LastName><ForeName>Yo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2705-1724</Identifier><AffiliationInfo><Affiliation>Department of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>F1000Res</MedlineTA><NlmUniqueID>101594320</NlmUniqueID><ISSNLinking>2046-1402</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="N">Workflow</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bioinformatics</Keyword><Keyword MajorTopicYN="Y">conference</Keyword><Keyword MajorTopicYN="Y">open science</Keyword><Keyword MajorTopicYN="Y">open source</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32025286</ArticleId><ArticleId IdType="doi">10.12688/f1000research.21568.1</ArticleId><ArticleId IdType="pmc">PMC6971845</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32011548</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1539-2570</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of pediatric orthopedics</Title><ISOAbbreviation>J Pediatr Orthop</ISOAbbreviation></Journal><ArticleTitle>Open Reduction of Neglected Supracondylar Humeral Fractures With Callus Formation in Children.</ArticleTitle><Pagination><MedlinePgn>e703-e707</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BPO.0000000000001518</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The standard treatment for supracondylar humeral fractures (SHFs) in children is closed reduction and percutaneous Kirschner (K)-wire fixation. In patients who present &gt;14 days after injury and show callus formation, this procedure cannot be performed. There are 2 options in these cases: functional exercises with osteotomy performed at a later stage if cubitus varus is present, or immediate open reduction and percutaneous K-wire fixation. This study aimed to evaluate the outcomes of K-wire fixation through an anterior approach in children with neglected SHF and identify factors predicting the outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study assessed the files of 32 children treated for neglected SHF at our hospital between June 2015 and May 2018. An incision was made along the anterior transverse groove of the elbow. The callus was removed, the fracture was reduced, and K-wire fixation was performed. The outcome evaluation included the radiological Baumann angle, pin fixation construct, carrying angles, and the functional outcome was Mayo Elbow Performance Score and Flynn criteria. Binary regression analysis compared the functional outcome as the dependent variable with age, time from injury to operation, operation time, and the amount of callus.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The interval between injury and operation was 14 to 40 days (average, 22.4 d). Patients were followed for 12 to 36 months (average, 21.5 mo). Fracture healing took 5 to 8 weeks (average, 6.6 wk). No patient had a vascular injury or compartment syndrome. Twelve patients were intraoperatively assessed for radial and median nerve injury. No nerve repair was required. All nerve injuries recovered within 3 months. No iatrogenic ulnar nerve injury occurred. One patient had an infected incision. Binary regression analysis showed that the time elapsed between injury and operation (P=0.033) and Gartland type (P=0.008) were inversely correlated with outcomes; the longer the duration, the poorer the outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The functional outcomes after open reduction and K-wire fixation through an anterior approach were poorer with longer time to surgery and Gartland type.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level III.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Meizhen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China International Science and Technology Cooperation Base of Child Development and Critical Disorders, The Children's Hospital of Chongqing Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Department, Maternal and Child Health Care Hospital of Chongqing Yubei District, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China International Science and Technology Cooperation Base of Child Development and Critical Disorders, The Children's Hospital of Chongqing Medical University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Orthop</MedlineTA><NlmUniqueID>8109053</NlmUniqueID><ISSNLinking>0271-6798</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001864" MajorTopicYN="N">Bone Wires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004551" MajorTopicYN="N">Elbow Joint</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017102" MajorTopicYN="N">Fracture Healing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006810" MajorTopicYN="N">Humeral Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070799" MajorTopicYN="N">Open Fracture Reduction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32011548</ArticleId><ArticleId IdType="doi">10.1097/BPO.0000000000001518</ArticleId><ArticleId IdType="pii">01241398-202009000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Farnsworth CL, Silva PD, Mubarak SJ. Etiology of supracondylar humerus fractures. J Pediatr Orthop. 1998;18:38–42.</Citation></Reference><Reference><Citation>Omid R, Choi PD, Skaggs DL. Supracondylar humeral fractures in children. J Bone Joint Surg Am. 2008;90:1121–1132.</Citation></Reference><Reference><Citation>Schmale GA, Mazor S, Mercer LD, et al. Lack of benefit of physical therapy on function following supracondylar humeral fracture: a randomized controlled trial. J Bone Joint Surg Am. 2014;96:944–950.</Citation></Reference><Reference><Citation>Peiró A, Andres F, Fernandez-Esteve F. Acute Monteggia lesions in children. J Bone Joint Surg Am. 1977;59:92–97.</Citation></Reference><Reference><Citation>Su Y, Nan G. Evaluation of a better approach for open reduction of severe Gartland type III supracondylar humeral fracture. J Invest Surg. 2019;12:1–7.</Citation></Reference><Reference><Citation>Flynn JC, Matthews JG, Benoit RL. Blind pinning of displaced supracondylar fractures of the humerus in children. Sixteen years’ experience with long-term follow-up. J Bone Joint Surg Am. 1974;56:263–272.</Citation></Reference><Reference><Citation>Broberg MA, Morrey BF. Results of delayed excision of the radial head after fracture. J Bone Joint Surg Am. 1986;68:669–674.</Citation></Reference><Reference><Citation>Iyengar SR, Hoffinger SA, Townsend DR. Early versus delayed reduction and pinning of type III displaced supracondylar fractures of the humerus in children: a comparative study. J Orthop Trauma. 1999;13:51–55.</Citation></Reference><Reference><Citation>Donnelly M, Green C, Kelly IP. An inconvenient truth: treatment of displaced paediatric supracondylar humeral fractures. Surgeon. 2012;10:143–147.</Citation></Reference><Reference><Citation>Kim TJ, Sponseller PD. Pediatric supracondylar humerus fractures. J Hand Surg Am. 2014;39:2308–2311; quiz 2311.</Citation></Reference><Reference><Citation>Gartland JJ. Management of supracondylar fractures of the humerus in children. Surg Gynecol Obstet. 1959;109:145–154.</Citation></Reference><Reference><Citation>Cashman JP, Guerin SM, Hemsing M, et al. Effect of deferred treatment of supracondylar humeral fractures. Surgeon. 2010;8:71–73.</Citation></Reference><Reference><Citation>Mehlman CT, Strub WM, Roy DR, et al. The effect of surgical timing on the perioperative complications of treatment of supracondylar humeral fractures in children. J Bone Joint Surg Am. 2001;83:323–327.</Citation></Reference><Reference><Citation>Murnaghan ML, Slobogean BL, Byrne A, et al. The effect of surgical timing on operative duration and quality of reduction in Type III supracondylar humeral fractures in children. J Child Orthop. 2010;4:153–158.</Citation></Reference><Reference><Citation>Sibinski M, Sharma H, Bennet GC. Early versus delayed treatment of extension type-3 supracondylar fractures of the humerus in children. J Bone Joint Surg Br. 2006;88:380–381.</Citation></Reference><Reference><Citation>Ramachandran M, Skaggs DL, Crawford HA, et al. Delaying treatment of supracondylar fractures in children: has the pendulum swung too far. J Bone Joint Surg Br. 2008;90:1228–1233.</Citation></Reference><Reference><Citation>Silva M, Wong TC, Bernthal NM. Outcomes of reduction more than 7 days after injury in supracondylar humeral fractures in children. J Pediatr Orthop. 2011;31:751–756.</Citation></Reference><Reference><Citation>Rizk AS. Triceps-sparing approach for open reduction and internal fixation of neglected displaced supracondylar and distal humeral fractures in children. J Orthop Traumatol. 2015;16:105–116.</Citation></Reference><Reference><Citation>Koudstaal MJ, De Ridder VA, De Lange S, et al. Pediatric supracondylar humerus fractures: the anterior approach. J Orthop Trauma. 2002;16:409–412.</Citation></Reference><Reference><Citation>Louahem D, Cottalorda J. Acute ischemia and pink pulseless hand in 68 of 404 gartland type III supracondylar humeral fractures in children: urgent management and therapeutic consensus. Injury. 2016;47:848–852.</Citation></Reference><Reference><Citation>Bashyal RK, Chu JY, Schoenecker PL, et al. Complications after pinning of supracondylar distal humerus fractures. J Pediatr Orthop. 2009;29:704–708.</Citation></Reference><Reference><Citation>Liem IS, Kolling C, Marks M, et al. Development of a score set to measure function and quality of life in patients suffering from elbow pathology. Arch Orthop Trauma Surg. 2012;132:831–837.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31985514</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-5159</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>04</Month></PubDate></JournalIssue><Title>Health physics</Title><ISOAbbreviation>Health Phys</ISOAbbreviation></Journal><ArticleTitle>A Mixed-methods Approach for Improving Radiation Safety Culture in Open-source University Laboratories.</ArticleTitle><Pagination><MedlinePgn>427-437</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/HP.0000000000001147</ELocationID><Abstract><AbstractText>The radiation safety culture of those working in university open-source radioactive material laboratories was assessed by conducting both surveys and behavioral observations. Baseline results (n = 82, 89% response rate) of assessed safety culture categories indicated safety practices and safety compliance were the most in need of improvement. Specific training based on these results was provided to laboratory members at Princeton University, with creative signage and a safety newsletter posted in and around laboratories for reinforcement, in a targeted effort to improve the radiation safety culture. Signage posted utilized pop cultural memes and other engaging graphics designed to raise awareness of appropriate safety practices and the minimum laboratory attire expected while working in radioactive material laboratories. Postintervention results (n = 38, 43% response rate) indicated improvement in 4 out of the 10 safety culture indicators considered as well as fewer instances of improper safety practices. Collaborative techniques and increased communication between researchers and radiation safety staff appear to have initiated an improvement in the radiation safety culture in open-source radioactive material laboratories at Princeton University.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Root</LastName><ForeName>Caitlin M</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>DeVol</LastName><ForeName>Timothy A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Robert R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Psychology, Clemson University, Clemson, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Nicole E</ForeName><Initials>NE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Health Phys</MedlineTA><NlmUniqueID>2985093R</NlmUniqueID><ISSNLinking>0017-9078</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007753" MajorTopicYN="Y">Laboratories</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011835" MajorTopicYN="Y">Radiation Protection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017751" MajorTopicYN="N">Safety Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014495" MajorTopicYN="Y">Universities</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31985514</ArticleId><ArticleId IdType="doi">10.1097/HP.0000000000001147</ArticleId><ArticleId IdType="pii">00004032-202004000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Chemical Society. Identifying and evaluating hazards in research laboratories [online]. 2015. Available at https://www.acs.org/content/dam/acsorg/about/governance/committees/chemicalsafety/publications/identifying-and-evaluating-hazards-in-research-laboratories.pdf. Accessed 10 January 2019.</Citation></Reference><Reference><Citation>American National Standards Institute/American Society of Safety Engineers. Occupational and educational eye and face personal protection devices. Park Ridge, IL: ASSE; ANSI Z87.1; 2003.</Citation></Reference><Reference><Citation>Cooper MD. Towards a model of safety culture. Safety Sci 36:111–136; 2000.</Citation></Reference><Reference><Citation>DeJoy DM, Schaffer BS, Wilson MG, Vandenberg RJ, Butts MM. Creating safer workplaces: assessing the determinants and role of safety climate. J Safety Res 35:81–90; 2004.</Citation></Reference><Reference><Citation>Griffin MA, Neal A. Perceptions of safety at work: a framework for linking safety climate to safety performance, knowledge, and motivation. J Occu Health Psychol 5:347–358; 2000.</Citation></Reference><Reference><Citation>Guldenmund FW. The nature of safety culture: a review of theory and research. Safety Sci 34:215–257; 2000.</Citation></Reference><Reference><Citation>Hudson P. Safety management and safety culture: the long, hard and winding road. In: Pearse W, Gallagher C, Bluff L, eds. Occupational health and safety mangement systems: proceedings of the first national conference. Melbourne, Australia: Crown Content; 2000: 3–31.</Citation></Reference><Reference><Citation>Keiser NL, Payne SC. Safety climate measurement: an empirical test of context-specific vs. general assessments. J Business Psychol 33:479–494; 2018.</Citation></Reference><Reference><Citation>Likert R. A technique for the measurement of attitudes. Arch Psychol 140:5–55; 1932.</Citation></Reference><Reference><Citation>Neal A, Griffin MA. A study of the lagged relationships among safety climate, safety motivation, safety behavior, and accidents at the individual and group levels. J Applied Psychol 91:946–953; 2006.</Citation></Reference><Reference><Citation>Occupational Safety and Health Administration. Occupational safety and health standards: eye and face protection. Washington, DC: US Department of Labor; 29 CFR Part 1910.133; 2016.</Citation></Reference><Reference><Citation>Ott L, Longnecker M. An introduction to statistical methods and data analysis. Boston, MA: Cengage Learning; 2016.</Citation></Reference><Reference><Citation>Probst TM, Estrada AX. Accident under-reporting among employees: testing the moderating influence of psychological safety climate and supervisor enforcement of safety practices. Accident Analysis Prevent 42:1438–1444; 2010.</Citation></Reference><Reference><Citation>Root C. A mixed methods approach for improving the radiation safety climate at Princeton University. Clemson, SC: Clemson University; 2019. Thesis.</Citation></Reference><Reference><Citation>Van Noorden R. Safety survey reveals lab risks. Nature 493:9–10; 2013.</Citation></Reference><Reference><Citation>Welch BL. The significance of the difference between two means when the population variances are unequal. Biometrika 29:350–362; 1938.</Citation></Reference><Reference><Citation>Welch BL. The generalization of students problem when several different population variances are involved. Biometrika 34:28–35; 1947.</Citation></Reference><Reference><Citation>Zalk DM, Kamerzell R, Paik S, Kapp J, Harrington D, Swuste P. Risk level based management system: a control banding model for occupational health and safety risk management in a highly regulated environment. Industrial Health 48:18–28; 2010.</Citation></Reference><Reference><Citation>Zittrain JL. Reflections on internet culture. J Visual Culture 13:388–394; 2014.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">31980469</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2515-4478</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>12</Month></PubDate></JournalIssue><Title>BMJ evidence-based medicine</Title><ISOAbbreviation>BMJ Evid Based Med</ISOAbbreviation></Journal><ArticleTitle>Limited engagement with transparent and open science standards in the policies of pain journals: a cross-sectional evaluation.</ArticleTitle><Pagination><MedlinePgn>313-319</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjebm-2019-111296</ELocationID><Abstract><AbstractText>Scientific progress requires transparency and openness. The ability to critique, replicate and implement scientific findings depends on the transparency of the study design and methods, and the open availability of study materials, data and code. Journals are key stakeholders in supporting transparency and openness. This study aimed to evaluate 10 highest ranked pain journals' authorship policies with respect to their support for transparent and open research practices. Two independent authors evaluated the journal policies (as at 27 May 2019) using three tools: the self-developed Transparency and Openness Evaluation Tool, the Centre for Open Science (COS) Transparency Factor and the International Committee of Medical Journal Editors (ICMJE) requirements for disclosure of conflicts of interest. We found that the journal policies had an overall low level of engagement with research transparency and openness standards. The median COS Transparency Factor score was 3.5 (IQR 2.8) of 29 possible points, and only 7 of 10 journals' stated requirements for disclosure of conflicts of interest aligned fully with the ICMJE recommendations. Improved transparency and openness of pain research has the potential to benefit all that are involved in generating and using research findings. Journal policies that endorse and facilitate transparent and open research practices will ultimately improve the evidence base that informs the care provided for people with pain.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cashin</LastName><ForeName>Aidan G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0003-4190-7912</Identifier><AffiliationInfo><Affiliation>Prince of Wales Clinical School, University of New South Wales Faculty of Medicine, Randwick, New South Wales, Australia a.cashin@neura.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Pain IMPACT, Neuroscience Research Australia, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagg</LastName><ForeName>Matthew K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-4812-3814</Identifier><AffiliationInfo><Affiliation>Prince of Wales Clinical School, University of New South Wales Faculty of Medicine, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Pain IMPACT, Neuroscience Research Australia, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Georgia C</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0003-0244-5620</Identifier><AffiliationInfo><Affiliation>Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toomey</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5941-0838</Identifier><AffiliationInfo><Affiliation>Health Behaviour Change Research Group, School of Psychology, National University of Ireland Galway, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>James H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Centre for Pain IMPACT, Neuroscience Research Australia, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, Faculty of Medicine, University of New South Wales, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hopin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5692-0314</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine &amp; Rehabilitation Research in Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, Oxfordshire, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Evid Based Med</MedlineTA><NlmUniqueID>101719009</NlmUniqueID><ISSNLinking>2515-446X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001319" MajorTopicYN="N">Authorship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010506" MajorTopicYN="Y">Periodicals as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057766" MajorTopicYN="N">Policy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">pain management</Keyword><Keyword MajorTopicYN="Y">statistics &amp; research methods</Keyword></KeywordList><CoiStatement>Competing interests: AGC is supported by the University of New South Wales Prince of Wales Clinical School Postgraduate Research Scholarship and a NeuRA PhD Candidature Supplementary Scholarship. AGC is a Catalyst for the Berkeley Initiative for Transparency in the Social Sciences and received travel support from Memorial University of Newfoundland to speak about engagement with research. MKB is supported by a NeuRA PhD Candidature Scholarship and Supplementary Scholarship. MKB is an ambassador for the Centre for Open Science and received travel support from the Chiropractor’s Association of Australia to speak about an unrelated topic and Memorial University of Newfoundland to speak about engagement with research. GCR receives funding from the NHS National Institute of Health Research (NIHR) School for Primary Care Research (SPCR), the Naji Foundation and the Rotary Foundation to study for a Doctor of Philosophy (DPhil) at the University of Oxford. ET is funded by the Health Research Board of Ireland Interdisciplinary Capacity Enhancement (ICE) awards (ICE-2015-1026) and is a Catalyst for the Berkeley Initiative for Transparency in the Social Sciences. HL is funded by the National Health and Medical Research Council (grant no. APP1126767); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust; received project funding from the Berkeley Initiative for Transparency in the Social Sciences, a program of the Center for Effective Global Action (CEGA), with support from the Laura and John Arnold Foundation; and is a Catalyst for the Berkeley Initiative for Transparency in the Social Sciences.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31980469</ArticleId><ArticleId IdType="pii">bmjebm-2019-111296</ArticleId><ArticleId IdType="doi">10.1136/bmjebm-2019-111296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31976450</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2520-8977</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Perspectives on behavior science</Title><ISOAbbreviation>Perspect Behav Sci</ISOAbbreviation></Journal><ArticleTitle>Furthering Open Science in Behavior Analysis: An Introduction and Tutorial for Using GitHub in Research.</ArticleTitle><Pagination><MedlinePgn>565-581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40614-019-00202-5</ELocationID><Abstract><AbstractText>Open and transparent practices in scholarly research are increasingly encouraged by academic journals and funding agencies. Various elements of behavior analytic research are communicated transparently, though it is not common practice to archive study materials to support future replications. This tutorial presents a review of the Transparent and Open Practices guidelines provided by the Open Science Foundation and provides instructions on how behavior analysts can use GitHub transparency in research across multiple levels. GitHub is presented as a service that can be used to publicly archive various elements of research and is uniquely suited to research that is technical, data driven, and collaborative. The GitHub platform is reviewed, and the steps necessary to create an account, initialize repositories, archive study files, and synchronize changes to remote repositories are described in several examples. Implications of increased calls for transparency and modern statistical methods are discussed with regard to behavior analysis, and archiving platforms such as GitHub are reviewed as one means of supporting transparent research.</AbstractText><CopyrightInformation>© Association for Behavior Analysis International 2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gilroy</LastName><ForeName>Shawn P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0002-1097-8366</Identifier><AffiliationInfo><Affiliation>1Louisiana State University, 226 Audubon Hall, Baton Rouge, LA 70802 USA.</Affiliation><Identifier Source="GRID">grid.64337.35</Identifier><Identifier Source="ISNI">0000 0001 0662 7451</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Brent A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>2Fralin Biomedical Research Institute at VTC, Virginia Polytechnic Institute and State University, Blacksburg, VA USA.</Affiliation><Identifier Source="GRID">grid.438526.e</Identifier><Identifier Source="ISNI">0000 0001 0694 4940</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Perspect Behav Sci</MedlineTA><NlmUniqueID>101743058</NlmUniqueID><ISSNLinking>2520-8969</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31976450</ArticleId><ArticleId IdType="doi">10.1007/s40614-019-00202-5</ArticleId><ArticleId IdType="pii">202</ArticleId><ArticleId IdType="pmc">PMC6768926</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2011;6(6):e21101</Citation><ArticleIdList><ArticleId IdType="pubmed">21738610</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):657-60</Citation><ArticleIdList><ArticleId IdType="pubmed">26168127</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2016 Dec;48(4):1205-1226</Citation><ArticleIdList><ArticleId IdType="pubmed">26497820</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Clin Psychopharmacol. 2019 Dec;27(6):588-597</Citation><ArticleIdList><ArticleId IdType="pubmed">30920256</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Behav Anal. 2016 Sep;49(3):656-73</Citation><ArticleIdList><ArticleId IdType="pubmed">27174301</ArticleId></ArticleIdList></Reference><Reference><Citation>J Learn Disabil. 1993 Dec;26(10):642-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8151203</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Anal Behav. 2018 Nov;110(3):553-568</Citation><ArticleIdList><ArticleId IdType="pubmed">30328109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Behav Anal. 2017 Jan;50(1):3-7</Citation><ArticleIdList><ArticleId IdType="pubmed">28083903</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):615-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26168121</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference><Reference><Citation>J Sch Psychol. 2014 Apr;52(2):243-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24606979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Anal Behav. 2018 Mar;109(2):433-449</Citation><ArticleIdList><ArticleId IdType="pubmed">29498424</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Methods. 2012 Dec;17(4):510-50</Citation><ArticleIdList><ArticleId IdType="pubmed">22845874</ArticleId></ArticleIdList></Reference><Reference><Citation>Autism Res. 2018 Dec;11(12):1701-1711</Citation><ArticleIdList><ArticleId IdType="pubmed">30475454</ArticleId></ArticleIdList></Reference><Reference><Citation>J Soc Psychol. 2018;158(1):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">29227737</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Anal. 2015 Jul 25;38(2):203-18</Citation><ArticleIdList><ArticleId IdType="pubmed">27606171</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Anal Behav. 2017 May;107(3):388-401</Citation><ArticleIdList><ArticleId IdType="pubmed">28467023</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2017 Jul;12(4):660-664</Citation><ArticleIdList><ArticleId IdType="pubmed">28727961</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2012 May 1;23(5):524-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22508865</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Anal. 1999 Fall;22(2):117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22478329</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 26;348(6242):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26113702</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Behav Anal. 2014 Fall;47(3):663-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24990802</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Sep 22;375(12):1112-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27653562</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31952211</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Open Data for Differential Network Analysis in Glioma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E547</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21020547</ELocationID><Abstract><AbstractText>The complexity of cancer diseases demands bioinformatic techniques and translational research based on big data and personalized medicine. Open data enables researchers to accelerate cancer studies, save resources and foster collaboration. Several tools and programming approaches are available for analyzing data, including annotation, clustering, comparison and extrapolation, merging, enrichment, functional association and statistics. We exploit openly available data via cancer gene expression analysis, we apply refinement as well as enrichment analysis via gene ontology and conclude with graph-based visualization of involved protein interaction networks as a basis for signaling. The different databases allowed for the construction of huge networks or specified ones consisting of high-confidence interactions only. Several genes associated to glioma were isolated via a network analysis from top hub nodes as well as from an outlier analysis. The latter approach highlights a mitogen-activated protein kinase next to a member of histondeacetylases and a protein phosphatase as genes uncommonly associated with glioma. Cluster analysis from top hub nodes lists several identified glioma-associated gene products to function within protein complexes, including epidermal growth factors as well as cell cycle proteins or RAS proto-oncogenes. By using selected exemplary tools and open-access resources for cancer research and differential network analysis, we highlight disturbed signaling components in brain cancer subtypes of glioma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jean-Quartier</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0840-2173</Identifier><AffiliationInfo><Affiliation>Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeanquartier</LastName><ForeName>Fleur</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8607-9255</Identifier><AffiliationInfo><Affiliation>Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holzinger</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6786-5194</Identifier><AffiliationInfo><Affiliation>Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="Y">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="N">Glioma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">astrocytoma</Keyword><Keyword MajorTopicYN="N">biological data integration</Keyword><Keyword MajorTopicYN="N">cancer research</Keyword><Keyword MajorTopicYN="N">differential gene expression</Keyword><Keyword MajorTopicYN="N">differential network analysis</Keyword><Keyword MajorTopicYN="N">glioblastoma multiforme</Keyword><Keyword MajorTopicYN="N">glioma</Keyword><Keyword MajorTopicYN="N">graph-based analysis</Keyword><Keyword MajorTopicYN="N">open data</Keyword><Keyword MajorTopicYN="N">protein-protein interaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31952211</ArticleId><ArticleId IdType="pii">ijms21020547</ArticleId><ArticleId IdType="doi">10.3390/ijms21020547</ArticleId><ArticleId IdType="pmc">PMC7013918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109</Citation><ArticleIdList><ArticleId IdType="pubmed">30371825</ArticleId></ArticleIdList></Reference><Reference><Citation>Signal Transduct Target Ther. 2017 Sep 29;2:17040</Citation><ArticleIdList><ArticleId IdType="pubmed">29263927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19880382</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecules. 2019 Mar 09;24(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">30857299</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Androl Urol. 2019 Mar;8(Suppl 1):S64-S77</Citation><ArticleIdList><ArticleId IdType="pubmed">31143673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Jul;47(7):692-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26111507</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 Jun 16;16:195</Citation><ArticleIdList><ArticleId IdType="pubmed">26077899</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogenesis. 2014 Jun 30;3:e108</Citation><ArticleIdList><ArticleId IdType="pubmed">24979279</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Syst Biol. 2012 Mar 10;6:15</Citation><ArticleIdList><ArticleId IdType="pubmed">22405054</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2013;9(9):e1003806</Citation><ArticleIdList><ArticleId IdType="pubmed">24068970</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Med. 2018 Oct 13;7(10):</Citation><ArticleIdList><ArticleId IdType="pubmed">30322114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2009 Dec;22(12):1600-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19767728</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE/ACM Trans Comput Biol Bioinform. 2015 Jul-Aug;12(4):815-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26357321</ArticleId></ArticleIdList></Reference><Reference><Citation>BioData Min. 2014 Aug 31;7:18</Citation><ArticleIdList><ArticleId IdType="pubmed">25228922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Jan 15;25(2):288-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19033274</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2011 Dec;9(12):e1001195</Citation><ArticleIdList><ArticleId IdType="pubmed">22162946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2019 Jan 14;9(1):96</Citation><ArticleIdList><ArticleId IdType="pubmed">30643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2010 Jan 19;17(1):98-110</Citation><ArticleIdList><ArticleId IdType="pubmed">20129251</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cancer Res. 2015 Feb 15;5(3):945-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26045979</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2019 Feb;24(2):656-664</Citation><ArticleIdList><ArticleId IdType="pubmed">30315890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med Rep. 2017 Nov;16(5):6580-6589</Citation><ArticleIdList><ArticleId IdType="pubmed">28901452</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2010 Dec;1(8):700-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21321379</ArticleId></ArticleIdList></Reference><Reference><Citation>Anticancer Res. 2016 Sep;36(9):4607-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27630302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Apr 3;8(1):5499</Citation><ArticleIdList><ArticleId IdType="pubmed">29615773</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D711-D715</Citation><ArticleIdList><ArticleId IdType="pubmed">30357387</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2018 Jan 1;132:34-41</Citation><ArticleIdList><ArticleId IdType="pubmed">28684340</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2013 Feb 15;19(4):764-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23209033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Clin Oncol. 2019 Aug;16(8):509-520</Citation><ArticleIdList><ArticleId IdType="pubmed">30733593</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Mar 18;9(5):471-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22426491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137</Citation><ArticleIdList><ArticleId IdType="pubmed">28472511</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D69-D73</Citation><ArticleIdList><ArticleId IdType="pubmed">30357349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198</Citation><ArticleIdList><ArticleId IdType="pubmed">31066453</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2018 Sep 23;10(10):</Citation><ArticleIdList><ArticleId IdType="pubmed">30249048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonsei Med J. 2013 Jan 1;54(1):92-100</Citation><ArticleIdList><ArticleId IdType="pubmed">23225804</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2014 Feb 6;123(6):894-904</Citation><ArticleIdList><ArticleId IdType="pubmed">24363398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515</Citation><ArticleIdList><ArticleId IdType="pubmed">30395287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W514-W522</Citation><ArticleIdList><ArticleId IdType="pubmed">29878180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2015 Jun;10(6):823-44</Citation><ArticleIdList><ArticleId IdType="pubmed">25950236</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2722-2730</Citation><ArticleIdList><ArticleId IdType="pubmed">31203421</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2007 May;170(5):1445-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17456751</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2014 Aug 19;588(16):2558-70</Citation><ArticleIdList><ArticleId IdType="pubmed">24561200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Commun Signal. 2017 Dec 19;15(1):54</Citation><ArticleIdList><ArticleId IdType="pubmed">29258522</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2017 Jan 27;17(2):93-115</Citation><ArticleIdList><ArticleId IdType="pubmed">28127048</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancers (Basel). 2011 Aug 10;3(3):3242-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24212955</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2017 May 18;13(5):e1005457</Citation><ArticleIdList><ArticleId IdType="pubmed">28545146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Dec 15;25(24):3327-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19837718</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D529-D541</Citation><ArticleIdList><ArticleId IdType="pubmed">30476227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2000;15(1):57-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10612823</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Aug 15;21(16):3448-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15972284</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2019 Jan 28;20(1):54</Citation><ArticleIdList><ArticleId IdType="pubmed">30691411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cancer. 2015 Jul 15;6(9):812-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26284131</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2014;2014:439476</Citation><ArticleIdList><ArticleId IdType="pubmed">24800226</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 1998 Sep 24;8(19):R687-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9768354</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426</Citation><ArticleIdList><ArticleId IdType="pubmed">30407594</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338</Citation><ArticleIdList><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cells. 2019 Aug 09;8(8):</Citation><ArticleIdList><ArticleId IdType="pubmed">31405017</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2003 Jan 13;4:2</Citation><ArticleIdList><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunotargets Ther. 2015 May 28;4:111-22</Citation><ArticleIdList><ArticleId IdType="pubmed">27471717</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2011;696:291-303</Citation><ArticleIdList><ArticleId IdType="pubmed">21063955</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 1997 Aug 1;57(15):3272-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9242460</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Bioinformatics. 2017 Dec 8;60:8.2.1-8.2.14</Citation><ArticleIdList><ArticleId IdType="pubmed">29220074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83</Citation><ArticleIdList><ArticleId IdType="pubmed">31665515</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Oncol. 2015 Apr;17(4):555-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25304134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D746-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26481351</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2018 Apr 12;18(1):408</Citation><ArticleIdList><ArticleId IdType="pubmed">29649981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2018 Apr 5;173(2):321-337.e10</Citation><ArticleIdList><ArticleId IdType="pubmed">29625050</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Nov 30;8(69):114371-114392</Citation><ArticleIdList><ArticleId IdType="pubmed">29371993</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D972-D978</Citation><ArticleIdList><ArticleId IdType="pubmed">27651457</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res. 2019 Jan 22;21(1):10</Citation><ArticleIdList><ArticleId IdType="pubmed">30670058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Aug 15;23(16):2198-200</Citation><ArticleIdList><ArticleId IdType="pubmed">17545183</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2020;2074:125-134</Citation><ArticleIdList><ArticleId IdType="pubmed">31583635</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2019 Mar 15;20(1):144</Citation><ArticleIdList><ArticleId IdType="pubmed">30876387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2019 Jan 1;35(1):62-68</Citation><ArticleIdList><ArticleId IdType="pubmed">30561551</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2006 Sep;7(3):243-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16880171</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Oct 27;5(10):e13696</Citation><ArticleIdList><ArticleId IdType="pubmed">21060876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D975-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24297256</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2011 Jul 23;2011:bar030</Citation><ArticleIdList><ArticleId IdType="pubmed">21785142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31948880</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Longitudinal clinical outcomes after full-endoscopic lumbar discectomy for recurrent disc herniation after open discectomy.</ArticleTitle><Pagination><MedlinePgn>124-129</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0967-5868(19)31808-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2019.12.047</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Full-endoscopic lumbar discectomy (FELD) is a minimally invasive surgical option for recurrent lumbar disc herniation (LDH). Nonetheless, patients' clinical outcomes may be poorer after surgery for recurrent LDH than for primary LDH. Therefore, we compared patients' longitudinal clinical outcomes after FELD for recurrent LDH or primary LDH.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The medical records of patients who underwent FELD for primary LDH (group A) or recurrent LDH (group B) were retrospectively reviewed. The inclusion criteria were: 1) single-level LDH or recurrent LDH at L4-5 or L5-S1, 2) age ≤60 years, 3) previous open discectomy (group B), and 4) ≥6 months of follow-up. In total, 244 patients (group A, 211; group B, 33) were included. Clinical outcomes (Oswestry Disability Index [ODI]; visual analogue pain score for the back and leg [VAS-B] and [VAS-L]) over 24 months of follow-up were compared between groups with a linear mixed-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All clinical outcomes significantly improved from pre-operation to 3 months postoperatively (p &lt; 0.01), and the improvement was maintained for 24 months postoperatively in both groups. The clinical outcomes of groups A and B were not significantly different during 24 months follow-up (ODI, p = 0.94; VAS-B, p = 0.11; and VAS-L, p = 0.48). The reoperation rate was 3.3% in group A and 3.0% in group B, but the overall complication rate was higher in group B (9.8%) than in group A (6.6%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The longitudinal clinical outcomes after FELD for recurrent LDH may not be poor as feared. However, the higher complication rate in patients undergoing FELD for recurrent LDH should be noted.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yunhee</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chi Heon</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Clinical Research Institute, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Orthopaedic Surgery and Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: chiheon1@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery and Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Calvin C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Regional Spine Surgery Department, Kaiser Permanente, 3600 Broadway, Suite 15, Oakland, CA 94611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Urim</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Human Brain Function Laboratory, Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sung Bae</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Clinical Research Institute, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Boramae Hospital, Borame Medical Center 20, Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chang-Hyun</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Clinical Research Institute, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Seung Heon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Clinical Research Institute, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyoung-Tae</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, South Korea; Department of Neurosurgery, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chun Kee</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Clinical Research Institute, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Human Brain Function Laboratory, Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-Ro, Jongno-gu, Seoul 03080, South Korea; Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017586" MajorTopicYN="N">Diskectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007405" MajorTopicYN="N">Intervertebral Disc Displacement</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endoscopic discectomy</Keyword><Keyword MajorTopicYN="N">Lumbar vertebrae</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Recurrence</Keyword><Keyword MajorTopicYN="N">Spine</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Treatment outcome</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest A grant from the Korea Health Technology R&amp;D Project supported this work through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health &amp; Welfare, Republic of Korea (HC15C1320). Grant No. 0320160210 (2016-1062) from the Seoul National University Hospital supported this study. This research was partially supported by Korean Spinal Neurosurgery Society. The first author (CHK) is a consultant of RIWOspine GmbH. The other authors declare that they have no conflicts of interest concerning the materials/methods used in this study or the findings described in this paper. The institutional review board at the Seoul National University Hospital approved this study (H-1611-015-803).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31948880</ArticleId><ArticleId IdType="pii">S0967-5868(19)31808-9</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2019.12.047</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31945300</PMID><DateRevised><Year>2022</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>201</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial.</ArticleTitle><Pagination><MedlinePgn>1416-1424</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201910-1960OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> High-dose isoniazid is recommended in short-course regimens for multidrug-resistant tuberculosis (TB). The optimal dose of isoniazid and its individual contribution to efficacy against TB strains with <i>inhA</i> or <i>katG</i> mutations are unknown.<b>Objectives:</b> To define the optimal dose of isoniazid for patients with isoniazid-resistant TB mediated by <i>inhA</i> mutations.<b>Methods:</b> AIDS Clinical Trials Group A5312 is a phase 2A, open-label trial in which individuals with smear-positive pulmonary TB with isoniazid resistance mediated by an <i>inhA</i> mutation were randomized to receive isoniazid 5, 10, or 15 mg/kg daily for 7 days (inhA group), and control subjects with drug-sensitive TB received the standard dose (5 mg/kg/d). Overnight sputum cultures were collected daily. The 7-day early bactericidal activity (EBA) of isoniazid was estimated as the average daily change in log<sub>10</sub> cfu on solid media (EBA<sub>cfu0-7</sub>) or as time to positivity (TTP) in liquid media in hours (EBA<sub>TTP0-7</sub>) using nonlinear mixed-effects models.<b>Measurements and Main Results:</b> Fifty-nine participants (88% with cavitary disease, 20% HIV-positive, 16 with isoniazid-sensitive TB, and 43 with isoniazid-monoresistant or multidrug-resistant TB) were enrolled at one site in South Africa. The mean EBA<sub>cfu0-7</sub> at doses of 5, 10, and 15 mg/kg in the inhA group was 0.07, 0.17, and 0.22 log<sub>10</sub> cfu/ml/d, respectively, and 0.16 log<sub>10</sub> cfu/ml/d in control subjects. EBA<sub>TTP0-7</sub> patterns were similar. There were no drug-related grade ≥3 adverse events.<b>Conclusions:</b> Isoniazid 10-15 mg/kg daily had activity against TB strains with <i>inhA</i> mutations similar to that of 5 mg/kg against drug-sensitive strains. The activity of high-dose isoniazid against strains with <i>katG</i> mutations will be explored next.Clinical trial registered with www.clinicaltrials.gov (NCT01936831).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dooley</LastName><ForeName>Kelly E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0001-9013-5256</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyahara</LastName><ForeName>Sachiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Groote-Bidlingmaier</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>TASK Applied Science and Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafner</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenkranz</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Harvard T. H. Chan School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Frontier Science and Technology Research Foundation, Amherst, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ignatius</LastName><ForeName>Elisa H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuermberger</LastName><ForeName>Eric L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Social &amp; Scientific Systems, Inc., Silver Spring, Maryland; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donahue</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Frontier Science and Technology Research Foundation, Amherst, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swindells</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanker</LastName><ForeName>Naadira</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>TASK Applied Science and Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diacon</LastName><ForeName>Andreas H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>TASK Applied Science and Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>A5312 Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01936831</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UM1 AI068634</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI068636</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI106701</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM066691</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Jun 1;201(11):1331-1333</RefSource><PMID Version="1">32078783</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Jun 15;201(12):1578-1579</RefSource><PMID Version="1">32130864</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Jun 15;201(12):1579-1580</RefSource><PMID Version="1">32130866</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2021 Mar 1;203(5):635-637</RefSource><PMID Version="1">33080154</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">early bactericidal activity</Keyword><Keyword MajorTopicYN="N">inhA mutation</Keyword><Keyword MajorTopicYN="N">isoniazid resistance</Keyword><Keyword MajorTopicYN="N">phase 2 clinical trial</Keyword><Keyword MajorTopicYN="N">tuberculosis</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Issa</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lojacono</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahachi</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murtaugh</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Purdue</LastName><ForeName>Lynette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shahkolahi</LastName><ForeName>Akbar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ssenyonga</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31945300</ArticleId><ArticleId IdType="doi">10.1164/rccm.201910-1960OC</ArticleId><ArticleId IdType="pmc">PMC7258626</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31933287</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1178-2595</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Pharmaceutical medicine</Title><ISOAbbreviation>Pharmaceut Med</ISOAbbreviation></Journal><ArticleTitle>Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.</ArticleTitle><Pagination><MedlinePgn>193-198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40290-019-00280-5</ELocationID><Abstract><AbstractText>The value of innovation in medicines is clear. Despite all of the progress in the twenty-first century, there are still many unmet medical needs and opportunities to improve healthcare. The challenges for pharmaceutical companies include ways in which to stay competitive and flexible in an environment of constant knowledge growth and increasingly sophisticated technologies, and ways to generate sufficient revenues to sustain their own growth. To that end, pharmaceutical companies are compelled to adapt different business models in the face of new challenges. The industry is plagued with long research and development (R&amp;D) cycles and low success rates for innovative treatments; something has to change. The need to collaborate externally across the process of discovery, development, manufacturing and commercialization is a must. Furthermore, collaborations have increased in frequency and scope, expanding the opportunities to access global scientific talent in academia, research institutes and biotechnology companies. Despite the perception that pharma companies are 'closed' or tightly controlled industries, open innovation is already well established in the pharmaceutical sector and used to supplement R&amp;D in the process of bringing new medicines for patients faster, and at a lower cost. Over the years, each pharma company has tailored the open-innovation concept to develop its own model based on particular needs and offerings. Independently of the model, the creation of successful partnerships in external innovation requires reaching out and connecting beyond the traditional organizational boundaries. Substantial internal cultural changes are required to implement open-innovation strategies that should co-exist without competing with the traditional ways of operating. Major changes bring challenges but create multiple opportunities for scientists and organizations. High-quality drug discovery requires continuous learning and an open way of thinking to adopt novel operational models and to implement efficient collaborations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez-Grau</LastName><ForeName>Maria Angeles</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvim-Gaston</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. alvim-gaston_maria@lilly.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Pharmaceut Med</MedlineTA><NlmUniqueID>101471195</NlmUniqueID><ISSNLinking>1178-2595</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31933287</ArticleId><ArticleId IdType="doi">10.1007/s40290-019-00280-5</ArticleId><ArticleId IdType="pii">10.1007/s40290-019-00280-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drug Discov Today. 2017 May;22(5):776-785</Citation><ArticleIdList><ArticleId IdType="pubmed">28137644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2009 May;15(5):502-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19424212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2010 Mar;9(3):203-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20168317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Jan;14(1):17-28</Citation><ArticleIdList><ArticleId IdType="pubmed">25503514</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Med Chem Lett. 2018 Jun 04;9(7):581-583</Citation><ArticleIdList><ArticleId IdType="pubmed">30034580</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2009 Jan;14(1-2):95-101</Citation><ArticleIdList><ArticleId IdType="pubmed">18992364</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2018 May 8;16(1):119</Citation><ArticleIdList><ArticleId IdType="pubmed">29739427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 11;533(7602):S54-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27167390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomol Screen. 2013 Dec;18(10):1143-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24080259</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2014 Aug;16(8):644-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25093570</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2016 May;21(5):779-88</Citation><ArticleIdList><ArticleId IdType="pubmed">26743597</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Sci Med. 2017 Oct;191:48-56</Citation><ArticleIdList><ArticleId IdType="pubmed">28889030</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomol Screen. 2011 Jul;16(6):588-602</Citation><ArticleIdList><ArticleId IdType="pubmed">21521801</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2010 Sep;2(9):1411-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21426136</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2013 Nov 27;6:e201303017</Citation><ArticleIdList><ArticleId IdType="pubmed">24688725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 May 9;373(9675):1645-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19427959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Metab. 2016 Sep 13;24(3):365-367</Citation><ArticleIdList><ArticleId IdType="pubmed">27626193</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2005 Sep;2(9):e302</Citation><ArticleIdList><ArticleId IdType="pubmed">16138789</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2015;7(14):1853-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26393392</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2013 Dec;18(23-24):1133-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23892183</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Med Chem. 2014;14(3):294-303</Citation><ArticleIdList><ArticleId IdType="pubmed">24283973</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2012 Oct;17(19-20):1088-102</Citation><ArticleIdList><ArticleId IdType="pubmed">22627006</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2018 Apr;23(4):771-775</Citation><ArticleIdList><ArticleId IdType="pubmed">29326079</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2015 Jul;20(7):874-83</Citation><ArticleIdList><ArticleId IdType="pubmed">25637169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Nov;31(11):979-85</Citation><ArticleIdList><ArticleId IdType="pubmed">24213770</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">31891233</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2486</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>01</Month></PubDate></JournalIssue><Title>Global change biology</Title><ISOAbbreviation>Glob Chang Biol</ISOAbbreviation></Journal><ArticleTitle>TRY plant trait database - enhanced coverage and open access.</ArticleTitle><Pagination><MedlinePgn>119-188</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/gcb.14904</ELocationID><Abstract><AbstractText>Plant traits-the morphological, anatomical, physiological, biochemical and phenological characteristics of plants-determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait-based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits-almost complete coverage for 'plant growth form'. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait-environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives.</AbstractText><CopyrightInformation>© 2019 The Authors. Global Change Biology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kattge</LastName><ForeName>Jens</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1022-8469</Identifier><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bönisch</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díaz</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0012-4612</Identifier><AffiliationInfo><Affiliation>Consejo Nacional de Investigaciones Científicas y Técnicas, Instituto Multidisciplinario de Biología Vegetal (IMBIV), and Factulad de Ciencias Exactas, Físicas y Naturales, Universidad Nacional de Córdoba, Córdoba, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavorel</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Univ. Grenoble Alpes, CNRS, Univ. Savoie Mont Blanc, LECA, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prentice</LastName><ForeName>Iain Colin</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leadley</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ecologie Systématique Evolution, CNRS, AgroParisTech, University of Paris-Sud, Université Paris-Saclay, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tautenhahn</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2753-3443</Identifier><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Gijsbert D A</ForeName><Initials>GDA</Initials><Identifier Source="ORCID">0000-0002-5426-2562</Identifier><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Balliol College, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aakala</LastName><ForeName>Tuomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0160-6410</Identifier><AffiliationInfo><Affiliation>University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1499-0119</Identifier><AffiliationInfo><Affiliation>Department of Range Management, Faculty of Natural Resources and Marine Sciences, Tarbiat Modares University, Noor, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>Alicia T R</ForeName><Initials>ATR</Initials><Identifier Source="ORCID">0000-0001-6572-3187</Identifier><AffiliationInfo><Affiliation>University of Roma Tre, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamidis</LastName><ForeName>George C</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0001-8704-6623</Identifier><AffiliationInfo><Affiliation>Biodiversity Conservation Laboratory, Department of Environment, University of the Aegean, Mytilene, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamson</LastName><ForeName>Kairi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tartu Observatory, University of Tartu, Tartumaa, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiba</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5966-1562</Identifier><AffiliationInfo><Affiliation>Graduate School of Life Sciences, Tohoku University, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Cécile H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-0991-1068</Identifier><AffiliationInfo><Affiliation>Aix Marseille Univ, Univ Avignon, CNRS, IRD, IMBE, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcántara</LastName><ForeName>Julio M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-8003-7844</Identifier><AffiliationInfo><Affiliation>Universidad de Jaén, Jaén, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcázar C</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9366-8098</Identifier><AffiliationInfo><Affiliation>Instituto Alexander Von Humboldt, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aleixo</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9220-8965</Identifier><AffiliationInfo><Affiliation>National Institute of Amazonian Research (INPA), Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Hamada</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7062-9344</Identifier><AffiliationInfo><Affiliation>Botany Department, Faculty of Science, Suez Canal University, Ismailia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amiaud</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Université de Lorraine, Lorraine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammer</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4235-0135</Identifier><AffiliationInfo><Affiliation>Forest Sciences, University of Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biodiversity and Sustainable Land-use, University of Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoroso</LastName><ForeName>Mariano M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones en Recursos Naturales, Agroecología y Desarrollo Rural (IRNAD), Universidad Nacional de Río Negro, El Bolsón, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Conicet-Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Madhur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Guelph, Guelph, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4211-5765</Identifier><AffiliationInfo><Affiliation>Pacific Northwest National Laboratory, Richland, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Massachusetts Amherst, Amherst, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anten</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Crop Systems Analysis, Wageningen University, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antos</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Victoria, Victoria, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apgaua</LastName><ForeName>Deborah Mattos Guimarães</ForeName><Initials>DMG</Initials><Identifier Source="ORCID">0000-0002-6303-6989</Identifier><AffiliationInfo><Affiliation>College of Science &amp; Engineering, James Cook University, Smithfield, Qld, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashman</LastName><ForeName>Tia-Lynn</ForeName><Initials>TL</Initials><Identifier Source="ORCID">0000-0002-9884-5954</Identifier><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asmara</LastName><ForeName>Degi Harja</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Centre for Forest Research, Institute for Integrative Systems Biology, Université Laval, Quebec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asner</LastName><ForeName>Gregory P</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0001-7893-6421</Identifier><AffiliationInfo><Affiliation>Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aspinwall</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0199-2972</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of North Florida, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkin</LastName><ForeName>Owen</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-1041-5202</Identifier><AffiliationInfo><Affiliation>ARC Centre for Excellence in Plant Energy Biology, Australian National University, Acton, ACT, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubin</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5953-1012</Identifier><AffiliationInfo><Affiliation>Great Lakes Forestry Centre, Canadian Forest Service, Natural Resources Canada, Sault Ste. Marie, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baastrup-Spohr</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8382-984X</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahalkeh</LastName><ForeName>Khadijeh</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1485-0316</Identifier><AffiliationInfo><Affiliation>Department of Range Management, Faculty of Natural Resources and Marine Sciences, Tarbiat Modares University, Noor, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahn</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7482-9776</Identifier><AffiliationInfo><Affiliation>Department of Ecology, University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Geography, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><Identifier Source="ORCID">0000-0001-6727-1831</Identifier><AffiliationInfo><Affiliation>Royal Botanic Gardens Kew, Richmond, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Jan P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-7475-5906</Identifier><AffiliationInfo><Affiliation>Conservation Ecology, Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldocchi</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3496-4919</Identifier><AffiliationInfo><Affiliation>Department of Environmental Science, Policy and Management, University of California Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltzer</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7476-5928</Identifier><AffiliationInfo><Affiliation>Biology Department, Wilfrid Laurier University, Waterloo, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Arindam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Forest Resources, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranger</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AgroParisTech, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barlow</LastName><ForeName>Jos</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4992-2594</Identifier><AffiliationInfo><Affiliation>Lancaster Environment Centre, Lancaster University, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barneche</LastName><ForeName>Diego R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-4568-2362</Identifier><AffiliationInfo><Affiliation>College of Life and Environmental Sciences, University of Exeter, Penryn, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baruch</LastName><ForeName>Zdravko</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7264-4812</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastianelli</LastName><ForeName>Denis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6394-5920</Identifier><AffiliationInfo><Affiliation>CIRAD, UMR SELMET, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SELMET, CIRAD, INRA, Univ Montpellier, Montpellier SupAgro, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battles</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7124-7893</Identifier><AffiliationInfo><Affiliation>University of California at Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauerle</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3090-234X</Identifier><AffiliationInfo><Affiliation>Department of Horticulture and Landscape Architecture, Colorado State University, Fort Collins, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauters</LastName><ForeName>Marijn</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0978-6639</Identifier><AffiliationInfo><Affiliation>Department of Green Chemistry and Technology, Ghent University, Gent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environment, Ghent University, Gent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazzato</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Botany Division, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckmann</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5678-265X</Identifier><AffiliationInfo><Affiliation>Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beeckman</LastName><ForeName>Hans</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8954-6277</Identifier><AffiliationInfo><Affiliation>Royal Museum for Central Africa, Tervuren, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beierkuhnlein</LastName><ForeName>Carl</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6456-4628</Identifier><AffiliationInfo><Affiliation>University of Bayreuth, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekker</LastName><ForeName>Renee</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Groningen Institute of Archaeology (GIA), University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belfry</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3405-5950</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Tennessee, Knoxville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rocky Mountain Biological Laboratory, Crested Butte, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belluau</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6707-546X</Identifier><AffiliationInfo><Affiliation>Département des Science, Université du Québec À Montréal, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beloiu</LastName><ForeName>Mirela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3592-8170</Identifier><AffiliationInfo><Affiliation>Department of Biogeography, University of Bayreuth, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benavides</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2328-5371</Identifier><AffiliationInfo><Affiliation>Museo Nacional de Ciencias Naturales-CSIC, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benomar</LastName><ForeName>Lahcen</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9301-5655</Identifier><AffiliationInfo><Affiliation>Université Laval, Quebec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berdugo-Lattke</LastName><ForeName>Mary Lee</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-6662-6458</Identifier><AffiliationInfo><Affiliation>Instituto de Ciencias Naturales, Universidad Nacional de Colombia, Bogota, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundación Natura, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berenguer</LastName><ForeName>Erika</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7357-8805</Identifier><AffiliationInfo><Affiliation>Environmental Change Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergamin</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2405-9977</Identifier><AffiliationInfo><Affiliation>Laboratório de Estudos em Vegetação Campestre (LEVCamp), Programa de Pós-Graduação em Botânica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergmann</LastName><ForeName>Joana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2008-4198</Identifier><AffiliationInfo><Affiliation>Institut für Biologie, Freie Universität Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergmann Carlucci</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5868-7090</Identifier><AffiliationInfo><Affiliation>Laboratório de Ecologia Funcional de Comunidades (LABEF), Departamento de Botânica, Universidade Federal do Paraná, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berner</LastName><ForeName>Logan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8947-0479</Identifier><AffiliationInfo><Affiliation>School of Informatics, Computing, and Cyber Systems, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernhardt-Römermann</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2740-2304</Identifier><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigler</LastName><ForeName>Christof</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3757-6356</Identifier><AffiliationInfo><Affiliation>ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjorkman</LastName><ForeName>Anne D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-2174-7800</Identifier><AffiliationInfo><Affiliation>Department of Biological and Environmental Sciences, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackman</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>PIAF, INRA, Université Clermont-Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8959-2633</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blonder</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5061-2385</Identifier><AffiliationInfo><Affiliation>Rocky Mountain Biological Laboratory, Crested Butte, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blumenthal</LastName><ForeName>Dana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7496-0766</Identifier><AffiliationInfo><Affiliation>USDA-ARS Rangeland Resources &amp; Systems Research Unit, Fort Collins, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocanegra-González</LastName><ForeName>Kelly T</ForeName><Initials>KT</Initials><Identifier Source="ORCID">0000-0001-7177-5856</Identifier><AffiliationInfo><Affiliation>Grupo de Investigación en Biodiversidad y Dinámica de Ecosistémas Tropicales - Universidad del Tolima, Ibagué, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeckx</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3998-0010</Identifier><AffiliationInfo><Affiliation>Isotope Bioscience Laboratory - ISOFYS, Ghent University, Gent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohlman</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Forest Resources and Conservation, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böhning-Gaese</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0477-5586</Identifier><AffiliationInfo><Affiliation>Senckenberg Biodiversity and Climate Research Centre, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Goethe Universität Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boisvert-Marsh</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0939-8196</Identifier><AffiliationInfo><Affiliation>Great Lakes Forestry Centre, Canadian Forest Service, Natural Resources Canada, Sault Ste. Marie, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bond</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-3441-2084</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SAEON Fynbos Node, Claremont, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bond-Lamberty</LastName><ForeName>Ben</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9525-4633</Identifier><AffiliationInfo><Affiliation>Pacific Northwest National Laboratory, College Park, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boom</LastName><ForeName>Arnoud</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1299-691X</Identifier><AffiliationInfo><Affiliation>School of Geography, Geology and Environment, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonman</LastName><ForeName>Coline C F</ForeName><Initials>CCF</Initials><Identifier Source="ORCID">0000-0003-2417-1579</Identifier><AffiliationInfo><Affiliation>Department of Environmental Science, Institute for Water and Wetland Research, Radboud University, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordin</LastName><ForeName>Kauane</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3871-6293</Identifier><AffiliationInfo><Affiliation>Laboratório de Ecologia Vegetal (LEVEG), Programa de Pós-Graduação em Ecologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boughton</LastName><ForeName>Elizabeth H</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0003-0932-280X</Identifier><AffiliationInfo><Affiliation>Archbold Biological Station's Buck Island Ranch, FL, Lake Placid, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boukili</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5950-2123</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, University of Connecticut, Storrs, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowman</LastName><ForeName>David M J S</ForeName><Initials>DMJS</Initials><AffiliationInfo><Affiliation>University of Tasmania, Hobart, Tas., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bravo</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6098-7255</Identifier><AffiliationInfo><Affiliation>Facultad de Ciencias Forestales, Universidad Nacional de Santiago del Estero, Santiago del Estero, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brendel</LastName><ForeName>Marco Richard</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-4356-4597</Identifier><AffiliationInfo><Affiliation>Institute of Landscape and Plant Ecology, University of Hohenheim, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broadley</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-3964-7226</Identifier><AffiliationInfo><Affiliation>School of Geography, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kerry A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-6342-8966</Identifier><AffiliationInfo><Affiliation>Department of Geography and Geology, Kingston University, Kingston upon Thames, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruelheide</LastName><ForeName>Helge</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3135-0356</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biology/Geobotany and Botanical Garden, Martin Luther University Halle-Wittenberg, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brumnich</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0502-6694</Identifier><AffiliationInfo><Affiliation>Conicet-Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ingeniería y Ciencias Hídricas, Universidad Nacional del Litoral (FICH-UNL), Santa Fe, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruun</LastName><ForeName>Hans Henrik</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0003-0674-2577</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruy</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7339-0375</Identifier><AffiliationInfo><Affiliation>AMAP, CIRAD, CNRS, IRD, INRA, Université de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AMAP, IRD, Herbier de Nouvelle-Calédonie, Nouméa, New Caledonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchanan</LastName><ForeName>Serra W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>University of Toronto Scarborough, Scarborough, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucher</LastName><ForeName>Solveig Franziska</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0002-2303-4583</Identifier><AffiliationInfo><Affiliation>Friedrich-Schiller-Universität Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchmann</LastName><ForeName>Nina</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0826-2980</Identifier><AffiliationInfo><Affiliation>ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buitenwerf</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3356-2301</Identifier><AffiliationInfo><Affiliation>Section for Ecoinformatics and Biodiversity, Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biodiversity Dynamics in a Changing World (BIOCHANGE), Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunker</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0002-7234-3403</Identifier><AffiliationInfo><Affiliation>New Jersey Institute of Technology, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bürger</LastName><ForeName>Jana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Agricultural and Environmental Sciences, University of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burrascano</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6537-3313</Identifier><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burslem</LastName><ForeName>David F R P</ForeName><Initials>DFRP</Initials><Identifier Source="ORCID">0000-0001-6033-0990</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butterfield</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0003-0974-9811</Identifier><AffiliationInfo><Affiliation>Center for Ecosystem Science and Society, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byun</LastName><ForeName>Chaeho</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3209-3275</Identifier><AffiliationInfo><Affiliation>School of Civil and Environmental Engineering, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Marcia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1003-9596</Identifier><AffiliationInfo><Affiliation>Departamento de Botânica, SCB, UFPR - Federal University of Parana, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scalon</LastName><ForeName>Marina C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-2069-8226</Identifier><AffiliationInfo><Affiliation>Centro Politécnico, Universidade Federal do Paraná, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caccianiga</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9715-1830</Identifier><AffiliationInfo><Affiliation>Dipartimento di Bioscienze, Università degli Studi di Milano, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadotte</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5816-7693</Identifier><AffiliationInfo><Affiliation>University of Toronto Scarborough, Scarborough, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cailleret</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6561-1943</Identifier><AffiliationInfo><Affiliation>IRSTEA Aix-en-Provence, UMR RECOVER, Aix-Marseille University, Aix-en-Provence, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camac</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4785-0742</Identifier><AffiliationInfo><Affiliation>Centre of Excellence for Bioscurity Risk Analysis, The University of Melbourne, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarero</LastName><ForeName>Jesús Julio</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-2436-2922</Identifier><AffiliationInfo><Affiliation>Instituto Pirenaico de Ecología (IPE-CSIC), Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campany</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Colgate University, Hamilton, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campetella</LastName><ForeName>Giandiego</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6126-522X</Identifier><AffiliationInfo><Affiliation>School of Biosciences and Veterinary Medicine, Plant Diversity and Ecosystems Management Unit, University of Camerino, Camerino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Juan Antonio</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5992-2753</Identifier><AffiliationInfo><Affiliation>Department of Plant Biology and Ecology, University of the Basque Country UPV/EHU, Bilbao, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano-Arboleda</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundación Natura, Bogota, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Geociencias y Medio Ambiente, Universidad Nacional de Colombia, Medellin, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canullo</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9913-6981</Identifier><AffiliationInfo><Affiliation>School of Biosciences and Veterinary Medicine, Plant Diversity and Ecosystems Management Unit, University of Camerino, Camerino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbognani</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7701-9859</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6305-5602</Identifier><AffiliationInfo><Affiliation>Lancaster Environment Centre, Lancaster University, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanoves</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8765-9382</Identifier><AffiliationInfo><Affiliation>CATIE-Centro Agronómico Tropical de Investigación y Enseñanza, Turrialba, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castagneyrol</LastName><ForeName>Bastien</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8795-7806</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INRAE, BIOGECO, Cestas, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catford</LastName><ForeName>Jane A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-0582-5960</Identifier><AffiliationInfo><Affiliation>Department of Geography, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavender-Bares</LastName><ForeName>Jeannine</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3375-9630</Identifier><AffiliationInfo><Affiliation>Department of Ecology, Evolution, and Behavior, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerabolini</LastName><ForeName>Bruno E L</ForeName><Initials>BEL</Initials><Identifier Source="ORCID">0000-0002-3793-0733</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervellini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0853-2330</Identifier><AffiliationInfo><Affiliation>School of Biosciences and Veterinary Medicine, Plant Diversity and Ecosystems Management Unit, University of Camerino, Camerino, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIGEA, Department of Biological, Geological and Environmental Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chacón-Madrigal</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8328-5456</Identifier><AffiliationInfo><Affiliation>Escuela de Biología, Universidad de Costa Rica, San José, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapin</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8382-4050</Identifier><AffiliationInfo><Affiliation>The University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapin</LastName><ForeName>F Stuart</ForeName><Initials>FS</Initials><Identifier Source="ORCID">0000-0002-2558-9910</Identifier><AffiliationInfo><Affiliation>Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7184-8242</Identifier><AffiliationInfo><Affiliation>School of Biosciences and Veterinary Medicine, Plant Diversity and Ecosystems Management Unit, University of Camerino, Camerino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Si-Chong</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-6855-2595</Identifier><AffiliationInfo><Affiliation>Royal Botanic Gardens, Kew, West Sussex, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Anping</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2085-3863</Identifier><AffiliationInfo><Affiliation>Department of Biology, Colorado State University, Fort Collins, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherubini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9809-250X</Identifier><AffiliationInfo><Affiliation>WSL Swiss Federal Research Institute, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Forestry, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chianucci</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5688-2060</Identifier><AffiliationInfo><Affiliation>CREA - Research Centre for Forestry and Wood, Arezzo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choat</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9105-640X</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Kyong-Sook</ForeName><Initials>KS</Initials><Identifier Source="ORCID">0000-0002-4464-4698</Identifier><AffiliationInfo><Affiliation>Jungwon University, Goesan, Chungbuk, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chytrý</LastName><ForeName>Milan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8122-3075</Identifier><AffiliationInfo><Affiliation>Department of Botany and Zoology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccarelli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9715-9779</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coll</LastName><ForeName>Lluís</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Agriculture and Forest Engineering (EAGROF), University of Lleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Research Unit CTFC - AGROTECNIO, Solsona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Courtney G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>University of California Riverside, Riverside, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8047-1467</Identifier><AffiliationInfo><Affiliation>Faculty of Environmental Sciences, University of Life Sciences Prague, Praha-Suchdol, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Botany, Czech Academy of Sciences, Třeboň, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coomes</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8261-2582</Identifier><AffiliationInfo><Affiliation>Department of Plant Sciences, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornelissen</LastName><ForeName>Johannes H C</ForeName><Initials>JHC</Initials><Identifier Source="ORCID">0000-0002-2346-1585</Identifier><AffiliationInfo><Affiliation>Systems Ecology, Department of Ecological Science, Vrije Universiteit, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornwell</LastName><ForeName>William K</ForeName><Initials>WK</Initials><Identifier Source="ORCID">0000-0003-4080-4073</Identifier><AffiliationInfo><Affiliation>School of Biological, Earth and Environmental Sciences, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corona</LastName><ForeName>Piermaria</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8105-0792</Identifier><AffiliationInfo><Affiliation>CREA - Research Centre for Forestry and Wood, Arezzo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coyea</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculté de foresterie, de géographie et de géomatique, Université Laval, Quebec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craine</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6561-3244</Identifier><AffiliationInfo><Affiliation>Jonah Ventures, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craven</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3940-833X</Identifier><AffiliationInfo><Affiliation>Centro de Modelación y Monitoreo de Ecosistemas, Universidad Mayor, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cromsigt</LastName><ForeName>Joris P G M</ForeName><Initials>JPGM</Initials><AffiliationInfo><Affiliation>Department of Wildlife, Fish and Environmental Studies, Swedish University of Agricultural Sciences, Umeå, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for African Conservation Ecology, Department of Zoology, Nelson Mandela University, Port Elizabeth, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csecserits</LastName><ForeName>Anikó</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0538-4520</Identifier><AffiliationInfo><Affiliation>MTA Centre for Ecological Research, Tihany, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cufar</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7403-3994</Identifier><AffiliationInfo><Affiliation>Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuntz</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5966-1829</Identifier><AffiliationInfo><Affiliation>Université de Lorraine, AgroParisTech, INRAE, UMR Silva, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-1285-640X</Identifier><AffiliationInfo><Affiliation>Santa Catarina State University, Lages, SC, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahlin</LastName><ForeName>Kyla M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-6016-2605</Identifier><AffiliationInfo><Affiliation>Department of Geography, Environment, and Spatial Sciences, Michigan State University, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dainese</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7052-5572</Identifier><AffiliationInfo><Affiliation>Eurac Research, Institute for Alpine Environment, Bozen-Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalke</LastName><ForeName>Igor</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5711-9916</Identifier><AffiliationInfo><Affiliation>Institute of Biology of Komi Science Centre of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Komi Republic, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalle Fratte</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7907-1586</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang-Le</LastName><ForeName>Anh Tuan</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0002-9794-0669</Identifier><AffiliationInfo><Affiliation>University of Science - Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danihelka</LastName><ForeName>Jirí</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2640-7867</Identifier><AffiliationInfo><Affiliation>Department of Botany and Zoology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Botany, Czech Academy of Sciences, Třeboň, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dannoura</LastName><ForeName>Masako</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0389-871X</Identifier><AffiliationInfo><Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Global Environmental Studies, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5165-9591</Identifier><AffiliationInfo><Affiliation>Swedish Species Information Centre, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Beer</LastName><ForeName>Arend Jacobus</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Plant and Soil Sciences, University of Pretoria, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Frutos</LastName><ForeName>Angel</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5250-9488</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Long</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-7951-4818</Identifier><AffiliationInfo><Affiliation>Department of Terrestrial Ecology, Netherlands Institute of Ecology, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dechant</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5171-2364</Identifier><AffiliationInfo><Affiliation>Department Computational Landscape Ecology, UFZ - Helmholtz Centre for Environmental Research, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Computational Hydrosystems, UFZ - Helmholtz Centre for Environmental Research, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Landscape Architecture and Rural Systems Engineering, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delagrange</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Temperate Forest Sciences (ISFORT), Ripon, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UQO, Department of Natural Sciences, Ripon, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delpierre</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0906-9402</Identifier><AffiliationInfo><Affiliation>Ecologie Systématique Evolution, CNRS, AgroParisTech, University of Paris-Sud, Université Paris-Saclay, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derroire</LastName><ForeName>Géraldine</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7239-2881</Identifier><AffiliationInfo><Affiliation>Cirad, UMR EcoFoG (Agroparistech, CNRS, INRA, Université des Antilles, Université de la Guyane), Kourou, French Guiana, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Arildo S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-5495-3435</Identifier><AffiliationInfo><Affiliation>Institut für Physische Geographie, Biogeography and Biodiversity Lab, Goethe-Universität Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Toribio</LastName><ForeName>Milton Hugo</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-1675-2699</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitrakopoulos</LastName><ForeName>Panayiotis G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-8374-4392</Identifier><AffiliationInfo><Affiliation>Biodiversity Conservation Laboratory, Department of Environment, University of the Aegean, Mytilene, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrowolski</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5586-4023</Identifier><AffiliationInfo><Affiliation>Iluka Resources, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doktor</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dřevojan</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0802-3509</Identifier><AffiliationInfo><Affiliation>Department of Botany and Zoology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0793-8854</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dransfield</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Botanic Gardens Kew, Richmond, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dressler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Botany and Molecular Evolution, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Leandro</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1771-0407</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducouret</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cirad, UMR EcoFoG (Agroparistech, CNRS, INRA, Université des Antilles, Université de la Guyane), Kourou, French Guiana, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dullinger</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3919-0887</Identifier><AffiliationInfo><Affiliation>Department of Botany and Biodiversity Research, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durka</LastName><ForeName>Walter</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6611-2246</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz Centre for Environmental Research - UFZ, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duursma</LastName><ForeName>Remko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymova</LastName><ForeName>Olga</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2008-6350</Identifier><AffiliationInfo><Affiliation>Institute of Biology of Komi Science Centre of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Komi Republic, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>E-Vojtkó</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6370-680X</Identifier><AffiliationInfo><Affiliation>Institute of Botany, Czech Academy of Sciences, Třeboň, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Botany, Faculty of Sciences, University of South Bohemia, Ceske Budejovice, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckstein</LastName><ForeName>Rolf Lutz</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0002-6953-3855</Identifier><AffiliationInfo><Affiliation>Department of Environmental and Life Sciences - Biology, Karlstad University, Karlstad, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ejtehadi</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6128-2481</Identifier><AffiliationInfo><Affiliation>Quantitative Plant Ecology and Biodiversity Research Laboratory, Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elser</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1460-2155</Identifier><AffiliationInfo><Affiliation>Flathead Lake Biological Station, University of Montana, Polson, MT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Sustainability, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emilio</LastName><ForeName>Thaise</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5415-1822</Identifier><AffiliationInfo><Affiliation>Programa Nacional de Pós-Doutorado (PNPD), Programa de Pós Graduação em Ecologia, Institute of Biology, University of Campinas UNICAMP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engemann</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1431-1726</Identifier><AffiliationInfo><Affiliation>Section for Ecoinformatics and Biodiversity, Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erfanian</LastName><ForeName>Mohammad Bagher</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0002-8671-9037</Identifier><AffiliationInfo><Affiliation>Quantitative Plant Ecology and Biodiversity Research Laboratory, Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erfmeier</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Ecosystem Research/Geobotany, Kiel University, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquivel-Muelbert</LastName><ForeName>Adriane</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5335-1259</Identifier><AffiliationInfo><Affiliation>School of Geography, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Geography, Earth and Environmental Sciences - University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esser</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Plant Ecology, Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estiarte</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1176-8480</Identifier><AffiliationInfo><Affiliation>Spanish National Research Council - CSIC, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CREAF, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domingues</LastName><ForeName>Tomas F</ForeName><Initials>TF</Initials><Identifier Source="ORCID">0000-0003-2857-9838</Identifier><AffiliationInfo><Affiliation>Department of Biology - FFCLRP/USP, Ribeirão Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>William F</ForeName><Initials>WF</Initials><Identifier Source="ORCID">0000-0003-2433-9052</Identifier><AffiliationInfo><Affiliation>University of Maryland, College Park, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagúndez</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6605-7278</Identifier><AffiliationInfo><Affiliation>Campus da Zapateira, University of A Coruña, A Coruña, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falster</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-9814-092X</Identifier><AffiliationInfo><Affiliation>Evolution &amp; Ecology Research Centre, and School of Biological, Earth and Environmental Sciences, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0024-7965</Identifier><AffiliationInfo><Affiliation>Rutgers University, Piscataway, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Jingyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farris</LastName><ForeName>Emmanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9843-5998</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazlioglu</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4723-3640</Identifier><AffiliationInfo><Affiliation>Faculty of Arts and Sciences, Molecular Biology and Genetics, Ordu University, Ordu, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yanhao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0460-4883</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Grassland Agro-ecosystems, College of Pastoral Agriculture Science and Technology, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Mendez</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8693-790X</Identifier><AffiliationInfo><Affiliation>Grupo de Investigación en Biodiversidad y Dinámica de Ecosistémas Tropicales - Universidad del Tolima, Ibagué, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Forestal Tropical Bajo Calima, Universidad del Tolima, Buenaventura, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CREA - Research Centre for Forestry and Wood, Arezzo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Joice</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4008-2341</Identifier><AffiliationInfo><Affiliation>Embrapa Amazônia Oriental, Belém, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fidelis</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9545-2285</Identifier><AffiliationInfo><Affiliation>Instituto de Biociências, Laboratory of Vegetation Ecology, Universidade Estadual Paulista (UNESP), Rio Claro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finegan</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CATIE-Centro Agronómico Tropical de Investigación y Enseñanza, Turrialba, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firn</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6026-8912</Identifier><AffiliationInfo><Affiliation>Queensland University of Technology (QUT), Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flowers</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-2712-9504</Identifier><AffiliationInfo><Affiliation>School of Life Sciences, University of Sussex, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Dan F B</ForeName><Initials>DFB</Initials><Identifier Source="ORCID">0000-0002-2978-5257</Identifier><AffiliationInfo><Affiliation>Arnold Arboretum of Harvard University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Eurac Research, Institute for Alpine Environment, Bozen-Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forey</LastName><ForeName>Estelle</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6082-3023</Identifier><AffiliationInfo><Affiliation>Laboratoire ECODIV URA, IRSTEA/EA 1293, Normandie Université, UFR ST, Université de Rouen, Mont Saint-Aignan, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forgiarini</LastName><ForeName>Cristiane</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0319-7430</Identifier><AffiliationInfo><Affiliation>Department of Botany, Biosciences Institute, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>François</LastName><ForeName>Louis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8292-8360</Identifier><AffiliationInfo><Affiliation>Unit of Research SPHERES, University of Liège, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frangipani</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8050-8282</Identifier><AffiliationInfo><Affiliation>University of Guelph, Guelph, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Dorothea</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenette-Dussault</LastName><ForeName>Cedric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Géopole de l'Université de Sherbrooke, Quebec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freschet</LastName><ForeName>Grégoire T</ForeName><Initials>GT</Initials><Identifier Source="ORCID">0000-0002-8830-3860</Identifier><AffiliationInfo><Affiliation>Theoretical and Experimental Ecology Station, CNRS, Paul Sabatier University Toulouse, Moulis, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Ellen L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0001-7513-2006</Identifier><AffiliationInfo><Affiliation>School of Earth and Environment Science, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fyllas</LastName><ForeName>Nikolaos M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0002-5651-5578</Identifier><AffiliationInfo><Affiliation>Biodiversity Conservation Laboratory, Department of Environment, University of the Aegean, Mytilene, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzochini</LastName><ForeName>Guilherme G</ForeName><Initials>GG</Initials><Identifier Source="ORCID">0000-0002-6932-8544</Identifier><AffiliationInfo><Affiliation>Department of Plant Biology, Institute of Biology, University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gachet</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aix Marseille Univ, Univ Avignon, CNRS, IRD, IMBE, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallagher</LastName><ForeName>Rachael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4680-8115</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganade</LastName><ForeName>Gislene</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Norte - UFRN, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganga</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Botany Division, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Palacios</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6367-4761</Identifier><AffiliationInfo><Affiliation>Departamento de Biología y Geología, Física y Química Inorgánica y Analítica, Universidad Rey Juan Carlos, Móstoles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargaglione</LastName><ForeName>Verónica</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0797-1868</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Tecnología Agropecuaria, Consejo Nacional de Invetigaciones Científicas y Técnicas, Universidad Nacional de La Patagonia Austral, Río Gallegos, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnier</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9392-5154</Identifier><AffiliationInfo><Affiliation>UMR 5175 CEFE, Univ. Montpellier, CNRS, EPHE, IRD, Univ. Paul Valéry, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrido</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-6859-4234</Identifier><AffiliationInfo><Affiliation>Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Estación Biológica de Doñana, Consejo Superior de Investigaciones Científicas, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Gasper</LastName><ForeName>André Luís</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-1940-9581</Identifier><AffiliationInfo><Affiliation>Universidade Regional de Blumenau, Blumenau, SC, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gea-Izquierdo</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0148-3721</Identifier><AffiliationInfo><Affiliation>INIA-CIFOR, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0308-7506</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, Southern Illinois University Carbondale, Carbondale, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillison</LastName><ForeName>Andrew N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0003-2781-1500</Identifier><AffiliationInfo><Affiliation>Center for Biodiversity Management, Yungaburra, Qld, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giroldo</LastName><ForeName>Aelton</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7850-0011</Identifier><AffiliationInfo><Affiliation>Instituto Federal de Educação Ciência e Tecnologia do Ceará, Crateús, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glasenhardt</LastName><ForeName>Mary-Claire</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>The Morton Arboretum, Lisle, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Sean</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5607-4741</Identifier><AffiliationInfo><Affiliation>Water Management and Systems Research Unit, United States Department of Agriculture, Agricultural Research Service, Fort Collins, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gliesch</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3226-6762</Identifier><AffiliationInfo><Affiliation>Institute of Integrative Biology, ETH Zürich (Swiss Federal Institute of Technology), Zürich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Ecology, Evolution &amp; Behavior, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Göldel</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Section for Ecoinformatics and Biodiversity, Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Akre</LastName><ForeName>Erika</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8305-6672</Identifier><AffiliationInfo><Affiliation>Smithsonian Conservation Biology Institute, Front Royal, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Andujar</LastName><ForeName>Jose L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-2356-4098</Identifier><AffiliationInfo><Affiliation>CSIC - Institute for Sustainable Agriculture (IAS), Cordoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González-Melo</LastName><ForeName>Andrés</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González-Robles</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3135-8905</Identifier><AffiliationInfo><Affiliation>Departamento de Biología Animal, Biología Vegetal y Ecología, Universidad de Jaén, Jaén, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graae</LastName><ForeName>Bente Jessen</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-5568-4759</Identifier><AffiliationInfo><Affiliation>Norwegian University of Science and Technology NTNU, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granda</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9559-4213</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, University of Alcalá, Alcala de Henares, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graves</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3805-4242</Identifier><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Walton A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregor</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7692-8348</Identifier><AffiliationInfo><Affiliation>Department of Botany and Molecular Evolution, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9730-3240</Identifier><AffiliationInfo><Affiliation>UCA, INRA, VetAgro Sup, UMR Ecosystème Prairial, Clermont-Ferrand, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Biología y Geología, Física y Química Inorgánica, Escuela Superior de Ciencias Experimentales y Tecnología, Universidad Rey Juan Carlos, Móstoles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerin</LastName><ForeName>Greg R</ForeName><Initials>GR</Initials><Identifier Source="ORCID">0000-0002-2104-6695</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Günther</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutiérrez</LastName><ForeName>Alvaro G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0001-8928-3198</Identifier><AffiliationInfo><Affiliation>Departamento de Ciencias Ambientales y Recursos Naturales Renovables, Facultad de Ciencias Agronómicas, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddock</LastName><ForeName>Lillie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3432-6191</Identifier><AffiliationInfo><Affiliation>Pacific Northwest National Laboratory, Joint Global Change Research Institute, College Park, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Jefferson</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4761-9268</Identifier><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hambuckers</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of research SPHERES, University of Liège, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Wenxuan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8678-7147</Identifier><AffiliationInfo><Affiliation>College of Resources and Environmental Sciences, China Agricultural University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Ecology and Environment of Central Asia, Chinese Academy of Sciences, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Sandy P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0001-5687-1903</Identifier><AffiliationInfo><Affiliation>University of Reading, Reading, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattingh</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Animal, Plant and Environmental Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawes</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-0053-2018</Identifier><AffiliationInfo><Affiliation>Applied Ecology Research Group, School of Life Sciences, Anglia Ruskin University, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, Ås, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Tianhua</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Molecular and Life Sciences, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Science, Health, Engineering and Education, Murdoch University, Murdoch, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Pengcheng</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9531-531X</Identifier><AffiliationInfo><Affiliation>South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heberling</LastName><ForeName>Jacob Mason</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-0756-5090</Identifier><AffiliationInfo><Affiliation>Carnegie Museum of Natural History, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helm</LastName><ForeName>Aveliina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2338-4564</Identifier><AffiliationInfo><Affiliation>Institute of Ecology and Earth Sciences, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hempel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut für Biologie, Freie Universität Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hentschel</LastName><ForeName>Jörn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Herbarium Haussknecht, Friedrich-Schiller-Universität Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hérault</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6950-7286</Identifier><AffiliationInfo><Affiliation>Cirad, Université de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut National Polytehcnique Félix Houphouet-Boigny, INP-HB, Yamoussoukro, Ivory Coast.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hereş</LastName><ForeName>Ana-Maria</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-1839-1770</Identifier><AffiliationInfo><Affiliation>Department of Forest Sciences, Transilvania University of Brasov, Brasov, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BC3 - Basque Centre for Climate Change, Scientific Campus of the University of the Basque Country, Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herz</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5676-3646</Identifier><AffiliationInfo><Affiliation>Institute of Biology/Geobotany and Botanical Garden, Martin Luther University Halle-Wittenberg, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuertz</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6322-3645</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INRAE, BIOGECO, Cestas, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickler</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Senckenberg Biodiversity and Climate Research Centre, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Geography, Goethe University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hietz</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0458-6593</Identifier><AffiliationInfo><Affiliation>Institute of Botany, University of Natural Resources and Life Sciences, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higuchi</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3855-555X</Identifier><AffiliationInfo><Affiliation>Santa Catarina State University, Lages, SC, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hipp</LastName><ForeName>Andrew L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-1241-9904</Identifier><AffiliationInfo><Affiliation>The Morton Arboretum, Lisle, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Field Museum, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirons</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Centre Myerscough, Preston, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hock</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8401-7309</Identifier><AffiliationInfo><Affiliation>Institute for Ecosystem Research/Geobotany, Kiel University, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogan</LastName><ForeName>James Aaron</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-9806-3074</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Florida International University, Miami, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oak Ridge National Laboratory, US Department of Energy, Oak Ridge, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holl</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2893-6161</Identifier><AffiliationInfo><Affiliation>University of California, Santa Cruz, Santa Cruz, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honnay</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4287-8511</Identifier><AffiliationInfo><Affiliation>Plant Conservation and Population Biology, Department of Biology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Ecology, Evolution and Biodiversity Conservation, Heverlee, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Bayreuth, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Enqing</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4864-2347</Identifier><AffiliationInfo><Affiliation>South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough-Snee</LastName><ForeName>Nate</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4581-0931</Identifier><AffiliationInfo><Affiliation>Four Peaks Environmental Science and Data Solutions, Wenatchee, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hovstad</LastName><ForeName>Knut Anders</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-7108-0787</Identifier><AffiliationInfo><Affiliation>Department of Landscape and Biodiversity, Norwegian Institute of Bioeconomy Research (NIBIO), Ås, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichie</LastName><ForeName>Tomoaki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1979-5806</Identifier><AffiliationInfo><Affiliation>Kochi University, Nankoku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Igić</LastName><ForeName>Boris</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6302-8030</Identifier><AffiliationInfo><Affiliation>University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illa</LastName><ForeName>Estela</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7136-6518</Identifier><AffiliationInfo><Affiliation>Department of Evolutionary Biology, Ecology and Environmental Sciences, Biodiversity Research Institute (IRBio), Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isaac</LastName><ForeName>Marney</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5975-833X</Identifier><AffiliationInfo><Affiliation>University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihara</LastName><ForeName>Masae</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8365-7766</Identifier><AffiliationInfo><Affiliation>Ashiu Forest Research Station, Field Science Education and Research Center, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanov</LastName><ForeName>Leonid</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6900-5086</Identifier><AffiliationInfo><Affiliation>Institute Botanic Garden, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tyumen State University, Tyumen, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanova</LastName><ForeName>Larissa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2363-9619</Identifier><AffiliationInfo><Affiliation>Institute Botanic Garden, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tyumen State University, Tyumen, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iversen</LastName><ForeName>Colleen M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-8293-3450</Identifier><AffiliationInfo><Affiliation>Oak Ridge National Laboratory, Oak Ridge, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3949-1295</Identifier><AffiliationInfo><Affiliation>Barcelona School of Agricultural Engineering, Universitat Politècnica de Catalunya, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><Identifier Source="ORCID">0000-0001-8846-7147</Identifier><AffiliationInfo><Affiliation>Earth System Science Department, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6405-8111</Identifier><AffiliationInfo><Affiliation>Global Academy of Agriculture and Food Security, University of Edinburgh, Midlothian, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jactel</LastName><ForeName>Hervé</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8106-5310</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INRAE, BIOGECO, Cestas, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagodzinski</LastName><ForeName>Andrzej M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-6899-0985</Identifier><AffiliationInfo><Affiliation>Institute of Dendrology, Polish Academy of Sciences, Kornik, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Game Management and Forest Protection, Faculty of Forestry, Poznan University of Life Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jandt</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geobotany and Botanical Garden, Martin Luther University Halle-Wittenberg, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4476-5334</Identifier><AffiliationInfo><Affiliation>Institute of Systematic Botany and Ecology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3036-971X</Identifier><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rocky Mountain Biological Laboratory, Crested Butte, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jentsch</LastName><ForeName>Anke</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2345-8300</Identifier><AffiliationInfo><Affiliation>BayCEER, Department of Disturbance Ecology, University of Bayreuth, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jespersen</LastName><ForeName>Jens Rasmus Plantener</ForeName><Initials>JRP</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guo-Feng</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-3221-8608</Identifier><AffiliationInfo><Affiliation>Plant Ecophysiology &amp; Evolution Group, Guangxi Key Laboratory of Forest Ecology and Conservation, College of Forestry, Guangxi University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangxi University, Nanning, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Jesper Liengaard</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-7602-316X</Identifier><AffiliationInfo><Affiliation>Terrestrial Ecology Section, Department of Biology, University of Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2299-2525</Identifier><AffiliationInfo><Affiliation>The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jokela</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-1819-1285</Identifier><AffiliationInfo><Affiliation>School of Forest Resources and Conservation, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joly</LastName><ForeName>Carlos Alfredo</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-7945-2805</Identifier><AffiliationInfo><Affiliation>State University of Campinas/UNICAMP, Campinas, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Gregory J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0002-6033-2766</Identifier><AffiliationInfo><Affiliation>Biological Sciences, University of Tasmania, Hobart, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Grant Stuart</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0002-8731-9828</Identifier><AffiliationInfo><Affiliation>Department of Zoology, School of Mathematical and Natural Science, University of Venda, Thohoyandou, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, DST/NRF Centre of Excellence, Percy FitzPatrick Institute of African Ornithology, University of Cape Town, Rondebosch, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junaedi</LastName><ForeName>Decky</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5846-6135</Identifier><AffiliationInfo><Affiliation>Cibodas Botanical Garden - Indonesian Institute of Sciences (LIPI), Jl. Kebun Raya Cibodas, Cipanas, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Excellence for Biosecurity Risk Analysis (CEBRA), School Of Biosciences, University of Melbourne, Parkville, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junker</LastName><ForeName>Robert R</ForeName><Initials>RR</Initials><Identifier Source="ORCID">0000-0002-7919-9678</Identifier><AffiliationInfo><Affiliation>Evolutionary Ecology of Plants, Department Biology, Philipps-University Marburg, Marburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioscience, University Salzburg, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Justes</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7390-7058</Identifier><AffiliationInfo><Affiliation>PERSYST Department, CIRAD, Montpellier Cedex 5, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabzems</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BC Ministry Forest, Lands, Natural Resource Operations and Rural Development, Dawson Creek, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kane</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1453-9608</Identifier><AffiliationInfo><Affiliation>Humboldt State University, Arcata, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Zdenek</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-1707-7461</Identifier><AffiliationInfo><Affiliation>Institute of Botany, The Czech Academy of Sciences, Prùhonice, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kattenborn</LastName><ForeName>Teja</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7381-3828</Identifier><AffiliationInfo><Affiliation>Institute of Geography and Geoecology, Karlsruhe Institute of Technology, Karlsruhe, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavelenova</LastName><ForeName>Lyudmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Samara National Research University, Samara, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kearsley</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0046-3606</Identifier><AffiliationInfo><Affiliation>CAVElab - Computational and Applied Vegetation Ecology, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempel</LastName><ForeName>Anne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0563-901X</Identifier><AffiliationInfo><Affiliation>Institute of Plant Sciences, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenzo</LastName><ForeName>Tanaka</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4856-7204</Identifier><AffiliationInfo><Affiliation>Forestry and Forest Products Research Institute, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerkhoff</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kenyon College, Gambier, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Mohammed I</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0002-9310-2780</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Garmian, Kalar, Iraq.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences and Center for Ecology, Southern Illinois University Carbondale, Carbondale, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinlock</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-2917-5133</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Evolution, State University of New York at Stony Brook, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissling</LastName><ForeName>Wilm Daniel</ForeName><Initials>WD</Initials><Identifier Source="ORCID">0000-0002-7274-6755</Identifier><AffiliationInfo><Affiliation>Institute for Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitajima</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6822-8536</Identifier><AffiliationInfo><Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Molecular and Life Sciences, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitzberger</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9754-4121</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaciones en Biodiversidad y Medioambiente (INIBIOMA), CONICET, Bariloche, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ecología, Universidad Nacional del Comahue, Bariloche, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kjøller</LastName><ForeName>Rasmus</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2027-4119</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Tamir</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3882-8845</Identifier><AffiliationInfo><Affiliation>Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleyer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0824-2974</Identifier><AffiliationInfo><Affiliation>Landscape Ecology Group, Institute of Biology and Environmental Sciences, University of Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klimešová</LastName><ForeName>Jitka</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0123-3263</Identifier><AffiliationInfo><Affiliation>Institute of Botany, Czech Academy of Sciences, Třeboň, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Sciences, Charles University, Praha, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klipel</LastName><ForeName>Joice</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3936-9692</Identifier><AffiliationInfo><Affiliation>Laboratório de Ecologia Vegetal (LEVEG), Programa de Pós-Graduação em Ecologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloeppel</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0215-4671</Identifier><AffiliationInfo><Affiliation>Department of Geosciences and Natural Resources, Western Carolina University, Cullowhee, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klotz</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Ecology, Helmholtz Centre for Environmental Research-UFZ, Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knops</LastName><ForeName>Johannes M H</ForeName><Initials>JMH</Initials><AffiliationInfo><Affiliation>Health and Environmental Sciences, Xi'an Jiaotong Liverpool University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohyama</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7186-8585</Identifier><AffiliationInfo><Affiliation>Hokkaido University, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Fumito</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6588-6485</Identifier><AffiliationInfo><Affiliation>Graduate School of Environment and Information Sciences, Yokohama National University, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kollmann</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4990-3636</Identifier><AffiliationInfo><Affiliation>Technical University of Munich, Freising, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komac</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut d Estudis Andorrans, Andorra.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7056-4547</Identifier><AffiliationInfo><Affiliation>Smithsonian Environmental Research Center, Edgewater, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>König</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0585-5983</Identifier><AffiliationInfo><Affiliation>Department of Geography, Humboldt University of Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biodiversity, Macroecology and Biogeography, University of Goettingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Nathan J B</ForeName><Initials>NJB</Initials><Identifier Source="ORCID">0000-0001-8867-7806</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Koen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1402-2775</Identifier><AffiliationInfo><Affiliation>Wageningen University &amp; Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Land Life Company, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreft</LastName><ForeName>Holger</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4471-8236</Identifier><AffiliationInfo><Affiliation>Biodiversity, Macroecology and Biogeography, University of Goettingen, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Biodiversity and Sustainable Land Use (CBL), University of Goettingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kühn</LastName><ForeName>Ingolf</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1691-8249</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helmholtz Centre for Environmental Research - UFZ, Halle, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Martin Luther University Halle-Wittenberg, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumarathunge</LastName><ForeName>Dushan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1309-4731</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plant Physiology Division, Coconut Research Institute of Sri Lanka, Lunuwila, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuppler</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4409-9367</Identifier><AffiliationInfo><Affiliation>Institute of Evolutionary Ecology and Conservation Genomics, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurokawa</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8778-8045</Identifier><AffiliationInfo><Affiliation>Forestry and Forest Products Research Institute, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurosawa</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1419-7575</Identifier><AffiliationInfo><Affiliation>Yamagata University, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuyah</LastName><ForeName>Shem</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7692-585X</Identifier><AffiliationInfo><Affiliation>Jomo Kenyatta University of Agriculture and Technology (JKUAT), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laclau</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-2506-214X</Identifier><AffiliationInfo><Affiliation>CIRAD, UMR Eco&amp;Sols, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eco&amp;Sols, CIRAD, INRA, IRD, SupAgro, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafleur</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut de recherche sur les forêts, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lallai</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Botany Division, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5201-4541</Identifier><AffiliationInfo><Affiliation>Department of Plant Sciences, University of Saskatchewan, Saskatoon, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamprecht</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8719-026X</Identifier><AffiliationInfo><Affiliation>GLORIA-Coordination, Institute for Interdisciplinary Mountain Research, Austrian Academy of Sciences &amp; Department of Integrative Biology and Biodiversity Research, University of Natural Resources and Life Sciences Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larkin</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0001-6378-0495</Identifier><AffiliationInfo><Affiliation>Department of Fisheries, Wildlife and Conservation Biology, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laughlin</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9651-5732</Identifier><AffiliationInfo><Affiliation>Botany Department, University of Wyoming, Laramie, WY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Bagousse-Pinguet</LastName><ForeName>Yoann</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5615-5541</Identifier><AffiliationInfo><Affiliation>Aix Marseille Univ, Univ Avignon, CNRS, IRD, IMBE, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>le Maire</LastName><ForeName>Guerric</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5227-958X</Identifier><AffiliationInfo><Affiliation>CIRAD, UMR Eco&amp;Sols, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eco&amp;Sols, CIRAD, INRA, IRD, SupAgro, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>le Roux</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-7941-7444</Identifier><AffiliationInfo><Affiliation>Department of Plant and Soil Sciences, University of Pretoria, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>le Roux</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8468-8284</Identifier><AffiliationInfo><Affiliation>Nelson Mandela University, Port Elizabeth, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Tali</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3933-6607</Identifier><AffiliationInfo><Affiliation>University of Wisconsin Eau Claire, Eau Claire, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lens</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5001-0149</Identifier><AffiliationInfo><Affiliation>Naturalis Biodiversity Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Simon L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-8066-6851</Identifier><AffiliationInfo><Affiliation>School of Geography, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geography, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lhotsky</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jonah Ventures, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanzhi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5258-877X</Identifier><AffiliationInfo><Affiliation>Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xine</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Yangzhou University, Yangzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichstein</LastName><ForeName>Jeremy W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0001-5553-6142</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebergesell</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jun Ying</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-7493-2159</Identifier><AffiliationInfo><Affiliation>Institute for Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yan-Shih</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Macquarie University, North Ryde, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linares</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-8375-6353</Identifier><AffiliationInfo><Affiliation>University Pablo de Olavide, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunjiang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Urban Forest Ecosystem Research Station, National Forestry and Grassland Administration, Shanghai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Daijun</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0993-0832</Identifier><AffiliationInfo><Affiliation>School of Geography, Earth and Environmental Sciences - University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Udayangani</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-6192-1319</Identifier><AffiliationInfo><Affiliation>Royal Botanic Gardens, Kew, West Sussex, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livingstone</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Toronto Scarborough, Scarborough, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llusià</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohbeck</LastName><ForeName>Madelon</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3959-1800</Identifier><AffiliationInfo><Affiliation>Forest Ecology and Forest Management Group, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>World Agroforestry (ICRAF), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-García</LastName><ForeName>Álvaro</ForeName><Initials>Á</Initials><Identifier Source="ORCID">0000-0001-8267-3572</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept. Animal Biology, Plant Biology and Ecology, University of Jaén, Jaén, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Gonzalez</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0814-8830</Identifier><AffiliationInfo><Affiliation>water@leeds, School of Geography, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lososová</LastName><ForeName>Zdeňka</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-9152-7462</Identifier><AffiliationInfo><Affiliation>Department of Botany and Zoology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louault</LastName><ForeName>Frédérique</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9430-4261</Identifier><AffiliationInfo><Affiliation>UCA, INRA, VetAgro Sup, UMR Ecosystème Prairial, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukács</LastName><ForeName>Balázs A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0002-3163-1281</Identifier><AffiliationInfo><Affiliation>Department for Tisza River Research, MTA Centre for Ecological Research, DRI, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukeš</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Change Research Institute AS CR, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yunjian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Ecology, School of Horticulture and Plant Protection, Yangzhou University, Yangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Urban and Regional Ecology, Research Centre for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lussu</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1313-4732</Identifier><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Botany Division, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Siyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of California at Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maciel Rabelo Pereira</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7027-7430</Identifier><AffiliationInfo><Affiliation>University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Ecosystem Science and Society, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maire</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-3245-2568</Identifier><AffiliationInfo><Affiliation>Université du Québec à Trois-Rivières, Trois-Rivières, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mäkelä</LastName><ForeName>Annikki</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9633-7350</Identifier><AffiliationInfo><Affiliation>Institute of Atmospheric and Earth System Research (INAR), University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mäkinen</LastName><ForeName>Harri</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1820-6264</Identifier><AffiliationInfo><Affiliation>Natural Resources Institute Finland, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malhado</LastName><ForeName>Ana Claudia Mendes</ForeName><Initials>ACM</Initials><Identifier Source="ORCID">0000-0003-3621-779X</Identifier><AffiliationInfo><Affiliation>Federal University of Alagoas, Maceió, AL, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallik</LastName><ForeName>Azim</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6275-6255</Identifier><AffiliationInfo><Affiliation>Lakehead University, Thunder Bay, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manning</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7940-2023</Identifier><AffiliationInfo><Affiliation>Senckenberg Biodiversity and Climate Research Centre, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzoni</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5960-5712</Identifier><AffiliationInfo><Affiliation>Department of Physical Geography, Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bolin Centre for Climate Research, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchetti</LastName><ForeName>Zuleica</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9241-9217</Identifier><AffiliationInfo><Affiliation>Conicet-Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ingeniería y Ciencias Hídricas, Universidad Nacional del Litoral (FICH-UNL), Santa Fe, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchino</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CREA - Research Centre for Forestry and Wood, Arezzo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcilio-Silva</LastName><ForeName>Vinicius</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5276-2838</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcon</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5249-321X</Identifier><AffiliationInfo><Affiliation>Cirad, UMR EcoFoG (Agroparistech, CNRS, INRA, Université des Antilles, Université de la Guyane), Kourou, French Guiana, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marignani</LastName><ForeName>Michela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8420-5454</Identifier><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Botany Division, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markesteijn</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3046-3121</Identifier><AffiliationInfo><Affiliation>School of Natural Sciences, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7207-4004</Identifier><AffiliationInfo><Affiliation>Department of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Garza</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9310-564X</Identifier><AffiliationInfo><Affiliation>Centro de Investigación en Biodiversidad y Conservación, Universidad Autónoma del Estado de Morelos, Morelos, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Vilalta</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2332-7298</Identifier><AffiliationInfo><Affiliation>CREAF, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Autònoma de Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mašková</LastName><ForeName>Tereza</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8386-5146</Identifier><AffiliationInfo><Affiliation>Faculty of Sciences, Charles University, Praha, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3426-3178</Identifier><AffiliationInfo><Affiliation>Centre for Ecology &amp; Hydrology, Lancaster Environment Centre, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Manaaki Whenua - Landcare Research, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massad</LastName><ForeName>Tara Joy</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Scientific Services, Gorongosa National Park, Beira, Sofala Province, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masse</LastName><ForeName>Jacynthe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut de recherche en biologie végétale, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université de Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayrose</LastName><ForeName>Itay</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8460-1502</Identifier><AffiliationInfo><Affiliation>School of Plant Sciences and Food Security, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3060-1678</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Queensland, Brisbane, Qld, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CSIRO, Canberra, ACT, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manaaki Whenua - Landcare Research, Lincoln, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormack</LastName><ForeName>M Luke</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-8300-5215</Identifier><AffiliationInfo><Affiliation>Center For Tree Science, The Morton Arboretum, Lisle, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCulloh</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0801-3968</Identifier><AffiliationInfo><Affiliation>Department of Botany, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McFadden</LastName><ForeName>Ian R</ForeName><Initials>IR</Initials><Identifier Source="ORCID">0000-0002-4508-7272</Identifier><AffiliationInfo><Affiliation>Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGill</LastName><ForeName>Brian J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>University of Maine, Orono, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPartland</LastName><ForeName>Mara Y</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0002-1242-0438</Identifier><AffiliationInfo><Affiliation>Department of Geography, Environment &amp; Society, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medeiros</LastName><ForeName>Juliana S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Holden Arboretum, Kirtland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medlyn</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5728-9827</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meerts</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Université Libre de Bruxelles, Bruxelles, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabi</LastName><ForeName>Zia</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-9574-0420</Identifier><AffiliationInfo><Affiliation>Institute for Resources Environment and Sustainability, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meir</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2362-0398</Identifier><AffiliationInfo><Affiliation>Research School of Biology, The Australian National University, Canberra, ACT, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Geosciences, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>Felipe P L</ForeName><Initials>FPL</Initials><Identifier Source="ORCID">0000-0002-1271-3214</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mencuccini</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0840-1477</Identifier><AffiliationInfo><Affiliation>ICREA, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CREAF, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meredieu</LastName><ForeName>Céline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2950-2253</Identifier><AffiliationInfo><Affiliation>INRA, UEFP, Cestas, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messier</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1637-6793</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Waterloo, Waterloo, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mészáros</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Botany, Faculty of Science and Technology, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metsaranta</LastName><ForeName>Juha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Natural Resources Canada, Canadian Forest Service, Northern Forestry Centre, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaletz</LastName><ForeName>Sean T</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0003-2158-6525</Identifier><AffiliationInfo><Affiliation>Department of Botany and Biodiversity Research Centre, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michelaki</LastName><ForeName>Chrysanthi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9217-0063</Identifier><AffiliationInfo><Affiliation>Biodiversity Conservation Laboratory, Department of Environment, University of the Aegean, Mytilene, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migalina</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute Botanic Garden, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tyumen State University, Tyumen, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milla</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8912-4373</Identifier><AffiliationInfo><Affiliation>Tulipan s/n, Móstoles-Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jesse E D</ForeName><Initials>JED</Initials><Identifier Source="ORCID">0000-0002-2316-779X</Identifier><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minden</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4933-5931</Identifier><AffiliationInfo><Affiliation>Institute of Biology and Environmental Sciences, University of Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ming</LastName><ForeName>Ray</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9417-5789</Identifier><AffiliationInfo><Affiliation>University of Illinois at Urbana-Champaign, Urbana-Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mokany</LastName><ForeName>Karel</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4199-3697</Identifier><AffiliationInfo><Affiliation>CSIRO, Canberra, ACT, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moles</LastName><ForeName>Angela T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0003-2041-7762</Identifier><AffiliationInfo><Affiliation>Evolution &amp; Ecology Research Centre, and School of Biological, Earth and Environmental Sciences, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnár</LastName><ForeName>Attila</ForeName><Initials>A</Initials><Suffix>5th</Suffix><Identifier Source="ORCID">0000-0001-7096-9579</Identifier><AffiliationInfo><Affiliation>Department of Botany, University of Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molofsky</LastName><ForeName>Jane</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7927-516X</Identifier><AffiliationInfo><Affiliation>University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molz</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundação Zoobotânica do Rio Grande do Sul, Porto Allegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monty</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1910-6748</Identifier><AffiliationInfo><Affiliation>Gembloux Agro-Bio Tech, Biodiversity and landscape, University of Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moravcová</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Invasion Ecology, Institute of Botany, Czech Academy of Sciences, Průhonice, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Martínez</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2990-7768</Identifier><AffiliationInfo><Affiliation>Numerical Terradynamic Simulation Group (NTSG), College of Forestry and Conservation, University of Montana, Missoula, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moretti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5845-3198</Identifier><AffiliationInfo><Affiliation>Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Akira S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-8422-1198</Identifier><AffiliationInfo><Affiliation>Graduate School of Environment and Information Sciences, Yokohama National University, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Shigeta</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5604-2443</Identifier><AffiliationInfo><Affiliation>Yamagata University, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Dave</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5739-0594</Identifier><AffiliationInfo><Affiliation>Ontario Ministry of Natural Resources and Forestry, Centre for Northern Forest Ecosystem Research, Thunder Bay, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Jane</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4055-4679</Identifier><AffiliationInfo><Affiliation>Universitat Politècnica de Catalunya, Castelldefels, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucina</LastName><ForeName>Ladislav</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0317-8886</Identifier><AffiliationInfo><Affiliation>Harry Butler Institute, Murdoch University, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Geography &amp; Environmental Studies, Stellenbosch University, Matieland, Stellenbosch, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geobotany, Faculty of Biology, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muir</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0003-2555-3878</Identifier><AffiliationInfo><Affiliation>Department of Botany, University of Hawai'i, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Sandra Cristina</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-6316-2897</Identifier><AffiliationInfo><Affiliation>Laboratório de Ecologia Vegetal, Departamento de Ecologia, Programa de Pós-Graduação em Ecologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz</LastName><ForeName>François</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8776-4705</Identifier><AffiliationInfo><Affiliation>Laboratoire d'Ecologie Alpine, Université Grenoble-Alpes, Grenoble Cedex 9, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>French Institute of Pondicherry, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers-Smith</LastName><ForeName>Isla H</ForeName><Initials>IH</Initials><Identifier Source="ORCID">0000-0002-8417-6112</Identifier><AffiliationInfo><Affiliation>School of Geosciences, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myster</LastName><ForeName>Randall W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Biology Department, Oklahoma State University, Oklahoma, OK, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagano</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Osaka City University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naidu</LastName><ForeName>Shawna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Illinois at Urbana-Champaign, Urbana-Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayanan</LastName><ForeName>Ayyappan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ecology, French Institute of Pondicherry, Pondicherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natesan</LastName><ForeName>Balachandran</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6396-3865</Identifier><AffiliationInfo><Affiliation>Department of Ecology, French Institute of Pondicherry, Pondicherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negoita</LastName><ForeName>Luka</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3225-7575</Identifier><AffiliationInfo><Affiliation>Galápagos Verde 2050, Charles Darwin Foundation, Charles Darwin Research Station, Galapagos, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-8715-7825</Identifier><AffiliationInfo><Affiliation>Forest, Rangeland, and Fire Sciences Department, University of Idaho, Moscow, ID, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuschulz</LastName><ForeName>Eike Lena</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0001-7526-2580</Identifier><AffiliationInfo><Affiliation>Senckenberg Biodiversity and Climate Research Centre, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5411-7050</Identifier><AffiliationInfo><Affiliation>College of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedrist</LastName><ForeName>Georg</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7511-6273</Identifier><AffiliationInfo><Affiliation>Eurac Research, Institute for Alpine Environment, Bozen-Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieto</LastName><ForeName>Jhon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Investigación de Recursos Biológicos Alexander von Humboldt, Bogota, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Distrital Francisco José de Caldas, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niinemets</LastName><ForeName>Ülo</ForeName><Initials>Ü</Initials><Identifier Source="ORCID">0000-0002-3078-2192</Identifier><AffiliationInfo><Affiliation>Estonian University of Life Sciences, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Rachael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9277-5142</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nottebrock</LastName><ForeName>Henning</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2238-2700</Identifier><AffiliationInfo><Affiliation>Plant Ecology, University of Bayreuth, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouvellon</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1920-3847</Identifier><AffiliationInfo><Affiliation>CIRAD, UMR Eco&amp;Sols, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eco&amp;Sols, CIRAD, INRA, IRD, SupAgro, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovskiy</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4105-7436</Identifier><AffiliationInfo><Affiliation>Institute of Biology of Komi Science Centre of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Komi Republic, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Nutrient Network</CollectiveName></Author><Author ValidYN="Y"><LastName>Nystuen</LastName><ForeName>Kristin Odden</ForeName><Initials>KO</Initials><Identifier Source="ORCID">0000-0003-1027-469X</Identifier><AffiliationInfo><Affiliation>Faculty of Biosciences and Aquaculture, NORD University, Steinkjer, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Grady</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CSIRO Land and Water, Hobart Tas, Tas., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3800-9188</Identifier><AffiliationInfo><Affiliation>University of California at Berkeley, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Reilly-Nugent</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2071-6279</Identifier><AffiliationInfo><Affiliation>Institute of Applied Ecology, University of Canberra, Canberra, ACT, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oakley</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5757-7420</Identifier><AffiliationInfo><Affiliation>Centre for Ecology &amp; Hydrology, Lancaster Environment Centre, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberhuber</LastName><ForeName>Walter</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5197-7044</Identifier><AffiliationInfo><Affiliation>University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohtsuka</LastName><ForeName>Toshiyuki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9032-7933</Identifier><AffiliationInfo><Affiliation>River Basin Research Center, Gifu University, Gifu, Gifu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8044-3458</Identifier><AffiliationInfo><Affiliation>Departamento de Botânica, Universidade Federal do Paraná, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Öllerer</LastName><ForeName>Kinga</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3142-0000</Identifier><AffiliationInfo><Affiliation>Institute of Biology Bucharest, Romanian Academy, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Ecology and Botany, MTA Centre for Ecological Research, Vácrátót, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>Mark E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-3715-4567</Identifier><AffiliationInfo><Affiliation>Instituto de Biología, Tercer Circuito s/n de Ciudad Universitaria, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional Autónoma de México, Coyoacán, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onipchenko</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-1626-1171</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Plant Geography, Faculty of Biology, Moscow Lomonosov State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onoda</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6245-2342</Identifier><AffiliationInfo><Affiliation>Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onstein</LastName><ForeName>Renske E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-2295-3510</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordonez</LastName><ForeName>Jenny C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Facultad de Ingeniería Agroindustrial, Universidad de las Américas, Quito, Equador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osada</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Meijo University, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostonen</LastName><ForeName>Ivika</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9043-6083</Identifier><AffiliationInfo><Affiliation>Institute of Ecology and Earth Sciences, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottaviani</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3027-4638</Identifier><AffiliationInfo><Affiliation>Institute of Botany, Czech Academy of Sciences, Třeboň, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3042-0818</Identifier><AffiliationInfo><Affiliation>Department of Zoology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overbeck</LastName><ForeName>Gerhard E</ForeName><Initials>GE</Initials><Identifier Source="ORCID">0000-0002-8716-5136</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozinga</LastName><ForeName>Wim A</ForeName><Initials>WA</Initials><Identifier Source="ORCID">0000-0002-6369-7859</Identifier><AffiliationInfo><Affiliation>Wageningen Environmental Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahl</LastName><ForeName>Anna T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Restoration Ecology, Technische Universität München, München, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paine</LastName><ForeName>C E Timothy</ForeName><Initials>CET</Initials><Identifier Source="ORCID">0000-0001-8705-3719</Identifier><AffiliationInfo><Affiliation>University of New England, Armidale, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakeman</LastName><ForeName>Robin J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6248-4133</Identifier><AffiliationInfo><Affiliation>The James Hutton Institute, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Aristotelis C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-6657-7820</Identifier><AffiliationInfo><Affiliation>Department for Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parfionova</LastName><ForeName>Evgeniya</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Samara National Research University, Samara, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pärtel</LastName><ForeName>Meelis</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5874-0138</Identifier><AffiliationInfo><Affiliation>University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patacca</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wageningen University &amp; Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paula</LastName><ForeName>Susana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5405-6155</Identifier><AffiliationInfo><Affiliation>Instituto de Ciencias Ambientales y Evolutivas, Universidad Austral de Chile, Valdivia, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paule</LastName><ForeName>Juraj</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5375-7689</Identifier><AffiliationInfo><Affiliation>Department of Botany and Molecular Evolution, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pauli</LastName><ForeName>Harald</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9842-9934</Identifier><AffiliationInfo><Affiliation>GLORIA-Coordination, Institute for Interdisciplinary Mountain Research, Austrian Academy of Sciences &amp; Department of Integrative Biology and Biodiversity Research, University of Natural Resources and Life Sciences Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pausas</LastName><ForeName>Juli G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-3533-5786</Identifier><AffiliationInfo><Affiliation>Desertification Research Center (CIDE-CSIC), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peco</LastName><ForeName>Begoña</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2149-1438</Identifier><AffiliationInfo><Affiliation>Departamento de Ecología, Centro de Investigación en Biodiversidad y Cambio Global (CIBC), Universidad Autónoma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penuelas</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7215-0150</Identifier><AffiliationInfo><Affiliation>CREAF, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Ecology Unit CREAF-CSIC, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perea</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8351-9358</Identifier><AffiliationInfo><Affiliation>University of Jaén, Jaén, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peri</LastName><ForeName>Pablo Luis</ForeName><Initials>PL</Initials><Identifier Source="ORCID">0000-0002-5398-4408</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Tecnología Agropecuaria (INTA), Río Gallegos, Santa Cruz, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Nacional de la Patagonia Austral (UNPA), CONICET, Rio Gallegos, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petisco-Souza</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-2393-6210</Identifier><AffiliationInfo><Affiliation>Pós-graduação em Ecologia e Conservação, Universidade Federal do Paraná, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petraglia</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4632-2251</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petritan</LastName><ForeName>Any Mary</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-3683-1108</Identifier><AffiliationInfo><Affiliation>National Institute for Research-Development in Forestry, Voluntari, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Oliver L</ForeName><Initials>OL</Initials><Identifier Source="ORCID">0000-0002-8993-6168</Identifier><AffiliationInfo><Affiliation>School of Geography, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1182-987X</Identifier><AffiliationInfo><Affiliation>Department of Agricultural and Environmental Sciences (DiSAA), University of Milan, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillar</LastName><ForeName>Valério D</ForeName><Initials>VD</Initials><Identifier Source="ORCID">0000-0001-6408-2891</Identifier><AffiliationInfo><Affiliation>Department of Ecology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0396-2072</Identifier><AffiliationInfo><Affiliation>Tartu Observatory, University of Tartu, Tartumaa, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomogaybin</LastName><ForeName>Alexandr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Botanical Garden of the Samara University, Samara, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poorter</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9900-2433</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Plant Sciences (IBG2), Forschungszentrum Jülich GmbH, Jülich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portsmuth</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5100-2888</Identifier><AffiliationInfo><Affiliation>Institute of Ecology, Tallinn University, Tallinn, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poschlod</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4473-7656</Identifier><AffiliationInfo><Affiliation>Ecology and Conservation Biology, Institute of Plant Sciences, University of Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potvin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pounds</LastName><ForeName>Devon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Morton Arboretum, Lisle, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>A Shafer</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-9622-0061</Identifier><AffiliationInfo><Affiliation>Environmental Sciences Division &amp; Climate Change Science Institute, Oak Ridge National Laboratory, Oak Ridge, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Power</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-2723-8671</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinzing</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Unit ECOBIO - Ecosystèmes, Biodiversité, Evolution, Université Rennes 1/CNRS, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puglielli</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0085-4535</Identifier><AffiliationInfo><Affiliation>Estonian University of Life Sciences, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyšek</LastName><ForeName>Petr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8500-442X</Identifier><AffiliationInfo><Affiliation>Department of Invasion Ecology, Institute of Botany, Czech Academy of Sciences, Průhonice, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raevel</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9631-114X</Identifier><AffiliationInfo><Affiliation>AMAP, CIRAD, CNRS, IRD, INRA, Université de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>French Institute of Pondicherry, Puducherry, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CEFE, CNRS, EPHE, Université de Montpellier, Université Paul Valéry, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rammig</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ransijn</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Courtenay A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-2276-5915</Identifier><AffiliationInfo><Affiliation>Rocky Mountain Biological Laboratory, Crested Butte, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Peter B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0003-4424-662X</Identifier><AffiliationInfo><Affiliation>Department of Forest Resources, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reichstein</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>Douglas E B</ForeName><Initials>DEB</Initials><Identifier Source="ORCID">0000-0002-0967-5122</Identifier><AffiliationInfo><Affiliation>Ontario Ministry of Natural Resources and Forestry, Centre for Northern Forest Ecosystem Research, Thunder Bay, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Réjou-Méchain</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2824-267X</Identifier><AffiliationInfo><Affiliation>AMAP, CIRAD, CNRS, IRD, INRA, Université de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Dios</LastName><ForeName>Victor Resco</ForeName><Initials>VR</Initials><Identifier Source="ORCID">0000-0002-5721-1656</Identifier><AffiliationInfo><Affiliation>School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Crop and Forest Sciences &amp; Agrotecnio Center, Universitat de Lleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4504-3050</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Acre, Rio Branco, AC, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4097-0381</Identifier><AffiliationInfo><Affiliation>Manaaki Whenua-Landcare Research, Lincoln, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riibak</LastName><ForeName>Kersti</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rillig</LastName><ForeName>Matthias C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-3541-7853</Identifier><AffiliationInfo><Affiliation>Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Freie Universität Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riviera</LastName><ForeName>Fiamma</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-2505-8180</Identifier><AffiliationInfo><Affiliation>The University of Western Australia, Crawley, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Elisabeth M R</ForeName><Initials>EMR</Initials><Identifier Source="ORCID">0000-0002-3611-7265</Identifier><AffiliationInfo><Affiliation>Centre for Ecological Research and Forestry Applications (CREAF), Cerdanyola del Vallès, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ecology and Biodiversity, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Wood Biology and Xylarium, Royal Museum for Central-Africa (RMCA), Tervuren, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Forestry, Mississippi State University, Starkville, MS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robroek</LastName><ForeName>Bjorn</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6714-0652</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aquatic Ecology and Environmental Biology, Radboud University Nijmegen, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roddy</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4423-8729</Identifier><AffiliationInfo><Affiliation>School of Forestry &amp; Environmental Studies, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Arthur Vinicius</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-2656-558X</Identifier><AffiliationInfo><Affiliation>Programa de pós-graduação em Ecologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Alistair</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9262-7430</Identifier><AffiliationInfo><Affiliation>Environmental and Climate Sciences Department, Brookhaven National Laboratory, NY, Upton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rollinson</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3428-2352</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, East Stroudsburg University, East Stroudsburg, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolo</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5854-9512</Identifier><AffiliationInfo><Affiliation>Forest Research Group, INDEHESA, University of Extremadura, Plasencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Römermann</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3471-0951</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronzhina</LastName><ForeName>Dina</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0854-0223</Identifier><AffiliationInfo><Affiliation>Institute Botanic Garden, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tyumen State University, Tyumen, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roscher</LastName><ForeName>Christiane</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9301-7909</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiological Diversity, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosell</LastName><ForeName>Julieta A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5741-8027</Identifier><AffiliationInfo><Affiliation>Laboratorio Nacional de Ciencias de la Sostenibilidad, Instituto de Ecología, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenfield</LastName><ForeName>Milena Fermina</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0002-1799-2822</Identifier><AffiliationInfo><Affiliation>School of Environmental Sciences, University of Guelph, Guelph, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Remote Sensing Laboratories, Department of Geography, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit Community Ecology, Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research and Geoinformation, Swiss National Park, Chastè Planta-Wildenberg, Zernez, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0002-5147-0331</Identifier><AffiliationInfo><Affiliation>Centre for Ecology &amp; Hydrology (CEH), Wallingford, Oxfordshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royer-Tardif</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7809-6485</Identifier><AffiliationInfo><Affiliation>Natural Resources Canada, Canadian Forest Service, Québec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rüger</LastName><ForeName>Nadja</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2371-4172</Identifier><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Peinado</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0126-1651</Identifier><AffiliationInfo><Affiliation>Departamento de Dinamica y Gestion Forestal, INIA-CIFOR, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sustainable Forest Management Research Institute, University of Valladolid-INIA, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rumpf</LastName><ForeName>Sabine B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0001-5909-9568</Identifier><AffiliationInfo><Affiliation>Department of Botany and Biodiversity Research, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology and Evolution, University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusch</LastName><ForeName>Graciela M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Norwegian Institute for Nature Research, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryo</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5271-3446</Identifier><AffiliationInfo><Affiliation>Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Freie Universität Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sack</LastName><ForeName>Lawren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7009-7202</Identifier><AffiliationInfo><Affiliation>Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saldaña</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidad Nacional Autónoma de México, Coyoacán, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado-Negret</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3103-9878</Identifier><AffiliationInfo><Affiliation>Departamento de Biología, Universidad Nacional de Colombia, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salguero-Gomez</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6085-4433</Identifier><AffiliationInfo><Affiliation>Oxford University, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santa-Regina</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7312-3605</Identifier><AffiliationInfo><Affiliation>Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA-CSIC), Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santacruz-García</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-3340-4859</Identifier><AffiliationInfo><Affiliation>Conicet-Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ciencias Forestales, Universidad Nacional de Santiago del Estero, Santiago del Estero, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2160-4968</Identifier><AffiliationInfo><Affiliation>Centre for Functional Ecology, Departamento de Ciências da Vida, Universidade de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardans</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2478-0219</Identifier><AffiliationInfo><Affiliation>Global Ecology Unit CREAF-CSIC, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schamp</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6885-2029</Identifier><AffiliationInfo><Affiliation>Algoma University, Sault Ste. Marie, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer-Lorenzen</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9566-590X</Identifier><AffiliationInfo><Affiliation>Geobotany, Faculty of Biology, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schleuning</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9426-045X</Identifier><AffiliationInfo><Affiliation>Senckenberg Biodiversity and Climate Research Centre, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8430-3214</Identifier><AffiliationInfo><Affiliation>Department of Geography, University of Zurich, Zürich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6087-6117</Identifier><AffiliationInfo><Affiliation>Senckenberg Biodiversität und Klima Forschungszentrum (SBiK-F), Frankfurt, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palmengarten der Stadt Frankfurt am Main, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7759-7106</Identifier><AffiliationInfo><Affiliation>Univ. Bordeaux, INRAE, BIOGECO, Cestas, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Julio V</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0002-9823-6569</Identifier><AffiliationInfo><Affiliation>Department of Botany and Molecular Evolution, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Entomology III, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schowanek</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-6036-7507</Identifier><AffiliationInfo><Affiliation>Section for Ecoinformatics and Biodiversity, Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biodiversity Dynamics in a Changing World (BIOCHANGE), Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrader</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8392-211X</Identifier><AffiliationInfo><Affiliation>Biodiversity, Macroecology and Biogeography, University of Goettingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrodt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9053-8872</Identifier><AffiliationInfo><Affiliation>School of Geography, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuldt</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Julius-von-Sachs-Institute for Biological Sciences, Chair of Ecophysiology and Vegetation Ecology, University of Wuerzburg, Wuerzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schurr</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4518-0602</Identifier><AffiliationInfo><Affiliation>Institute of Landscape and Plant Ecology, University of Hohenheim, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selaya Garvizu</LastName><ForeName>Galia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1920-7450</Identifier><AffiliationInfo><Affiliation>Herencia, Santa Cruz, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semchenko</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6196-3562</Identifier><AffiliationInfo><Affiliation>Department of Earth and Environmental Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seymour</LastName><ForeName>Colleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>South African National Biodiversity Institute, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sfair</LastName><ForeName>Julia C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0003-3823-7233</Identifier><AffiliationInfo><Affiliation>Federal University of Pernambuco, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharpe</LastName><ForeName>Joanne M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Sharplex Services, Edgecomb, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-7847-2310</Identifier><AffiliationInfo><Affiliation>Institute of Landscape and Plant Ecology, University of Hohenheim, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheremetiev</LastName><ForeName>Serge</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0318-6766</Identifier><AffiliationInfo><Affiliation>Komarov Botanical Institute RAS, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiodera</LastName><ForeName>Satomi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6849-8568</Identifier><AffiliationInfo><Affiliation>Research Institute for Humanity and Nature, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Southeast Asian Studies, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shipley</LastName><ForeName>Bill</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7026-3880</Identifier><AffiliationInfo><Affiliation>Université de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shovon</LastName><ForeName>Tanvir Ahmed</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0003-3311-1797</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Regina, Regina, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebenkäs</LastName><ForeName>Alrun</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9676-7094</Identifier><AffiliationInfo><Affiliation>Technische Universität Ilmenau, Ilmenau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0009-4169</Identifier><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Vasco</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2729-1824</Identifier><AffiliationInfo><Affiliation>Centre for Applied Ecology "Professor Baeta Neves" (CEABN), School of Agriculture, University of Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Mateus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4281-3400</Identifier><AffiliationInfo><Affiliation>Department of Biology, Federal University of Lavras, Lavras, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitzia</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6221-4256</Identifier><AffiliationInfo><Affiliation>Department Land, Environment, Agriculture and Forestry, Università degli Studi di Padova, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sjöman</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5526-6303</Identifier><AffiliationInfo><Affiliation>Department of Landscape Architecture, Planning and Management, Swedish University of Agricultural Sciences, Alnarp, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gothenburg Botanical Garden, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gothenburg Global Biodiversity Centre, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slot</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5558-1792</Identifier><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Nicholas G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0001-7048-4387</Identifier><AffiliationInfo><Affiliation>Texas Tech University, Lubbock, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sodhi</LastName><ForeName>Darwin</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2119-2681</Identifier><AffiliationInfo><Affiliation>Forest Sciences Centre, Faculty of Forestry and Conservation Science, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soltis</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9310-8659</Identifier><AffiliationInfo><Affiliation>Florida Museum of Natural History, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soltis</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8638-4137</Identifier><AffiliationInfo><Affiliation>Florida Museum of Natural History, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somers</LastName><ForeName>Ben</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7875-107X</Identifier><AffiliationInfo><Affiliation>Department of Earth and Environmental Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnier</LastName><ForeName>Grégory</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0614-7033</Identifier><AffiliationInfo><Affiliation>Archbold Biological Station, Venus, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sørensen</LastName><ForeName>Mia Vedel</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-2225-6117</Identifier><AffiliationInfo><Affiliation>Norwegian University of Science and Technology NTNU, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosinski</LastName><ForeName>Enio Egon</ForeName><Initials>EE</Initials><Suffix>Jr</Suffix><Identifier Source="ORCID">0000-0001-6310-9474</Identifier><AffiliationInfo><Affiliation>Embrapa Recursos Genéticos e Biotecnologia, Brasilia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soudzilovskaia</LastName><ForeName>Nadejda A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-9584-2109</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Sciences, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Alexandre F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-7468-3631</Identifier><AffiliationInfo><Affiliation>Departamento de Ecologia, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spasojevic</LastName><ForeName>Marko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1808-0048</Identifier><AffiliationInfo><Affiliation>Department of Evolution, Ecology, and Organismal Biology, University of California Riverside, Riverside, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sperandii</LastName><ForeName>Marta Gaia</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-2507-5928</Identifier><AffiliationInfo><Affiliation>University of Roma Tre, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stan</LastName><ForeName>Amanda B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0001-6111-0578</Identifier><AffiliationInfo><Affiliation>Department of Geography, Planning and Recreation, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stegen</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9135-7424</Identifier><AffiliationInfo><Affiliation>Pacific Northwest National Laboratory, Richland, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbauer</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3730-9920</Identifier><AffiliationInfo><Affiliation>GLORIA-Coordination, Institute for Interdisciplinary Mountain Research, Austrian Academy of Sciences &amp; Department of Integrative Biology and Biodiversity Research, University of Natural Resources and Life Sciences Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephan</LastName><ForeName>Jörg G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0001-6195-7867</Identifier><AffiliationInfo><Affiliation>Swedish Species Information Centre, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterck</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Forest Ecology and Forest Management Group, Wageningen University, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stojanovic</LastName><ForeName>Dejan B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0003-2967-2049</Identifier><AffiliationInfo><Affiliation>Institute of Lowland Forestry and Environment, University of Novi Sad, Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strydom</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones en Biodiversidad y Medioambiente-CONICET, Universidad Nacional del Comahue, Bariloche, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svenning</LastName><ForeName>Jens-Christian</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-3415-0862</Identifier><AffiliationInfo><Affiliation>Section for Ecoinformatics and Biodiversity, Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biodiversity Dynamics in a Changing World (BIOCHANGE), Department of Bioscience, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svitková</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5671-0330</Identifier><AffiliationInfo><Affiliation>Institute of Botany, Plant Science and Biodiversity Center, Slovak Academy of Sciences, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svitok</LastName><ForeName>Marek</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2710-8102</Identifier><AffiliationInfo><Affiliation>Department of Ecology and General Biology, Faculty of Ecology and Environmental Sciences, Technical University in Zvolen, Zvolen, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecosystem Biology, Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svoboda</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4050-3422</Identifier><AffiliationInfo><Affiliation>Faculty of Forestry and Wood Sciences, Czech University of Life Sciences, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swaine</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swenson</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3819-9767</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Maryland, College Park, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabarelli</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7573-7216</Identifier><AffiliationInfo><Affiliation>Departamento de Botânica, Universidade Federal de Pernambuco, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1321-2841</Identifier><AffiliationInfo><Affiliation>Teshio Experimental Forest, Hokkaido University, Horonobe, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tappeiner</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-0195-7459</Identifier><AffiliationInfo><Affiliation>Department of Ecology, University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eurac Research, Institute for Alpine Environment, Bozen-Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarifa</LastName><ForeName>Rubén</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0288-1978</Identifier><AffiliationInfo><Affiliation>Departamento de Ecología Funcional y Evolutiva, Estación Experimental de Zonas Áridas (CSIC), La Cañada de San Urbano, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tauugourdeau</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6561-3228</Identifier><AffiliationInfo><Affiliation>SELMET, CIRAD, INRA, Univ Montpellier, Montpellier SupAgro, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIRAD-UMR SELMET-PZZS, Dakar, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavsanoglu</LastName><ForeName>Cagatay</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4447-6492</Identifier><AffiliationInfo><Affiliation>Department of Biology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Beest</LastName><ForeName>Mariska</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3673-4105</Identifier><AffiliationInfo><Affiliation>Environmental Sciences, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for African Conservation Ecology, Nelson Mandela University, Port Elizabeth, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedersoo</LastName><ForeName>Leho</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1635-1249</Identifier><AffiliationInfo><Affiliation>Institute of Ecology and Earth Sciences, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiffault</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2017-6890</Identifier><AffiliationInfo><Affiliation>Natural Resources Canada, Canadian Wood Fibre Centre, Quebec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thom</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8091-6075</Identifier><AffiliationInfo><Affiliation>Rubenstein School of Environment and Natural Resources, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Evert</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7838-6228</Identifier><AffiliationInfo><Affiliation>Bioversity International, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Animal and Plant Sciences, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><Identifier Source="ORCID">0000-0002-4759-5158</Identifier><AffiliationInfo><Affiliation>Oak Ridge National Laboratory, Oak Ridge, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thuiller</LastName><ForeName>Wilfried</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5388-5274</Identifier><AffiliationInfo><Affiliation>Univ. Grenoble Alpes, CNRS, Univ. Savoie Mont Blanc, LECA, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tichý</LastName><ForeName>Lubomír</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8400-7741</Identifier><AffiliationInfo><Affiliation>Department of Botany and Zoology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissue</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8497-2047</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjoelker</LastName><ForeName>Mark G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0003-4607-5238</Identifier><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tng</LastName><ForeName>David Yue Phin</ForeName><Initials>DYP</Initials><Identifier Source="ORCID">0000-0001-5135-0922</Identifier><AffiliationInfo><Affiliation>Centre for Rainforest Studies, The School for Field Studies, Yungaburra, Qld, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobias</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2429-6179</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, Imperial College London, Silwood Park, Ascot, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Török</LastName><ForeName>Péter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4428-3327</Identifier><AffiliationInfo><Affiliation>MTA-DE Lendület Functional and Restoration Ecology Research Group, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarin</LastName><ForeName>Tonantzin</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5125-579X</Identifier><AffiliationInfo><Affiliation>Department of Soil and Plant Sciences, University of Delaware, Newark, DE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ruiz</LastName><ForeName>José M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-1367-7056</Identifier><AffiliationInfo><Affiliation>INRA - Université Clermont-Auvergne, UMR PIAF, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tóthmérész</LastName><ForeName>Béla</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4766-7668</Identifier><AffiliationInfo><Affiliation>MTA-TKI Biodiversity and Ecosystem Services Research Group, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treurnicht</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0853-0247</Identifier><AffiliationInfo><Affiliation>SAEON Fynbos Node, Claremont, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Conservation Ecology and Entomology, Stellenbosch University, Matieland, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivellone</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Illinois Natural History Survey, Prairie Research Institute, University of Illinois, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trolliet</LastName><ForeName>Franck</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1472-2592</Identifier><AffiliationInfo><Affiliation>Unit for Modelling of Climate and Biogeochemical Cycles, UR-SPHERES, University of Liège, Liège, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trotsiuk</LastName><ForeName>Volodymyr</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8363-656X</Identifier><AffiliationInfo><Affiliation>Swiss Federal Institute for Forest, Snow and Landscape Research WSL, Birmensdorf, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Forestry and Wood Sciences, Czech University of Life Sciences, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Agricultural Sciences, Department of Environmental Systems Science, ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsakalos</LastName><ForeName>James L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-5067-196X</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, The University of Western Australia, Crawley, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsiripidis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9373-676X</Identifier><AffiliationInfo><Affiliation>School of Biology, Department of Botany, Aristotle University of Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tysklind</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CIRAD, UMR EcoFoG (Agroparistech, CNRS, INRA, Université des Antilles, Université de la Guyane), Kourou, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umehara</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka Natural History Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usoltsev</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4587-8952</Identifier><AffiliationInfo><Affiliation>Ural State Forest Engineering University, Ekaterinburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Botanical Garden of Ural Branch of Russian Academy of Sciences, Ekaterinburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vadeboncoeur</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8269-0708</Identifier><AffiliationInfo><Affiliation>University of New Hampshire, Durham, NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaezi</LastName><ForeName>Jamil</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valladares</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5374-4682</Identifier><AffiliationInfo><Affiliation>Museo Nacional de Ciencias Naturales-CSIC, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vamosi</LastName><ForeName>Jana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2376-0729</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bodegom</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-0771-4500</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Sciences, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Breugel</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2778-7803</Identifier><AffiliationInfo><Affiliation>College Environmental Studies, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Panama City, Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Cleemput</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5305-9749</Identifier><AffiliationInfo><Affiliation>Department of Earth and Environmental Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Weg</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Geosciences, Edinburgh University, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Merwe</LastName><ForeName>Stephni</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6385-8536</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Plas</LastName><ForeName>Fons</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Systematic Botany and Functional Biodiversity, Institute of Biology, Leipzig University, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Sande</LastName><ForeName>Masha T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-6845-2308</Identifier><AffiliationInfo><Affiliation>Institute for Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Forest Ecology and Forest Management Group, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Global Ecology, Florida Institute of Technology, Melbourne, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kleunen</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2861-3701</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Konstanz, Konstanz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zhejiang Provincial Key Laboratory of Plant Evolutionary Ecology and Conservation, Taizhou University, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Meerbeek</LastName><ForeName>Koenraad</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9260-3815</Identifier><AffiliationInfo><Affiliation>Department of Earth and Environmental Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderwel</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Regina, Regina, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanselow</LastName><ForeName>Kim André</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0003-3299-6220</Identifier><AffiliationInfo><Affiliation>Institute of Geography, University of Erlangen-Nuremberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vårhammar</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hawkesbury Institute for the Environment, Western Sydney University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varone</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9989-5283</Identifier><AffiliationInfo><Affiliation>Department of Environmental Biology, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasquez Valderrama</LastName><ForeName>Maribel Yesenia</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0001-7839-7229</Identifier><AffiliationInfo><Affiliation>Universidad Distrital Francisco José de Caldas, Bogota, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratorio de invasiones Biológicas, Universidad de Concepcion, Concepcion, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassilev</LastName><ForeName>Kiril</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4376-5575</Identifier><AffiliationInfo><Affiliation>Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vellend</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2491-956X</Identifier><AffiliationInfo><Affiliation>Université de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veneklaas</LastName><ForeName>Erik J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-7030-4056</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences and School of Agriculture and Environment, The University of Western Australia, Crawley, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verbeeck</LastName><ForeName>Hans</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1490-0168</Identifier><AffiliationInfo><Affiliation>CAVElab - Computational and Applied Vegetation Ecology, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verheyen</LastName><ForeName>Kris</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2067-9108</Identifier><AffiliationInfo><Affiliation>Department of Environment, Forest &amp; Nature Lab, Ghent University, Gontrode-Melle, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vibrans</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8789-5833</Identifier><AffiliationInfo><Affiliation>Universidade Regional de Blumenau, Blumenau, SC, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Ima</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1233-318X</Identifier><AffiliationInfo><Affiliation>Museu Paraense Emilio Goeldi, Belém, PA, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villacís</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7752-8506</Identifier><AffiliationInfo><Affiliation>Departamento de Ciencias de la Vida, Universidad de las Fuerzas Armadas (ESPE), Sangolquí, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Violle</LastName><ForeName>Cyrille</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2471-9226</Identifier><AffiliationInfo><Affiliation>UMR 5175 CEFE, Univ. Montpellier, CNRS, EPHE, IRD, Univ. Paul Valéry, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vivek</LastName><ForeName>Pandi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Botany, Goa University, Goa, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ecology and Environmental Sciences, Pondicherry University, Puducherry, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4326-1086</Identifier><AffiliationInfo><Affiliation>Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldram</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Geography, Geology and Environment, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldron</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Zoology Department, Edward Grey Institute, Oxford University, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Zoology, Cambridge University, Cambridge Conservation Initiative, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Anthony P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0003-0557-5594</Identifier><AffiliationInfo><Affiliation>Environmental Sciences Division &amp; Climate Change Science Institute, Oak Ridge National Laboratory, Oak Ridge, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waller</LastName><ForeName>Martyn</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3876-2492</Identifier><AffiliationInfo><Affiliation>Department of Geography and Geology, Kingston University, Kingston upon Thames, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walther</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Han</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2482-1818</Identifier><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory for Earth System Modeling, Department of Earth System Science, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3595-515X</Identifier><AffiliationInfo><Affiliation>Institute of Desertification Studies, Chinese Academy of Forestry, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Weiqi</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8503-0978</Identifier><AffiliationInfo><Affiliation>Institute of Geography, Fujian Normal University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4038-7145</Identifier><AffiliationInfo><Affiliation>Department of Landscape Architecture, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biology, Colgate University, Hamilton, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weedon</LastName><ForeName>James T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0003-0491-8719</Identifier><AffiliationInfo><Affiliation>Ecological Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Liping</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4296-9851</Identifier><AffiliationInfo><Affiliation>Institut de recherche sur les forêts, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigelt</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2485-3708</Identifier><AffiliationInfo><Affiliation>Biodiversity, Macroecology and Biogeography, University of Goettingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiher</LastName><ForeName>Evan</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5375-9964</Identifier><AffiliationInfo><Affiliation>University of Wisconsin Eau Claire, Eau Claire, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Aidan W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-2209-3282</Identifier><AffiliationInfo><Affiliation>Rocky Mountain Biological Laboratory, Crested Butte, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maritime and Science Technology Academy, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wellstein</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6994-274X</Identifier><AffiliationInfo><Affiliation>Free University of Bozen-Bolzano, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenk</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Evolution &amp; Ecology Research Centre, and School of Biological, Earth and Environmental Sciences, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westoby</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7690-4530</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westwood</LastName><ForeName>Alana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Winnipeg, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Philip John</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0003-0827-288X</Identifier><AffiliationInfo><Affiliation>The James Hutton Institute, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitten</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6117-5208</Identifier><AffiliationInfo><Affiliation>School of Geosciences, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0003-4825-9073</Identifier><AffiliationInfo><Affiliation>University of California - Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Southwest Biological Science Center, U. S. Geological Survey, Moab, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Womack</LastName><ForeName>Chevonne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Plant and Soil Sciences, University of Pretoria, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Ian J</ForeName><Initials>IJ</Initials><Identifier Source="ORCID">0000-0001-8338-9143</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>S Joseph</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-4260-5676</Identifier><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Justin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9102-5347</Identifier><AffiliationInfo><Affiliation>Department of Biology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinho</LastName><ForeName>Bruno X</ForeName><Initials>BX</Initials><Identifier Source="ORCID">0000-0002-6588-3575</Identifier><AffiliationInfo><Affiliation>Departamento de Botânica, Universidade Federal de Pernambuco, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ximenes</LastName><ForeName>Fabiano</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0516-9414</Identifier><AffiliationInfo><Affiliation>NSW Department of Primary Industries, Parramatta, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Toshihiro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9307-6255</Identifier><AffiliationInfo><Affiliation>Hiroshima University, Higashi-Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaji</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2875-5619</Identifier><AffiliationInfo><Affiliation>Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanai</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6987-2489</Identifier><AffiliationInfo><Affiliation>SUNY-College of Environmental Science and Forestry, Syracuse, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yankov</LastName><ForeName>Nikolay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Botanical Garden of the Samara University, Samara, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yguel</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre d'Ecologie et des Sciences de la Conservation (CESCO), Muséum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Sorbonne-Université, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanini</LastName><ForeName>Kátia Janaina</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia Vegetal (LEVEG), Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanne</LastName><ForeName>Amy E</ForeName><Initials>AE</Initials><Identifier Source="ORCID">0000-0001-6379-9452</Identifier><AffiliationInfo><Affiliation>Biological Sciences, George Washington University, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelený</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5157-044X</Identifier><AffiliationInfo><Affiliation>National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yun-Peng</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jingming</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8517-9999</Identifier><AffiliationInfo><Affiliation>Forestry College, Beijing Forestry University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Ji</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4936-1168</Identifier><AffiliationInfo><Affiliation>School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Urban Forest Ecosystem Research Station, National Forestry and Grassland Administration, Shanghai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziemińska</LastName><ForeName>Kasia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7750-4758</Identifier><AffiliationInfo><Affiliation>Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zirbel</LastName><ForeName>Chad R</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-9289-1722</Identifier><AffiliationInfo><Affiliation>Department of Ecology, Evolution, and Behavior, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zizka</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Goethe Universität Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Botany and Molecular Evolution, Senckenberg Research Institute and Natural History Museum, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zo-Bi</LastName><ForeName>Irié Casimir</ForeName><Initials>IC</Initials><Identifier Source="ORCID">0000-0003-0982-8579</Identifier><AffiliationInfo><Affiliation>Institut National Polytechnique Félix Houphouët-Boigny (INP-HB), Yamoussoukro, Côte d'Ivoire.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zotz</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6823-2268</Identifier><AffiliationInfo><Affiliation>Smithsonian Tropical Research Institute, Balboa, Ancon, Republic of Panama.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biology and Environmental Sciences, University Oldenburg, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Biogeochemistry, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>International Geosphere-Biosphere Programme (IGBP)</Agency><Country>International</Country></Grant><Grant><Agency>GIS 'Climat, Environnement et Société' France</Agency><Country>International</Country></Grant><Grant><Agency>German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig</Agency><Country>International</Country></Grant><Grant><Agency>AXA Research Fund</Agency><Country>International</Country></Grant><Grant><Agency>Max Planck Society</Agency><Country>International</Country></Grant><Grant><Agency>UK Natural Environment Research Council (NERC)</Agency><Country>International</Country></Grant><Grant><Agency>French Foundation for Biodiversity Research (FRB)</Agency><Country>International</Country></Grant><Grant><Agency>Max Planck Institute for Biogeochemistry</Agency><Country>International</Country></Grant><Grant><Agency>International Programme of Biodiversity Science (DIVERSITAS)</Agency><Country>International</Country></Grant><Grant><GrantID>P 29142</GrantID><Acronym>FWF_</Acronym><Agency>Austrian Science Fund FWF</Agency><Country>Austria</Country></Grant><Grant><Agency>Future Earth</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Glob Chang Biol</MedlineTA><NlmUniqueID>9888746</NlmUniqueID><ISSNLinking>1354-1013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Glob Chang Biol. 2020 Jan;26(1):189-190</RefSource><PMID Version="1">31891658</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="Y">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044822" MajorTopicYN="N">Biodiversity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004463" MajorTopicYN="N">Ecology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017753" MajorTopicYN="Y">Ecosystem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010944" MajorTopicYN="N">Plants</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">TRY plant trait database</Keyword><Keyword MajorTopicYN="Y">data coverage</Keyword><Keyword MajorTopicYN="Y">data integration</Keyword><Keyword MajorTopicYN="Y">data representativeness</Keyword><Keyword MajorTopicYN="Y">functional diversity</Keyword><Keyword MajorTopicYN="Y">plant traits</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31891233</ArticleId><ArticleId IdType="doi">10.1111/gcb.14904</ArticleId></ArticleIdList><ReferenceList/></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31884184</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-4754</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><MedlineDate>2020 Mar - Apr</MedlineDate></PubDate></JournalIssue><Title>Brain stimulation</Title><ISOAbbreviation>Brain Stimul</ISOAbbreviation></Journal><ArticleTitle>Strengthened theta-burst transcranial magnetic stimulation as an adjunctive treatment for Alzheimer's disease: An open-label pilot study.</ArticleTitle><Pagination><MedlinePgn>484-486</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1935-861X(19)30491-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.brs.2019.12.020</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xingqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, 230022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Gong-Jun</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230022, China; Department of Medical Psychology, Chaohu Clinical Medical College, Anhui Medical University, Hefei 230000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yibing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Bensheng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering, University of Science and Technology of China, Hefei, 230027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yanghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230022, China. Electronic address: ayfytyh@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230022, China; Department of Medical Psychology, Chaohu Clinical Medical College, Anhui Medical University, Hefei 230000, China. Electronic address: wangkai1964@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Stimul</MedlineTA><NlmUniqueID>101465726</NlmUniqueID><ISSNLinking>1876-4754</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Declaration of competing interest There are no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31884184</ArticleId><ArticleId IdType="pii">S1935-861X(19)30491-7</ArticleId><ArticleId IdType="doi">10.1016/j.brs.2019.12.020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31879566</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2053-9711</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of law and the biosciences</Title><ISOAbbreviation>J Law Biosci</ISOAbbreviation></Journal><ArticleTitle>Open forensic science.</ArticleTitle><Pagination><MedlinePgn>255-288</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jlb/lsz009</ELocationID><Abstract><AbstractText>The mainstream sciences are experiencing a revolution of methodology. This revolution was inspired, in part, by the realization that a surprising number of findings in the bioscientific literature could not be replicated or reproduced by independent laboratories. In response, scientific norms and practices are rapidly moving towards openness. These reforms promise many enhancements to the scientific process, notably improved efficiency and reliability of findings. Changes are also underway in the forensic. After years of legal-scientific criticism and several reports from peak scientific bodies, efforts are underway to establish the validity of several forensic practices and ensure forensic scientists perform and present their work in a scientifically valid way. In this article, the authors suggest that open science reforms are distinctively suited to addressing the problems faced by forensic science. Openness comports with legal and criminal justice values, helping ensure expert forensic evidence is more reliable and susceptible to rational evaluation by the trier of fact. In short, open forensic science allows parties in legal proceedings to understand and assess the strength of the case against them, resulting in fairer outcomes. Moreover, several emerging open science initiatives allow for speedier and more collaborative research.</AbstractText><CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-6573-2670</Identifier><AffiliationInfo><Affiliation>The University of Sydney Law School, Law School Building (F10), Eastern Avenue, Camperdown Campus, The University of Sydney, New South Wales, NSW 2006, Australia; Institute for Globally Distributed Open Research and Education (IGDORE).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gianni Ribeiro School of Psychology, The University of Queensland, St Lucia QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rairden</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Houston Forensic Science Center, Houston, TX 77002, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Law Biosci</MedlineTA><NlmUniqueID>101633120</NlmUniqueID><ISSNLinking>2053-9711</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">neuroscience</Keyword><Keyword MajorTopicYN="N">open science</Keyword><Keyword MajorTopicYN="N">reproducibility</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31879566</ArticleId><ArticleId IdType="doi">10.1093/jlb/lsz009</ArticleId><ArticleId IdType="pii">lsz009</ArticleId><ArticleId IdType="pmc">PMC6922081</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31850398</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2572-4754</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Gates open research</Title><ISOAbbreviation>Gates Open Res</ISOAbbreviation></Journal><ArticleTitle>An open toolkit for tracking open science partnership implementation and impact.</ArticleTitle><Pagination><MedlinePgn>1442</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12688/gatesopenres.12958.2</ELocationID><Abstract><AbstractText>Serious concerns about the way research is organized collectively are increasingly being raised. They include the escalating costs of research and lower research productivity, low public trust in researchers to report the truth, lack of diversity, poor community engagement, ethical concerns over research practices, and irreproducibility. Open science (OS) collaborations comprise of a set of practices including open access publication, open data sharing and the absence of restrictive intellectual property rights with which institutions, firms, governments and communities are experimenting in order to overcome these concerns. We gathered two groups of international representatives from a large variety of stakeholders to construct a toolkit to guide and facilitate data collection about OS and non-OS collaborations. Ultimately, the toolkit will be used to assess and study the impact of OS collaborations on research and innovation. The toolkit contains the following four elements: 1) an annual report form of quantitative data to be completed by OS partnership administrators; 2) a series of semi-structured interview guides of stakeholders; 3) a survey form of participants in OS collaborations; and 4) a set of other quantitative measures best collected by other organizations, such as research foundations and governmental or intergovernmental agencies. We opened our toolkit to community comment and input. We present the resulting toolkit for use by government and philanthropic grantors, institutions, researchers and community organizations with the aim of measuring the implementation and impact of OS partnership across these organizations. We invite these and other stakeholders to not only measure, but to share the resulting data so that social scientists and policy makers can analyse the data across projects.</AbstractText><CopyrightInformation>Copyright: © 2019 Gold ER et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>E Richard</ForeName><Initials>ER</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3789-9238</Identifier><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, H3A 0C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali-Khan</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Liz</ForeName><Initials>L</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9298-3168</Identifier><AffiliationInfo><Affiliation>F1000, London, W1T 4LB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballell</LastName><ForeName>Lluis</ForeName><Initials>L</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3029-1860</Identifier><AffiliationInfo><Affiliation>Diseases of the Developing World, Global Health R&amp;D, GlaxoSmithKline, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barral-Netto</LastName><ForeName>Manoel</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-5823-7903</Identifier><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wellcome Trust, London, NW1 2BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalaud</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaplin</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2705-6480</Identifier><AffiliationInfo><Affiliation>Wellcome Trust, London, NW1 2BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clancy</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-7177-1038</Identifier><AffiliationInfo><Affiliation>US Department of Agriculture Economic Research Service, Washington, DC, 20024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Research Board, Dublin, D02 H638, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook-Deegan</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Arizona State University, Washington, DC, 20006, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinsmore</LastName><ForeName>A P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3314-7944</Identifier><AffiliationInfo><Affiliation>Wellcome Trust, London, NW1 2BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doerr</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, 98121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federer</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>US National Library of Medicine, Bethesda, MD, 20894, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Research England, UK Research and Innovation, Bristol, BS34 8SR, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Jisc, Bristol, BS2 0JA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Osmat Azzam</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Queensland University of Technology, Brisbane, QLD, 4000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Lens, Canberra, ACT, 2601, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Chonnettia</ForeName><Initials>C</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3430-8110</Identifier><AffiliationInfo><Affiliation>Wellcome Trust, London, NW1 2BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahl</LastName><ForeName>Linda J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>The Lens, Canberra, ACT, 2601, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kariuki</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>African Academy of Sciences, Karen, Nairobi, 00502, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassel</LastName><ForeName>Sophie N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiley</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4733-2558</Identifier><AffiliationInfo><Affiliation>Wellcome Trust, London, NW1 2BE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kittrie</LastName><ForeName>Elizabeth Robboy</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>US National Library of Medicine, Bethesda, MD, 20894, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Utrecht University Library, Utrecht, CX, 3584, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wen Hwa</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangravite</LastName><ForeName>Lara M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, 98121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marincola</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>African Academy of Sciences, Karen, Nairobi, 00502, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mietchen</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9488-1870</Identifier><AffiliationInfo><Affiliation>Data Science Institute, University of Virginia, Charlottesville, VA, 22904, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molloy</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>University of Cambridge, Cambridge, CB2 3EA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namchuk</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alkermes, Waltham, MA, 02451, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nosek</LastName><ForeName>Brian A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Virginia, Charlottesville, VA, 22904-4400, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Open Science, Charlottesville, VA, 22903-5083, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquet</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Element AI, Montreal, QC, H2W 2R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirmez</LastName><ForeName>Claude</ForeName><Initials>C</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7443-0455</Identifier><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyller</LastName><ForeName>Annabel</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2168-3125</Identifier><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skingle</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Stevenage, Herts, SG1 2NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadotto</LastName><ForeName>S Nicole</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staniszewska</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7723-9074</Identifier><AffiliationInfo><Affiliation>Warwick Research in Nursing, University of Warwick Medical School, Coventry, CV4 7AL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thelwall</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Wolverhampton, Wolverhampton, WV1 1LY, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gates Open Res</MedlineTA><NlmUniqueID>101717821</NlmUniqueID><ISSNLinking>2572-4754</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Open science</Keyword><Keyword MajorTopicYN="N">impact</Keyword><Keyword MajorTopicYN="N">implementation</Keyword><Keyword MajorTopicYN="N">indicator</Keyword><Keyword MajorTopicYN="N">innovation</Keyword><Keyword MajorTopicYN="N">intellectual property</Keyword><Keyword MajorTopicYN="N">partnership</Keyword><Keyword MajorTopicYN="N">performance</Keyword><Keyword MajorTopicYN="N">policy</Keyword><Keyword MajorTopicYN="N">toolkit</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31850398</ArticleId><ArticleId IdType="doi">10.12688/gatesopenres.12958.2</ArticleId><ArticleId IdType="pmc">PMC6904887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2012 Mar 28;483(7391):531-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22460880</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jul 07;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27387362</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2009 Jul;5(7):436-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19536100</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Oct 30;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">29082866</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12240-2</Citation><ArticleIdList><ArticleId IdType="pubmed">26392553</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Sep 15;357(6356):1101-1102</Citation><ArticleIdList><ArticleId IdType="pubmed">28912234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Jan 1;31(1):124-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12519964</ArticleId></ArticleIdList></Reference><Reference><Citation>J Contin Educ Health Prof. 2006 Winter;26(1):13-24</Citation><ArticleIdList><ArticleId IdType="pubmed">16557505</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 26;348(6242):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26113702</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2017 Aug 30;95(5):1002-1006</Citation><ArticleIdList><ArticleId IdType="pubmed">28858611</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2017 Jul 21;15(1):134</Citation><ArticleIdList><ArticleId IdType="pubmed">28728605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2016 May;47:20-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2009 Dec;8(12):959-68</Citation><ArticleIdList><ArticleId IdType="pubmed">19949401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2014 Jun;20(6):564-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24901552</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 May 12;14(5):e1002456</Citation><ArticleIdList><ArticleId IdType="pubmed">27171007</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates Open Res. 2019 Apr 30;3:1442</Citation><ArticleIdList><ArticleId IdType="pubmed">31850398</ArticleId></ArticleIdList></Reference><Reference><Citation>Rand Health Q. 2014 Dec 30;4(3):19</Citation><ArticleIdList><ArticleId IdType="pubmed">28560088</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 Dec 7;14(12):e2001259</Citation><ArticleIdList><ArticleId IdType="pubmed">27932848</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2011 Jun;10(6):428-38</Citation><ArticleIdList><ArticleId IdType="pubmed">21629293</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2016 Feb 03;5:130</Citation><ArticleIdList><ArticleId IdType="pubmed">26962436</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):615-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26168121</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Law J. 2008;16:207-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19536982</ArticleId></ArticleIdList></Reference><Reference><Citation>MNI Open Res. 2018 Feb 9;2:2</Citation><ArticleIdList><ArticleId IdType="pubmed">29553146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31849336</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1474-760X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>12</Month><Day>18</Day></PubDate></JournalIssue><Title>Genome biology</Title><ISOAbbreviation>Genome Biol</ISOAbbreviation></Journal><ArticleTitle>TRITEX: chromosome-scale sequence assembly of Triticeae genomes with open-source tools.</ArticleTitle><Pagination><MedlinePgn>284</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13059-019-1899-5</ELocationID><Abstract><AbstractText>Chromosome-scale genome sequence assemblies underpin pan-genomic studies. Recent genome assembly efforts in the large-genome Triticeae crops wheat and barley have relied on the commercial closed-source assembly algorithm DeNovoMagic. We present TRITEX, an open-source computational workflow that combines paired-end, mate-pair, 10X Genomics linked-read with chromosome conformation capture sequencing data to construct sequence scaffolds with megabase-scale contiguity ordered into chromosomal pseudomolecules. We evaluate the performance of TRITEX on publicly available sequence data of tetraploid wild emmer and hexaploid bread wheat, and construct an improved annotated reference genome sequence assembly of the barley cultivar Morex as a community resource.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monat</LastName><ForeName>Cécile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padmarasu</LastName><ForeName>Sudharsan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lux</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>PGSB - Plant Genome and Systems Biology, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicker</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundlach</LastName><ForeName>Heidrun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>PGSB - Plant Genome and Systems Biology, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himmelbach</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ens</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chengdao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Western Barley Genetics Alliance, School of Veterinary and Life Sciences (VLS), Murdoch University, Murdoch, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Collaborative Innovation Center for Grain Industry/School of Agriculture, Yangtze University, Jingzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muehlbauer</LastName><ForeName>Gary J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Agronomy and Plant Genetics &amp; Department of Plant and Microbial Biology, University of Minnesota, St. Paul, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Alan H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Green Technology, Natural Resources Institute (Luke), Viikki Plant Science Centre, and Institute of Biotechnology, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waugh</LastName><ForeName>Robbie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The James Hutton Institute, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braumann</LastName><ForeName>Ilka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Carlsberg Research Laboratory, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozniak</LastName><ForeName>Curtis</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Plant Sciences, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scholz</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Klaus F X</ForeName><Initials>KFX</Initials><AffiliationInfo><Affiliation>PGSB - Plant Genome and Systems Biology, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spannagl</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>PGSB - Plant Genome and Systems Biology, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany. stein@ipk-gatersleben.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Crop Sciences, Center for Integrated Breeding Research (CiBreed), Georg-August-University Göttingen, Göttingen, Germany. stein@ipk-gatersleben.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascher</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6373-6013</Identifier><AffiliationInfo><Affiliation>Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) Gatersleben, Seeland, Germany. mascher@ipk-gatersleben.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany. mascher@ipk-gatersleben.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genome Biol</MedlineTA><NlmUniqueID>100960660</NlmUniqueID><ISSNLinking>1474-7596</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032461" MajorTopicYN="Y">Chromosomes, Plant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005821" MajorTopicYN="Y">Genetic Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018745" MajorTopicYN="Y">Genome, Plant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001467" MajorTopicYN="N">Hordeum</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014908" MajorTopicYN="N">Triticum</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31849336</ArticleId><ArticleId IdType="doi">10.1186/s13059-019-1899-5</ArticleId><ArticleId IdType="pii">10.1186/s13059-019-1899-5</ArticleId><ArticleId IdType="pmc">PMC6918601</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Plant J. 2013 Nov;76(4):718-27</Citation><ArticleIdList><ArticleId IdType="pubmed">23998490</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant J. 2017 Mar;89(5):853-869</Citation><ArticleIdList><ArticleId IdType="pubmed">27888547</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2017 May;27(5):885-896</Citation><ArticleIdList><ArticleId IdType="pubmed">28420692</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Oct 26;12(10):e0185056</Citation><ArticleIdList><ArticleId IdType="pubmed">29073143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Jul 1;32(13):1925-32</Citation><ArticleIdList><ArticleId IdType="pubmed">27153683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2012 Aug;30(8):771-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22797562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2019 Feb;51(2):224-229</Citation><ArticleIdList><ArticleId IdType="pubmed">30510239</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2014 Jun 24;15:214</Citation><ArticleIdList><ArticleId IdType="pubmed">24958009</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2004 Oct;168(2):1087-96</Citation><ArticleIdList><ArticleId IdType="pubmed">15514080</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2014 Aug 15;15:281</Citation><ArticleIdList><ArticleId IdType="pubmed">25128196</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2012 Dec 27;1(1):18</Citation><ArticleIdList><ArticleId IdType="pubmed">23587118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Nov 1;29(21):2669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23990416</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Nov 20;326(5956):1112-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19965430</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2017 Jul 12;18(1):527</Citation><ArticleIdList><ArticleId IdType="pubmed">28701198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Jun 22;546(7659):524-527</Citation><ArticleIdList><ArticleId IdType="pubmed">28605751</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Feb 15;409(6822):934-41</Citation><ArticleIdList><ArticleId IdType="pubmed">11237014</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Physiol. 2009 Jan;149(1):142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19126706</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Aug 1;30(15):2114-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 1998 Sep;20(1):43-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9731528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2017 Apr 27;4:170044</Citation><ArticleIdList><ArticleId IdType="pubmed">28448065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jul;41(12):e121</Citation><ArticleIdList><ArticleId IdType="pubmed">23598997</ArticleId></ArticleIdList></Reference><Reference><Citation>G3 (Bethesda). 2018 May 31;8(6):2059-2065</Citation><ArticleIdList><ArticleId IdType="pubmed">29674436</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2014 Jul 18;345(6194):1249721</Citation><ArticleIdList><ArticleId IdType="pubmed">25035497</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2000 Jun;16(6):276-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10827456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 May;557(7705):424-428</Citation><ArticleIdList><ArticleId IdType="pubmed">29743678</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Physiol. 2011 May;156(1):20-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21415278</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2015 Jan 31;16:26</Citation><ArticleIdList><ArticleId IdType="pubmed">25637298</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2016 Apr 17;2016:</Citation><ArticleIdList><ArticleId IdType="pubmed">27087305</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1999 Jan 15;27(2):573-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9862982</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biotechnol. 2017 Nov 10;261:37-45</Citation><ArticleIdList><ArticleId IdType="pubmed">28698099</ArticleId></ArticleIdList></Reference><Reference><Citation>Algorithms Mol Biol. 2013 Sep 16;8(1):22</Citation><ArticleIdList><ArticleId IdType="pubmed">24040893</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Oct 1;31(19):3210-2</Citation><ArticleIdList><ArticleId IdType="pubmed">26059717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Nov 29;491(7426):711-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23075845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2015 Mar;33(3):290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25690850</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2018 May 1;7(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">29762659</ArticleId></ArticleIdList></Reference><Reference><Citation>Theor Appl Genet. 2019 Mar;132(3):785-796</Citation><ArticleIdList><ArticleId IdType="pubmed">30446793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2019 Oct;37(10):1155-1162</Citation><ArticleIdList><ArticleId IdType="pubmed">31406327</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2008 Jan 14;9:18</Citation><ArticleIdList><ArticleId IdType="pubmed">18194517</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2017 Aug;35(8):793-796</Citation><ArticleIdList><ArticleId IdType="pubmed">28504667</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant J. 2018 Dec;96(6):1309-1316</Citation><ArticleIdList><ArticleId IdType="pubmed">30256471</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2019;1933:441-472</Citation><ArticleIdList><ArticleId IdType="pubmed">30945203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2019 May;51(5):885-895</Citation><ArticleIdList><ArticleId IdType="pubmed">30962619</ArticleId></ArticleIdList></Reference><Reference><Citation>Theor Appl Genet. 2017 Jun;130(6):1207-1222</Citation><ArticleIdList><ArticleId IdType="pubmed">28275817</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2011 Oct;7(10):e1002195</Citation><ArticleIdList><ArticleId IdType="pubmed">22039361</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Dis. 2018 Jun;102(6):1124-1135</Citation><ArticleIdList><ArticleId IdType="pubmed">30673435</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2006 Feb 09;7:62</Citation><ArticleIdList><ArticleId IdType="pubmed">16469098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 May 1;21(9):1859-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15728110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Mar 1;30(5):614-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24142950</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 May 11;17:102</Citation><ArticleIdList><ArticleId IdType="pubmed">27169502</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Jul 7;357(6346):93-97</Citation><ArticleIdList><ArticleId IdType="pubmed">28684525</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2018 Aug 17;361(6403):</Citation><ArticleIdList><ArticleId IdType="pubmed">30115783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 May 1;33(9):1324-1330</Citation><ArticleIdList><ArticleId IdType="pubmed">28453674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Sep 1;31(17):2885-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25953801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Apr 26;544(7651):427-433</Citation><ArticleIdList><ArticleId IdType="pubmed">28447635</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Plant. 2015 Oct 5;8(10):1507-19</Citation><ArticleIdList><ArticleId IdType="pubmed">25983208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Jun 15;31(12):2035-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25661542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2017 Nov 1;6(11):1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">29069494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Nov 23;551(7681):498-502</Citation><ArticleIdList><ArticleId IdType="pubmed">29143815</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2008 Oct 31;9:517</Citation><ArticleIdList><ArticleId IdType="pubmed">18976482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Apr;12(4):357-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Dec;31(12):1119-25</Citation><ArticleIdList><ArticleId IdType="pubmed">24185095</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2017 May 9;(123):</Citation><ArticleIdList><ArticleId IdType="pubmed">28518075</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Cell. 2017 Oct;29(10):2336-2348</Citation><ArticleIdList><ArticleId IdType="pubmed">29025960</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008 Jan 11;9(1):R7</Citation><ArticleIdList><ArticleId IdType="pubmed">18190707</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Dec 1;28(23):3131-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23023982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 15;25(16):2078-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Sep 07;7:12790</Citation><ArticleIdList><ArticleId IdType="pubmed">27599761</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Physiol. 2009 Jul;150(3):1135-46</Citation><ArticleIdList><ArticleId IdType="pubmed">19448038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Dec;31(12):1143-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24270850</ArticleId></ArticleIdList></Reference><Reference><Citation>G3 (Bethesda). 2019 Mar 7;9(3):619-624</Citation><ArticleIdList><ArticleId IdType="pubmed">30622124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D1141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26527721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2018 Sep 15;34(18):3094-3100</Citation><ArticleIdList><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Jun 15;32(12):i201-i208</Citation><ArticleIdList><ArticleId IdType="pubmed">27307618</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2017 May;27(5):787-792</Citation><ArticleIdList><ArticleId IdType="pubmed">28130360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Mar 15;26(6):841-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Biotechnol J. 2016 Jul;14(7):1511-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26801048</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2007 Dec;8(12):973-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17984973</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1990 Oct 5;215(3):403-10</Citation><ArticleIdList><ArticleId IdType="pubmed">2231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2018 Sep;50(9):1282-1288</Citation><ArticleIdList><ArticleId IdType="pubmed">30061736</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2016 Mar;26(3):342-50</Citation><ArticleIdList><ArticleId IdType="pubmed">26848124</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2016;1374:339-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26519415</ArticleId></ArticleIdList></Reference><Reference><Citation>Plant Cell. 2016 Nov;28(11):2700-2714</Citation><ArticleIdList><ArticleId IdType="pubmed">27803309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Dec 15;30(24):3541-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25355787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31822223</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-5662</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>161</Issue><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>Journal of the Royal Society, Interface</Title><ISOAbbreviation>J R Soc Interface</ISOAbbreviation></Journal><ArticleTitle>Transcription closed and open complex formation coordinate expression of genes with a shared promoter region.</ArticleTitle><Pagination><MedlinePgn>20190507</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsif.2019.0507</ELocationID><Abstract><AbstractText>Many genes are spaced closely, allowing coordination without explicit control through shared regulatory elements and molecular interactions. We study the dynamics of a stochastic model of a gene-pair in a head-to-head configuration, sharing promoter elements, which accounts for the rate-limiting steps in transcription initiation. We find that only in specific regions of the parameter space of the rate-limiting steps is orderly coexpression exhibited, suggesting that successful cooperation between closely spaced genes requires the coevolution of compatible rate-limiting step configuration. The model predictions are validated using <i>in vivo</i> single-cell, single-RNA measurements of the dynamics of pairs of genes sharing promoter elements. Our results suggest that, in <i>E. coli</i>, the kinetics of the rate-limiting steps in active transcription can play a central role in shaping the dynamics of gene-pairs sharing promoter elements.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Häkkinen</LastName><ForeName>Antti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BioMediTech Institute and Department of Signal Processing, Tampere University of Technology, PO Box 553 33101, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Samuel M D</ForeName><Initials>SMD</Initials><AffiliationInfo><Affiliation>BioMediTech Institute and Department of Signal Processing, Tampere University of Technology, PO Box 553 33101, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neeli-Venkata</LastName><ForeName>Ramakanth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BioMediTech Institute and Department of Signal Processing, Tampere University of Technology, PO Box 553 33101, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Andre S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>BioMediTech Institute and Department of Signal Processing, Tampere University of Technology, PO Box 553 33101, Tampere, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Soc Interface</MedlineTA><NlmUniqueID>101217269</NlmUniqueID><ISSNLinking>1742-5662</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029968">Escherichia coli Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012329">RNA, Bacterial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029968" MajorTopicYN="N">Escherichia coli Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015964" MajorTopicYN="N">Gene Expression Regulation, Bacterial</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012329" MajorTopicYN="N">RNA, Bacterial</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013269" MajorTopicYN="N">Stochastic Processes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bidirectional promoter</Keyword><Keyword MajorTopicYN="Y">gene expression noise</Keyword><Keyword MajorTopicYN="Y">transcription</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31822223</ArticleId><ArticleId IdType="doi">10.1098/rsif.2019.0507</ArticleId><ArticleId IdType="pmc">PMC6936044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Comput Biol. 2016 Oct 28;12(10):e1005174</Citation><ArticleIdList><ArticleId IdType="pubmed">27792724</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Oct 19;4(10):e7526</Citation><ArticleIdList><ArticleId IdType="pubmed">19838305</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochimie. 2015 Dec;119:80-91</Citation><ArticleIdList><ArticleId IdType="pubmed">26482806</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Phys Chem. 2007;58:35-55</Citation><ArticleIdList><ArticleId IdType="pubmed">17037977</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1998 Nov 26;223(1-2):221-31</Citation><ArticleIdList><ArticleId IdType="pubmed">9858738</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2005 Jun;6(6):451-64</Citation><ArticleIdList><ArticleId IdType="pubmed">15883588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Jan 1;31(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25189780</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1980 Oct;77(10):5634-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6160577</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2004 Jun 4;14(5):647-56</Citation><ArticleIdList><ArticleId IdType="pubmed">15175159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Sep 1;40(17):8472-83</Citation><ArticleIdList><ArticleId IdType="pubmed">22730294</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Res. 2016 Jun;23(3):203-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27026687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Syst Biol. 2006;2:2006.0008</Citation><ArticleIdList><ArticleId IdType="pubmed">16738554</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2011 Jul;27(7):267-76</Citation><ArticleIdList><ArticleId IdType="pubmed">21601935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2002 Jun 28;109(7):807-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12110178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Syst Biol. 2017 Aug 23;13(8):937</Citation><ArticleIdList><ArticleId IdType="pubmed">28835372</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2899-905</Citation><ArticleIdList><ArticleId IdType="pubmed">27162333</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2008 Jan 18;319(5861):339-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18202292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2011 Oct 7;412(5):814-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21255583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2005 Feb 18;346(2):399-409</Citation><ArticleIdList><ArticleId IdType="pubmed">15670592</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2012 Dec 13;1:e00078</Citation><ArticleIdList><ArticleId IdType="pubmed">23240084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 May 1;32(9):1346-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26722120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Jul 01;29(13):1708-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23613488</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9160-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15967986</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Genet. 1995 Aug;28(3):205-16</Citation><ArticleIdList><ArticleId IdType="pubmed">8529266</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2001 Sep 15;29(18):3873-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11557820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2009 Jun 12;34(5):545-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19524535</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8796-801</Citation><ArticleIdList><ArticleId IdType="pubmed">12077310</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 Feb 25;331(6020):1081-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21350180</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4776-80</Citation><ArticleIdList><ArticleId IdType="pubmed">15037753</ArticleId></ArticleIdList></Reference><Reference><Citation>Epigenetics Chromatin. 2018 Nov 10;11(1):66</Citation><ArticleIdList><ArticleId IdType="pubmed">30414612</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2016 Oct;1859(10):1281-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27452766</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2009 May;1789(5):432-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19439209</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2015 Jun 18;58(6):1101-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26028540</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2012 May 21;301:83-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22370562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2011 Jul 21;281(1):74-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21549717</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1986 May;83(9):2807-11</Citation><ArticleIdList><ArticleId IdType="pubmed">3010319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Apr 15;30(8):1146-1153</Citation><ArticleIdList><ArticleId IdType="pubmed">24389660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Sep 1;39(16):6879-85</Citation><ArticleIdList><ArticleId IdType="pubmed">21609952</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2004 Jan;14(1):62-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14707170</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):234-244</Citation><ArticleIdList><ArticleId IdType="pubmed">30646012</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11310-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15277674</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2004 Jul;22(7):911-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15229555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Mar 24;7:11099</Citation><ArticleIdList><ArticleId IdType="pubmed">27010670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31819687</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1594</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Risk management and healthcare policy</Title><ISOAbbreviation>Risk Manag Healthc Policy</ISOAbbreviation></Journal><ArticleTitle>Jordanians' Perspectives On Open Consent In Biomedical Research.</ArticleTitle><Pagination><MedlinePgn>265-273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/RMHP.S217209</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The informed consent process is an integral step in biomedical research. However, the emergence of biobanks and the need for open consent (also called "broad" or "blanket" consent) create challenges to this process.</AbstractText><AbstractText Label="AIMS AND METHODOLOGY" NlmCategory="OBJECTIVE">A survey was used to examine Jordanians' perspectives on open consent and reuse of stored samples in future research.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The majority of participants had positive perceptions of informed consent and its importance. In addition, they appreciated the challenges that are associated with multiple uses of their biospecimens. About 55% agreed to provide open consent for reuse of their donated biospecimens. Participants (75-80%) also agreed that issues such as the possibility of sharing samples with international research centers, storage duration, and use of biospecimens after their death should be clarified as part of open consent. The inconvenience of the re-contact process, trust in the research team, and the importance of biobanks were all associated with participants' willingness to provide open consent (P&lt;0.05). On the other hand, privacy and confidentiality, doubt about future use of samples, unknown storage period, and the possibility of cross-border sample sharing were significantly associated with participants' reluctance to provide open consent.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The majority of Jordanians accept the idea of open consent. Clarification of issues such as international sample sharing, duration of storage, domains of intended research, confidentiality, and privacy can provide more support for the use of open consent.</AbstractText><CopyrightInformation>© 2019 Alrabadi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alrabadi</LastName><ForeName>Nasr</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-5541-8362</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty Of Medicine, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makhlouf</LastName><ForeName>Hanin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khabour</LastName><ForeName>Omar F</ForeName><Initials>OF</Initials><Identifier Source="ORCID">0000-0002-3006-3104</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzoubi</LastName><ForeName>Karem H</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-2808-5099</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Risk Manag Healthc Policy</MedlineTA><NlmUniqueID>101566264</NlmUniqueID><ISSNLinking>1179-1594</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biobank</Keyword><Keyword MajorTopicYN="N">human ethics</Keyword><Keyword MajorTopicYN="N">human research</Keyword><Keyword MajorTopicYN="N">open consent</Keyword><Keyword MajorTopicYN="N">sample reuse</Keyword><Keyword MajorTopicYN="N">sample storage</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31819687</ArticleId><ArticleId IdType="doi">10.2147/RMHP.S217209</ArticleId><ArticleId IdType="pii">217209</ArticleId><ArticleId IdType="pmc">PMC6897061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biopreserv Biobank. 2012 Aug;10(4):361-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24849885</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;1:4085-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17945825</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jul 08;10(7):e0129893</Citation><ArticleIdList><ArticleId IdType="pubmed">26154134</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci Soc Policy. 2015;11:1</Citation><ArticleIdList><ArticleId IdType="pubmed">26085311</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Soc Policy. 2000;12(2):23-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11184441</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2015 Apr;84(4):237-47</Citation><ArticleIdList><ArticleId IdType="pubmed">25649841</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Bioeth. 2015;15(9):34-42</Citation><ArticleIdList><ArticleId IdType="pubmed">26305750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioethics. 2006 Aug;20(4):180-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17044151</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Ethics. 2010 Sep;36(9):539-47</Citation><ArticleIdList><ArticleId IdType="pubmed">20663757</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Sep;9(9):885-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22936169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1440-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18559560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Ethics. 2005 Jul;31(7):415-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15994363</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2017 Mar 2;100(3):414-427</Citation><ArticleIdList><ArticleId IdType="pubmed">28190457</ArticleId></ArticleIdList></Reference><Reference><Citation>S Afr Med J. 2013 Mar 01;103(4):225-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23547695</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Sep 18;349(12):1180-4</Citation><ArticleIdList><ArticleId IdType="pubmed">13679534</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2013 May;21(5):567-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22968133</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2015 Dec;23(12):1607-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25735479</ArticleId></ArticleIdList></Reference><Reference><Citation>Biopreserv Biobank. 2014 Feb;12(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24620764</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Ethics. 2002 Jan 9;3:E1</Citation><ArticleIdList><ArticleId IdType="pubmed">11825345</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmgenomics Pers Med. 2019 Mar 21;12:23-32</Citation><ArticleIdList><ArticleId IdType="pubmed">30962705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2006 Mar;7(3):266-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16510336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31807684</PMID><DateRevised><Year>2021</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2374-7943</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>ACS central science</Title><ISOAbbreviation>ACS Cent Sci</ISOAbbreviation></Journal><ArticleTitle>The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery.</ArticleTitle><Pagination><MedlinePgn>1824-1833</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acscentsci.9b00806</ELocationID><Abstract><AbstractText>Despite rapid evolution in the area of microbial natural products chemistry, there is currently no open access database containing all microbially produced natural product structures. Lack of availability of these data is preventing the implementation of new technologies in natural products science. Specifically, development of new computational strategies for compound characterization and identification are being hampered by the lack of a comprehensive database of known compounds against which to compare experimental data. The creation of an open access, community-maintained database of microbial natural product structures would enable the development of new technologies in natural products discovery and improve the interoperability of existing natural products data resources. However, these data are spread unevenly throughout the historical scientific literature, including both journal articles and international patents. These documents have no standard format, are often not digitized as machine readable text, and are not publicly available. Further, none of these documents have associated structure files (e.g., MOL, InChI, or SMILES), instead containing images of structures. This makes extraction and formatting of relevant natural products data a formidable challenge. Using a combination of manual curation and automated data mining approaches we have created a database of microbial natural products (The Natural Products Atlas, www.npatlas.org) that includes 24 594 compounds and contains referenced data for structure, compound names, source organisms, isolation references, total syntheses, and instances of structural reassignment. This database is accompanied by an interactive web portal that permits searching by structure, substructure, and physical properties. The Web site also provides mechanisms for visualizing natural products chemical space and dashboards for displaying author and discovery timeline data. These interactive tools offer a powerful knowledge base for natural products discovery with a central interface for structure and property-based searching and presents new viewpoints on structural diversity in natural products. The Natural Products Atlas has been developed under FAIR principles (Findable, Accessible, Interoperable, and Reusable) and is integrated with other emerging natural product databases, including the Minimum Information About a Biosynthetic Gene Cluster (MIBiG) repository, and the Global Natural Products Social Molecular Networking (GNPS) platform. It is designed as a community-supported resource to provide a central repository for known natural product structures from microorganisms and is the first comprehensive, open access resource of this type. It is expected that the Natural Products Atlas will enable the development of new natural products discovery modalities and accelerate the process of structural characterization for complex natural products libraries.</AbstractText><CopyrightInformation>Copyright © 2019 American Chemical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Santen</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Grégoire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Amrit Leen</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aniebok</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 65064, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balunas</LastName><ForeName>Marcy J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunsko</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Fausto Carnevale</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physics and Chemistry Department, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington 98109, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castaño-Espriu</LastName><ForeName>Laia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Trevor N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleary Little</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgadillo</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 65064, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorrestein</LastName><ForeName>Pieter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92037, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Katherine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galey</LastName><ForeName>Melissa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haeckl</LastName><ForeName>F P Jake</ForeName><Initials>FPJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Alison H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iskakova</LastName><ForeName>Dasha</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khadilkar</LastName><ForeName>Aswad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 65064, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jung-Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sanghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeGrow</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dennis Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macho</LastName><ForeName>Jocelyn M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 65064, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCaughey</LastName><ForeName>Catherine S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medema</LastName><ForeName>Marnix H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Bioinformatics Group, Wageningen University, 6700 AP Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neupane</LastName><ForeName>Ram P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paula</LastName><ForeName>Jasmine S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Anam F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soldatou</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terlouw</LastName><ForeName>Barbara R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Bioinformatics Group, Wageningen University, 6700 AP Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Tuan Anh</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Cau Giay, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentine</LastName><ForeName>Mercia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Hooft</LastName><ForeName>Justin J J</ForeName><Initials>JJJ</Initials><AffiliationInfo><Affiliation>Bioinformatics Group, Wageningen University, 6700 AP Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vo</LastName><ForeName>Duy A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 65064, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingxun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92037, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Darryl</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zink</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linington</LastName><ForeName>Roger G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 CA236237</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AT010098</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>D43 TW009343</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 GM058903</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM125943</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Cent Sci</MedlineTA><NlmUniqueID>101660035</NlmUniqueID><ISSNLinking>2374-7943</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare the following competing financial interest(s): RGL and MW are consultants for Sirenas. PCD is on the scientific advisory board for Sirenas. MHM is a member of the Scientific Advisory Board of Hexagon Bio and co-founder of Design Pharmaceuticals. MW is a founder of Ometa Labs.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31807684</ArticleId><ArticleId IdType="doi">10.1021/acscentsci.9b00806</ArticleId><ArticleId IdType="pmc">PMC6891855</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D613-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24243842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Chem Biol. 2019 Oct 17;26(10):1380-1392.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">31378711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2015 Sep;11(9):625-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26284661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Prod Rep. 2019 Jun 19;36(6):855-868</Citation><ArticleIdList><ArticleId IdType="pubmed">31073562</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 30;8(10):e78085</Citation><ArticleIdList><ArticleId IdType="pubmed">24205103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Oct 2;9(1):4035</Citation><ArticleIdList><ArticleId IdType="pubmed">30279420</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W276-W282</Citation><ArticleIdList><ArticleId IdType="pubmed">30997504</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2019 Aug;29(8):1352-1362</Citation><ArticleIdList><ArticleId IdType="pubmed">31160374</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2019 Apr;16(4):299-302</Citation><ArticleIdList><ArticleId IdType="pubmed">30886413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Aug 3;7(1):7215</Citation><ArticleIdList><ArticleId IdType="pubmed">28775335</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2001 Oct 10;123(40):9900-1</Citation><ArticleIdList><ArticleId IdType="pubmed">11583556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2016 Aug 9;34(8):828-837</Citation><ArticleIdList><ArticleId IdType="pubmed">27504778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1999 Jan 1;27(1):29-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9847135</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2019 Sep 3;91(17):11297-11305</Citation><ArticleIdList><ArticleId IdType="pubmed">31365233</ArticleId></ArticleIdList></Reference><Reference><Citation>IMA Fungus. 2013 Dec;4(2):371-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24563843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D509-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26615197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D935-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25300487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31803502</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2059-7029</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>6</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>ESMO open</Title><ISOAbbreviation>ESMO Open</ISOAbbreviation></Journal><ArticleTitle>Awareness of predatory journals and open access among medical oncologists: results of an online survey.</ArticleTitle><Pagination><MedlinePgn>e000580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/esmoopen-2019-000580</ELocationID><Abstract><AbstractText Label="Introduction">Predatory journals harm the integrity of science as principles of 'good scientific practice' are bypassed by omitting a proper peer-review process. Therefore, we aimed to explore the awareness of predatory journals among oncologists.</AbstractText><AbstractText Label="Methods">An online survey among oncologists working in Germany or Austria of various professional surroundings was conducted between October 2018 and April 2019.</AbstractText><AbstractText Label="Results">One hundred and eighty-eight participants (55 women (29.2%), 128 men (68.1%)) completed the questionnaire. 41 (21.8%) participants indicated to work in a hospital, 24 (12.8%) in private practice and 112 (59.6%) in a university hospital. 98.9% of participants indicated to actively read scientific articles and consider them in clinical decision-making (96.3%). 90.4% of participants indicated to have scientific experience by publishing papers in journals with peer-review system. The open-access system was known by 170 (90.4%), predatory journals by 131 (69.7%) and Beall's list by 52 participants (27.7%). Predatory journals were more likely to be known by participants with a higher number of publications (p&lt;0.001), with more high-impact publications (p=0.005) and with recent publications (p&lt;0.001). Awareness of predatory journals did not correlate with gender (p=0.515) or translation of scientific literature into clinical practice (p=0.543).</AbstractText><AbstractText Label="Conclusions">The problematic topic of 'predatory journals' is still unknown by a considerable amount of oncologist, although the survey was taken in a cohort of oncologists with scientific experience. Dedicated educational initiatives are needed to raise awareness of this problem and to aid in the identification of predatory journals for the scientific oncology community.</AbstractText><CopyrightInformation>© Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richtig</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Otto-Loewi Research Center, Pharmacology Section, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divison of Oncology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richtig</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böhm</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>3rd Medical Department, Division of Hematology and Oncology, Hanusch Hospital, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oing</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5578-3418</Identifier><AffiliationInfo><Affiliation>Department of Oncology, Hematology and Bone Marrow Transplantation with Divison of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, School of Medical Sciences, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozorgmehr</LastName><ForeName>Farastuk</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Centre Heidelberg (TLRC-H), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Member of the German Center for Lung Research (DZL), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiesewetter</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5490-2371</Identifier><AffiliationInfo><Affiliation>Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vienna Cancer Center, Central European Cooperative Oncology Group (CECOG), Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berghoff</LastName><ForeName>Anna S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-0767-6241</Identifier><AffiliationInfo><Affiliation>Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ESMO Open</MedlineTA><NlmUniqueID>101690685</NlmUniqueID><ISSNLinking>2059-7029</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>ESMO Open. 2020 Apr;5(2):</RefSource><PMID Version="1">32269024</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001364" MajorTopicYN="Y">Awareness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072103" MajorTopicYN="N">Oncologists</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066295" MajorTopicYN="N">Open Access Publishing</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010380" MajorTopicYN="N">Peer Review</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010506" MajorTopicYN="N">Periodicals as Topic</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">influence</Keyword><Keyword MajorTopicYN="Y">knowledge</Keyword><Keyword MajorTopicYN="Y">oncologist</Keyword><Keyword MajorTopicYN="Y">oncology</Keyword><Keyword MajorTopicYN="Y">predatory journals</Keyword><Keyword MajorTopicYN="Y">survey</Keyword></KeywordList><CoiStatement>Competing interests: ASB has research support from Daiichi Sankyo (≤ €10 000), Roche (&gt; €10 000) and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo (all &lt; €5000) as well as travel support from Roche, Amgen and AbbVie.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31803502</ArticleId><ArticleId IdType="doi">10.1136/esmoopen-2019-000580</ArticleId><ArticleId IdType="pii">S2059-7029(20)30091-0</ArticleId><ArticleId IdType="pmc">PMC6890386</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ESMO Open. 2016 Jan 18;1(1):e000008</Citation><ArticleIdList><ArticleId IdType="pubmed">27843582</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Derm Venereol. 2018 Dec 27;99(1):58-62</Citation><ArticleIdList><ArticleId IdType="pubmed">30206639</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Oct 4;342(6154):60-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24092725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Aug 19;390(10096):734-735</Citation><ArticleIdList><ArticleId IdType="pubmed">28831988</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2019 Aug 16;365(6454):629</Citation><ArticleIdList><ArticleId IdType="pubmed">31416942</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Ophthalmol. 2016 Nov;44(8):666-668</Citation><ArticleIdList><ArticleId IdType="pubmed">27870492</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2017 Jun 14;353:166-173</Citation><ArticleIdList><ArticleId IdType="pubmed">28433651</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1441-1449</Citation><ArticleIdList><ArticleId IdType="pubmed">29729106</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2011 Dec 16;13(4):e115</Citation><ArticleIdList><ArticleId IdType="pubmed">22173122</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2018 Sep;56(9):821-822</Citation><ArticleIdList><ArticleId IdType="pubmed">30194444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31799253</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Open Practices and Resources for Collaborative Digital Pathology.</ArticleTitle><Pagination><MedlinePgn>255</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2019.00255</ELocationID><Abstract><AbstractText>In this paper, we describe open practices and open resources in the field of digital pathology with a specific focus on approaches that ease collaboration in research and education settings. Our review includes open access journals and open peer review, open-source software (libraries, desktop tools, and web applications), and open access collections. We illustrate applications and discuss current limitations and perspectives.</AbstractText><CopyrightInformation>Copyright © 2019 Marée.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marée</LastName><ForeName>Raphaël</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montefiore Institute, University of Liège, Liège, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">collaboration</Keyword><Keyword MajorTopicYN="N">digital pathology</Keyword><Keyword MajorTopicYN="N">image analysis</Keyword><Keyword MajorTopicYN="N">open data</Keyword><Keyword MajorTopicYN="N">open science</Keyword><Keyword MajorTopicYN="N">open source</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31799253</ArticleId><ArticleId IdType="doi">10.3389/fmed.2019.00255</ArticleId><ArticleId IdType="pmc">PMC6868018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thorax. 2019 Aug;74(8):768-779</Citation><ArticleIdList><ArticleId IdType="pubmed">31142617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2018 Oct;24(10):1559-1567</Citation><ArticleIdList><ArticleId IdType="pubmed">30224757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pathol. 2018 Apr;38(2):76-84</Citation><ArticleIdList><ArticleId IdType="pubmed">29571562</ArticleId></ArticleIdList></Reference><Reference><Citation>Digit Pathol (2019). 2019 Apr;2019:3-10</Citation><ArticleIdList><ArticleId IdType="pubmed">31579322</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2019 Apr 24;10:847</Citation><ArticleIdList><ArticleId IdType="pubmed">31068935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2019 Feb;566(7745):543-547</Citation><ArticleIdList><ArticleId IdType="pubmed">30747918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc Res. 2019 Feb 1;115(2):463-475</Citation><ArticleIdList><ArticleId IdType="pubmed">29982533</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Nov 05;9(11):e110289</Citation><ArticleIdList><ArticleId IdType="pubmed">25372389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Dec 4;7(1):16878</Citation><ArticleIdList><ArticleId IdType="pubmed">29203879</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagn Pathol. 2013 Jun 06;8:92</Citation><ArticleIdList><ArticleId IdType="pubmed">23829479</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol Inform. 2017 Apr 10;8:19</Citation><ArticleIdList><ArticleId IdType="pubmed">28480122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2017 Aug;14(8):775-781</Citation><ArticleIdList><ArticleId IdType="pubmed">28775673</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Oct 1;32(19):3047-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Feb 28;9(3):245-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22373911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2017 Jul;92(1):214-226</Citation><ArticleIdList><ArticleId IdType="pubmed">28318622</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteomics Clin Appl. 2019 Jan;13(1):e1800057</Citation><ArticleIdList><ArticleId IdType="pubmed">30520559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2017 Nov 1;77(21):e75-e78</Citation><ArticleIdList><ArticleId IdType="pubmed">29092945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2018 Jun 1;7(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">29860392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Dis. 2019 Feb 4;10(2):103</Citation><ArticleIdList><ArticleId IdType="pubmed">30718510</ArticleId></ArticleIdList></Reference><Reference><Citation>JCO Clin Cancer Inform. 2019 Apr;3:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">30990737</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jul;9(7):671-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jun 28;9(7):690-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22743774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31798979</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2059-7029</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>6</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>ESMO open</Title><ISOAbbreviation>ESMO Open</ISOAbbreviation></Journal><ArticleTitle>CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussion.</ArticleTitle><Pagination><MedlinePgn>e000565</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/esmoopen-2019-000565</ELocationID><Abstract><AbstractText>In December 2017, <i>ESMO Open-Cancer Horizons</i> convened a round-table discussion on the background and latest data regarding cyclin-dependent kinase (CDK)4/6 inhibitors with endocrine therapy (ET) in the treatment of endocrine-sensitive breast cancer (BC). A review on this discussion was published in summer 2018 (https://esmoopen.bmj.com/content/3/5/e000368).Endocrine-sensitive BC with non-visceral disease and limited spread of the metastases.Endocrine-sensitive BC with non-life-threatening visceral involvement. Several open questions were identified, which led to a second <i>ESMO Open</i> discussion on CDK4/6 inhibitors, taking place in December 2018 and covered in this article. The panel discussed two important clinical scenarios and the pro and cons of a treatment approach with CDK4/6 inhibitors for each scenario:Endocrine-sensitive BC with non-visceral disease and limited spread of the metastases.Endocrine-sensitive BC with non-life-threatening visceral involvement. Regarding scenario 1, the panel agreed that CDK4/6 inhibitors should be recommended in first-line therapy for most patients if cost and practicality allow. However, the use of single-agent ET with an aromatase inhibitor in the first-line treatment of these patients is still a possibility for a small group of patients with very limited disease, such as one or two bone lesions or limited lymph node involvement. Regarding scenario 2, chemotherapy is the first approach for patients with endocrine-sensitive metastatic BC with life-threatening visceral involvement because of the need for a faster response. The therapeutic approaches for patients with non-life-threatening visceral involvement are still under debate. Nevertheless, CDK4/6 inhibitors are currently the treatment of choice for most patients with a close follow-up of tumour response. A treatment algorithm has been suggested at the round table.</AbstractText><CopyrightInformation>© Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Awada</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oncology Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gligorov</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut Universitaire de Cancérologie, APHP-Sorbonne Université, Hôpital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerusalem</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CHU Liege and Liege University, Domaine Universitaire du Sart Tilman, Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preusser</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3541-2315</Identifier><AffiliationInfo><Affiliation>Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Breast Health, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vienna Cancer Center, Medical University of Vienna and Vienna Hospital Association, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central European Cooperative Oncology Group (CECOG), Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ESMO Open</MedlineTA><NlmUniqueID>101690685</NlmUniqueID><ISSNLinking>2059-7029</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047072">Aromatase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="C495900">CDK4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="C495911">CDK6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D051358">Cyclin-Dependent Kinase 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D051361">Cyclin-Dependent Kinase 6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047072" MajorTopicYN="N">Aromatase Inhibitors</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051358" MajorTopicYN="N">Cyclin-Dependent Kinase 4</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051361" MajorTopicYN="N">Cyclin-Dependent Kinase 6</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047368" MajorTopicYN="N">Tumor Burden</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">CDK4/6 inhibitors</Keyword><Keyword MajorTopicYN="Y">HR-positive/HER2-negative breast cancer</Keyword><Keyword MajorTopicYN="Y">aromatase inhibitors</Keyword><Keyword MajorTopicYN="Y">breast cancer</Keyword><Keyword MajorTopicYN="Y">chemotherapy</Keyword><Keyword MajorTopicYN="Y">endocrine resistance</Keyword><Keyword MajorTopicYN="Y">endocrine therapy</Keyword><Keyword MajorTopicYN="Y">metastatic breast cancer</Keyword></KeywordList><CoiStatement>Competing interests: MP: honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo and Merck Sharp &amp; Dome. JG: research support from Eisai, Genomic Health, Novartis, Pfizer and Roche; travel grants from Eisai, Genomic Health, Novartis, Pfizer and Roche; honoraria for advisory boards and speaker fees from Daiichi, Eisai, Genomic Health, Ipsen, Macrogenics, MSD, Novartis, Onxeo, Pfizer and Roche. GJ: grants, personal fees and non-financial support from Novartis and Roche; personal fees and non-financial support from Pfizer, Lilly, Amgen, BMS, Astra-Zeneca; personal fees from Celgene, Puma Technology, Daiichi Sankyo and Abbvie. AA: advisory boards, travel grants, speaker fees: Novartis, Roche, Lilly, Amgen, Eisai, BMS, MSD, LeoPharma, Genomic Health and Ipsen. CS: honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Novartis, Gerson Lehrman Group, Astra-Zeneca, Lilly, Roche, Amgen, Pfitzer, Merck KGaA, and Tesaro. CCZ: honoraria from Roche, Novartis, BMS, MSD, Imugene, Ariad, Pfizer, Merrimack, Merck KGaA, Fibrogen, AstraZeneca, Tesaro, Gilead, Servier and Shire.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31798979</ArticleId><ArticleId IdType="doi">10.1136/esmoopen-2019-000565</ArticleId><ArticleId IdType="pii">S2059-7029(20)30088-0</ArticleId><ArticleId IdType="pmc">PMC6863664</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2017 Dec 17;388(10063):2997-3005</Citation><ArticleIdList><ArticleId IdType="pubmed">27908454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Mar 1;29(3):669-680</Citation><ArticleIdList><ArticleId IdType="pubmed">29342248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Med Oncol. 2018 Sep 03;10:1758835918793326</Citation><ArticleIdList><ArticleId IdType="pubmed">30202447</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 Mar 28;380(13):1226-1234</Citation><ArticleIdList><ArticleId IdType="pubmed">30917258</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res Treat. 2018 Feb;167(3):607-614</Citation><ArticleIdList><ArticleId IdType="pubmed">29103175</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Breast Cancer. 2018 Dec 18;4:41</Citation><ArticleIdList><ArticleId IdType="pubmed">30588487</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Nov 17;375(20):1925-1936</Citation><ArticleIdList><ArticleId IdType="pubmed">27959613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2013 Sep;14(10):989-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23902874</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2015 Feb 20;33(6):594-601</Citation><ArticleIdList><ArticleId IdType="pubmed">25605862</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2018 Aug 20;36(24):2465-2472</Citation><ArticleIdList><ArticleId IdType="pubmed">29860922</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2017 Sep 1;35(25):2875-2884</Citation><ArticleIdList><ArticleId IdType="pubmed">28580882</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 May 16;380(20):1929-1940</Citation><ArticleIdList><ArticleId IdType="pubmed">31091374</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2012 Jul 20;30(21):2601-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22711854</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Nov 3;375(18):1738-1748</Citation><ArticleIdList><ArticleId IdType="pubmed">27717303</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2017 Nov 10;35(32):3638-3646</Citation><ArticleIdList><ArticleId IdType="pubmed">28968163</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Nov 15;379(20):1926-1936</Citation><ArticleIdList><ArticleId IdType="pubmed">30345905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2018 Jul;19(7):904-915</Citation><ArticleIdList><ArticleId IdType="pubmed">29804902</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 Jul 25;381(4):307-316</Citation><ArticleIdList><ArticleId IdType="pubmed">31166679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2001 Sep;12(9):1259-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11697837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Compr Canc Netw. 2018 Mar;16(3):310-320</Citation><ArticleIdList><ArticleId IdType="pubmed">29523670</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncology. 2005;68(4-6):438-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16020974</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2666-76</Citation><ArticleIdList><ArticleId IdType="pubmed">18160686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nucl Med. 2018 Aug;59(8):1212-1218</Citation><ArticleIdList><ArticleId IdType="pubmed">29602822</ArticleId></ArticleIdList></Reference><Reference><Citation>ESMO Open. 2018 Aug 20;3(5):e000368</Citation><ArticleIdList><ArticleId IdType="pubmed">30167331</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res Treat. 2018 Feb;167(3):659-669</Citation><ArticleIdList><ArticleId IdType="pubmed">29058175</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res Treat. 2018 Aug;170(3):535-545</Citation><ArticleIdList><ArticleId IdType="pubmed">29654415</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2016 Sep 1;34(25):3069-103</Citation><ArticleIdList><ArticleId IdType="pubmed">27217461</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2015 Jul 20;33(21):2361-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26056183</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2004;9(6):606-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15561805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Apr;17(4):425-439</Citation><ArticleIdList><ArticleId IdType="pubmed">26947331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2004 Mar;15(3):440-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14998846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Aug 1;29(8):1634-1657</Citation><ArticleIdList><ArticleId IdType="pubmed">30032243</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2012 Jun 1;30(16):1919-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22370325</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Feb 9;366(6):520-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22149876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Apr 1;29(4):888-894</Citation><ArticleIdList><ArticleId IdType="pubmed">29360932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31798624</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Genomic Education at Scale: The Benefits of Massive Open Online Courses for the Healthcare Workforce.</ArticleTitle><Pagination><MedlinePgn>1094</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2019.01094</ELocationID><Abstract><AbstractText>To support the delivery of the UK's 100,000 Genomes Project, Health Education England's Genomics Education Programme developed a suite of resources, including a 3-week Massive Open Online Course (MOOC) on whole genome sequencing <i>via</i> the FutureLearn platform. This MOOC is a synchronous learning event, with course educators and mentors (NHS healthcare science trainees in genomics) facilitating the experience in real time. Crucially, the platform allows participants to interact and learn from each other's experiences. The evaluation of the course was considered from the learners' and mentors' perspectives. Perceptions of course relevance were examined through analysis of learner comments made throughout the course and responses to an end-of-course survey. Evaluation of mentors' experiences focused on how prepared they felt to undertake their role and the value and benefit of their experience. Data was collected through a mixed methods study after the first two runs of the course. Here we present findings from 440 learners who provided end-of-course reflections, 360 learners who completed the post-course survey and 14 mentors who facilitated the course. The course met learners' needs by providing a greater understanding of whole genome sequencing and the application of this technology in healthcare. Learners also highly valued the engagement with mentors. Mentors appreciated the experience and identified areas of professional development gained through the mentoring experience. Our findings show that a team of specialist healthcare course mentors engaging with a range of different healthcare professional MOOC learners in online conversation can enhance the learners' experiences and provide a beneficial continuing professional development opportunity for mentors.</AbstractText><CopyrightInformation>Copyright © 2019 Bishop, Miller, McPherson, Simpson, Sutherland and Seller.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genomics Education Programme, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genomics Education Programme, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPherson</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genomics Education Programme, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Siobhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genomics Education Programme, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherland</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National School of Healthcare Science, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seller</LastName><ForeName>Anneke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genomics Education Programme, Health Education England, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Massive Open Online Course</Keyword><Keyword MajorTopicYN="N">evaluation</Keyword><Keyword MajorTopicYN="N">genomic education</Keyword><Keyword MajorTopicYN="N">genomic medicine</Keyword><Keyword MajorTopicYN="N">multi-disciplinary education</Keyword><Keyword MajorTopicYN="N">online learning</Keyword><Keyword MajorTopicYN="N">workforce development</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31798624</ArticleId><ArticleId IdType="doi">10.3389/fgene.2019.01094</ArticleId><ArticleId IdType="pmc">PMC6863921</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Antimicrob Chemother. 2018 Apr 1;73(4):1091-1097</Citation><ArticleIdList><ArticleId IdType="pubmed">29340600</ArticleId></ArticleIdList></Reference><Reference><Citation>Glob Health Promot. 2018 Sep;25(3):74-76</Citation><ArticleIdList><ArticleId IdType="pubmed">28134014</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2014 Aug 14;16(8):e191</Citation><ArticleIdList><ArticleId IdType="pubmed">25123952</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2019 Jan 11;363(6423):130-131</Citation><ArticleIdList><ArticleId IdType="pubmed">30630920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Jun 3;7(290):290ps13</Citation><ArticleIdList><ArticleId IdType="pubmed">26041702</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Educ. 2017 May 31;17(1):97</Citation><ArticleIdList><ArticleId IdType="pubmed">28566091</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2019 Jan 3;104(1):13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">30609404</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31785827</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>394</Volume><Issue>10214</Issue><PubDate><Year>2019</Year><Month>12</Month><Day>07</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Corruption in global health: the open secret.</ArticleTitle><Pagination><MedlinePgn>2119-2124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(19)32527-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(19)32527-9</ELocationID><Abstract><AbstractText>Corruption is embedded in health systems. Throughout my life-as a researcher, public health worker, and a Minister of Health-I have been able to see entrenched dishonesty and fraud. But despite being one of the most important barriers to implementing universal health coverage around the world, corruption is rarely openly discussed. In this Lecture, I outline the magnitude of the problem of corruption, how it started, and what is happening now. I also outline people's fears around the topic, what is needed to address corruption, and the responsibilities of the academic and research communities in all countries, irrespective of their level of economic development. Policy makers, researchers, and funders need to think about corruption as an important area of research in the same way we think about diseases. If we are really aiming to achieve the Sustainable Development Goals and ensure healthy lives for all, corruption in global health must no longer be an open secret.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>García</LastName><ForeName>Patricia J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>School of Public Health, Cayetano Heredia University, Lima, Peru. Electronic address: patricia.garcia@upch.pe.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D019531">Lecture</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Glob Health. 2020 Mar;8(3):e325-e326</RefSource><PMID Version="1">32087162</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2020 Jul 18;396(10245):161</RefSource><PMID Version="1">32682472</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2020 Jul 18;396(10245):161-162</RefSource><PMID Version="1">32682473</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2020 Jul 18;396(10245):162</RefSource><PMID Version="1">32682475</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003415" MajorTopicYN="N">Crime</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005607" MajorTopicYN="Y">Fraud</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019981" MajorTopicYN="Y">Health Care Sector</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028743" MajorTopicYN="Y">Professional Misconduct</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012941" MajorTopicYN="N">Social Responsibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080423" MajorTopicYN="N">Universal Health Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31785827</ArticleId><ArticleId IdType="pii">S0140-6736(19)32527-9</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(19)32527-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31742563</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>19</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Evidence on User-Led Innovation in Diabetes Technology (The OPEN Project): Protocol for a Mixed Methods Study.</ArticleTitle><Pagination><MedlinePgn>e15368</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/15368</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Digital innovations in health care have traditionally followed a top-down pathway, with manufacturers leading the design and production of technology-enabled solutions and those living with chronic conditions involved only as passive recipients of the end product. However, user-driven open-source initiatives in health care are becoming increasingly popular. An example is the growing movement of people with diabetes, who create their own "Do-It-Yourself Artificial Pancreas Systems" (DIYAPS).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The overall aim of this study is to establish the empirical evidence base for the clinical effectiveness and quality-of-life benefits of DIYAPS and identify the challenges and possible solutions to enable their wider diffusion.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A research program comprising 5 work packages will examine the outcomes and potential for scaling up DIYAPS solutions. Quantitative and qualitative methodologies will be used to examine clinical and self-reported outcome measures of DIYAPS users. The majority of members of the research team live with type 1 diabetes and are active DIYAPS users, making Outcomes of Patients' Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology (OPEN) a unique, user-driven research project.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This project has received funding from the European Commission's Horizon 2020 Research and Innovation Program, under the Marie Skłodowska-Curie Action Research and Innovation Staff Exchange. Researchers with both academic and nonacademic backgrounds have been recruited to formulate research questions, drive the research process, and disseminate ongoing findings back to the DIYAPS community and other stakeholders.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The OPEN project is unique in that it is a truly patient- and user-led research project, which brings together an international, interdisciplinary, and intersectoral research group, comprising health care professionals, technical developers, biomedical and social scientists, the majority of whom are also living with diabetes. Thus, it directly addresses the core research and user needs of the DIYAPS movement. As a new model of cooperation, it will highlight how researchers in academia, industry, and the patient community can create patient-centric innovation and reduce disease burden together.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">PRR1-10.2196/15368.</AbstractText><CopyrightInformation>©Shane O'Donnell, Dana Lewis, María Marchante Fernández, Mandy Wäldchen, Bryan Cleal, Timothy Skinner, Klemens Raile, Adrian Tappe, Tebbe Ubben, Ingrid Willaing, Bastian Hauck, Saskia Wolf, Katarina Braune. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.11.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Shane</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3778-705X</Identifier><AffiliationInfo><Affiliation>School of Sociology, University College Dublin, Belfield, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Dana</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4063-4350</Identifier><AffiliationInfo><Affiliation>OpenAPS, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchante Fernández</LastName><ForeName>María</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3973-7803</Identifier><AffiliationInfo><Affiliation>School of Sociology, University College Dublin, Belfield, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wäldchen</LastName><ForeName>Mandy</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0404-517X</Identifier><AffiliationInfo><Affiliation>School of Sociology, University College Dublin, Belfield, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleal</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3065-7364</Identifier><AffiliationInfo><Affiliation>Diabetes Management Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skinner</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0018-6963</Identifier><AffiliationInfo><Affiliation>Diabetes Management Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut for Psykologi, Københavns Universitet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raile</LastName><ForeName>Klemens</ForeName><Initials>K</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0842-1737</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Endocrinology and Diabetes, Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tappe</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8501-7247</Identifier><AffiliationInfo><Affiliation>AndroidAPS, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ubben</LastName><ForeName>Tebbe</ForeName><Initials>T</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-2573-2198</Identifier><AffiliationInfo><Affiliation>AndroidAPS, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>#dedoc° Diabetes Online Community, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willaing</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3082-8816</Identifier><AffiliationInfo><Affiliation>Diabetes Management Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauck</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9374-8971</Identifier><AffiliationInfo><Affiliation>#dedoc° Diabetes Online Community, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9348-7545</Identifier><AffiliationInfo><Affiliation>#dedoc° Diabetes Online Community, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braune</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-6590-245X</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Endocrinology and Diabetes, Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">#WeAreNotWaiting</Keyword><Keyword MajorTopicYN="N">automated insulin delivery systems</Keyword><Keyword MajorTopicYN="N">closed-loop insulin delivery systems</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">open source</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31742563</ArticleId><ArticleId IdType="pii">v8i11e15368</ArticleId><ArticleId IdType="doi">10.2196/15368</ArticleId><ArticleId IdType="pmc">PMC6891827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2018 Nov;20(11):744-750</Citation><ArticleIdList><ArticleId IdType="pubmed">30285476</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Educ. 2017 Apr;43(2):223-232</Citation><ArticleIdList><ArticleId IdType="pubmed">28340542</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Dec;18(12):772-783</Citation><ArticleIdList><ArticleId IdType="pubmed">27835037</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Jul;19(7):410-416</Citation><ArticleIdList><ArticleId IdType="pubmed">28537437</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Jan;21(1):11-19</Citation><ArticleIdList><ArticleId IdType="pubmed">30585770</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2019 Apr;42(4):594-600</Citation><ArticleIdList><ArticleId IdType="pubmed">30692242</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Mhealth Uhealth. 2019 Jul 30;7(7):e14087</Citation><ArticleIdList><ArticleId IdType="pubmed">31364599</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1996 Mar;19(3):195-203</Citation><ArticleIdList><ArticleId IdType="pubmed">8742561</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Apr;17(4):295-300</Citation><ArticleIdList><ArticleId IdType="pubmed">25549042</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1411</Citation><ArticleIdList><ArticleId IdType="pubmed">27510442</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Mar;21(3):119-127</Citation><ArticleIdList><ArticleId IdType="pubmed">30720338</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2007 Sep-Oct;10(5):326-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17888097</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2019 Oct;21(10):2333-2337</Citation><ArticleIdList><ArticleId IdType="pubmed">31183929</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Res. 2015;2015:590308</Citation><ArticleIdList><ArticleId IdType="pubmed">26581230</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Nov;11(6):1080-1088</Citation><ArticleIdList><ArticleId IdType="pubmed">28367636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Oct 13;392(10155):1321-1329</Citation><ArticleIdList><ArticleId IdType="pubmed">30292578</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Mar;19(3):155-163</Citation><ArticleIdList><ArticleId IdType="pubmed">28134564</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open Diabetes Res Care. 2014 Apr 16;2(1):e000025</Citation><ArticleIdList><ArticleId IdType="pubmed">25452866</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Nov;12(6):1125-1131</Citation><ArticleIdList><ArticleId IdType="pubmed">30288999</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Med (Zagreb). 2017 Oct 15;27(3):030201</Citation><ArticleIdList><ArticleId IdType="pubmed">29180912</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2015 May;32(5):601-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25615888</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2019 Feb;21(2):66-72</Citation><ArticleIdList><ArticleId IdType="pubmed">30657336</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2017 Oct;34(10):1461-1469</Citation><ArticleIdList><ArticleId IdType="pubmed">28631849</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2012 Sep;97(3):425-31</Citation><ArticleIdList><ArticleId IdType="pubmed">22513346</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Jun 28;10(4):840-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26993252</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2019 Jul;13(4):790-793</Citation><ArticleIdList><ArticleId IdType="pubmed">30348013</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Oct;20(10):648-653</Citation><ArticleIdList><ArticleId IdType="pubmed">30239219</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jul;9(4):932-3</Citation><ArticleIdList><ArticleId IdType="pubmed">25852073</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Med J. 2018 Nov;48(11):1400-1404</Citation><ArticleIdList><ArticleId IdType="pubmed">30387315</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64</Citation><ArticleIdList><ArticleId IdType="pubmed">29222377</ArticleId></ArticleIdList></Reference><Reference><Citation>Implement Sci. 2015 Apr 16;10:49</Citation><ArticleIdList><ArticleId IdType="pubmed">25885787</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26740634</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31727538</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.</ArticleTitle><Pagination><MedlinePgn>1730-1739</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(19)30688-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(19)30688-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Abiraterone acetate plus prednisone and enzalutamide are both used for the treatment of metastatic castration-resistant prostate cancer. We aimed to determine the best sequence in which to use both drugs, as well as their second-line efficacy.</AbstractText><AbstractText Label="METHODS">In this multicentre, randomised, open-label, phase 2, crossover trial done in six cancer centres in British Columbia, Canada, we recruited patients aged 18 years or older with newly-diagnosed metastatic castration-resistant prostate cancer without neuroendocrine differentiation and Eastern Cooperative Oncology Group performance status 2 or less. Patients were randomly assigned (1:1) using a computer-generated random number table to receive either abiraterone acetate 1000 mg orally once daily plus prednisone 5 mg orally twice daily until PSA progression followed by crossover to enzalutamide 160 mg orally once daily (group A), or the opposite sequence (group B). Treatment was not masked to investigators or participants. Primary endpoints were time to second PSA progression and PSA response (≥30% decline from baseline) on second-line therapy, analysed by intention-to-treat in all randomly assigned patients and in patients who crossed over, respectively. The trial is registered with ClinicalTrials.gov, NCT02125357.</AbstractText><AbstractText Label="FINDINGS">Between Oct 21, 2014, and Dec 13, 2016, 202 patients were enrolled and randomly assigned to either group A (n=101) or group B (n=101). At the time of data cutoff, 73 (72%) patients in group A and 75 (74%) patients in group B had crossed over. Time to second PSA progression was longer in group A than in group B (median 19·3 months [95% CI 16·0-30·5] vs 15·2 months [95% CI 11·9-19·8] months; hazard ratio 0·66, 95% CI 0·45-0·97, p=0·036), at a median follow-up of 22·8 months (IQR 10·3-33·4). PSA responses to second-line therapy were seen in 26 (36%) of 73 patients for enzalutamide and three (4%) of 75 for abiraterone (χ<sup>2</sup> p&lt;0·0001). The most common grade 3-4 adverse events throughout the trial were hypertension (27 [27%] of 101 patients in group A vs 18 [18%] of 101 patients in group B) and fatigue (six [10%] vs four [4%]). Serious adverse events were reported in 15 (15%) of 101 patients in group A and 20 (20%) of 101 patients in group B. There were no treatment-related deaths.</AbstractText><AbstractText Label="INTERPRETATION">Enzalutamide showed activity as a second-line novel androgen receptor pathway inhibitor, whereas abiraterone acetate did not, leading to a longer time to second PSA progression for the sequence of abiraterone followed by enzalutamide than with the opposite treatment sequence. Our data suggest that using a sequencing strategy of abiraterone acetate followed by enzalutamide provides the greatest clinical benefit.</AbstractText><AbstractText Label="FUNDING">Canadian Cancer Society Research Institute, Prostate Cancer Canada, Movember Foundation, Prostate Cancer Foundation, Terry Fox New Frontiers Program, BC Cancer Foundation, Jane and Aatos Erkko Foundation, Janssen, and Astellas.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khalaf</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annala</LastName><ForeName>Matti</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vancouver Prostate Centre, Vancouver, BC, Canada; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taavitsainen</LastName><ForeName>Sinja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vancouver Prostate Centre, Vancouver, BC, Canada; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finch</LastName><ForeName>Daygen L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>BC Cancer, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Conrad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>BC Cancer, Surrey, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergidis</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BC Cancer, Victoria, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zulfiqar</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BC Cancer, Abbotsford, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunderland</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cancer Surveillance and Outcomes, BC Cancer, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azad</LastName><ForeName>Arun A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kollmannsberger</LastName><ForeName>Christian K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eigl</LastName><ForeName>Bernhard J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noonan</LastName><ForeName>Krista</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>BC Cancer, Surrey, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadhwa</LastName><ForeName>Deepa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>BC Cancer, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attwell</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BC Cancer, Victoria, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keith</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>BC Cancer, Abbotsford, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellard</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>BC Cancer, Kelowna, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Lyly</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>BC Cancer, Surrey, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleave</LastName><ForeName>Martin E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vancouver Prostate Centre, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyatt</LastName><ForeName>Alexander W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Vancouver Prostate Centre, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Kim N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: kchi@bccancer.bc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02125357</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009570">Nitriles</NameOfSubstance></Chemical><Chemical><RegistryNumber>2010-15-3</RegistryNumber><NameOfSubstance UI="D010669">Phenylthiohydantoin</NameOfSubstance></Chemical><Chemical><RegistryNumber>93T0T9GKNU</RegistryNumber><NameOfSubstance UI="C540278">enzalutamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EM5OCB9YJ6</RegistryNumber><NameOfSubstance UI="D000069501">Abiraterone Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Clin Oncol. 2020 Feb;17(2):69</RefSource><PMID Version="1">31772332</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2019 Dec;20(12):1628-1630</RefSource><PMID Version="1">31797776</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Urol. 2020 Apr;17(4):197-198</RefSource><PMID Version="1">32047281</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000069501" MajorTopicYN="N">Abiraterone Acetate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009570" MajorTopicYN="N">Nitriles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010669" MajorTopicYN="N">Phenylthiohydantoin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064129" MajorTopicYN="N">Prostatic Neoplasms, Castration-Resistant</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>08</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31727538</ArticleId><ArticleId IdType="pii">S1470-2045(19)30688-6</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(19)30688-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31712420</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>48</Issue><PubDate><Year>2019</Year><Month>11</Month><Day>26</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>An open challenge to advance probabilistic forecasting for dengue epidemics.</ArticleTitle><Pagination><MedlinePgn>24268-24274</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1909865116</ELocationID><Abstract><AbstractText>A wide range of research has promised new tools for forecasting infectious disease dynamics, but little of that research is currently being applied in practice, because tools do not address key public health needs, do not produce probabilistic forecasts, have not been evaluated on external data, or do not provide sufficient forecast skill to be useful. We developed an open collaborative forecasting challenge to assess probabilistic forecasts for seasonal epidemics of dengue, a major global public health problem. Sixteen teams used a variety of methods and data to generate forecasts for 3 epidemiological targets (peak incidence, the week of the peak, and total incidence) over 8 dengue seasons in Iquitos, Peru and San Juan, Puerto Rico. Forecast skill was highly variable across teams and targets. While numerous forecasts showed high skill for midseason situational awareness, early season skill was low, and skill was generally lowest for high incidence seasons, those for which forecasts would be most valuable. A comparison of modeling approaches revealed that average forecast skill was lower for models including biologically meaningful data and mechanisms and that both multimodel and multiteam ensemble forecasts consistently outperformed individual model forecasts. Leveraging these insights, data, and the forecasting framework will be critical to improve forecast skill and the application of forecasts in real time for epidemic preparedness and response. Moreover, key components of this project-integration with public health needs, a common forecasting framework, shared and standardized data, and open participation-can help advance infectious disease forecasting beyond dengue.</AbstractText><CopyrightInformation>Copyright © 2019 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-5090-7722</Identifier><AffiliationInfo><Affiliation>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan 00920, Puerto Rico; mjohansson@cdc.gov.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfeldorf</LastName><ForeName>Karyn M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Data Analytics, Areté Associates, Northridge, CA 91324.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Data Analytics, Areté Associates, Northridge, CA 91324.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devita</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Data Analytics, Areté Associates, Northridge, CA 91324.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buczak</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baugher</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moniz</LastName><ForeName>Linda J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagley</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babin</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guven</LastName><ForeName>Erhan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Systems Integration Branch, Johns Hopkins University Applied Physics Laboratory, Laurel, MD 20723.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamana</LastName><ForeName>Teresa K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschou</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Data to Decisions Cooperative Research Center, Kent Town, SA 5067, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lothian</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Data to Decisions Cooperative Research Center, Kent Town, SA 5067, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Data to Decisions Cooperative Research Center, Kent Town, SA 5067, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Data to Decisions Cooperative Research Center, Kent Town, SA 5067, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Gao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Heinz College Information System Management, Carnegie Mellon University, Adelaide, SA 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Logan C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrow</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyun</LastName><ForeName>Sangwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tibshirani</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Roni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessler</LastName><ForeName>Justin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9741-8109</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Nicholas G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0003-3503-9899</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Derek A T</ForeName><Initials>DAT</Initials><Identifier Source="ORCID">0000-0002-9437-1907</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Florida, Gainesville, FL 32611.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emerging Pathogens Institute, University of Florida, Gainesville, FL 32611.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauer</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-2948-630X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clapham</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0002-2531-161X</Identifier><AffiliationInfo><Affiliation>Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3939-7343</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London WC1E 7HT, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Climate and Health Program, Barcelona Institute for Global Health, 08003 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Trevor C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter EX4 4QF, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Díez</LastName><ForeName>Markel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Predictia Intelligent Data Solutions, 39005 Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Marilia Sá</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-9566-0284</Identifier><AffiliationInfo><Affiliation>Scientific Computation Program, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodó</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4843-6180</Identifier><AffiliationInfo><Affiliation>Climate and Health Program, Barcelona Institute for Global Health, 08003 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardar</LastName><ForeName>Tridip</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Mathematical Biology, Indian Statistical Institute, Kolkata, India 700108.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pasteur Kyoto International Joint Research Unit for Integrative Vaccinomics, 606-8501 Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Evan L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-4035-0243</Identifier><AffiliationInfo><Affiliation>Department of Global Health, Centre National de la Recherche Scientifique, 75016 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakrejda</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Alexandria C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-2046-9415</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osoba</LastName><ForeName>Osonde</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, Mount Holyoke College, South Hadley, MA 01075.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardavas</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, Mount Holyoke College, South Hadley, MA 01075.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manheim</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8599-8380</Identifier><AffiliationInfo><Affiliation>RAND Corporation, Santa MonicaCA 90401.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Melinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, Mount Holyoke College, South Hadley, MA 01075.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Dhananjai M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Open Philanthropy, San Francisco, CA 94105.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porco</LastName><ForeName>Travis C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Software Engineering, Miami University, Oxford, OH 45056.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackley</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Software Engineering, Miami University, Oxford, OH 45056.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fengchen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Software Engineering, Miami University, Oxford, OH 45056.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worden</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Software Engineering, Miami University, Oxford, OH 45056.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Convertino</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>F. I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94122.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Information Science and Technology, Hokkaido University, Sapporo 060-0808, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Information Science and Technology, Hokkaido University, Sapporo 060-0808, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Eloy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Twin Cities, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Twin Cities, MN 55455.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Humberto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Twin Cities, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VectorAnalytica, Washington, DC 20007.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juarrero</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Twin Cities, MN 55455.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Aeronautical Engineering, Universidade de Sao Paolo, Sao Paolo 13566-590, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Leah R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Philosophy, University of Miami, Coral Gables, FL 33146.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gramacy</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Statistics, Virginia Tech, Blacksburg, VA 24060.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Jeremy M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-9611-9150</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Virginia Tech, Blacksburg, VA 24060.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mordecai</LastName><ForeName>Erin A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-4402-5547</Identifier><AffiliationInfo><Affiliation>Integrative Biology, University of South Florida, Tampa, FL 33620.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murdock</LastName><ForeName>Courtney C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA 94305.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohr</LastName><ForeName>Jason R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Sadie J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-4308-6321</Identifier><AffiliationInfo><Affiliation>Emerging Pathogens Institute, University of Florida, Gainesville, FL 32611.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odum School of Ecology, University of Georgia, Athens, GA 30602.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geography, University of Florida, Gainesville, FL 32608.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart-Ibarra</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of KwaZulu, Natal 3629, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weikel</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY 13421.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jutla</LastName><ForeName>Antarpreet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Rakibul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poultney</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colwell</LastName><ForeName>Rita R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Civil and Environmental Engineering, West Virginia University, Morgantown, WV 26505.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-García</LastName><ForeName>Brenda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Puerto Rico Department of Health, San Juan 00927, Puerto Rico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Jesse E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biggerstaff</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Environmental, Agricultural, and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swerdlow</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Environmental, Agricultural, and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mier-Y-Teran-Romero</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan 00920, Puerto Rico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forshey</LastName><ForeName>Brett M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trtanj</LastName><ForeName>Juli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Armed Forces Health Surveillance Branch, Department of Defense, Silver Spring, MD 20904.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asher</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Climate Program Office, National Oceanic and Atmospheric Administration, Silver Spring, MD 20910.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clay</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Climate Program Office, National Oceanic and Atmospheric Administration, Silver Spring, MD 20910.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margolis</LastName><ForeName>Harold S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan 00920, Puerto Rico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hebbeler</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Leidos supporting the Biomedical Advanced Research and Development Authority, Department of Health and Human Services, Washington, DC 20201.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bureau of Oceans, International Environmental and Scientific Affairs, US Department of State, Washington, DC 20520.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bureau of Oceans, International Environmental and Scientific Affairs, US Department of State, Washington, DC 20520.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Science and Technology Policy, The White House, Washington, DC 20502.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chretien</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-8143-6823</Identifier><AffiliationInfo><Affiliation>Bureau of Oceans, International Environmental and Scientific Affairs, US Department of State, Washington, DC 20520.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BNext, In-Q-Tel, Arlington, VA 22201.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 EB009403</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119582</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM100467</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GM087728</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GM110748</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI102939</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI115173</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM088491</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI122284</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM133439</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):26087-26088</RefSource><PMID Version="1">31818939</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20336</RefSource><PMID Version="1">32778595</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="N">Epidemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="Y">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011647" MajorTopicYN="N" Type="Geographic">Puerto Rico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Peru</Keyword><Keyword MajorTopicYN="Y">Puerto Rico</Keyword><Keyword MajorTopicYN="Y">dengue</Keyword><Keyword MajorTopicYN="Y">epidemic</Keyword><Keyword MajorTopicYN="Y">forecast</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31712420</ArticleId><ArticleId IdType="pii">1909865116</ArticleId><ArticleId IdType="doi">10.1073/pnas.1909865116</ArticleId><ArticleId IdType="pmc">PMC6883829</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stat Med. 2017 Sep 30;36(22):3443-3460</Citation><ArticleIdList><ArticleId IdType="pubmed">28656694</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2014 Jul 17;8(7):e3003</Citation><ArticleIdList><ArticleId IdType="pubmed">25033412</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2013 Oct;9(10):e1003308</Citation><ArticleIdList><ArticleId IdType="pubmed">24204241</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Jan 3;13(1):e0189988</Citation><ArticleIdList><ArticleId IdType="pubmed">29298320</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2016 Oct;13(123):</Citation><ArticleIdList><ArticleId IdType="pubmed">27733698</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2013 Jul 03;10(86):20130414</Citation><ArticleIdList><ArticleId IdType="pubmed">23825116</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemics. 2018 Sep;24:26-33</Citation><ArticleIdList><ArticleId IdType="pubmed">29506911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Apr 25;496(7446):504-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):790-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9892712</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemics. 2015 Jun;11:92-102</Citation><ArticleIdList><ArticleId IdType="pubmed">25979287</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Feb 24;5:null</Citation><ArticleIdList><ArticleId IdType="pubmed">26910315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2015 Nov;33(11):1107-35</Citation><ArticleIdList><ArticleId IdType="pubmed">26048354</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Aug 11;29(35):5860-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21699949</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemics. 2018 Mar;22:13-21</Citation><ArticleIdList><ArticleId IdType="pubmed">28958414</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Nov;6(11):e1000168</Citation><ArticleIdList><ArticleId IdType="pubmed">19918363</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2013 Apr 04;7(4):e2159</Citation><ArticleIdList><ArticleId IdType="pubmed">23593526</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15259-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16217017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2016 Aug;16(8):935-41</Citation><ArticleIdList><ArticleId IdType="pubmed">27091092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Sep 26;6:33707</Citation><ArticleIdList><ArticleId IdType="pubmed">27665707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Planet Health. 2017 Jul;1(4):e142-e151</Citation><ArticleIdList><ArticleId IdType="pubmed">29851600</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2013 Feb 13;10(81):20120921</Citation><ArticleIdList><ArticleId IdType="pubmed">23407571</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13069-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26438851</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2010 Aug 10;4(8):e787</Citation><ArticleIdList><ArticleId IdType="pubmed">20706628</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16966609</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemics. 2016 Dec;17:19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27770752</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11802-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16868086</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2694-702</Citation><ArticleIdList><ArticleId IdType="pubmed">24847073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31689876</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>44</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Retrospective study of open reduction and internal fixation of lateral humeral condyle fractures with absorbable screws and absorbable sutures in children.</ArticleTitle><Pagination><MedlinePgn>e17850</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000017850</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lateral humeral condyle fractures are the second most common elbow fracture in children. Displaced and rotated fractures require stabilization and reduction. Kirschner wires (K-wires) are most commonly used in the fixation of these fractures. Here, we introduce a new fixation method that uses an absorbable screw. We aim to determine if it is feasible to treat lateral humeral condyle fractures with an absorbable screw by comparing functional outcomes following absorbable screw fixation vs. K-wire fixation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between May 2007 and September 2010, 86 patients were treated with absorbable screws (43 patients) or K-wire (43 patients). All patients had been diagnosed with lateral condyle fractures that were classified as either Jacob type II (unstable) or III. One absorbable screw (3.5 mm-diameter) was used for fixation in 1 group, while two 1.6 to 1.8 mm K-wires were used in the other group. Patients were followed 6 months about the elbow function according to Broberg and Morrey standard. On 5-7 years, the patients were followed about the carrying angle (valgus deformities and varus deformities), range of motion (flexion loss and extension loss), prominent lateral condyle, symptomatic implants, and fishtail deformity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Anatomic reduction was achieved in all patients. Each group had one radial nerve injury that were present preoperatively. Nerve function recovered spontaneously within 3 to 4 weeks of surgery in both patients. No patient developed necrosis of the capitulum in both groups. Nine patients in K-wires group and 2 in absorbable screw group developed symptomatic implants (P = .048). On the sixth month, there was no significant difference on elbow function according to Broberg and Morrey standard. On 5 to 7 years (average, 6.7 ± 1.3 years), valgus deformities was 6.8 ± 1.2 vs 5.7 ± 0.8, varus deformities was 7.2 ± 1.5 vs 5.1 ± 1.9, flexion loss was 12.4 ± 2.2 vs 9.5 ± 3.1, extension loss was 11.1 ± 3.1 vs 10.2 ± 2.7, prominent lateral condyle was 27.9% vs 37.2%, fishtail deformity was 7.3% vs 4.9%, no significant difference between these groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Open reduction with absorbable screw fixation is feasible and safe for the treatment of lateral condyle fractures of the humerus in children.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Therapeutic III.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, the Children's Hospital of Chongqing Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, the Children's Hospital of Chongqing Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, the Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001863" MajorTopicYN="Y">Bone Screws</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001864" MajorTopicYN="N">Bone Wires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006810" MajorTopicYN="N">Humeral Fractures</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070799" MajorTopicYN="Y">Open Fracture Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013537" MajorTopicYN="Y">Sutures</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31689876</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000017850</ArticleId><ArticleId IdType="pii">00005792-201911010-00136</ArticleId><ArticleId IdType="pmc">PMC6946392</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Injury. 1985 May;16(6):364-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4008023</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 2017 Jan;37(1):7-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26192878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Radiol. 2015 Jun;45(6):814-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25527301</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Orthop Surg. 2020 Jan 1;28(1):e9-e19</Citation><ArticleIdList><ArticleId IdType="pubmed">31268870</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Res. 2011 Dec;29(12):1834-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21618598</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Orthop. 2011 Oct;5(5):329-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23024723</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 1975 Nov;57(4):430-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1104630</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 1986 Jun;(207):290-305</Citation><ArticleIdList><ArticleId IdType="pubmed">3522015</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 2015 Dec;35(8):e93-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25985374</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 1987 Mar;(216):109-19</Citation><ArticleIdList><ArticleId IdType="pubmed">3102139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma. 1964 Sep;4:592-607</Citation><ArticleIdList><ArticleId IdType="pubmed">14208785</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 1985 Jul;67(6):851-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4019532</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Orthop Trauma Surg. 2018 Jun;138(6):809-817</Citation><ArticleIdList><ArticleId IdType="pubmed">29574555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2012 Oct;94(7):513-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23031772</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Orthop. 2012 Jun;36(6):1261-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22179811</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 2017 Mar;37(2):e83-e87</Citation><ArticleIdList><ArticleId IdType="pubmed">26840272</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 2001 Jan;(382):247-57</Citation><ArticleIdList><ArticleId IdType="pubmed">11153995</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 1998 Mar-Apr;18(2):149-54</Citation><ArticleIdList><ArticleId IdType="pubmed">9531394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech Eng. 1980 Nov;102(4):301-10</Citation><ArticleIdList><ArticleId IdType="pubmed">6965193</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 2012 Sep;32(6):573-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22892618</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Radiol. 2014 Aug;44(8):963-70</Citation><ArticleIdList><ArticleId IdType="pubmed">24577686</ArticleId></ArticleIdList></Reference><Reference><Citation>ScientificWorldJournal. 2013 Oct 09;2013:869418</Citation><ArticleIdList><ArticleId IdType="pubmed">24228016</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Orthop. 2016 Dec;36(8):780-786</Citation><ArticleIdList><ArticleId IdType="pubmed">26090985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31676459</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Sex, obesity, diabetes, and exposure to particulate matter among patients with severe asthma: Scientific insights from a comparative analysis of open clinical data sources during a five-day hackathon.</ArticleTitle><Pagination><MedlinePgn>103325</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30244-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103325</ELocationID><Abstract><AbstractText>This special communication describes activities, products, and lessons learned from a recent hackathon that was funded by the National Center for Advancing Translational Sciences via the Biomedical Data Translator program ('Translator'). Specifically, Translator team members self-organized and worked together to conceptualize and execute, over a five-day period, a multi-institutional clinical research study that aimed to examine, using open clinical data sources, relationships between sex, obesity, diabetes, and exposure to airborne fine particulate matter among patients with severe asthma. The goal was to develop a proof of concept that this new model of collaboration and data sharing could effectively produce meaningful scientific results and generate new scientific hypotheses. Three Translator Clinical Knowledge Sources, each of which provides open access (via Application Programming Interfaces) to data derived from the electronic health record systems of major academic institutions, served as the source of study data. Jupyter Python notebooks, shared in GitHub repositories, were used to call the knowledge sources and analyze and integrate the results. The results replicated established or suspected relationships between sex, obesity, diabetes, exposure to airborne fine particulate matter, and severe asthma. In addition, the results demonstrated specific differences across the three Translator Clinical Knowledge Sources, suggesting cohort- and/or environment-specific factors related to the services themselves or the catchment area from which each service derives patient data. Collectively, this special communication demonstrates the power and utility of intense, team-oriented hackathons and offers general technical, organizational, and scientific lessons learned.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fecho</LastName><ForeName>Karamarie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Renaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: kfecho@copperlineprofessionalsolutions.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahalt</LastName><ForeName>Stanley C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Renaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arunachalam</LastName><ForeName>Saravanan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for the Environment, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Champion</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Renaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gersing</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glusman</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadlock</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jewel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sid</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Renaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peden</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Center for Environmental Medicine, Asthma &amp; Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Biomedical Data Translator Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002026</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 ES010126</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR002520</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR002514</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002019</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR002584</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR002517</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002020</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 TR002515</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="Y">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052638" MajorTopicYN="N">Particulate Matter</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="Y">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Application programming interface</Keyword><Keyword MajorTopicYN="Y">Clinical data</Keyword><Keyword MajorTopicYN="Y">Hackathon</Keyword><Keyword MajorTopicYN="Y">Multi-institutional collaboration</Keyword><Keyword MajorTopicYN="Y">Open data</Keyword><Keyword MajorTopicYN="Y">Team science</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31676459</ArticleId><ArticleId IdType="pii">S1532-0464(19)30244-8</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103325</ArticleId><ArticleId IdType="pmc">PMC6953386</ArticleId><ArticleId IdType="mid">NIHMS1065289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Opin Pulm Med. 2011 Jan;17(1):6-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21045697</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 2016 Jun;37(3):278-316</Citation><ArticleIdList><ArticleId IdType="pubmed">27159875</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Sci. 2019 Jul;12(4):329-333</Citation><ArticleIdList><ArticleId IdType="pubmed">31074176</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chest Med. 2019 Mar;40(1):97-106</Citation><ArticleIdList><ArticleId IdType="pubmed">30691720</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2015 Jan 29;11(1):e1003905</Citation><ArticleIdList><ArticleId IdType="pubmed">25633715</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Sci. 2019 Mar;12(2):91-94</Citation><ArticleIdList><ArticleId IdType="pubmed">30412340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2018 Nov 27;5:180273</Citation><ArticleIdList><ArticleId IdType="pubmed">30480666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Total Environ. 2017 Apr 15;584-585:1077-1083</Citation><ArticleIdList><ArticleId IdType="pubmed">28169030</ArticleId></ArticleIdList></Reference><Reference><Citation>Asthma Res Pract. 2019 Jan 18;5:1</Citation><ArticleIdList><ArticleId IdType="pubmed">30680222</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2013 Aug 1;188(3):319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">23905525</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Health Perspect. 2015 May;123(5):381-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25625876</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Sci. 2019 Mar;12(2):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">30412337</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 May-Jun;17(3):265-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20442143</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 23;10(6):e0130337</Citation><ArticleIdList><ArticleId IdType="pubmed">26103580</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Mar 29;543(7647):615-617</Citation><ArticleIdList><ArticleId IdType="pubmed">28358098</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Health Perspect. 2016 Dec;124(12):1882-1890</Citation><ArticleIdList><ArticleId IdType="pubmed">27385358</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Sci. 2019 Mar;12(2):85</Citation><ArticleIdList><ArticleId IdType="pubmed">30412342</ArticleId></ArticleIdList></Reference><Reference><Citation>J Investig Med. 2012 Jun;60(5):768-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22525233</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2019 Oct 1;26(10):1064-1073</Citation><ArticleIdList><ArticleId IdType="pubmed">31077269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31654482</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2163-8306</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>CPT: pharmacometrics &amp; systems pharmacology</Title><ISOAbbreviation>CPT Pharmacometrics Syst Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Performance of the SAEM and FOCEI Algorithms in the Open-Source, Nonlinear Mixed Effect Modeling Tool nlmixr.</ArticleTitle><Pagination><MedlinePgn>923-930</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/psp4.12471</ELocationID><Abstract><AbstractText>The free and open-source package nlmixr implements pharmacometric nonlinear mixed effects model parameter estimation in R. It provides a uniform language to define pharmacometric models using ordinary differential equations. Performances of the stochastic approximation expectation-maximization (SAEM) and first order-conditional estimation with interaction (FOCEI) algorithms in nlmixr were compared with those found in the industry standards, Monolix and NONMEM, using the following two scenarios: a simple model fit to 500 sparsely sampled data sets and a range of more complex compartmental models with linear and nonlinear clearance fit to data sets with rich sampling. Estimation results obtained from nlmixr for FOCEI and SAEM matched the corresponding output from NONMEM/FOCEI and Monolix/SAEM closely both in terms of parameter estimates and associated standard errors. These results indicate that nlmixr may provide a viable alternative to existing tools for pharmacometric parameter estimation.</AbstractText><CopyrightInformation>© 2019 The Authors. CPT: Pharmacometrics &amp; Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schoemaker</LastName><ForeName>Rik</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7538-3005</Identifier><AffiliationInfo><Affiliation>Occams Coöperatie UA, Amstelveen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fidler</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8538-6691</Identifier><AffiliationInfo><Affiliation>Novartis Pharmaceuticals Corporation, Fort Worth, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laveille</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Calvagone, Liergues, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-7099-9396</Identifier><AffiliationInfo><Affiliation>Occams Coöperatie UA, Amstelveen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooijmaijers</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>LAP&amp;P Consultants BV, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Post</LastName><ForeName>Teun M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>LAP&amp;P Consultants BV, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trame</LastName><ForeName>Mirjam N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Certara, Princeton, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>CPT Pharmacometrics Syst Pharmacol</MedlineTA><NlmUniqueID>101580011</NlmUniqueID><ISSNLinking>2163-8306</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="N">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001699" MajorTopicYN="N">Biometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017711" MajorTopicYN="N">Nonlinear Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013269" MajorTopicYN="N">Stochastic Processes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31654482</ArticleId><ArticleId IdType="doi">10.1002/psp4.12471</ArticleId><ArticleId IdType="pmc">PMC6930853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Comput Methods Programs Biomed. 2005 Sep;79(3):241-57</Citation><ArticleIdList><ArticleId IdType="pubmed">16023764</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):3-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26844010</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):621-633</Citation><ArticleIdList><ArticleId IdType="pubmed">31207186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31651473</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-0911</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Advances in neonatal care : official journal of the National Association of Neonatal Nurses</Title><ISOAbbreviation>Adv Neonatal Care</ISOAbbreviation></Journal><ArticleTitle>NICU Nurses' Stress and Work Environment in an Open Ward Compared to a Combined Pod and Single-Family Room Design.</ArticleTitle><Pagination><MedlinePgn>416-424</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ANC.0000000000000603</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The architectural design of a neonatal intensive care unit may affect the quality of the work environment for nurses, yet few studies have been conducted using reliable and valid measures. Recent studies have suggested some drawbacks of single-family rooms (SFRs) for both infants and parents. Research is needed to explore nurses' work environment in units combining pods and SFRs.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To compare neonatal intensive care unit nurses' work stress, satisfaction, obstacles, support, team effectiveness, ability to provide family-centered care, and satisfaction with noise, light, and sightlines in an open ward with a new unit of pods and SFRs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A pre-post occupancy study was conducted in a level 3 unit before and after transitioning to a new unit of 6-bed pods and SFRs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no significant differences in nurse stress, satisfaction, support from colleagues, perceptions of team effectiveness, and ability to provide family-centered care between the open ward and the pod/SFR unit. Organizational obstacles, such as difficulties obtaining information from colleagues, were significantly lower in the pod/SFR. In contrast, environmental and technology obstacles were greater in the new pod/SFR unit.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">Some specific aspects of the pod/SFR unit are optimal for neonatal intensive care unit nurses, while other aspects of the open ward are perceived more favorably.</AbstractText><AbstractText Label="IMPLICATIONS FOR RESEARCH" NlmCategory="CONCLUSIONS">Studies are needed to examine the isolation the nurses may experience in SFR units, as well as strategies to reduce isolation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feeley</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ingram School of Nursing, McGill University, Centre for Nursing Research, Jewish General Hospital, Montreal, Quebec, Canada (Dr Feeley); Department of Psychiatry, Jewish General Hospital, Montreal, Quebec, Canada (Ms Robins); Neonatology, Jewish General Hospital, Montreal, Quebec, Canada (Ms Charbonneau); Faculty of Nursing, University of Montreal, Montreal, Quebec, Canada (Dr Genest); and Ingram School of Nursing, McGill University, Montreal, Quebec, Canada (Drs Lavigne and Lavoie-Tremblay).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Charbonneau</LastName><ForeName>Lyne</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Genest</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lavigne</LastName><ForeName>Geneviève</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Lavoie-Tremblay</LastName><ForeName>Mélanie</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Neonatal Care</MedlineTA><NlmUniqueID>101125644</NlmUniqueID><ISSNLinking>1536-0903</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="Y">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006749" MajorTopicYN="Y">Hospital Design and Construction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007363" MajorTopicYN="N">Intensive Care Units, Neonatal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007588" MajorTopicYN="N">Job Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017283" MajorTopicYN="N">Neonatal Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009741" MajorTopicYN="N">Nursing Staff, Hospital</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073397" MajorTopicYN="N">Occupational Stress</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010362" MajorTopicYN="N">Patients' Rooms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017132" MajorTopicYN="N">Workplace</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31651473</ArticleId><ArticleId IdType="doi">10.1097/ANC.0000000000000603</ArticleId><ArticleId IdType="pii">00149525-201910000-00012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31647060</PMID><DateRevised><Year>2019</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1188-4169</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title><ISOAbbreviation>Can Commun Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Reaping the benefits of Open Data in public health.</ArticleTitle><Pagination><MedlinePgn>252-256</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14745/ccdr.v45i10a01</ELocationID><Abstract><AbstractText>Open Data is part of a broad global movement that is not only advancing science and scientific communication but also transforming modern society and how decisions are made. What began with a call for Open Science and the rise of online journals has extended to Open Data, based on the premise that if reports on data are open, then the generated or supporting data should be open as well. There have been a number of advances in Open Data over the last decade, spearheaded largely by governments. A real benefit of Open Data is not simply that single databases can be used more widely; it is that these data can also be leveraged, shared and combined with other data. Open Data facilitates scientific collaboration, enriches research and advances analytical capacity to inform decisions. In the human and environmental health realms, for example, the ability to access and combine diverse data can advance early signal detection, improve analysis and evaluation, inform program and policy development, increase capacity for public participation, enable transparency and improve accountability. However, challenges remain. Enormous resources are needed to make the technological shift to open and interoperable databases accessible with common protocols and terminology. Amongst data generators and users, this shift also involves a cultural change: from regarding databases as restricted intellectual property, to considering data as a common good. There is a need to address legal and ethical considerations in making this shift. Finally, along with efforts to modify infrastructure and address the cultural, legal and ethical issues, it is important to share the information equitably and effectively. While there is great potential of the open, timely, equitable and straightforward sharing of data, fully realizing the myriad of benefits of Open Data will depend on how effectively these challenges are addressed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huston</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Office of the Chief Science Officer, Public Health Agency of Canada, OttawaON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edge</LastName><ForeName>V L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Office of the Chief Science Officer, Public Health Agency of Canada, OttawaON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernier</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Office of the Chief Science Officer, Public Health Agency of Canada, OttawaON.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Commun Dis Rep</MedlineTA><NlmUniqueID>9303729</NlmUniqueID><ISSNLinking>1188-4169</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Open Data</Keyword><Keyword MajorTopicYN="N">Open Science</Keyword><Keyword MajorTopicYN="N">Open access</Keyword><Keyword MajorTopicYN="N">big data</Keyword><Keyword MajorTopicYN="N">public health science</Keyword></KeywordList><CoiStatement>Conflict of interest: None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31647060</ArticleId><ArticleId IdType="doi">10.14745/ccdr.v45i10a01</ArticleId><ArticleId IdType="pii">451001</ArticleId><ArticleId IdType="pmc">PMC6781855</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Prev Med. 2014 Feb;46(2):179-87</Citation><ArticleIdList><ArticleId IdType="pubmed">24439353</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2019 May 02;45(5):133-142</Citation><ArticleIdList><ArticleId IdType="pubmed">31285704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31647032</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study.</ArticleTitle><Pagination><MedlinePgn>988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-019-6188-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Laparoscopic surgery, fast-track perioperative treatment and XELOX chemotherapy are effective strategies for shortening the duration of hospital stay for cancer patients. This trial aimed to clarify the safety and efficacy of the fast-track multidisciplinary treatment (FTMDT) model compared to conventional surgery combined with chemotherapy in Chinese colorectal cancer patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This trial was a prospective randomized controlled study with a 2 × 2 balanced factorial design and was conducted at six hospitals. Patients in group 1 (FTMDT) received fast-track perioperative treatment and XELOX adjuvant chemotherapy. Patients in group 2 (conventional treatment) received conventional perioperative treatment and mFOLFOX6 adjuvant chemotherapy. Subgroups 1a and 2a had laparoscopic surgery and subgroups 1b and 2b had open surgery. The primary endpoint was total length of hospital stay during treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 374 patients were randomly assigned to the four subgroups, and 342 patients were finally analyzed, including 87 patients in subgroup 1a, 85 in subgroup 1b, 86 in subgroup 2a, and 84 in subgroup 2b. The total hospital stay of group 1 was shorter than that of group 2 [13 days, (IQR, 11-17 days) vs. 23.5 days (IQR, 15-42 days), P = 0.0001]. Compared to group 2, group 1 had lower surgical costs, fewer in-hospital complications and faster recovery (all P &lt; 0.05). Subgroup 1a showed faster surgical recovery than that of subgroup 1b (all P &lt; 0.05). There was no difference in 5-year overall survival between groups 1 and 2 [87.1% (95% CI, 80.7-91.5%) vs. 87.1% (95% CI, 80.8-91.4%), P = 0.7420].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The FTMDT model, which integrates laparoscopic surgery, fast-track treatment, and XELOX chemotherapy, was the superior model for enhancing the recovery of Chinese patients with colorectal cancer.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov: NCT01080547 , registered on March 4, 2010.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Xiang-Xing</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiao-Jiao</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yong-Mao</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xue-Feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Anus and Large Intestine, Sir Run Shaw Hospital, Zhejiang University College of Medicine, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Gen-Hai</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Anus and Large Intestine, People's Hospital of Yuyao, 800 City Road East, Yuyao, 315400, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Xiao-Jiang</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Department of Anorectum, People's Hospital of Shaoxing, 568 Zhong-Xing North Rd, Shaoxing, 312000, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Anus and Large Intestine, Ningbo No. 2 Hospital, No. 41 Northwest Road, Ningbo, 315010, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anus and Large Intestine, Second Affiliated Hospital, Wenzhou Medicine College, 109 Xue-Yuan West Rd, Wenzhou, 325027, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Dong-Liang</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin-Lin</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jin-Jie</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Li-Feng</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jing-Yan</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anus and Large Intestine, Sir Run Shaw Hospital, Zhejiang University College of Medicine, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou, 310027, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing-Song</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, College of Biomedical Engineering and Instrument Science, Zhejiang University, No. 38 Zheda Road, Hangzhou, 310027, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Second Affiliated Hospital, and The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ke-Feng</ForeName><Initials>KF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2380-3717</Identifier><AffiliationInfo><Affiliation>Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. dingkefeng@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01080547</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>2017C03017</GrantID><Agency>the Key Technology Research and Development Program of Zhejiang Province</Agency><Country/></Grant><Grant><GrantID>2017YFC0908200</GrantID><Agency>Key Technology Research and Development Program of Shandong (CN)</Agency><Country/></Grant><Grant><GrantID>81672916</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81301890</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009944">Organoplatinum Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010071">Oxaloacetates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W860991D6</RegistryNumber><NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>6804DJ8Z9U</RegistryNumber><NameOfSubstance UI="D000069287">Capecitabine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q573I9DVLP</RegistryNumber><NameOfSubstance UI="D002955">Leucovorin</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C410216">Folfox protocol</SupplMeshName><SupplMeshName Type="Protocol" UI="C519688">XELOX</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069287" MajorTopicYN="N">Capecitabine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003365" MajorTopicYN="N">Costs and Cost Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002955" MajorTopicYN="N">Leucovorin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009944" MajorTopicYN="N">Organoplatinum Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010071" MajorTopicYN="N">Oxaloacetates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31647032</ArticleId><ArticleId IdType="doi">10.1186/s12885-019-6188-x</ArticleId><ArticleId IdType="pii">10.1186/s12885-019-6188-x</ArticleId><ArticleId IdType="pmc">PMC6806550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Cancer. 2011 Nov 24;11:494</Citation><ArticleIdList><ArticleId IdType="pubmed">22111914</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2013 Feb;37(2):259-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23052794</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2010 Jun 14;10:18</Citation><ArticleIdList><ArticleId IdType="pubmed">20546569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Nov 23;382(9906):1703-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24267999</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dig Dis. 2014 Jun;15(6):306-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24597608</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2009 Apr;23(4):854-61</Citation><ArticleIdList><ArticleId IdType="pubmed">18946703</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2006 Nov 29;6:16</Citation><ArticleIdList><ArticleId IdType="pubmed">17134506</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2017 May 6;67(3):177-193</Citation><ArticleIdList><ArticleId IdType="pubmed">28248415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Feb;255(2):216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22241289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2011 Dec;254(6):868-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21597360</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2013 Feb;37(2):285-305</Citation><ArticleIdList><ArticleId IdType="pubmed">23052796</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26808342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2008 Aug;248(2):189-98</Citation><ArticleIdList><ArticleId IdType="pubmed">18650627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2014 Jun 10;32(17):1804-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24799480</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2012 Aug;36(8):1874-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22526050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2012 Oct;59(119):2158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22366526</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2012 May 16;12:181</Citation><ArticleIdList><ArticleId IdType="pubmed">22591460</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2012 Feb;36(2):407-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22102090</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2004 Aug;47(8):1269-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15484340</ArticleId></ArticleIdList></Reference><Reference><Citation>CA Cancer J Clin. 2017 Jan;67(1):7-30</Citation><ArticleIdList><ArticleId IdType="pubmed">28055103</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2005 Aug 14;11(30):4685-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16094710</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2010 Oct;40(10):917-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20872193</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg Oncol. 2015 Feb 04;13:18</Citation><ArticleIdList><ArticleId IdType="pubmed">25649903</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31641158</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>10</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Diat.barcode, an open-access curated barcode library for diatoms.</ArticleTitle><Pagination><MedlinePgn>15116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-51500-6</ELocationID><Abstract><AbstractText>Diatoms (Bacillariophyta) are ubiquitous microalgae which produce a siliceous exoskeleton and which make a major contribution to the productivity of oceans and freshwaters. They display a huge diversity, which makes them excellent ecological indicators of aquatic ecosystems. Usually, diatoms are identified using characteristics of their exoskeleton morphology. DNA-barcoding is an alternative to this and the use of High-Throughput-Sequencing enables the rapid analysis of many environmental samples at a lower cost than analyses under microscope. However, to identify environmental sequences correctly, an expertly curated reference library is needed. Several curated libraries for protists exists; none, however are dedicated to diatoms. Diat.barcode is an open-access library dedicated to diatoms which has been maintained since 2012. Data come from two sources (1) the NCBI nucleotide database and (2) unpublished sequencing data of culture collections. Since 2017, several experts have collaborated to curate this library for rbcL, a chloroplast marker suitable for species-level identification of diatoms. For the latest version of the database (version 7), 605 of the 3482 taxonomical names originally assigned by the authors of the rbcL sequences were modified after curation. The database is accessible at https://www6.inra.fr/carrtel-collection_eng/Barcoding-database .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rimet</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5514-869X</Identifier><AffiliationInfo><Affiliation>INRA, UMR CARRTEL, 75bis av. de Corzent - CS 50511, FR-74203, Thonon les Bains cedex, France. frederic.rimet@inra.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Savoie Mont-Blanc, UMR CARRTEL, FR-73370, Le Bourget du Lac, France. frederic.rimet@inra.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gusev</LastName><ForeName>Evgenuy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Plant Physiology, Russian Academy of Sciences, 127276, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlert</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swedish University of Agricultural Sciences, Department of Aquatic Sciences and Assessment, PO Box 7050, SE- 750 07, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Martyn G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Bowburn Consultancy, 11 Monteigne Drive, Bowburn, Durham, DH6 5QB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulikovskiy</LastName><ForeName>Maxim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Plant Physiology, Russian Academy of Sciences, 127276, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maltsev</LastName><ForeName>Yevhen</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4710-319X</Identifier><AffiliationInfo><Affiliation>Institute of Plant Physiology, Russian Academy of Sciences, 127276, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>David G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0522-6802</Identifier><AffiliationInfo><Affiliation>Royal Botanic Garden Edinburgh, Edinburgh, EH3 5LR, Scotland, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marine and Continental Waters, Institute for Food and Agricultural Research and Technology (IRTA), Crta de Poble Nou Km 5.5, Sant Carles de la Ràpita, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfannkuchen</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6253-4716</Identifier><AffiliationInfo><Affiliation>Institut Ruđer Bošković, Giordano Paliaga 5, 52210, Rovinj, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trobajo</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Marine and Continental Waters, Institute for Food and Agricultural Research and Technology (IRTA), Crta de Poble Nou Km 5.5, Sant Carles de la Ràpita, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasselon</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>INRA, UMR CARRTEL, 75bis av. de Corzent - CS 50511, FR-74203, Thonon les Bains cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Savoie Mont-Blanc, UMR CARRTEL, FR-73370, Le Bourget du Lac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmermann</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Botanischer Garten und Botanisches Museum Berlin-Dahlem, Freie Universität Berlin, Königin-Luise-Str. 6-8, 14195, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouchez</LastName><ForeName>Agnès</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INRA, UMR CARRTEL, 75bis av. de Corzent - CS 50511, FR-74203, Thonon les Bains cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Savoie Mont-Blanc, UMR CARRTEL, FR-73370, Le Bourget du Lac, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.1.1.39</RegistryNumber><NameOfSubstance UI="C101625">RbcL protein, plastid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.1.1.39</RegistryNumber><NameOfSubstance UI="D012273">Ribulose-Bisphosphate Carboxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058893" MajorTopicYN="Y">DNA Barcoding, Taxonomic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066289" MajorTopicYN="N">Data Curation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017377" MajorTopicYN="N">Diatoms</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015723" MajorTopicYN="Y">Gene Library</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012273" MajorTopicYN="N">Ribulose-Bisphosphate Carboxylase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31641158</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-51500-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-51500-6</ArticleId><ArticleId IdType="pmc">PMC6805954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Eukaryot Microbiol. 2013 Jul-Aug;60(4):414-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23710621</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2018 Sep 17;16(9):e2005849</Citation><ArticleIdList><ArticleId IdType="pubmed">30222734</ArticleId></ArticleIdList></Reference><Reference><Citation>Protist. 2014 May;165(3):245-59</Citation><ArticleIdList><ArticleId IdType="pubmed">24739436</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Pollut Res Int. 2018 Dec;25(34):33858-33866</Citation><ArticleIdList><ArticleId IdType="pubmed">29732510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2015 May;15(3):526-42</Citation><ArticleIdList><ArticleId IdType="pubmed">25270047</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8369-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15928076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Total Environ. 2018 Oct 1;637-638:1295-1310</Citation><ArticleIdList><ArticleId IdType="pubmed">29801222</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D597-604</Citation><ArticleIdList><ArticleId IdType="pubmed">23193267</ArticleId></ArticleIdList></Reference><Reference><Citation>J Phycol. 2014 Jun;50(3):437-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26988318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Phylogenet Evol. 2015 Aug;89:28-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25848969</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Apr 16;13(4):e0195770</Citation><ArticleIdList><ArticleId IdType="pubmed">29659610</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eukaryot Microbiol. 2019 Jan;66(1):4-119</Citation><ArticleIdList><ArticleId IdType="pubmed">30257078</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Microbiol. 2018 Jun;20(6):2218-2230</Citation><ArticleIdList><ArticleId IdType="pubmed">29727060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Jul 19;8(1):10916</Citation><ArticleIdList><ArticleId IdType="pubmed">30026492</ArticleId></ArticleIdList></Reference><Reference><Citation>Izv Akad Nauk Ser Biol. 2016 Sep;(5):468-478</Citation><ArticleIdList><ArticleId IdType="pubmed">30226934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol. 2012 Apr;21(8):1918-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22221342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2013 Jul;13(4):607-19</Citation><ArticleIdList><ArticleId IdType="pubmed">23590277</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2015 Nov;15(6):1435-45</Citation><ArticleIdList><ArticleId IdType="pubmed">25740460</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eukaryot Microbiol. 2011 Nov-Dec;58(6):529-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22092527</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 2003 Feb 7;270(1512):313-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12614582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D23-D28</Citation><ArticleIdList><ArticleId IdType="pubmed">30395293</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2015 Nov;15(6):1472-85</Citation><ArticleIdList><ArticleId IdType="pubmed">25828689</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eukaryot Microbiol. 2015 Nov-Dec;62(6):815-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26046925</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Microbiol. 2017 Jul;19(7):2873-2892</Citation><ArticleIdList><ArticleId IdType="pubmed">28585365</ArticleId></ArticleIdList></Reference><Reference><Citation>Microb Ecol. 2018 Apr;75(3):674-687</Citation><ArticleIdList><ArticleId IdType="pubmed">28951994</ArticleId></ArticleIdList></Reference><Reference><Citation>Protist. 2011 Jul;162(3):405-22</Citation><ArticleIdList><ArticleId IdType="pubmed">21239228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Phylogenet Evol. 2016 Oct;103:155-171</Citation><ArticleIdList><ArticleId IdType="pubmed">27456747</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Sep 29;9(9):e108793</Citation><ArticleIdList><ArticleId IdType="pubmed">25265556</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2016 Mar 17;2016:</Citation><ArticleIdList><ArticleId IdType="pubmed">26989149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Phycol. 2019 Aug;55(4):948-970</Citation><ArticleIdList><ArticleId IdType="pubmed">31106407</ArticleId></ArticleIdList></Reference><Reference><Citation>Protist. 2007 Jul;158(3):349-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17581782</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Technol. 2014;48(3):1921-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24392792</ArticleId></ArticleIdList></Reference><Reference><Citation>Protist. 2013 Sep;164(5):686-705</Citation><ArticleIdList><ArticleId IdType="pubmed">23994722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2018 Mar 30;:</Citation><ArticleIdList><ArticleId IdType="pubmed">29603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Resour. 2009 May;9 Suppl s1:65-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21564966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ecol Notes. 2007 May 1;7(3):355-364</Citation><ArticleIdList><ArticleId IdType="pubmed">18784790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2010 Feb;27(2):221-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19854763</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Jun 16;12(6):e0179422</Citation><ArticleIdList><ArticleId IdType="pubmed">28622375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31627931</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>4 Pt A</Issue><PubDate><Year>2020</Year><Month>04</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>644-649</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(19)30872-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2019.09.185</ELocationID><Abstract><AbstractText Label="BACKGROUND">Transoral robotic surgery (TORS) has recently emerged as a surgical technique for oropharyngeal cancer. We performed a systematic review to investigate the clinical safety and effectiveness of robotic surgery compared with conventional open surgery in primary oropharyngeal cancer.</AbstractText><AbstractText Label="METHODS">A literature search was conducted using the English-language databases Ovid-MEDLINE, Ovid-Embase, and the Cochrane Library, as well as local databases containing publications through July 2018. The outcomes included demographic characteristics, adverse events, and complications, as well as oncologic, functional, and surgical outcomes.</AbstractText><AbstractText Label="RESULTS">Nine papers (n = 574 patients) met the inclusion criteria. Disease-free survival rate was significantly higher in the TORS group than open surgery group (n = 5 studies, RR: 1.13, 95% CI: 1.03, 1.24, I<sup>2</sup> = 0%). Primary TORS compared with open surgery was associated with lower risks of free flap reconstruction (relative risk [RR]: 0.33, 95% confidence interval [CI]: 0.12.0.88, I<sup>2</sup> = 6%). In subgroup analyses, the time to decannulation reconstruction (N = 2 concurrent studies, mean difference [MD]: -6.71, 95% CI: -8.40, -5.03, I<sup>2</sup> = 78%) in the TORS group shortened by 6.7 days than open surgery group. The length of hospital stay showed significant shorter by 1.09 days in three concurrent studies (95% CI -3.49, 1.30, I<sup>2</sup> = 72%).</AbstractText><AbstractText Label="CONCLUSIONS">From current non-randomized studies, TORS could have advantage for disease-free survival and lowering the risk of free flap reconstruction compared to open surgery. However, due to lack of relevant studies, oncologic, functional, surgical outcomes including complications of TORS versus open surgery for oropharyngeal cancer are need to be verified with long-term follow-up comparative studies.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dong Ah</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Division for Health Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Min Jin</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division for Health Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Se-Heon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, of College of Medicine, Yonsei University, Republic of Korea. Electronic address: shkimmd@yuhs.ac.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seon Heui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Nursing Science, College of Nursing, Gachon University, Incheon, Republic of Korea. Electronic address: sunarea87@gachon.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058752" MajorTopicYN="N">Free Tissue Flaps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063168" MajorTopicYN="N">Mandibular Osteotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009055" MajorTopicYN="N">Mouth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057605" MajorTopicYN="N">Natural Orifice Endoscopic Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037981" MajorTopicYN="N">Neck Dissection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009959" MajorTopicYN="N">Oropharyngeal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010611" MajorTopicYN="N">Pharyngectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="N">Reconstructive Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077195" MajorTopicYN="N">Squamous Cell Carcinoma of Head and Neck</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Oropharyngeal cancer</Keyword><Keyword MajorTopicYN="Y">RAND</Keyword><Keyword MajorTopicYN="Y">Robot-assisted neck dissection</Keyword><Keyword MajorTopicYN="Y">Systematic review</Keyword><Keyword MajorTopicYN="Y">TORS</Keyword><Keyword MajorTopicYN="Y">Transoral robotic surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31627931</ArticleId><ArticleId IdType="pii">S0748-7983(19)30872-8</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2019.09.185</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31611417</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>44</Issue><PubDate><Year>2019</Year><Month>10</Month><Day>29</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Efficient team structures in an open-ended cooperative creativity experiment.</ArticleTitle><Pagination><MedlinePgn>22088-22093</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1909827116</ELocationID><Abstract><AbstractText>Creativity is progressively acknowledged as the main driver for progress in all sectors of humankind's activities: arts, science, technology, business, and social policies. Nowadays, many creative processes rely on many actors collectively contributing to an outcome. The same is true when groups of people collaborate in the solution of a complex problem. Despite the critical importance of collective actions in human endeavors, few works have tackled this topic extensively and quantitatively. Here we report about an experimental setting to single out some of the key determinants of efficient teams committed to an open-ended creative task. In this experiment, dynamically forming teams were challenged to create several artworks using LEGO bricks. The growth rate of the artworks, the dynamical network of social interactions, and the interaction patterns between the participants and the artworks were monitored in parallel. The experiment revealed that larger working teams are building at faster rates and that higher commitment leads to higher growth rates. Even more importantly, there exists an optimal number of weak ties in the social network of creators that maximizes the growth rate. Finally, the presence of influencers within the working team dramatically enhances the building efficiency. The generality of the approach makes it suitable for application in very different settings, both physical and online, whenever a creative collective outcome is required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monechi</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3841-3989</Identifier><AffiliationInfo><Affiliation>Sony Computer Science Laboratories, 75005 Paris, France; bernardo.monechi@sony.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pullano</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75012 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sociology and Economics of Networks and Services lab at Orange Experience Design Lab (SENSE/XDLab) Chatillion, 92320 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loreto</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sony Computer Science Laboratories, 75005 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physics Department, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complexity Science Hub Vienna, A-1080 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003405" MajorTopicYN="Y">Creativity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004526" MajorTopicYN="Y">Efficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">collective creativity</Keyword><Keyword MajorTopicYN="Y">exploit/explore</Keyword><Keyword MajorTopicYN="Y">open-ended experiments</Keyword><Keyword MajorTopicYN="Y">weak ties</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31611417</ArticleId><ArticleId IdType="pii">1909827116</ArticleId><ArticleId IdType="doi">10.1073/pnas.1909827116</ArticleId><ArticleId IdType="pmc">PMC6825265</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Rep. 2014 Feb 10;4:4001</Citation><ArticleIdList><ArticleId IdType="pubmed">24510159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Feb 5;8(1):2352</Citation><ArticleIdList><ArticleId IdType="pubmed">29403006</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Jun 8;12(6):e0179303</Citation><ArticleIdList><ArticleId IdType="pubmed">28594909</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Sep 11;8(9):e73970</Citation><ArticleIdList><ArticleId IdType="pubmed">24040129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2012;2:469</Citation><ArticleIdList><ArticleId IdType="pubmed">22741058</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Lett. 2018 Jan 26;120(4):048301</Citation><ArticleIdList><ArticleId IdType="pubmed">29437427</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14569-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26554009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 May 11;7(1):1781</Citation><ArticleIdList><ArticleId IdType="pubmed">28496113</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jul 15;5(7):e11596</Citation><ArticleIdList><ArticleId IdType="pubmed">20657651</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Netw Sci. 2017;2(1):14</Citation><ArticleIdList><ArticleId IdType="pubmed">30443569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Jul 15;5:12197</Citation><ArticleIdList><ArticleId IdType="pubmed">26174482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2014 Jul 31;4:5890</Citation><ArticleIdList><ArticleId IdType="pubmed">25080941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Dec 8;8(1):2002</Citation><ArticleIdList><ArticleId IdType="pubmed">29222458</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23176</Citation><ArticleIdList><ArticleId IdType="pubmed">21858018</ArticleId></ArticleIdList></Reference><Reference><Citation>AJS. 2015 Jan;120(4):1144-94</Citation><ArticleIdList><ArticleId IdType="pubmed">26046227</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31611177</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7886</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of visceral surgery</Title><ISOAbbreviation>J Visc Surg</ISOAbbreviation></Journal><ArticleTitle>Peritoneal carcinomatosis is multifaceted, treatment requires expertise and collaboration with other health care personnel: New avenues of research are open.</ArticleTitle><Pagination><MedlinePgn>471-472</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1878-7886(19)30140-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviscsurg.2019.09.006</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pocard</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>U-1275 carcinose péritoine Paris technologique, CAP Paris tech, université de Paris, hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France; Service de chirurgie digestive et cancérologique, hôpital Lariboisière, AP-HP, 2, rue Ambroise Paré, 75010 Paris, France. Electronic address: marc.pocard@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Visc Surg</MedlineTA><NlmUniqueID>101532664</NlmUniqueID><ISSNLinking>1878-7886</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007400" MajorTopicYN="Y">Interprofessional Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="N">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31611177</ArticleId><ArticleId IdType="pii">S1878-7886(19)30140-7</ArticleId><ArticleId IdType="doi">10.1016/j.jviscsurg.2019.09.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31608767</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9042</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>03</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of neurotrauma</Title><ISOAbbreviation>J Neurotrauma</ISOAbbreviation></Journal><ArticleTitle>FAIR SCI Ahead: The Evolution of the Open Data Commons for Pre-Clinical Spinal Cord Injury Research.</ArticleTitle><Pagination><MedlinePgn>831-838</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/neu.2019.6674</ELocationID><Abstract><AbstractText>Over the last 5 years, multiple stakeholders in the field of spinal cord injury (SCI) research have initiated efforts to promote publications standards and enable sharing of experimental data. In 2016, the National Institutes of Health/National Institute of Neurological Disorders and Stroke hosted representatives from the SCI community to streamline these efforts and discuss the future of data sharing in the field according to the FAIR (Findable, Accessible, Interoperable and Reusable) data stewardship principles. As a next step, a multi-stakeholder group hosted a 2017 symposium in Washington, DC entitled "FAIR SCI Ahead: the Evolution of the Open Data Commons for Spinal Cord Injury research." The goal of this meeting was to receive feedback from the community regarding infrastructure, policies, and organization of a community-governed Open Data Commons (ODC) for pre-clinical SCI research. Here, we summarize the policy outcomes of this meeting and report on progress implementing these policies in the form of a digital ecosystem: the Open Data Commons for Spinal Cord Injury (ODC-SCI.org). ODC-SCI enables data management, harmonization, and controlled sharing of data in a manner consistent with the well-established norms of scholarly publication. Specifically, ODC-SCI is organized around virtual "laboratories" with the ability to share data within each of three distinct data-sharing spaces: within the laboratory, across verified laboratories, or publicly under a creative commons license (CC-BY 4.0) with a digital object identifier that enables data citation. The ODC-SCI implements FAIR data sharing and enables pooled data-driven discovery while crediting the generators of valuable SCI data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fouad</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Rehabilitation Medicine and Institute for Neuroscience and Mental Health, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bixby</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Miami Project to Cure Paralysis, Department of Neurological Surgery and Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grethe</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Research in Biological Systems, University of California San Diego, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakeman</LastName><ForeName>Lyn B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, National Institute of Neurological Disorders and Stroke, The National Institutes of Health, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemmon</LastName><ForeName>Vance P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Miami Project to Cure Paralysis, Department of Neurological Surgery and Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnuson</LastName><ForeName>David S K</ForeName><Initials>DSK</Initials><AffiliationInfo><Affiliation>Kentucky Spinal Cord Injury Research Center, Department of Neurological Surgery, Anatomical Sciences and Neurobiology and Department of Physiology, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martone</LastName><ForeName>Maryann E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of California San Diego, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielson</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Institute of Health Informatics, University of Minnesota Medical School, Minneapolis, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwab</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Belford Center for Spinal Cord Injury, Spinal Cord Injury Division (Paraplegiology), Department of Neurology and Discovery Theme Initiative of the Ohio State University (Chronic Brain Injury), The Ohio State University, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor-Burds</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, National Institute of Neurological Disorders and Stroke, The National Institutes of Health, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetzlaff</LastName><ForeName>Wolfram</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of International Collaboration on Repair Discoveries (ICORD), The University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Espin</LastName><ForeName>Abel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Brain and Spinal Injury Center, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Adam R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Brain and Spinal Injury Center, University of California San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>FAIR-SCI Ahead Workshop Participants</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UG3 NS106899</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 RX002787</GrantID><Acronym>RX</Acronym><Agency>RRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH116156</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088475</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS106899</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 RX002245</GrantID><Acronym>RX</Acronym><Agency>RRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurotrauma</MedlineTA><NlmUniqueID>8811626</NlmUniqueID><ISSNLinking>0897-7151</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">FAIR data</Keyword><Keyword MajorTopicYN="Y">ODC-SCI</Keyword><Keyword MajorTopicYN="Y">community-based repository</Keyword><Keyword MajorTopicYN="Y">data sharing</Keyword><Keyword MajorTopicYN="Y">spinal cord injury</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Alam</LastName><ForeName>Sabina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacon</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bambrick</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basso</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bresnahan</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gensel</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Dustin</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grethe</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russell Huie</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabitzke</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleitman</LastName><ForeName>Naomi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kusiak</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwon</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lederer</LastName><ForeName>Rosi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Malcom</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>May</LastName><ForeName>Verena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neff</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rabchevsky</LastName><ForeName>Sasha</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31608767</ArticleId><ArticleId IdType="doi">10.1089/neu.2019.6674</ArticleId><ArticleId IdType="pmc">PMC7071068</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Med. 2005 Aug;2(8):e124</Citation><ArticleIdList><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2019 Jul 2;93(1):e40-e51</Citation><ArticleIdList><ArticleId IdType="pubmed">31175207</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2017 Sep;295:135-143</Citation><ArticleIdList><ArticleId IdType="pubmed">28576567</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e59712</Citation><ArticleIdList><ArticleId IdType="pubmed">23544088</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2018 Jul;56(7):656-665</Citation><ArticleIdList><ArticleId IdType="pubmed">29795173</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 2015 Sep 4;1619:124-38</Citation><ArticleIdList><ArticleId IdType="pubmed">25451131</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurotrauma. 2014 Nov 1;31(21):1789-99</Citation><ArticleIdList><ArticleId IdType="pubmed">25077610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2014 Nov;17(11):1442-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25349910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2016 Oct;139 Suppl 2:253-270</Citation><ArticleIdList><ArticleId IdType="pubmed">27797406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Jan 11;383(9912):101-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24411643</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2014 Oct 21;11(10):e1001747</Citation><ArticleIdList><ArticleId IdType="pubmed">25334033</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2016 Apr 07;2016:</Citation><ArticleIdList><ArticleId IdType="pubmed">27055827</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2012 Feb;233(2):597-605</Citation><ArticleIdList><ArticleId IdType="pubmed">22078756</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Oct 14;6:8581</Citation><ArticleIdList><ArticleId IdType="pubmed">26466022</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2015 Jan 2;116(1):116-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25552691</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Apr 27;376(17):1684-1687</Citation><ArticleIdList><ArticleId IdType="pubmed">28402238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurotrauma. 2014 Aug 1;31(15):1354-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24870067</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Aug 30;7:18</Citation><ArticleIdList><ArticleId IdType="pubmed">24009581</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 May 31;14(5):e1002468</Citation><ArticleIdList><ArticleId IdType="pubmed">27244556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2018 Sep;21(9):1171-1184</Citation><ArticleIdList><ArticleId IdType="pubmed">30154505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Jul 4;374(9683):86-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19525005</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31579260</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1683-1470</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Data science journal</Title><ISOAbbreviation>Data Sci J</ISOAbbreviation></Journal><ArticleTitle>Building Open Access to Research (OAR) Data Infrastructure at NIST.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.5334/dsj-2019-030</ELocationID><Abstract><AbstractText>As a National Metrology Institute (NMI), the USA National Institute of Standards and Technology (NIST) scientists, engineers and technology experts conduct research across a full spectrum of physical science domains. NIST is a non-regulatory agency within the U.S. Department of Commerce with a mission to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve our quality of life. NIST research results in the production and distribution of standard reference materials, calibration services, and datasets. These are generated from a wide range of complex laboratory instrumentation, expert analyses, and calibration processes. In response to a government open data policy, and in collaboration with the broader research community, NIST has developed a federated Open Access to Research (OAR) scientific data infrastructure aligned with FAIR (Findable, Accessible, Interoperable, Reusable) data principles. Through the OAR initiatives, NIST's Material Measurement Laboratory Office of Data and Informatics (ODI) recently released a new scientific data discovery portal and public data repository. These science-oriented applications provide dissemination and public access for data from across the broad spectrum of NIST research disciplines, including chemistry, biology, materials science (such as crystallography, nanomaterials, etc.), physics, disaster resilience, cyberinfrastructure, communications, forensics, and others. NIST's public data consist of carefully curated Standard Reference Data, legacy high valued data, and new research data publications. The repository is thus evolving both in content and features as the nature of research progresses. Implementation of the OAR infrastructure is key to NIST's role in sharing high integrity reproducible research for measurement science in a rapidly changing world.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Gretchen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Institute of Standards and Technology, Material Measurement Laboratory Office of Data and Informatics, Gaithersburg, Maryland, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plante</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Institute of Standards and Technology, Material Measurement Laboratory Office of Data and Informatics, Gaithersburg, Maryland, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanisch</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Institute of Standards and Technology, Material Measurement Laboratory Office of Data and Informatics, Gaithersburg, Maryland, US.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>9999-NIST</GrantID><Agency>Intramural NIST DOC</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Data Sci J</MedlineTA><NlmUniqueID>101707552</NlmUniqueID><ISSNLinking>1683-1470</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Repository</Keyword><Keyword MajorTopicYN="N">FAIR</Keyword><Keyword MajorTopicYN="N">data portal</Keyword><Keyword MajorTopicYN="N">government</Keyword><Keyword MajorTopicYN="N">metrology</Keyword><Keyword MajorTopicYN="N">research metadata</Keyword></KeywordList><CoiStatement>Competing Interests The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31579260</ArticleId><ArticleId IdType="doi">10.5334/dsj-2019-030</ArticleId><ArticleId IdType="pmc">PMC6774380</ArticleId><ArticleId IdType="mid">NIHMS1540257</ArticleId></ArticleIdList><?nihms ?><ReferenceList><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31567556</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2202-4433</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>JBI database of systematic reviews and implementation reports</Title><ISOAbbreviation>JBI Database System Rev Implement Rep</ISOAbbreviation></Journal><ArticleTitle>Pain relief during wound care for patients with a deep open wound in an orthopedic trauma department: a best practice implementation project.</ArticleTitle><Pagination><MedlinePgn>2559-2569</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11124/JBISRIR-D-19-00126</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The aim of this project was to implement best practice in pain relief during wound care for patients with deep open wounds in the orthopedic trauma department of a tertiary teaching hospital in China.</AbstractText><AbstractText Label="INTRODUCTION">Patients with deep open wounds often suffer from severe pain during wound care. Inadequate pain relief for these patients calls for evidence-based changes to close the gap between current and best practice.</AbstractText><AbstractText Label="METHODS">The current quality improvement project was carried out over six months using the JBI Practical Application of Clinical Evidence System (JBI PACES). A baseline and two follow-up audits of wound pain management practice were conducted to identify practice gaps and post implementation compliance in pain management in wound care. The sample comprised 20 patients and two dressing nurses. The Getting Research into Practice tool identified barriers to and strategies for improvement in practice. The patients' pain experiences were measured following the implementation of changes.</AbstractText><AbstractText Label="RESULTS">The baseline audit identified poor compliance with best practice. Following implementation of the recommended changes, some significant improvements in practice were made by the dressing nurses; however, these were inadequately maintained at the second post implementation audit. Patients' pain scores improved following the nurses' practice changes (t = 2.272, P &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSION">The implementation of best practice in pain relief during wound care for patients with deep open wounds has led to significant improvement in nurses' performance in the orthopedic trauma department. The most challenging barriers involved interdisciplinary collaborations and organizational structure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yaxuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>PR China Southern Centre for Evidence Based Nursing and Midwifery Practice: A Joanna Briggs Institute Affiliated Group, School of Nursing, Southern Medical University, Guangzhou, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>PR China Southern Centre for Evidence Based Nursing and Midwifery Practice: A Joanna Briggs Institute Affiliated Group, School of Nursing, Southern Medical University, Guangzhou, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>PR China Southern Centre for Evidence Based Nursing and Midwifery Practice: A Joanna Briggs Institute Affiliated Group, School of Nursing, Southern Medical University, Guangzhou, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Trauma, Nanfang Hospital of Southern Medical University, Guangzhou, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>JBI Database System Rev Implement Rep</MedlineTA><NlmUniqueID>101648258</NlmUniqueID><ISSNLinking>2202-4433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055317" MajorTopicYN="N">Evidence-Based Practice</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="N">Trauma Centers</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31567556</ArticleId><ArticleId IdType="doi">10.11124/JBISRIR-D-19-00126</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31567172</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1938-808X</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>01</Month></PubDate></JournalIssue><Title>Academic medicine : journal of the Association of American Medical Colleges</Title><ISOAbbreviation>Acad Med</ISOAbbreviation></Journal><ArticleTitle>Open Office Space: The Wave of the Future for Academic Health Centers?</ArticleTitle><Pagination><MedlinePgn>52-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ACM.0000000000002992</ELocationID><Abstract><AbstractText>Facing space constraints similar to those experienced by many urban campuses, the University of California, San Francisco (UCSF) looked to innovative office workplace design to curb growing facilities expenditures. Mission Hall, a new office building primarily for desktop and clinical researchers and staff, was designed as an activity-based workplace (ABW), a type of open-space design. ABW was simultaneously being proposed as the template for future UCSF desktop research workspaces. ABWs can be less costly to construct than other designs, and their mix of shared and open workspaces is intended to improve efficiency and interaction. Evaluations of ABWs in corporate settings have yielded mixed results. Examples of ABW buildings for faculty in academic health centers (AHCs) are rare.The Mission Hall experience provided a unique opportunity to understand the impact of an ABW design on faculty satisfaction, work effectiveness, well-being, and engagement. In a 2016 survey of faculty, 1 year after occupancy, respondents reported adverse changes in all 4 areas. The most common complaints involved noise exposure and lack of visual and auditory privacy. In response to these issues, faculty reported working at home or elsewhere more frequently, making collaboration more difficult. In 2018, UCSF retrofitted the building to create some private offices and adjusted its overall program to balance private office and open workspaces in future projects.Lessons drawn from this experience can inform workplace solutions at other AHCs. Most critical are the needs to assess functional requirements of work and align design, change management, and technologies to support those requirements.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>J. Barnes is founding partner, Climate Adaptation Partners, New York, New York. The author was global director of planning and strategies, Perkins + Will, New York, New York, at the time of writing. J. Wineman is professor emerita, A. Alfred Taubman College of Architecture and Urban Planning and Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan. N. Adler is professor, Departments of Psychiatry and Pediatrics, and director, Center for Health and Community, University of California, San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wineman</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acad Med</MedlineTA><NlmUniqueID>8904605</NlmUniqueID><ISSNLinking>1040-2446</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004526" MajorTopicYN="N">Efficiency</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005160" MajorTopicYN="N">Facility Design and Construction</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005178" MajorTopicYN="N">Faculty</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009622" MajorTopicYN="N">Noise</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010549" MajorTopicYN="N">Personal Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010550" MajorTopicYN="N">Personal Space</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012108" MajorTopicYN="N">Research Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012495" MajorTopicYN="N" Type="Geographic">San Francisco</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014495" MajorTopicYN="N">Universities</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074824" MajorTopicYN="N">Work Engagement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017132" MajorTopicYN="N">Workplace</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31567172</ArticleId><ArticleId IdType="doi">10.1097/ACM.0000000000002992</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31559379</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2475-3246</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Journal of pancreatic cancer</Title><ISOAbbreviation>J Pancreat Cancer</ISOAbbreviation></Journal><ArticleTitle>A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer.</ArticleTitle><Pagination><MedlinePgn>35-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/pancan.2019.0012</ELocationID><Abstract><AbstractText><b>Purpose:</b> To evaluate safety and preliminary efficacy of metronomic 5-fluorouracil plus <i>nab</i>-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with newly diagnosed metastatic pancreatic cancer (MPC). <b>Methods:</b> A total of 12 treatment-naive patients (aged 18-65 years, Eastern Cooperative Oncology Group performance status [ECOG PS] ≤1) with MPC received 5-fluorouracil 180 mg/m<sup>2</sup> per day (days 1-14 continuous infusion); <i>nab</i>-paclitaxel 75 mg/m<sup>2</sup>, leucovorin 20 mg/m<sup>2</sup>, and oxaliplatin 40 mg/m<sup>2</sup> (days 1, 8, and 15); and bevacizumab 5 mg/kg (days 1 and 15) administered intravenously in each 28-day cycle. The primary end-point was incidence of dose-limiting toxicities (DLTs) in cycle 1. Safety was further evaluated as a secondary end-point; preliminary efficacy was also examined. <b>Results:</b> Two DLTs (grade 3 anemia requiring transfusion and grade 3 mucositis unresponsive to treatment within 4 days of onset) were observed in one of six patients enrolled in dose cohort 1. Cohort 1 was expanded from 6 to 12 patients to further evaluate safety, per the investigators' recommendation. All patients discontinued treatment. The most common grade ≥3 adverse events were abdominal pain, fatigue, mucositis, and decreased neutrophil count. Objective response rate was 33% (four partial responses). Median progression-free survival (PFS) and overall survival (OS) were 5.6 (95% confidence interval [CI], 1.7-11.3) and 9.9 (95% CI, 4.4-13.2) months, respectively; 1-year PFS and OS rates were 12.2% (95% CI, 0.7-40.8) and 38.9% (95% CI, 12.6-65.0). <b>Conclusion:</b> FABLOx is feasible and tolerable in patients newly diagnosed with MPC. However, preliminary efficacy data are inconclusive for continued investigation in a phase II trial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sahai</LastName><ForeName>Vaibhav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saif</LastName><ForeName>M Wasif</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Medical Oncology, Northwell Health Cancer Institute, Lake Success, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalyan</LastName><ForeName>Aparna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha-Lima</LastName><ForeName>Caio M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Oncology, Wake Forest School of Medicine, Bowman Gray Center, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocean</LastName><ForeName>Allyson</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Weill Cornell Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ondovik</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simeone</LastName><ForeName>Diane M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, NYU Langone Perlmutter Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Sibabrata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhore</LastName><ForeName>Rafia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louis</LastName><ForeName>Chrystal U</ForeName><Initials>CU</Initials><AffiliationInfo><Affiliation>Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picozzi</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Oncology, Virginia Mason Medical Center, Seattle, Washington.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pancreat Cancer</MedlineTA><NlmUniqueID>101703452</NlmUniqueID><ISSNLinking>2475-3246</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-fluorouracil</Keyword><Keyword MajorTopicYN="N">combination chemotherapy</Keyword><Keyword MajorTopicYN="N">metastatic pancreatic cancer</Keyword><Keyword MajorTopicYN="N">nab-paclitaxel</Keyword></KeywordList><CoiStatement>V.S. has received institutional research funding from Agios, Celgene, Bristol-Myers Squibb, Ipsen, Incyte, Halozyme, Debiopharm, Rafael, Fibrogen, Medimmune and Clovis, and is/was a consultant for Celgene, Halozyme, Incyte, QED, and NewLink Genetics. M.W.S. is a consultant for EMD Serono; serves on the speakers' bureau for Genentech, Ipsen, Celgene, Novartis, and Sirtex Medical; and has received research funding from Genentech, ImClone Systems, Merrimack, Taiho, Celgene, and Bayer. A.K. has received research funding from Bristol-Myers Squibb and is a consultant for Ipsen, Excelsis, Eisai, and Bristol-Myers Squibb. P.A.P., C.M.R.-L., and D.M.S. have nothing to disclose. A.O. serves on the speakers' bureau for Daiichi Sankyo and is a consultant for Celgene. M.S.O., S.B., R.B., and C.U.L. are employed by Celgene and own stock in the company. V.P. has received grants from AbbVie, Celgene, FibroGen, OncoMed, Aduro, Immunomedics, Lilly, Halozyme, Takeda, and Taiho.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31559379</ArticleId><ArticleId IdType="doi">10.1089/pancan.2019.0012</ArticleId><ArticleId IdType="pii">10.1089/pancan.2019.0012</ArticleId><ArticleId IdType="pmc">PMC6761587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Oncol. 2006 Sep 20;24(27):4441-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16983112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2007 May 20;25(15):1960-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17452677</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Dec 27;357(26):2666-76</Citation><ArticleIdList><ArticleId IdType="pubmed">18160686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Nov 20;27(33):5513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19858379</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2010 Apr 1;28(10):1645-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20194854</ArticleId></ArticleIdList></Reference><Reference><Citation>Neoplasia. 2011 Apr;13(4):327-38</Citation><ArticleIdList><ArticleId IdType="pubmed">21472137</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 May 12;364(19):1817-25</Citation><ArticleIdList><ArticleId IdType="pubmed">21561347</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Oct 31;369(18):1691-703</Citation><ArticleIdList><ArticleId IdType="pubmed">24131140</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2015 Jan 31;107(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">25638248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2015 Sep;26 Suppl 5:v56-68</Citation><ArticleIdList><ArticleId IdType="pubmed">26314780</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2016 Dec;39(6):619-622</Citation><ArticleIdList><ArticleId IdType="pubmed">26523444</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2016 Jul;62:132-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27189322</ArticleId></ArticleIdList></Reference><Reference><Citation>Target Oncol. 2018 Aug;13(4):461-468</Citation><ArticleIdList><ArticleId IdType="pubmed">29882102</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1997 Jun;15(6):2403-13</Citation><ArticleIdList><ArticleId IdType="pubmed">9196156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31554884</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>09</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Online division of labour: emergent structures in Open Source Software.</ArticleTitle><Pagination><MedlinePgn>13890</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-50463-y</ELocationID><Abstract><AbstractText>The development Open Source Software fundamentally depends on the participation and commitment of volunteer developers to progress on a particular task. Several works have presented strategies to increase the on-boarding and engagement of new contributors, but little is known on how these diverse groups of developers self-organise to work together. To understand this, one must consider that, on one hand, platforms like GitHub provide a virtually unlimited development framework: any number of actors can potentially join to contribute in a decentralised, distributed, remote, and asynchronous manner. On the other, however, it seems reasonable that some sort of hierarchy and division of labour must be in place to meet human biological and cognitive limits, and also to achieve some level of efficiency. These latter features (hierarchy and division of labour) should translate into detectable structural arrangements when projects are represented as developer-file bipartite networks. Thus, in this paper we analyse a set of popular open source projects from GitHub, placing the accent on three key properties: nestedness, modularity and in-block nestedness -which typify the emergence of heterogeneities among contributors, the emergence of subgroups of developers working on specific subgroups of files, and a mixture of the two previous, respectively. These analyses show that indeed projects evolve into internally organised blocks. Furthermore, the distribution of sizes of such blocks is bounded, connecting our results to the celebrated Dunbar number both in off- and on-line environments. Our conclusions create a link between bio-cognitive constraints, group formation and online working environments, opening up a rich scenario for future research on (online) work team assembly (e.g. size, composition, and formation). From a complex network perspective, our results pave the way for the study of time-resolved datasets, and the design of suitable models that can mimic the growth and evolution of OSS projects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palazzi</LastName><ForeName>María J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabot</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2418-2489</Identifier><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICREA, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cánovas Izquierdo</LastName><ForeName>Javier Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solé-Ribalta</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borge-Holthoefer</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9036-8463</Identifier><AffiliationInfo><Affiliation>Internet Interdisciplinary Institute (IN3), Universitat Oberta de Catalunya, Barcelona, Catalonia, Spain. jborgeh@uoc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31554884</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-50463-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-50463-y</ArticleId><ArticleId IdType="pmc">PMC6761182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phys Rev E. 2016 Feb;93(2):022306</Citation><ArticleIdList><ArticleId IdType="pubmed">26986351</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2013 Mar;7(3):520-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23178671</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3648-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21307311</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 22;500(7463):449-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23969462</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Feb;69(2 Pt 2):026113</Citation><ArticleIdList><ArticleId IdType="pubmed">14995526</ArticleId></ArticleIdList></Reference><Reference><Citation>Interface Focus. 2013 Dec 6;3(6):20130033</Citation><ArticleIdList><ArticleId IdType="pubmed">24516719</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Dec;76(6 Pt 2):066102</Citation><ArticleIdList><ArticleId IdType="pubmed">18233893</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9383-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12881488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Sep 14;478(7368):233-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21918515</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2982-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26929364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jan 30;7:41673</Citation><ArticleIdList><ArticleId IdType="pubmed">28134358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Apr 23;458(7241):1018-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19396144</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E. 2018 Jun;97(6-1):062302</Citation><ArticleIdList><ArticleId IdType="pubmed">30011537</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Aug;72(2 Pt 2):027104</Citation><ArticleIdList><ArticleId IdType="pubmed">16196754</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Oct;76(4 Pt 2):046118</Citation><ArticleIdList><ArticleId IdType="pubmed">17995071</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(11):e49393</Citation><ArticleIdList><ArticleId IdType="pubmed">23185326</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):111-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24324143</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e22656</Citation><ArticleIdList><ArticleId IdType="pubmed">21826200</ArticleId></ArticleIdList></Reference><Reference><Citation>Oecologia. 1993 Dec;96(3):373-382</Citation><ArticleIdList><ArticleId IdType="pubmed">28313653</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23883</Citation><ArticleIdList><ArticleId IdType="pubmed">21886834</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2018 Apr 5;373(1743):</Citation><ArticleIdList><ArticleId IdType="pubmed">29440527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31538937</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2561-326X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>JMIR formative research</Title><ISOAbbreviation>JMIR Form Res</ISOAbbreviation></Journal><ArticleTitle>Technology-Enabled Mental Health Service Reform for Open Arms - Veterans and Families Counselling: Participatory Design Study.</ArticleTitle><Pagination><MedlinePgn>e13662</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/13662</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of mental ill-health on every aspect of the lives of a large number of Australian Defence Force (ADF) personnel, their partners, and their families is widely recognized. Recent Senate inquiries have highlighted gaps in service delivery as well as the need for service reform to ensure appropriate care options for individuals who are currently engaged with mental health and support services as well as for those who, for a variety of reasons, have not sought help. To that end, successive Australian governments generally and the Department of Veterans' Affairs specifically have prioritized veteran-centric reform. Open Arms is an Australia-wide service that provides counseling and support to current and former ADF personnel, and their family members, for mental health conditions.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to develop and configure a prototypic Web-based platform for Open Arms - Veterans &amp; Families Counselling (formerly Veterans and Veterans Families Counselling Service) with the Open Arms community to enhance the quality of mental health services provided by Open Arms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study aimed to recruit up to 100 people from the Open Arms community (current and former ADF personnel and their families, health professionals, service managers, and administrators) in regions of New South Wales, including Sydney, Canberra, Maitland, Singleton, and Port Stephens. Participants were invited to participate in 4-hour participatory design workshops. A variety of methods were used within the workshops, including prompted discussion, review of working prototypes, creation of descriptive artifacts, and group-based development of user journeys.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven participatory design workshops were held, including a total of 49 participants. Participants highlighted that the prototype has the potential to (1) provide the opportunity for greater and better-informed personal choice in relation to options for care based on the level of need and personal preferences; (2) ensure transparency in care by providing the individual with access to all of their personal health information; and (3) improve collaborative care and care continuity by allowing information to be shared securely with current and future providers.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings highlight the value of actively engaging stakeholders in participatory design processes for the development and configuration of new technologies.</AbstractText><CopyrightInformation>©Haley M LaMonica, Tracey A Davenport, Jane Burns, Shane Cross, Stephanie Hodson, Jennifer Veitch, Ian B Hickie. Originally published in JMIR Formative Research (http://formative.jmir.org), 19.09.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>LaMonica</LastName><ForeName>Haley M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6563-5467</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, The University of Sydney, Camperdown, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Tracey A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4218-9238</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, The University of Sydney, Camperdown, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Jane</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0725-9520</Identifier><AffiliationInfo><Affiliation>InnoWell Pty Ltd, Camperdown, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, The University of Sydney, Camperdown, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Shane</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5413-8342</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, The University of Sydney, Camperdown, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodson</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9464-0644</Identifier><AffiliationInfo><Affiliation>Open Arms-Veterans &amp; Families Counselling, Canberra, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veitch</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3183-4537</Identifier><AffiliationInfo><Affiliation>Open Arms-Veterans &amp; Families Counselling, Canberra, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickie</LastName><ForeName>Ian B</ForeName><Initials>IB</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8832-9895</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, The University of Sydney, Camperdown, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Form Res</MedlineTA><NlmUniqueID>101726394</NlmUniqueID><ISSNLinking>2561-326X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">community-based participatory research</Keyword><Keyword MajorTopicYN="N">health care reform</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">stakeholder participation</Keyword><Keyword MajorTopicYN="N">technology</Keyword><Keyword MajorTopicYN="N">veterans</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31538937</ArticleId><ArticleId IdType="pii">v3i3e13662</ArticleId><ArticleId IdType="doi">10.2196/13662</ArticleId><ArticleId IdType="pmc">PMC6754687</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Public Health Res Pract. 2017 Apr 27;27(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28474049</ArticleId></ArticleIdList></Reference><Reference><Citation>Inform Health Soc Care. 2015 Mar;40(2):167-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24786524</ArticleId></ArticleIdList></Reference><Reference><Citation>J Contin Educ Health Prof. 2006 Winter;26(1):81-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16557508</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2013 May 20;198(9):461-2</Citation><ArticleIdList><ArticleId IdType="pubmed">23682872</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Health Perspect. 2002 Apr;110 Suppl 2:155-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11929724</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Health Res. 2007 Jan;17(1):122-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17170250</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2019 Oct;211 Suppl 7:S3-S39</Citation><ArticleIdList><ArticleId IdType="pubmed">31587276</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Res Protoc. 2019 May 31;8(5):e13955</Citation><ArticleIdList><ArticleId IdType="pubmed">31152524</ArticleId></ArticleIdList></Reference><Reference><Citation>Milbank Q. 2012 Jun;90(2):311-46</Citation><ArticleIdList><ArticleId IdType="pubmed">22709390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 28;20(5):e188</Citation><ArticleIdList><ArticleId IdType="pubmed">29807878</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">31536624</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>08</Month><Day>14</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial.</ArticleTitle><Pagination><MedlinePgn>933-943</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciz889</ELocationID><Abstract><AbstractText Label="BACKGROUND">Improved treatment for onchocerciasis is needed to accelerate onchocerciasis elimination in Africa. Aiming to better exploit registered drugs, this study was undertaken to determine whether annual or semiannual treatment with ivermectin (IVM; 200 µg/kg) plus albendazole (ALB; 800 mg single dose) is superior to IVM alone.</AbstractText><AbstractText Label="METHODS">This trial was performed in Ghana and included 272 participants with microfilariae (MF), who were randomly assigned to 4 treatment arms: (1) IVM annually at 0, 12, and 24 months; (2) IVM semiannually at 0, 6, 12, 18, and 24 months; (3) IVM+ALB annually; or (4) IVM+ALB semiannually. Microfiladermia was determined pretreatment and at 6, 18, and 36 months. The primary outcome was the proportion of fertile and viable female worms in onchocercomata excised at 36 months.</AbstractText><AbstractText Label="RESULTS">Posttreatment nodule histology showed that 15/135 (11.1%), 22/155 (14.2%), 35/154 (22.7%), and 20/125 (16.0%) living female worms had normal embryogenesis in the IVM annual, IVM semiannual, IVM+ALB annual, and IVM+ALB semiannual groups, respectively (P = .1229). Proportions of dead worms also did not differ between the 4 groups (P = .9198). Proportions of patients without MF at 36 months (1 year after the last treatment) were 35/56 (63%) after annual IVM, 42/59 (71%) after semiannual IVM, 39/64 (61%) after annual IVM+ALB, and 43/53 (81%) after semiannual IVM+ALB.</AbstractText><AbstractText Label="CONCLUSIONS">The combination treatment of IVM plus ALB was no better than IVM alone for sterilizing, killing adult worms, or achieving sustained MF clearance. However, semiannual treatment was superior to annual treatment for achieving sustained clearance of Onchocerca volvulus MF from the skin (P = .024).</AbstractText><AbstractText Label="CLINICAL TRIALS REGISTRATION">ISRCTN50035143.</AbstractText><CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batsa Debrah</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Kumasi Center for Collaborative Research, Kumasi, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarmann-Schulz</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research, Bonn-Cologne site, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osei-Mensah</LastName><ForeName>Jubin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kumasi Center for Collaborative Research, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubben</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubarik</LastName><ForeName>Yusif</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kumasi Center for Collaborative Research, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayisi-Boateng</LastName><ForeName>Nana Kwame</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>University Hospital, , Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricchiuto</LastName><ForeName>Arcangelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fimmers</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konadu</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadal</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruetzmacher</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weil</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazura</LastName><ForeName>James W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Christopher L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Medical Center, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debrah</LastName><ForeName>Alexander Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Kumasi Center for Collaborative Research, Kumasi, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty for Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoerauf</LastName><ForeName>Achim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research, Bonn-Cologne site, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN50035143</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017181" MajorTopicYN="Y">Onchocerca volvulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009855" MajorTopicYN="Y">Onchocerciasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">albendazole</Keyword><Keyword MajorTopicYN="Y">ivermectin</Keyword><Keyword MajorTopicYN="Y">onchocerciasis</Keyword><Keyword MajorTopicYN="Y">semiannual treatment</Keyword><Keyword MajorTopicYN="Y">therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31536624</ArticleId><ArticleId IdType="pii">5571844</ArticleId><ArticleId IdType="doi">10.1093/cid/ciz889</ArticleId><ArticleId IdType="pmc">PMC7428389</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Biomed Inform. 2009 Apr;42(2):377-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Nov;13(11):922-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24319775</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Trop. 1993 Jan;52(4):221-66</Citation><ArticleIdList><ArticleId IdType="pubmed">8094587</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Oct;59(7):923-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24944228</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasitol Res. 2009 Dec;106(1):23-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19756742</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):94-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9692166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2008 May;8(5):310-22</Citation><ArticleIdList><ArticleId IdType="pubmed">18471776</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2008 Sep;197(3):295-311</Citation><ArticleIdList><ArticleId IdType="pubmed">17999080</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Sep;3(9):e371</Citation><ArticleIdList><ArticleId IdType="pubmed">17002504</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):332-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11491010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Trop Med Parasitol. 2003 Mar;97(2):165-78</Citation><ArticleIdList><ArticleId IdType="pubmed">12803872</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasitol Res. 2009 Nov;105(6):1531-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19784672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Oct 6;392(10154):1207-1216</Citation><ArticleIdList><ArticleId IdType="pubmed">29361335</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemics. 2017 Mar;18:4-15</Citation><ArticleIdList><ArticleId IdType="pubmed">28279455</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Dec 29;9(12):e115886</Citation><ArticleIdList><ArticleId IdType="pubmed">25545677</ArticleId></ArticleIdList></Reference><Reference><Citation>Trop Med Parasitol. 1995 Dec;46(4):213-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8826100</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasit Vectors. 2015 Mar 19;8:167</Citation><ArticleIdList><ArticleId IdType="pubmed">25889256</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005156</Citation><ArticleIdList><ArticleId IdType="pubmed">28056021</ArticleId></ArticleIdList></Reference><Reference><Citation>Trop Med Parasitol. 1991 Dec;42(4):356-60</Citation><ArticleIdList><ArticleId IdType="pubmed">1796233</ArticleId></ArticleIdList></Reference><Reference><Citation>Filaria J. 2005 Mar 23;4(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">15788103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 May;14(5):373-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24758997</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953</Citation><ArticleIdList><ArticleId IdType="pubmed">24968000</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19805362</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasitol Res. 2009 Jan;104(2):437-47</Citation><ArticleIdList><ArticleId IdType="pubmed">18850111</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2015 Sep 11;9(9):e0004056</Citation><ArticleIdList><ArticleId IdType="pubmed">26360917</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Health. 2016 Mar;8 Suppl 1:i28-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26940307</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2003 Apr;5(4):261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12706439</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31528716</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2399-5300</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Innovation in aging</Title><ISOAbbreviation>Innov Aging</ISOAbbreviation></Journal><ArticleTitle>Open Science is for Aging Research, Too.</ArticleTitle><Pagination><MedlinePgn>igz028</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geroni/igz028</ELocationID><Abstract><AbstractText>In response to concerns about the replicability of published research, some disciplines have used open science practices to try to enhance the credibility of published findings. Gerontology has been slow to embrace these changes. We argue that open science is important for aging research, both to reduce questionable research practices that may also be prevalent in the field (such as too many reported significant age differences in the literature, underpowered studies, hypothesizing after the results are known, and lack of belief updating when findings do not support theories), as well as to make research in the field more transparent overall. To ensure the credibility of gerontology research moving forward, we suggest concrete ways to incorporate open science into gerontology research: for example, by using available preregistration templates adaptable to a variety of study designs typical for aging research (even secondary analyses of existing data). Larger sample sizes may be achieved by many-lab collaborations. Though using open science practices may make some aspects of gerontology research more challenging, we believe that gerontology needs open science to ensure credibility now and in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Isaacowitz</LastName><ForeName>Derek M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Psychology, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lind</LastName><ForeName>Majse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG048731</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Innov Aging</MedlineTA><NlmUniqueID>101703706</NlmUniqueID><ISSNLinking>2399-5300</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Methodology</Keyword><Keyword MajorTopicYN="N">Quantitative research methods</Keyword><Keyword MajorTopicYN="N">Research methods</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31528716</ArticleId><ArticleId IdType="doi">10.1093/geroni/igz028</ArticleId><ArticleId IdType="pii">igz028</ArticleId><ArticleId IdType="pmc">PMC6736348</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2010 Apr 21;5(4):e10271</Citation><ArticleIdList><ArticleId IdType="pubmed">20422014</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2584-2589</Citation><ArticleIdList><ArticleId IdType="pubmed">29531050</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2600-2606</Citation><ArticleIdList><ArticleId IdType="pubmed">29531091</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2012 May 1;23(5):524-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22508865</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Oct 4;342(6154):60-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24092725</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Assess. 2019 Dec;31(12):1386-1394</Citation><ArticleIdList><ArticleId IdType="pubmed">30869959</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol B Psychol Sci Soc Sci. 2020 Jan 1;75(1):45-57</Citation><ArticleIdList><ArticleId IdType="pubmed">29878211</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 26;348(6242):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26113702</ArticleId></ArticleIdList></Reference><Reference><Citation>Infancy. 2017 Jul-Aug;22(4):421-435</Citation><ArticleIdList><ArticleId IdType="pubmed">31772509</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2014 Jan 3;343(6166):30-1</Citation><ArticleIdList><ArticleId IdType="pubmed">24385620</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2011 Sep;43(3):666-78</Citation><ArticleIdList><ArticleId IdType="pubmed">21494917</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jul 07;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27387362</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):562-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26168113</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10516-E10517</Citation><ArticleIdList><ArticleId IdType="pubmed">30341225</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerontologist. 2015 Dec;55(6):893</Citation><ArticleIdList><ArticleId IdType="pubmed">26585601</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2017 Mar 31;6:405</Citation><ArticleIdList><ArticleId IdType="pubmed">28580128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol B Psychol Sci Soc Sci. 2018 Mar 2;73(3):361-362</Citation><ArticleIdList><ArticleId IdType="pubmed">29301035</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Nov 21;503(7476):333-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24273798</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2011 Nov;22(11):1359-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22006061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers Soc Psychol Rev. 1998;2(3):196-217</Citation><ArticleIdList><ArticleId IdType="pubmed">15647155</ArticleId></ArticleIdList></Reference><Reference><Citation>Account Res. 2019 Apr;26(3):229-244</Citation><ArticleIdList><ArticleId IdType="pubmed">30741570</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2018 Jul;13(4):411-417</Citation><ArticleIdList><ArticleId IdType="pubmed">29961410</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 Jun 9;435(7043):737-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15944677</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2014 Sep;9(5):552-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26186757</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Oct 08;9(10):e109019</Citation><ArticleIdList><ArticleId IdType="pubmed">25296159</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2014 Dec 10;3:</Citation><ArticleIdList><ArticleId IdType="pubmed">25490932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31522846</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>394</Volume><Issue>10207</Issue><PubDate><Year>2019</Year><Month>10</Month><Day>19</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.</ArticleTitle><Pagination><MedlinePgn>1425-1436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(19)31790-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(19)31790-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Heavy menstrual bleeding affects 25% of women in the UK, many of whom require surgery to treat it. Hysterectomy is effective but has more complications than endometrial ablation, which is less invasive but ultimately leads to hysterectomy in 20% of women. We compared laparoscopic supracervical hysterectomy with endometrial ablation in women seeking surgical treatment for heavy menstrual bleeding.</AbstractText><AbstractText Label="METHODS">In this parallel-group, multicentre, open-label, randomised controlled trial in 31 hospitals in the UK, women younger than 50 years who were referred to a gynaecologist for surgical treatment of heavy menstrual bleeding and who were eligible for endometrial ablation were randomly allocated (1:1) to either laparoscopic supracervical hysterectomy or second generation endometrial ablation. Women were randomly assigned by either an interactive voice response telephone system or an internet-based application with a minimisation algorithm based on centre and age group (&lt;40 years vs ≥40 years). Laparoscopic supracervical hysterectomy involves laparoscopic (keyhole) surgery to remove the upper part of the uterus (the body) containing the endometrium. Endometrial ablation aims to treat heavy menstrual bleeding by destroying the endometrium, which is responsible for heavy periods. The co-primary clinical outcomes were patient satisfaction and condition-specific quality of life, measured with the menorrhagia multi-attribute quality of life scale (MMAS), assessed at 15 months after randomisation. Our analysis was based on the intention-to-treat principle. The trial was registered with the ISRCTN registry, number ISRCTN49013893.</AbstractText><AbstractText Label="FINDINGS">Between May 21, 2014, and March 28, 2017, we enrolled and randomly assigned 660 women (330 in each group). 616 (93%) of 660 women were operated on within the study period, 588 (95%) of whom received the allocated procedure and 28 (5%) of whom had an alternative surgery. At 15 months after randomisation, more women allocated to laparoscopic supracervical hysterectomy were satisfied with their operation compared with those in the endometrial ablation group (270 [97%] of 278 women vs 244 [87%] of 280 women; adjusted percentage difference 9·8, 95% CI 5·1-14·5; adjusted odds ratio [OR] 2·53, 95% CI 1·83-3·48; p&lt;0·0001). Women randomly assigned to laparoscopic supracervical hysterectomy were also more likely to have the best possible MMAS score of 100 than women assigned to endometrial ablation (180 [69%] of 262 women vs 146 [54%] of 268 women; adjusted percentage difference 13·3, 95% CI 3·8-22·8; adjusted OR 1·87, 95% CI 1·31-2·67; p=0·00058). 14 (5%) of 309 women in the laparoscopic supracervical hysterectomy group and 11 (4%) of 307 women in the endometrial ablation group had at least one serious adverse event (adjusted OR 1·30, 95% CI 0·56-3·02; p=0·54).</AbstractText><AbstractText Label="INTERPRETATION">Laparoscopic supracervical hysterectomy is superior to endometrial ablation in terms of clinical effectiveness and has a similar proportion of complications, but takes longer to perform and is associated with a longer recovery.</AbstractText><AbstractText Label="FUNDING">UK National Institute for Health Research Health Technology Assessment Programme.</AbstractText><CopyrightInformation>Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK. Electronic address: kevincooper@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breeman</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Neil W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Medical Statistics Team, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotland</LastName><ForeName>Graham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Aberdeen, UK; Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Birmingham Women's and Children's NHS Foundation Trust, Birmingham Women's and Children's Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawe</LastName><ForeName>Jed</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Countess of Chester Hospital NHS Foundation Trust, Chester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawthorn</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Southern General Hospital, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLennan</LastName><ForeName>Graeme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wileman</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormack</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Services Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norrie</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, Centre for Population Health Sciences, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharya</LastName><ForeName>Siladitya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>HEALTH Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HSRU1</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2019 Oct 19;394(10207):1390-1392</RefSource><PMID Version="1">31522847</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet. 2019 Oct 19;394(10207):e32</RefSource><PMID Version="1">31631859</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2020 Jan 3;368:l6764</RefSource><PMID Version="1">31900245</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055356" MajorTopicYN="Y">Endometrial Ablation Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="N">Hysterectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057194" MajorTopicYN="N">Intention to Treat Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008595" MajorTopicYN="N">Menorrhagia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063868" MajorTopicYN="N">Patient Outcome Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31522846</ArticleId><ArticleId IdType="pii">S0140-6736(19)31790-8</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(19)31790-8</ArticleId><ArticleId IdType="pmc">PMC6891255</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Obstet Gynecol Surv. 2015 Dec;70(12):780-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26676149</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Obstet Gynecol Reprod Biol. 2016 Jan;196:52-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26675056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Aug 12;356(9229):535-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10950229</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2003 Jan;188(1):7-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12548189</ArticleId></ArticleIdList></Reference><Reference><Citation>BJOG. 2011 Nov;118(12):1528-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21790952</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2013 Nov 29;(11):CD000329</Citation><ArticleIdList><ArticleId IdType="pubmed">24288154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004993</Citation><ArticleIdList><ArticleId IdType="pubmed">16625620</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 Jan 17;328(7432):129</Citation><ArticleIdList><ArticleId IdType="pubmed">14711749</ArticleId></ArticleIdList></Reference><Reference><Citation>J Obstet Gynaecol Res. 2011 Nov;37(11):1650-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21790890</ArticleId></ArticleIdList></Reference><Reference><Citation>J Womens Health (Larchmt). 2012 May;21(5):539-47</Citation><ArticleIdList><ArticleId IdType="pubmed">22360696</ArticleId></ArticleIdList></Reference><Reference><Citation>Gynecol Surg. 2015;12(3):165-177</Citation><ArticleIdList><ArticleId IdType="pubmed">26283890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2015 Aug 12;(8):CD003677</Citation><ArticleIdList><ArticleId IdType="pubmed">26264829</ArticleId></ArticleIdList></Reference><Reference><Citation>BJOG. 2008 Dec;115(13):1605-10</Citation><ArticleIdList><ArticleId IdType="pubmed">18752588</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Gen Pract. 2004 May;54(502):359-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15113519</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2016 Jan 29;(1):CD003855</Citation><ArticleIdList><ArticleId IdType="pubmed">26820670</ArticleId></ArticleIdList></Reference><Reference><Citation>J Obstet Gynaecol. 2005 Jul;25(5):469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16183583</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Aug 16;341:c3929</Citation><ArticleIdList><ArticleId IdType="pubmed">20713583</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2004 Dec;191(6):1875-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15592268</ArticleId></ArticleIdList></Reference><Reference><Citation>Womens Health Issues. 2009 Jan-Feb;19(1):70-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19111789</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Apr 26;342:d2202</Citation><ArticleIdList><ArticleId IdType="pubmed">21521730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2019 Jan 22;1:CD001501</Citation><ArticleIdList><ArticleId IdType="pubmed">30667064</ArticleId></ArticleIdList></Reference><Reference><Citation>BJOG. 2011 Sep;118(10):1171-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21624035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Nov 27;354(9193):1859-63</Citation><ArticleIdList><ArticleId IdType="pubmed">10584722</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2017 Mar;216(3):259.e1-259.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">27890646</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2018 Jan 24;19(1):63</Citation><ArticleIdList><ArticleId IdType="pubmed">29368658</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2009 May;18(4):403-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19242822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31522294</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-3890</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>09</Month><Day>14</Day></PubDate></JournalIssue><Title>Metabolomics : Official journal of the Metabolomic Society</Title><ISOAbbreviation>Metabolomics</ISOAbbreviation></Journal><ArticleTitle>Toward collaborative open data science in metabolomics using Jupyter Notebooks and cloud computing.</ArticleTitle><Pagination><MedlinePgn>125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11306-019-1588-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">A lack of transparency and reporting standards in the scientific community has led to increasing and widespread concerns relating to reproduction and integrity of results. As an omics science, which generates vast amounts of data and relies heavily on data science for deriving biological meaning, metabolomics is highly vulnerable to irreproducibility. The metabolomics community has made substantial efforts to align with FAIR data standards by promoting open data formats, data repositories, online spectral libraries, and metabolite databases. Open data analysis platforms also exist; however, they tend to be inflexible and rely on the user to adequately report their methods and results. To enable FAIR data science in metabolomics, methods and results need to be transparently disseminated in a manner that is rapid, reusable, and fully integrated with the published work. To ensure broad use within the community such a framework also needs to be inclusive and intuitive for both computational novices and experts alike.</AbstractText><AbstractText Label="AIM OF REVIEW">To encourage metabolomics researchers from all backgrounds to take control of their own data science, mould it to their personal requirements, and enthusiastically share resources through open science.</AbstractText><AbstractText Label="KEY SCIENTIFIC CONCEPTS OF REVIEW">This tutorial introduces the concept of interactive web-based computational laboratory notebooks. The reader is guided through a set of experiential tutorials specifically targeted at metabolomics researchers, based around the Jupyter Notebook web application, GitHub data repository, and Binder cloud computing platform.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendez</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-8832-2607</Identifier><AffiliationInfo><Affiliation>Centre for Metabolomics &amp; Computational Biology, School of Science, Edith Cowan University, Joondalup, 6027, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pritchard</LastName><ForeName>Leighton</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8392-2822</Identifier><AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy &amp; Biomedical Sciences, University of Strathclyde, Cathedral Street, Glasgow, G1 1XQ, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinke</LastName><ForeName>Stacey N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-0758-0330</Identifier><AffiliationInfo><Affiliation>Centre for Metabolomics &amp; Computational Biology, School of Science, Edith Cowan University, Joondalup, 6027, Australia. stacey.n.reinke@ecu.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broadhurst</LastName><ForeName>David I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0003-0775-9581</Identifier><AffiliationInfo><Affiliation>Centre for Metabolomics &amp; Computational Biology, School of Science, Edith Cowan University, Joondalup, 6027, Australia. d.broadhurst@ecu.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Metabolomics</MedlineTA><NlmUniqueID>101274889</NlmUniqueID><ISSNLinking>1573-3882</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="Y">Cloud Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Cloud computing</Keyword><Keyword MajorTopicYN="Y">Data science</Keyword><Keyword MajorTopicYN="Y">Jupyter</Keyword><Keyword MajorTopicYN="Y">Open access</Keyword><Keyword MajorTopicYN="Y">Reproducibility</Keyword><Keyword MajorTopicYN="Y">Statistics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31522294</ArticleId><ArticleId IdType="doi">10.1007/s11306-019-1588-0</ArticleId><ArticleId IdType="pii">10.1007/s11306-019-1588-0</ArticleId><ArticleId IdType="pmc">PMC6745024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Metabolomics. 2018;14(6):72</Citation><ArticleIdList><ArticleId IdType="pubmed">29805336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2017 Sep 26;4:170138</Citation><ArticleIdList><ArticleId IdType="pubmed">29989594</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2006 Sep-Oct;12(5):741-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17080795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2019 Feb 1;8(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">30535405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 25;533(7604):452-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2004 Nov;22(11):1459-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15529173</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617</Citation><ArticleIdList><ArticleId IdType="pubmed">29140435</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2017 Nov 3;13(11):e1005752</Citation><ArticleIdList><ArticleId IdType="pubmed">29099853</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolomics. 2013 Apr;9(2):280-299</Citation><ArticleIdList><ArticleId IdType="pubmed">23543913</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolites. 2019 Apr 18;9(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">31003499</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2019 Mar 12;10(1):1092</Citation><ArticleIdList><ArticleId IdType="pubmed">30862783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D463-70</Citation><ArticleIdList><ArticleId IdType="pubmed">26467476</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2010 Mar;7(3 Suppl):S56-68</Citation><ArticleIdList><ArticleId IdType="pubmed">20195258</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mass Spectrom. 2010 Jul;45(7):703-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20623627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544</Citation><ArticleIdList><ArticleId IdType="pubmed">29790989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Drug Monit. 2005 Dec;27(6):747-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16404815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D781-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23109552</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Mater. 2019 May;18(5):422-427</Citation><ArticleIdList><ArticleId IdType="pubmed">30478452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 May 1;31(9):1493-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25527831</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2018 Nov 20;90(22):13400-13408</Citation><ArticleIdList><ArticleId IdType="pubmed">30335973</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolomics. 2017 Dec 1;14(1):7</Citation><ArticleIdList><ArticleId IdType="pubmed">30830321</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Bioinformatics. 2011 Jun;Chapter 14:Unit 14.10</Citation><ArticleIdList><ArticleId IdType="pubmed">21633943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2016 Feb 23;5:10</Citation><ArticleIdList><ArticleId IdType="pubmed">26913198</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2016 Jan 12;114(1):59-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26645240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31513567</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>Ten simple rules for helping newcomers become contributors to open projects.</ArticleTitle><Pagination><MedlinePgn>e1007296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1007296</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sholler</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2517-4317</Identifier><AffiliationInfo><Affiliation>Berkeley Institute for Data Science, University of California Berkeley, Berkeley, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinmacher</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>School of Informatics, Computing, and Cyber Systems, Northern Arizona University, Flagstaff, Arizona, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Denae</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0654-4335</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, North Carolina State University, Raleigh, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Averick</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>RStudio, Inc., Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoye</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mozilla Corporation, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Greg</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8659-8979</Identifier><AffiliationInfo><Affiliation>RStudio, Inc., Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007857" MajorTopicYN="N">Leadership</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31513567</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1007296</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-19-00595</ArticleId><ArticleId IdType="pmc">PMC6742214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):8872-8877</Citation><ArticleIdList><ArticleId IdType="pubmed">30127025</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31497307</PMID><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2054-670X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Psychologica Belgica</Title><ISOAbbreviation>Psychol Belg</ISOAbbreviation></Journal><ArticleTitle>Open Up - the Mission Statement of the Control of Impulsive Action (Ctrl-ImpAct) Lab on Open Science.</ArticleTitle><Pagination><MedlinePgn>321-337</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5334/pb.494</ELocationID><Abstract><AbstractText>The present paper is the mission statement of the Control of Impulsive Action (Ctrl-ImpAct) Lab regarding Open Science. As early-career researchers (ECRs) in the lab, we first state our personal motivation to conduct research based on the principles of Open Science. We then describe how we incorporate four specific Open Science practices (i.e., Open Methodology, Open Data, Open Source, and Open Access) into our scientific workflow. In more detail, we explain how Open Science practices are embedded into the so-called 'co-pilot' system in our lab. The 'co-pilot' researcher is involved in all tasks of the 'pilot' researcher, that is designing a study, double-checking experimental and data analysis scripts, as well as writing the manuscript. The lab has set up this co-pilot system to increase transparency, reduce potential errors that could occur during the entire workflow, and to intensify collaborations between lab members. Finally, we discuss potential solutions for general problems that could arise when practicing Open Science.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reimer</LastName><ForeName>Christina B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bundt</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eben</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>London</LastName><ForeName>Raquel E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardanian</LastName><ForeName>Sirarpi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Ghent University, BE.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Belg</MedlineTA><NlmUniqueID>0067335</NlmUniqueID><ISSNLinking>0033-2879</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Open Access</Keyword><Keyword MajorTopicYN="N">Open Data</Keyword><Keyword MajorTopicYN="N">Open Methodology</Keyword><Keyword MajorTopicYN="N">Open Science</Keyword><Keyword MajorTopicYN="N">Open Source</Keyword><Keyword MajorTopicYN="N">Transparency</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31497307</ArticleId><ArticleId IdType="doi">10.5334/pb.494</ArticleId><ArticleId IdType="pmc">PMC6707000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ. 2000 Mar 18;320(7237):768-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10720363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers Soc Psychol Rev. 1998;2(3):196-217</Citation><ArticleIdList><ArticleId IdType="pubmed">15647155</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2005 Aug;2(8):e124</Citation><ArticleIdList><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2007 May 15;162(1-2):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17254636</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2010 Jul;11(3):385-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20538873</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2011 Sep;43(3):666-78</Citation><ArticleIdList><ArticleId IdType="pubmed">21494917</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2011 Nov;22(11):1359-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22006061</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Nov 30;480(7375):7</Citation><ArticleIdList><ArticleId IdType="pubmed">22129686</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2012 May 1;23(5):524-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22508865</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortex. 2013 Mar;49(3):609-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23347556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2013 May;14(5):365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23571845</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ. 2013 Oct 01;1:e175</Citation><ArticleIdList><ArticleId IdType="pubmed">24109559</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2015 Mar;47(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24683129</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Dec 10;9(12):e114876</Citation><ArticleIdList><ArticleId IdType="pubmed">25493918</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):528-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26168108</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):562-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26168113</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2014 Jan;9(1):59-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26173241</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 Oct 8;526(7572):182-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26450039</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2016 Dec;48(4):1205-1226</Citation><ArticleIdList><ArticleId IdType="pubmed">26497820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Jan 7;529(7584):117-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26744755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Jan 28;529(7587):459-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26819029</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Mar 4;351(6277):1037</Citation><ArticleIdList><ArticleId IdType="pubmed">26941311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 May 12;14(5):e1002456</Citation><ArticleIdList><ArticleId IdType="pubmed">27171007</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 May 12;14(5):e1002460</Citation><ArticleIdList><ArticleId IdType="pubmed">27171138</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jul 07;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27387362</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2016 Sep;11(5):702-712</Citation><ArticleIdList><ArticleId IdType="pubmed">27694465</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2584-2589</Citation><ArticleIdList><ArticleId IdType="pubmed">29531050</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2628-2631</Citation><ArticleIdList><ArticleId IdType="pubmed">29531051</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2600-2606</Citation><ArticleIdList><ArticleId IdType="pubmed">29531091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Stat Assoc. 2017;112(517):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">29861517</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2018 Jul;13(4):439-447</Citation><ArticleIdList><ArticleId IdType="pubmed">29961408</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2018 Nov;22(11):953-956</Citation><ArticleIdList><ArticleId IdType="pubmed">30041865</ArticleId></ArticleIdList></Reference><Reference><Citation>R Soc Open Sci. 2018 Aug 15;5(8):180448</Citation><ArticleIdList><ArticleId IdType="pubmed">30225032</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2019 Jan 2;101(1):11-14</Citation><ArticleIdList><ArticleId IdType="pubmed">30605654</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2019 Apr;23(4):265-267</Citation><ArticleIdList><ArticleId IdType="pubmed">30712996</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2019 May 1;17(5):e3000246</Citation><ArticleIdList><ArticleId IdType="pubmed">31042704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Hum Behav. 2018 Sep;2(9):637-644</Citation><ArticleIdList><ArticleId IdType="pubmed">31346273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31474261</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-6752</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics</Title><ISOAbbreviation>Am J Orthod Dentofacial Orthop</ISOAbbreviation></Journal><ArticleTitle>The National Dental Practice-Based Research Network Adult Anterior Open Bite Study: Treatment recommendations and their association with patient and practitioner characteristics.</ArticleTitle><Pagination><MedlinePgn>312-325</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0889-5406(19)30515-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajodo.2019.05.005</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">This aim of this paper is to describe and identify the practitioner and patient characteristics that are associated with treatment recommendations for adult anterior open bite patients across the United States.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Practitioners and patients were recruited within the framework of the National Dental Practice-Based Research Network. Practitioners were asked about their demographic characteristics and their treatment recommendations for these patients. The practitioners also reported on their patients' dentofacial characteristics and provided initial cephalometric scans and intraoral photographs. Patients were asked about their demographic characteristics, previous orthodontic treatment, and goals for treatment. Four main treatment groups were evaluated: aligners, fixed appliances, temporary anchorage devices (TADs), and orthognathic surgery. Extractions were also investigated. Predictive multivariable models were created comparing various categories of treatment as well as extraction/nonextraction decisions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ninety-one practitioners (mostly orthodontists) and 347 patients were recruited from October 2015 to December 2016. Increased aligner recommendations were associated with white and Asian patients, the presence of tongue habits, and female practitioners. TADs were recommended more often in academic settings. Recommendations for orthognathic surgery were associated with demographic factors, such as availability of insurance coverage and practitioner race/ethnicity, and dentofacial characteristics, such as anteroposterior discrepancies, more severe open bites, and steeper mandibular plane angles. Extraction recommendations were largely associated with severe crowding and incisor proclination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both doctor and patient demographic factors, as well as dentofacial characteristics, were significantly associated with treatment recommendations for adult anterior open bite patients.</AbstractText><CopyrightInformation>Copyright © 2019 American Association of Orthodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash. Electronic address: ghuang@u.washington.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltuck</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Western Region, National Dental Practice-Based Research Network, Portland, Ore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funkhouser</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Preventive Medicine, School of Medicine, University of Alabama, Birmingham, Ala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hsuan-Fang Cathy</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash; Division of Orthodontics, Department of Dentistry, Far Eastern Memorial Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todoki</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finkleman</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosravi</LastName><ForeName>Roozbah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Hsiu-Ching Joanna</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenlee</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jesus-Vinas</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Private practice, San Juan, Puerto Rico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermette</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Private practice, Concord, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Private practice, Eau Claire, Wis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolce</LastName><ForeName>Calogero</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Florida, Gainesville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kau</LastName><ForeName>Chung How</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Orthodontics, University of Alabama, Birmingham, Ala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harnick</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Private practice, Albuquerque, NM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>National Dental Practice-Based Research Network Collaborative Group</CollectiveName><AffiliationInfo><Affiliation>National Dental Practice-Based Research Network (PBRN) Collaborative Group includes practitioner, faculty, and staff investigators who contributed to this activity. A full list is available at http://nationaldentalpbrn.org/collaborative-group.php.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 DE022516</GrantID><Acronym>DE</Acronym><Agency>NIDCR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Orthod Dentofacial Orthop</MedlineTA><NlmUniqueID>8610224</NlmUniqueID><ISSNLinking>0889-5406</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002508" MajorTopicYN="N">Cephalometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007180" MajorTopicYN="N">Incisor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008334" MajorTopicYN="N">Mandible</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024343" MajorTopicYN="N">Open Bite</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009967" MajorTopicYN="N">Orthodontic Appliances</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009971" MajorTopicYN="N">Orthodontics, Corrective</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066792" MajorTopicYN="N">Orthodontists</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056948" MajorTopicYN="N">Orthognathic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019239" MajorTopicYN="N">Practice Patterns, Dentists'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014087" MajorTopicYN="N">Tooth Movement Techniques</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Basile</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Enstad</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Lith</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hodge</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stewart</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ragusa</LastName><ForeName>Pat</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McEdward</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Danny</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carcelén</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massingale</LastName><ForeName>Shermetria</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sowell</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reyes</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buchberg</LastName><ForeName>Meredith</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castillo</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31474261</ArticleId><ArticleId IdType="pii">S0889-5406(19)30515-3</ArticleId><ArticleId IdType="doi">10.1016/j.ajodo.2019.05.005</ArticleId><ArticleId IdType="pmc">PMC6774609</ArticleId><ArticleId IdType="mid">NIHMS1537652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Semin Orthod. 1999 Dec;5(4):275-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10860064</ArticleId></ArticleIdList></Reference><Reference><Citation>Angle Orthod. 1989 Spring;59(1):5-10</Citation><ArticleIdList><ArticleId IdType="pubmed">2923322</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Orthod Dentofacial Orthop. 2018 Apr;153(4):577-587</Citation><ArticleIdList><ArticleId IdType="pubmed">29602350</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Maxillofac Surg Clin North Am. 2007 Aug;19(3):339-50, vi</Citation><ArticleIdList><ArticleId IdType="pubmed">18088889</ArticleId></ArticleIdList></Reference><Reference><Citation>Angle Orthod. 1990 Spring;60(1):17-24; discussion 25-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2316899</ArticleId></ArticleIdList></Reference><Reference><Citation>Angle Orthod. 2018 Nov;88(6):675-683</Citation><ArticleIdList><ArticleId IdType="pubmed">30207487</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent Res. 2013 Sep;92(9):782-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23857643</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Orthod. 2016;17:9</Citation><ArticleIdList><ArticleId IdType="pubmed">26980200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cranio. 2005 Jul;23(3):229-38</Citation><ArticleIdList><ArticleId IdType="pubmed">16128358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Dent. 1997 Mar-Apr;19(2):91-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9106869</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent. 2013 Nov;41(11):1051-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23597500</ArticleId></ArticleIdList></Reference><Reference><Citation>Angle Orthod. 2013 Sep;83(5):913-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23363479</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Adult Orthodon Orthognath Surg. 2001 Winter;16(4):280-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12390006</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Orthod Dentofacial Orthop. 2010 May;137(5):605-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20451779</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Orthod Dentofacial Orthop. 2006 Jun;129(6):768-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16769495</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31472381</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7870</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>Evaluation and program planning</Title><ISOAbbreviation>Eval Program Plann</ISOAbbreviation></Journal><ArticleTitle>Will the children use it?-A RE-AIM evaluation of a local public open space intervention involving children from a deprived neighbourhood.</ArticleTitle><Pagination><MedlinePgn>101706</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0149-7189(18)30340-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.evalprogplan.2019.101706</ELocationID><Abstract><AbstractText>Knowledge on how to improve public open spaces in deprived neighbourhoods to increase active living among children is scarce and comprehensively evaluated public open space interventions are needed. Firstly, the aim was to explore if involving 39 local fifth-grade children (10-11 years old) from a deprived neighbourhood in creating playable installations in a public open space influenced their use of this space. Secondly, we wanted to explore if the Reach, Effectiveness, Adoption, Implementation and Maintenance framework (RE-AIM) was useful for evaluating different stages in the intervention project. RE-AIM was applied through a convergent mixed-methods triangulation design using survey, accelerometer, GPS, and interviews as data sources. Effectiveness outcomes revealed that on average the space was used less by the 39 children after the intervention. The implementation and maintenance dimensions revealed aspects of why most children involved in the project did not use the space after intervention. The evaluation cast light on children's perceptions of their role, and importance of maintenance when the intervention was completed. In future, all dimensions of built environmental projects would benefit from being planned and evaluated in a collaboration with all project partners using an evaluation framework integrated and applied from the beginning of the project.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pawlowski</LastName><ForeName>Charlotte Skau</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Research unit for Active Living, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark. Electronic address: cspawlowski@health.sdu.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research unit for Active Living, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark. Electronic address: tbschmidt@health.sdu.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Jonas Vestergaard</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Research unit for Active Living, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark. Electronic address: jvestergaard@health.sdu.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troelsen</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research unit for Active Living, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark. Electronic address: jtroelsen@health.sdu.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schipperijn</LastName><ForeName>Jasper</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research unit for Active Living, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark. Electronic address: jschipperijn@health.sdu.dk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eval Program Plann</MedlineTA><NlmUniqueID>7801727</NlmUniqueID><ISSNLinking>0149-7189</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000076624" MajorTopicYN="N">Built Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004779" MajorTopicYN="N">Environment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068316" MajorTopicYN="Y">Parks, Recreational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010988" MajorTopicYN="Y">Play and Playthings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011204" MajorTopicYN="Y">Poverty Areas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Active living</Keyword><Keyword MajorTopicYN="Y">Children</Keyword><Keyword MajorTopicYN="Y">Deprived neighbourhood</Keyword><Keyword MajorTopicYN="Y">Implementation</Keyword><Keyword MajorTopicYN="Y">Maintenance</Keyword><Keyword MajorTopicYN="Y">Participatory design</Keyword><Keyword MajorTopicYN="Y">Public open space</Keyword><Keyword MajorTopicYN="Y">RE-AIM</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31472381</ArticleId><ArticleId IdType="pii">S0149-7189(18)30340-9</ArticleId><ArticleId IdType="doi">10.1016/j.evalprogplan.2019.101706</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31451207</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>394</Volume><Issue>10202</Issue><PubDate><Year>2019</Year><Month>09</Month><Day>14</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.</ArticleTitle><Pagination><MedlinePgn>919-928</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(19)31948-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(19)31948-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe exacerbations compared with short-acting β-agonist (SABA) reliever therapy. We investigated the efficacy of combination budesonide-formoterol reliever therapy compared with maintenance budesonide plus as-needed terbutaline.</AbstractText><AbstractText Label="METHODS">We did a 52-week, open-label, parallel-group, multicentre, superiority, randomised controlled trial at 15 primary care or hospital-based clinical trials units and primary care practices in New Zealand. Participants were adults aged 18-75 years with a self-reported doctor's diagnosis of asthma who were using SABA for symptom relief with or without maintenance low to moderate doses of inhaled corticosteroids in the previous 12 weeks. We randomly assigned participants (1:1) to either reliever therapy with budesonide 200 μg-formoterol 6 μg Turbuhaler (one inhalation as needed for relief of symptoms) or maintenance budesonide 200 μg Turbuhaler (one inhalation twice daily) plus terbutaline 250 μg Turbuhaler (two inhalations as needed). Participants and investigators were not masked to group assignment; the statistician was masked for analysis of the primary outcome. Six study visits were scheduled: randomisation, and weeks 4, 16, 28, 40, and 52. The primary outcome was the number of severe exacerbations per patient per year analysed by intention to treat (severe exacerbations defined as use of systemic corticosteroids for at least 3 days because of asthma, or admission to hospital or an emergency department visit because of asthma requiring systemic corticosteroids). Safety analyses included all participants who had received at least one dose of study treatment. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12616000377437.</AbstractText><AbstractText Label="FINDINGS">Between May 4, 2016, and Dec 22, 2017, we assigned 890 participants to treatment and included 885 eligible participants in the analysis: 437 assigned to budesonide-formoterol as needed and 448 to budesonide maintenance plus terbutaline as needed. Severe exacerbations per patient per year were lower with as-needed budesonide-formoterol than with maintenance budesonide plus terbutaline as needed (absolute rate per patient per year 0·119 vs 0·172; relative rate 0·69, 95% CI 0·48-1·00; p=0·049). Nasopharyngitis was the most common adverse event in both groups, occurring in 154 (35%) of 440 patients receiving as-needed budesonide-formoterol and 144 (32%) of 448 receiving maintenance budesonide plus terbutaline as needed.</AbstractText><AbstractText Label="INTERPRETATION">In adults with mild to moderate asthma, budesonide-formoterol used as needed for symptom relief was more effective at preventing severe exacerbations than maintenance low-dose budesonide plus as-needed terbutaline. The findings support the 2019 Global Initiative for Asthma recommendation that inhaled corticosteroid-formoterol reliever therapy is an alternative regimen to daily low-dose inhaled corticosteroid for patients with mild asthma.</AbstractText><AbstractText Label="FUNDING">Health Research Council of New Zealand.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Jo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baggott</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fingleton</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand; Capital and Coast District Health Board, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddel</LastName><ForeName>Helen K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hancox</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Waikato Hospital, Hamilton, New Zealand; University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harwood</LastName><ForeName>Matire</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corin</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Horizons, Tauranga, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparks</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabbagh</LastName><ForeName>Doñah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mane</LastName><ForeName>Saras</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vohlidkova</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martindale</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirtcliffe</LastName><ForeName>Philippa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holliday</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherall</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beasley</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Newtown, Wellington, New Zealand; Capital and Coast District Health Board, Wellington, New Zealand. Electronic address: richard.beasley@mrinz.ac.nz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PRACTICAL study team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069502">Budesonide, Formoterol Fumarate Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>51333-22-3</RegistryNumber><NameOfSubstance UI="D019819">Budesonide</NameOfSubstance></Chemical><Chemical><RegistryNumber>N8ONU3L3PG</RegistryNumber><NameOfSubstance UI="D013726">Terbutaline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2019 Sep 14;394(10202):897-898</RefSource><PMID Version="1">31451208</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet. 2020 May 2;395(10234):1422</RefSource><PMID Version="1">32359459</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Fam Pract. 2021 Mar;70(2):90-92</RefSource><PMID Version="1">33760899</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="N">Anti-Asthmatic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019819" MajorTopicYN="N">Budesonide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069502" MajorTopicYN="N">Budesonide, Formoterol Fumarate Drug Combination</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074099" MajorTopicYN="N">Equivalence Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009330" MajorTopicYN="N">Nebulizers and Vaporizers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013726" MajorTopicYN="N">Terbutaline</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Corin</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dronfield</LastName><ForeName>Liz</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helm</LastName><ForeName>Colin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paterson</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poudel</LastName><ForeName>Bhuwan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dyer</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jasinski</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheahan</LastName><ForeName>Davitt</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheahan</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gailer</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Zuilen</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basa</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egan</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haughey</LastName><ForeName>Sneha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marks</LastName><ForeName>Rodney</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venter</LastName><ForeName>Dirk</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hank</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trevithick</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Philippa</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baggott</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beasley</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Braithwaite</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eathorne</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebmeier</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fingleton</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardy</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harwood</LastName><ForeName>Matire</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holliday</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houghton</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mane</LastName><ForeName>Saras</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martindale</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oldfield</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilcher</LastName><ForeName>Janine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabbagh</LastName><ForeName>Doñah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shirtcliffe</LastName><ForeName>Philippa</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snively</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sparks</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vohlidkova</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Mathew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Collins</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>Summer</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lam</LastName><ForeName>Annika</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lionnet</LastName><ForeName>Claudette</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Barney</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smaill</LastName><ForeName>Liz</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moon</LastName><ForeName>Stella</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Dean</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bayly-McCredie</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Millar-Coote</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Millar-Coote</LastName><ForeName>Dean</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reid</LastName><ForeName>Jim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samuel</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burton</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mullard</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tranquilino</LastName><ForeName>Tyronne</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watson</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Jill</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richmond</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krivan</LastName><ForeName>Brent</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robertson</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hancox</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weatherall</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glensor</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Dermot</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porrachia</LastName><ForeName>Anne-Christine</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reddel</LastName><ForeName>Helen K</ForeName><Initials>HK</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31451207</ArticleId><ArticleId IdType="pii">S0140-6736(19)31948-8</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(19)31948-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31437889</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Romedi: An Open Data Source About French Drugs on the Semantic Web.</ArticleTitle><Pagination><MedlinePgn>79-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190187</ELocationID><Abstract><AbstractText>The W3C project, "Linking Open Drug Data" (LODD), linked several publicly available sources of drug data together. So far, French data, like marketed drugs and their summary of product characteristics, were not integrated and remained difficult to query. In this paper, we present Romedi (Référentiel Ouvert du Médicament), an open dataset that links French data on drugs to international resources. The principles and standard recommendations created by the W3C for sharing information were adopted. Romedi was connected to the Unified Medical Language System and DrugBank, two central resources of the LODD project. A SPARQL endpoint is available to query Romedi and services are provided to annotate textual content with Romedi terms. This paper describes its content, its services, its links to external resources, and expected future developments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cossin</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebrun</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobre</LastName><ForeName>Grégory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loustau</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jouhet</LastName><ForeName>Vianney</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffier</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mougin</LastName><ForeName>Fleur</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Gayo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiessard</LastName><ForeName>Frantz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Bordeaux university hospital, Pôle de santé publique, Service d'information médicale, Unité Informatique et Archivistique Médicales, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team ERIAS, UMR 1219, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075403" MajorTopicYN="Y">Semantic Web</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017432" MajorTopicYN="N">Unified Medical Language System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Controlled</Keyword><Keyword MajorTopicYN="N">Pharmaceutical Preparations</Keyword><Keyword MajorTopicYN="N">Semantics</Keyword><Keyword MajorTopicYN="N">Vocabulary</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31437889</ArticleId><ArticleId IdType="pii">SHTI190187</ArticleId><ArticleId IdType="doi">10.3233/SHTI190187</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31434941</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>08</Month><Day>21</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>High-speed device synchronization in optical microscopy with an open-source hardware control platform.</ArticleTitle><Pagination><MedlinePgn>12188</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-48455-z</ELocationID><Abstract><AbstractText>Azimuthal beam scanning eliminates the uneven excitation field arising from laser interference in through-objective total internal reflection fluorescence (TIRF) microscopy. The same principle can be applied to scanning angle interference microscopy (SAIM), where precision control of the scanned laser beam presents unique technical challenges for the builders of custom azimuthal scanning microscopes. Accurate synchronization between the instrument computer, beam scanning system and excitation source is required to collect high quality data and minimize sample damage in SAIM acquisitions. Drawing inspiration from open-source prototyping systems, like the Arduino microcontroller boards, we developed a new instrument control platform to be affordable, easily programmed, and broadly useful, but with integrated, precision analog circuitry and optimized firmware routines tailored to advanced microscopy. We show how the integration of waveform generation, multiplexed analog outputs, and native hardware triggers into a single central hub provides a versatile platform for performing fast circle-scanning acquisitions, including azimuthal scanning SAIM and multiangle TIRF. We also demonstrate how the low communication latency of our hardware platform can reduce image intensity and reconstruction artifacts arising from synchronization errors produced by software control. Our complete platform, including hardware design, firmware, API, and software, is available online for community-based development and collaboration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colville</LastName><ForeName>Marshall J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5397-8382</Identifier><AffiliationInfo><Affiliation>Field of Biophysics, Cornell University, Ithaca, NY, 14853, USA. mjc449@cornell.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sangwoo</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2701-3114</Identifier><AffiliationInfo><Affiliation>Field of Biophysics, Cornell University, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zipfel</LastName><ForeName>Warren R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Field of Biophysics, Cornell University, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute at Cornell for Nanoscale Science, Ithaca, NY, 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paszek</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Field of Biophysics, Cornell University, Ithaca, NY, 14853, USA. mjp31@cornell.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA. mjp31@cornell.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Field of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA. mjp31@cornell.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kavli Institute at Cornell for Nanoscale Science, Ithaca, NY, 14853, USA. mjp31@cornell.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM008267</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA210184</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R33-CA193043</GrantID><Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute (NCI)</Agency><Country>International</Country></Grant><Grant><GrantID>U54-CS210184</GrantID><Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute (NCI)</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016477" MajorTopicYN="N">Artifacts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007834" MajorTopicYN="N">Lasers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008051" MajorTopicYN="N">Lipid Bilayers</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008857" MajorTopicYN="N">Microscopy, Interference</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31434941</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-48455-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-48455-z</ArticleId><ArticleId IdType="pmc">PMC6704125</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4864-73</Citation><ArticleIdList><ArticleId IdType="pubmed">26283369</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2011 May;8(5):417-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21378978</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2017 Jul 18;15(7):e2002702</Citation><ArticleIdList><ArticleId IdType="pubmed">28719603</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 2018 Apr 1;43(7):1423-1426</Citation><ArticleIdList><ArticleId IdType="pubmed">29600995</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 1993 Apr 1;18(7):549-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19802197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jun 28;9(7):676-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsc Res Tech. 2006 Aug;69(8):642-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16770769</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jul 01;9(8):825-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22751201</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20</Citation><ArticleIdList><ArticleId IdType="pubmed">20890901</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">27044072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2016 Oct 31;13(11):897-898</Citation><ArticleIdList><ArticleId IdType="pubmed">27798596</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsc Res Tech. 2008 Jan;71(1):45-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17886344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Nov;10(11):1122-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24097271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Sep 14;7(1):11651</Citation><ArticleIdList><ArticleId IdType="pubmed">28912565</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2008 Oct 27;16(22):18495-504</Citation><ArticleIdList><ArticleId IdType="pubmed">18958128</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroeng. 2014 Dec 11;7:43</Citation><ArticleIdList><ArticleId IdType="pubmed">25566051</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Nov 25;468(7323):580-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21107430</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2014 Mar 4;106(5):1008-19</Citation><ArticleIdList><ArticleId IdType="pubmed">24606926</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Opt Express. 2014 Apr 15;5(5):1530-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24877013</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Image Process. 2008 Aug;17(8):1323-30</Citation><ArticleIdList><ArticleId IdType="pubmed">18632342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 May 8;7(1):1542</Citation><ArticleIdList><ArticleId IdType="pubmed">28484239</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microsc. 2013 Oct;252(1):16-22</Citation><ArticleIdList><ArticleId IdType="pubmed">23889125</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">31405310</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-0553</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of investigative surgery : the official journal of the Academy of Surgical Research</Title><ISOAbbreviation>J Invest Surg</ISOAbbreviation></Journal><ArticleTitle>Evaluation of A Better Approach for Open Reduction Of Severe Gartland Type III Supracondylar Humeral Fracture.</ArticleTitle><Pagination><MedlinePgn>479-485</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08941939.2019.1649766</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An optimal surgical approach is required to treat Gartland type III supracondylar humerus fractures (SHFs) in children when open reduction is inevitable, especially in patients with neurovascular injuries. The purposes of this study were to find a better approach for open reduction of Gartland type III SHFs and to achieve anatomic reduction, stable fixation, and good functional and cosmetic outcomes with this approach. <i>Methods:</i> This retrospective study was performed in our hospital between January 2008 and June 2014. After the exclusion criteria were applied, 91 children were treated with the mini-anterior approach for severe Gartland type III SHFs. A 2-3-cm long anterior incision was made radially along the anterior transverse groove of the elbow, through which the nerve and vessel were probed, if necessary, and fracture reduction and Kirschner (K)-wire insertion were performed. Radiological evaluation included the Baumann angle and carrying angle. The functional and cosmetic evaluation was based on range-of-motion measurements and the criteria defined by Flynn. Chi-square and independent t tests were used for the statistical analyses. <i>Results:</i> Thirty-two patients were impossible to reduce, 1 patient had brachial artery injury, 37 patients had a sign with compartmental syndrome, 6 patients had open fractures, and 15 patients had multiple trauma. The interval between injury and hospitalization was 1 hour to 12 days. Overall, 91 patients were followed for 12 months to 4 years (average, 26.5 months). All incisions were healed by primary intervention. The fracture healing time was 3-5 weeks (average, 3.8 weeks). Elbow function recovered after 3 months, without obvious cubitus varus. Postoperative radial nerve paralysis occurred in 2 patients and healed within 2 months. Postoperative ulnar nerve paralysis occurred in 2 patients, and one of the K-wires was removed after 1 day. Nerve injuries were relieved within 3 months for both patients. The outcomes, according to the Flynn criteria, were excellent in 73 patients, good in 12 patients, and fair in 6 patients. The rate of excellent and good outcomes was 93.41%. <i>Conclusions:</i> The advantages of the mini-anterior approach include minimal trauma, simple and rapid exposure, easy tissue repair, and possibility of probing and repairing nerves, vessels, and muscles. It is an optimal surgical approach for the treatment of Gartland type III SHFs when open reduction is inevitable, especially in patients with neurovascular injuries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, The Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nan</LastName><ForeName>Guoxin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department II of Orthopaedics, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, The Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Surg</MedlineTA><NlmUniqueID>8809255</NlmUniqueID><ISSNLinking>0894-1939</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001864" MajorTopicYN="N">Bone Wires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004551" MajorTopicYN="Y">Elbow Joint</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006810" MajorTopicYN="Y">Humeral Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gartland type</Keyword><Keyword MajorTopicYN="N">Level of evidence: III</Keyword><Keyword MajorTopicYN="N">anterior approach</Keyword><Keyword MajorTopicYN="N">mini incision</Keyword><Keyword MajorTopicYN="N">supracondylar humeral fracture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31405310</ArticleId><ArticleId IdType="doi">10.1080/08941939.2019.1649766</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31397314</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>266</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Can Wikipedia Be Used to Derive an Open Clinical Terminology?</ArticleTitle><Pagination><MedlinePgn>136-141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190785</ELocationID><Abstract><AbstractText>Clinical terminologies play an essential role in enabling semantic interoperability between medical records. However, existing terminologies have several issues that impact data quality, such as content gaps and slow updates. In this study we explore the suitability of existing, community-driven resources, specifically Wikipedia, as a potential source to bootstrap an open clinical terminology, in terms of content coverage. In order to establish the extent of the coverage, a team of expert clinical terminologists manually mapped a clinically-relevant subset of SNOMED CT to Wikipedia articles. The results show that approximately 80% of the concepts are covered by Wikipedia. Most concepts that do not have a direct match in Wikipedia are composable from multiple articles. These findings are encouraging and suggest that it should be possible to bootstrap an open clinical terminology from Wikipedia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Duy Hoa</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>The Australian e-Health Research Centre, CSIRO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truran</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Australian e-Health Research Centre, CSIRO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kemp</LastName><ForeName>Madonna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Australian e-Health Research Centre, CSIRO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawley</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Australian e-Health Research Centre, CSIRO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metke-Jimenez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Australian e-Health Research Centre, CSIRO.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="Y">Medical Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical terminology alignment</Keyword><Keyword MajorTopicYN="N">SNOMED CT</Keyword><Keyword MajorTopicYN="N">Wikipedia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31397314</ArticleId><ArticleId IdType="pii">SHTI190785</ArticleId><ArticleId IdType="doi">10.3233/SHTI190785</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31392665</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-2027</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>11</Month></PubDate></JournalIssue><Title>PharmacoEconomics</Title><ISOAbbreviation>Pharmacoeconomics</ISOAbbreviation></Journal><ArticleTitle>Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.</ArticleTitle><Pagination><MedlinePgn>1313-1320</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40273-019-00827-z</ELocationID><Abstract><AbstractText>The Innovation and Value Initiative started the Open-Source Value Project with the aim to improve the credibility and relevance of model-based value assessment in the context of the US healthcare environment. As a core activity of the Open-Source Value Project, the Innovation and Value Initiative develops and provides access to flexible open-source economic models that are developed iteratively based on public feedback and input. In this article, we describe our experience to date with the development of two currently released, Open-Source Value Project models, one in rheumatoid arthritis and one in epidermal growth factor receptor-positive non-small-cell lung cancer. We developed both Open-Source Value Project models using the statistical programming language R instead of spreadsheet software (i.e., Excel), which allows the models to capture multiple model structures, model sequential treatment with individual patient simulations, and improve integration with formal evidence synthesis. By developing the models in R, we were also able to use version control systems to manage changes to the source code, which is needed for iterative and collaborative model development. Similarly, Open-Source Value Project models are freely available to the public to provide maximum transparency and facilitate collaboration. Development of the rheumatoid arthritis and non-small-cell lung cancer model platforms has presented multiple challenges. The development of multiple components of the model platform tailored to different audiences, including web interfaces, required more resources than a cost-effectiveness analysis for a publication would. Furthermore, we faced methodological hurdles, in particular related to the incorporation of multiple competing model structures and novel elements of value. The iterative development based on public feedback also posed some challenges during the review phase, where methodological experts did not always understand feedback from clinicians and vice versa. Response to the Open-Source Value Project by the modeling community and patient organizations has been positive, but feedback from US decision makers has been limited to date. As we progress with this project, we hope to learn more about the feasibility, benefits, and challenges of an open-source and collaborative approach to model development for value assessment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Jeroen P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, Alexandria, VA, USA. jeroen.jansen@thevalueinitiative.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA. jeroen.jansen@thevalueinitiative.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Incerti</LastName><ForeName>Devin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, Alexandria, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linthicum</LastName><ForeName>Mark T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, Alexandria, VA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Pharmacoeconomics</MedlineTA><NlmUniqueID>9212404</NlmUniqueID><ISSNLinking>1170-7690</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018803" MajorTopicYN="Y">Models, Economic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31392665</ArticleId><ArticleId IdType="doi">10.1007/s40273-019-00827-z</ArticleId><ArticleId IdType="pii">10.1007/s40273-019-00827-z</ArticleId><ArticleId IdType="pmc">PMC6860458</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Value Health. 2018 Feb;21(2):124-130</Citation><ArticleIdList><ArticleId IdType="pubmed">29477389</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2018 Feb;21(2):131-139</Citation><ArticleIdList><ArticleId IdType="pubmed">29477390</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2008 Sep 20;27(21):4340-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18425994</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 2018 Jun;122(6):607-613</Citation><ArticleIdList><ArticleId IdType="pubmed">29731176</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2017 May;37(4):340-352</Citation><ArticleIdList><ArticleId IdType="pubmed">27281337</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 1990 Jul-Sep;10(3):212-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2115096</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2017 Aug;35(8):817-830</Citation><ArticleIdList><ArticleId IdType="pubmed">28488257</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2018 Apr;38(3):400-422</Citation><ArticleIdList><ArticleId IdType="pubmed">29587047</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Technol Assess Health Care. 2014 Jan;30(1):105-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24451150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2019 Jun;37(6):829-843</Citation><ArticleIdList><ArticleId IdType="pubmed">30737711</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2014 Apr;32(4):345-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24504851</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2017 Jan;35(1):125-128</Citation><ArticleIdList><ArticleId IdType="pubmed">27928759</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2015 Sep;21(9):632-40</Citation><ArticleIdList><ArticleId IdType="pubmed">26618366</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2012 Apr;31(4):676-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22492883</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2008 Sep-Oct;11(5):886-97</Citation><ArticleIdList><ArticleId IdType="pubmed">18489513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2018 Apr 3;168(7):529</Citation><ArticleIdList><ArticleId IdType="pubmed">29610903</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;226:115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27350481</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2001 Dec;10(8):779-87</Citation><ArticleIdList><ArticleId IdType="pubmed">11747057</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2018 Feb;21(2):155-160</Citation><ArticleIdList><ArticleId IdType="pubmed">29477393</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2008 Dec 22;8:270</Citation><ArticleIdList><ArticleId IdType="pubmed">19102752</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2012 Sep-Oct;32(5):733-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22990088</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2017 Oct;37(7):735-746</Citation><ArticleIdList><ArticleId IdType="pubmed">28061043</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31321059</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2052-4439</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.</ArticleTitle><Pagination><MedlinePgn>e000443</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2019-000443</ELocationID><Abstract><AbstractText Label="Introduction">Transbronchial lung cryobiopsy (TBLC) is a novel, minimally invasive technique for obtaining lung tissue for histopathological assessment in interstitial lung disease (ILD). Despite its increasing popularity, the diagnostic accuracy of TBLC is not yet known. The COLDICE Study (Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease allianCE) aims to evaluate the agreement between TBLC and surgical lung biopsy sampled concurrently from the same patients, for both histopathological and multidisciplinary discussion (MDD) diagnoses.</AbstractText><AbstractText Label="Methods and analysis">This comparative, multicentre, prospective trial is enrolling patients with ILD requiring surgical lung biopsy to aid with their diagnosis. Participants are consented for both video-assisted thoracoscopic surgical (VATS) biopsy and TBLC within the same anaesthetic episode. Specimens will be blindly assessed by three expert pathologists both individually and by consensus. Each tissue sample will then be considered in conjunction with clinical and radiological data, within a centralised MDD. Each patient will be presented twice in random order, once with TBLC data and once with VATS data. Meeting participants will be blinded to the method of tissue sampling. The accuracy of TBLC will be assessed by agreement with VATS at (1) histopathological analysis and (2) MDD diagnosis. Data will be collected on interobserver agreement between pathologists, interobserver agreement between MDD participants, and detailed clinical and procedural characteristics.</AbstractText><AbstractText Label="Ethics and dissemination">The study is being conducted in accordance with the International Conference on Harmonisation Guideline for Good Clinical Practice and Australian legislation for the ethical conduct of research.</AbstractText><AbstractText Label="Trial registration number">ACTRN12615000718549.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Troy</LastName><ForeName>Lauren K</ForeName><Initials>LK</Initials><Identifier Source="ORCID">0000-0002-7426-336X</Identifier><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grainge</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corte</LastName><ForeName>Tamera</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Liverpool Hospital, Liverpool, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Macquarie University Hospital, North Ryde BC, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallely</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, Macquarie University Hospital, North Ryde BC, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahar</LastName><ForeName>Annabelle M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Radiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulyadi</LastName><ForeName>Ellie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Radiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torzillo</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salamonsen</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Don</LastName><ForeName>Garrick</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Royal North Shore Hospital School, Saint Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pathology, University of Michigan Hospital, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghu</LastName><ForeName>Ganesh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Sleep and Critical Care Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Edmund M T</ForeName><Initials>EMT</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COLDICE Investigator Team</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ANZCTR</DataBankName><AccessionNumberList><AccessionNumber>ACTRN12615000718549</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003452" MajorTopicYN="N">Cryosurgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="N">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">diagnostic accuracy</Keyword><Keyword MajorTopicYN="Y">interstitial lung disease</Keyword><Keyword MajorTopicYN="Y">surgical lung biopsy</Keyword><Keyword MajorTopicYN="Y">transbronchial lung cryobiopsy</Keyword></KeywordList><CoiStatement>Competing interests: LKT received study-related unrestricted educational grants or inkind support from the aforementioned commercial entities, on behalf of the COLDICE Investigator Team. MPV sits on the advisory boards of Medtronic and Edwards Lifesciences, and consults for Edwards Lifesciences and Abbott. GR provides consultation for Bellerophon, Biogen, BMS, FibroGen, Gilead, Nitto, Revistan, Promedior, Sanofi, Veracyte, Roche-Genentech, Avalyn and Boehringer Ingelheim. JM is an unpaid collaborator in the Veracyte BRAVE Trial.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cao</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cashmore</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cleary</LastName><ForeName>Shannon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>French</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geis</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glenn</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hibbert</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ing</LastName><ForeName>Alvin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>James</LastName><ForeName>Allen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jo</LastName><ForeName>Helen E</ForeName><Initials>HE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Qi Tina</ForeName><Initials>QT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meredith</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merry</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pudipeddi</LastName><ForeName>Anand</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rhodes</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saghaie</LastName><ForeName>Tajalli</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomson</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Twaddell</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webster</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wrobel</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oldmeadow</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31321059</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2019-000443</ArticleId><ArticleId IdType="pii">bmjresp-2019-000443</ArticleId><ArticleId IdType="pmc">PMC6606076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur Respir J. 2017 Feb 23;49(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28232409</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 May 29;370(22):2083-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24836312</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiration. 2018;95(3):188-200</Citation><ArticleIdList><ArticleId IdType="pubmed">29316560</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2017 Nov 15;196(10):1249-1254</Citation><ArticleIdList><ArticleId IdType="pubmed">28414524</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2014 Aug;19(6):900-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24890124</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Res. 2018 Jul 28;19(1):141</Citation><ArticleIdList><ArticleId IdType="pubmed">30055613</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiration. 2009;78(2):203-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19246874</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Sep 22;365(12):1079-87</Citation><ArticleIdList><ArticleId IdType="pubmed">21992121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Am Thorac Soc. 2016 Oct;13(10):1828-1838</Citation><ArticleIdList><ArticleId IdType="pubmed">27466899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 May 21;377(9779):1760-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21571362</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2013 Sep;42(3):750-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23222877</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiration. 2016;91(3):215-27</Citation><ArticleIdList><ArticleId IdType="pubmed">26926876</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2016 Apr 1;193(7):745-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26562389</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2015 May;149(5):1394-401.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">25648484</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2011 Apr;37(4):743-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21454891</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256</Citation><ArticleIdList><ArticleId IdType="pubmed">30864813</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2014 Aug;19(6):773-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24965516</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2016 Apr 1;193(7):707-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27035778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bronchology Interv Pulmonol. 2019 Jan;26(1):22-32</Citation><ArticleIdList><ArticleId IdType="pubmed">29901533</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824</Citation><ArticleIdList><ArticleId IdType="pubmed">21471066</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2019 Mar;24(3):270-277</Citation><ArticleIdList><ArticleId IdType="pubmed">30282111</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2015 Dec 15;192(12):1475-82</Citation><ArticleIdList><ArticleId IdType="pubmed">26331942</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2007 Apr 1;175(7):705-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17218621</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68</Citation><ArticleIdList><ArticleId IdType="pubmed">30168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2016 May 15;193(10):1161-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26646481</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Nov 14;6(11):e012799</Citation><ArticleIdList><ArticleId IdType="pubmed">28137831</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2003 Nov;56(11):1029</Citation><ArticleIdList><ArticleId IdType="pubmed">14614992</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48</Citation><ArticleIdList><ArticleId IdType="pubmed">24032382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31274982</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1314-2828</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Biodiversity data journal</Title><ISOAbbreviation>Biodivers Data J</ISOAbbreviation></Journal><ArticleTitle>Biodiversidata: An Open-Access Biodiversity Database for Uruguay.</ArticleTitle><Pagination><MedlinePgn>e36226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3897/BDJ.7.e36226</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The continental and marine territories of Uruguay are characterised by a rich convergence of multiple biogeographic ecoregions of the Neotropics, making this country a peculiar biodiversity spot. However, despite the biological significance of Uruguay for the South American subcontinent, the distribution of biodiversity patterns in this country remain poorly understood, given the severe gaps in available records of geographic species distributions. Currently, national biodiversity datasets are not openly available and, thus, a dominant proportion of the primary biodiversity data produced by researchers and institutions across Uruguay remains highly dispersed and difficult to access for the wider scientific and environmental community. In this paper, we aim to fill this gap by developing the first comprehensive, open-access database of biodiversity records for Uruguay (Biodiversidata), which is the result of a large-scale collaboration involving experts working across the entire range of taxonomic diversity found in the country.</AbstractText><AbstractText Label="NEW INFORMATION" NlmCategory="CONCLUSIONS">As part of the first phase of Biodiversidata, we here present a comprehensive database of tetrapod occurrence records native from Uruguay, with the latest taxonomic updates. The database provides primary biodiversity data on extant Amphibia, Reptilia, Aves and Mammalia species recorded within the country. The total number of records collated is 69,380, spanning 673 species and it is available at the Zenodo repository: https://doi.org/10.5281/zenodo.2650169. This is the largest and most geographically and taxonomically comprehensive database of Uruguayan tetrapod species available to date and it represents the first open repository for the country.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grattarola</LastName><ForeName>Florencia</ForeName><Initials>F</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8282-5732</Identifier><AffiliationInfo><Affiliation>School of Life Sciences, University of Lincoln, Brayford Campus, Lincoln, United Kingdom School of Life Sciences, University of Lincoln, Brayford Campus Lincoln United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botto</LastName><ForeName>Germán</ForeName><Initials>G</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4055-9277</Identifier><AffiliationInfo><Affiliation>Department of Micriobiology and Immunology, Montana State Universitiy, Bozeman, United States of America Department of Micriobiology and Immunology, Montana State Universitiy Bozeman United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Métodos Cuantitativos, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay Departamento de Métodos Cuantitativos, Facultad de Medicina, Universidad de la República Montevideo Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa para la Conservación de los Murciélagos de Uruguay, Museo Nacional de Historia Natural, Montevideo, Uruguay Programa para la Conservación de los Murciélagos de Uruguay, Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Rosa</LastName><ForeName>Inés</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratorio de Sistemática e Historia Natural de Vertebrados, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay Laboratorio de Sistemática e Historia Natural de Vertebrados, Facultad de Ciencias, Universidad de la República Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobel</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Área Biodiversidad y Conservación, Museo Nacional de Historia Natural, Montevideo, Uruguay Área Biodiversidad y Conservación, Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González</LastName><ForeName>Enrique M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Museo Nacional de Historia Natural, Montevideo, Uruguay Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Museo Nacional de Historia Natural, Montevideo, Uruguay Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>NGO JULANA (Jugando en la Naturaleza), Montevideo, Uruguay NGO JULANA (Jugando en la Naturaleza) Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laufer</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Área Biodiversidad y Conservación, Museo Nacional de Historia Natural, Montevideo, Uruguay Área Biodiversidad y Conservación, Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maneyro</LastName><ForeName>Raúl</ForeName><Initials>R</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3440-8701</Identifier><AffiliationInfo><Affiliation>Laboratorio de Sistemática e Historia Natural de Vertebrados, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay Laboratorio de Sistemática e Historia Natural de Vertebrados, Facultad de Ciencias, Universidad de la República Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Lanfranco</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Museo Nacional de Historia Natural, Montevideo, Uruguay Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Wildlife, Fisheries and Aquaculture, Mississippi State University, Mississippi, United States of America Department of Wildlife, Fisheries and Aquaculture, Mississippi State University Mississippi United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naya</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Departamento de Ecología y Evolución, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay Departamento de Ecología y Evolución, Facultad de Ciencias, Universidad de la República Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodales</LastName><ForeName>Ana L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Programa para la Conservación de los Murciélagos de Uruguay, Museo Nacional de Historia Natural, Montevideo, Uruguay Programa para la Conservación de los Murciélagos de Uruguay, Museo Nacional de Historia Natural Montevideo Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Lucía</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro Universitario Regional del Este (CURE), Universidad de la República, Maldonado, Uruguay Centro Universitario Regional del Este (CURE), Universidad de la República Maldonado Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pincheira-Donoso</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MacroBiodiversity Lab, School of Science and Technology, Department of Biosciences, Trent University, Nottingham, United Kingdom MacroBiodiversity Lab, School of Science and Technology, Department of Biosciences, Trent University Nottingham United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Bulgaria</Country><MedlineTA>Biodivers Data J</MedlineTA><NlmUniqueID>101619899</NlmUniqueID><ISSNLinking>1314-2828</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"> Amphibia </Keyword><Keyword MajorTopicYN="N"> Aves </Keyword><Keyword MajorTopicYN="N"> Mammalia </Keyword><Keyword MajorTopicYN="N"> Reptilia </Keyword><Keyword MajorTopicYN="N">Biodiversity</Keyword><Keyword MajorTopicYN="N">Species Occurrence Records</Keyword><Keyword MajorTopicYN="N">Tetrapods</Keyword><Keyword MajorTopicYN="N">Uruguay</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31274982</ArticleId><ArticleId IdType="doi">10.3897/BDJ.7.e36226</ArticleId><ArticleId IdType="pii">36226</ArticleId><ArticleId IdType="pmc">PMC6597616</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annu Rev Entomol. 2006;51:467-94</Citation><ArticleIdList><ArticleId IdType="pubmed">16332220</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(1):e29715</Citation><ArticleIdList><ArticleId IdType="pubmed">22238640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zootaxa. 2014 Mar 25;3782:1-110</Citation><ArticleIdList><ArticleId IdType="pubmed">24871951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Biodivers Data J. 2018 Nov 07;(6):e26826</Citation><ArticleIdList><ArticleId IdType="pubmed">30473617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31273862</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-0705</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</Title><ISOAbbreviation>Ultrasound Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Learning curves of open and endoscopic fetal spina bifida closure: systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>730-739</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/uog.20389</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The Management of Myelomeningocele Study (MOMS) trial demonstrated the safety and efficacy of open fetal surgery for spina bifida aperta (SBA). Recently developed alternative techniques may reduce maternal risks without compromising the fetal neuroprotective effects. The aim of this systematic review was to assess the learning curve (LC) of different fetal SBA closure techniques.</AbstractText><AbstractText Label="METHODS">MEDLINE, Web of Science, EMBASE, Scopus and Cochrane databases and the gray literature were searched to identify relevant articles on fetal surgery for SBA, without language restriction, published between January 1980 and October 2018. Identified studies were reviewed systematically and those reporting all consecutive procedures and with postnatal follow-up ≥ 12 months were selected. Studies were included only if they reported outcome variables necessary to measure the LC, as defined by fetal safety and efficacy. Two authors independently retrieved data, assessed the quality of the studies and categorized observations into blocks of 30 patients. For meta-analysis, data were pooled using a random-effects model when heterogeneous. To measure the LC, we used two complementary methods. In the group-splitting method, competency was defined when the procedure provided results comparable to those in the MOMS trial for 12 outcome variables representing the immediate surgical outcome, short-term neonatal neuroprotection and long-term neuroprotection at ≥ 12 months of age. Then, when raw patient data were available, we performed cumulative sum analysis based on a composite binary outcome defining successful surgery. The composite outcome combined four clinically relevant variables for safety (absence of extreme preterm delivery &lt; 30 weeks, absence of fetal death ≤ 7 days after surgery) and efficacy (reversal of hindbrain herniation and absence of any neonatal treatment of dehiscence or cerebrospinal fluid leakage at the closure site).</AbstractText><AbstractText Label="RESULTS">Of 6024 search results, 17 (0.3%) studies were included, all of which had low, moderate or unclear risk of bias. Fetal SBA closure was performed using standard hysterotomy (11 studies), mini-hysterotomy (one study) or fetoscopy by either exteriorized-uterus single-layer closure (one study), percutaneous single-layer closure (three studies) or percutaneous two-layer closure (one study). Only outcomes for standard hysterotomy could be meta-analyzed. Overall, outcomes improved significantly with experience. Competency was reached after 35 consecutive cases for standard hysterotomy and was predicted to be achieved after ≥ 57 cases for mini-hysterotomy and ≥ 56 for percutaneous two-layer fetoscopy. For percutaneous and exteriorized-uterus single-layer fetoscopy, competency was not reached in the 81 and 28 cases available for analysis, respectively, and LC prediction analysis could not be performed.</AbstractText><AbstractText Label="CONCLUSIONS">The number of cases operated is correlated with the outcome of fetal SBA closure, and the number of operated cases required to reach competency ranges from 35 for standard hysterotomy to ≥ 56-57 for minimally invasive modifications. Our observations provide important information for institutions looking to establish a new fetal center, develop a new fetal surgery technique or train their team, and inform referring clinicians, potential patients and third parties. Copyright © 2019 ISUOG. Published by John Wiley &amp; Sons Ltd.</AbstractText><CopyrightInformation>Copyright © 2019 ISUOG. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joyeux</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7331-6354</Identifier><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division Women and Child, Fetal Medicine Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bie</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danzer</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>F M</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0002-5029-7899</Identifier><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division Women and Child, Fetal Medicine Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javaux</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peralta</LastName><ForeName>C F A</ForeName><Initials>CFA</Initials><AffiliationInfo><Affiliation>Department of Fetal Medicine, The Heart Hospital, University of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Fetal Medicine, Pro Matre Hospital, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Salles</LastName><ForeName>A A F</ForeName><Initials>AAF</Initials><AffiliationInfo><Affiliation>Neuroscience Institute, The Heart Hospital, University of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastuszka</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Descriptive and Topografic Anatomy, Medical University of Silesia, Katowice, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Dentistry, School of Medicine, Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olejek</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gynecology, Obstetrics and Gynecologic Oncology, Medical University of Silesia, Bytom, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Mieghem</LastName><ForeName>T</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3034-6905</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Coppi</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division Women and Child, Fetal Medicine Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Specialist Neonatal and Paediatric Surgery Unit, Great Ormond Street Hospital, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moldenhauer</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehead</LastName><ForeName>W E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Fetal Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belfort</LastName><ForeName>M A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-7887-5737</Identifier><AffiliationInfo><Affiliation>Texas Children's Fetal Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapa</LastName><ForeName>D A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-3150-9187</Identifier><AffiliationInfo><Affiliation>Fetal Therapy Center, Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acacio</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Taubate University, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devlieger</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division Women and Child, Fetal Medicine Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirose</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fetal Care and Treatment Center, UC Davis Children's Hospital, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farmer</LastName><ForeName>D L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Fetal Care and Treatment Center, UC Davis Children's Hospital, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Calenbergh</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adzick</LastName><ForeName>N S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>M P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deprest</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4920-945X</Identifier><AffiliationInfo><Affiliation>MyFetUZ Fetal Research Center, Department of Development and Regeneration, Biomedical Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Division Women and Child, Fetal Medicine Unit, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Women's Health, University College London Hospitals, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Great Ormond Street Hospital Charity</Agency><Country/></Grant><Grant><GrantID>WT101957</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ultrasound Obstet Gynecol</MedlineTA><NlmUniqueID>9108340</NlmUniqueID><ISSNLinking>0960-7692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ultrasound Obstet Gynecol. 2020 Oct;56(4):633</RefSource><PMID Version="1">33001493</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ultrasound Obstet Gynecol. 2020 Oct;56(4):634-635</RefSource><PMID Version="1">33001498</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005332" MajorTopicYN="N">Fetoscopy</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="N">Fetus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020883" MajorTopicYN="N">Hysterotomy</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059032" MajorTopicYN="N">Learning Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016137" MajorTopicYN="N">Spina Bifida Cystica</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Curvas de aprendizaje del cierre de la espina bífida fetal mediante cirugía abierta y endoscópica: revisión sistemática y metaanálisis OBJETIVO: El ensayo del Estudio sobre la Gestión del Mielomeningocele (MOMS, por sus siglas en inglés) demostró la seguridad y eficacia de la cirugía fetal abierta para la espina bífida aperta (EBA). Las técnicas alternativas recientemente desarrolladas pueden reducir los riesgos de la madre sin comprometer los efectos neuroprotectores del feto. El objetivo de esta revisión sistemática fue evaluar la curva de aprendizaje (CA) de diferentes técnicas de cierre de la EBA fetal. MÉTODOS: Se realizaron búsquedas en las bases de datos de MEDLINE, Web of Science, EMBASE, Scopus y Cochrane, así como en la literatura gris, para identificar artículos relevantes sobre cirugía fetal para la EBA, sin restricción de idioma, publicados entre enero de 1980 y octubre de 2018. Se examinaron sistemáticamente los estudios identificados y se seleccionaron los que informaban de todos los procedimientos consecutivos y con seguimiento postnatal ≥12 meses. Los estudios se incluyeron sólo si informaban sobre las variables de resultado necesarias para medir la CA, definidas por la seguridad y la eficacia para el feto. Dos autores recuperaron los datos de forma independiente, evaluaron la calidad de los estudios y clasificaron las observaciones en bloques de 30 pacientes. Para el metaanálisis, los datos se agruparon mediante un modelo de efectos aleatorios cuando fueron heterogéneos. Para medir la CA, se usaron dos métodos complementarios. En el método de división de grupos, la competencia se definió cuando el procedimiento proporcionó resultados comparables a los del ensayo MOMS para 12 variables de resultados que representaban el resultado quirúrgico inmediato, la neuroprotección neonatal a corto plazo y la neuroprotección a largo plazo a ≥12 meses de edad. Luego, cuando se dispuso de los datos brutos de los pacientes, se realizó un análisis de suma acumulada basado en un resultado binario compuesto que definió el éxito de la cirugía. El resultado compuesto combinó cuatro variables clínicamente relevantes en cuanto a la seguridad (ausencia de parto pretérmino extremo &lt;30 semanas; ausencia de muerte fetal a ≤7 días después de la cirugía) y eficacia (reducción de la hernia del rombencéfalo y ausencia de cualquier tratamiento neonatal de dehiscencia o derrame de líquido cefalorraquídeo en el lugar del cierre). RESULTADOS: De los 6024 resultados de la búsqueda, se incluyeron 17 (0,3%) estudios, todos ellos con un riesgo de sesgo bajo, moderado o incierto. El cierre de la EBA fetal se realizó mediante histerotomía estándar (11 estudios), mini histerotomía (un estudio) o fetoscopia, ya fuera mediante el cierre exteriorizado del útero de una sola capa (un estudio), el cierre percutáneo de una sola capa (tres estudios) o el cierre percutáneo de dos capas (un estudio). Sólo se pudieron metaanalizar los resultados de la histerotomía estándar. En general, los resultados mejoraron significativamente con la experiencia. Se alcanzó la competencia después de 35 casos consecutivos para la histerotomía estándar y se predijo que se alcanzaría después de ≥57 casos para la mini histerotomía y ≥56 para la fetoscopia percutánea de dos capas. En el caso de las fetoscopias percutánea y exteriorizada del útero de una sola capa, no se alcanzó la competencia en los 81 y 28 casos disponibles para el análisis, respectivamente, y no se pudo realizar el análisis de predicción de la CA. CONCLUSIONES: El número de casos operados está correlacionado con el resultado del cierre de la EBA fetal, y el número de casos operados necesarios para alcanzar la competencia estuvo entre 35 para la histerotomía estándar y ≥56-57 para las operaciones con mínima agresividad. Las observaciones realizadas proporcionan información importante para las instituciones que buscan establecer un nuevo centro fetal, desarrollar una nueva técnica de cirugía fetal o entrenar a su equipo, e informar a los médicos que remiten a especialistas a los posibles pacientes y a terceros. Copyright © 2019 ISUOG. Published by John Wiley &amp; Sons Ltd.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="chi"><AbstractText>开放式和内窥镜下胎儿脊柱裂闭合术学习曲线:系统回顾和荟萃分析 目标: 脊髓膜膨出研究管理(MOMS)试验证明了开放式胎儿手术治疗脊柱裂 (SBA) 的安全性有效性。最近开发的替代技术可以在不损害胎儿神经保护作用的情况下降低孕产妇风险。此次系统回顾旨在评估不同胎儿SBA闭合技术的学习曲线(LC)。 方法: 检索了MEDLINE、Web of Science、EMBASE、Scopus和Cochrane数据库以及相关的灰色文献，查找1980年1月至2018年10月之间以任何语言出版的SBA胎儿手术相关文章。系统回顾了甄别出来的几个研究项目，选择了几个报告全部连续程序且术后随访期≥12个月的研究项目。只有当研究报告了根据胎儿安全性有效性定义的测量LC所需的结果变量时，才纳入研究。两位作者独立检索了数据，评估了研究质量，对30例患者进行分组观察。荟萃分析过程中，用一个随机效应模型进行 异构数据汇总。为测量LC，我们应用了两种非主流方法。在分组法中，当程序提供的结果与MOMS试验所得结果类似时，定义了12个结果变量的能力。这些变量表示≥12个月时的即刻手术结果、短期新生儿神经保护和长期神经保护。然后在可以获取病人原始数据时，我们根据决定手术成功与否的复合二元结果进行累积总和分析。综合结果结合了四个临床相关的安全性变量(无30周内极端早产，术后7天内无胎儿死亡)和疗效变量(后脑疝逆转，闭合处无任何新生儿裂开或脑脊液漏治疗)。 结果: 在6024个检索结果中，纳入了17(0.3%)项研究。所有这些研究的偏倚风险较低，中度或不明。通过标准的子宫切开术(11项研究)、微型子宫切开术(1项研究)或子宫镜检查，通过室外子宫单层闭合(1项研究)、经皮单层闭合(3项研究)或经皮两层闭合(1项研究)进行胎儿SBA闭合。标准子宫切开术的结果才可以进行荟萃分析。总体而言，随着经验的积累，结果显著改善。连续35例标准子宫切除术后达到合格标准。 预计在微型子宫切开术≥57例，经皮两层胎儿镜检查≥56例后达到相关能力标准。经皮和体外子宫单层宫腔镜检查，分别有可供分析的81例和28例没有达到相关能力标准，无法进行LC预测分析。 结论: 手术病例数与胎儿SBA闭合结果相关， 要求达到规定能力的手术病例数量，从标准子宫切开术的35例到微创改造术≥56-57例不等。我们的观察结果为那些希望建立新的胎儿中心、开发新的胎儿手术技术或培训团队成员，以及临床转诊医生、潜在患者和第三方提供了重要信息。版权 © 2019 ISUOG。由威利父子公司(John Wiley &amp; Sons Ltd)出版。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">fetal surgery</Keyword><Keyword MajorTopicYN="Y">fetoscopy</Keyword><Keyword MajorTopicYN="Y">learning curve</Keyword><Keyword MajorTopicYN="Y">meta-analysis</Keyword><Keyword MajorTopicYN="Y">myelomeningocele</Keyword><Keyword MajorTopicYN="Y">open fetal surgery</Keyword><Keyword MajorTopicYN="Y">spina bifida</Keyword><Keyword MajorTopicYN="Y">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31273862</ArticleId><ArticleId IdType="doi">10.1002/uog.20389</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Harrysson IJ, Cook J, Sirimanna P, Feldman LS, Darzi A, Aggarwal R. Systematic review of learning curves for minimally invasive abdominal surgery: a review of the methodology of data collection, depiction of outcomes, and statistical analysis. Ann Surg 2014; 260: 37-45.</Citation></Reference><Reference><Citation>Khan N, Abboudi H, Khan MS, Dasgupta P, Ahmed K. Measuring the surgical ‘learning curve’: methods, variables and competency. BJU Int 2014; 113: 504-508.</Citation></Reference><Reference><Citation>Adzick NS, Thom EA, Spong CY, Brock JW, 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL, Investigators M. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993-1004.</Citation></Reference><Reference><Citation>Farmer DL, Thom EA, Brock JW, 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Gupta N, Adzick NS, Management of Myelomeningocele Study I. The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 2018; 218: 256.e1-13.</Citation></Reference><Reference><Citation>Bruner JP, Tulipan NB, Richards WO, Walsh WF, Boehm FH, Vrabcak EK. In utero repair of myelomeningocele: a comparison of endoscopy and hysterotomy. Fetal Diagn Ther 2000; 15: 83-88.</Citation></Reference><Reference><Citation>Flake A. Percutaneous minimal-access fetoscopic surgery for myelomeningocele - not so minimal! Ultrasound Obstet Gynecol 2014; 44: 499-500.</Citation></Reference><Reference><Citation>Belfort M, Deprest J, Hecher K. Current controversies in prenatal diagnosis 1: in utero therapy for spina bifida is ready for endoscopic repair. Prenat Diagn 2016; 36: 1161-1166.</Citation></Reference><Reference><Citation>Cohen AR, Couto J, Cummings JJ, Johnson A, Joseph G, Kaufman BA, Litman RS, Menard MK, Moldenhauer JS, Pringle KC, Schwartz MZ, Walker WO, Jr., Warf BC, Wax JR, Force MMCM-FMT. Position statement on fetal myelomeningocele repair. Am J Obstet Gynecol 2014; 210: 107-111.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.</Citation></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.</Citation></Reference><Reference><Citation>Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995; 123: A12-13.</Citation></Reference><Reference><Citation>Tulipan N, Wellons JC, 3rd, Thom EA, Gupta N, Sutton LN, Burrows PK, Farmer D, Walsh W, Johnson MP, Rand L, Tolivaisa S, D'Alton M E, Adzick NS, Investigators M. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 2015; 16: 613-620.</Citation></Reference><Reference><Citation>Johnson MP, Bennett KA, Rand L, Burrows PK, Thom EA, Howell LJ, Farrell JA, Dabrowiak ME, Brock JW, 3rd, Farmer DL, Adzick NS, Management of Myelomeningocele Study I. The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol 2016; 215: 778.e1-9.</Citation></Reference><Reference><Citation>Joyeux L, Engels AC, Russo FM, Eastwood MP, Van Calenbergh F, De Coppi P, Van Mieghem T, Deprest J, De Bie F, Danzer E. There is a different learning curve for open and fetoscopic spina bifida surgery - a systematic review and meta-analysis. PROSPERO: International prospective register of systematic reviews. 2016. CRD42016033285. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42016033285</Citation></Reference><Reference><Citation>Qi X, Yang M, Ren W, Jia J, Wang J, Han G, Fan D. Find duplicates among the PubMed, EMBASE, and Cochrane Library Databases in systematic review. PLoS One 2013; 8: e71838.</Citation></Reference><Reference><Citation>Moore MJ, Bennett CL. The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club. Am J Surg 1995; 170: 55-59.</Citation></Reference><Reference><Citation>Claerhout F, Verguts J, Werbrouck E, Veldman J, Lewi P, Deprest J. Analysis of the learning process for laparoscopic sacrocolpopexy: identification of challenging steps. Int Urogynecol J 2014; 25: 1185-1191.</Citation></Reference><Reference><Citation>Vossaert K, Housmans S, Pacquee S, Callewaert G, Cattani L, Van der Aa F, Wolthuis A, D'hoore A, Roelandt P, Deprest J. Laparoscopic sacrocolpopexy is as safe in septuagenarians or elder as in younger women. Gynecol Surg 2018; 15: 11.</Citation></Reference><Reference><Citation>Oomen MW, Hoekstra LT, Bakx R, Heij HA. Learning curves for pediatric laparoscopy: how many operations are enough? The Amsterdam experience with laparoscopic pyloromyotomy. Surg Endosc 2010; 24: 1829-1833.</Citation></Reference><Reference><Citation>Peeters SH, Van Zwet EW, Oepkes D, Lopriore E, Klumper FJ, Middeldorp JM. Learning curve for fetoscopic laser surgery using cumulative sum analysis. Acta Obstet Gynecol Scand 2014; 93: 705-711.</Citation></Reference><Reference><Citation>Johnson MP, Sutton LN, Rintoul N, Crombleholme TM, Flake AW, Howell LJ, Hedrick HL, Wilson RD, Adzick NS. Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 2003; 189: 482-487.</Citation></Reference><Reference><Citation>Biau DJ, Porcher R. A method for monitoring a process from an out of control to an in control state: Application to the learning curve. Stat Med 2010; 29: 1900-1909.</Citation></Reference><Reference><Citation>Adzick NS, Sutton LN, Crombleholme TM, Flake AW. Successful fetal surgery for spina bifida. Lancet 1998; 352: 1675-1676.</Citation></Reference><Reference><Citation>Kabagambe SK, Jensen GW, Chen YJ, Vanover MA, Farmer DL. Fetal Surgery for Myelomeningocele: A Systematic Review and Meta-Analysis of Outcomes in Fetoscopic versus Open Repair. Fetal Diagn Ther 2018; 43: 161-174.</Citation></Reference><Reference><Citation>Papanna R, Biau DJ, Mann LK, Johnson A, Moise KJ, Jr. Use of the Learning Curve-Cumulative Summation test for quantitative and individualized assessment of competency of a surgical procedure in obstetrics and gynecology: fetoscopic laser ablation as a model. Am J Obstet Gynecol 2011; 204: 218.e1-9.</Citation></Reference><Reference><Citation>Song X, Mitnitski A, Cox J, Rockwood K. Comparison of machine learning techniques with classical statistical models in predicting health outcomes. Stud Health Technol Inform 2004; 107: 736-740.</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane Statistical Methods G. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.</Citation></Reference><Reference><Citation>National Institutes of Health N. Study Quality Assessment Tools. http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools.</Citation></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm</Citation></Reference><Reference><Citation>Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-406.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.</Citation></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins J, Rothstein HR. Introduction to meta-analysis. Wiley Online Library: Chichester, UK, 2009.</Citation></Reference><Reference><Citation>Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, McCabe C, Boelaert K, Franklyn JA. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab 2014; 99: 2834-2843.</Citation></Reference><Reference><Citation>Zamlyniski J, Olejek A, Bohosiewicz J, Bodzek P, Manka G, Grettka K, Paliga M, Gajewska A. [Perinatal results of intrauterine open fetal surgery of fetuses diagnosed with myelomeningocoele-the clinical report of ten cases]. Ginekol Pol 2007; 78: 647-651.</Citation></Reference><Reference><Citation>Moldenhauer JS, Soni S, Rintoul NE, Spinner SS, Khalek N, Martinez-Poyer J, Flake AW, Hedrick HL, Peranteau WH, Rendon N, Koh J, Howell LJ, Heuer GG, Sutton LN, Johnson MP, Adzick NS. Fetal myelomeningocele repair: the post-MOMS experience at the Children's Hospital of Philadelphia. Fetal Diagn Ther 2015; 37: 235-240.</Citation></Reference><Reference><Citation>Hisaba WJ, Cavalheiro S, Almodim CG, Borges CP, de Faria TC, Araujo Junior E, Nardozza LM, Moron AF. Intrauterine myelomeningocele repair postnatal results and follow-up at 3.5 years of age-initial experience from a single reference service in Brazil. Childs Nerv Syst 2012; 28: 461-467.</Citation></Reference><Reference><Citation>Farmer DL, von Koch CS, Peacock WJ, Danielpour M, Gupta N, Lee H, Harrison MR. In utero repair of myelomeningocele: experimental pathophysiology, initial clinical experience, and outcomes. Arch Surg 2003; 138: 872-878.</Citation></Reference><Reference><Citation>Danzer E, Gerdes M, Bebbington MW, Zarnow DM, Adzick NS, Johnson MP. Preschool neurodevelopmental outcome of children following fetal myelomeningocele closure. Am J Obstet Gynecol 2010; 202: 450.e1-9.</Citation></Reference><Reference><Citation>Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz-Schulman M, Lowe LH, Reed GW. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282: 1819-1825.</Citation></Reference><Reference><Citation>Bennett KA, Carroll MA, Shannon CN, Braun SA, Dabrowiak ME, Crum AK, Paschall RL, Kavanaugh-McHugh AL, Wellons JC, 3rd, Tulipan NB. Reducing perinatal complications and preterm delivery for patients undergoing in utero closure of fetal myelomeningocele: further modifications to the multidisciplinary surgical technique. J Neurosurg Pediatr 2014; 14: 108-114.</Citation></Reference><Reference><Citation>Botelho RD, Imada V, Rodrigues da Costa KJ, Watanabe LC, Rossi Junior R, De Salles AAF, Romano E, Peralta CFA. Fetal Myelomeningocele Repair through a Mini-Hysterotomy. Fetal Diagn Ther 2017; 42: 28-34.</Citation></Reference><Reference><Citation>Verbeek RJ, Heep A, Maurits NM, Cremer R, Hoving EW, Brouwer OF, van der Hoeven JH, Sival DA. Fetal endoscopic myelomeningocele closure preserves segmental neurological function. Dev Med Child Neurol 2012; 54: 15-22.</Citation></Reference><Reference><Citation>Degenhardt J, Schurg R, Winarno A, Oehmke F, Khaleeva A, Kawecki A, Enzensberger C, Tinneberg HR, Faas D, Ehrhardt H, Axt-Fliedner R, Kohl T. Percutaneous minimal-access fetoscopic surgery for spina bifida aperta. Part II: maternal management and outcome. Ultrasound Obstet Gynecol 2014; 44: 525-531.</Citation></Reference><Reference><Citation>Kohl T. Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part I: surgical technique and perioperative outcome. Ultrasound Obstet Gynecol 2014; 44: 515-524.</Citation></Reference><Reference><Citation>Lapa Pedreira DA, Acacio GL, Goncalves RT, Sa RAM, Brandt RA, Chmait RH, Kontopoulos EV, Quintero RA. Percutaneous fetoscopic closure of large open spina bifida using a bilaminar skin substitute. Ultrasound Obstet Gynecol 2018; 52: 458-466.</Citation></Reference><Reference><Citation>Belfort MA, Whitehead WE, Shamshirsaz AA, Bateni ZH, Olutoye OO, Olutoye OA, Mann DG, Espinoza J, Williams E, Lee TC, Keswani SG, Ayres N, Cassady CI, Mehollin-Ray AR, Sanz Cortes M, Carreras E, Peiro JL, Ruano R, Cass DL. Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. Obstet Gynecol 2017; 129: 734-743.</Citation></Reference><Reference><Citation>Jamali FR, Soweid AM, Dimassi H, Bailey C, Leroy J, Marescaux J. Evaluating the degree of difficulty of laparoscopic colorectal surgery. Arch Surg 2008; 143: 762-767; discussion 768.</Citation></Reference><Reference><Citation>Tekkis PP, Senagore AJ, Delaney CP, Fazio VW. Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg 2005; 242: 83-91.</Citation></Reference><Reference><Citation>Joyeux L, Engels AC, Russo FM, Jimenez J, Van Mieghem T, De Coppi P, Van Calenbergh F, Deprest J. Fetoscopic versus Open Repair for Spina Bifida Aperta: A Systematic Review of Outcomes. Fetal Diagn Ther 2016; 39: 161-171.</Citation></Reference><Reference><Citation>FDA drug safety communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. 2017. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-review-results-new-warnings-about-using-general-anesthetics-and</Citation></Reference><Reference><Citation>Baschat AA, Ahn ES, Murphy J, Miller JL. Fetal blood gas values during fetoscopic myelomeningocele repair performed under carbon dioxide insufflation. Ultrasound Obstet Gynecol 2018; 52: 400-402.</Citation></Reference><Reference><Citation>Gratacós E, Wu J, Devlieger R, Van de Velde M, Deprest JA. Effects of amniodistention with carbon dioxide on fetal acid-base status during fetoscopic surgery in a sheep model. Surg Endosc 2001; 15: 368-372.</Citation></Reference><Reference><Citation>Skinner S, Crossley K, Amberg B, Kashyap A, Hooper S, Deprest JA, Hodges R, DeKoninck P. The effects of partial amniotic carbon dioxide insufflation in an ovine model. Prenat Diagn 2018; 38: 994-1003.</Citation></Reference><Reference><Citation>Sanz Cortes M, Castro E, Sharhan D, Torres P, Yepez M, Espinoza J, Shamshirsaz AA, Nassr AA, Popek E, Whitehead W, Belfort MA. Amniotic membrane and placental histopathological findings after open and fetoscopic prenatal neural tube defect repair. Prenat Diagn 2019; 39: 269-279.</Citation></Reference><Reference><Citation>Ovaere C, Eggink A, Richter J, Cohen-Overbeek TE, Van Calenbergh F, Jansen K, Oepkes D, Devlieger R, De Catte L, Deprest JA. Prenatal diagnosis and patient preferences in patients with neural tube defects around the advent of fetal surgery in Belgium and Holland. Fetal Diagn Ther 2015; 37: 226-234.</Citation></Reference><Reference><Citation>Wilson RD, Johnson MP, Flake AW, Crombleholme TM, Hedrick HL, Wilson J, Adzick NS. Reproductive outcomes after pregnancy complicated by maternal-fetal surgery. Am J Obstet Gynecol 2004; 191: 1430-1436.</Citation></Reference><Reference><Citation>Wilson RD, Lemerand K, Johnson MP, Flake AW, Bebbington M, Hedrick HL, Adzick NS. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996-2007). Am J Obstet Gynecol 2010; 203: 209.e1-6.</Citation></Reference><Reference><Citation>Sanz Cortes M, Lapa DA, Acacio GL, Belfort M, Carreras E, Maiz N, Peiro JL, Lim FY, Miller J, Baschat A, Sepulveda G, Davila I, Gielchinsky Y, Benifla M, Stirnemann J, Ville Y, Yamamoto M, Figueroa H, Simpson L, Nicolaides KH. Proceedings of the First Annual Meeting of the International Fetoscopic Myelomeningocele Repair Consortium. Ultrasound Obstet Gynecol 2019; 53: 855-863.</Citation></Reference><Reference><Citation>Joyeux L, De Bie F, Danzer E, Van Mieghem T, Flake AW, Deprest J. Safety and efficacy of fetal surgery techniques to close a spina bifida defect in the fetal lamb model: A systematic review. Prenat Diagn 2018; 38: 231-242.</Citation></Reference><Reference><Citation>Bangdiwala SI, Bhargava A, O'Connor DP, Robinson TN, Michie S, Murray DM, Stevens J, Belle SH, Templin TN, Pratt CA. Statistical methodologies to pool across multiple intervention studies. Transl Behav Med 2016; 6: 228-235.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31269035</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Using citizen science to expand the global map of landslides: Introducing the Cooperative Open Online Landslide Repository (COOLR).</ArticleTitle><Pagination><MedlinePgn>e0218657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0218657</ELocationID><Abstract><AbstractText>Robust inventories are vital for improving assessment of and response to deadly and costly landslide hazards. However, collecting landslide events in inventories is difficult at the global scale due to inconsistencies in or the absence of landslide reporting. Citizen science is a valuable opportunity for addressing some of these challenges. The new Cooperative Open Online Landslide Repository (COOLR) supplements data in a NASA-developed Global Landslide Catalog (GLC) with citizen science reports to build a more robust, publicly available global inventory. This manuscript introduces the COOLR project and its methods, evaluates the initial citizen science results from the first 13 months, and discusses future improvements to increase the global engagement with the project. The COOLR project (https://landslides.nasa.gov) contains Landslide Reporter, the first global citizen science project for landslides, and Landslide Viewer, a portal to visualize data from COOLR and other satellite and model products. From March 2018 to April 2019, 49 citizen scientists contributed 162 new landslide events to COOLR. These events spanned 37 countries in five continents. The initial results demonstrated that both expert and novice participants are contributing via Landslide Reporter. Citizen scientists are filling in data gaps through news sources in 11 different languages, in-person observations, and new landslide events occurring hundreds and thousands of kilometers away from any existing GLC data. The data is of sufficient accuracy to use in NASA susceptibility and hazard models. COOLR continues to expand as an open platform of landslide inventories with new data from citizen scientists, NASA scientists, and other landslide groups. Future work on the COOLR project will seek to increase participation and functionality of the platform as well as move towards collective post-disaster mapping.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juang</LastName><ForeName>Caroline S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-5963-7888</Identifier><AffiliationInfo><Affiliation>Hydrological Sciences Laboratory, NASA Goddard Space Flight Center, Greenbelt, MD, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hydrospheric and Biospheric Sciences, Science Systems and Applications, Inc., Lanham, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanley</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Hydrological Sciences Laboratory, NASA Goddard Space Flight Center, Greenbelt, MD, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universities Space Research Association, Columbia, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirschbaum</LastName><ForeName>Dalia B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Hydrological Sciences Laboratory, NASA Goddard Space Flight Center, Greenbelt, MD, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000080029" MajorTopicYN="Y">Citizen Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004190" MajorTopicYN="Y">Disasters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040362" MajorTopicYN="N">Geographic Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055876" MajorTopicYN="N">Landslides</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="Y">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018557" MajorTopicYN="N">United States National Aeronautics and Space Administration</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>We would like to declare that our first author Caroline Juang has a commercial affiliation with Science Systems and Applications, Inc. (SSAI). Our first author is primarily affiliated with NASA GSFC but as she is not a civil servant on NASA permanent staff, her funding is managed by SSAI. The funder provided support in the form of salary for author C.S.J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the ‘author contributions’ section. This affiliation does not alter our adherence to all PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31269035</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0218657</ArticleId><ArticleId IdType="pii">PONE-D-18-31611</ArticleId><ArticleId IdType="pmc">PMC6608936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2013 Apr 11;496(7444):259-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23586092</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2011 May;176(1-4):273-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20640506</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Nov 23;10(11):e0143687</Citation><ArticleIdList><ArticleId IdType="pubmed">26600041</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Ecol Evol. 2009 Sep;24(9):467-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19586682</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Dec 11;12(12):e0188819</Citation><ArticleIdList><ArticleId IdType="pubmed">29228053</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Jan 8;351(6269):aac8353</Citation><ArticleIdList><ArticleId IdType="pubmed">26676355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35515564</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-2069</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>36</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>RSC advances</Title><ISOAbbreviation>RSC Adv</ISOAbbreviation></Journal><ArticleTitle>Stable P3HT: amorphous non-fullerene solar cells with a high open-circuit voltage of 1 V and efficiency of 4.</ArticleTitle><Pagination><MedlinePgn>20733-20741</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c9ra03188j</ELocationID><Abstract><AbstractText>A non-fullerene small molecule acceptor, SF-HR composed of 3D-shaped spirobifluorene and hexyl rhodanine, was synthesized for use in bulk heterojunction organic solar cells (OSCs). It possesses harmonious molecular aggregation between the donor and acceptor, due to the interesting diagonal molecular shape of SF-HR. Furthermore, the energy level of SF-HR matches well with that of the donor polymer, poly(3-hexyl thiophene) (P3HT) in this system which can affect efficient charge transfer and transport properties. As a result, OSCs made from a P3HT:SF-HR photoactive layer exhibited a power conversion efficiency rate of 4.01% with a high <i>V</i> <sub>OC</sub> of 1.00 V, a <i>J</i> <sub>SC</sub> value of 8.23 mA cm<sup>-2</sup>, and a FF value of 49%. Moreover, the P3HT:SF-HR film showed superior thermal and photo-stability to P3HT:PC<sub>71</sub>BM. These results indicate that SF-HR is specialized as a non-fullerene acceptor for use in high-performance OSCs.</AbstractText><CopyrightInformation>This journal is © The Royal Society of Chemistry.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>HyunKyung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Sora</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Chang Eun</ForeName><Initials>CE</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-6910-8755</Identifier><AffiliationInfo><Affiliation>Energy Materials Research Center, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea songce@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hang Ken</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Energy Materials Research Center, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea songce@krict.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Kyu</ForeName><Initials>SK</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7568-2902</Identifier><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Won Suk</ForeName><Initials>WS</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-7151-519X</Identifier><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU-KRICT Collaborative Research Center, Division of Display and Semiconductor Physics, Department of Advanced Materials Chemistry, Korea University 2511 Sejong-ro Sejong 30019 Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Won-Wook</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Energy Materials Research Center, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea songce@krict.re.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Sang-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Cheol</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Advanced Materials Division, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong Daejeon 34114 Republic of Korea leejc@krict.re.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Materials and Chemical Engineering, University of Science and Technology (UST) 217 Gajeongro, Yuseong Daejeon 34113 Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>RSC Adv</MedlineTA><NlmUniqueID>101581657</NlmUniqueID><ISSNLinking>2046-2069</ISSNLinking></MedlineJournalInfo><CoiStatement>There are no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35515564</ArticleId><ArticleId IdType="doi">10.1039/c9ra03188j</ArticleId><ArticleId IdType="pii">c9ra03188j</ArticleId><ArticleId IdType="pmc">PMC9065772</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adv Mater. 2015 Mar 18;27(11):1951-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25655948</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2018 Jul;30(28):e1801501</Citation><ArticleIdList><ArticleId IdType="pubmed">29782685</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Omega. 2017 Apr 28;2(4):1702-1709</Citation><ArticleIdList><ArticleId IdType="pubmed">31457535</ArticleId></ArticleIdList></Reference><Reference><Citation>Angew Chem Int Ed Engl. 2002 Jul 2;41(13):2344-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12203587</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2013 Aug 21;25(31):4245-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23703861</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2013 Oct 25;25(40):5791-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23925952</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2016 Feb 3;28(5):910-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26640168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2018 Jun 13;140(23):7159-7167</Citation><ArticleIdList><ArticleId IdType="pubmed">29737160</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2015 Jul 22;137(28):8991-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26104833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Jan 14;6:6013</Citation><ArticleIdList><ArticleId IdType="pubmed">25586307</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2008 Sep 24;130(38):12828-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18759400</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2016 Aug 17;138(32):10265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">27448181</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2015 Jan 21;137(2):898-904</Citation><ArticleIdList><ArticleId IdType="pubmed">25545017</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2016 Nov;28(44):9811-9818</Citation><ArticleIdList><ArticleId IdType="pubmed">27647512</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2016 Jun 15;138(23):7248-51</Citation><ArticleIdList><ArticleId IdType="pubmed">27219665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2017 Feb 8;139(5):1958-1966</Citation><ArticleIdList><ArticleId IdType="pubmed">28081597</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2016 Sep;28(36):8021-8028</Citation><ArticleIdList><ArticleId IdType="pubmed">27337385</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Nov 10;5:5293</Citation><ArticleIdList><ArticleId IdType="pubmed">25382026</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Energy Lett. 2017 May 12;2(5):1214-1222</Citation><ArticleIdList><ArticleId IdType="pubmed">28540366</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2016 Oct;28(37):8184-8190</Citation><ArticleIdList><ArticleId IdType="pubmed">27414963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Soc Rev. 2019 Mar 18;48(6):1596-1625</Citation><ArticleIdList><ArticleId IdType="pubmed">29697109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nano Lett. 2013 Jan 9;13(1):59-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23237567</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Appl Mater Interfaces. 2015 Jun 10;7(22):12119-27</Citation><ArticleIdList><ArticleId IdType="pubmed">25961668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Rev. 2012 Oct 10;112(10):5488-519</Citation><ArticleIdList><ArticleId IdType="pubmed">22877516</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2015 Feb;27(6):1015-20</Citation><ArticleIdList><ArticleId IdType="pubmed">25429918</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2016 Jan 6;28(1):69-76</Citation><ArticleIdList><ArticleId IdType="pubmed">26539752</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2014 Aug 13;26(30):5137-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24659432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Commun (Camb). 2011 Sep 28;47(36):10082-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21833380</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Mater. 2018 Jul;30(28):e1800613</Citation><ArticleIdList><ArticleId IdType="pubmed">29806223</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31257670</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-7641</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>10</Month><Day>16</Day></PubDate></JournalIssue><Title>Chemphyschem : a European journal of chemical physics and physical chemistry</Title><ISOAbbreviation>Chemphyschem</ISOAbbreviation></Journal><ArticleTitle>A New Small-Molecule Donor Containing Non-Fused Ring π-Bridge Enables Efficient Organic Solar Cells with High Open Circuit Voltage and Low Acceptor Content.</ArticleTitle><Pagination><MedlinePgn>2674-2682</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cphc.201900368</ELocationID><Abstract><AbstractText>To achieve high open-circuit voltage (V<sub>oc</sub> ) and low acceptor content, the molecular design of a small-molecule donor with low energy loss (E<sub>loss</sub> ) is very important for solution-processable organic solar cells (OSCs). Herein, we designed and synthesized a new coplanar A-D-A structured organic small-molecule semiconductor with non-fused ring structure π-bridge, namely B2TPR, and applied it as donor material in OSCs. Owing to the strong electron-withdrawing effect of the end group and the coplanar π-bridge, B2TPR exhibits a low-lying highest occupied molecular orbital and strong crystallinity. Furthermore, benefiting from the coplanar molecular skeleton, the high hole mobility, balanced charge transport and reduced recombination were achieved, leading to a high fill factor (FF). The OSCs based on B2TPR : PC<sub>71</sub> BM blend film (w/w=1 : 0.35) demonstrates a moderate power conversion efficiency (PCE) of 7.10 % with a remarkable V<sub>oc</sub> of 0.98 V and FF of 64 %, corresponding to a low fullerene content of 25.9 % and a low E<sub>loss</sub> of 0.70 eV. These results demonstrate the great potential of small-molecule with structure of B2TPR for future low-cost organic photovoltaic applications.</AbstractText><CopyrightInformation>© 2019 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of of Materials and Chemical Engineering, Zhongyuan University of Technology, Zhengzhou, 451191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Chennan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yulong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of of Materials and Chemical Engineering, Zhongyuan University of Technology, Zhengzhou, 451191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Maojie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6102-5856</Identifier><AffiliationInfo><Affiliation>Laboratory of Advanced Optoelectronic Materials College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>51573120</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>51773142</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>21502134</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><Agency>Priority Academic Program Development of Jiangsu Higher Education Institutions</Agency><Country>International</Country></Grant><Grant><Agency>Collaborative Innovation Center of Suzhou Nano Science &amp;amp; Technology</Agency><Country>International</Country></Grant><Grant><Agency>Henan Province Science</Agency><Country>International</Country></Grant><Grant><GrantID>182102210530</GrantID><Agency>Technology Planning Project</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Chemphyschem</MedlineTA><NlmUniqueID>100954211</NlmUniqueID><ISSNLinking>1439-4235</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">benzodithiophene</Keyword><Keyword MajorTopicYN="Y">high open circuit voltage</Keyword><Keyword MajorTopicYN="Y">low acceptor content</Keyword><Keyword MajorTopicYN="Y">organic small-molecule donor</Keyword><Keyword MajorTopicYN="Y">organic solar cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31257670</ArticleId><ArticleId IdType="doi">10.1002/cphc.201900368</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A. Polman, M. Knight, E. C. Garnett, B. Ehrler, W. C. Sinke, Science 2016, 352, aad4424.</Citation></Reference><Reference><Citation>M. C. Scharber, N. S. Sariciftci, Prog. Polym. Sci. 2013, 38 1929-1940.</Citation></Reference><Reference><Citation>L. Lu, T. Zheng, Q. Wu, A. M. Schneider, D. Zhao, L. Yu, Chem. Rev. 2015, 115, 12666-12731.</Citation></Reference><Reference><Citation>G. Li, W.-H. Chang, Y. Yang, Nat. Rev. Mater. 2017, 2, 17043.</Citation></Reference><Reference><Citation>T. R. Andersen, H. F. Dam, M. Hösel, M. Helgesen, J. E. Carlé, T. T. Larsen-Olsen, S. A. Gevorgyan, J. W. Andreasen, J. Adams, N. Li, F. Machui, G. D. Spyropoulos, T. Ameri, N. Lemaître, M. Legros, A. Scheel, D. Gaiser, K. Kreul, S. Berny, O. R. Lozman, S. Nordman, M. Välimäki, M. Vilkman, R. R. Søndergaard, M. Jørgensen, C. J. Brabec, F. C. Krebs, Energy Environ. Sci. 2014, 7, 2925-2933.</Citation></Reference><Reference><Citation>K. Sun, Z. Xiao, S. Lu, W. Zajaczkowski, W. Pisula, E. Hanssen, J. M. White, R. M. Williamson, J. Subbiah, J. Y. Ouyang, A. B. Holmes, W. W. H. Wong, D. J. Jones, Nat. Commun. 2015, 6, 6013.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Q. Zhang, B. Kan, F. Liu, G. Long, X. Wan, X. Chen, Y. Zuo, W. Ni, H. Zhang, M. Li, Z. Hu, F. Huang, Y. Cao, Z. Liang, M. Zhang, T. P. Russell, Y. Chen, Nat. Photonics 2014, 9, 35-41;</Citation></Reference><Reference><Citation>M. Li, K. Gao, X. Wan, Q. Zhang, B. Kan, R. Xia, F. Liu, X. Yang, H. Feng, W. Ni, Y. Wang, J. Peng, H. Zhang, Z. Liang, H.-L. Yip, X. Peng, Y. Cao, Y. Chen, Nat. Photonics 2017, 11, 85-90.</Citation></Reference><Reference><Citation>T. Li, T. Meyer, Z. Ma, J. Benduhn, C. Körner, O. Zeika, K. Vandewal, K. Leo, J. Am. Chem. Soc. 2017, 139 13636-13639.</Citation></Reference><Reference><Citation>H. Bin, Y. Yang, Z.-G. Zhang, L. Ye, M. Ghasemi, S. Chen, Y. Zhang, C. Zhang, C. Sun, L.-W. Xue, C. Yang, H. Ade, Y. Li, J. Am. Chem. Soc. 2017, 139, 5085-5094.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>L. Meng, Y. Zhang, X. Wan, C. Li, X. Zhang, Y. Wang, X. Ke, Z. Xiao, L. Ding, R. Xia, H.-L. Yip, Y. Cao, Y. Chen, Science 2018, 361, 1094;</Citation></Reference><Reference><Citation>J. Yuan, Y. Zhang, L. Zhou, G. Zhang, H.-L. Yip, T.-K. Lau, X. Lu, C. Zhu, H. Peng, P. A. Johnson, M. Leclerc, Y. Cao, J. Ulanski, Y. Li, Y. Zou, Joule 2019, 3, 1140;</Citation></Reference><Reference><Citation>B. Fan, D. Zhang, M. Li, W. Zhong, Z. Zeng, L. Ying, F. Huang, Y. Cao, Sci. China Chem. 2019, DOI: https://doi.org/10.1007/s11426-019-9457-5;</Citation></Reference><Reference><Citation>J. Yuan, T. Huang, P. Cheng, Y. Zou, H. Zhang, J. L. Yang, S.-Y. Chang, Z. Zhang, W. Huang, R. Wang, D. Meng, F. Gao, Y. Yang, Nat. Commun. 2019, 10, 570.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Y. Cui, H. Yao, J. Zhang, T. Zhang, Y. Wang, L. Hong, K. Xian, B. Xu, S. Zhang, J. Peng, Z. Wei, F. Gao, J. Hou, Nat. Commun. 2019, 10, 2515;</Citation></Reference><Reference><Citation>X. Xu, K. Feng, Z. Bi, W. Ma, G. Zhang, Q. Peng, Adv. Mater. 2019, 1901872;</Citation></Reference><Reference><Citation>Q. An, X. Ma, J. Gao, F. Zhang, Sci. Bull. 2019, 64, 504-506;</Citation></Reference><Reference><Citation>L. Ye, S. Li, X. Liu, S. Zhang, M. Ghasemi, Y. Xiong, J. Hou, H. Ade, Joule 2019, 3, 443-458;</Citation></Reference><Reference><Citation>L. Ye, H. Hu, M. Ghasemi, T. Wang, B. A. Collins, J.-H. Kim, K. Jiang, J. H. Carpenter, H. Li, Z. Li, T. McAfee, J. Zhao, X. Chen, J. L. Y. Lai, T. Ma, J.-L. Bredas, H. Yan, H. Ade, Nat. Mater. 2018, 17, 253-260.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>S. D. Collins, N. A. Ran, M. C. Heiber, T.-Q. Nguyen, Adv. Energy Mater. 2017, 7, 1602242;</Citation></Reference><Reference><Citation>J. E. Coughlin, Z. B. Henson, G. C. Welch, G. C. Bazan, Acc. Chem. Res. 2014, 47, 257-270.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Y. Chen, X. J. Wan, G. Long, Acc. Chem. Res. 2013, 46, 2645-2655;</Citation></Reference><Reference><Citation>J.-L. Wang, K.-K. Liu, J. Yan, Z. Wu, F. Liu, F. Xiao, Z.-F. Chang, H.-B. Wu, Y. Cao, T. P. Russell, J. Am. Chem. Soc. 2016, 138, 7687-7697.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Y. F. Li, Acc. Chem. Res. 2012, 45, 723-733;</Citation></Reference><Reference><Citation>C. Liu, K. Wang, X. Gong, A. J. Heeger, Chem. Soc. Rev. 2016, 45, 4852-4826.</Citation></Reference><Reference><Citation>L. Dou, Y. Liu, Z. Hong, G. Li, Y. Yang, Chem. Rev. 2015, 115, 12633-12665.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>M. J. Zhang, Y. Gu, X. Guo, F. Liu, S. Zhang, L. Huo, T. P. Russell, J. Hou, Adv. Mater. 2013, 25, 4944-4949;</Citation></Reference><Reference><Citation>M. J. Zhang, X. Guo, S. Zhang, J. Hou, Adv. Mater. 2014, 26, 1118-1123.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Q. Fan, W. Su, Y. Wang, B. Guo, Y. Jiang, X. Guo, F. Liu, T. P. Russell, M. J. Zhang, Y. Li, Sci. China Chem. 2018, 61, 531-537;</Citation></Reference><Reference><Citation>Q. Fan, Y. Wang, M. J. Zhang, B. Wu, X. Guo, Y. Jiang, W. Li, B. Guo, C. Ye, W. Su, J. Fang, X. Ou, F. Liu, Z. Wei, T. C. Sum, T. P. Russell, Y. Li, Adv. Mater. 2018, 30, 1704546;</Citation></Reference><Reference><Citation>B. Guo, W. Li, X. Guo, X. Meng, W. Ma, M. J. Zhang, Y. Li, Adv. Mater. 2017, 29, 1702291.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>H. Hu, P. C. Y. Chow, G. Zhang, T. Ma, J. Liu, G. Yang, H. Yan, Acc. Chem. Res. 2017, 50, 2519-2528;</Citation></Reference><Reference><Citation>Q. Wan, X. Guo, Z. Wang, W. Li, B. Guo, W. Ma, M. J. Zhang, Y. Li, Adv. Funct. Mater. 2016, 26, 6635-6640.</Citation></Reference><Reference><Citation>M. J. Zhang, X. Guo, W. Ma, H. Ade, J. Hou, Adv. Mater. 2015, 27, 4655-4660.</Citation></Reference><Reference><Citation>D. Deng, Y. J. Zhang, J. Zhang, Z. Q. Wang, L. Y. Zhu, J. Fang, B. Z. Xia, Z. Wang, K. Lu, W. Ma, Z. X. Wei, Nat. Commun. 2016, 7, 13740.</Citation></Reference><Reference><Citation>J. Wan, X. Xu, G. Zhang, Y. Li, K. Feng, Q. Peng, Energy Environ. Sci. 2017, 10, 1739-1745.</Citation></Reference><Reference><Citation>B. Kan, M. M. Li, Q. Zhang, F. Liu, X. J. Wan, Y. C. Wang, W. Ni, G. K. Long, X. Yang, H. R. Feng, Y. Zuo, M. T. Zhang, F. Huang, Y. Cao, T. P. Russell, Y. Chen, J. Am. Chem. Soc. 2015, 137, 3886-3893.</Citation></Reference><Reference><Citation>M. Li, W. Ni, X. Wan, Q. Zhang, B. Kan, Y. Chen, J. Mater. Chem. A 2015, 3, 4765-4776.</Citation></Reference><Reference><Citation>K. Wang, B. Guo, Z. Xu, X. Guo, M. Zhang, Y. Li, ACS Appl. Mater. Interfaces 2015, 7, 24686-24693.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>K. Wang, Z. Xu, Y. Geng, H. Li, C. Lin, L. Mi, X. Guo, M. Zhang, Y. Li, Org. Electron. 2019, 64, 54-61;</Citation></Reference><Reference><Citation>C. Ye, Y. Wang, Z. Bi, X. Guo, Q. Fan, J. Chen, X. Ou, W. Ma, M. Zhang, Org. Electron. 2018, 53, 273-279.</Citation></Reference><Reference><Citation>T. Dong, L. Lv, L. Feng, Y. Xia, W. Deng, P. Ye, B. Yang, S. Ding, A. Facchetti, H. Dong, H. Huang, Adv. Mater. 2017, 29, 1606025.</Citation></Reference><Reference><Citation>H. Huang, N. Zhou, R. P. Ortiz, Z. Chen, S. Loser, S. Zhang, X. Guo, J. Casado, J. T. L. Navarrete, X. Yu, A. Facchetti, T. J. Marks, Adv. Funct. Mater. 2014, 24, 2782-2793.</Citation></Reference><Reference><Citation>X. Li, Z. Xu, X. Guo, Q. Fana, M. Zhang, Y. Li, Org. Electron. 2018, 58, 133-138.</Citation></Reference><Reference><Citation>J. H. Burroughes, D. D. C. Bradley, A. R. Brown, R. N. Marks, K. Mackay, R. H. Friend, P. L. Burns, A. B. Holmes, Nature 1990, 347, 539-541.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>J. Hou, M. H. Park, S. Zhang, Y. Yao, L. Chen, J. Li, Y. Yang, Macromolecules 2008, 41, 6012-6018;</Citation></Reference><Reference><Citation>L. Ye, S. Zhang, L. Huo, M. Zhang, J. Hou, Acc. Chem. Res. 2014, 47, 1595-1603;</Citation></Reference><Reference><Citation>H. Yao, L. Ye, H. Zhang, S. Li, S. Zhang, J. Hou, Chem. Rev. 2016, 116, 7397-7457.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>Y. M. Sun, G. C. Welch, W. L. Leong, C. J. Takacs, G. C. Bazan, A. J. Heeger, Nat. Mater. 2011, 11, 44-48;</Citation></Reference><Reference><Citation>D. Qian, W. Ma, Z. Li, X. Guo, S. Zhang, L. Ye, H. Ade, Z. Tan, J. Hou, J. Am. Chem. Soc. 2013, 135, 8464-8467.</Citation></Reference><Reference><Citation>W. L. Leong, G. C. Welch, J. Seifter, J. H. Seo, G. C. Bazan, A. J. Heeger, Adv. Energy Mater. 2013, 3, 356-363.</Citation></Reference><Reference><Citation>J.-L. Wu, F.-C. Chen, Y.-S. Hsiao, F.-C. Chien, P. Chen, C.-H. Kuo, M. H. Huang, C.-S. Hsu, ACS Nano 2011, 5, 959-967.</Citation></Reference><Reference><Citation>V. D. Mihailetchi, L. J. A. Koster, J. C. Hummelen, P. W. M. Blom, Phys. Rev. Lett. 2004, 93, 216601.</Citation></Reference><Reference><Citation>B. Fan, X. Du, F. Liu, W. Zhong, L. Ying, R. Xie, X. Tang, K. An, J. Xin, N. Li, W. Ma, C. J. Brabec, F. Huang, Y. Cao, Nat. Energy 2018, 3, 1051-1058.</Citation></Reference><Reference><Citation>L. J. A. Koster, V. D. Mihailetchi, R. Ramaker, P. W. M. Blom, Appl. Phys. Lett. 2005, 86, 123509.</Citation></Reference><Reference><Citation>P. Schilinsky, C. Waldauf, C. Brabec, J. Appl. Phys. Lett. 2002, 81, 3885.</Citation></Reference><Reference><Citation>L. J. A. Koster, V. D. Mihailetchi, H. Xie, P. W. M. Blom, Appl. Phys. Lett. 2005, 87, 203502.</Citation></Reference><Reference><Citation> </Citation></Reference><Reference><Citation>M. Kim, J.-H. Kim, H. H. Choi, J. H. Park, S. B. Jo, M. Sim, J. S. Kim, H. Jinnai, Y. D. Park, K. Cho, Adv. Energy Mater. 2014, 4, 1300612;</Citation></Reference><Reference><Citation>J. Fang, D. Deng, Z. Wang, M. A. Adil, T. Xiao, Y. Wang, G. Lu, Y. Zhang, J. Zhang, W. Ma, Z. Wei, ACS Appl. Mater. Interfaces 2018, 10, 12913.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31243916</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1751-7893</ISSN><JournalIssue CitedMedium="Internet"><Volume>13 Suppl 1</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Early intervention in psychiatry</Title><ISOAbbreviation>Early Interv Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Improving youth mental wellness services in an Indigenous context in Ulukhaktok, Northwest Territories: ACCESS Open Minds Project.</ArticleTitle><Pagination><MedlinePgn>35-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eip.12816</ELocationID><Abstract><AbstractText Label="AIM">To describe a community-specific and culturally coherent approach to youth mental health services in a small and remote northern Indigenous community in Canada's Northwest Territories, under the framework of ACCESS Open Minds (ACCESS OM), a pan-Canadian youth mental health research and evaluation network.</AbstractText><AbstractText Label="METHODS">As 1 of the 14 Canadian communities participating in a 5-year, federally funded service transformation and evaluation project, the arctic Inuit community of Ulukhaktok has undertaken culturally relevant adjustments in their delivery of youth mental wellness services and related community wellness initiatives. These enhancement activities highlight connections to culture and traditional skills, honour youth- and community-expressed desires to incorporate Inuvialuit-specific approaches to wellness, and strengthen the support systems to improve access to mainstream mental healthcare, when needed. The adaptation of a Lay Health Worker model from Global Mental Health to the local circumstances resulting in creation of lay community health workers is central to this approach in meeting contextual needs.</AbstractText><AbstractText Label="RESULTS">Community leaders identified key activities for sustainable change, including human capital development, authentic collaboration and diversified engagement strategies. Building around five ACCESS OM objectives, the local site team in Ulukhaktok has identified its youth programming and mental wellness service gaps through an ongoing process of community mapping.</AbstractText><AbstractText Label="CONCLUSIONS">Information from service providers, youth and other community members demonstrates attuning of the ACCESS OM framework to Inuit paradigms in Ulukhaktok. It could prove to be a sustainable prototype for delivering youth mental health services in other communities in the Inuvialuit Settlement Region and possibly across the entire Inuit Nunangat. It needs, however, to be further supported by easier access to specialized mental health services when needed.</AbstractText><CopyrightInformation>© 2019 The Authors Early Intervention in Psychiatry Published by John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Etter</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds Ulukhaktok, Ulukhaktok, Northwest Territories, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inuvialuit Regional Corporation, Inuvik, Northwest Territories, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goose</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds Ulukhaktok, Ulukhaktok, Northwest Territories, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inuvialuit Regional Corporation, Inuvik, Northwest Territories, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nossal</LastName><ForeName>Margot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chishom-Nelson</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heck</LastName><ForeName>Carly</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nursing, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joober</LastName><ForeName>Ridha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boksa</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lal</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7501-5018</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Jai L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7549-6990</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Community Information and Epidemiological Technologies (CIET) Institute and Participatory Research at McGill (PRAM), McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGill Institute of Human Development and Well-being, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Srividya N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0001-5367-9086</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malla</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><Agency>Graham Boeckh Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Early Interv Psychiatry</MedlineTA><NlmUniqueID>101320027</NlmUniqueID><ISSNLinking>1751-7885</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016497" MajorTopicYN="N">Adolescent Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003156" MajorTopicYN="N">Community Mental Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003266" MajorTopicYN="N">Continuity of Patient Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065246" MajorTopicYN="N">Culturally Competent Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006303" MajorTopicYN="N">Health Services, Indigenous</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004930" MajorTopicYN="N">Inuits</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015873" MajorTopicYN="N" Type="Geographic">Northwest Territories</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">Indigenous</Keyword><Keyword MajorTopicYN="Y">Inuit</Keyword><Keyword MajorTopicYN="Y">culture</Keyword><Keyword MajorTopicYN="Y">lay health worker</Keyword><Keyword MajorTopicYN="Y">youth mental health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31243916</ArticleId><ArticleId IdType="doi">10.1111/eip.12816</ArticleId><ArticleId IdType="pmc">PMC6771701</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soc Sci Med. 2014 Oct;118:33-42</Citation><ArticleIdList><ArticleId IdType="pubmed">25089962</ArticleId></ArticleIdList></Reference><Reference><Citation>Telemed J E Health. 2013 Jun;19(6):444-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23697504</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Child. 2010 Spring;20(1):209-29</Citation><ArticleIdList><ArticleId IdType="pubmed">20364628</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2001 Sep 18;165(6):749-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2019 Sep;64(9):621-629</Citation><ArticleIdList><ArticleId IdType="pubmed">30917693</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2010 Oct;197(4):305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20884954</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2015 Oct;14(3):358-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26407794</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2015 May;203(5):356-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25900548</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13 Suppl 1:35-41</Citation><ArticleIdList><ArticleId IdType="pubmed">31243916</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Serv Insights. 2017 Mar 28;10:1178632917694350</Citation><ArticleIdList><ArticleId IdType="pubmed">28469456</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2018 Apr;63(4):216-222</Citation><ArticleIdList><ArticleId IdType="pubmed">29528719</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Psychol Med. 2017 May-Jun;39(3):271-275</Citation><ArticleIdList><ArticleId IdType="pubmed">28615759</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Psychiatry. 2016 Jun 22;6(2):269-82</Citation><ArticleIdList><ArticleId IdType="pubmed">27354970</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13(3):697-706</Citation><ArticleIdList><ArticleId IdType="pubmed">30556335</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Sci Med. 2017 Mar;176:93-112</Citation><ArticleIdList><ArticleId IdType="pubmed">28135694</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2015 Nov;17(11):89</Citation><ArticleIdList><ArticleId IdType="pubmed">26384338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31243913</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1751-7893</ISSN><JournalIssue CitedMedium="Internet"><Volume>13 Suppl 1</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Early intervention in psychiatry</Title><ISOAbbreviation>Early Interv Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Eskasoni First Nation's transformation of youth mental healthcare: Partnership between a Mi'kmaq community and the ACCESS Open Minds research project in implementing innovative practice and service evaluation.</ArticleTitle><Pagination><MedlinePgn>42-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eip.12817</ELocationID><Abstract><AbstractText Label="AIM">ACCESS Open Minds (ACCESS OM) is a pan-Canadian project aimed at improving youth mental healthcare. This paper describes implementation of the ACCESS OM objectives for youth mental health service transformation within a pre-existing Fish Net Model of transformative youth mental healthcare service in the First Nation community of Eskasoni, on Canada's east coast.</AbstractText><AbstractText Label="METHODS">We describe an adaptation of the ACCESS OM service transformation objectives through the complementary blending of Indigenous and Western methodologies. This concept of "Two-Eyed Seeing" is illustrated as central to engaging youth in the community and attending to their mental health needs and wellness.</AbstractText><AbstractText Label="RESULTS">The ACCESS OM Eskasoni First Nation Youth Space acts as a central location for the site team and its activities, which expand into the rest of the community to facilitate early identification of youth in need. Rapid access to care is promoted via barrier-free availability through a central intake crisis and referral centre, and ease of contact through social media and other modalities. Youth are given the choice between standard Western mental health services, or Indigenous methods of improving well-being, or a combination of the two.</AbstractText><AbstractText Label="CONCLUSIONS">The ACCESS OM framework has shown early results of being a positive addition to the Eskasoni community. Local leadership and community buy-in are identified as key factors to success. Further exploration, research, and evaluation of this transformation is ongoing. Successful implementation of this model in Eskasoni could act as a model for youth mental health programmes in other First Nations across Canada.</AbstractText><CopyrightInformation>© 2019 The Authors Early Intervention in Psychiatry Published by John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hutt-MacLeod</LastName><ForeName>Daphne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudderham</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylliboy</LastName><ForeName>Arnold</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylliboy-Denny</LastName><ForeName>Mallery</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebenberg</LastName><ForeName>Linda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5309-6745</Identifier><AffiliationInfo><Affiliation>Faculty of Graduate Studies, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Jeannine F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gould</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gould</LastName><ForeName>Norma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Eskasoni Mental Health Services, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds Eskasoni, Eskasoni First Nation, Nova Scotia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nossal</LastName><ForeName>Margot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Srividya N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0001-5367-9086</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malla</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boksa</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montréal, Québec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><Agency>Graham Boeckh Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Early Interv Psychiatry</MedlineTA><NlmUniqueID>101320027</NlmUniqueID><ISSNLinking>1751-7885</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003156" MajorTopicYN="N">Community Mental Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003256" MajorTopicYN="N">Community Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006303" MajorTopicYN="N">Health Services, Indigenous</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081034" MajorTopicYN="N">Indigenous Peoples</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007857" MajorTopicYN="N">Leadership</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">Indigenous community mental health services</Keyword><Keyword MajorTopicYN="Y">community participation</Keyword><Keyword MajorTopicYN="Y">health promotion</Keyword><Keyword MajorTopicYN="Y">suicide</Keyword><Keyword MajorTopicYN="Y">youth mental health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31243913</ArticleId><ArticleId IdType="doi">10.1111/eip.12817</ArticleId><ArticleId IdType="pmc">PMC6771551</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Public Health Rev. 2017 Mar 2;38:8</Citation><ArticleIdList><ArticleId IdType="pubmed">29450080</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13(3):697-706</Citation><ArticleIdList><ArticleId IdType="pubmed">30556335</ArticleId></ArticleIdList></Reference><Reference><Citation>Transcult Psychiatry. 2014 Jun;51(3):299-319</Citation><ArticleIdList><ArticleId IdType="pubmed">24855142</ArticleId></ArticleIdList></Reference><Reference><Citation>J Prim Prev. 2017 Apr;38(1-2):67-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27807659</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2000 Sep;45(7):607-16</Citation><ArticleIdList><ArticleId IdType="pubmed">11056823</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13 Suppl 1:42-47</Citation><ArticleIdList><ArticleId IdType="pubmed">31243913</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dev Orig Health Dis. 2019 Feb;10(1):123-131</Citation><ArticleIdList><ArticleId IdType="pubmed">29923477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31243909</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1751-7893</ISSN><JournalIssue CitedMedium="Internet"><Volume>13 Suppl 1</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Early intervention in psychiatry</Title><ISOAbbreviation>Early Interv Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Transforming youth mental health care in a semi-urban and rural region of Canada: A service description of ACCESS Open Minds Chatham-Kent.</ArticleTitle><Pagination><MedlinePgn>48-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eip.12818</ELocationID><Abstract><AbstractText Label="AIM">This study describes how mental health services for youth are being transformed within the context of a semi-urban and rural region of Canada (Chatham-Kent, Ontario), based on the framework of ACCESS Open Minds (ACCESS OM), a pan-Canadian youth mental health research and evaluation network.</AbstractText><AbstractText Label="METHODS">Transformation has focused on the five key objectives of ACCESS OM, namely early identification, rapid access, appropriate care, continuity of care, and youth and family engagement. A community mapping process was conducted at the beginning of the transformation to help develop a comprehensive inventory of services, identify challenges and optimize partnerships to address the five key objectives.</AbstractText><AbstractText Label="RESULTS">The following strategies represent key elements in the transformation: coordination and partnerships between hospital, community and voluntary organizations, as well as different sectors of the community (e.g., Child and Youth Services, Education, Community Safety and Correctional Services, CSCS); working with local champions (e.g., Youth Diversion Officer and the Mental Health and Addictions Nurse in the school sectors); establishing a youth-friendly space in a central part of the community, where services are co-located and operate within an open-concept design; training of ACCESS Clinicians to conduct an initial assessment; engaging youth and family in service-level recruitment, planning, daily operations, and evaluation, including hiring of youth and family peer navigators; and, engaging the community through awareness and educational events.</AbstractText><AbstractText Label="CONCLUSIONS">The success of this transformation needs to be measured on various outcome parameters, but it is notable that neighbouring communities are already beginning to implement a similar model.</AbstractText><CopyrightInformation>© 2019 The Authors Early Intervention in Psychiatry Published by John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reaume-Zimmer</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mental Health and Addiction Services, Bluewater Health and Canadian Mental Health Association Lambton-Kent, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrasena</LastName><ForeName>Ranjith</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shulich School of Medicine, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malla</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joober</LastName><ForeName>Ridha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boksa</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Jai L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7549-6990</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Srividya N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0001-5367-9086</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lal</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7501-5018</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><Agency>Graham Boeckh Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Early Interv Psychiatry</MedlineTA><NlmUniqueID>101320027</NlmUniqueID><ISSNLinking>1751-7885</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016497" MajorTopicYN="N">Adolescent Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033183" MajorTopicYN="N">Interdisciplinary Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070516" MajorTopicYN="N">Intersectoral Collaboration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008605" MajorTopicYN="N">Mental Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019035" MajorTopicYN="N">Rural Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019037" MajorTopicYN="N">Urban Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">access</Keyword><Keyword MajorTopicYN="Y">community participation</Keyword><Keyword MajorTopicYN="Y">health care quality</Keyword><Keyword MajorTopicYN="Y">mental health services</Keyword><Keyword MajorTopicYN="Y">youth mental health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31243909</ArticleId><ArticleId IdType="doi">10.1111/eip.12818</ArticleId><ArticleId IdType="pmc">PMC6771628</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13(3):697-706</Citation><ArticleIdList><ArticleId IdType="pubmed">30556335</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2002 Oct 01;2:10</Citation><ArticleIdList><ArticleId IdType="pubmed">12359045</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13 Suppl 1:48-55</Citation><ArticleIdList><ArticleId IdType="pubmed">31243909</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ment Health. 2013 Feb;22(1):60-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23343048</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ment Health. 2016 Oct;25(5):403-409</Citation><ArticleIdList><ArticleId IdType="pubmed">26667144</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rural Health. 2006 Spring;22(2):182-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16606432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31243903</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1751-7893</ISSN><JournalIssue CitedMedium="Internet"><Volume>13 Suppl 1</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Early intervention in psychiatry</Title><ISOAbbreviation>Early Interv Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Transforming child and youth mental health care: ACCESS Open Minds New Brunswick in the rural Francophone region of the Acadian Peninsula.</ArticleTitle><Pagination><MedlinePgn>29-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eip.12815</ELocationID><Abstract><AbstractText Label="AIM">This paper describes how the transformation of youth mental health services in the rural Francophone region of the Acadian Peninsula in New Brunswick, Canada, is meeting the five objectives of ACCESS Open Minds.</AbstractText><AbstractText Label="METHODS">Implementation of the ACCESS Open Minds framework of care in the Acadian Peninsula of New Brunswick began in 2016 at a well-established volunteer centre and community-based mental health organization. Through focus groups with youth aged 14 to 22 (n = 13), community mapping was used to describe the youth-related mental health service transformation, followed by thematic analysis, validation by member checking and triangulation.</AbstractText><AbstractText Label="RESULTS">Preliminary results show a generally successful implementation of the ACCESS Open Minds model, as evidenced by the transformation of mental health service provision, the enhancement of capacity in human resources and the participation of youth. Transformation was evidenced across the five objectives of mental healthcare of ACCESS Open Minds, albeit to variable extents. Several facilitating factors and challenges are identified based on youths' accounts.</AbstractText><AbstractText Label="CONCLUSIONS">It is possible to successfully implement the ACCESS Open Minds model among francophones living in a minority setting and despite the constraints of a rural area. Most key components of the framework were implemented with high program fidelity. The rural context presents unique challenges that require creative and effective use of resources, while offering opportunities that arise from a culture of resourcefulness and collaboration.</AbstractText><CopyrightInformation>© 2019 The Authors Early Intervention in Psychiatry Published by John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubé</LastName><ForeName>Anik</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Nursing, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iancu</LastName><ForeName>Penelopia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Arts and Social Sciences, School of Social Work, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tranchant</LastName><ForeName>Carole C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-2026-819X</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Food Science, Nutrition and Family Studies, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doucet</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Chair on Children and Youth Mental Health, Faculty of Educational Sciences, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joachin</LastName><ForeName>Aduel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Chair on Children and Youth Mental Health, Faculty of Educational Sciences, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malchow</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Psychology, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robichaud</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Psychology, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haché</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds-Esprits ouverts New Brunswick, Acadian Peninsula, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godin</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds-Esprits ouverts New Brunswick, Acadian Peninsula, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourdon</LastName><ForeName>Laure</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Food Science, Nutrition and Family Studies, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourque</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Chair on Children and Youth Mental Health, Faculty of Educational Sciences, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Srividya N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0001-5367-9086</Identifier><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malla</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention and Early Intervention Program for Psychosis (PEPP), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaton</LastName><ForeName>Ann M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>ACCESS Open Minds (Pan-Canadian Youth Mental Health Services Research Network), Douglas Mental Health University Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences and Community Services, School of Psychology, Université de Moncton, Moncton, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><Agency>Graham Boeckh Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Early Interv Psychiatry</MedlineTA><NlmUniqueID>101320027</NlmUniqueID><ISSNLinking>1751-7885</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003266" MajorTopicYN="N">Continuity of Patient Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061345" MajorTopicYN="N">Early Medical Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008605" MajorTopicYN="N">Mental Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009509" MajorTopicYN="N" Type="Geographic">New Brunswick</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019035" MajorTopicYN="N">Rural Health Services</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">access</Keyword><Keyword MajorTopicYN="Y">francophone linguistic minority</Keyword><Keyword MajorTopicYN="Y">mental health care</Keyword><Keyword MajorTopicYN="Y">transformation</Keyword><Keyword MajorTopicYN="Y">youth</Keyword><Keyword MajorTopicYN="Y">youth mental health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31243903</ArticleId><ArticleId IdType="doi">10.1111/eip.12815</ArticleId><ArticleId IdType="pmc">PMC6771959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can J Public Health. 2013 Apr 05;104(6 Suppl 1):S5-S11</Citation><ArticleIdList><ArticleId IdType="pubmed">24300322</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2018 Apr;63(4):216-222</Citation><ArticleIdList><ArticleId IdType="pubmed">29528719</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2016 Feb;61(2):125-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27253704</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Child Health. 2009 Jan;14(1):15-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19436458</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2019 Jun;13 Suppl 1:29-34</Citation><ArticleIdList><ArticleId IdType="pubmed">31243903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic Dis Can. 2010 Jun;30(3):84-94</Citation><ArticleIdList><ArticleId IdType="pubmed">20609292</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31233491</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>Open collaborative writing with Manubot.</ArticleTitle><Pagination><MedlinePgn>e1007128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1007128</ELocationID><Abstract><AbstractText>Open, collaborative research is a powerful paradigm that can immensely strengthen the scientific process by integrating broad and diverse expertise. However, traditional research and multi-author writing processes break down at scale. We present new software named Manubot, available at https://manubot.org, to address the challenges of open scholarly writing. Manubot adopts the contribution workflow used by many large-scale open source software projects to enable collaborative authoring of scholarly manuscripts. With Manubot, manuscripts are written in Markdown and stored in a Git repository to precisely track changes over time. By hosting manuscript repositories publicly, such as on GitHub, multiple authors can simultaneously propose and review changes. A cloud service automatically evaluates proposed changes to catch errors. Publication with Manubot is continuous: When a manuscript's source changes, the rendered outputs are rebuilt and republished to a web page. Manubot automates bibliographic tasks by implementing citation by identifier, where users cite persistent identifiers (e.g. DOIs, PubMed IDs, ISBNs, URLs), whose metadata is then retrieved and converted to a user-specified style. Manubot modernizes publishing to align with the ideals of open science by making it transparent, reproducible, immediate, versioned, collaborative, and free of charge.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Himmelstein</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-3012-7446</Identifier><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubinetti</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4655-3773</Identifier><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slochower</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0003-3928-5050</Identifier><AffiliationInfo><Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, San Diego, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Dongbo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malladi</LastName><ForeName>Venkat S</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-0144-0564</Identifier><AffiliationInfo><Affiliation>Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Core Facility, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Casey S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0001-8713-9213</Identifier><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gitter</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5324-9833</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Morgridge Institute for Research, Madison, Wisconsin, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008374" MajorTopicYN="N">Manuscripts, Medical as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011643" MajorTopicYN="Y">Publishing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014956" MajorTopicYN="Y">Writing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31233491</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1007128</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-18-01884</ArticleId><ArticleId IdType="pmc">PMC6611653</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Biotechnol. 2017 Apr;35(4):342-346</Citation><ArticleIdList><ArticleId IdType="pubmed">28288103</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2016 Jan;17(1):23-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25888696</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jul 07;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27387362</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2018 Oct 17;7:1656</Citation><ArticleIdList><ArticleId IdType="pubmed">30473781</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2018 Apr;15(141):</Citation><ArticleIdList><ArticleId IdType="pubmed">29618526</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Ref Serv Q. 2012;31(1):45-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22289095</ArticleId></ArticleIdList></Reference><Reference><Citation>mSphere. 2019 May 29;4(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">31142623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2020 Jan 1;36(1):250-256</Citation><ArticleIdList><ArticleId IdType="pubmed">31165141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Aug 03;536(7614):16-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27488781</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Jul 14;12(7):e1004947</Citation><ArticleIdList><ArticleId IdType="pubmed">27415786</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2018 Nov 15;14(11):e1006508</Citation><ArticleIdList><ArticleId IdType="pubmed">30439938</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2013;9(7):e1003149</Citation><ArticleIdList><ArticleId IdType="pubmed">23874189</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2011 Dec;9(12):e1001195</Citation><ArticleIdList><ArticleId IdType="pubmed">22162946</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Jan 19;12(1):e1004668</Citation><ArticleIdList><ArticleId IdType="pubmed">26785377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2019 Feb;566(7742):141-142</Citation><ArticleIdList><ArticleId IdType="pubmed">30718888</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Dec 21;552(7685):304-307</Citation><ArticleIdList><ArticleId IdType="pubmed">29293246</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2016 Apr 11;5:632</Citation><ArticleIdList><ArticleId IdType="pubmed">27158456</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2012 Aug 30;6:63</Citation><ArticleIdList><ArticleId IdType="pubmed">22969719</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Sep 22;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">28936969</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2017 Jan;23(1):341-350</Citation><ArticleIdList><ArticleId IdType="pubmed">27875150</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2015 May;31(5):221-3</Citation><ArticleIdList><ArticleId IdType="pubmed">25851694</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Oct 4;550(7674):143-144</Citation><ArticleIdList><ArticleId IdType="pubmed">28980652</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2018 Mar 01;7:</Citation><ArticleIdList><ArticleId IdType="pubmed">29424689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Feb 1;554(7690):133-134</Citation><ArticleIdList><ArticleId IdType="pubmed">29388968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Model Mech. 2009 May-Jun;2(5-6):201-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19407323</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Lett. 2015 May 15;114(19):191803</Citation><ArticleIdList><ArticleId IdType="pubmed">26024162</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2014 Dec 30;11(12):e1001772</Citation><ArticleIdList><ArticleId IdType="pubmed">25548904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Oct 2;514(7520):127-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25279924</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2018 Jun 11;7:</Citation><ArticleIdList><ArticleId IdType="pubmed">29889024</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Feb 22;482(7386):485-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22358837</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Dec 9;354(6317):1240-1241</Citation><ArticleIdList><ArticleId IdType="pubmed">27940837</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2017 Jul 20;6:1151</Citation><ArticleIdList><ArticleId IdType="pubmed">29188015</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jun 16;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27310529</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(9):e23477</Citation><ArticleIdList><ArticleId IdType="pubmed">21931600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2019 Jun;37(6):592-600</Citation><ArticleIdList><ArticleId IdType="pubmed">31138913</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Feb 3;6(2):e23</Citation><ArticleIdList><ArticleId IdType="pubmed">19192943</ArticleId></ArticleIdList></Reference><Reference><Citation>G3 (Bethesda). 2015 Mar 04;5(5):719-40</Citation><ArticleIdList><ArticleId IdType="pubmed">25740935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31209695</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6792</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>Brain topography</Title><ISOAbbreviation>Brain Topogr</ISOAbbreviation></Journal><ArticleTitle>EECoG-Comp: An Open Source Platform for Concurrent EEG/ECoG Comparisons-Applications to Connectivity Studies.</ArticleTitle><Pagination><MedlinePgn>550-568</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10548-019-00708-w</ELocationID><Abstract><AbstractText>Electrophysiological Source Imaging (ESI) is hampered by lack of "gold standards" for model validation. Concurrent electroencephalography (EEG) and electrocorticography (ECoG) experiments (EECoG) are useful for this purpose, especially primate models due to their flexibility and translational value for human research. Unfortunately, there is only one EECoG experiments in the public domain that we know of: the Multidimensional Recording (MDR) is based on a single monkey ( www.neurotycho.org ). The mining of this type of data is hindered by lack of specialized procedures to deal with: (1) Severe EECoG artifacts due to the experimental produces; (2) Sophisticated forward models that account for surgery induced skull defects and implanted ECoG electrode strips; (3) Reliable statistical procedures to estimate and compare source connectivity (partial correlation). We provide solutions to the processing issues just mentioned with EECoG-Comp: an open source platform ( https://github.com/Vincent-wq/EECoG-Comp ). EECoG lead fields calculated with FEM (Simbio) for MDR data are also provided and were used in other papers of this special issue. As a use case with the MDR, we show: (1) For real MDR data, 4 popular ESI methods (MNE, LCMV, eLORETA and SSBL) showed significant but moderate concordance with a usual standard, the ECoG Laplacian (standard partial [Formula: see text]); (2) In both monkey and human simulations, all ESI methods as well as Laplacian had a significant but poor correspondence with the true source connectivity. These preliminary results may stimulate the development of improved ESI connectivity estimators but require the availability of more EECoG data sets to obtain neurobiologically valid inferences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, Center for Information in Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdés-Hernández</LastName><ForeName>Pedro Antonio</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Florida International University, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz-Linares</LastName><ForeName>Deirel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch-Bayard</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unity of Neurodevelopment, Institute of Neurobiology, UNAM, Campus Juriquilla, Santiago de Querétaro, Querétaro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oosugi</LastName><ForeName>Naoya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory for Adaptive Intelligence, RIKEN Brain Science Institute, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Misako</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular Analysis of Higher Brain Function, RIKEN Center for Brain Science, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Naotaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory for Adaptive Intelligence, RIKEN Brain Science Institute, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdés-Sosa</LastName><ForeName>Pedro Antonio</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China. pedro.valdes@neuroinformatics-collaboratory.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, Center for Information in Medicine, University of Electronic Science and Technology of China, Chengdu, China. pedro.valdes@neuroinformatics-collaboratory.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cuban Neuro Science Center, La Habana, Cuba. pedro.valdes@neuroinformatics-collaboratory.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Topogr</MedlineTA><NlmUniqueID>8903034</NlmUniqueID><ISSNLinking>0896-0267</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016477" MajorTopicYN="N">Artifacts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069280" MajorTopicYN="N">Electrocorticography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004567" MajorTopicYN="N">Electrodes, Implanted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Connectivity</Keyword><Keyword MajorTopicYN="Y">ECoG</Keyword><Keyword MajorTopicYN="Y">EEG</Keyword><Keyword MajorTopicYN="Y">Electrophysiological source imaging</Keyword><Keyword MajorTopicYN="Y">Forward modeling</Keyword><Keyword MajorTopicYN="Y">Monkey electrophysiology</Keyword><Keyword MajorTopicYN="Y">Open science</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31209695</ArticleId><ArticleId IdType="doi">10.1007/s10548-019-00708-w</ArticleId><ArticleId IdType="pii">10.1007/s10548-019-00708-w</ArticleId><ArticleId IdType="pmc">PMC6592977</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain Topogr. 2019 Jul;32(4):583-598</Citation><ArticleIdList><ArticleId IdType="pubmed">29362974</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2011 Jul;58(7):1918-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21478071</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Intell Neurosci. 2011;2011:879716</Citation><ArticleIdList><ArticleId IdType="pubmed">21584256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Sep;52(3):812-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20100578</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2017 Sep;93:1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">28505599</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2018 Apr 1;141(4):1130-1144</Citation><ArticleIdList><ArticleId IdType="pubmed">29506200</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 1989 Jul-Sep;9(3):190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2668680</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1998 Aug;107(2):159-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9751287</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Connect. 2011;1(1):13-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22432952</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 1994 Jan;32(1):35-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8182960</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2015 Oct 21;35(42):14341-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26490871</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2018 Jun;173:632-643</Citation><ArticleIdList><ArticleId IdType="pubmed">29477441</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2004 Mar 15;134(1):9-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15102499</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14332-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25205811</ArticleId></ArticleIdList></Reference><Reference><Citation>eNeuro. 2018 Aug 13;5(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">30105299</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2018 Jul 15;175:22-31</Citation><ArticleIdList><ArticleId IdType="pubmed">29571717</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Topogr. 2019 Jul;32(4):741-752</Citation><ArticleIdList><ArticleId IdType="pubmed">26350398</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroeng Rehabil. 2008 Nov 07;5:25</Citation><ArticleIdList><ArticleId IdType="pubmed">18990257</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 1997 Sep;44(9):867-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9282479</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Intell Neurosci. 2011;2011:156869</Citation><ArticleIdList><ArticleId IdType="pubmed">21253357</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Dec;53(4):1197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">20600983</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2017 May 15;152:590-601</Citation><ArticleIdList><ArticleId IdType="pubmed">28300640</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1998 Jun;106(6):522-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9741752</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Connect. 2016 Feb;6(1):57-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26415043</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Topogr. 2019 Mar;32(2):193-214</Citation><ArticleIdList><ArticleId IdType="pubmed">30684161</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2007 Dec;63(4):1181-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17489968</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2018 Feb 02;12:30</Citation><ArticleIdList><ArticleId IdType="pubmed">29456487</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2017 Nov 16;11:635</Citation><ArticleIdList><ArticleId IdType="pubmed">29200994</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Med Biol. 2001 Jan;46(1):77-96</Citation><ArticleIdList><ArticleId IdType="pubmed">11197680</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2017 Feb 23;20(3):353-364</Citation><ArticleIdList><ArticleId IdType="pubmed">28230844</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(7):e22561</Citation><ArticleIdList><ArticleId IdType="pubmed">21811633</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2002 May;125(Pt 5):935-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11960884</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 1998;6(4):250-69</Citation><ArticleIdList><ArticleId IdType="pubmed">9704264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2003 Jul;21(7):803-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12808463</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurophysiol. 2007 Apr;24(2):130-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17414968</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Sep;59(9):2628-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22911537</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2011 Mar 30;31(13):4935-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21451032</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 Aug;54(8):1446-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17694865</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2001 May;13(5):856-76</Citation><ArticleIdList><ArticleId IdType="pubmed">11304082</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31207186</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2163-8306</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>CPT: pharmacometrics &amp; systems pharmacology</Title><ISOAbbreviation>CPT Pharmacometrics Syst Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Nonlinear Mixed-Effects Model Development and Simulation Using nlmixr and Related R Open-Source Packages.</ArticleTitle><Pagination><MedlinePgn>621-633</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/psp4.12445</ELocationID><Abstract><AbstractText>nlmixr is a free and open-source R package for fitting nonlinear pharmacokinetic (PK), pharmacodynamic (PD), joint PK-PD, and quantitative systems pharmacology mixed-effects models. Currently, nlmixr is capable of fitting both traditional compartmental PK models as well as more complex models implemented using ordinary differential equations. We believe that, over time, it will become a capable, credible alternative to commercial software tools, such as NONMEM, Monolix, and Phoenix NLME.</AbstractText><CopyrightInformation>© 2019 The Authors CPT: Pharmacometrics &amp; Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fidler</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals Corporation, Fort Worth, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Occams Coöperatie UA, Amstelveen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooijmaijers</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>LAP&amp;P Consultants BV, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Post</LastName><ForeName>Teun M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>LAP&amp;P Consultants BV, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoemaker</LastName><ForeName>Rik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Occams Coöperatie UA, Amstelveen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trame</LastName><ForeName>Mirjam N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Certara, Princeton, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>CPT Pharmacometrics Syst Pharmacol</MedlineTA><NlmUniqueID>101580011</NlmUniqueID><ISSNLinking>2163-8306</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017711" MajorTopicYN="N">Nonlinear Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010599" MajorTopicYN="Y">Pharmacokinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31207186</ArticleId><ArticleId IdType="doi">10.1002/psp4.12445</ArticleId><ArticleId IdType="pmc">PMC6765694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Comput Methods Programs Biomed. 1999 Jan;58(1):51-64</Citation><ArticleIdList><ArticleId IdType="pubmed">10195646</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2007 Jul;82(1):21-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17522597</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2007 Aug;82(2):137-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17632539</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2008 May;90(2):154-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18215437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2008 May;48(5):632-49</Citation><ArticleIdList><ArticleId IdType="pubmed">18440922</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharmacol Ther. 2010 Oct;48(10):662-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20875372</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1:e6</Citation><ArticleIdList><ArticleId IdType="pubmed">23835886</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2013 Apr 17;2:e38</Citation><ArticleIdList><ArticleId IdType="pubmed">23887688</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2014 Jan 02;3:e88</Citation><ArticleIdList><ArticleId IdType="pubmed">24384783</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2014 May;69(5):1339-49</Citation><ArticleIdList><ArticleId IdType="pubmed">24486870</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacokinet Pharmacodyn. 2014 Aug;41(4):319-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25056507</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2015 Mar;97(3):221-33</Citation><ArticleIdList><ArticleId IdType="pubmed">25670629</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):191-209</Citation><ArticleIdList><ArticleId IdType="pubmed">25801663</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2015 Dec 07;60(3):1234-41</Citation><ArticleIdList><ArticleId IdType="pubmed">26643345</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2016 Apr;99(4):405-18</Citation><ArticleIdList><ArticleId IdType="pubmed">26785109</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):3-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26844010</ArticleId></ArticleIdList></Reference><Reference><Citation>CPT Pharmacometrics Syst Pharmacol. 2016 Mar;5(3):93-122</Citation><ArticleIdList><ArticleId IdType="pubmed">27069774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 25;533(7604):452-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharm Sci. 2017 Nov 15;109S:S39-S46</Citation><ArticleIdList><ArticleId IdType="pubmed">28506868</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharm Sci. 2017 Nov 15;109S:S65-S71</Citation><ArticleIdList><ArticleId IdType="pubmed">28684136</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 2018 May;57(5):591-599</Citation><ArticleIdList><ArticleId IdType="pubmed">28779464</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:567-582</Citation><ArticleIdList><ArticleId IdType="pubmed">28992431</ArticleId></ArticleIdList></Reference><Reference><Citation>AAPS J. 2018 Mar 16;20(3):52</Citation><ArticleIdList><ArticleId IdType="pubmed">29549459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31202468</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-4465</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>The Lancet. Neurology</Title><ISOAbbreviation>Lancet Neurol</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.</ArticleTitle><Pagination><MedlinePgn>631-642</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1474-4422(19)30142-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1474-4422(19)30142-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic disorder characterised by progressive generalised dystonia and brain iron accumulation. We assessed whether the iron chelator deferiprone can reduce brain iron and slow disease progression.</AbstractText><AbstractText Label="METHODS">We did an 18-month, randomised, double-blind, placebo-controlled trial (TIRCON2012V1), followed by a pre-planned 18-month, open-label extension study, in patients with PKAN in four hospitals in Germany, Italy, England, and the USA. Patients aged 4 years or older with a genetically confirmed diagnosis of PKAN, a total score of at least 3 points on the Barry-Albright Dystonia (BAD) scale, and no evidence of iron deficiency, neutropenia, or abnormal hepatic or renal function, were randomly allocated (2:1) to receive an oral solution of either deferiprone (30 mg/kg per day divided into two equal doses) or placebo for 18 months. Randomisation was done with a centralised computer random number generator and with stratification based on age group at onset of symptoms. Patients were allocated to groups by a randomisation team not masked for study intervention that was independent of the study. Patients, caregivers, and investigators were masked to treatment allocation. Co-primary endpoints were the change from baseline to month 18 in the total score on the BAD scale (which measures severity of dystonia in eight body regions) and the score at month 18 on the Patient Global Impression of Improvement (PGI-I) scale, which is a patient-reported interpretation of symptom improvement. Efficacy analyses were done on all patients who received at least one dose of the study drug and who provided a baseline and at least one post-baseline efficacy assessment. Safety analyses were done for all patients who received at least one dose of the study drug. Patients who completed the randomised trial were eligible to enrol in a single-arm, open-label extension study of another 18 months, in which all participants received deferiprone with the same regimen as the main study. The trial was registered on ClinicalTrials.gov, number NCT01741532, and EudraCT, number 2012-000845-11.</AbstractText><AbstractText Label="FINDINGS">Following a screening of 100 prospective patients, 88 were randomly assigned to the deferiprone group (n=58) or placebo group (n=30) between Dec 13, 2012, and April 21, 2015. Of these, 76 patients completed the study (49 in the deferiprone group and 27 in the placebo group). After 18 months, the BAD score worsened by a mean of 2·48 points (SE 0·63) in patients in the deferiprone group versus 3·99 points (0·82) for patients in the control group (difference -1·51 points, 95% CI -3·19 to 0·16, p=0·076). No subjective change was detected as assessed by the PGI-I scale: mean scores at month 18 were 4·6 points (SE 0·3) for patients in the deferiprone group versus 4·7 points (0·4) for those in the placebo group (p=0·728). In the extension study, patients continuing deferiprone retained a similar rate of disease progression as assessed by the BAD scale (1·9 points [0·5] in the first 18 months vs 1·4 points [0·4] in the second 18 months, p=0·268), whereas progression in patients switching from placebo to deferiprone seemed to slow (4·4 points [1·1] vs 1·4 points [0·9], p=0·021). Patients did not detect a change in their condition after the additional 18 months of treatment as assessed by the PGI-I scale, with mean scores of 4·1 points [0·2] in the deferiprone-deferiprone group and of 4·7 points [0·3] in the placebo-deferiprone group. Deferiprone was well tolerated and adverse events were similar between the treatment groups, except for anaemia, which was seen in 12 (21%) of 58 patients in the deferiprone group, but was not seen in any patients in the placebo group. No patient discontinued therapy because of anaemia, and three discontinued because of moderate neutropenia. There was one death in each group of the extension study and both were secondary to aspiration. Neither of these events was considered related to deferiprone use.</AbstractText><AbstractText Label="INTERPRETATION">Deferiprone was well tolerated, achieved target engagement (lowering of iron in the basal ganglia), and seemed to somewhat slow disease progression at 18 months, although not significantly, as assessed by the BAD scale. These findings were corroborated by the results of an additional 18 months of treatment in the extension study. The subjective PGI-I scale was largely unchanged during both study periods, indicating that might not be an adequate tool for assessment of disease progression in patients with PKAN. Our trial provides the first indication of a decrease in disease progression in patients with neurodegeneration with brain iron accumulation. The extensive information collected and long follow-up of patients in the trial will improve the definition of appropriate endpoints, increase the understanding of the natural history, and thus help to shape the design of future trials in this ultra-orphan disease.</AbstractText><AbstractText Label="FUNDING">European Commission, US Food and Drug Administration, and ApoPharma Inc.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klopstock</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany. Electronic address: thomas.klopstock@med.lmu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tricta</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ApoPharma Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumayr</LastName><ForeName>Lynne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Hematology Oncology, UCSF Benioff Children's Hospital and Research Center Oakland, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karin</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorzi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neuroscience, Neurological Institute Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fradette</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ApoPharma Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kmieć</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology and Epileptology, Children's Memorial Health Institute, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Büchner</LastName><ForeName>Boriana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinnery</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basu</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Küpper</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuhofer</LastName><ForeName>Christiane</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kálmán</LastName><ForeName>Bernadette</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Medicine, Szentagothai Research Center, University of Pécs, Pécs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dušek</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yapici</LastName><ForeName>Zuhal</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Child Neurology, Istanbul Faculty of Medicine, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine and Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ApoPharma Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zibordi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neuroscience, Neurological Institute Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardocci</LastName><ForeName>Nardo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neuroscience, Neurological Institute Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Rehabilitation Department, UCSF Benioff Children's Hospital and Research Center Oakland, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayflick</LastName><ForeName>Susan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Molecular &amp; Medical Genetics, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spino</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ApoPharma Inc, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blamire</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine and Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogarth</LastName><ForeName>Penelope</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Molecular &amp; Medical Genetics, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vichinsky</LastName><ForeName>Elliott</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Hematology Oncology, UCSF Benioff Children's Hospital and Research Center Oakland, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01741532</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>309548</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Neurol</MedlineTA><NlmUniqueID>101139309</NlmUniqueID><ISSNLinking>1474-4422</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007502">Iron Chelating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BTY8KH53L</RegistryNumber><NameOfSubstance UI="D000077543">Deferiprone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Neurol. 2019 Jul;18(7):616-617</RefSource><PMID Version="1">31202464</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2019 Sep;15(9):492-493</RefSource><PMID Version="1">31263258</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077543" MajorTopicYN="N">Deferiprone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007502" MajorTopicYN="N">Iron Chelating Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006211" MajorTopicYN="N">Pantothenate Kinase-Associated Neurodegeneration</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31202468</ArticleId><ArticleId IdType="pii">S1474-4422(19)30142-5</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(19)30142-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31201398</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-9982</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JPMA. The Journal of the Pakistan Medical Association</Title><ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Open Researcher and Contributor Identifier and other author identifiers: Perspective from Pakistan.</ArticleTitle><Pagination><MedlinePgn>888-891</MedlinePgn></Pagination><Abstract><AbstractText>The Open Researcher and Contributor ID (ORCID) is a globally trending initiative for author name disambiguation and serves as a 'digital curriculum vitae' for displaying an individual's research output. Although there are several other tools similar to ORCID, the collaborative efforts by ORCID make it the most attractive option. Most of the organizations and publishers are increasingly adopting ORCID in their systems, and authors from West and other parts of the world have attempted to create awareness about ORCID initiative. However, researchers from Pakistan and other developing countries should be introduced to this concept and be encouraged to adopt to such initiatives. Therefore, this paper aims to present a brief introduction to author identifiers, with special focus on the ORCID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Memon</LastName><ForeName>Aamir Raoof</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Institute of Physiotherapy and Rehabilitation Sciences, Peoples University of Medical and Health Sciences for Women, Nawabshah, Sindh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azim</LastName><ForeName>Muhammad Ehab</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Foundation University Institute of Rehabilitation Sciences, Foundation University, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>J Pak Med Assoc</MedlineTA><NlmUniqueID>7501162</NlmUniqueID><ISSNLinking>0030-9982</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001319" MajorTopicYN="Y">Authorship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009275" MajorTopicYN="Y">Names</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011643" MajorTopicYN="Y">Publishing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"> Author Identifier; Open Researchers and Contributors ID; ORCID; Scholarly publishing.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31201398</ArticleId><ArticleId IdType="pii">9205</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31201137</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study.</ArticleTitle><Pagination><MedlinePgn>938-947</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(19)30333-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(19)30333-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Whether machine-learning algorithms can diagnose all pigmented skin lesions as accurately as human experts is unclear. The aim of this study was to compare the diagnostic accuracy of state-of-the-art machine-learning algorithms with human readers for all clinically relevant types of benign and malignant pigmented skin lesions.</AbstractText><AbstractText Label="METHODS">For this open, web-based, international, diagnostic study, human readers were asked to diagnose dermatoscopic images selected randomly in 30-image batches from a test set of 1511 images. The diagnoses from human readers were compared with those of 139 algorithms created by 77 machine-learning labs, who participated in the International Skin Imaging Collaboration 2018 challenge and received a training set of 10 015 images in advance. The ground truth of each lesion fell into one of seven predefined disease categories: intraepithelial carcinoma including actinic keratoses and Bowen's disease; basal cell carcinoma; benign keratinocytic lesions including solar lentigo, seborrheic keratosis and lichen planus-like keratosis; dermatofibroma; melanoma; melanocytic nevus; and vascular lesions. The two main outcomes were the differences in the number of correct specific diagnoses per batch between all human readers and the top three algorithms, and between human experts and the top three algorithms.</AbstractText><AbstractText Label="FINDINGS">Between Aug 4, 2018, and Sept 30, 2018, 511 human readers from 63 countries had at least one attempt in the reader study. 283 (55·4%) of 511 human readers were board-certified dermatologists, 118 (23·1%) were dermatology residents, and 83 (16·2%) were general practitioners. When comparing all human readers with all machine-learning algorithms, the algorithms achieved a mean of 2·01 (95% CI 1·97 to 2·04; p&lt;0·0001) more correct diagnoses (17·91 [SD 3·42] vs 19·92 [4·27]). 27 human experts with more than 10 years of experience achieved a mean of 18·78 (SD 3·15) correct answers, compared with 25·43 (1·95) correct answers for the top three machine algorithms (mean difference 6·65, 95% CI 6·06-7·25; p&lt;0·0001). The difference between human experts and the top three algorithms was significantly lower for images in the test set that were collected from sources not included in the training set (human underperformance of 11·4%, 95% CI 9·9-12·9 vs 3·6%, 0·8-6·3; p&lt;0·0001).</AbstractText><AbstractText Label="INTERPRETATION">State-of-the-art machine-learning classifiers outperformed human experts in the diagnosis of pigmented skin lesions and should have a more important role in clinical practice. However, a possible limitation of these algorithms is their decreased performance for out-of-distribution images, which should be addressed in future research.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tschandl</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ViDIR Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Codella</LastName><ForeName>Noel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IBM Research AI, T J Watson Research Center, Yorktown Heights, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akay</LastName><ForeName>Bengü Nisa</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Medicine Faculty, Ankara University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argenziano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dermatology Unit, University of Campania, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braun</LastName><ForeName>Ralph P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Skin Cancer Center, Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabo</LastName><ForeName>Horacio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Instituto de Investigaciones Médicas, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halpern</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helba</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kitware, Clifton Park, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmann-Wellenhof</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Medical University Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lallas</LastName><ForeName>Aimilios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First Department of Dermatology, Aristotle University, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapins</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Centro Oncologico ad Alta Tecnologia Diagnostica-Dermatologia, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malvehy</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Melanoma Unit, Dermatology Department, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Rarasd (CIBER ER), Instituto de Salud Carlos III, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchetti</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marghoob</LastName><ForeName>Ashfaq</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, Hauppauge, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menzies</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sydney Melanoma Diagnostic Centre &amp; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oakley</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Waikato District Health Board and Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paoli</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puig</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Melanoma Unit, Dermatology Department, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Rarasd (CIBER ER), Instituto de Salud Carlos III, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosendahl</LastName><ForeName>Cliff</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, University of Queensland, University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scope</LastName><ForeName>Alon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Screening Institute, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinz</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ViDIR Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soyer</LastName><ForeName>H Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Dermatology Research Centre, The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hospitalier Lyon Sud, Lyon, France; Lyon Cancer Research Center INSERM U1052-CNRS UMR5286, Lyon, France; Lyon 1 University, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zalaudek</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kittler</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>ViDIR Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria. Electronic address: harald.kittler@meduniwien.ac.at.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2019 Jul;20(7):891-892</RefSource><PMID Version="1">31201138</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046169" MajorTopicYN="Y">Dermoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010859" MajorTopicYN="N">Pigmentation Disorders</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>04</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31201137</ArticleId><ArticleId IdType="pii">S1470-2045(19)30333-X</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(19)30333-X</ArticleId><ArticleId IdType="pmc">PMC8237239</ArticleId><ArticleId IdType="mid">NIHMS1716706</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Dermatol. 2005 Nov;141(11):1388-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16301386</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Dermatol. 2015 Oct;151(10):1081-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25928283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Feb 2;542(7639):115-118</Citation><ArticleIdList><ArticleId IdType="pubmed">28117445</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Jun 12;319(22):2267-2268</Citation><ArticleIdList><ArticleId IdType="pubmed">29800012</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2014 Nov;171(5):1099-107</Citation><ArticleIdList><ArticleId IdType="pubmed">24841846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2018 Feb;78(2):270-277.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">28969863</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Dermatol. 2017 Apr 1;153(4):279-284</Citation><ArticleIdList><ArticleId IdType="pubmed">28196213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2002 Mar;3(3):159-65</Citation><ArticleIdList><ArticleId IdType="pubmed">11902502</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dermatol. 2011 Feb;147(2):188-94</Citation><ArticleIdList><ArticleId IdType="pubmed">20956633</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Mar 17;12:77</Citation><ArticleIdList><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 1994 Apr;130(4):460-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8186110</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2018 Jul;138(7):1529-1538</Citation><ArticleIdList><ArticleId IdType="pubmed">29428356</ArticleId></ArticleIdList></Reference><Reference><Citation>Melanoma Res. 2009 Jun;19(3):180-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19369900</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2012 Nov;67(5):846-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22325462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Aug 1;29(8):1836-1842</Citation><ArticleIdList><ArticleId IdType="pubmed">29846502</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2011 Jun;64(6):1068-73</Citation><ArticleIdList><ArticleId IdType="pubmed">21440329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2018 Aug 14;5:180161</Citation><ArticleIdList><ArticleId IdType="pubmed">30106392</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Dermatol. 2017 May 1;153(5):453-457</Citation><ArticleIdList><ArticleId IdType="pubmed">28241182</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1988 Sep;44(3):837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2016 Dec;175(6):1329-1337</Citation><ArticleIdList><ArticleId IdType="pubmed">27469990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31201122</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>08</Month><Day>07</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Open Source Brain: A Collaborative Resource for Visualizing, Analyzing, Simulating, and Developing Standardized Models of Neurons and Circuits.</ArticleTitle><Pagination><MedlinePgn>395-411.e5</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(19)30444-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2019.05.019</ELocationID><Abstract><AbstractText>Computational models are powerful tools for exploring the properties of complex biological systems. In neuroscience, data-driven models of neural circuits that span multiple scales are increasingly being used to understand brain function in health and disease. But their adoption and reuse has been limited by the specialist knowledge required to evaluate and use them. To address this, we have developed Open Source Brain, a platform for sharing, viewing, analyzing, and simulating standardized models from different brain regions and species. Model structure and parameters can be automatically visualized and their dynamical properties explored through browser-based simulations. Infrastructure and tools for collaborative interaction, development, and testing are also provided. We demonstrate how existing components can be reused by constructing new models of inhibition-stabilized cortical networks that match recent experimental results. These features of Open Source Brain improve the accessibility, transparency, and reproducibility of models and facilitate their reuse by the wider community.</AbstractText><CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gleeson</LastName><ForeName>Padraig</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantarelli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK; MetaCell Limited, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marin</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK; Centro de Matemática, Computação e Cognição, Universidade Federal do ABC, Santo André, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Earnshaw</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeh</LastName><ForeName>Sadra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piasini</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK; Computational Neuroscience Initiative and Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birgiolas</LastName><ForeName>Justas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannon</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Annotate Software Limited, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cayco-Gajic</LastName><ForeName>N Alex</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crook</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Arizona State University, Tempe, AZ, USA; School of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Unité de Neuroscience, Information et Complexité, Centre National de la Recherche Scientifique, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dura-Bernal</LastName><ForeName>Salvador</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SUNY Downstate Medical Center and Kings County Hospital, Brooklyn, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ecker</LastName><ForeName>András</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK; Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hines</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idili</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>MetaCell Limited, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanore</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Stephen D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>OpenWorm Foundation, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lytton</LastName><ForeName>William W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>SUNY Downstate Medical Center and Kings County Hospital, Brooklyn, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majumdar</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of California, San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDougal</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA; Center for Medical Informatics, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivagnanam</LastName><ForeName>Subhashini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of California, San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solinas</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, University of Sassari, Sassari, Italy; Institute of Neuroinformatics, University of Zurich and ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanislovas</LastName><ForeName>Rokas</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Albada</LastName><ForeName>Sacha J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience and Medicine (INM-6), Institute for Advanced Simulation (IAS-6) and JARA-Institut Brain Structure-Function Relationships (INM-10), Jülich Research Centre, Jülich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Geit</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silver</LastName><ForeName>R Angus</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK. Electronic address: a.silver@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 EB028998</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DC009977</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>086699</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>101445</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 EB022903</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>203048/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>095667</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="Y">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009862" MajorTopicYN="N">Online Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">circuits</Keyword><Keyword MajorTopicYN="Y">collaboration</Keyword><Keyword MajorTopicYN="Y">computational neuroscience</Keyword><Keyword MajorTopicYN="Y">modelling</Keyword><Keyword MajorTopicYN="Y">networks</Keyword><Keyword MajorTopicYN="Y">neurons</Keyword><Keyword MajorTopicYN="Y">open source</Keyword><Keyword MajorTopicYN="Y">simulation</Keyword><Keyword MajorTopicYN="Y">standardization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31201122</ArticleId><ArticleId IdType="pii">S0896-6273(19)30444-1</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2019.05.019</ArticleId><ArticleId IdType="pmc">PMC6693896</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elife. 2016 Dec 23;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">28009257</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2009 Jan 27;2:11</Citation><ArticleIdList><ArticleId IdType="pubmed">19194529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Mar 1;27(5):743-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21216774</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Sep 25;8:79</Citation><ArticleIdList><ArticleId IdType="pubmed">25309419</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Apr 23;8:38</Citation><ArticleIdList><ArticleId IdType="pubmed">24795618</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1988 Sep 9;241(4871):1299-306</Citation><ArticleIdList><ArticleId IdType="pubmed">3045969</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Sep 12;12(9):e1005045</Citation><ArticleIdList><ArticleId IdType="pubmed">27617444</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2010 Jun 17;6(6):e1000815</Citation><ArticleIdList><ArticleId IdType="pubmed">20585541</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2018 Mar 21;97(6):1341-1355.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">29503186</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2014 Mar;24(3):785-806</Citation><ArticleIdList><ArticleId IdType="pubmed">23203991</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Jan 20;5:e10566</Citation><ArticleIdList><ArticleId IdType="pubmed">26796534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2017 Jul;20(7):1004-1013</Citation><ArticleIdList><ArticleId IdType="pubmed">28581480</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Oct 6;314(5796):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17023649</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2011 Dec 30;5:36</Citation><ArticleIdList><ArticleId IdType="pubmed">22232598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2004 Dec;7(12):1345-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15558066</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Dec 19;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">29256863</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2014 Aug 20;83(4):960-74</Citation><ArticleIdList><ArticleId IdType="pubmed">25123311</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1997 Jun 1;17(11):4382-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9151754</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2018 Sep 10;373(1758):</Citation><ArticleIdList><ArticleId IdType="pubmed">30201845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Oct 8;163(2):456-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26451489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Oct 03;538(7623):127-128</Citation><ArticleIdList><ArticleId IdType="pubmed">27708327</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 8;500(7461):168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23925239</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">27382147</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2016 Nov 2;92(3):574-581</Citation><ArticleIdList><ArticleId IdType="pubmed">27809997</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2018 Oct 18;14(10):e1006359</Citation><ArticleIdList><ArticleId IdType="pubmed">30335761</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1996 Oct 15;16(20):6402-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8815919</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Struct Funct. 2018 Apr;223(3):1409-1435</Citation><ArticleIdList><ArticleId IdType="pubmed">29143946</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 1998 Nov;80(5):2521-37</Citation><ArticleIdList><ArticleId IdType="pubmed">9819260</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2014 Nov 03;8:137</Citation><ArticleIdList><ArticleId IdType="pubmed">25404913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2015 Dec;18(12):1713-21</Citation><ArticleIdList><ArticleId IdType="pubmed">26605882</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 May 10;340(6133):687-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23661744</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Cell Neurosci. 2007 Dec 30;1:2</Citation><ArticleIdList><ArticleId IdType="pubmed">18946520</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2019 Apr 26;8:</Citation><ArticleIdList><ArticleId IdType="pubmed">31025934</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Jul 30;162(3):648-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26232230</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2013 Sep;14(9):659-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23958663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D689-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16381960</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2017 Aug 30;95(5):1147-1159.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">28858618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2017 Dec 6;37(49):12050-12067</Citation><ArticleIdList><ArticleId IdType="pubmed">29074575</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2017 Jul 19;95(2):412-423.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">28689982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1999 Dec 2;402(6761):529-33</Citation><ArticleIdList><ArticleId IdType="pubmed">10591212</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neural Circuits. 2015 Oct 08;9:44</Citation><ArticleIdList><ArticleId IdType="pubmed">26500503</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2007 Aug 29;27(35):9247-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17728438</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2017 Aug 30;95(5):1048-1055.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">28858615</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2018 Apr 4;98(1):222-234.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">29576389</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2009 May 28;62(4):578-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19477158</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2013 Oct 22;7:144</Citation><ArticleIdList><ArticleId IdType="pubmed">24155715</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2017 Apr 25;11:28</Citation><ArticleIdList><ArticleId IdType="pubmed">28487644</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 2005 Apr;93(4):2194-232</Citation><ArticleIdList><ArticleId IdType="pubmed">15525801</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 1962 Mar;2(2 Pt 2):145-67</Citation><ArticleIdList><ArticleId IdType="pubmed">14490040</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2011 Jul 17;14(8):1045-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21765421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 May;10(5):413-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23524393</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 1961 Jul;1(6):445-66</Citation><ArticleIdList><ArticleId IdType="pubmed">19431309</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2007 Apr 19;54(2):219-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17442244</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Sep 9;353(6304):1117-23</Citation><ArticleIdList><ArticleId IdType="pubmed">27609885</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Oct 24;8(1):1116</Citation><ArticleIdList><ArticleId IdType="pubmed">29061964</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 1972 Jan;12(1):1-24</Citation><ArticleIdList><ArticleId IdType="pubmed">4332108</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Jun 11;7:10</Citation><ArticleIdList><ArticleId IdType="pubmed">23781198</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 1954 Jun 28;124(3):560-73</Citation><ArticleIdList><ArticleId IdType="pubmed">13175199</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2014 Apr 29;8:50</Citation><ArticleIdList><ArticleId IdType="pubmed">24808855</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2018 Sep 10;373(1758):</Citation><ArticleIdList><ArticleId IdType="pubmed">30201843</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Cybern. 2008 Nov;99(4-5):427-41</Citation><ArticleIdList><ArticleId IdType="pubmed">19011929</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Nov 7;503(7474):115-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24162850</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 2005 Dec;94(6):4145-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16293591</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2017 Apr 19;13(4):e1005507</Citation><ArticleIdList><ArticleId IdType="pubmed">28422957</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2015 Jan 21;85(2):402-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25611511</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM J Res Dev. 2017 Mar-May;61(2-3):6.1-6.14</Citation><ArticleIdList><ArticleId IdType="pubmed">29200477</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosystems. 2008 Oct-Nov;94(1-2):170-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18619514</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2011 Jul;7(7):e1002107</Citation><ArticleIdList><ArticleId IdType="pubmed">21829333</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2008 Nov 18;2:5</Citation><ArticleIdList><ArticleId IdType="pubmed">19115011</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2008 Dec 19;2:6</Citation><ArticleIdList><ArticleId IdType="pubmed">19129924</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Neurosci. 1994 Jun;1(1-2):39-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8792224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Sep 1;20(13):2143-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15072998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 1998 Oct 1;84(1-2):49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">9821633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Mar 1;19(4):524-31</Citation><ArticleIdList><ArticleId IdType="pubmed">12611808</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 2005 Nov;94(5):3637-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16014787</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biotechnol. 2001 Oct;19(10):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11587765</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 1995 Feb;73(2):468-84</Citation><ArticleIdList><ArticleId IdType="pubmed">7760112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Neurosci. 2000 May-Jun;8(3):183-208</Citation><ArticleIdList><ArticleId IdType="pubmed">10809012</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 1952 Aug;117(4):500-44</Citation><ArticleIdList><ArticleId IdType="pubmed">12991237</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2009 Jun 10;29(23):7513-7518</Citation><ArticleIdList><ArticleId IdType="pubmed">19515919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Neurosci. 2017 Feb;42(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">27629590</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2017 Sep 1;27(9):4570-4585</Citation><ArticleIdList><ArticleId IdType="pubmed">28637203</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2010 Aug 12;67(3):435-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20696381</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 2003;14(6):1569-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18244602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2017 May 25;20(6):770-773</Citation><ArticleIdList><ArticleId IdType="pubmed">28542156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31162017</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>The American journal of tropical medicine and hygiene</Title><ISOAbbreviation>Am J Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>The Efficacy of Doxycycline Treatment on <i>Mansonella perstans</i> Infection: An Open-Label, Randomized Trial in Ghana.</ArticleTitle><Pagination><MedlinePgn>84-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.18-0491</ELocationID><Abstract><AbstractText>Treating <i>Mansonella perstans</i> is challenged by the low efficacy of registered antihelminthics. <i>Wolbachia</i> endobacteria provide an alternative treatment target because depletion results in amicrofilaremia in filarial infections with <i>Wuchereria bancrofti</i> and <i>Onchocerca volvulus</i> infections. This open-label, randomized study sought to confirm that i) <i>Wolbachia</i> are present in <i>M. perstans</i> in Ghana and ii) doxycycline treatment will deplete <i>Wolbachia</i> and cause a slow, sustained decline in microfilariae (MF). Two hundred and two Ghanaians with <i>M. perstans</i> infection were randomized into early (immediate) and delayed (6 months deferred) treatment groups, given doxycycline 200 mg/day for 6 weeks, and monitored for MF and <i>Wolbachia</i> levels at baseline, 4, 12, and 24 months after the study onset (= time of randomization and start of treatment for the early group). Per protocol analysis revealed that the median MF/mL in the early group declined from 138 at baseline to 64 at month 4 and further to 0 at month 12. In the delayed group, MF load did not change from a baseline median of 97 to 102 at month 4 but declined to 42 at month 12, that is, 6 months after receiving treatment, trailing the early group as expected. By month 24, both treatment groups had reached a median MF level of 0. After treatment, <i>Wolbachia</i> were depleted from MF by ≥ 1-log drop compared with baseline levels. We conclude that <i>M. perstans</i> in Ghana harbor <i>Wolbachia</i> that are effectively depleted by doxycycline with subsequent reduction in MF loads, most likely because of interruption of fertility of adult worms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batsa Debrah</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Richard O</ForeName><Initials>RO</Initials><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfarr</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarmann-Schulz</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opoku</LastName><ForeName>Vera Serwaa</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nausch</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, Neonatology, and Paediatric Cardiology, University Children's Hospital, Heinrich-Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owusu</LastName><ForeName>Wellington</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubarik</LastName><ForeName>Yusif</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Anna-Lena</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lämmer</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritter</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Layland</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Paediatrics, Neonatology, and Paediatric Cardiology, University Children's Hospital, Heinrich-Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debrah</LastName><ForeName>Alexander Yaw</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Faculty of Allied Health Sciences of Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoerauf</LastName><ForeName>Achim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/J01477X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Trop Med Hyg</MedlineTA><NlmUniqueID>0370507</NlmUniqueID><ISSNLinking>0002-9637</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N12000U13O</RegistryNumber><NameOfSubstance UI="D004318">Doxycycline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004318" MajorTopicYN="N">Doxycycline</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008366" MajorTopicYN="Y">Mansonella</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008368" MajorTopicYN="N">Mansonelliasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31162017</ArticleId><ArticleId IdType="doi">10.4269/ajtmh.18-0491</ArticleId><ArticleId IdType="pmc">PMC6609185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2001 May 5;357(9266):1415-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11356444</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasit Vectors. 2017 Jan 7;10(1):15</Citation><ArticleIdList><ArticleId IdType="pubmed">28061905</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2006 Apr 15;42(8):1081-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16575724</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 8;361(15):1502-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19812409</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2003 Apr;5(4):261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12706439</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2003 Feb;192(1):15-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12592559</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Ther. 2009 Nov-Dec;22(6):475-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19889133</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasitol Res. 2003 Aug;90(5):405-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12748849</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Parasitol. 2005;60:245-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16230105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Trop Med Parasitol. 2009 Jan;103(1):31-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19173774</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3414</Citation><ArticleIdList><ArticleId IdType="pubmed">25569210</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2008 Nov;38(11):3101-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18924213</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2016 Aug;49:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27210267</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2006 Sep;2(9):e92</Citation><ArticleIdList><ArticleId IdType="pubmed">17044733</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Marit Health. 2000;51(1-4):51-61</Citation><ArticleIdList><ArticleId IdType="pubmed">11214111</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Parasitol. 2014 Apr;30(4):163-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24636357</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 8;361(15):1448-58</Citation><ArticleIdList><ArticleId IdType="pubmed">19812401</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2003 Nov;192(4):211-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12684759</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasitol Today. 1999 Nov;15(11):437-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10511685</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Sep 15;198(6):920-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18721060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Oct 15;388(10054):1912-1920</Citation><ArticleIdList><ArticleId IdType="pubmed">27495354</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 2009 Mar;103(3):274-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19081121</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Trop. 2011 Sep;120 Suppl 1:S109-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20152790</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8761565</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Nov 15;210(10):1633-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24903665</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jan 21;362(3):272; author reply 272-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20089982</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2016 Jan 21;10(1):e0004319</Citation><ArticleIdList><ArticleId IdType="pubmed">26793972</ArticleId></ArticleIdList></Reference><Reference><Citation>J Helminthol. 2016 Jul;90(4):469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26268068</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 2007 Sep;101(9):899-907</Citation><ArticleIdList><ArticleId IdType="pubmed">17555783</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Dec 16;29(2):247-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21040693</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1000-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24857346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biochem Parasitol. 2008 Aug;160(2):123-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18538871</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2008 Sep;197(3):335</Citation><ArticleIdList><ArticleId IdType="pubmed">27517272</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006184</Citation><ArticleIdList><ArticleId IdType="pubmed">29324739</ArticleId></ArticleIdList></Reference><Reference><Citation>Trop Med Int Health. 2000 Apr;5(4):275-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10810023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Oct 2;376(9747):1175-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20739055</ArticleId></ArticleIdList></Reference><Reference><Citation>Filaria J. 2003 May 9;2(1):10</Citation><ArticleIdList><ArticleId IdType="pubmed">12801420</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2012;6(11):e1890</Citation><ArticleIdList><ArticleId IdType="pubmed">23133692</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2015 Aug 15;61(4):517-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25948064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31150290</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-9185</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Season>Spring</Season></PubDate></JournalIssue><Title>Artificial life</Title><ISOAbbreviation>Artif Life</ISOAbbreviation></Journal><ArticleTitle>How to Make Swarms Open-Ended? Evolving Collective Intelligence Through a Constricted Exploration of Adjacent Possibles.</ArticleTitle><Pagination><MedlinePgn>178-197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1162/artl_a_00288</ELocationID><Abstract><AbstractText>We propose an approach to open-ended evolution via the simulation of swarm dynamics. In nature, swarms possess remarkable properties, which allow many organisms, from swarming bacteria to ants and flocking birds, to form higher-order structures that enhance their behavior as a group. Swarm simulations highlight three important factors to create novelty and diversity: (a) communication generates combinatorial cooperative dynamics, (b) concurrency allows for separation of time scales, and (c) complexity and size increases push the system towards transitions in innovation. We illustrate these three components in a model computing the continuous evolution of a swarm of agents. The results, divided into three distinct applications, show how emergent structures are capable of filtering information through the bottleneck of their memory, to produce meaningful novelty and diversity within their simulated environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Witkowski</LastName><ForeName>Olaf</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Tokyo Institute of Technology, Earth Life Science Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Advanced Study, Princeton. okw@elsi.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikegami</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Tokyo.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Life</MedlineTA><NlmUniqueID>9433814</NlmUniqueID><ISSNLinking>1064-5462</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000819" MajorTopicYN="N">Animal Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005075" MajorTopicYN="Y">Biological Evolution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007360" MajorTopicYN="Y">Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056265" MajorTopicYN="Y">Microbial Interactions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Open-ended evolution</Keyword><Keyword MajorTopicYN="Y">artificial neural networks</Keyword><Keyword MajorTopicYN="Y">collective intelligence</Keyword><Keyword MajorTopicYN="Y">continuous swarm evolution</Keyword><Keyword MajorTopicYN="Y">evolution of cooperation</Keyword><Keyword MajorTopicYN="Y">intrinsic novelty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31150290</ArticleId><ArticleId IdType="doi">10.1162/artl_a_00288</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31150287</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-9185</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Season>Spring</Season></PubDate></JournalIssue><Title>Artificial life</Title><ISOAbbreviation>Artif Life</ISOAbbreviation></Journal><ArticleTitle>Toward Open-Ended Fraternal Transitions in Individuality.</ArticleTitle><Pagination><MedlinePgn>117-133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1162/artl_a_00284</ELocationID><Abstract><AbstractText>The emergence of new replicating entities from the union of simpler entities characterizes some of the most profound events in natural evolutionary history. Such transitions in individuality are essential to the evolution of the most complex forms of life. Thus, understanding these transitions is critical to building artificial systems capable of open-ended evolution. Alas, these transitions are challenging to induce or detect, even with computational organisms. Here, we introduce the DISHTINY (Distributed Hierarchical Transitions in Individuality) platform, which provides simple cell-like organisms with the ability and incentive to unite into new individuals in a manner that can continue to scale to subsequent transitions. The system is designed to encourage these transitions so that they can be studied: Organisms that coordinate spatiotemporally can maximize the rate of resource harvest, which is closely linked to their reproductive ability. We demonstrate the hierarchical emergence of multiple levels of individuality among simple cell-like organisms that evolve parameters for manually designed strategies. During evolution, we observe reproductive division of labor and close cooperation among cells, including resource-sharing, aggregation of resource endowments for propagules, and emergence of an apoptosis response to somatic mutation. Many replicate populations evolved to direct their resources toward low-level groups (behaving like multicellular individuals), and many others evolved to direct their resources toward high-level groups (acting as larger-scale multicellular individuals).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Matthew Andres</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Michigan State University. mmore500@msu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofria</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Michigan State University. ofria@msu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Life</MedlineTA><NlmUniqueID>9433814</NlmUniqueID><ISSNLinking>1064-5462</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005075" MajorTopicYN="Y">Biological Evolution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007206" MajorTopicYN="Y">Individuality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012098" MajorTopicYN="Y">Reproduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Open-ended evolution</Keyword><Keyword MajorTopicYN="Y">cooperation</Keyword><Keyword MajorTopicYN="Y">evolutionary dynamics</Keyword><Keyword MajorTopicYN="Y">fraternal transitions</Keyword><Keyword MajorTopicYN="Y">major transitions in evolution</Keyword><Keyword MajorTopicYN="Y">multicellularity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31150287</ArticleId><ArticleId IdType="doi">10.1162/artl_a_00284</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31119546</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1614-7499</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>21</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Environmental science and pollution research international</Title><ISOAbbreviation>Environ Sci Pollut Res Int</ISOAbbreviation></Journal><ArticleTitle>Heavy metals and PAHs in an open fishing area of the East China Sea: Multimedia distribution, source diagnosis, and dietary risk assessment.</ArticleTitle><Pagination><MedlinePgn>21140-21150</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11356-019-05355-z</ELocationID><Abstract><AbstractText>This study involved a comprehensive investigation of heavy metals and polycyclic aromatic hydrocarbons (PAHs) in seawater, sediments, and seafoods in an important open fishing area connecting China and Japan. Cu, Pb, Cd, Cr, As, and PAHs were detected in all the studied environmental media. Specifically, Pb and low molecular weight PAHs (LMW-PAHs) were observed at high levels, due to intensive ship activities and accidental crude oil spills. Additionally, source diagnosis of PAHs suggested a potential impact from combustion. Bioaccumulation factors (BAFs) and biota-sediment accumulation factors (BSAF) suggested moderate or low bioaccumulation potentials of the analytes from water and sediments, respectively. Noncarcinogenic risk assessment, based on target hazard quotients (THQs), indicated a potential low risk by consuming the studied seafoods, while the incremental lifetime carcinogenic risk assessment (ILCRs) suggested "acceptable risk" or "potential risk." However, it should be noted that there have been possibilities that the carcinogenic risk could be elevated due to bioaccumulation of the PAHs in the seafoods after long-term exposure. In summary, it is necessary to evaluate the seafood security carefully in this open fishing area due to the potential health risks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yiqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Civil and Environmental Engineering, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Juan-Ying</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>College of Marine Ecology and Environment, Shanghai Ocean University, Shanghai, China. jyli@shou.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>18050502100</GrantID><Agency>the Shanghai Municipal Science and Technology Commission</Agency><Country/></Grant><Grant><GrantID>A1-2037-17-000112</GrantID><Agency>the Shanghai Collaborative Innovation Center for Aquatic Animal Genetics and Breeding</Agency><Country/></Grant><Grant><GrantID>A2-2006-00-200366</GrantID><Agency>the Doctoral Research Foundation of Shanghai Ocean University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Environ Sci Pollut Res Int</MedlineTA><NlmUniqueID>9441769</NlmUniqueID><ISSNLinking>0944-1344</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019216">Metals, Heavy</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011084">Polycyclic Aromatic Hydrocarbons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014874">Water Pollutants, Chemical</NameOfSubstance></Chemical><Chemical><RegistryNumber>059QF0KO0R</RegistryNumber><NameOfSubstance UI="D014867">Water</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058448" MajorTopicYN="N">Biota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074341" MajorTopicYN="N">Dietary Exposure</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="Y">Environmental Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019015" MajorTopicYN="N">Geologic Sediments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019216" MajorTopicYN="N">Metals, Heavy</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019212" MajorTopicYN="N">Multimedia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059392" MajorTopicYN="N">Petroleum Pollution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011084" MajorTopicYN="N">Polycyclic Aromatic Hydrocarbons</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017747" MajorTopicYN="N">Seafood</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012623" MajorTopicYN="N">Seawater</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014867" MajorTopicYN="N">Water</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014874" MajorTopicYN="N">Water Pollutants, Chemical</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health risk</Keyword><Keyword MajorTopicYN="N">Heavy metal</Keyword><Keyword MajorTopicYN="N">Polycyclic aromatic hydrocarbons</Keyword><Keyword MajorTopicYN="N">Source diagnosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31119546</ArticleId><ArticleId IdType="doi">10.1007/s11356-019-05355-z</ArticleId><ArticleId IdType="pii">10.1007/s11356-019-05355-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Environ Int. 2001 Jun;26(7-8):505-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11485218</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Technol. 2002 May 1;36(9):1907-18</Citation><ArticleIdList><ArticleId IdType="pubmed">12026970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2003 Aug;46(8):941-53</Citation><ArticleIdList><ArticleId IdType="pubmed">12907187</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Food Sci Nutr. 2005 Jun;56(4):231-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16096134</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Biodivers. 2004 Nov;1(11):1708-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17191811</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2008 Jan;136(1-3):227-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17370131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2009 Jun;58(6):818-26</Citation><ArticleIdList><ArticleId IdType="pubmed">19268317</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2010 May;164(1-4):173-87</Citation><ArticleIdList><ArticleId IdType="pubmed">19373439</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Pollut. 2011 Oct;159(10):2454-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21764195</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2012 Sep;184(9):5755-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22146816</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Pollut. 2012 Mar;162:110-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22243855</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Technol. 2012 May 15;46(10):5310-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22524970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2012 Oct;64(10):2151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22906733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecotoxicol Environ Saf. 2013 Apr;90:151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23352128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecotoxicology. 1996 Aug;5(4):253-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24193815</ArticleId></ArticleIdList></Reference><Reference><Citation>Obes Rev. 2014 Jan;15 Suppl 1:2-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24341753</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Int. 2014 Apr;65:135-46</Citation><ArticleIdList><ArticleId IdType="pubmed">24486971</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Pollut Res Int. 2014 Oct;21(20):12028-39</Citation><ArticleIdList><ArticleId IdType="pubmed">24920262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2014 Nov 15;88(1-2):373-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25148756</ArticleId></ArticleIdList></Reference><Reference><Citation>N Biotechnol. 2015 May 25;32(3):369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">25500720</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Pollut Res Int. 2015 Aug;22(16):12355-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25903171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2015 Dec 30;101(2):930-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26506025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2015 Dec 30;101(2):867-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26563548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2015 Dec 30;101(2):845-51</Citation><ArticleIdList><ArticleId IdType="pubmed">26589640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecotoxicol Environ Saf. 2016 Jun;128:11-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26874984</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Food Sci. 2016;2016:7879097</Citation><ArticleIdList><ArticleId IdType="pubmed">27034924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2016 Nov 15;112(1-2):420-426</Citation><ArticleIdList><ArticleId IdType="pubmed">27491366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2017 Feb 15;115(1-2):489-497</Citation><ArticleIdList><ArticleId IdType="pubmed">27912914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2017 Feb 15;115(1-2):515-524</Citation><ArticleIdList><ArticleId IdType="pubmed">28007386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2017 Feb 15;115(1-2):539-550</Citation><ArticleIdList><ArticleId IdType="pubmed">28012736</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2017 Jun 15;119(1):407-415</Citation><ArticleIdList><ArticleId IdType="pubmed">28343632</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2017 Jun;189(6):247</Citation><ArticleIdList><ArticleId IdType="pubmed">28466449</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Environ Contam Toxicol. 2017 Jul;73(1):103-117</Citation><ArticleIdList><ArticleId IdType="pubmed">28695254</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemosphere. 2017 Oct;185:1090-1111</Citation><ArticleIdList><ArticleId IdType="pubmed">28764111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2017 Oct 15;123(1-2):373-380</Citation><ArticleIdList><ArticleId IdType="pubmed">28899598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2018 Apr;129(2):534-544</Citation><ArticleIdList><ArticleId IdType="pubmed">29108740</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Pollut. 2018 Feb;233:992-1002</Citation><ArticleIdList><ArticleId IdType="pubmed">29122365</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Total Environ. 2018 Sep 1;634:983-989</Citation><ArticleIdList><ArticleId IdType="pubmed">29660892</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Pollut Bull. 2018 Jun;131(Pt A):356-364</Citation><ArticleIdList><ArticleId IdType="pubmed">29886958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Total Environ. 2018 Dec 10;644:298-305</Citation><ArticleIdList><ArticleId IdType="pubmed">29981977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecotoxicol Environ Saf. 2018 Oct 30;162:554-562</Citation><ArticleIdList><ArticleId IdType="pubmed">30029101</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Pollut. 2018 Nov;242(Pt B):1353-1361</Citation><ArticleIdList><ArticleId IdType="pubmed">30130716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecotoxicol Environ Saf. 1997 Feb;36(1):89-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9056405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31082265</PMID><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-9626</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of chemical theory and computation</Title><ISOAbbreviation>J Chem Theory Comput</ISOAbbreviation></Journal><ArticleTitle>Quantum Package 2.0: An Open-Source Determinant-Driven Suite of Programs.</ArticleTitle><Pagination><MedlinePgn>3591-3609</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jctc.9b00176</ELocationID><Abstract><AbstractText>Quantum chemistry is a discipline which relies heavily on very expensive numerical computations. The scaling of correlated wave function methods lies, in their standard implementation, between <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>O</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math> and <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>O</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math> , where N is proportional to the system size. Therefore, performing accurate calculations on chemically meaningful systems requires (i) approximations that can lower the computational scaling and (ii) efficient implementations that take advantage of modern massively parallel architectures. Quantum Package is an open-source programming environment for quantum chemistry specially designed for wave function methods. Its main goal is the development of determinant-driven selected configuration interaction (sCI) methods and multireference second-order perturbation theory (PT2). The determinant-driven framework allows the programmer to include any arbitrary set of determinants in the reference space, hence providing greater methodological freedom. The sCI method implemented in Quantum Package is based on the CIPSI (Configuration Interaction using a Perturbative Selection made Iteratively) algorithm which complements the variational sCI energy with a PT2 correction. Additional external plugins have been recently added to perform calculations with multireference coupled cluster theory and range-separated density-functional theory. All the programs are developed with the IRPF90 code generator, which simplifies collaborative work and the development of new features. Quantum Package strives to allow easy implementation and experimentation of new methods, while making parallel computation as simple and efficient as possible on modern supercomputer architectures. Currently, the code enables, routinely, to realize runs on roughly 2 000 CPU cores, with tens of millions of determinants in the reference space. Moreover, we have been able to push up to 12 288 cores in order to test its parallel efficiency. In the present manuscript, we also introduce some key new developments: (i) a renormalized second-order perturbative correction for efficient extrapolation to the full CI limit and (ii) a stochastic version of the CIPSI selection performed simultaneously to the PT2 calculation at no extra cost.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garniron</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Applencourt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Computational Science Division , Argonne National Laboratory , Argonne , Illinois 60439 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasperich</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2210-5498</Identifier><AffiliationInfo><Affiliation>Computational Science Division , Argonne National Laboratory , Argonne , Illinois 60439 , United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry , University of Pittsburgh , Pittsburgh , Pennsylvania 15260 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benali</LastName><ForeName>Anouar</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2133-0338</Identifier><AffiliationInfo><Affiliation>Computational Science Division , Argonne National Laboratory , Argonne , Illinois 60439 , United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferté</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquier</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradines</LastName><ForeName>Barthélémy</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut des Sciences du Calcul et des Données , Sorbonne Université , F-75005 Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assaraf</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhardt</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8644-7468</Identifier><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toulouse</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbaresco</LastName><ForeName>Pierrette</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CALMIP , Université de Toulouse , CNRS, INPT, INSA, UPS, UMS 3667 , Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renon</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CALMIP , Université de Toulouse , CNRS, INPT, INSA, UPS, UMS 3667 , Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Grégoire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aix-Marseille Univ , CNRS, ICR, Marseille , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malrieu</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0868-8391</Identifier><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Véril</LastName><ForeName>Mickaël</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffarel</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loos</LastName><ForeName>Pierre-François</ForeName><Initials>PF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0598-7425</Identifier><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giner</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6206-1103</Identifier><AffiliationInfo><Affiliation>Laboratoire de Chimie Théorique , Sorbonne Université , CNRS, Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scemama</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie et Physique Quantiques (UMR 5626) , Université de Toulouse , CNRS, UPS, Toulouse , France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Chem Theory Comput</MedlineTA><NlmUniqueID>101232704</NlmUniqueID><ISSNLinking>1549-9618</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31082265</ArticleId><ArticleId IdType="doi">10.1021/acs.jctc.9b00176</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31040096</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-4650</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>The Lancet. Child &amp; adolescent health</Title><ISOAbbreviation>Lancet Child Adolesc Health</ISOAbbreviation></Journal><ArticleTitle>Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.</ArticleTitle><Pagination><MedlinePgn>381-390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2352-4642(19)30114-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-4642(19)30114-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Bloodstream infection is associated with high mortality and serious morbidity in preterm babies. Evidence from clinical trials shows that antimicrobial-impregnated central venous catheters (CVCs) reduce catheter-related bloodstream infection in adults and children receiving intensive care, but there is a paucity of similar evidence for babies receiving neonatal intensive care.</AbstractText><AbstractText Label="METHODS">This open-label, parallel-group, pragmatic, randomised controlled trial was done in 18 neonatal intensive care units in England. Newborn babies who needed a peripherally inserted CVC (PICC) were allocated randomly (1:1) to receive either a PICC impregnated with miconazole and rifampicin or a standard (non-antimicrobial-impregnated) PICC. Random allocation was done with a web-based program, which was centrally controlled to ensure allocation concealment. Randomisation sequences were computer-generated in random blocks of two and four, and stratified by site. Masking of clinicians to PICC allocation was impractical because rifampicin caused brown staining of the antimicrobial-impregnated PICC. However, participant inclusion in analyses and occurrence of outcome events were determined following an analysis plan that was specified before individuals saw the unblinded data. The primary outcome was the time from random allocation to first microbiologically confirmed bloodstream or cerebrospinal fluid (CSF) infection between 24 h after randomisation and 48 h after PICC removal or death. We analysed outcome data according to the intention-to-treat principle. We excluded babies for whom a PICC was not inserted from safety analyses, as these analyses were done with groups defined by the PICC used. This trial is registered with ISRCTN, number 81931394.</AbstractText><AbstractText Label="FINDINGS">Between Aug 12, 2015, and Jan 11, 2017, we randomly assigned 861 babies (754 [88%] born before 32 weeks of gestation) to receive an antimicrobial-impregnated PICC (430 babies) or standard PICC (431 babies). The median time to PICC removal was 8·20 days (IQR 4·77-12·13) in the antimicrobial-impregnated PICC group versus 7·86 days (5·00-12·53) days in the standard PICC group (hazard ratio [HR] 1·03, 95% CI 0·89-1·18, p=0·73), with 46 (11%) of 430 babies versus 44 (10%) of 431 babies having a microbiologically confirmed bloodstream or CSF infection. The time from random allocation to first bloodstream or CSF infection was similar between the two groups (HR 1·11, 95% CI 0·73-1·67, p=0·63). Secondary outcomes relating to infection, rifampicin resistance in positive blood or CSF cultures, mortality, clinical outcomes at neonatal unit discharge, and time to PICC removal were similar between the two groups, although rifampicin resistance in positive cultures of PICC tips was higher in the antimicrobial-impregnated PICC group (relative risk 3·51, 95% CI 1·16-10·57, p=0·018). 60 adverse events were reported from 49 (13%) patients in the antimicrobial-impregnated PICC group and 50 events from 45 (10%) babies in the standard PICC group.</AbstractText><AbstractText Label="INTERPRETATION">We found no evidence of benefit or harm associated with miconazole and rifampicin-impregnated PICCs compared with standard PICCs for newborn babies. Future research should focus on other types of antimicrobial impregnation of PICCs and alternative approaches for preventing infection.</AbstractText><AbstractText Label="FUNDING">UK National Institute for Health Research Health Technology Assessment programme.</AbstractText><CopyrightInformation>Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access license under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK; Health Data Research UK, London, UK. Electronic address: r.gilbert@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rainford</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donohue</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK; Blizard Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorling</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Neonatal-Perinatal Medicine, Dalhousie University IWK Health Centre, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre for Reviews and Dissemination, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamble</LastName><ForeName>Carrol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oddie</LastName><ForeName>Sam J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Centre for Reviews and Dissemination, University of York, York, UK; Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PREVAIL trial team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Child Adolesc Health</MedlineTA><NlmUniqueID>101712925</NlmUniqueID><ISSNLinking>2352-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>FYY3R43WGO</RegistryNumber><NameOfSubstance UI="D008911">Minocycline</NameOfSubstance></Chemical><Chemical><RegistryNumber>VJT6J7R4TR</RegistryNumber><NameOfSubstance UI="D012293">Rifampin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Child Adolesc Health. 2019 Jun;3(6):366-367</RefSource><PMID Version="1">31040095</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2019 Nov 4;367:l4993</RefSource><PMID Version="1">31685481</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055499" MajorTopicYN="N">Catheter-Related Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002405" MajorTopicYN="N">Catheterization, Central Venous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062905" MajorTopicYN="N">Central Venous Catheters</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007363" MajorTopicYN="Y">Intensive Care Units, Neonatal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008911" MajorTopicYN="N">Minocycline</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071074" MajorTopicYN="N">Neonatal Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012293" MajorTopicYN="N">Rifampin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rainford</LastName><ForeName>Naomi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donohue</LastName><ForeName>Chloe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraser</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sinha</LastName><ForeName>Ajay K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dorling</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gray</LastName><ForeName>Jim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGuire</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gamble</LastName><ForeName>Carrol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oddie</LastName><ForeName>Sam J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wane</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hubbard</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Astles</LastName><ForeName>Rosalind</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ewer</LastName><ForeName>Andrew K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranganna</LastName><ForeName>Ranganath</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Booth</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yajamanyam</LastName><ForeName>Phani Kiran</ForeName><Initials>PK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harvey</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aladangady</LastName><ForeName>Narendra</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathew</LastName><ForeName>Asha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilling</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bayliss</LastName><ForeName>Pauline</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maddock</LastName><ForeName>Natasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woodhead</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>MaySze</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dharmaraj</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lodge</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navarra</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roehr</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barlow</LastName><ForeName>Sheula</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yadav</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbott</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Batra</LastName><ForeName>Dushyant</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hooton</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chapman</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Bal Krishnan</ForeName><Initials>BK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ali</LastName><ForeName>Imdad</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lancoma-Malcolm</LastName><ForeName>Ivone</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muller-Pebody</LastName><ForeName>Berit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harron</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moitt</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31040096</ArticleId><ArticleId IdType="pii">S2352-4642(19)30114-2</ArticleId><ArticleId IdType="doi">10.1016/S2352-4642(19)30114-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31020328</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-0929</ISSN><JournalIssue CitedMedium="Internet"><Volume>170</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>08</Month><Day>01</Day></PubDate></JournalIssue><Title>Toxicological sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol Sci</ISOAbbreviation></Journal><ArticleTitle>A Novel Open Access Web Portal for Integrating Mechanistic and Toxicogenomic Study Results.</ArticleTitle><Pagination><MedlinePgn>296-309</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/toxsci/kfz101</ELocationID><Abstract><AbstractText>Applying toxicogenomics to improving the safety profile of drug candidates and crop protection molecules is most useful when it identifies relevant biological and mechanistic information that highlights risks and informs risk mitigation strategies. Pathway-based approaches, such as gene set enrichment analysis, integrate toxicogenomic data with known biological process and pathways. Network methods help define unknown biological processes and offer data reduction advantages. Integrating the 2 approaches would improve interpretation of toxicogenomic information. Barriers to the routine application of these methods in genome-wide transcriptomic studies include a need for "hands-on" computer programming experience, the selection of 1 or more analysis methods (eg pathway analysis methods), the sensitivity of results to algorithm parameters, and challenges in linking differential gene expression to variation in safety outcomes. To facilitate adoption and reproducibility of gene expression analysis in safety studies, we have developed Collaborative Toxicogeomics, an open-access integrated web portal using the Django web framework. The software, developed with the Python programming language, is modular, extensible and implements "best-practice" methods in computational biology. New study results are compared with over 4000 rodent liver experiments from Drug Matrix and open TG-GATEs. A unique feature of the software is the ability to integrate clinical chemistry and histopathology-derived outcomes with results from gene expression studies, leading to relevant mechanistic conclusions. We describe its application by analyzing the effects of several toxicants on liver gene expression and exemplify application to predicting toxicity study outcomes upon chronic treatment from expression changes in acute-duration studies.</AbstractText><CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sutherland</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Indiana Biosciences Research Institute, 1345 W. 16th St. Suite 300, Indianapolis, IN 46202.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paradox Found LLC, 212 Wooded Lake Drive, Apex, NC 27523.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kamin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Corteva AgriscienceTM, Agriculture Division of DowDuPontTM, 9330 Zionsville Rd, Indianapolis, Indiana, 46268.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elango</LastName><ForeName>Navin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Corteva AgriscienceTM, Agriculture Division of DowDuPontTM, 9330 Zionsville Rd, Indianapolis, Indiana, 46268.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Yue W</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Indiana Biosciences Research Institute, 1345 W. 16th St. Suite 300, Indianapolis, IN 46202.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Indiana Biosciences Research Institute, 1345 W. 16th St. Suite 300, Indianapolis, IN 46202.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001572">Benzofurans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>4POG0RL69O</RegistryNumber><NameOfSubstance UI="D001553">Benzbromarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>75CL65GTYR</RegistryNumber><NameOfSubstance UI="C058702">benziodarone</NameOfSubstance></Chemical><Chemical><RegistryNumber>KG60484QX9</RegistryNumber><NameOfSubstance UI="D009853">Omeprazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="Y">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001553" MajorTopicYN="N">Benzbromarone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001572" MajorTopicYN="N">Benzofurans</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009853" MajorTopicYN="N">Omeprazole</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043922" MajorTopicYN="Y">Toxicogenetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">gene expression analysis</Keyword><Keyword MajorTopicYN="Y">mechanism inference</Keyword><Keyword MajorTopicYN="Y">systems biology</Keyword><Keyword MajorTopicYN="Y">toxicity prediction</Keyword><Keyword MajorTopicYN="Y">toxicogenomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31020328</ArticleId><ArticleId IdType="pii">5478579</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfz101</ArticleId><ArticleId IdType="pmc">PMC6657575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Protoc. 2009;4(1):44-57</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2016 Oct 6;17(Suppl 13):368</Citation><ArticleIdList><ArticleId IdType="pubmed">27766956</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2003 Apr;4(2):249-64</Citation><ArticleIdList><ArticleId IdType="pubmed">12925520</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Syst Biol. 2014 Aug 13;8:93</Citation><ArticleIdList><ArticleId IdType="pubmed">25115450</ArticleId></ArticleIdList></Reference><Reference><Citation>PPAR Res. 2007;2007:36092</Citation><ArticleIdList><ArticleId IdType="pubmed">18274627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2014 Sep;32(9):926-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25150839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D743-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25355511</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics J. 2018 May 22;18(3):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28440344</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Toxicol. 2016 Sep;36(9):1137-49</Citation><ArticleIdList><ArticleId IdType="pubmed">26725466</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Sep 29;313(5795):1929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17008526</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Apr;41(8):4378-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23444143</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Sep 16;9(9):e107230</Citation><ArticleIdList><ArticleId IdType="pubmed">25226513</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol Sci. 2014 Feb;137(2):385-403</Citation><ArticleIdList><ArticleId IdType="pubmed">24194394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D921-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25313160</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2018 Nov;19(11):697-712</Citation><ArticleIdList><ArticleId IdType="pubmed">30065390</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2005 Jun 08;6:144</Citation><ArticleIdList><ArticleId IdType="pubmed">15941488</ArticleId></ArticleIdList></Reference><Reference><Citation>Horm Metab Res. 2009 Apr;41(4):327-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19048458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Nov 10;33(20):e175</Citation><ArticleIdList><ArticleId IdType="pubmed">16284200</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicology. 2010 Feb 9;268(3):143-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19788908</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Mar 30;12(3):e1004847</Citation><ArticleIdList><ArticleId IdType="pubmed">27028627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biotechnol. 2005 Sep 29;119(3):219-44</Citation><ArticleIdList><ArticleId IdType="pubmed">16005536</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2019 Jan 22;9:636</Citation><ArticleIdList><ArticleId IdType="pubmed">30723492</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2015 Dec 23;1(6):417-425</Citation><ArticleIdList><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Syst Biol Appl. 2017 Dec 19;4:2</Citation><ArticleIdList><ArticleId IdType="pubmed">29263798</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol Sci. 2016 Apr;150(2):510-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26895641</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31012498</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial).</ArticleTitle><Pagination><MedlinePgn>910-921</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.11147</ELocationID><Abstract><AbstractText Label="BACKGROUND">Minimally invasive distal pancreatectomy decreases time to functional recovery compared with open distal pancreatectomy, but the cost-effectiveness and impact on disease-specific quality of life have yet to be established.</AbstractText><AbstractText Label="METHODS">The LEOPARD trial randomized patients to minimally invasive (robot-assisted or laparoscopic) or open distal pancreatectomy in 14 Dutch centres between April 2015 and March 2017. Use of hospital healthcare resources, complications and disease-specific quality of life were recorded up to 1 year after surgery. Unit costs of hospital healthcare resources were determined, and cost-effectiveness and cost-utility analyses were performed. Primary outcomes were the costs per day earlier functional recovery and per quality-adjusted life-year.</AbstractText><AbstractText Label="RESULTS">All 104 patients who had a distal pancreatectomy (48 minimally invasive and 56 open) in the trial were included in this study. Patients who underwent a robot-assisted procedure were excluded from the cost analysis. Total medical costs were comparable after laparoscopic and open distal pancreatectomy (mean difference €-427 (95 per cent bias-corrected and accelerated confidence interval €-4700 to 3613; P = 0·839). Laparoscopic distal pancreatectomy was shown to have a probability of at least 0·566 of being more cost-effective than the open approach at a willingness-to-pay threshold of €0 per day of earlier recovery, and a probability of 0·676 per additional quality-adjusted life-year at a willingness-to-pay threshold of €80 000. There were no significant differences in cosmetic satisfaction scores (median 9 (i.q.r. 5·75-10) versus 7 (4-8·75); P = 0·056) and disease-specific quality of life after minimally invasive (laparoscopic and robot-assisted procedures) versus open distal pancreatectomy.</AbstractText><AbstractText Label="CONCLUSION">Laparoscopic distal pancreatectomy was at least as cost-effective as open distal pancreatectomy in terms of time to functional recovery and quality-adjusted life-years. Cosmesis and quality of life were similar in the two groups 1 year after surgery.</AbstractText><CopyrightInformation>© 2019 The Authors. BJS published by John Wiley &amp; Sons Ltd on behalf of BJS Society Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Hilst</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strating</LastName><ForeName>E A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Rooij</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daams</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Festen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groot Koerkamp</LastName><ForeName>B</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1917-6973</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaase</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyer</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dijkgraaf</LastName><ForeName>M G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besselink</LastName><ForeName>M G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0003-2650-9350</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Cancer Center Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch Pancreatic Cancer Group and LEOPARD trial collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="Y">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010180" MajorTopicYN="N">Pancreatectomy</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>van Santvoort</LastName><ForeName>H C</ForeName><Initials>HC</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Boer</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boerma</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>van den Boezem</LastName><ForeName>P B</ForeName><Initials>PB</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dam</LastName><ForeName>R M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dejong</LastName><ForeName>C H</ForeName><Initials>CH</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Duyn</LastName><ForeName>E B</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Eijck</LastName><ForeName>C H</ForeName><Initials>CH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerhards</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Hingh</LastName><ForeName>I H</ForeName><Initials>IH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kazemier</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Kleine</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Laarhoven</LastName><ForeName>C J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patijn</LastName><ForeName>G A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steenvoorde</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suker</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hilal</LastName><ForeName>M Abu</ForeName><Initials>MA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31012498</ArticleId><ArticleId IdType="doi">10.1002/bjs.11147</ArticleId><ArticleId IdType="pmc">PMC6594097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dis Colon Rectum. 2001 Dec;44(12):1800-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11742165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16038162</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2007 Jul;142(1):20-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17629996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2019 Mar;269(3):530-536</Citation><ArticleIdList><ArticleId IdType="pubmed">29099396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2009 Aug;250(2):187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 9;12(11):e0187477</Citation><ArticleIdList><ArticleId IdType="pubmed">29121647</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):227-38</Citation><ArticleIdList><ArticleId IdType="pubmed">26882881</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2017 Mar;19(3):225-233</Citation><ArticleIdList><ArticleId IdType="pubmed">28268161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2019 Jan;269(1):2-9</Citation><ArticleIdList><ArticleId IdType="pubmed">30080726</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2017 Mar;161(3):584-591</Citation><ArticleIdList><ArticleId IdType="pubmed">28040257</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2017 Apr 8;18(1):166</Citation><ArticleIdList><ArticleId IdType="pubmed">28388963</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2007 Nov;142(5):761-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17981197</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2000 Dec 15;19(23):3219-36</Citation><ArticleIdList><ArticleId IdType="pubmed">11113956</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2010 Apr;97(4):563-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20175126</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8433390</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2014 Jan;101(2):51-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24281948</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Dec 22;12(12):e0189631</Citation><ArticleIdList><ArticleId IdType="pubmed">29272281</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2017 Mar;19(3):190-204</Citation><ArticleIdList><ArticleId IdType="pubmed">28215904</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2013 Mar-Apr;16(2):231-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23538175</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2016 Oct;40(10):2319-30</Citation><ArticleIdList><ArticleId IdType="pubmed">27146053</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 1998 Nov;12(11):1334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9788857</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2011 Sep;25(9):2871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21424200</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013 Mar 25;346:f1049</Citation><ArticleIdList><ArticleId IdType="pubmed">23529982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2018 Feb;267(2):199-207</Citation><ArticleIdList><ArticleId IdType="pubmed">28657937</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 1990 Dec;16(3):199-208</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2009 Dec;19(6):479-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20027091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Jun;255(6):1048-59</Citation><ArticleIdList><ArticleId IdType="pubmed">22511003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31005385</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>393</Volume><Issue>10186</Issue><PubDate><Year>2019</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.</ArticleTitle><Pagination><MedlinePgn>2125-2134</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(19)30724-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(19)30724-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Phenytoin is the recommended second-line intravenous anticonvulsant for treatment of paediatric convulsive status epilepticus in the UK; however, some evidence suggests that levetiracetam could be an effective and safer alternative. This trial compared the efficacy and safety of phenytoin and levetiracetam for second-line management of paediatric convulsive status epilepticus.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This open-label, randomised clinical trial was undertaken at 30 UK emergency departments at secondary and tertiary care centres. Participants aged 6 months to under 18 years, with convulsive status epilepticus requiring second-line treatment, were randomly assigned (1:1) using a computer-generated randomisation schedule to receive levetiracetam (40 mg/kg over 5 min) or phenytoin (20 mg/kg over at least 20 min), stratified by centre. The primary outcome was time from randomisation to cessation of convulsive status epilepticus, analysed in the modified intention-to-treat population (excluding those who did not require second-line treatment after randomisation and those who did not provide consent). This trial is registered with ISRCTN, number ISRCTN22567894.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Between July 17, 2015, and April 7, 2018, 1432 patients were assessed for eligibility. After exclusion of ineligible patients, 404 patients were randomly assigned. After exclusion of those who did not require second-line treatment and those who did not consent, 286 randomised participants were treated and had available data: 152 allocated to levetiracetam, and 134 to phenytoin. Convulsive status epilepticus was terminated in 106 (70%) children in the levetiracetam group and in 86 (64%) in the phenytoin group. Median time from randomisation to cessation of convulsive status epilepticus was 35 min (IQR 20 to not assessable) in the levetiracetam group and 45 min (24 to not assessable) in the phenytoin group (hazard ratio 1·20, 95% CI 0·91-1·60; p=0·20). One participant who received levetiracetam followed by phenytoin died as a result of catastrophic cerebral oedema unrelated to either treatment. One participant who received phenytoin had serious adverse reactions related to study treatment (hypotension considered to be immediately life-threatening [a serious adverse reaction] and increased focal seizures and decreased consciousness considered to be medically significant [a suspected unexpected serious adverse reaction]).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Although levetiracetam was not significantly superior to phenytoin, the results, together with previously reported safety profiles and comparative ease of administration of levetiracetam, suggest it could be an appropriate alternative to phenytoin as the first-choice, second-line anticonvulsant in the treatment of paediatric convulsive status epilepticus.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">National Institute for Health Research Health Technology Assessment programme.</AbstractText><CopyrightInformation>Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyttle</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Emergency Department, Bristol Royal Hospital for Children, Bristol, UK; Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rainford</LastName><ForeName>Naomi E A</ForeName><Initials>NEA</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, University of Liverpool, Liverpool, UK; Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamble</LastName><ForeName>Carrol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Liverpool, Liverpool, UK; Clinical Trials Research Centre, University of Liverpool, Liverpool, UK; Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messahel</LastName><ForeName>Shrouk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, University of Liverpool, Liverpool, UK; Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickey</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, University of Liverpool, Liverpool, UK; Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolfall</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roper</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noblet</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Elizabeth D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Bristol Royal Hospital for Children, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Trials Research Centre, University of Liverpool, Liverpool, UK; Institute of Child Health, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Vicki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Wrexham, Clwyd, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appleton</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Electronic address: richardappleton55@hotmail.co.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Paediatric Emergency Research in the United Kingdom &amp; Ireland (PERUKI) collaborative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>12/127/134</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>44YRR34555</RegistryNumber><NameOfSubstance UI="D000077287">Levetiracetam</NameOfSubstance></Chemical><Chemical><RegistryNumber>6158TKW0C5</RegistryNumber><NameOfSubstance UI="D010672">Phenytoin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2019 May 25;393(10186):2101-2102</RefSource><PMID Version="1">31005387</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2019 Nov 11;367:l5464</RefSource><PMID Version="1">31712247</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Arch Dis Child Educ Pract Ed. 2020 Oct;105(5):319-320</RefSource><PMID Version="1">31826874</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069279" MajorTopicYN="N">Drug Resistant Epilepsy</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077287" MajorTopicYN="N">Levetiracetam</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010672" MajorTopicYN="N">Phenytoin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013226" MajorTopicYN="N">Status Epilepticus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardwick</LastName><ForeName>Susie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messahel</LastName><ForeName>Shrouk</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noblet</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Elizabeth D</ForeName><Initials>ED</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greenwood-Bibby</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buchanan</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartshorn</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Juliet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyttle</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Daphin</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lavigne-Smith</LastName><ForeName>Holly R</ForeName><Initials>HR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moulsdale</LastName><ForeName>Phoebe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bingham</LastName><ForeName>Tracey</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ross</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Natasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hacking</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mullen</LastName><ForeName>Niall</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corrigan</LastName><ForeName>Paul P</ForeName><Initials>PP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prudhoe</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faza</LastName><ForeName>Hani</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Gisela</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sunley</LastName><ForeName>Rachel C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Coral J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unsworth</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Criddle</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laque</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheedy</LastName><ForeName>Alyce B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devine</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kumar</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sutherland</LastName><ForeName>Emer</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cantle</LastName><ForeName>Fleur</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helyer</LastName><ForeName>Sinead</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riozzi</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cotton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Downes</LastName><ForeName>Alice J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mollard</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roland</LastName><ForeName>Damian</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hay</LastName><ForeName>Felix</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gough</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finucane</LastName><ForeName>Sonya</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bevan</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramsay</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walton</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maney</LastName><ForeName>Julie-Ann</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalzell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Millar</LastName><ForeName>Muriel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Howells</LastName><ForeName>Rachel J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Appelboam</LastName><ForeName>Andy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mackle</LastName><ForeName>Daisy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Small</LastName><ForeName>Jennie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neil</LastName><ForeName>Ashleigh</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choudhery</LastName><ForeName>Vince</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Stewart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Browning</LastName><ForeName>Jen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grahamslaw</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parikh</LastName><ForeName>Ami</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skene</LastName><ForeName>Imogen</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Rhys</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potier de la Morandiere</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>Jill L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danziger</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burke</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramlakhan</LastName><ForeName>Shammi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Jayne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morcombe</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gormley</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barling</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cathie</LastName><ForeName>Katrina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bayreuther</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ensom</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Yasser</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rounding</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulligan</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLellan</LastName><ForeName>Shona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leighton</LastName><ForeName>Shona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sajjanhar</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyirenda</LastName><ForeName>Maggie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crome</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alcock</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edwards</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Powell</LastName><ForeName>Colin Ve</ForeName><Initials>CV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramesh</LastName><ForeName>Chaniyil A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamal-Uddin</LastName><ForeName>Solomon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linney</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vamvakiti</LastName><ForeName>Katia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Floyd</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hobden</LastName><ForeName>Gill</ForeName><Initials>G</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31005385</ArticleId><ArticleId IdType="pii">S0140-6736(19)30724-X</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(19)30724-X</ArticleId><ArticleId IdType="pmc">PMC6551349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurol. 2012 Apr;259(4):645-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21898137</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2018 Jan 10;1:CD001905</Citation><ArticleIdList><ArticleId IdType="pubmed">29320603</ArticleId></ArticleIdList></Reference><Reference><Citation>Epilepsy Res. 2015 Aug;114:52-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26088885</ArticleId></ArticleIdList></Reference><Reference><Citation>Epilepsy Behav. 2016 Nov;64(Pt A):110-115</Citation><ArticleIdList><ArticleId IdType="pubmed">27736657</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2014 Jun;99(6):602-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24615624</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurocrit Care. 2005;3(2):161-70</Citation><ArticleIdList><ArticleId IdType="pubmed">16174888</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Med Child Neurol. 2004 Jan;46(1):4-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14974641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 Jul 15;368(9531):222-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16844492</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2005 Oct 25;65(8):1316-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16247069</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2017 Jun;96(25):e7206</Citation><ArticleIdList><ArticleId IdType="pubmed">28640109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Neurosci. 2018 Apr-Jun;13(2):158-164</Citation><ArticleIdList><ArticleId IdType="pubmed">30090128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurosci. 2015 Jun;22(6):959-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25899652</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2014 May 15;4(5):e005045</Citation><ArticleIdList><ArticleId IdType="pubmed">24833694</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizure. 2007 Jun;16(4):305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17292636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Jul 16-22;366(9481):205-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16023510</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2017 Jun 19;18(1):283</Citation><ArticleIdList><ArticleId IdType="pubmed">28629473</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizure. 2012 Sep;21(7):529-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22722010</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2007 Nov;92(11):948-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17954477</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Emerg Care. 2009 Feb;25(2):83-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19194344</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2019 May;104(5):426-431</Citation><ArticleIdList><ArticleId IdType="pubmed">30087153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2009 Mar;2(2):79-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21180643</ArticleId></ArticleIdList></Reference><Reference><Citation>Epilepsia. 2013 Jan;54(1):45-57</Citation><ArticleIdList><ArticleId IdType="pubmed">22738092</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizure. 2003 Sep;12(6):369-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12915082</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2019 Mar 21;20(1):181</Citation><ArticleIdList><ArticleId IdType="pubmed">30898169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31004794</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0240</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>Insect biochemistry and molecular biology</Title><ISOAbbreviation>Insect Biochem Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Synergism of open chromatin regions involved in regulating genes in Bombyx mori.</ArticleTitle><Pagination><MedlinePgn>10-18</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0965-1748(18)30480-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ibmb.2019.04.014</ELocationID><Abstract><AbstractText>The dynamic variability of transcription factors (TFs) and their binding sites makes it challenging to conduct genome-wide transcription regulation research. The silkworm Bombyx mori, which produces silk, is one of the most valuable model insects in the order Lepidoptera. The "opening" and "closing" of chromatin in different silk yield strains is associated with changes in silk production, making this insect a good model for studying the transcriptional regulation of genes. However, few studies have examined the open chromatin regions (OCRs) of silkworms, and studying OCR synergism and their function in silk production remains challenging. Here, we performed formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate OCRs from the silk glands of fifth-instar larvae of the DaZao and D872 strains. In total, 128,908 high confidence OCRs were identified and approximately 80% of OCRs were located in non-coding regions. OCRs upregulated adjacent genes and showed signal-dependent vulnerability to single-nucleotide polymorphisms. Mid- and low-signal OCRs were more likely to have single-nucleotide polymorphisms (SNP). Further, OCRs interacted with each other within a distance of 5 kb. We named the OCR interaction complex as the "cluster of related regions" (COREs). The functions of the CORE and its harbored OCRs showed some differences. Additionally, COREs enriched many silk protein synthesis-associated genes, some of which were upregulated. This study identified numerous high confidence regulation sites and synergistic regulatory modes of OCRs that affect adjacent genes. These results provide insight into silkworm transcriptional regulation and improve our understanding of cis-element cooperation.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Biological Science Research Center, Southwest University, Chongqing 400715, China; State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Tingcai</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China. Electronic address: chengtc@swu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yueting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biological Science Research Center, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Tieshan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaohong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lihaoyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhiqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Biological Science Research Center, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Qingyou</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Biological Science Research Center, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China. Electronic address: xiaqy@swu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Huawei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biological Science Research Center, Southwest University, Chongqing 400715, China; Chongqing Key Laboratory of Sericultural Science, Chongqing Engineering and Technology Research Center for Novel Silk Materials, Southwest University, Chongqing 400715, China. Electronic address: hehuawei@swu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Insect Biochem Mol Biol</MedlineTA><NlmUniqueID>9207282</NlmUniqueID><ISSNLinking>0965-1748</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002843">Chromatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019476">Insect Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047011">Silk</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012831" MajorTopicYN="N">Bombyx</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="N">Chromatin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019476" MajorTopicYN="N">Insect Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007814" MajorTopicYN="N">Larva</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047011" MajorTopicYN="N">Silk</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Formaldehyde-assisted isolation of regulatory elements-sequencing</Keyword><Keyword MajorTopicYN="Y">Open chromatin regions</Keyword><Keyword MajorTopicYN="Y">Silkworm</Keyword><Keyword MajorTopicYN="Y">Synergism</Keyword><Keyword MajorTopicYN="Y">Transcriptional regulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31004794</ArticleId><ArticleId IdType="pii">S0965-1748(18)30480-6</ArticleId><ArticleId IdType="doi">10.1016/j.ibmb.2019.04.014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31003911</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.</ArticleTitle><Pagination><MedlinePgn>849-861</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(19)30027-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(19)30027-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Microsatellite-stable metastatic colorectal cancer is typically unresponsive to immunotherapy. This phase 3 study was designed to assess atezolizumab plus cobimetinib in metastatic colorectal cancer. Here, we report the comparison of atezolizumab plus cobimetinib or atezolizumab monotherapy versus regorafenib in the third-line setting.</AbstractText><AbstractText Label="METHODS">IMblaze 370 is a multicentre, open-label, phase 3, randomised, controlled trial, done at 73 academic medical centres and community oncology practices in 11 countries. Patients aged at least 18 years with unresectable locally advanced or metastatic colorectal cancer, baseline Eastern Cooperative Oncology Group performance status of 0-1, and disease progression on or intolerance to at least two previous systemic chemotherapy regimens were enrolled. We used permuted-block randomisation (block size four) to assign patients (2:1:1) via an interactive voice and web response system to atezolizumab (840 mg intravenously every 2 weeks) plus cobimetinib (60 mg orally once daily for days 1-21 of a 28-day cycle), atezolizumab monotherapy (1200 mg intravenously every 3 weeks), or regorafenib (160 mg orally once daily for days 1-21 of a 28-day cycle). Stratification factors were extended RAS status (wild-type vs mutant) and time since diagnosis of first metastasis (&lt;18 months vs ≥18 months). Recruitment of patients with high microsatellite instability was capped at 5%. The primary endpoint was overall survival in the intention-to-treat population. Safety was assessed in the population of patients who received at least one dose of their assigned treatment. IMblaze370 is ongoing and is registered with ClinicalTrials.gov, number NCT02788279.</AbstractText><AbstractText Label="FINDINGS">Between July 27, 2016, and Jan 19, 2017, 363 patients were enrolled (183 patients in the atezolizumab plus cobimetinib group, 90 in the atezolizumab group, and 90 in the regorafenib group). At data cutoff (March 9, 2018), median follow-up was 7·3 months (IQR 3·7-13·6). Median overall survival was 8·87 months (95% CI 7·00-10·61) with atezolizumab plus cobimetinib, 7·10 months (6·05-10·05) with atezolizumab, and 8·51 months (6·41-10·71) with regorafenib; the hazard ratio was 1·00 (95% CI 0·73-1·38; p=0·99) for the combination versus regorafenib and 1·19 (0·83-1·71; p=0·34) for atezolizumab versus regorafenib. Grade 3-4 adverse events were reported in 109 (61%) of 179 patients in the atezolizumab plus cobimetinib group, 28 (31%) of 90 in the atezolizumab group, and 46 (58%) of 80 in the regorafenib group. The most common all-cause grade 3-4 adverse events in the combination group were diarrhoea (20 [11%] of 179), anaemia (ten [6%]), increased blood creatine phosphokinase (12 [7%]), and fatigue (eight [4%]). Serious adverse events were reported in 71 (40%) of 179 patients in the combination group, 15 (17%) of 90 in the atezolizumab group, and 18 (23%) of 80 in the regorafenib group. Two treatment-related deaths occurred in the combination group (sepsis) and one in the regorafenib group (intestinal perforation).</AbstractText><AbstractText Label="INTERPRETATION">IMblaze370 did not meet its primary endpoint of improved overall survival with atezolizumab plus cobimetinib or atezolizumab versus regorafenib. The safety of atezolizumab plus cobimetinib was consistent with those of the individual drugs. These results underscore the challenge of expanding the benefit of immunotherapy to patients whose tumours have lower baseline levels of immune inflammation, such as those with microsatellite-stable metastatic colorectal cancer.</AbstractText><AbstractText Label="FUNDING">F Hoffmann-La Roche Ltd/Genentech Inc.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eng</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Won</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Asan Medical Center, University of Ulsan, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendell</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argilés</LastName><ForeName>Guillem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Vall d'Hebrón Institute of Oncology, Vall d'Hebrón University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebbutt</LastName><ForeName>Niall C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Medical Oncology, Austin Health, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Bartolomeo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakih</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>City of Hope, Duarte, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozloff</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Neil H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobrero</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale San Martino IST, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yibing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Genentech Inc, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ilsung</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Genentech Inc, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyei</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genentech Inc, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Genentech Inc, South San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciardiello</LastName><ForeName>Fortunato</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. Electronic address: fortunato.ciardiello@unicampania.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>IMblaze370 Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02788279</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001384">Azetidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010671">Phenylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>24T2A1DOYB</RegistryNumber><NameOfSubstance UI="C559147">regorafenib</NameOfSubstance></Chemical><Chemical><RegistryNumber>52CMI0WC3Y</RegistryNumber><NameOfSubstance UI="C000594389">atezolizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>ER29L26N1X</RegistryNumber><NameOfSubstance UI="C574276">cobimetinib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2019 Jun;20(6):752-753</RefSource><PMID Version="1">31003912</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet Oncol. 2019 Jun;20(6):e293</RefSource><PMID Version="1">31162101</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Transl Med. 2019 Nov;7(21):602</RefSource><PMID Version="1">32047763</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001384" MajorTopicYN="N">Azetidines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010671" MajorTopicYN="N">Phenylurea Compounds</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="Y">Salvage Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Ahn</LastName><ForeName>J B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asselah</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badarinath</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baijal</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Begbie</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canon</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carbone</LastName><ForeName>R G</ForeName><Initials>RG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cervantes</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cha</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chmielowska</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cho</LastName><ForeName>S H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chu</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couture</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cultrera</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cunningham</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Cutsem</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuyle</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davies</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dowden</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dvorkin</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ganju</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia</LastName><ForeName>R V</ForeName><Initials>RV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerr</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>T Y</ForeName><Initials>TY</Initials></Investigator><Investigator ValidYN="Y"><LastName>King</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kortmansky</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kozloff</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lam</LastName><ForeName>K O</ForeName><Initials>KO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>A S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lesperance</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luppi</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maiello</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mandanas</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marx</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mullamitha</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nechaeva</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>J O</ForeName><Initials>JO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pavlakis</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ponce</LastName><ForeName>C G</ForeName><Initials>CG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potemski</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raouf</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reeves</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segal</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siena</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smolin</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Streb</LastName><ForeName>J O</ForeName><Initials>JO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strickland</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szutowicz-Zielinska</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tabernero</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tan</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valera</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van den Eynde</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vergauwe</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vickers</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Womack</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wroblewska</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31003911</ArticleId><ArticleId IdType="pii">S1470-2045(19)30027-0</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(19)30027-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30994258</PMID><DateRevised><Year>2019</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-3773</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>25</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>Angewandte Chemie (International ed. in English)</Title><ISOAbbreviation>Angew Chem Int Ed Engl</ISOAbbreviation></Journal><ArticleTitle>Induced Fit of C<sub>2</sub> H<sub>2</sub> in a Flexible MOF Through Cooperative Action of Open Metal Sites.</ArticleTitle><Pagination><MedlinePgn>8515-8519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201904160</ELocationID><Abstract><AbstractText>Porous materials that can undergo pore-structure adjustment to better accommodate specific molecules are ideal for separation and purification. Here, we report a stable microporous metal-organic framework, JNU-1, featuring one-dimensional diamond-shaped channels with a high density of open metal sites arranged on the surface for the cooperative binding of acetylene. Together with its framework flexibility and appropriate pore geometry, JNU-1 exhibits an induced-fit behavior for acetylene. The specific binding sites and continuous framework adaptation upon increased acetylene pressure are validated by molecular modeling and in situ X-ray diffraction study. This unique induced-fit behavior endows JNU-1 with an unprecedented increase in the acetylene binding affinity (adsorption enthalpy: up to 47.6 kJ mol<sup>-1</sup> at ca. 2.0 mmol g<sup>-1</sup> loading).</AbstractText><CopyrightInformation>© 2019 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Mo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yong-Liang</ForeName><Initials>YL</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1569-014X</Identifier><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yifang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xiao-Jing</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Jian-Ping</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Meng-Yan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Rajamani</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4784-8530</Identifier><AffiliationInfo><Affiliation>Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Weigang</ForeName><Initials>W</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9751-8241</Identifier><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4936-4599</Identifier><AffiliationInfo><Affiliation>College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Nos. 21731002, 91222202</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angew Chem Int Ed Engl</MedlineTA><NlmUniqueID>0370543</NlmUniqueID><ISSNLinking>1433-7851</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">binding affinity</Keyword><Keyword MajorTopicYN="N">cooperative action</Keyword><Keyword MajorTopicYN="N">gas separation</Keyword><Keyword MajorTopicYN="N">induced fit</Keyword><Keyword MajorTopicYN="N">porous materials</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30994258</ArticleId><ArticleId IdType="doi">10.1002/anie.201904160</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33191949</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0022-3727</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>16</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of physics D: Applied physics</Title><ISOAbbreviation>J Phys D Appl Phys</ISOAbbreviation></Journal><ArticleTitle>NanoJ: a high-performance open-source super-resolution microscopy toolbox.</ArticleTitle><Pagination><MedlinePgn>163001</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1088/1361-6463/ab0261</ELocationID><Abstract><AbstractText>Super-resolution microscopy (SRM) has become essential for the study of nanoscale biological processes. This type of imaging often requires the use of specialised image analysis tools to process a large volume of recorded data and extract quantitative information. In recent years, our team has built an open-source image analysis framework for SRM designed to combine high performance and ease of use. We named it NanoJ-a reference to the popular ImageJ software it was developed for. In this paper, we highlight the current capabilities of NanoJ for several essential processing steps: spatio-temporal alignment of raw data (NanoJ-Core), super-resolution image reconstruction (NanoJ-SRRF), image quality assessment (NanoJ-SQUIRREL), structural modelling (NanoJ-VirusMapper) and control of the sample environment (NanoJ-Fluidics). We expect to expand NanoJ in the future through the development of new tools designed to improve quantitative data analysis and measure the reliability of fluorescent microscopy studies.</AbstractText><CopyrightInformation>© 2019 IOP Publishing Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laine</LastName><ForeName>Romain F</ForeName><Initials>RF</Initials><Identifier Source="ORCID">0000-0002-2151-4487</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosheva</LastName><ForeName>Kalina L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gustafsson</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Mathematics and Physics in Life Sciences and Experimental Biology (CoMPLEX), University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Robert D M</ForeName><Initials>RDM</Initials><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Mathematics and Physics in Life Sciences and Experimental Biology (CoMPLEX), University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almada</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrecht</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9455-1134</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risa</LastName><ForeName>Gabriel T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurtig</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindås</LastName><ForeName>Ann-Christin</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-0368-3295</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baum</LastName><ForeName>Buzz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9201-6186</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercer</LastName><ForeName>Jason</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1466-9541</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leterrier</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2957-2032</Identifier><AffiliationInfo><Affiliation>CNRS, INP, Institute of Neurophysiopathology, NeuroCyto, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Pedro M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-1426-9540</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>p.pereira@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culley</LastName><ForeName>Siân</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2112-0143</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>s.culley@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2043-5234</Identifier><AffiliationInfo><Affiliation>MRC-Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for the Physics of Living Systems, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>r.henriques@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/M022374/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/P001440/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K015826/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Phys D Appl Phys</MedlineTA><NlmUniqueID>1256300</NlmUniqueID><ISSNLinking>0022-3727</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fiji</Keyword><Keyword MajorTopicYN="N">ImageJ</Keyword><Keyword MajorTopicYN="N">fluidics</Keyword><Keyword MajorTopicYN="N">image analysis</Keyword><Keyword MajorTopicYN="N">image quality assessment</Keyword><Keyword MajorTopicYN="N">single-particle analysis</Keyword><Keyword MajorTopicYN="N">super-resolution microscopy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>16</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33191949</ArticleId><ArticleId IdType="doi">10.1088/1361-6463/ab0261</ArticleId><ArticleId IdType="pii">dab0261</ArticleId><ArticleId IdType="pmc">PMC7655149</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Dev Cell. 2018 Apr 9;45(1):132-145.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">29634933</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2018 Dec;15(12):1090-1097</Citation><ArticleIdList><ArticleId IdType="pubmed">30478326</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 1994 Jun 1;19(11):780-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19844443</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 May 29;109(22):8564-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22586087</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol Sci. 2009 Apr;8(4):465-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19337659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2011 Nov 06;8(12):1027-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22056676</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1419-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15668396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2006 Oct;3(10):793-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16896339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2017 Dec;14(12):1184-1190</Citation><ArticleIdList><ArticleId IdType="pubmed">29083400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jul 04;6:29132</Citation><ArticleIdList><ArticleId IdType="pubmed">27374400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Oct 20;5:15348</Citation><ArticleIdList><ArticleId IdType="pubmed">26481189</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Cell Biol. 2015;125:95-117</Citation><ArticleIdList><ArticleId IdType="pubmed">25640426</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microsc. 2000 May;198(Pt 2):82-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10810003</ArticleId></ArticleIdList></Reference><Reference><Citation>Biopolymers. 2011 May;95(5):322-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21254001</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2017 Apr 9;(122):</Citation><ArticleIdList><ArticleId IdType="pubmed">28448005</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Mar 2;12(3):e0172943</Citation><ArticleIdList><ArticleId IdType="pubmed">28253349</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2013 May 6;21(9):10978-88</Citation><ArticleIdList><ArticleId IdType="pubmed">23669954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Photonics. 2016 Nov;10(11):705-708</Citation><ArticleIdList><ArticleId IdType="pubmed">27818707</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2015 Oct 15;88:109-21</Citation><ArticleIdList><ArticleId IdType="pubmed">26079924</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Jan 22;6:5980</Citation><ArticleIdList><ArticleId IdType="pubmed">25609143</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22287-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20018714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jun 28;9(7):676-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2019 Mar 15;10(1):1223</Citation><ArticleIdList><ArticleId IdType="pubmed">30874553</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2017 May;12(5):988-1010</Citation><ArticleIdList><ArticleId IdType="pubmed">28406496</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Dev Biol. 2009;53(8-10):1569-79</Citation><ArticleIdList><ArticleId IdType="pubmed">19247949</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4275-4284</Citation><ArticleIdList><ArticleId IdType="pubmed">30770448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Aug 15;30(16):2389-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24771516</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Jun;10(6):557-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23624665</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechnol J. 2009 Jun;4(6):846-57</Citation><ArticleIdList><ArticleId IdType="pubmed">19548237</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biochem Cell Biol. 2018 Aug;101:74-79</Citation><ArticleIdList><ArticleId IdType="pubmed">29852248</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsc Microanal. 2012 Dec;18(6):1419-29</Citation><ArticleIdList><ArticleId IdType="pubmed">23113972</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2018 Dec 13;7:</Citation><ArticleIdList><ArticleId IdType="pubmed">30543181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Oct 05;6:34486</Citation><ArticleIdList><ArticleId IdType="pubmed">27703238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2018 Apr;15(4):263-266</Citation><ArticleIdList><ArticleId IdType="pubmed">29457791</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2018 Oct;15(10):777-780</Citation><ArticleIdList><ArticleId IdType="pubmed">30275574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2010 May;7(5):339-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20431545</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Sep 15;313(5793):1642-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16902090</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Aug 9;341(6146):655-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23845946</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2011 Aug 1;19(16):15009-19</Citation><ArticleIdList><ArticleId IdType="pubmed">21934862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Nov 03;5:15915</Citation><ArticleIdList><ArticleId IdType="pubmed">26525406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2011 Dec 04;9(2):195-200</Citation><ArticleIdList><ArticleId IdType="pubmed">22138825</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Aug 12;7:12471</Citation><ArticleIdList><ArticleId IdType="pubmed">27514992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2014 Mar;11(3):313-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24487583</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30911325</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1749-7922</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>World journal of emergency surgery : WJES</Title><ISOAbbreviation>World J Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Intra-operative gallbladder scoring predicts conversion of laparoscopic to open cholecystectomy: a WSES prospective collaborative study.</ArticleTitle><Pagination><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13017-019-0230-9</ELocationID><Abstract><AbstractText Label="Introduction">Laparoscopic cholecystectomy, the gold-standard approach for cholecystectomy, has surprisingly variable outcomes and conversion rates. Only recently has operative grading been reported to define disease severity and few have been validated. This multicentre, multinational study assessed an operative scoring system to assess its ability to predict the need for conversion from laparoscopic to open cholecystectomy.</AbstractText><AbstractText Label="Methods">A prospective, web-based, ethically approved study was established by WSES with a 10-point gallbladder operative scoring system; enrolling patients undergoing elective or emergency laparoscopic cholecystectomy between January 2016 and December 2017. Gallbladder surgery was considered easy if the G10 score &lt; 2, moderate (2 ≦ 4), difficult (5 ≦ 7) and extreme (8 ≦ 10). Demographics about the patients, surgeons and operative procedures, use of cholangiography and conversion rates were recorded.</AbstractText><AbstractText Label="Results">Five hundred four patients, mean age 53.5 (range 18-89), were enrolled by 55 surgeons in 16 countries. Surgery was performed by consultants in 70% and was elective in (56%) with a mean operative time of 78.7 min (range 15-400). The mean G10 score was 3.21, with 22% deemed to have difficult or extreme surgical gallbladders, and 71/504 patients were converted. The G10 score was 2.98 in those completed laparoscopically and 4.65 in the 71/504 (14%) converted. (<i>p</i> &lt;  0.0001; AUC 0.772 (CI 0.719-0.825). The optimal cut-off point of 0.067 (score of 3) was identified in G10 vs conversion to open cholecystectomy. Conversion occurred in 33% of patients with G10 scores of ≥ 5. The four variables statistically predictive of conversion were GB appearance-completely buried GB, impacted stone, bile or pus outside GB and fistula.</AbstractText><AbstractText Label="Conclusion">The G10 operative scores provide simple grading of operative cholecystectomy and are predictive of the need to convert to open cholecystectomy. Broader adaptation and validation may provide a benchmark to understand and improve care and afford more standardisation in global comparisons of care for cholecystectomy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4155-124X</Identifier><AffiliationInfo><Affiliation>1Donegal Clinical Research Academy, Letterkenny University Hospital, Donegal, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coccolini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Papa Giovanni Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucholc</LastName><ForeName>Magda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3EU INTERREG Centre for Personalised Medicine, Intelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Magee Campus, Derry~Londonderry, Northern Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Donegal Clinical Research Academy, Letterkenny University Hospital, Donegal, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Contributors from WSES</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Emerg Surg</MedlineTA><NlmUniqueID>101266603</NlmUniqueID><ISSNLinking>1749-7922</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002758" MajorTopicYN="N">Cholangiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002763" MajorTopicYN="N">Cholecystectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017081" MajorTopicYN="N">Cholecystectomy, Laparoscopic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061887" MajorTopicYN="N">Conversion to Open Surgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005704" MajorTopicYN="N">Gallbladder</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Cholecystitis</Keyword><Keyword MajorTopicYN="Y">Conversion to open cholecystectomy</Keyword><Keyword MajorTopicYN="Y">Index surgery</Keyword><Keyword MajorTopicYN="Y">Operative severity scoring system</Keyword><Keyword MajorTopicYN="Y">Surgical outcomes</Keyword></KeywordList><CoiStatement>Not applicableEthical approval for the audit was obtained from each contributor’s individual institution. Consent to participate was not applicable.Not applicableMichael Sugrue is a consultant with Smith &amp; Nephew and Acelity.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Manatakis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ioannidis</LastName><ForeName>Orestis</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonilauri</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gachabayov</LastName><ForeName>Mahir</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isik</LastName><ForeName>Arda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghnnam</LastName><ForeName>Wagih</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelat</LastName><ForeName>Vishal</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aremu</LastName><ForeName>Muyiwa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohan</LastName><ForeName>Rajashekar</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montori</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walędziak</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pisarska</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kong</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strzałka</LastName><ForeName>Marcin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fugazzola</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nita</LastName><ForeName>Gabriela Elisa</ForeName><Initials>GE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nardi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Major</LastName><ForeName>Piotr</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Negoi</LastName><ForeName>Ionut</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allegri</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Konstantoudakis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Carlo</LastName><ForeName>Isidoro</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massalou</LastName><ForeName>Damien</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solaini</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceresoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomasoni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Litvin</LastName><ForeName>Andrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Simone</LastName><ForeName>Belinda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lostoridis</LastName><ForeName>Eftychios</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Fernando</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panyor</LastName><ForeName>Gabor</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machain V</LastName><ForeName>Gustavo M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pentara</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baiocchi</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Kin Cheung</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ansaloni</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arellano</LastName><ForeName>Miguel Leon</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savala</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couse</LastName><ForeName>Neville</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>McBride</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30911325</ArticleId><ArticleId IdType="doi">10.1186/s13017-019-0230-9</ArticleId><ArticleId IdType="pii">230</ArticleId><ArticleId IdType="pmc">PMC6417130</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Surg Res. 2018 Sep;229:186-191</Citation><ArticleIdList><ArticleId IdType="pubmed">29936988</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatobiliary Pancreat Sci. 2016 Jan;23(1):65-73</Citation><ArticleIdList><ArticleId IdType="pubmed">26580708</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2018 Apr;215(4):625-630</Citation><ArticleIdList><ArticleId IdType="pubmed">28619262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):73-86</Citation><ArticleIdList><ArticleId IdType="pubmed">29095575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2014 Jan;259(1):16-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24326747</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2015 Mar 08;10:14</Citation><ArticleIdList><ArticleId IdType="pubmed">25870652</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2018 Feb;84(2):280-286</Citation><ArticleIdList><ArticleId IdType="pubmed">29194319</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2018 Apr;163(4):739-746</Citation><ArticleIdList><ArticleId IdType="pubmed">29325783</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2017 Jul;31(7):2892-2900</Citation><ArticleIdList><ArticleId IdType="pubmed">27804044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2018 Aug;268(2):247-253</Citation><ArticleIdList><ArticleId IdType="pubmed">29533266</ArticleId></ArticleIdList></Reference><Reference><Citation>JSLS. 2002 Jan-Mar;6(1):59-63</Citation><ArticleIdList><ArticleId IdType="pubmed">12002299</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2019 Jan;217(1):193</Citation><ArticleIdList><ArticleId IdType="pubmed">29397886</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2018 Mar 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">29525733</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2018 Nov;216(5):949-954</Citation><ArticleIdList><ArticleId IdType="pubmed">29631908</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2018 Jul;32(7):3149-3157</Citation><ArticleIdList><ArticleId IdType="pubmed">29340820</ArticleId></ArticleIdList></Reference><Reference><Citation>HPB (Oxford). 2016 Nov;18(11):922-928</Citation><ArticleIdList><ArticleId IdType="pubmed">27591176</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2018 Apr;84(4):650-654</Citation><ArticleIdList><ArticleId IdType="pubmed">29271871</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2016 Nov;103(12):1704-1715</Citation><ArticleIdList><ArticleId IdType="pubmed">27561954</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2015 Sep;210(3):492-500</Citation><ArticleIdList><ArticleId IdType="pubmed">26094149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2011 May;212(5):835-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21398156</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2018 Sep;164(3):525-529</Citation><ArticleIdList><ArticleId IdType="pubmed">29945783</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2018 Nov;164(5):1030-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">30054013</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2016 Jun 14;11:25</Citation><ArticleIdList><ArticleId IdType="pubmed">27307785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Jan 24;351(9098):248-51</Citation><ArticleIdList><ArticleId IdType="pubmed">9457094</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2012 Feb;214(2):196-201</Citation><ArticleIdList><ArticleId IdType="pubmed">22192897</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2018 Jul;105(8):1014-1019</Citation><ArticleIdList><ArticleId IdType="pubmed">29663311</ArticleId></ArticleIdList></Reference><Reference><Citation>JSLS. 1998 Oct-Dec;2(4):341-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10036125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):578-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22872303</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2012 Oct 11;345:e6457</Citation><ArticleIdList><ArticleId IdType="pubmed">23060654</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2018 Jul;216(1):116-119</Citation><ArticleIdList><ArticleId IdType="pubmed">29128102</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2017 Oct 23;12:47</Citation><ArticleIdList><ArticleId IdType="pubmed">29075316</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Gastroenterol. 2016;51(4):465-71</Citation><ArticleIdList><ArticleId IdType="pubmed">26784974</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30907482</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-4095</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>18</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Advanced materials (Deerfield Beach, Fla.)</Title><ISOAbbreviation>Adv Mater</ISOAbbreviation></Journal><ArticleTitle>Fabricating Single-Atom Catalysts from Chelating Metal in Open Frameworks.</ArticleTitle><Pagination><MedlinePgn>e1808193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/adma.201808193</ELocationID><Abstract><AbstractText>In the present study, a highly efficient strategy is reported using open framework platforms with abundant chelating ligands to fabricate a series of stable metal single-atom catalysts (SACs). Here, the metal ions are initially anchored onto the active bipyridine sites through postsynthetic modification, followed by pyrolysis and acid leaching. The resulting single metal atoms are uniformly distributed on a nitrogen-doped carbon (N-C) matrix. Interestingly, each metal atom is found to be coordinated with five N atoms, in contrast to the average coordination number of four as previously reported. The as-prepared Fe SAC/N-C catalyst exhibits excellent oxygen reduction reaction (ORR) activity (with a half-wave potential of 0.89 V), outstanding stability, and good methanol tolerance. The density functional calculations reveal that the coordinated pyridine can favorably modulate the interaction strength of oxygen on the Fe ion and thus improve the ORR activity. More importantly, it is demonstrated that this strategy can be successfully extended to the preparation of other transition metal SACs, simply by altering the metal precursors used in the metalation step.</AbstractText><CopyrightInformation>© 2019 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yichao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials Science and Opto-Electronic Technology, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pingying</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Materials Science and Engineering, Jingdezhen Ceramic Institute, Jingdezhen, Jiangxi, 333403, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>Ever</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Physics, Collaborative Innovation Center of Advanced Microstructures, and National Laboratory of Solid State Microstructures, Nanjing University, Nanjing, 210093, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Ziqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials Science and Opto-Electronic Technology, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Institute of Innovation, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linjuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liang</ForeName><Initials>L</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0667-540X</Identifier><AffiliationInfo><Affiliation>Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, Zhejiang, 315201, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials Science and Opto-Electronic Technology, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>51602320</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>51872306</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2015B11002</GrantID><Agency>science and technology innovative research team of Ningbo municipality</Agency><Country/></Grant><Grant><GrantID>2016B10005</GrantID><Agency>science and technology innovative research team of Ningbo municipality</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Adv Mater</MedlineTA><NlmUniqueID>9885358</NlmUniqueID><ISSNLinking>0935-9648</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DFT calculations</Keyword><Keyword MajorTopicYN="N">Single atom catalysis</Keyword><Keyword MajorTopicYN="N">electrocatalysts</Keyword><Keyword MajorTopicYN="N">oxygen reduction reaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30907482</ArticleId><ArticleId IdType="doi">10.1002/adma.201808193</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30867157</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>364</Volume><PubDate><Year>2019</Year><Month>03</Month><Day>13</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Negative pressure dressings are no better than standard dressings for open fractures.</ArticleTitle><Pagination><MedlinePgn>k4411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.k4411</ELocationID><Abstract><AbstractText>The studyEffect of negative pressure wound therapy vs standard wound management on 12-month disability among adults with severe open fracture of the lower limb: the WOLLF randomised clinical trial.Costa ML, Achten J, Bruce J, et al; UK WOLLF CollaborationPublished on 9 October 2018 <i>JAMA</i> 2018;319:2280-8.This project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 10/57/20).To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000655/negative-pressure-dressings-are-no-better-than-standard-dressings-for-open-fractures.</AbstractText><CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bazian, Economist Intelligence Unit healthcare, London, UK rob.cook@bazian.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Vaughan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Wessex Institute, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Rosie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bazian, Economist Intelligence Unit healthcare, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NIHR Dissemination Centre</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001458" MajorTopicYN="N">Bandages</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="N">Disabled Persons</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005597" MajorTopicYN="N">Fractures, Open</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054843" MajorTopicYN="N">Negative-Pressure Wound Therapy</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013673" MajorTopicYN="N">Technology Assessment, Biomedical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interestsThe BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none. Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30867157</ArticleId><ArticleId IdType="doi">10.1136/bmj.k4411</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33869337</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2297-7775</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in sociology</Title><ISOAbbreviation>Front Sociol</ISOAbbreviation></Journal><ArticleTitle>Open to All: Dementia, Creativity, and Open Ecosystem Innovation.</ArticleTitle><Pagination><MedlinePgn>10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fsoc.2019.00010</ELocationID><Abstract><AbstractText>In the health arena, open innovation approaches strive to address real-world complexity through driving multi-stakeholder collaborative activities that can better identify and respond to complex health needs. This paper will argue for the value of an open ecosystem innovation approach, one that explores the full implications of what it means to be "open" in a health innovation context. To these ends, the paper will outline the origins of open innovation in the health arena, suggesting that it has become an important site for pushing the limits of open methods and challenging mainstream conceptions of the targets of health innovation. Five guiding principles for open ecosystem innovation will then be proposed, drawing on learning from the Knowledge Exchange Hubs for the Creative Economy funded by the UK's Arts and Humanities Research Council. These principles point to a configuration of open activities that are maximally sensitive to (1) knowledge diversity in innovation work; (2) the consequences of adopting an open-orientation across all stages of innovation programming; (3) the value of deepening and broadening the targets of innovation activity; (4) the role of mediation in supporting cross-sector partnerships; and, (5) the importance of operating in an adaptive and sustainable manner in the long-term. A follow-on project from the AHRC Hubs-Dementia Connect-sought to apply this learning to an important health focus: dementia and the role played by creative participation in delivering important health outcomes. Through Dementia Connect, the applicability of open ecosystem innovation thinking was assessed, revealing the conditions under which it might deliver innovation-led improvements to the quality of life for those living with a dementia diagnosis. A detailed blueprint for conducting open ecosystem innovation is then proposed in full-a new and comprehensive response to the complex reality of living with a dementia diagnosis today.</AbstractText><CopyrightInformation>Copyright © 2019 Senior.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Senior</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Digital Cultures Research Centre, University of the West of England, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Sociol</MedlineTA><NlmUniqueID>101777459</NlmUniqueID><ISSNLinking>2297-7775</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">collaboration</Keyword><Keyword MajorTopicYN="N">creativity</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">ecosystems</Keyword><Keyword MajorTopicYN="N">health</Keyword><Keyword MajorTopicYN="N">hubs</Keyword><Keyword MajorTopicYN="N">open innovation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33869337</ArticleId><ArticleId IdType="doi">10.3389/fsoc.2019.00010</ArticleId><ArticleId IdType="pmc">PMC8022449</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Syst Rev. 2014 Aug 15;3:91</Citation><ArticleIdList><ArticleId IdType="pubmed">25128286</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia (London). 2018 Aug;17(6):702-727</Citation><ArticleIdList><ArticleId IdType="pubmed">28914090</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2014 Jan 09;4(1):e004119</Citation><ArticleIdList><ArticleId IdType="pubmed">24413352</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychophysiol. 2018 Jan;123:64-73</Citation><ArticleIdList><ArticleId IdType="pubmed">29158118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociol Health Illn. 2017 Feb;39(2):182-198</Citation><ArticleIdList><ArticleId IdType="pubmed">28177149</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2019 Jan;34(1):67-71</Citation><ArticleIdList><ArticleId IdType="pubmed">30248208</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 2012 May;105(2-3):165-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22440194</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs Aging. 2017 Nov;34(11):811-820</Citation><ArticleIdList><ArticleId IdType="pubmed">29116600</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Psychogeriatr. 2018 Mar;30(3):409-423</Citation><ArticleIdList><ArticleId IdType="pubmed">29113610</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Qual Saf. 2011 Apr;20 Suppl 1:i47-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21450771</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging Ment Health. 2016;20(4):337-51</Citation><ArticleIdList><ArticleId IdType="pubmed">25683767</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2014 Jan;76 Pt A:27-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23891641</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2013 Nov;13(11):1235-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24134650</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Nov 2;6(11):e011634</Citation><ArticleIdList><ArticleId IdType="pubmed">27807080</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Public Health. 2013 Jan;133(1):66-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23308010</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Inf Manag. 2016 Dec;45(3):121-133</Citation><ArticleIdList><ArticleId IdType="pubmed">27105481</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia (London). 2018 Aug;17(6):775-784</Citation><ArticleIdList><ArticleId IdType="pubmed">28980477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30843654</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-3773</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>23</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Angewandte Chemie (International ed. in English)</Title><ISOAbbreviation>Angew Chem Int Ed Engl</ISOAbbreviation></Journal><ArticleTitle>Stable Diindeno-Fused Corannulene Regioisomers with Open-Shell Singlet Ground States and Large Diradical Characters.</ArticleTitle><Pagination><MedlinePgn>7600-7605</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201902028</ELocationID><Abstract><AbstractText>The synthesis of open-shell polycyclic hydrocarbons with large diradical characters is challenging because of their high reactivities. Herein, two diindeno-fused corannulene regioisomers DIC-1 and DIC-2, curved fragments of fullerene C<sub>104</sub> , were synthesized that exhibit open-shell singlet ground states. The incorporation of the curved and non-alternant corannulene moiety within diradical systems leads to significant diradical characters as high as 0.98 for DIC-1 and 0.89 for DIC-2. Such high diradical characters can presumably be ascribed to the re-aromatization of the corannulene π system. Although the DIC compounds have large diradical characters, they display excellent stability under ambient conditions. The half-lives are 37 days for DIC-1 and 6.6 days for DIC-2 in solution. This work offers a new design strategy towards diradicaloids with large diradical characters yet maintain high stability.</AbstractText><CopyrightInformation>© 2019 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ru-Qiang</ForeName><Initials>RQ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lin-Lin</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wen-Bin</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Hang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Ye</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Max Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jun-Bo</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hai-Yan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0219-1798</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials (iChEM), Key Laboratory of Chemical Biology of Fujian Province, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2015CB856505</GrantID><Agency>National Basic Research Program of China (973 Program)</Agency><Country/></Grant><Grant><GrantID>Nos. 21722304, 91427304, 21573181, and 91227111</GrantID><Agency>National Natural Science Foundation of China (NSFC)</Agency><Country/></Grant><Grant><Agency>the Top-Notch Young Talents Program of China</Agency><Country/></Grant><Grant><GrantID>20720160050</GrantID><Agency>the Fundamental Research Funds for the Central Universities of China</Agency><Country/></Grant><Grant><GrantID>2015CB856505</GrantID><Agency>the 973 Programpean Research Council ()</Agency><Country/></Grant><Grant><GrantID>Nos. 21722304, 91427304, 21573181, and 91227111</GrantID><Agency>the NSFC</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angew Chem Int Ed Engl</MedlineTA><NlmUniqueID>0370543</NlmUniqueID><ISSNLinking>1433-7851</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">corannulene</Keyword><Keyword MajorTopicYN="N">macrocycles</Keyword><Keyword MajorTopicYN="N">polycycles</Keyword><Keyword MajorTopicYN="N">radicals</Keyword><Keyword MajorTopicYN="N">structure elucidation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30843654</ArticleId><ArticleId IdType="doi">10.1002/anie.201902028</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30818354</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>GenomeGraphR: A user-friendly open-source web application for foodborne pathogen whole genome sequencing data integration, analysis, and visualization.</ArticleTitle><Pagination><MedlinePgn>e0213039</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0213039</ELocationID><Abstract><AbstractText>Food safety risk assessments and large-scale epidemiological investigations have the potential to provide better and new types of information when whole genome sequence (WGS) data are effectively integrated. Today, the NCBI Pathogen Detection database WGS collections have grown significantly through improvements in technology, coordination, and collaboration, such as the GenomeTrakr and PulseNet networks. However, high-quality genomic data is not often coupled with high-quality epidemiological or food chain metadata. We have created a set of tools for cleaning, curation, integration, analysis and visualization of microbial genome sequencing data. It has been tested using Salmonella enterica and Listeria monocytogenes data sets provided by NCBI Pathogen Detection (160,000 sequenced isolates in 2018). GenomeGraphR presents foodborne pathogen WGS data and associated curated metadata in a user-friendly interface that allows a user to query a variety of research questions such as, transmission sources and dynamics, global reach, and persistence of genotypes associated with contamination in the food supply and foodborne illness across time or space. The application is freely available (https://fda-riskmodels.foodrisk.org/genomegraphr/).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanaa</LastName><ForeName>Moez</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouillot</LastName><ForeName>Régis</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6107-5212</Identifier><AffiliationInfo><Affiliation>Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Francisco Garcés</ForeName><Initials>FG</Initials><Identifier Source="ORCID">0000-0003-3512-4356</Identifier><AffiliationInfo><Affiliation>Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strain</LastName><ForeName>Errol</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Doren</LastName><ForeName>Jane M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005516" MajorTopicYN="Y">Food Microbiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059022" MajorTopicYN="Y">Food Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005517" MajorTopicYN="N">Foodborne Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008089" MajorTopicYN="N">Listeria monocytogenes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008088" MajorTopicYN="N">Listeriosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="N">Metadata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012478" MajorTopicYN="N">Salmonella Food Poisoning</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019779" MajorTopicYN="N">Salmonella enterica</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30818354</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0213039</ArticleId><ArticleId IdType="pii">PONE-D-18-36078</ArticleId><ArticleId IdType="pmc">PMC6394949</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genome Res. 2018 Sep;28(9):1395-1404</Citation><ArticleIdList><ArticleId IdType="pubmed">30049790</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Feb 04;9(2):e87991</Citation><ArticleIdList><ArticleId IdType="pubmed">24505344</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2017 May 09;8:808</Citation><ArticleIdList><ArticleId IdType="pubmed">28536563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2018 Dec 1;34(23):4121-4123</Citation><ArticleIdList><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>J Food Prot. 2016 Jul;79(7):1161-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27357035</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Food Microbiol. 2018 Dec 20;287:28-39</Citation><ArticleIdList><ArticleId IdType="pubmed">29703417</ArticleId></ArticleIdList></Reference><Reference><Citation>R Soc Open Sci. 2017 Mar 29;4(3):160721</Citation><ArticleIdList><ArticleId IdType="pubmed">28405360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Nov 15;31(22):3718-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26209431</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2018 Jul 10;9:1482</Citation><ArticleIdList><ArticleId IdType="pubmed">30042741</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2016 Aug 1;63(3):380-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27090985</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2015 Apr;53(4):1063-71</Citation><ArticleIdList><ArticleId IdType="pubmed">25609719</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Microbiol. 2016 Mar;24(3):224-237</Citation><ArticleIdList><ArticleId IdType="pubmed">26774999</ArticleId></ArticleIdList></Reference><Reference><Citation>Foodborne Pathog Dis. 2017 Dec;14(12):701-710</Citation><ArticleIdList><ArticleId IdType="pubmed">28926300</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Food Microbiol. 2018 Dec 20;287:18-27</Citation><ArticleIdList><ArticleId IdType="pubmed">29032838</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Food Microbiol. 2018 Dec 20;287:3-9</Citation><ArticleIdList><ArticleId IdType="pubmed">29246458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jul 8;44(W1):W246-51</Citation><ArticleIdList><ArticleId IdType="pubmed">27131357</ArticleId></ArticleIdList></Reference><Reference><Citation>Microb Genom. 2016 Nov 30;2(11):e000093</Citation><ArticleIdList><ArticleId IdType="pubmed">28348833</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2016 Aug;54(8):1975-83</Citation><ArticleIdList><ArticleId IdType="pubmed">27008877</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30815061</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>FAIRness and Usability for Open-access Omics Data Systems.</ArticleTitle><Pagination><MedlinePgn>232-241</MedlinePgn></Pagination><Abstract><AbstractText>Omics data sharing is crucial to the biological research community, and the last decade or two has seen a huge rise in collaborative analysis systems, databases, and knowledge bases for omics and other systems biology data. We assessed the "FAIRness" of NASA's GeneLab Data Systems (GLDS) along with four similar kinds of systems in the research omics data domain, using 14 FAIRness metrics. The range of overall FAIRness scores was 6-12 (out of 14), average 10.1, and standard deviation 2.4. The range of Pass ratings for the metrics was 29-79%, Partial Pass 0-21%, and Fail 7-50%. The systems we evaluated performed the best in the areas of data findability and accessibility, and worst in the area of data interoperability. Reusability of metadata, in particular, was frequently not well supported. We relate our experiences implementing semantic integration of omics data from some of the assessed systems for federated querying and retrieval functions, given their shortcomings in data interoperability. Finally, we propose two new principles that Big Data system developers, in particular, should consider for maximizing data accessibility.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berrios</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Universities Space Research Association.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NASA Ames Research Center, Moffett Field, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beheshti</LastName><ForeName>Afshin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KBRwyle.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NASA Ames Research Center, Moffett Field, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costes</LastName><ForeName>Sylvain V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>NASA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NASA Ames Research Center, Moffett Field, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="Y">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078327" MajorTopicYN="Y">Data Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="N">Health Information Interoperability</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815061</ArticleId><ArticleId IdType="pmc">PMC6371294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Data. 2018 Jun 26;5:180118</Citation><ArticleIdList><ArticleId IdType="pubmed">29944145</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2008 Sep 19;9:386</Citation><ArticleIdList><ArticleId IdType="pubmed">18803844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D781-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23109552</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D19-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21062823</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Plant Sci. 2011 Jul 25;2:34</Citation><ArticleIdList><ArticleId IdType="pubmed">22645531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D659-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16381953</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Feb 23;10(2):e0117619</Citation><ArticleIdList><ArticleId IdType="pubmed">25706992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D28-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20972220</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2001 Jan 1;29(1):82-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11125056</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ Comput Sci. 2015;1:</Citation><ArticleIdList><ArticleId IdType="pubmed">26167542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Jan 1;33(Database issue):D428-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15608231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2002 Jan 1;30(1):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2017 Jun 29;15(6):e2001414</Citation><ArticleIdList><ArticleId IdType="pubmed">28662064</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1996 Jan 1;24(1):53-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8594600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2000 May;25(1):25-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2001 Jan 1;29(1):102-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11125061</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2005 Oct;15(10):1451-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16169926</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2016 Apr 17;2016:</Citation><ArticleIdList><ArticleId IdType="pubmed">27087305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamm Genome. 2015 Aug;26(7-8):325-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26092688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Aided Mol Des. 2014 Oct;28(10):1035-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25038897</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1999 Jan 1;27(1):29-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9847135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Mar 8;8(1):4191</Citation><ArticleIdList><ArticleId IdType="pubmed">29520055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30805317</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Anterior Urethral Strictures in Children: Disease Etiology and Comparative Effectiveness of Endoscopic Treatment vs. Open Surgical Reconstruction.</ArticleTitle><Pagination><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2019.00005</ELocationID><Abstract><AbstractText>Pediatric anterior urethral strictures are rare and recommendations regarding treatment strategies derive from small monocentric case series. In 2014, a collaborative effort of the Société Internationale d'Urologie and the International Consultation on Urological Diseases drafted the first systematic and evidence-based guideline for diagnosis and treatment of urethral strictures in children. Against this backdrop, we performed an updated literature review to provide a comprehensive summary of the available evidence and contemporary outcomes with a focus on comparative effectiveness of endoscopic treatment (dilation or urethrotomy) vs. open surgical reconstruction. Overall, 22 articles reporting on children with anterior urethral strictures were included into the review. Most strictures were iatrogenic (48%) and traumatic (34%), whereas congenital (13%), inflammatory (4%), or postinfectious strictures (1%) were rather rare. The cumulative success rate of endoscopic treatment and urethroplasty was 46% (range: 21-75; <i>N</i> = 334) and 84% (range: 25-100; <i>N</i> = 347), respectively. After stratifying patients according to urethroplasty technique, success rates were 82% (range: 25-100; <i>N</i> = 206) for excision and primary anastomosis, 94% (range: 75-100; <i>N</i> = 40) for graft augmentation, 97% (range: 87-100; <i>N</i> = 30) for flap urethroplasty, and 70% (one study; <i>N</i> = 20) for pull-through urethroplasty. In conclusion, endoscopic approaches are rather ineffective in the long-term and open surgical reconstruction via urethroplasty should be preferred to avoid multiple, repetitive interventions. Future research may involve multi-institutional, collaborative, and prospective studies, incorporating well-defined outcome criteria and assessing objective surgical endpoints as well as patient-reported functional outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vetterlein</LastName><ForeName>Malte W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisbach</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riechardt</LastName><ForeName>Silke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisch</LastName><ForeName>Margit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endoscopy</Keyword><Keyword MajorTopicYN="N">iatrogenic disease</Keyword><Keyword MajorTopicYN="N">mouth mucosa</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">urethral stricture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30805317</ArticleId><ArticleId IdType="doi">10.3389/fped.2019.00005</ArticleId><ArticleId IdType="pmc">PMC6371027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Urol. 2001 Jul;166(1):231-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11435875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2003 May;169(5):1818-21; discussion 1821</Citation><ArticleIdList><ArticleId IdType="pubmed">12686852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2003 Sep;170(3):952-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12913749</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2005 Feb;173(2):595-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15643267</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2005 Feb;95(3):403-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15679803</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2007 Dec;178(6):2268-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17936829</ArticleId></ArticleIdList></Reference><Reference><Citation>Urol J. 2007 Fall;4(4):226-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18270947</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2008 Mar;71(3):430-3; discussion 433-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18342179</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2009 Apr;55(4):945-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18691809</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2009 Jun;5(3):215-8; discussion 219-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19230775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2009 Oct;182(4):1266-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19683309</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2011 Feb;7(1):34-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20462798</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2011 Mar;77(3):706-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20970838</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2011 Jun;185(6 Suppl):2479-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21527203</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2012 Jun;8(3):258-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21664873</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Urol. 2012 Nov;22(6):462-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22918037</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2013 Dec;9(6 Pt A):769-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23073040</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2014 Jan;83(1):232-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24200196</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2014 Mar;83(3 Suppl):S1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24210733</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2014 Mar;83(3 Suppl):S71-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24231203</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2014 Mar;83(3 Suppl):S27-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24268357</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2014 Mar;83(3 Suppl):S8-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24275285</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2014 Jun;10(3):545-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24388665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2014 Apr;10(2):268-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24726239</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2016 Feb;12(1):42.e1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26302829</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr Surg. 2016 Feb;26(1):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26540444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2018 Feb;14(1):66.e1-66.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">29150196</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Urol Nephrol. 2018 Apr;50(4):605-609</Citation><ArticleIdList><ArticleId IdType="pubmed">29397549</ArticleId></ArticleIdList></Reference><Reference><Citation>Urol J. 2019 Feb 21;16(1):67-71</Citation><ArticleIdList><ArticleId IdType="pubmed">30058064</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Urol. 2018 Dec;14(6):555.e1-555.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">30131215</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 1994 Aug;44(2):264-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8048204</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 1998 Jul;160(1):170-1</Citation><ArticleIdList><ArticleId IdType="pubmed">9628643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30801523</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1534-6080</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>Transplantation</Title><ISOAbbreviation>Transplantation</ISOAbbreviation></Journal><ArticleTitle>Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients.</ArticleTitle><Pagination><MedlinePgn>1903-1915</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0000000000002605</ELocationID><Abstract><AbstractText Label="BACKGROUND">Regenerative medicine using stem cell technology is an emerging field that is currently tested for inborn and acquired liver diseases.</AbstractText><AbstractText Label="OBJECTIVE">This phase I/II prospective, open label, multicenter, randomized trial aimed primarily at evaluating the safety of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in pediatric patients with urea cycle disorders (UCDs) or Crigler-Najjar (CN) syndrome 6 months posttransplantation. The secondary objective included the assessment of safety up to 12 months postinfusion and of preliminary efficacy.</AbstractText><AbstractText Label="METHODS">Fourteen patients with UCDs and 6 with CN syndrome were divided into 3 cohorts by body weight and intraportally infused with 3 doses of HepaStem. Clinical status, portal vein hemodynamics, morphology of the liver, de novo detection of circulating anti-human leukocyte antigen antibodies, and clinically significant adverse events (AEs) and serious adverse events to infusion were evaluated by using an intent-to-treat analysis.</AbstractText><AbstractText Label="RESULTS">The overall safety of HepaStem was confirmed. For the entire study period, patient-month incidence rate was 1.76 for the AEs and 0.21 for the serious adverse events, of which 38% occurred within 1 month postinfusion. There was a trend of higher events in UCD as compared with CN patients. Segmental left portal vein thrombosis occurred in 1 patient and intraluminal local transient thrombus in a second patient. The other AEs were in line with expectations for catheter placement, cell infusion, concomitant medications, age, and underlying diseases.</AbstractText><AbstractText Label="CONCLUSIONS">This study led to European clinical trial authorization for a phase II study in a homogeneous patient cohort, with repeated infusions and intermediate doses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smets</LastName><ForeName>Françoise</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Paediatric Gastroenterology and Hepatology Unit, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobbelaere</LastName><ForeName>Dries</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Reference Center for Inherited Metabolic Diseases, University Children's Hospital Jeanne de Flandre and RADEME Research Team for Rare Metabolic and Developmental Diseases, EA 7364, University Lille 2, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKiernan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liver Unit, Birmingham Children's Hospital, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dionisi-Vici</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Gastroenterology and Nutrition, Ospedale Pediatrico Bambino Gesù di Roma, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broué</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hépatologie pédiatrique et maladies héréditaires du métabolisme, Centre de compétences maladies héréditaires du métabolisme, Hôpital des enfants, CHU Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemin</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Liver Transplantation Unit, Reference Centre for Rare Liver Diseases, CHU Bicêtre, Assistance Publique, Hôpitaux de Paris, DHU Hepatinov, INSERM 1174, University Paris Sud, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Ana Isabel</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Gastroenterology Unit, Medical Faculty of Lisbon, University Hospital Santa Maria, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonçalves</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital Pediátrico de Coimbra, Centro Hospitalar da Universidade de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandel</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Metabolic Unit, Rambam Medical Center, Meyer Children's Hospital, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlowska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Hepatology and Nutritional Disorders, The Children's Memorial Health Institute, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamińska</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Hepatology and Nutritional Disorders, The Children's Memorial Health Institute, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shteyer</LastName><ForeName>Eyal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hadassah Ein-Kerem Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Hepatology, Gastroenterology and Nutrition, Ospedale Pediatrico Bambino Gesù di Roma, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Riki</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Liver Transplantation Unit, Institute of Gastroenterology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eyskens</LastName><ForeName>François</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Paediatric department, Universitair Ziekenhuis Antwerpen, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clapuyt</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gissen</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>GOSH UCL Biomedical Center, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pariente</LastName><ForeName>Danièle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, CHU Bicêtre, Le Kremlin Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunewald</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Inborn Errors of Metabolism, Great Ormond Street Hospital and Institute of Child Health, UCL, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yudkoff</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mass Spectroscopy Center, The Children's Hospital of Philadelphia, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>Maria Mercedes</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najimi</LastName><ForeName>Mustapha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belmonte</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vos</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thonnard</LastName><ForeName>Joelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokal</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Paediatric Gastroenterology and Hepatology Unit, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Promethera Biosciences, Mont-Saint-Guibert, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>EudraCT</DataBankName><AccessionNumberList><AccessionNumber>2011-004074-28</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>U54 HD086984</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplantation</MedlineTA><NlmUniqueID>0132144</NlmUniqueID><ISSNLinking>0041-1337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003414" MajorTopicYN="N">Crigler-Najjar Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008115" MajorTopicYN="N">Liver Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014183" MajorTopicYN="N">Transplantation, Heterologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056806" MajorTopicYN="N">Urea Cycle Disorders, Inborn</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30801523</ArticleId><ArticleId IdType="doi">10.1097/TP.0000000000002605</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30793596</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-510X</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Inorganic chemistry</Title><ISOAbbreviation>Inorg Chem</ISOAbbreviation></Journal><ArticleTitle>Two Penta-Supertetrahedral Cluster-Based Chalcogenide Open Frameworks: Effect of the Cluster Spatial Connectivity on the Electron-Transport Efficiency.</ArticleTitle><Pagination><MedlinePgn>3582-3585</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.inorgchem.8b03503</ELocationID><Abstract><AbstractText>High-degree connectivity of clusters in open-framework chalcogenide semiconductors conceptually facilitates electron mobility between clusters; however, no direct evidence was obtained to prove the prediction because of the shortage of suitable structure models among such systems. Herein, two open-framework chalcogenides built from the same types of heterometallic P2-CuInSnS clusters but with different spatial connectivities of clusters were obtained, in which 3-connected clusters are assembled into a 3D framework with SrSi<sub>2</sub> topology (MCOF-1) and 4-connected clusters (μ<sub>4</sub>-P2) are arranged into diamond topology (MCOF-2). Compared to MCOF-1, MCOF-2 exhibits a relatively rapid photocurrent response, good reproducibility, and high electrocatalytic oxygen reduction reaction activity. This work substantially demonstrates that cluster-based chalcogenide frameworks with higher-degree cluster connectivity possess faster electron-transport efficiency between adjacent clusters relative to low-connected ones with the same building units.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaxu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Chaozhuang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7354-6491</Identifier><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong-Sheng</ForeName><Initials>DS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1283-6334</Identifier><AffiliationInfo><Affiliation>College of Materials and Chemical Engineering, Hubei Provincial Collaborative Innovation Center for New Energy Microgrid, Key Laboratory of Inorganic Nonmetallic Crystalline and Energy Conversion Materials , China Three Gorges University , Yichang , Hubei 443002 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4443-1227</Identifier><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Inorg Chem</MedlineTA><NlmUniqueID>0366543</NlmUniqueID><ISSNLinking>0020-1669</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30793596</ArticleId><ArticleId IdType="doi">10.1021/acs.inorgchem.8b03503</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30774487</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1594</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Risk management and healthcare policy</Title><ISOAbbreviation>Risk Manag Healthc Policy</ISOAbbreviation></Journal><ArticleTitle>Open disclosure of adverse events: exploring the implications of service and policy structures on practice.</ArticleTitle><Pagination><MedlinePgn>5-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/RMHP.S180359</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to explore the service and policy structures that impact open disclosure (OD) practices in New South Wales (NSW), Australia.</AbstractText><AbstractText Label="PARTICIPANTS AND METHODS" NlmCategory="METHODS">An explorative study using semi-structured interviews was undertaken with 12 individuals closely involved in the implementation of OD in hospitals at policy or practice levels within the state of NSW, Australia. Interviews explored the service and policy structures surrounding OD and the perceived impact of these on the implementation of the OD policy. These data were thematically analyzed to understand the factors facilitating and creating barriers to openness after adverse events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The data identified three key areas in which greater alignment between OD policy and the wider service and policy structures may enhance the implementation of OD practice: 1) alignment between OD and root cause analysis processes, 2) holistic training that links to other relevant processes such as communicating bad news, risk management, and professional regulation and insurance, and 3) policy clarification regarding the disclosure of incidents that result in no or low-level harm.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Evidence from this study indicates that formal OD processes are not routinely applied after adverse events in NSW, despite clear guidelines for OD. The reasons for this are unclear as the service-level and policy-level phenomena that support or hinder OD are understudied. This knowledge is critical to addressing the policy-practice gap. Our paper provides insights regarding the influence of current service-level and policy-level phenomena on the delivery of OD and how policy clarification may contribute to addressing some of the challenges for implementing OD policy. The principles of virtue ethics - specifically, openness and the involvement of service users - may contribute to progressing in this area.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Reema</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Public Health and Community Medicine, UNSW, Sydney, NSW, Australia, reema.harrison@unsw.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>Merrilyn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith-Merry</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Disability Research and Policy, Faculty of Health Sciences, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manias</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Faculty of Health, Centre for Quality and Patient Safety Research, Deakin University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iedema</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Team-Based Practice and Learning in Health Care, King's College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>17/99/85</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Risk Manag Healthc Policy</MedlineTA><NlmUniqueID>101566264</NlmUniqueID><ISSNLinking>1179-1594</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">hospitals</Keyword><Keyword MajorTopicYN="N">incident disclosure</Keyword><Keyword MajorTopicYN="N">patient-centered care</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30774487</ArticleId><ArticleId IdType="doi">10.2147/RMHP.S180359</ArticleId><ArticleId IdType="pii">rmhp-12-005</ArticleId><ArticleId IdType="pmc">PMC6350650</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Qual Health Care. 2008 Dec;20(6):421-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18801752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociol Health Illn. 2009 Mar;31(2):262-77</Citation><ArticleIdList><ArticleId IdType="pubmed">18983420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2008 Dec 2;149(11):811-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19047028</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Saf Health Care. 2010 Dec;19(6):e11</Citation><ArticleIdList><ArticleId IdType="pubmed">20194217</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2013 May 6;198(8):445-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23641998</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Educ. 2014 Jan;48(1):17-27</Citation><ArticleIdList><ArticleId IdType="pubmed">24330113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Serv Res Policy. 2015 Jan;20(1 Suppl):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25472990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eval Clin Pract. 2017 Aug;23(4):713-718</Citation><ArticleIdList><ArticleId IdType="pubmed">28220984</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Qual Saf. 2017 Sep;26(9):743-750</Citation><ArticleIdList><ArticleId IdType="pubmed">28356333</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust Health Rev. 2018 Apr 26;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">29695314</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30770298</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2496</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>Urologic oncology</Title><ISOAbbreviation>Urol Oncol</ISOAbbreviation></Journal><ArticleTitle>Robotic vs. open cystectomy: How length-of-stay differences relate conditionally to age.</ArticleTitle><Pagination><MedlinePgn>354.e1-354.e8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1078-1439(19)30049-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urolonc.2019.01.028</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The length-of-stay (LOS) benefit of minimally invasive cystectomy varies in the published literature, potentially because of subgroup effects. Here, we investigated the effect of minimally invasive cystectomy on LOS among different age groups.</AbstractText><AbstractText Label="METHODS AND MATERIALS">Adult patients who underwent cystectomy (open or minimally invasive) from January 1, 2012, to December 31, 2016, were identified from the National Surgical Quality Improvement Program database. Multivariable linear regression was used to evaluate the adjusted association between the surgical approach and LOS after stratifying patients by age (40-64, 65-79, and ≥80 years). A sensitivity analysis was performed after multiple imputation by using age as a continuous variable with a third-order polynomial term.</AbstractText><AbstractText Label="RESULTS">Of the 5,561 patients identified, 640 underwent minimally invasive cystectomy and 4,921 had open cystectomy. The unadjusted analysis showed that minimally invasive cystectomy was associated with a shorter mean LOS compared with the open approach (8.0 vs. 9.7 days; P &lt; 0.001). The predicted difference in LOS between the 2 approaches was 0.72 days (95% confidence interval (CI), -0.28 to 1.72; P = 0.16) for patients aged 40 to 64 years, 1.48 days (95% CI, 0.73-2.23; P &lt; 0.001) for 65 to 79 years, and 2.56 days (95% CI, 0.84-4.29; P = 0.01) for ≥80 years favoring the minimally invasive approach. The sensitivity analysis did not materially change the results.</AbstractText><AbstractText Label="CONCLUSIONS">Older patients may derive more LOS benefit from minimally invasive approaches than younger patients. Given the greater expense associated with the minimally invasive approach, an age-adapted strategy to using this technology may be reasonable.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faraj</LastName><ForeName>Kassem</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Urology, Mayo Clinic Hospital, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Hui H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Biostatistics, Mayo Clinic, Scottsdale, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neville</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Biostatistics, Mayo Clinic, Scottsdale, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blodgett</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biostatistics, and Patient Collaborator, Mayo Clinic, Scottsdale, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etzioni</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Urology, Division of Colon and Rectal Surgery, Mayo Clinic Hospital, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habermann</LastName><ForeName>Elizabeth B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Urology, Mayo Clinic Hospital, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Erik P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Urology, Mayo Clinic Hospital, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Mitchell R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Urology, Mayo Clinic Hospital, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Mark D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Urology, Mayo Clinic Hospital, Phoenix, AZ. Electronic address: tyson.mark@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Urol Oncol</MedlineTA><NlmUniqueID>9805460</NlmUniqueID><ISSNLinking>1078-1439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bladder cancer</Keyword><Keyword MajorTopicYN="Y">Cystectomy</Keyword><Keyword MajorTopicYN="Y">Length of stay</Keyword><Keyword MajorTopicYN="Y">Robotic surgery procedures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30770298</ArticleId><ArticleId IdType="pii">S1078-1439(19)30049-3</ArticleId><ArticleId IdType="doi">10.1016/j.urolonc.2019.01.028</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30741177</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>257</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>FHIRForm: An Open-Source Framework for the Management of Electronic Forms in Healthcare.</ArticleTitle><Pagination><MedlinePgn>80-85</MedlinePgn></Pagination><Abstract><AbstractText>Electronic Forms (E-Forms) for data capture are vital for most health information systems in public health and clinical research. Standardized electronic forms ensure accurate data collection, consistent form rendering, easy maintainability, and interoperability. Adopting an innovation research method we explore the challenges of standardized data capture in healthcare and offer a pragmatic solution. We appraise existing standards and software to propose the list of requirements for an ideal E-form framework. Our proposed solution leverages FHIR specification and existing open-source software tools. We discuss how our open-source solution can be extended collaboratively and discuss its value using InterRAI instruments as examples.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eapen</LastName><ForeName>Bell Raj</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Information Systems, McMaster University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology and Biostatistics, McMaster University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>Norm</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Information Systems, McMaster University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartipi</LastName><ForeName>Kamran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Information Systems, McMaster University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004581" MajorTopicYN="N">Electronics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063025" MajorTopicYN="Y">Health Information Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">E-Form</Keyword><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">InterRAI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30741177</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30737711</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-2027</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>PharmacoEconomics</Title><ISOAbbreviation>Pharmacoeconomics</ISOAbbreviation></Journal><ArticleTitle>A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis.</ArticleTitle><Pagination><MedlinePgn>829-843</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40273-018-00765-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The nature of model-based cost-effectiveness analysis can lead to disputes in the scientific community. We propose an iterative and collaborative approach to model development by presenting a flexible open-source simulation model for rheumatoid arthritis (RA), accessible to both technical and non-technical end-users.</AbstractText><AbstractText Label="METHODS">The RA model is a discrete-time individual patient simulation with 6-month cycles. Model input parameters were estimated based on currently available evidence and treatment effects were obtained with Bayesian network meta-analysis techniques. The model contains 384 possible model structures informed by previously published models. The model consists of the following components: (i) modifiable R and C++ source code available in a GitHub repository; (ii) an R package to run the model for custom analyses; (iii) detailed model documentation; (iv) a web-based user interface for full control over the model without the need to be well-versed in the programming languages; and (v) a general audience web-application allowing those who are not experts in modeling or health economics to interact with the model and contribute to value assessment discussions.</AbstractText><AbstractText Label="RESULTS">A primary function of the initial version of RA model is to help understand and quantify the impact of parameter uncertainty (with probabilistic sensitivity analysis), structural uncertainty (with multiple competing model structures), the decision framework (cost-effectiveness analysis or multi-criteria decision analysis), and perspective (healthcare or limited societal) on estimates of value.</AbstractText><AbstractText Label="CONCLUSION">In order for a decision model to remain relevant over time it needs to evolve along with its supporting body of clinical evidence and scientific insight. Multiple clinical and methodological experts can modify or contribute to the RA model at any time due to its open-source nature.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Incerti</LastName><ForeName>Devin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafrin</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakdawalla</LastName><ForeName>Darius N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Jeroen P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Innovation and Value Initiative, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, USA. jeroen.jansen@thevalueinitiative.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research and Policy (Epidemiology), Stanford University School of Medicine, Stanford, CA, USA. jeroen.jansen@thevalueinitiative.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Pharmacoeconomics</MedlineTA><NlmUniqueID>9212404</NlmUniqueID><ISSNLinking>1170-7690</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001688">Biological Products</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035501" MajorTopicYN="N">Uncertainty</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30737711</ArticleId><ArticleId IdType="doi">10.1007/s40273-018-00765-2</ArticleId><ArticleId IdType="pii">10.1007/s40273-018-00765-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rheumatology (Oxford). 2004 Jan;43(1):62-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12890861</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv10-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21859700</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Res Opin. 2010 Jan;26(1):77-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19908947</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2015 Sep;35(9):1489-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25794569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Manag Care Spec Pharm. 2016 Sep;22(9):1088-102</Citation><ArticleIdList><ArticleId IdType="pubmed">27579831</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2012 Jan;39(1):54-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22089466</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2017 Jan;35(1):125-128</Citation><ArticleIdList><ArticleId IdType="pubmed">27928759</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Jun;48(6):1530-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12794820</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2015 Dec;24(6):615-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21930515</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16273793</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Sep;52(9):2625-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16142705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2018 Apr 3;168(7):529</Citation><ArticleIdList><ArticleId IdType="pubmed">29610903</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Nov;56(11):3583-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2014 Oct;44(2):131-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24925692</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2013 May;52(5):944-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23339232</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1995 Jan;38(1):44-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7818570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008794</Citation><ArticleIdList><ArticleId IdType="pubmed">21328309</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2017 Oct;37(7):735-746</Citation><ArticleIdList><ArticleId IdType="pubmed">28061043</ArticleId></ArticleIdList></Reference><Reference><Citation>Natl Vital Stat Rep. 2015 Sep 22;64(11):1-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26460931</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2003 Feb;42(2):244-57</Citation><ArticleIdList><ArticleId IdType="pubmed">12595618</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2011 Mar;63(3):366-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21080449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jun;76(6):1101-1136</Citation><ArticleIdList><ArticleId IdType="pubmed">28298374</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Apr;58(4):939-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18383356</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2005;7(4):R796-806</Citation><ArticleIdList><ArticleId IdType="pubmed">15987481</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2010;12(2):R35</Citation><ArticleIdList><ArticleId IdType="pubmed">20196859</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Sep 13;316(10):1093-103</Citation><ArticleIdList><ArticleId IdType="pubmed">27623463</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2016 Oct 15;35(23):4264-80</Citation><ArticleIdList><ArticleId IdType="pubmed">27189534</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2016 Jan;19(1):1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26797229</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2015 Mar;18(2):173-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25773552</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Stat Soc Ser C Appl Stat. 2010 Mar;59(2):233-253</Citation><ArticleIdList><ArticleId IdType="pubmed">20383261</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2016 Apr;34(4):349-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26660529</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2010 Aug;40(1):2-14.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">20674669</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2013 May-Jun;31(3):334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23324808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv26-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21859702</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26545825</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Mar;62(3):362-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20391482</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2015 Jun 09;5(6):e006560</Citation><ArticleIdList><ArticleId IdType="pubmed">26059521</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2005 Apr;14(4):339-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15736142</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2011 Dec;63(12):1672-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21954144</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 May;64(5):640-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22473918</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2017 Jul;44(7):973-980</Citation><ArticleIdList><ArticleId IdType="pubmed">28202743</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;226:115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27350481</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2013 Oct;33(7):880-90</Citation><ArticleIdList><ArticleId IdType="pubmed">23811758</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Health Econ. 2008 Jan;8 Suppl 2:S49-60</Citation><ArticleIdList><ArticleId IdType="pubmed">18157732</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Technol Assess. 2016 Apr;20(35):1-610</Citation><ArticleIdList><ArticleId IdType="pubmed">27140438</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Health Econ. 2013 Apr;14(2):197-209</Citation><ArticleIdList><ArticleId IdType="pubmed">22057665</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jan;58(1):15-25</Citation><ArticleIdList><ArticleId IdType="pubmed">18163481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2014 Aug;32(8):775-87</Citation><ArticleIdList><ArticleId IdType="pubmed">24854959</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2017 Feb;20(2):213-216</Citation><ArticleIdList><ArticleId IdType="pubmed">28237197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30735109</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8674</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><MedlineDate>2019 May/Jun</MedlineDate></PubDate></JournalIssue><Title>Surgical infections</Title><ISOAbbreviation>Surg Infect (Larchmt)</ISOAbbreviation></Journal><ArticleTitle>Rate of Glove Perforation in Open Abdominal Surgery and the Associated Risk Factors.</ArticleTitle><Pagination><MedlinePgn>286-291</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/sur.2018.229</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> Glove perforation is common during surgery. Surgical gloves are used as personal protective equipment to reduce infection risks from bloodborne pathogens for both the surgical team and patients. This research was conducted to determine the perforation rates of gloves worn in open abdominal surgery performed in a general surgery department and the risk factors affecting perforation. <b><i>Methods:</i></b> This research was designed as an observational prospective cohort study including 70 open abdominal operations. There were four members of the surgical team (surgeon, first assistant, second assistant, and scrub nurse). A total of 280 (70 × 4) pairs of gloves in 70 consecutive open abdominal procedures were included in this study. A total of 140 unused gloves were tested as control group to assess perforations and pre-existing leaks. After the operation, all gloves were checked for water impermeability using the EN455-1 method and the presence or absence of a puncture hole was recorded. <b><i>Results:</i></b> Glove perforation was detected in 54.3% of operations. The rate of perforation in all gloves was 10.7%, of which 78% unnoticed by the surgical team during surgical procedure. It was determined that the puncture in the gloves was mostly on the non-dominant hand (left). For the left-hand glove, the highest number of holes was observed on the index finger (21.1%) and palm/dorsum of the hand (21.1%). The risk of glove perforation was 5.8 times greater for surgeons compared with the other team members, and operation time of 61 minutes or longer increased the risk of perforation by 12.77 times. <b><i>Conclusions:</i></b> Glove perforation rates are high in open abdominal surgery. The highest number of perforations occurred in the non-dominant hand (left) has a high rate of perforation in surgeons and long operations. It may be beneficial for surgical team members to change gloves at certain intervals during surgery or use indicator glove systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sayın</LastName><ForeName>Selma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1 Institute of Health Science, Department of Surgical Nursing, Manisa Celal Bayar University, Manisa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yılmaz</LastName><ForeName>Emel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>2 Faculty of Health Science, Department of Surgical Nursing, Manisa Celal Bayar University, Manisa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baydur</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>3 Faculty of Health Science, Department of Social Work, Manisa Celal Bayar University, Manisa, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Infect (Larchmt)</MedlineTA><NlmUniqueID>9815642</NlmUniqueID><ISSNLinking>1096-2964</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D034841" MajorTopicYN="N">Abdominal Cavity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004868" MajorTopicYN="N">Equipment Failure</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005932" MajorTopicYN="Y">Gloves, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">abdominal surgery</Keyword><Keyword MajorTopicYN="N">glove perforation</Keyword><Keyword MajorTopicYN="N">surgical gloves</Keyword><Keyword MajorTopicYN="N">surgical team</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30735109</ArticleId><ArticleId IdType="doi">10.1089/sur.2018.229</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30732624</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial.</ArticleTitle><Pagination><MedlinePgn>105</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-019-3179-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While the majority of seriously ill people wish to die at home, only half achieve this. The likelihood of someone dying at home often depends on the availability of able and willing lay carers to support them. Dying people are usually unable to take oral medication. When top-up symptom relief medication is required, a clinician travels to the home to administer injectable medication, with attendant delays. The administration of subcutaneous injections by lay carers, though not widespread practice in the UK, has proven key in achieving home deaths in other countries. Our aim is to determine if carer-administration of as-needed subcutaneous medication for four frequent breakthrough symptoms (pain, nausea, restlessness and noisy breathing) in home-based dying patients is feasible and acceptable in the UK.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This paper describes a randomised pilot trial across three UK sites, with an embedded qualitative study. Dyads of adult patients/carers are eligible, where patients are in the last weeks of life and wish to die at home, and lay carers who are willing to be trained to give subcutaneous medication. Dyads who do not meet strict risk assessment criteria (including known history of substance abuse or carer ability to be trained to competency) will not be approached. Carers in the intervention arm will receive a manualised training package delivered by their local nursing team. Dyads in the control arm will receive usual care. The main outcomes of interest are feasibility, acceptability, recruitment rates, attrition and selection of the most appropriate outcome measures. Interviews with carers and healthcare professionals will explore attitudes to, experiences of and preferences for giving subcutaneous medication and experience of trial processes. The study has obtained full ethical approval.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This study will rehearse the procedures and logistics which will be undertaken in a future definitive randomised controlled trial and will inform the design of such a study. Findings will illuminate methodological and ethical issues pertaining to researching last days of life care. The study is funded by the National Institute for Health Research (Health Technology Assessment [HTA] project 15/10/37).</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ISRCTN, ISRCTN 11211024 . Registered on 27 September 2016.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poolman</LastName><ForeName>Marlise</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2837-363X</Identifier><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK. m.poolman@bangor.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Betsi Cadwaladr University Health Board, Bangor, UK. m.poolman@bangor.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Marie Curie Research Centre, Cardiff University, Bangor, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiff and Vale University Health Board, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sue Ryder Leckhampton Court Hospice, Cheltenham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoare</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Annmarie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Marie Curie Research Centre, Cardiff University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiscock</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Dyfrig</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foster</LastName><ForeName>Betty</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>North Wales Cancer Network Patient Forum, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sue Ryder Leckhampton Court Hospice, Cheltenham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reymond</LastName><ForeName>Liz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Queensland Health Metro South Hospital Health Service, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healy</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Queensland Health Metro South Hospital Health Service, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Rossela</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Betsi Cadwaladr University Health Board, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>Bee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Penney</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Dickson Poon School of Law, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnstone</LastName><ForeName>Rosalynde</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Betsi Cadwaladr University Health Board, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Sian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Betsi Cadwaladr University Health Board, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendry</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bangor Institute for Health &amp; Medical Research, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HTA/15/10/37</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MCCC-FCO-11-C</GrantID><Acronym>MCCC_</Acronym><Agency>Marie Curie</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>15/10/37</GrantID><Agency>Health Technology Assessment Programme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="N">Antiemetics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001293" MajorTopicYN="N">Attitude to Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004505" MajorTopicYN="N">Education, Nonprofessional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007279" MajorTopicYN="N">Injections, Subcutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="N">Terminal Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Care of the dying</Keyword><Keyword MajorTopicYN="N">Carer administration</Keyword><Keyword MajorTopicYN="N">End-of-life care</Keyword><Keyword MajorTopicYN="N">Palliative care</Keyword><Keyword MajorTopicYN="N">Randomised pilot trial</Keyword><Keyword MajorTopicYN="N">Symptom control</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30732624</ArticleId><ArticleId IdType="doi">10.1186/s13063-019-3179-9</ArticleId><ArticleId IdType="pii">10.1186/s13063-019-3179-9</ArticleId><ArticleId IdType="pmc">PMC6367805</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Pain Symptom Manage. 2001 Jul;22(1):565-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11516598</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Sci Med. 2002 Feb;54(4):529-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11848273</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2003 Jul;26(1):644-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12850647</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2005 Mar;19(2):91-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15810745</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Mar 4;332(7540):515-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16467346</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Med. 2006 Aug;9(4):968-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16910811</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2006 Oct;32(4):300-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17000347</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2006 Dec;20(8):755-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17148530</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2007 Jul;34(1):94-104</Citation><ArticleIdList><ArticleId IdType="pubmed">17509812</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Decis Making. 2011 May-Jun;31(3):458-68</Citation><ArticleIdList><ArticleId IdType="pubmed">20924044</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2011 Apr 30;30(9):922-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21284014</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2012 Jun;21(6):730-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21557381</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2012 Mar;65(3):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22169081</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Palliat Care. 2012 Nov 22;11:23</Citation><ArticleIdList><ArticleId IdType="pubmed">23173986</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2013 Jun;27(6):562-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23175512</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2013 Feb;66(2):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">23195919</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013 Jan 08;346:e7586</Citation><ArticleIdList><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2013 Apr 24;11:111</Citation><ArticleIdList><ArticleId IdType="pubmed">23618406</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2013 Nov 26;14:405</Citation><ArticleIdList><ArticleId IdType="pubmed">24279296</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2014 Aug;23(6):1743-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24381112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Med. 2014 May;17(5):575-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24708221</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2014 Jun 1;32(16):1712-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24799486</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hosp Palliat Care. 2015 Aug;32(5):484-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24803586</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Support Palliat Care. 2015 Jun;5(2):181-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25256259</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2015 May;24(5):1255-73</Citation><ArticleIdList><ArticleId IdType="pubmed">25381122</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Med. 2015 Mar;18(3):241-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25517136</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2015 Jun;29(6):487-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25634635</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2015 Nov;80(5):1149-59</Citation><ArticleIdList><ArticleId IdType="pubmed">26138622</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2016 Oct 24;355:i5239</Citation><ArticleIdList><ArticleId IdType="pubmed">27777223</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Palliat Care. 2018 Apr 16;17(1):60</Citation><ArticleIdList><ArticleId IdType="pubmed">29656713</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2018 Jul;32(7):1208-1215</Citation><ArticleIdList><ArticleId IdType="pubmed">29749803</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 1994;30A(9):1326-36</Citation><ArticleIdList><ArticleId IdType="pubmed">7999421</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30689965</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-5053</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons</Title><ISOAbbreviation>J Oral Maxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Physiotherapy After Open Temporomandibular Joint Surgery: A 3-Step Program.</ArticleTitle><Pagination><MedlinePgn>932-950</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0278-2391(18)31397-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joms.2018.12.027</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aimed to ascertain the value of postoperative physiotherapy after open temporomandibular joint (TMJ) surgery and provide a usable approach for practitioners.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The authors performed a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines of literature concerning the results of postoperative physiotherapy after open TMJ surgery to evaluate its effect on rehabilitation. PubMed Central, Web of Science, Cochrane Library Plus, CINAHL, and EMBASE were used to conduct this search and all articles up to April 1, 2018 (total, 675 articles) were included. Risk of bias in nonrandomized controlled trials (non-RCTs) and other observational studies was assessed using the Methodological Index for Non-Randomized Studies (MINORS) scale. The Cochrane Collaboration's tool was used for evaluating RCTs. Maximal mouth opening (MMO) before and after surgery was evaluated, as was the physiotherapeutic protocol used during the postoperative period. Evaluation of lateral movement and pain also was included, if this information was provided.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Initially, 675 articles were found, 6 of which were included after screening. Risk of bias was found to be unclear in the included RCTs and rather high in comparative and noncomparative articles. Three studies concluded that patients who received postoperative physiotherapy had a significantly larger increase in MMO (P &lt; .05) compared with patients who did not receive any postoperative physiotherapy. No difference in lateral movement was found (P &gt; .05). Mean visual analog scale pain score was significantly lower in patients who were treated with physiotherapy according to 2 of the included articles (P &lt; .05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the current scientific literature included in this systematic review, it can be concluded physiotherapy after open TMJ surgery plays an important role in achieving good postoperative results. The authors provide a scheme for its effective use.</AbstractText><CopyrightInformation>Copyright © 2018 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Meurechy</LastName><ForeName>Nikolas K G</ForeName><Initials>NKG</Initials><AffiliationInfo><Affiliation>Resident, European Face Centre, University Hospital Brussels, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loos</LastName><ForeName>Pieter-Jan</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Resident, Physical Medicine and Rehabilitation, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mommaerts</LastName><ForeName>Maurice Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Professor and Department Head, European Face Centre, University Hospital Brussels, Brussels, Belgium. Electronic address: Maurice.Mommaerts@uzbrussel.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Oral Maxillofac Surg</MedlineTA><NlmUniqueID>8206428</NlmUniqueID><ISSNLinking>0278-2391</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013704" MajorTopicYN="Y">Temporomandibular Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30689965</ArticleId><ArticleId IdType="pii">S0278-2391(18)31397-1</ArticleId><ArticleId IdType="doi">10.1016/j.joms.2018.12.027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30689735</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1569-8041</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>04</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of oncology : official journal of the European Society for Medical Oncology</Title><ISOAbbreviation>Ann Oncol</ISOAbbreviation></Journal><ArticleTitle>Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial.</ArticleTitle><Pagination><MedlinePgn>637-643</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0923-7534(19)31116-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/annonc/mdz020</ELocationID><Abstract><AbstractText Label="BACKGROUND">We conducted a single-arm phase II trial to evaluate the efficacy and adverse effects (AEs) of an anti-epidermal growth factor receptor monoclonal antibody, nimotuzumab, combined with cisplatin and 5-fluorouracil (PF) as first-line treatment in recurrent metastatic nasopharyngeal carcinoma after radical radiotherapy.</AbstractText><AbstractText Label="METHODS">Patients who met the eligibility criteria were recruited from ten institutions (ClinicalTrials.gov; NCT01616849). A Simon optimal two-stage design was used to calculate the sample size. All patients received weekly nimotuzumab (200 mg) added to cisplatin (100 mg/m2 D1) and 5-fluorouracil (4 g/m2 continuous infusion D1-4) every 3-weekly for a maximum of six cycles. Primary end point was objective response rate (ORR). Secondary end points included disease control rate (DCR), progression-free survival (PFS), overall survival (OS) and AEs.</AbstractText><AbstractText Label="RESULTS">A total of 35 patients were enrolled (13 in stage 1 and 22 in stage 2). Overall ORR and DCR were 71.4% (25/35) and 85.7% (30/35), respectively. Median PFS and OS were 7.0 (95% CI 5.8-8.2) months and 16.3 (95% CI 11.4-21.3) months, respectively. Unplanned exploratory analyses suggest that patients who received ≥2400 mg nimotuzumab and ≥4 cycles of PF had superior ORR, PFS and OS than those who did not (88.9% versus 12.5%, P &lt; 0.001; 7.4 versus 2.7 months, P = 0.081; 17.0 versus 8.0 months, P = 0.202). Favourable subgroups included patients with lung metastasis [HROS 0.324 (95% CI 0.146-0.717), P = 0.008] and disease-free interval of &gt;12 months [HROS 0.307 (95% CI 0.131-0.724), P = 0.004], but no difference was observed for metastatic burden. The only major grade 3/4 AE was leukopenia (62.9%).</AbstractText><AbstractText Label="CONCLUSION">Combination nimotuzumab-PF chemotherapy demonstrates potential efficacy, and is well tolerated as first-line chemotherapy regimen in recurrent metastatic nasopharyngeal carcinoma.</AbstractText><CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Centre, Zhongnan Hospital of Wuhan University, Wuhan; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation centre of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation centre of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, Cancer Center of Guangzhou Medical University, Guangzhou; Department of Radiation Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Jiangxi Province Tumour Hospital, Nanchang.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, The First People's Hospital of Foshan, Foshan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, The First People's Hospital of Foshan, Foshan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Radiation Oncology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, Cancer Center of Guangzhou Medical University, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation centre of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation centre of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>M L K</ForeName><Initials>MLK</Initials><AffiliationInfo><Affiliation>Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore. Electronic address: melvin.chua.l.k@singhealth.com.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Centre, Zhongnan Hospital of Wuhan University, Wuhan. Electronic address: chxie_65@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01616849</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Oncol</MedlineTA><NlmUniqueID>9007735</NlmUniqueID><ISSNLinking>0923-7534</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>6NS400BXKH</RegistryNumber><NameOfSubstance UI="C501466">nimotuzumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D066246">ErbB Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066246" MajorTopicYN="N">ErbB Receptors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077274" MajorTopicYN="N">Nasopharyngeal Carcinoma</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009303" MajorTopicYN="N">Nasopharyngeal Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">adverse effects</Keyword><Keyword MajorTopicYN="Y">anti-epidermal growth factor receptor monoclonal antibody</Keyword><Keyword MajorTopicYN="Y">chemotherapy</Keyword><Keyword MajorTopicYN="Y">distant metastasis</Keyword><Keyword MajorTopicYN="Y">efficacy</Keyword><Keyword MajorTopicYN="Y">nasopharyngeal carcinoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30689735</ArticleId><ArticleId IdType="pii">S0923-7534(19)31116-0</ArticleId><ArticleId IdType="doi">10.1093/annonc/mdz020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30682632</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-491X</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>International journal of nursing studies</Title><ISOAbbreviation>Int J Nurs Stud</ISOAbbreviation></Journal><ArticleTitle>The association between Open Dialogue to young Danes in acute psychiatric crisis and their use of health care and social services: A retrospective register-based cohort study.</ArticleTitle><Pagination><MedlinePgn>119-127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0020-7489(18)30275-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijnurstu.2018.12.015</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although most mental disorders have their onset in early life, the mental health needs of young people are often not addressed adequately. Open Dialogue is a need-adapted approach that mobilizes psychosocial resources in a crisis struck person's social network. Open Dialogue is organised as a series of network meetings and seeks to promote collaborative integrated care, and a non-directive psychotherapeutic stance. Its effectiveness for young people has not previously been assessed.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the study was to examine whether a Danish Open Dialogue approach directed at young people, who sought help from Child and Adolescent Mental Health Services, reduced their utilisation of psychiatric and other health services, compared to peers receiving usual psychiatric treatment.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective register-based cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using clinical and national register data, a cohort of patients aged 14-19 years (n = 503) enrolled from one region during 2000 to 2015 were compared to a matched comparison group from two other regions using propensity scores. Utilisation of psychiatric health services, GP services, and social markers were assessed after 1, 2, 5 and 10 year of follow-up using logistic and Poisson regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients receiving Open Dialogue intervention had more psychiatric outpatient treatments at one year of follow-up (RR = 1.2, CI: 1.1-1.4) than the comparison group, but not at subsequent follow-ups. Recipients of the intervention had fewer emergency psychiatric treatments (1 year follow-up: RR = 0.2, CI: 0.1-0.5; 10 years follow-up: RR = 0.5, CI: 0.3-0.8) and less use of general practitioner services (1 year follow-up: RR = 0.90, CI: 0.82-0.99; 10 years follow-up: RR = 0.85, CI: 0.78-0.92). There was no significant reduction in the number of psychiatric hospitalisation contacts or treatment days.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Open Dialogue was significantly associated with some reduced risks of utilising health care services. These mixed results should be tested in a randomized design.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buus</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, University of Sydney, Australia; St. Vincent's Hospital Sydney, Australia; St. Vincent's Private Hospital Sydney, Australia; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark. Electronic address: niels.buus@sydney.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kragh Jacobsen</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Research Unit, University of Southern Denmark, Odense, Region of Southern Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bojesen</LastName><ForeName>Anders Bo</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Research Unit, University of Southern Denmark, Odense, Region of Southern Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bikic</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Department of Child and Adolescent Mental Health Services in Southern Jutland, Psychiatric Hospital Region of Southern Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller-Nielsen</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Department of Child and Adolescent Mental Health Services in Southern Jutland, Psychiatric Hospital Region of Southern Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aagaard</LastName><ForeName>Jørgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Psychosis Research, Aalborg University Hospital, Psychiatric Hospital, Region of North Denmark, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erlangsen</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; Danish Research Institute for Suicide Prevention, Mental Health Centre Copenhagen, Capital Region of Denmark, Denmark; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Nurs Stud</MedlineTA><NlmUniqueID>0400675</NlmUniqueID><ISSNLinking>0020-7489</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008605" MajorTopicYN="Y">Mental Health Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011369" MajorTopicYN="Y">Professional-Patient Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delivery of health care, integrated</Keyword><Keyword MajorTopicYN="N">Mental health services</Keyword><Keyword MajorTopicYN="N">Psychosocial support systems</Keyword><Keyword MajorTopicYN="N">Psychotherapy</Keyword><Keyword MajorTopicYN="N">Retrospective studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>09</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30682632</ArticleId><ArticleId IdType="pii">S0020-7489(18)30275-X</ArticleId><ArticleId IdType="doi">10.1016/j.ijnurstu.2018.12.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30659767</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2574-173X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>03</Month></PubDate></JournalIssue><Title>Neuropsychopharmacology reports</Title><ISOAbbreviation>Neuropsychopharmacol Rep</ISOAbbreviation></Journal><ArticleTitle>Open source code for behavior analysis in rodents.</ArticleTitle><Pagination><MedlinePgn>67-69</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/npr2.12047</ELocationID><Abstract><AbstractText Label="AIM">We have conducted a series of behavioral tests, which cover a broad range of behavioral domains, on various strains of genetically engineered mice. For the behavioral screening, we have been using Image J plugins that we developed for most of the tests in the battery. Our behavioral analysis system with the plugins enables systematic and automated image analysis of behavior. The plugins are freely available on the "Mouse Phenotype Database" website (http://www.mouse-phenotype.org/software.html). Here, we release the source code of the plugins in a Git repository with the aim of promoting their use and expanding their functionality.</AbstractText><AbstractText Label="METHODS">We published the source code of the Image J plugins for behavioral analysis at Git repository (https://github.com/neuroinformatics). The source code for light/dark transition, elevated plus maze, open filed, T-maze, and fear conditioning tests was made publicly available in the repository.</AbstractText><AbstractText Label="CONCLUSIONS">The source code of the plugins for the behavioral tests as well as the pre-compiled binaries can be freely obtained. The open source code could promote the development and modification of the plugins for additional behavioral indices in these tests and for other behavioral tests.</AbstractText><CopyrightInformation>© 2019 The Authors. Neuropsychopharmacology Reports published by John Wiley &amp; Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Satoko</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1047-6454</Identifier><AffiliationInfo><Affiliation>Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okumura</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Center, RIKEN Center for Brain Science, Wako, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takao</LastName><ForeName>Keizo</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4734-3583</Identifier><AffiliationInfo><Affiliation>Division of Animal Resources and Development, Life Science Research Center, University of Toyama, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Center, RIKEN Center for Brain Science, Wako, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyakawa</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0137-8200</Identifier><AffiliationInfo><Affiliation>Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuropsychopharmacol Rep</MedlineTA><NlmUniqueID>101719700</NlmUniqueID><ISSNLinking>2574-173X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="Y">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005824" MajorTopicYN="N">Genetics, Behavioral</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007858" MajorTopicYN="N">Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Image J</Keyword><Keyword MajorTopicYN="Y">comprehensive behavioral test battery</Keyword><Keyword MajorTopicYN="Y">open source code</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30659767</ArticleId><ArticleId IdType="doi">10.1002/npr2.12047</ArticleId><ArticleId IdType="pmc">PMC7292282</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Exp Med. 2017 May 1;214(5):1431-1452</Citation><ArticleIdList><ArticleId IdType="pubmed">28408410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2006 Nov;1086:144-59</Citation><ArticleIdList><ArticleId IdType="pubmed">17185513</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Apr 27;13(4):e0196587</Citation><ArticleIdList><ArticleId IdType="pubmed">29702698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jun 27;6:28636</Citation><ArticleIdList><ArticleId IdType="pubmed">27346785</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacol Rep. 2019 Mar;39(1):67-69</Citation><ArticleIdList><ArticleId IdType="pubmed">30659767</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2019 Jan;33(1):928-941</Citation><ArticleIdList><ArticleId IdType="pubmed">30085884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2012 Feb 26;(60):</Citation><ArticleIdList><ArticleId IdType="pubmed">22395674</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Res. 2007 Jun;58(2):124-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17524507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1985 Oct 28;346(1):8-14</Citation><ArticleIdList><ArticleId IdType="pubmed">4052773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2006 Nov 13;(1):104</Citation><ArticleIdList><ArticleId IdType="pubmed">18704188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Jul;9(7):671-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2014 Mar 01;(85):</Citation><ArticleIdList><ArticleId IdType="pubmed">24637495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Feb 11;6:20775</Citation><ArticleIdList><ArticleId IdType="pubmed">26865403</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov J Biol Sci. 1980 Oct-Dec;15(4):177-82</Citation><ArticleIdList><ArticleId IdType="pubmed">7208128</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Behav Neurosci. 2017 Jul 11;11:125</Citation><ArticleIdList><ArticleId IdType="pubmed">28744205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1980 Aug;13(2):167-70</Citation><ArticleIdList><ArticleId IdType="pubmed">6106204</ArticleId></ArticleIdList></Reference><Reference><Citation>Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6149466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Brain. 2018 May 10;11(1):27</Citation><ArticleIdList><ArticleId IdType="pubmed">29747665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2017 Jul 1;27(7):3485-3501</Citation><ArticleIdList><ArticleId IdType="pubmed">26762856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 19;7(1):5801</Citation><ArticleIdList><ArticleId IdType="pubmed">28724954</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2008 Dec 22;(22):</Citation><ArticleIdList><ArticleId IdType="pubmed">19229173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30637505</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Open versus arthroscopic acromioclavicular joint resection: a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>685-694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-019-03114-w</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The purpose of this study was to perform a meta-analysis comparing open and arthroscopic surgical techniques for distal clavicle resection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of Medline, Embase, Scopus, and Google Scholar identified relevant publications in the English and German literature between 1997 and 2017. All included studies were levels I-IV, describing both treatments, with a minimum of 12 month follow-up, had at least one validated outcome score and documented patient recruitment, study design, demographic details, and surgical technique. Studies were excluded if they were only abstracts or conference proceedings, involved revision procedures, or the loss to follow-up exceeded 20%. Publication bias and risk of bias were assessed using the Cochrane Collaboration tools, and heterogeneity was assessed using the I<sup>2</sup> statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four studies (n = 319 patients) met the criteria for inclusion. The pooled estimate for clinical outcomes (Constant, ASES) demonstrated no significant differences (SMD 0.323, I<sup>2</sup> = 0%, p = 0.065) between open and arthroscopic resection, although the analysis favored open resection. The pooled estimate for clinical outcomes (SST) also demonstrated no significant differences (SMD 0.744, I<sup>2</sup> = 49.82%, p = 0.144) between open and arthroscopic resection, but the analysis again favored open resection. The pooled estimate for VAS assessment of pain demonstrated no differences (SMD 0.217, I<sup>2</sup> = 58.96%; p = 0.404) between open and arthroscopic resection.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study suggest that similar functional and clinical outcomes can be achieved with either open or arthroscopic distal clavicle resection. The observed trend that open resection may have a more favorable outcome warrants further investigation.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level 3; systematic review and meta-analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hohmann</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. ehohmann@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery and Sports Medicine, Valiant Clinic/Houston Methodist Group, Dubai, United Arab Emirates. ehohmann@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetsworth</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Royal Brisbane Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, University of Queensland, St Lucia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland University of Technology, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Research Centre of Australia, Chatswood, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatt</LastName><ForeName>Vaida</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000173" MajorTopicYN="N">Acromioclavicular Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002968" MajorTopicYN="N">Clavicle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007592" MajorTopicYN="N">Joint Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acromioclavicular joint</Keyword><Keyword MajorTopicYN="N">Arthroscopic resection</Keyword><Keyword MajorTopicYN="N">Distal clavicle resection</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Mumford procedure</Keyword><Keyword MajorTopicYN="N">Open resection</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30637505</ArticleId><ArticleId IdType="doi">10.1007/s00402-019-03114-w</ArticleId><ArticleId IdType="pii">10.1007/s00402-019-03114-w</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30630745</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-4650</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>03</Month></PubDate></JournalIssue><Title>The Lancet. Child &amp; adolescent health</Title><ISOAbbreviation>Lancet Child Adolesc Health</ISOAbbreviation></Journal><ArticleTitle>Hospitalising preterm infants in single family rooms versus open bay units: a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>147-157</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2352-4642(18)30375-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-4642(18)30375-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">The effect of the hospital environment on health and specifically neurodevelopment in preterm infants remains under debate. We assessed outcomes of preterm infants hospitalised in single family rooms compared with common open bay units.</AbstractText><AbstractText Label="METHODS">For this systematic review and meta-analysis, we searched MEDLINE, Embase, PsycInfo, CENTRAL (the Cochrane Central Register of Controlled Trials), Web of Science, and ClinicalTrials.gov from inception to Aug 13, 2018, using controlled terms (ie, MeSH terms) and text words related to prematurity and neonatal intensive care unit design. We included randomised and non-randomised studies investigating clinical outcomes of preterm infants. We assessed methodological quality using the Cochrane Collaboration's Risk of Bias Tool for randomised controlled trials and the Cochrane Risk of Bias Tool for Non-randomised Studies of Interventions. We calculated summary estimates for meta-analysis using random effects models. The primary outcome was age appropriate long-term neurodevelopment. Secondary outcomes were length of hospital stay, sepsis, breastfeeding, growth, bronchopulmonary dysplasia, intraventricular haemorrhage, retinopathy of prematurity, and mortality. This systematic review is registered with PROSPERO, number CRD42016050643.</AbstractText><AbstractText Label="FINDINGS">We identified 487 records. 13 study populations (n=4793) were included. No difference in cognitive neurodevelopment was found on the Bayley Scales of Infant and Toddler Development-III at 18-24 months of corrected age (680 infants analysed; mean difference 1·04 [95% CI -3·45 to 5·52], p=0·65; I<sup>2</sup>=42%). The incidence of sepsis was lower (4165 infants analysed; 108 035 days in hospital [hospitalisation days]; risk ratio 0·63 [95% CI 0·50 to 0·78], p&lt;0·0001; I<sup>2</sup>=0%) and exclusive breastfeeding at discharge was higher (484 infants analysed; 1·31 [1·07 to 1·61], p=0·01; I<sup>2</sup>=0%) in single family rooms than in open bay units. We found no differences in length of hospital stay, growth, bronchopulmonary dysplasia, intraventricular haemorrhage, retinopathy of prematurity, and mortality.</AbstractText><AbstractText Label="INTERPRETATION">Single family rooms should be considered to hospitalise preterm infants because incidence of sepsis is reduced and exclusive breastfeeding is higher. No difference in long-term neurodevelopment was detected.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Veenendaal</LastName><ForeName>Nicole R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Neonatology, OLVG, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heideman</LastName><ForeName>Wieke H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Research and Epidemiology, OLVG, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limpens</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Library, Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lee</LastName><ForeName>Johanna H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Goudoever</LastName><ForeName>Johannes B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Vrije Universiteit, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kempen</LastName><ForeName>Anne A M W</ForeName><Initials>AAMW</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Neonatology, OLVG, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Schoor</LastName><ForeName>Sophie R D</ForeName><Initials>SRD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Neonatology, OLVG, Amsterdam, Netherlands. Electronic address: s.r.d.vanderschoor@olvg.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Child Adolesc Health</MedlineTA><NlmUniqueID>101712925</NlmUniqueID><ISSNLinking>2352-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Child Adolesc Health. 2019 Mar;3(3):130-131</RefSource><PMID Version="1">30630746</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001942" MajorTopicYN="N">Breast Feeding</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007235" MajorTopicYN="N">Infant, Premature, Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007363" MajorTopicYN="N">Intensive Care Units, Neonatal</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065886" MajorTopicYN="N">Neurodevelopmental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010362" MajorTopicYN="N">Patients' Rooms</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30630745</ArticleId><ArticleId IdType="pii">S2352-4642(18)30375-4</ArticleId><ArticleId IdType="doi">10.1016/S2352-4642(18)30375-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30585710</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1526-744X</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>6</Issue><PubDate><MedlineDate>2018 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>Nephrology nursing journal : journal of the American Nephrology Nurses' Association</Title><ISOAbbreviation>Nephrol Nurs J</ISOAbbreviation></Journal><ArticleTitle>Examining the Transition from Child to Adult Care in Chronic Kidney Disease: An Open Exploratory Approach.</ArticleTitle><Pagination><MedlinePgn>553-559</MedlinePgn></Pagination><Abstract><AbstractText>For youth with chronic kidney disease (CKD) and their families, shifting from pediatric to adult systems of renal care can be challenging. This study explored the transitional process experienced by youth with CKD and their families, including perceived facilitators and barriers to effective transition. Qualitative interviews were conducted with youth with CKD (n=28) and their parents (n=28). Ambiguity regarding healthcare provider roles within the adult system was frequently reported. Themes reflected parental challenge relinquishing care responsibility, synergistic and divergent expectations between youth and parents, tensions in youth self-care readiness, desired healthcare provider roles in transition preparedness, and system considerations in transition. A "learning stage" was recommended in which youth experienced the adult system while supported by known pediatric team members.</AbstractText><CopyrightInformation>Copyright© by the American Nephrology Nurses Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nicholas</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Professor, Faculty of Social Work, University of Calgary (Central and Northern Alberta Region), Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>former Staff Physician and Division Head, Division of Adolescent Medicine, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsk</LastName><ForeName>Maury</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Professor, Pediatrics and Child Health (Nephrology), and Director of Northern and Rural Pediatric Education, Winnipeg Children's Hospital, University of Manitoba, Winnipeg, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Professor, Pediatrics and Child Health (Nephrology), and Director of Northern and Rural Pediatric Education, Winnipeg Children's Hospital, University of Manitoba, Winnipeg, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamiwka</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Associate Professor, Department of Pediatrics, University of Calgary, and a Pediatric Nephrologist, Alberta Children's Hospital, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molzahn</LastName><ForeName>Anita E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Professor, Faculty of Nursing, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nephrol Nurs J</MedlineTA><NlmUniqueID>100909377</NlmUniqueID><ISSNLinking>1526-744X</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="Y">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069341" MajorTopicYN="Y">Transitional Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adolescent</Keyword><Keyword MajorTopicYN="N">chronic disease</Keyword><Keyword MajorTopicYN="N">nephrology</Keyword><Keyword MajorTopicYN="N">transition</Keyword></KeywordList><CoiStatement>The authors reported no actual or potential conflict of interest in relation to this continuing nursing education activity.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30585710</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30575281</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1864-564X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>ChemSusChem</Title><ISOAbbreviation>ChemSusChem</ISOAbbreviation></Journal><ArticleTitle>Hollow Mesoporous Co<sub>3</sub> O<sub>4</sub> -CeO<sub>2</sub> Composite Nanotubes with Open Ends for Efficient Catalytic CO Oxidation.</ArticleTitle><Pagination><MedlinePgn>1084-1090</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cssc.201802501</ELocationID><Abstract><AbstractText>Catalytic performance is heavily dependent on how the structures of nanomaterials are designed. Co<sub>3</sub> O<sub>4</sub> -CeO<sub>2</sub> composite nanotubes with open ends and mesoporous structures were fabricated through a facile and environmentally friendly reaction. The mesoporous Co<sub>3</sub> O<sub>4</sub> nanotubes were synthesized by the calcination of cobalt-aspartic acid (Co-Asp) nanowires and coated with a CeO<sub>2</sub> shell. The composite nanotubes were characterized by SEM, TEM, XRD, and X-ray photoelectron spectroscopy. The composite materials comprise a combination of Co<sub>3</sub> O<sub>4</sub> nanotubes and CeO<sub>2</sub> nanoparticles with a hollow and mesoporous bimetallic oxide structure. The large BET surface area led to a higher degree of accessible active sites compared with other Co<sub>3</sub> O<sub>4</sub> -CeO<sub>2</sub> composite nanomaterials with other structures. The resulting Co<sub>3</sub> O<sub>4</sub> -CeO<sub>2</sub> -26.3 wt % composite nanotubes, with a CeO<sub>2</sub> content of approximately 26.3 wt %, achieved 100 % CO conversion at 145 °C. Additionally, the synergistic effect between the two metal oxides comprising the Co<sub>3</sub> O<sub>4</sub> -CeO<sub>2</sub> composite nanotubes was demonstrated by the enhanced catalytic activity compared with pure Co<sub>3</sub> O<sub>4</sub> nanotubes and CeO<sub>2</sub> nanoparticles.</AbstractText><CopyrightInformation>© 2019 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jiaqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dongyun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Najun</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qingfeng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jianmei</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2451-7154</Identifier><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, 199 Ren'ai Road, Sushou, Jiangsu, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017YFC0210901, 2017YFC0210906</GrantID><Agency>the National Key R&amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>51573122, 21722607, 21776190</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>17KJA430014, 17KJA150009</GrantID><Agency>Natural Science Foundation of the Jiangsu Higher Education Institutions of China</Agency><Country/></Grant><Grant><GrantID>BE2015637</GrantID><Agency>the Science and Technology Program for Social Development of Jiangsu</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>ChemSusChem</MedlineTA><NlmUniqueID>101319536</NlmUniqueID><ISSNLinking>1864-5631</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CO oxidation</Keyword><Keyword MajorTopicYN="N">Co3O4-CeO2</Keyword><Keyword MajorTopicYN="N">catalysis</Keyword><Keyword MajorTopicYN="N">composite nanotubes</Keyword><Keyword MajorTopicYN="N">hollow mesoporous structure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30575281</ArticleId><ArticleId IdType="doi">10.1002/cssc.201802501</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30557380</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A modular and customizable open-source package for quantum voltage standards operation and control.</ArticleTitle><Pagination><MedlinePgn>e0209246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0209246</ELocationID><Abstract><AbstractText>This paper presents an open-source package developed in Python that controls and drives a programmable Josephson array to synthesize dc and ac quantum-accurate voltages. Programmable arrays are devices subdivided into independent subsections, each counting a number of series connected Josephson junctions that follows a binary sequence (1, 2, 4, 8, …) to control the output voltage. Our software allows to independently measure the current-voltage characteristics of each subsection by means of a set of arbitrary waveform generators and a nanovoltmeter that measures the voltage across the whole array with high sensitivity. A quantization test tool is also provided to check with sub-microvolt resolution whether the array is operating on its quantum margins. The code is modular and easily expandable with the support of many libraries, allowing prompt reconfiguration for different calibration and testing purposes. It is aimed at being a starting point for cooperation between National Metrology Institutes towards the realization of a shared quantum voltage calibration infrastructure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Durandetto</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9553-5961</Identifier><AffiliationInfo><Affiliation>INRiM - Istituto Nazionale di Ricerca Metrologica, Torino, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Politecnico di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosso</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INRiM - Istituto Nazionale di Ricerca Metrologica, Torino, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="N">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055615" MajorTopicYN="Y">Electrical Equipment and Supplies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004560" MajorTopicYN="N">Electricity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011789" MajorTopicYN="N">Quantum Theory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30557380</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0209246</ArticleId><ArticleId IdType="pii">PONE-D-18-17228</ArticleId><ArticleId IdType="pmc">PMC6296529</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 2004 Nov 19;306(5700):1318-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15550659</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Appl Supercond. 2016 Sep;26(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27453676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30527329</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2352-3018</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>12</Month></PubDate></JournalIssue><Title>The lancet. HIV</Title><ISOAbbreviation>Lancet HIV</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.</ArticleTitle><Pagination><MedlinePgn>e715-e722</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2352-3018(18)30257-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-3018(18)30257-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Raltegravir is an integrase inhibitor approved for use in adults and children with HIV-1 infection, but there are no data on the long-term use of this medication in children. We aimed to assess the long-term safety, tolerability, pharmacokinetics, and efficacy of multiple raltegravir formulations in children aged 4 weeks to 18 years with HIV-1 infection.</AbstractText><AbstractText Label="METHODS">In this phase 1/2 open-label multicentre trial (IMPAACT P1066), done in 43 IMPAACT network sites in the USA, South Africa, Brazil, Botswana, and Argentina, eligible participants were children aged 4 weeks to 18 years with HIV-1 infection who had previously received antiretroviral therapy (ART), had HIV-1 RNA higher than 1000 copies per mL, and no exposure to integrase inhibitors. Participants were separated into five age groups and enrolled in six cohorts. Three formulations of open-label raltegravir-adult tablets, chewable tablets, and granules for oral suspension-were added to individualised optimised background therapy, according to the age and weight of participants. The primary outcome at 48 weeks has been previously reported. In the 240-week follow-up, outcomes of interest included graded clinical and laboratory safety of raltegravir formulations during the study and virological efficacy (with virological success defined as HIV-1 RNA reduction of &gt;1 log<sub>10</sub> from baseline or HIV-1 RNA &lt;400 copies per mL) at week 240. The primary analysis group for safety and efficacy comprised patients treated only with the final selected dose of raltegravir. This trial is registered with ClinicalTrials.gov, number NCT00485264.</AbstractText><AbstractText Label="FINDINGS">Between August, 2007, and December, 2012, 220 patients were assessed for eligibility, and 153 were enrolled and treated. Of these patients, 122 received only the final selected dose of raltegravir (63 received adult tablets, 33 chewable tablets, and 26 oral granules), and one was not treated. There were few serious clinical or laboratory safety events noted, with two patients having a drug-related adverse event (skin rash), which led one patient to discontinue the study treatment. The addition of raltegravir to an individually optimised ART regimen resulted in virological success at week 240 in 19 (44·2%, 95% CI 29·1-60·1) of 43 patients receiving 400 mg tablets, 24 (77·4%, 58·9-90·4) of 31 patients receiving the chewable tablets, and 13 (86·7%, 59·5-98·3) of 15 patients receiving oral granules. Among patients with virological failure, raltegravir resistance was noted in 19 (38%) of 50 patients who had virological rebound after initial suppression and had samples at virological failure available for testing.</AbstractText><AbstractText Label="INTERPRETATION">Our study suggests that raltegravir can be used for the treatment of HIV-1 infection in children as young as 4 weeks, with the expectation of long-term safety and efficacy, but should be used with caution among older children who had previous extensive antiretroviral therapy.</AbstractText><AbstractText Label="FUNDING">National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Mental Health, and Merck.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nachman</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Sciences Center, Department of Pediatrics, SUNY Stony Brook, New York, NY, USA. Electronic address: sharon.nachman@stonybrook.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvero</LastName><ForeName>Carmelita</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teppler</LastName><ForeName>Hedy</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Merck &amp; Co Inc, Kenilworth, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Homony</LastName><ForeName>Brenda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Merck &amp; Co Inc, Kenilworth, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodgers</LastName><ForeName>Anthony J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Merck &amp; Co Inc, Kenilworth, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Bobbie L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Frontier Science and Technology Research Foundation, Buffalo, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenton</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenkel</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>University of Washington and Seattle Children's Research Institute, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Browning</LastName><ForeName>Renee S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hazra</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiznia</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Jacobi Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>IMPAACT 1066 study team</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00485264</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UM1 AI068616</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069456</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN275200800001I</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI106716</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI068632</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Lancet HIV</MedlineTA><NlmUniqueID>101645355</NlmUniqueID><ISSNLinking>2352-3018</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019428">HIV Integrase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>43Y000U234</RegistryNumber><NameOfSubstance UI="D000068898">Raltegravir Potassium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet HIV. 2018 Dec;5(12):e676-e678</RefSource><PMID Version="1">30527322</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000569" MajorTopicYN="N" Type="Geographic">Americas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001902" MajorTopicYN="N" Type="Geographic">Botswana</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019428" MajorTopicYN="N">HIV Integrase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068898" MajorTopicYN="N">Raltegravir Potassium</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Acosta</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fry</LastName><ForeName>Carrie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuryla</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perdue</LastName><ForeName>Lynette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samson</LastName><ForeName>Pearl</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spector</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toye</LastName><ForeName>MariPat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tustin</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watson</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worrell</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zheng</LastName><ForeName>Nan</ForeName><Initials>N</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30527329</ArticleId><ArticleId IdType="pii">S2352-3018(18)30257-1</ArticleId><ArticleId IdType="doi">10.1016/S2352-3018(18)30257-1</ArticleId><ArticleId IdType="pmc">PMC6537590</ArticleId><ArticleId IdType="mid">NIHMS1017214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2008 Jul 24;359(4):339-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18650512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Sep 5;374(9692):796-806</Citation><ArticleIdList><ArticleId IdType="pubmed">19647866</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2013 May 1;63(1):77-85</Citation><ArticleIdList><ArticleId IdType="pubmed">23412015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Jul;13(7):587-96</Citation><ArticleIdList><ArticleId IdType="pubmed">23664333</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Feb;58(3):413-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24145879</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2015;20(1):77-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24831260</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2015 Jul;55(7):748-56</Citation><ArticleIdList><ArticleId IdType="pubmed">25753401</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2015 Oct 15;61(8):1328-35</Citation><ArticleIdList><ArticleId IdType="pubmed">26105170</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2015 Nov;34(11):1207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26244832</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatric Infect Dis Soc. 2015 Dec;4(4):e76-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26582887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30520559</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1862-8354</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Proteomics. Clinical applications</Title><ISOAbbreviation>Proteomics Clin Appl</ISOAbbreviation></Journal><ArticleTitle>Cytomine: Toward an Open and Collaborative Software Platform for Digital Pathology Bridged to Molecular Investigations.</ArticleTitle><Pagination><MedlinePgn>e1800057</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/prca.201800057</ELocationID><Abstract><AbstractText Label="PURPOSE">Digital histology is being increasingly used in research and clinical applications. In parallel, new tissue imaging methods (e.g., imaging mass spectrometry) are currently regarded as very promising approaches for better molecular diagnosis in pathology. However, these new data sources are still often underexploited because of the lack of collaborative software to share and correlate information for multimodal analysis.</AbstractText><AbstractText Label="EXPERIMENTAL DESIGN">The open science paradigm is followed to develop new features in the web-based Cytomine software to support next-generation digital pathology bridged to molecular investigations.</AbstractText><AbstractText Label="RESULTS">New open-source developments allow to explore whole-slide classical histology with Matrix Assisted Laser Desorption Ionisation (MALDI) imaging and to support preprocessing for biomarker discovery using laser microdissection-based microproteomics.</AbstractText><AbstractText Label="CONCLUSIONS AND CLINICAL RELEVANCE">The updated version of Cytomine is the first open and web-based tool to enable sharing data from classical histology, molecular imaging, and cell counting for proteomics preprocessing. It holds good promise to fulfill imminent needs in molecular histopathology.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rubens</LastName><ForeName>Ulysse</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Montefiore Institute, Department of Electrical Engineering and Computer Science, University of Liège, 4000, Liège, Sart-Tilman, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoyoux</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cytomine SCRL FS, 4102, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanosmael</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montefiore Institute, Department of Electrical Engineering and Computer Science, University of Liège, 4000, Liège, Sart-Tilman, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouras</LastName><ForeName>Mehdy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Haute École de la Province de Liège, 4100, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasset</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Montefiore Institute, Department of Electrical Engineering and Computer Science, University of Liège, 4000, Liège, Sart-Tilman, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cytomine SCRL FS, 4102, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longuespée</LastName><ForeName>Rémi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Pathology, University of Heidelberg, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marée</LastName><ForeName>Raphaël</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9587-1954</Identifier><AffiliationInfo><Affiliation>Montefiore Institute, Department of Electrical Engineering and Computer Science, University of Liège, 4000, Liège, Sart-Tilman, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>IDEES</Agency><Country>International</Country></Grant><Grant><Agency>Wallonia and the European Regional Development Fund</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Proteomics Clin Appl</MedlineTA><NlmUniqueID>101298608</NlmUniqueID><ISSNLinking>1862-8346</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000070516" MajorTopicYN="Y">Intersectoral Collaboration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064847" MajorTopicYN="N">Multimodal Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010336" MajorTopicYN="N">Pathology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30520559</ArticleId><ArticleId IdType="doi">10.1002/prca.201800057</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30506533</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1671-0274</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery</Title><ISOAbbreviation>Zhonghua Wei Chang Wai Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Preliminary report on prospective, multicenter, open research of selective surgery after expandable stent combined with neoadjuvant chemotherapy in the treatment of obstructive left hemicolon cancer].</ArticleTitle><Pagination><MedlinePgn>1233-1239</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the safety and feasibility of neoadjuvant chemotherapy prior elective surgery following self-expanding metallic stents (SEMS) for complete obstructive left hemicolon cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective, multicenter, open-labelled trial was approved by the Ethics Committee of Beijing Chaoyang Hospital, Capital Medical University(2016-ke-161-1) and registered in Clinicaltrials.gov (NCT02972541).</AbstractText><AbstractText Label="INCLUSION CRITERIA" NlmCategory="METHODS">(1)age between 18 and 75 years old;(2) adenocarcinoma confirmed by pathology;(3) left hemicolon cancer confirmed by clinical manifestations and imaging examinations with the distance to anal verge &gt; 15 cm; (4) resectable cancer evaluated by imaging examination without distant metastasis; (5) Eastern Cooperative Oncology Group (ECOG) score ≤ 1 or Karnofsky Performance Scale (KPS) &gt; 70, indicating tolerance of neoadjuvant chemotherapy and operation; (6) absence of chemotherapy or radiotherapy within past six months; (7) bone marrow system and hepatorenal function: hemoglobin ≥ 90 g/L, neutrophil ≥ 1.5×10<sup>9</sup>/L, platelet ≥ 80×10<sup>9</sup>/L, total bilirubin ≤ 1.5×ULN(upper limits of normal), serum transaminase ≤ 2.5×ULN, serum creatinine ≤ 1.0×ULN, endogenous creatinine clearance rate &gt; 50 ml/min; (8) sign for informed consent.</AbstractText><AbstractText Label="EXCLUSION CRITERIA" NlmCategory="METHODS">(1) multiple primary colorectal cancer; (2) rejection of operation;(3) presenting peritonitis or bowel perforation before SEMS; (4) unqualified conditions proved by inspector from registration data. According to inclusion criteria, 62 consecutive patients receiving neoadjuvant chemotherapy prior to elective surgery following SEMS for complete obstructive left hemicolon cancer from Beijing Chaoyang Hospital of Capital Medical University (n=31), Qilu Hospital of Shandong University (n=14), the Third Xiangya Hospital of Central South University (n=13), Zhongnan Hospital of Wuhan University (n=2), the Fourth Hospital of Hebei Medical University (n=2) between December 2015 and December 2017 were prospectively enrolled in this study. Patients were divided into neoadjuvant chemotherapy group and elective surgery group according to the investigator's clinical experience and patient's preference. Patients in the elective surgery group received surgery within one to two weeks after SEMS placement without neoadjuvant chemotherapy. Those in the neoadjuvant chemotherapy group received 2 cycles of CapeOX or 3 cycles of mFOLFOX6 neoadjuvant chemotherapy within one to two weeks after SEMS placement, and then underwent surgery within 3 weeks after finishing neoadjuvant chemotherapy. Data between groups were compared using Student t-test, chi-square analysis or Fisher exact test analysis, including basic clinical informations, operational conditions and postoperative complications. The adverse reactions during the neoadjuvant chemotherapy were recorded. Surgical difficulty was assessed using visual analog scales ranging from 1 to 10, where 1 represented the lowest and 10 the highest degree of surgical difficulty, as judged by the surgeon.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 38 males and 24 females with mean age of (64.8±8.8) years. The clinical baseline data between 2 groups were not significantly different (all P&gt;0.05) except the average time interval between SEMS and surgery was significantly longer in neoadjuvant chemotherapy group [(61.6±13.5) days vs. (10.4±5.2) days, t=16.679, P&lt;0.001]. There was no stent migration in either group. Three patients had perforation in the elective surgery group; one patient had perforation and one had obstruction in the neoadjuvant chemotherapy group; and all these patients received emergent surgery. Adverse reactions of neodajuvant chemotherapy were mainly degree 1 and 2 except one patient with degree 3 diarrhea. Patients in neoadjuvant chemotherapy group had significantly lower rate of stoma [4.8%(1/21) vs. 34.1%(14/41), χ²=6.538, P=0.011], higher rate of laparoscopic surgery [71.4%(15/21) vs. 36.6%(15/41), χ²=6.751, P=0.009], shorter mean operative time (147 minutes vs. 178 minutes, t=-3.255, P=0.002), less mean intraoperative blood loss (47 ml vs. 127 ml, t=-4.129, P&lt;0.001), lower degree of surgical difficulty(3.3 vs. 5.6, t=-5.091, P&lt;0.001), shorter mean postoperative exhausting time (56.2 hours vs. 69.0 hours, t=-2.891, P=0.006), and shorter mean postoperative hospital stay (8.5 days vs. 13.5 days, t=-2.246, P=0.028) as compared with patients in the elective surgery group. Surgical site infection rate and anastomotic leakage rate did not differ significantly between two groups(all P&gt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neoadjuvant chemotherapy prior elective surgery following SEMS is a relatively safe and feasible approach in the treatment for obstructive left hemicolon cancer, and is associated with less stoma, more laparoscopic surgery, shorter operative time, less blood loss, lower surgical difficulty, and faster postoperative recovery as compared with conventional elective surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jiagang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhenjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China. Email:drzhenjun@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guiying</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Guanghui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Weigen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Liangang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Baocheng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Beijing Chaoyang Hosptial, Capital Medical University, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanlei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kaiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xuhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of General Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02972541</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>2015AA033602</GrantID><Agency>National High Technology Research and Development Program 863</Agency><Country/></Grant><Grant><GrantID>81541101</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2018-1-2032</GrantID><Agency>The Capital Health Research and Development of Special</Agency><Country/></Grant><Grant><GrantID>CYXZ-2017-09</GrantID><Agency>Project of Beijing Chaoyang Hospital 1351 talents training</Agency><Country/></Grant><Grant><GrantID>PX2019012</GrantID><Agency>Beijing Municipal Administration of Hospitals Incubating Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Wei Chang Wai Ke Za Zhi</MedlineTA><NlmUniqueID>101177990</NlmUniqueID><ISSNLinking>1671-0274</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007415" MajorTopicYN="Y">Intestinal Obstruction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="Y">Neoadjuvant Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30506533</ArticleId><ArticleId IdType="pii">100001882012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30513747</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Field Performance of Open-Ended Prestressed High-Strength Concrete Pipe Piles Jacked into Clay.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E4216</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s18124216</ELocationID><Abstract><AbstractText>The behavior of open-ended pipe piles is different from that of closed-ended pipe piles due to the soil plugging effect. In this study, a series of field tests were conducted to investigate the behavior of open-ended prestressed high-strength concrete (PHC) pipe piles installed into clay. Two open-ended PHC pipe piles were instrumented with Fiber Bragg Grating (FBG) sensors and jacked into clay for subsequent static loading tests. Soil plug length of the test piles was continuously measured during installation, allowing for calculation of the incremental filling ratio. The recorded data in static loading test were reported and analyzed. The distribution of residual forces after installation and the effect on the bearing capacity were also discussed in detail. The test piles were observed to be in partially plugged condition during installation. The measured ultimate shaft resistance and total resistance of the test piles were 639 and 1180 kN, respectively. The residual forces locked in the test piles after installation significantly affected the evaluation of the axial forces, and thus the shaft and end resistances. It tended to underestimate the end resistances and overestimate the shaft resistances if the residual forces were not considered in the loading test. However, the residual forces did not affect the total bearing capacity of open-ended PHC pipe piles in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kou</LastName><ForeName>Hai-Lei</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>College of Engineering, Ocean University of China, Qingdao 266100, China. hlkou@ouc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cooperative Innovation Center of Engineering Construction and Safety in Shandong Blue Economic Zone, Qingdao 266033, China. hlkou@ouc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Wen-Zhou</ForeName><Initials>WZ</Initials><AffiliationInfo><Affiliation>College of Engineering, Ocean University of China, Qingdao 266100, China. dwzouc@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Environmental Science and Engineering, Ocean University of China, Qingdao 266100, China. danliang1995@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dan-Liang</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>College of Engineering, Ocean University of China, Qingdao 266100, China. ltmilan@ouc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horpibulsuk</LastName><ForeName>Suksun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Civil Engineering, and Center of Excellence in Innovation for Sustainable Infrastructure Development, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand. suksun@g.sut.ac.th.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">field test</Keyword><Keyword MajorTopicYN="N">open-ended pipe piles</Keyword><Keyword MajorTopicYN="N">residual forces</Keyword><Keyword MajorTopicYN="N">soil plugging</Keyword><Keyword MajorTopicYN="N">static loading test</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30513747</ArticleId><ArticleId IdType="pii">s18124216</ArticleId><ArticleId IdType="doi">10.3390/s18124216</ArticleId><ArticleId IdType="pmc">PMC6308617</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30508949</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>48</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Minimally invasive and open gastrectomy for gastric cancer: A protocol for systematic review and network meta-analysis.</ArticleTitle><Pagination><MedlinePgn>e13419</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000013419</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study is to find the better treatment for gastric cancer by comparing robotic gastrectomy, laparoscopic gastrectomy, and open gastrectomy using Bayesian network meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We will search PubMed, Embase, and the Cochrane Library for eligible studies published before 1 September 2018. There will be no language restrictions. Randomized clinical trials that compare robotic gastrectomy, laparoscopic gastrectomy, or open gastrectomy for patients with gastric cancer will be included. The risk of bias of included studies will be assessed by the Cochrane Collaboration's tool for assessing risk of bias in randomized trial. The outcomes of the study include operation time, estimated blood loss, time of ambulation, times to first flatus, time of oral intake, hospitalization, and the occurrence of complication. If sufficient data is collected and adequate clinical homogeneity is established among studies, we will conduct pairwise meta-analyses and Bayesian network meta-analyses for all related outcome measures.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">The study does not involve human subjects and does not need ethical approval and patient consent. The results of the network meta-analysis will be disseminated in a peer-reviewed journal for publication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xixiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Boao Evergrande International Hospital, Qionghai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Sanya People's Hospital, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Meizhu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Sanya People's Hospital, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chenming</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Sanya People's Hospital, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yexiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Sanya People's Hospital, Sanya, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005743" MajorTopicYN="N">Gastrectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071076" MajorTopicYN="Y">Network Meta-Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="Y">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30508949</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000013419</ArticleId><ArticleId IdType="pii">00005792-201811300-00069</ArticleId><ArticleId IdType="pmc">PMC6283097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2017 Oct;31(10):4244-4251</Citation><ArticleIdList><ArticleId IdType="pubmed">28963583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2016 Jun;113(7):756-67</Citation><ArticleIdList><ArticleId IdType="pubmed">27076039</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2018 Nov 1;4(11):1553-1568</Citation><ArticleIdList><ArticleId IdType="pubmed">29860482</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2003 Jun 15;21(12):2234-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12805321</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Oncol. 2013 Dec;108(8):550-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24115104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2015 Jun 2;162(11):777-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2011 Feb;64(2):163-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20688472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2012 Mar;255(3):446-56</Citation><ArticleIdList><ArticleId IdType="pubmed">22330034</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Oct 18;343:d5928</Citation><ArticleIdList><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2013 Nov;100(12):1566-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24264778</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2015 Sep 09;5(9):e007768</Citation><ArticleIdList><ArticleId IdType="pubmed">26353868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2011 Jun;22 Suppl 5:v1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21633049</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Oncol. 2012 Dec;21(4):274-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22789391</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 03;8(12):e81946</Citation><ArticleIdList><ArticleId IdType="pubmed">24312610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2004 Jun;77(6):1978-82; discussion 1982-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15172249</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2011 Sep;146(9):1086-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21576595</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2015 Jan 01;4:1</Citation><ArticleIdList><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Clin Oncol. 2017 Jun 10;8(3):273-284</Citation><ArticleIdList><ArticleId IdType="pubmed">28638798</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2016 Jul 7;22(25):5694-717</Citation><ArticleIdList><ArticleId IdType="pubmed">27433084</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc. 1994 Apr;4(2):146-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8180768</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2010 Mar 30;29(7-8):932-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20213715</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 03;8(10):e76654</Citation><ArticleIdList><ArticleId IdType="pubmed">24098547</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2014 Oct;28(10):2795-802</Citation><ArticleIdList><ArticleId IdType="pubmed">24789136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30466390</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2105</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC bioinformatics</Title><ISOAbbreviation>BMC Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>knnAUC: an open-source R package for detecting nonlinear dependence between one continuous variable and one binary variable.</ArticleTitle><Pagination><MedlinePgn>448</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12859-018-2427-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Testing the dependence of two variables is one of the fundamental tasks in statistics. In this work, we developed an open-source R package (knnAUC) for detecting nonlinear dependence between one continuous variable X and one binary dependent variables Y (0 or 1).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We addressed this problem by using knnAUC (k-nearest neighbors AUC test, the R package is available at https://sourceforge.net/projects/knnauc/ ). In the knnAUC software framework, we first resampled a dataset to get the training and testing dataset according to the sample ratio (from 0 to 1), and then constructed a k-nearest neighbors algorithm classifier to get the yhat estimator (the probability of y = 1) of testy (the true label of testing dataset). Finally, we calculated the AUC (area under the curve of receiver operating characteristic) estimator and tested whether the AUC estimator is greater than 0.5. To evaluate the advantages of knnAUC compared to seven other popular methods, we performed extensive simulations to explore the relationships between eight different methods and compared the false positive rates and statistical power using both simulated and real datasets (Chronic hepatitis B datasets and kidney cancer RNA-seq datasets).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We concluded that knnAUC is an efficient R package to test non-linear dependence between one continuous variable and one binary dependent variable especially in computational biology area.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Contemporary Anthropology, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Six Industrial Research Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Contemporary Anthropology, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yanyun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Contemporary Anthropology, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Six Industrial Research Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Contemporary Anthropology, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weichen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Medicine &amp; Bioinformatics, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Contemporary Anthropology, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhenghong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai Medical School, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai Medical School, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Digestive Diseases of Huashan Hospital, Collaborative Innovation Center for Genetics and Development, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Momiao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human Genetics Center, School of Public Health, University of Texas Houston Health Sciences Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shugart</LastName><ForeName>Yin Yao</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Unit on Statistical Genomics, Division of Intramural Division Programs, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. yinyao21043@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiucun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Six Industrial Research Institute, Fudan University, Shanghai, China. jcwang@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. jcwang@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China. jcwang@fudan.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Six Industrial Research Institute, Fudan University, Shanghai, China. lijin@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. lijin@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Phenome Institute, Fudan University, Shanghai, China. lijin@fudan.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31330038, 31521003</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2015FY111700</GrantID><Agency>Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>B13016</GrantID><Agency>Ministry of Education of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>2014CB541801</GrantID><Agency>National Basic Research Program</Agency><Country/></Grant><Grant><GrantID>2017SHZDZX01</GrantID><Agency>Shanghai Municipal Science and Technology Major Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Bioinformatics</MedlineTA><NlmUniqueID>100965194</NlmUniqueID><ISSNLinking>1471-2105</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUC</Keyword><Keyword MajorTopicYN="N">Association analysis</Keyword><Keyword MajorTopicYN="N">Nonlinear dependence</Keyword><Keyword MajorTopicYN="N">One binary dependent variable</Keyword><Keyword MajorTopicYN="N">One continuous variable</Keyword><Keyword MajorTopicYN="N">Open source</Keyword><Keyword MajorTopicYN="N">R package</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30466390</ArticleId><ArticleId IdType="doi">10.1186/s12859-018-2427-4</ArticleId><ArticleId IdType="pii">10.1186/s12859-018-2427-4</ArticleId><ArticleId IdType="pmc">PMC6249767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biometrika. 1967 Jun;54(1):167-79</Citation><ArticleIdList><ArticleId IdType="pubmed">6049533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mech Dev. 1998 May;73(2):221-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9622638</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2015 May;115(5):829-38</Citation><ArticleIdList><ArticleId IdType="pubmed">25130393</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Res. 2017 Nov;82(5):855-862</Citation><ArticleIdList><ArticleId IdType="pubmed">28665931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liver Int. 2017 Nov;37(11):1632-1641</Citation><ArticleIdList><ArticleId IdType="pubmed">28328162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Appl Stat. 2009 Jan 1;3(4):1266-1269</Citation><ArticleIdList><ArticleId IdType="pubmed">20574547</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(9):e46001</Citation><ArticleIdList><ArticleId IdType="pubmed">23029358</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1988 Oct 13;319(15):961-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3419477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2017 Nov;89(11):1937-1943</Citation><ArticleIdList><ArticleId IdType="pubmed">28464339</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2012 Jun 26;13:147</Citation><ArticleIdList><ArticleId IdType="pubmed">22734592</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Genet. 1999 Jan;34(6):419-29</Citation><ArticleIdList><ArticleId IdType="pubmed">9933353</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 Dec 16;334(6062):1518-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22174245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Rep. 2005 Sep-Oct;57(5):596-603</Citation><ArticleIdList><ArticleId IdType="pubmed">16227642</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Feb 1;29(3):407-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23242262</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 1982 Apr;143(1):29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cytopathol. 2015 May;123(5):298-305</Citation><ArticleIdList><ArticleId IdType="pubmed">25739652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jul 4;499(7456):43-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23792563</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2013 Oct 30;13:509</Citation><ArticleIdList><ArticleId IdType="pubmed">24168110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2009 Oct 15;69(20):8001-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19808960</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Chem. 2008 Feb;389(2):179-87</Citation><ArticleIdList><ArticleId IdType="pubmed">18163890</ArticleId></ArticleIdList></Reference><Reference><Citation>Antioxid Redox Signal. 2017 Nov 15;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28990419</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2013 Jan 10;13:14</Citation><ArticleIdList><ArticleId IdType="pubmed">23305401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Pathol. 2013 Mar;44(3):336-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22995329</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Biosci (Landmark Ed). 2012 Jan 01;17:1835-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22201839</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Metab Dispos. 2015 Apr;43(4):611-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25650382</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2014 Jan 30;5(2):386-402</Citation><ArticleIdList><ArticleId IdType="pubmed">24481423</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2017 Jul;23(7):869-877</Citation><ArticleIdList><ArticleId IdType="pubmed">28553932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Jun 19;43(7):639-47</Citation><ArticleIdList><ArticleId IdType="pubmed">21685914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Exp Biol Med. 2001 Nov;132(5):1096-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11865331</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Urol. 2014 Aug;11(8):465-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25048860</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 Aug 19;16:260</Citation><ArticleIdList><ArticleId IdType="pubmed">26283601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2012 May;56(5):1201-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22133568</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunopharmacol. 2011 Jun;11(6):639-45</Citation><ArticleIdList><ArticleId IdType="pubmed">21238623</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Genet. 2016 Oct;209(10):463-473</Citation><ArticleIdList><ArticleId IdType="pubmed">27810075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30457984</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>11</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017.</ArticleTitle><Pagination><MedlinePgn>e2006930</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.2006930</ELocationID><Abstract><AbstractText>Currently, there is a growing interest in ensuring the transparency and reproducibility of the published scientific literature. According to a previous evaluation of 441 biomedical journals articles published in 2000-2014, the biomedical literature largely lacked transparency in important dimensions. Here, we surveyed a random sample of 149 biomedical articles published between 2015 and 2017 and determined the proportion reporting sources of public and/or private funding and conflicts of interests, sharing protocols and raw data, and undergoing rigorous independent replication and reproducibility checks. We also investigated what can be learned about reproducibility and transparency indicators from open access data provided on PubMed. The majority of the 149 studies disclosed some information regarding funding (103, 69.1% [95% confidence interval, 61.0% to 76.3%]) or conflicts of interest (97, 65.1% [56.8% to 72.6%]). Among the 104 articles with empirical data in which protocols or data sharing would be pertinent, 19 (18.3% [11.6% to 27.3%]) discussed publicly available data; only one (1.0% [0.1% to 6.0%]) included a link to a full study protocol. Among the 97 articles in which replication in studies with different data would be pertinent, there were five replication efforts (5.2% [1.9% to 12.2%]). Although clinical trial identification numbers and funding details were often provided on PubMed, only two of the articles without a full text article in PubMed Central that discussed publicly available data at the full text level also contained information related to data sharing on PubMed; none had a conflicts of interest statement on PubMed. Our evaluation suggests that although there have been improvements over the last few years in certain key indicators of reproducibility and transparency, opportunities exist to improve reproducible research practices across the biomedical literature and to make features related to reproducibility more readily visible in PubMed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wallach</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research Integrity and Transparency, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyack</LastName><ForeName>Kevin W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>SciTech Strategies, Inc., Albuquerque, New Mexico, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioannidis</LastName><ForeName>John P A</ForeName><Initials>JPA</Initials><Identifier Source="ORCID">0000-0003-3118-6859</Identifier><AffiliationInfo><Affiliation>Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research and Policy, Stanford University, Stanford, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Data Science, Stanford University, Stanford, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Stanford University, Stanford, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Meta-Research Innovation Center at Stanford, Stanford University, Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="N">Access to Information</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016265" MajorTopicYN="N">Conflict of Interest</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030881" MajorTopicYN="N">Disclosure</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011642" MajorTopicYN="N">Publications</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30457984</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.2006930</ArticleId><ArticleId IdType="pii">pbio.2006930</ArticleId><ArticleId IdType="pmc">PMC6245499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2016 Jan 28;374(4):384-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26786954</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2018 Jan;93:88-93</Citation><ArticleIdList><ArticleId IdType="pubmed">29042327</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 May 2;13(5):e0194768</Citation><ArticleIdList><ArticleId IdType="pubmed">29719004</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jan 22-29;289(4):454-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12533125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2007 Oct 10;25(29):4642-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17925561</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 Jan 04;14(1):e1002333</Citation><ArticleIdList><ArticleId IdType="pubmed">26726926</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 Oct;69(10):1546-1557</Citation><ArticleIdList><ArticleId IdType="pubmed">27863164</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2005 Aug;2(8):e124</Citation><ArticleIdList><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2014 Jan 11;383(9912):166-75</Citation><ArticleIdList><ArticleId IdType="pubmed">24411645</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2002 Jun 5;287(21):2831-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12038926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 25;533(7604):452-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2016 Jun 1;8(341):341ps12</Citation><ArticleIdList><ArticleId IdType="pubmed">27252173</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2018 Feb;94:8-18</Citation><ArticleIdList><ArticleId IdType="pubmed">29113936</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2017 May;63(5):943-945</Citation><ArticleIdList><ArticleId IdType="pubmed">28298413</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2017 Sep 11;15(9):e2002173</Citation><ArticleIdList><ArticleId IdType="pubmed">28892482</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2016 May 12;14(5):e1002456</Citation><ArticleIdList><ArticleId IdType="pubmed">27171007</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):615-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26168121</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jun 27;317(24):2491-2492</Citation><ArticleIdList><ArticleId IdType="pubmed">28586895</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2018 Feb 13;360:k400</Citation><ArticleIdList><ArticleId IdType="pubmed">29440066</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Brief. 2016 Aug 16;8:1421-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27617276</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 26;348(6242):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26113702</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2014 Oct 21;11(10):e1001747</Citation><ArticleIdList><ArticleId IdType="pubmed">25334033</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Apr 10;319(14):1429-1430</Citation><ArticleIdList><ArticleId IdType="pubmed">29566133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2009 Jun 15;115(12):2783-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19434666</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Jan 19;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">28100398</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(7):e39464</Citation><ArticleIdList><ArticleId IdType="pubmed">22808037</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4343-4350</Citation><ArticleIdList><ArticleId IdType="pubmed">27363404</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Mar 15;315(11):1141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26978209</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30427903</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Open-source sensor for measuring oxygen partial pressures below 100 microbars.</ArticleTitle><Pagination><MedlinePgn>e0206678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0206678</ELocationID><Abstract><AbstractText>The ability to measure partial pressures of oxygen below 100 microbars and nanomolar dissolved oxygen concentrations in in situ laboratory systems benefits many fields including microbiology, geobiology, oceanography, chemistry, and materials science. Here, we present an easily constructible open-source design for a networked luminescence lifetime measurement system for in situ measurements in arbitrary laboratory containers. The system is well suited for measuring oxygen partial pressures in the 0-100 μbar range, with the maximum potentially usable upper range limit at around 10 mbar, depending on experimental conditions. The sensor has a limited drift and its detectability limit for oxygen is at 0.02 μbar for short timescale measurements. Each sensor can connect to a Wi-Fi network and send the logged data either over the Internet or to a local server, enabling a large number of parallel unattended experiments. Designs are also provided for attaching the sensor to various commercially available containers used in laboratories. The design files are released under an open source license, which enables other laboratories to build, customize, and use these sensors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pajusalu</LastName><ForeName>Mihkel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3500-2770</Identifier><AffiliationInfo><Affiliation>Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borlina</LastName><ForeName>Cauê S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosak</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="N">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055615" MajorTopicYN="Y">Electrical Equipment and Supplies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005898" MajorTopicYN="N">Glass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061848" MajorTopicYN="N">Optical Imaging</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010313" MajorTopicYN="N">Partial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066330" MajorTopicYN="N">Printing, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059015" MajorTopicYN="N">Wireless Technology</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>This work has been supported from “FESD Type I: The Dynamics of Earth System Oxygenation” NSF project #1338810, “The Alien Earths Initiative: Pursuing Humanity's Quest to Understand Inhabited Planets Orbiting Other Stars” project from John Templeton foundation, the Simons Foundation Collaboration on the Origins of Life grant #327126, and "Mapping Biochemical Space to Search for Life Beyond Earth and for Fundamental Terrestrial Applications” The Professor Amar G. Bose Research Grant Program, MIT. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30427903</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0206678</ArticleId><ArticleId IdType="pii">PONE-D-18-06393</ArticleId><ArticleId IdType="pmc">PMC6235348</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioessays. 2015 Aug;37(8):921-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26113255</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrobiology. 2002 Spring;2(1):27-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12449853</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 01;10(6):e0128125</Citation><ArticleIdList><ArticleId IdType="pubmed">26029920</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cheminform. 2011 Oct 07;3:33</Citation><ArticleIdList><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 2011;486:325-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21185442</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30387326</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2192-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>23</Issue><PubDate><Year>2018</Year><Month>12</Month></PubDate></JournalIssue><Title>Advanced healthcare materials</Title><ISOAbbreviation>Adv Healthc Mater</ISOAbbreviation></Journal><ArticleTitle>Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma.</ArticleTitle><Pagination><MedlinePgn>e1801047</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/adhm.201801047</ELocationID><Abstract><AbstractText>Nitric oxide (NO) donors are ideal drug candidates for reducing intraocular pressure in the treatment of glaucoma. However, poor cornea penetration, short duration of efficacy, and narrow therapeutic index of most NO donors obstruct their clinical applications in glaucoma treatment. This study reports a novel NO donor delivery system based on mesoporous silica nanoparticles that can readily overcome the above difficulties and deliver the NO-donating drug sodium nitroprusside to the target tissues (trabecular meshwork and Schlemm's canal). Mesoporous silica nanoparticles loaded with sodium nitroprusside can produce more exogenous NO and sustain higher NO concentration in animal eye models, which significantly extend the duration of intraocular pressure reduction from 3 to 48 h with only 1/40 of the dose of sodium nitroprusside solution. These findings open up the possibility of mesoporous silica nanoparticles loading sodium nitroprusside for effective management of ocular hypertension.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chunchun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye Institute, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye Institute, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key NHC Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, iChEM, Fudan University, Shanghai, 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Energy and Power Engineering, the University of Shanghai for Science and Technology, Shanghai, 200093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye Institute, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key NHC Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xinghuai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye Institute, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key NHC Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0657-9397</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, iChEM, Fudan University, Shanghai, 200433, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81430007</GrantID><Agency>State Key Program of National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>2015DFA31340</GrantID><Agency>Funds for International Cooperation of Ministry of Science and Technology</Agency><Country>International</Country></Grant><Grant><GrantID>81100662</GrantID><Agency>National Science Foundation China</Agency><Country>International</Country></Grant><Grant><GrantID>81371015</GrantID><Agency>National Science Foundation China</Agency><Country>International</Country></Grant><Grant><GrantID>21673048</GrantID><Agency>National Science Foundation China</Agency><Country>International</Country></Grant><Grant><GrantID>21875044</GrantID><Agency>National Science Foundation China</Agency><Country>International</Country></Grant><Grant><GrantID>2018112</GrantID><Agency>BrightFocus Foundation</Agency><Country>International</Country></Grant><Grant><GrantID>XYQ2013083</GrantID><Agency>Shanghai Municipal Health Bureau Young Outstanding Scientist Program</Agency><Country>International</Country></Grant><Grant><GrantID>EHF158351</GrantID><Agency>211 Project of Fudan University</Agency><Country>International</Country></Grant><Grant><GrantID>17410712500</GrantID><Agency>International Cooperation Program of Shanghai Municipal Commission of Science and Technology Commission</Agency><Country>International</Country></Grant><Grant><GrantID>15ZR1405900</GrantID><Agency>Natural Science Foundation of Shanghai</Agency><Country>International</Country></Grant><Grant><GrantID>SKT1503</GrantID><Agency>State Key Laboratory of Transducer Technology of China</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Adv Healthc Mater</MedlineTA><NlmUniqueID>101581613</NlmUniqueID><ISSNLinking>2192-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020030">Nitric Oxide Donors</NameOfSubstance></Chemical><Chemical><RegistryNumber>169D1260KM</RegistryNumber><NameOfSubstance UI="D009599">Nitroprusside</NameOfSubstance></Chemical><Chemical><RegistryNumber>7631-86-9</RegistryNumber><NameOfSubstance UI="D012822">Silicon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020030" MajorTopicYN="N">Nitric Oxide Donors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009599" MajorTopicYN="N">Nitroprusside</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016062" MajorTopicYN="N">Porosity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012822" MajorTopicYN="N">Silicon Dioxide</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">drug delivery</Keyword><Keyword MajorTopicYN="Y">glaucoma</Keyword><Keyword MajorTopicYN="Y">mesoporous silica nanoparticles</Keyword><Keyword MajorTopicYN="Y">nitric oxide</Keyword><Keyword MajorTopicYN="Y">sustained release</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30387326</ArticleId><ArticleId IdType="doi">10.1002/adhm.201801047</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30382933</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3548</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>11</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer communications (London, England)</Title><ISOAbbreviation>Cancer Commun (Lond)</ISOAbbreviation></Journal><ArticleTitle>Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study.</ArticleTitle><Pagination><MedlinePgn>66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40880-018-0330-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Famitinib is a tyrosine kinase inhibitor against multiple targets, including vascular endothelial growth factor receptor 2/3, platelet-derived growth factor receptor, and stem cell factor receptor (c-kit). Previous studies have demonstrated anti-tumour activities of famitinib against a wide variety of advanced-stage solid cancers. We aimed to determine the safety and efficacy of famitinib with concurrent chemoradiotherapy (CCRT) in patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We also evaluated the feasibility of contrast-enhanced ultrasound (D-CEUS) as a predictor of early tumour response to famitinib and to correlate functional parameters with clinical efficacy.</AbstractText><AbstractText Label="METHODS">The trial was conducted in subjects with stage III or IVa-b NPC using a 3 + 3 design of escalating famitinib doses. Briefly, subjects received 2 weeks of famitinib monotherapy followed by 7 weeks of famitinib plus CCRT. D-CEUS of the neck lymph nodes was performed at day 0, 8 and 15 after famitinib was administered before starting concurrent chemoradiotherapy. End points included safety, tolerability and anti-tumour activity.</AbstractText><AbstractText Label="RESULTS">Twenty patients were enrolled (six each for 12.5, 16.5 and 20 mg and two for 25 mg). Two patients in the 25 mg cohort developed dose-limiting toxicities, including grade 4 thrombocytopenia and grade 3 hypertension. The most common grade 3/4 adverse events were leukopenia, neutropenia and radiation mucositis. D-CEUS tests showed that more than 60% of patients achieved a perfusion parameter response after 2 weeks taking famitinib alone, and the parameter response was associated with disease improvement. In the famitinib monotherapy stage, three patients (15%) showed partial responses. The complete response rate was 65% at the completion of treatment and 95% 3 months after the treatment ended. After a median follow-up of 44 months, the 3-year progression-free survival (PFS) and distant metastasis-free survival were 70% and 75%, respectively. Subjects with a decrease of perfusion parameter response, such as peak intensity decreased at least 30% after 1 week of famitinib treatment, had higher 3-year PFS (90.9% vs. 44.4%, 95% CI 73.7%-100% vs. 11.9%-76.9%, P &lt; 0.001) than those with an increase or a reduction of less than 30%.</AbstractText><AbstractText Label="CONCLUSIONS">The recommended famitinib dose for phase II trial is 20 mg with CCRT for patients with local advanced NPC. D-CEUS is a reliable and early measure of efficacy for famitinib therapies. Further investigation is required to confirm the effects of famitinib plus chemoradiotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiuyan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Linquan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ultrasound, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ultrasound, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Yanfang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Science and Education, Sun Yat-sen Memorial Hospital, Guangzhou, 510120, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liting</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yingqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qingmei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaoqun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qingnan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>YuJing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>XueSong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Chuanmiao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Yunxian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Trial Center, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Haoyuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Kajia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Musheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Haiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. maihq@sysucc.org.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. maihq@sysucc.org.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0037-6257</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. majun@sysucc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. majun@sysucc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81230056</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>2014BAI09B10</GrantID><Agency>the National Science &amp;amp; Technology Pillar Program during the Twelfth Five-year Plan Period</Agency><Country>International</Country></Grant><Grant><GrantID>S2013010012220</GrantID><Agency>the Natural Science Foundation of Guangdong Province</Agency><Country>International</Country></Grant><Grant><GrantID>2017A030312003</GrantID><Agency>the Natural Science Foundation of Guangdong Province</Agency><Country>International</Country></Grant><Grant><GrantID>132000507</GrantID><Agency>the Science and Technology Project of Guangzhou City, China</Agency><Country>International</Country></Grant><Grant><GrantID>201400000001</GrantID><Agency>the Health &amp;amp; Medical Collaborative Innovation Project of Guangzhou City, China</Agency><Country>International</Country></Grant><Grant><GrantID>IRT_17R110</GrantID><Agency>the Innovation Team Development Plan of the Ministry of Education</Agency><Country>International</Country></Grant><Grant><GrantID>B14035</GrantID><Agency>the Program of Introducing Talents of Discipline to Universities</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Commun (Lond)</MedlineTA><NlmUniqueID>101723675</NlmUniqueID><ISSNLinking>2523-3548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>768FW21J3L</RegistryNumber><NameOfSubstance UI="C584390">famitinib</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D020794">Receptor Protein-Tyrosine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059248" MajorTopicYN="N">Chemoradiotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077274" MajorTopicYN="N">Nasopharyngeal Carcinoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020794" MajorTopicYN="N">Receptor Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Concurrent chemoradiotherapy</Keyword><Keyword MajorTopicYN="Y">Famitinib</Keyword><Keyword MajorTopicYN="Y">Nasopharyngeal carcinoma</Keyword><Keyword MajorTopicYN="Y">Phase I, dynamic contrast-enhanced ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30382933</ArticleId><ArticleId IdType="doi">10.1186/s40880-018-0330-z</ArticleId><ArticleId IdType="pii">10.1186/s40880-018-0330-z</ArticleId><ArticleId IdType="pmc">PMC6235389</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Radiat Biol. 2015;91(9):771-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26073526</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2015 Oct 14;108(1):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26467665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Laryngol Otol. 1998 Sep;112(9):849-53</Citation><ArticleIdList><ArticleId IdType="pubmed">9876375</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiother Oncol. 2014 Mar;110(3):377-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24630534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2005 Oct 1;23(28):6966-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16192584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2005 Oct;207(2):216-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16021677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2012 Feb;13(2):172-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22178121</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J Cancer. 2017 Nov 9;36(1):90</Citation><ArticleIdList><ArticleId IdType="pubmed">29122009</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2011 Aug 15;17(16):5481-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21712450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2013 Nov;59(5):1014-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23811306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Chemother Pharmacol. 2013 Nov;72(5):1043-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24043137</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2011 Dec 7;103(23):1761-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22056739</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2002 Apr 15;20(8):2038-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11956263</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2003 Feb 15;21(4):631-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12586799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2012 Feb;13(2):163-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22154591</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2007 Jun 1;13(11):3395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">17545548</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2013 Aug 10;31(23):2861-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23857969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2013 Nov;126(22):4277-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24238512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ultrasound Med Biol. 2015 Oct;41(10):2621-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26210785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J Cancer. 2010 Feb;29(2):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20109338</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2002 Jun;25(3):219-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12040275</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Rep. 2016 Oct;5(4):437-442</Citation><ArticleIdList><ArticleId IdType="pubmed">27699010</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Mar 20;27(9):1432-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19224847</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncology. 1999 Jul;57(1):36-41</Citation><ArticleIdList><ArticleId IdType="pubmed">10394123</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2005 Sep 20;23(27):6730-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16170180</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2013 Apr;168(7):1687-706</Citation><ArticleIdList><ArticleId IdType="pubmed">23126373</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2003 Oct;16(10):1035-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14559987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2013 Apr;24(4):1055-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23172635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Radiol. 2004 May;85(5 Pt 2):704-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15238871</ArticleId></ArticleIdList></Reference><Reference><Citation>Laryngoscope. 1999 May;109(5):810-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10334236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2009 Oct;10(10):967-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19767240</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2002 Aug;8(8):2595-604</Citation><ArticleIdList><ArticleId IdType="pubmed">12171890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2003 Jul 15;63(14):4009-16</Citation><ArticleIdList><ArticleId IdType="pubmed">12873999</ArticleId></ArticleIdList></Reference><Reference><Citation>Anticancer Drugs. 2006 Mar;17(3):353-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16520665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2011 Jun;22(6):1280-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21317222</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Aug 1;27(22):3684-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19564532</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2010 Feb 15;16(4):1216-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiother Oncol. 2014 Mar;110(3):398-403</Citation><ArticleIdList><ArticleId IdType="pubmed">24231245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2015 Jun;16(6):645-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25957714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2012 May;23(5):1287-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21948811</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):12-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12007936</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1998 Apr;16(4):1310-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9552031</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Radiol. 2012 Jun;81(6):1360-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21345633</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Oncol. 2007 Feb;30(2):403-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17203222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Nov;17(11):1509-1520</Citation><ArticleIdList><ArticleId IdType="pubmed">27686945</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004329</Citation><ArticleIdList><ArticleId IdType="pubmed">17054200</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Nov 15;22(22):4604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15542811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30373621</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1476-072X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>10</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of health geographics</Title><ISOAbbreviation>Int J Health Geogr</ISOAbbreviation></Journal><ArticleTitle>Developing a representative community health survey sampling frame using open-source remote satellite imagery in Mozambique.</ArticleTitle><Pagination><MedlinePgn>37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12942-018-0158-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lack of accurate data on the distribution of sub-national populations in low- and middle-income countries impairs planning, monitoring, and evaluation of interventions. Novel, low-cost methods to develop unbiased survey sampling frames at sub-national, sub-provincial, and even sub-district levels are urgently needed. This article details our experience using remote satellite imagery to develop a provincial-level representative community survey sampling frame to evaluate the effects of a 7-year health system intervention in Sofala Province, Mozambique.</AbstractText><AbstractText Label="METHODS">Mozambique's most recent census was conducted in 2007, and no data are readily available to generate enumeration areas for representative health survey sampling frames. To remedy this, we partnered with the Humanitarian OpenStreetMap Team to digitize every building in Sofala and Manica provinces (685,189 Sofala; 925,713 Manica) using up-to-date remote satellite imagery, with final results deposited in the open-source OpenStreetMap database. We then created a probability proportional to size sampling frame by overlaying a grid of 2.106 km resolution (0.02 decimal degrees) across each province, and calculating the number of buildings within each grid square. Squares containing buildings were used as our primary sampling unit with replacement. Study teams navigated to the geographic center of each selected square using geographic positioning system coordinates, and then conducted a standard "random walk" procedure to select 20 households for each time a given square was selected. Based on sample size calculations, we targeted a minimum of 1500 households in each province. We selected 88 grids within each province to reach 1760 households, anticipating ongoing conflict and transport issues could preclude the inclusion of some clusters.</AbstractText><AbstractText Label="RESULTS">Civil conflict issues forced the exclusion of 8 of 31 subdistricts in Sofala and 15 of 39 subdistricts in Manica. Using Android tablets, Open Data Kit software, and a remote RedCap data capture system, our final sample included 1549 households in Sofala (4669 adults; 4766 children; 33 missing age) and 1538 households in Manica (4422 adults; 4898 children; 33 missing age).</AbstractText><AbstractText Label="CONCLUSIONS">Other implementation or evaluation teams may consider employing similar methods to track population distributions for health systems planning or the development of representative sampling frames using remote satellite imagery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wagenaar</LastName><ForeName>Bradley H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. wagenaarb@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Alliance International, Seattle, WA, USA. wagenaarb@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augusto</LastName><ForeName>Orvalho</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Alliance International, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Eduardo Mondlane, Maputo, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ásbjörnsdóttir</LastName><ForeName>Kristjana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Alliance International, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akullian</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Disease Modeling, Bellevue, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manaca</LastName><ForeName>Nelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Health Alliance International, Beira, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chale</LastName><ForeName>Falume</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Beira Operations Research Center, Beira, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muanido</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Alliance International, Beira, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covele</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Alliance International, Beira, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Alliance International, Beira, Mozambique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gimbel</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Alliance International, Beira, Mozambique.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Humanitarian OpenStreetMap Team, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardot</LastName><ForeName>Blake</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Humanitarian OpenStreetMap Team, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherr</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Alliance International, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>with input from the INCOMAS Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Health Geogr</MedlineTA><NlmUniqueID>101152198</NlmUniqueID><ISSNLinking>1476-072X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019352" MajorTopicYN="N">Censuses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005191" MajorTopicYN="Y">Family Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009073" MajorTopicYN="N" Type="Geographic">Mozambique</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063809" MajorTopicYN="N">Satellite Imagery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Evaluation</Keyword><Keyword MajorTopicYN="Y">Geographic information systems</Keyword><Keyword MajorTopicYN="Y">Mozambique</Keyword><Keyword MajorTopicYN="Y">Remote sensing</Keyword><Keyword MajorTopicYN="Y">Sampling</Keyword><Keyword MajorTopicYN="Y">Satellite imagery</Keyword><Keyword MajorTopicYN="Y">Survey design</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Manuel</LastName><ForeName>João Luis</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hicks</LastName><ForeName>Leecreesha</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahumane</LastName><ForeName>Arlete</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pfeiffer</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gloyd</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuembelo</LastName><ForeName>Fatima</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nhumba</LastName><ForeName>Miguel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lequechane</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Napua</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vieira</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30373621</ArticleId><ArticleId IdType="doi">10.1186/s12942-018-0158-4</ArticleId><ArticleId IdType="pii">10.1186/s12942-018-0158-4</ArticleId><ArticleId IdType="pmc">PMC6206736</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Biomed Inform. 2009 Apr;42(2):377-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2014 Aug;2(8):e468-77</Citation><ArticleIdList><ArticleId IdType="pubmed">25103520</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Health Geogr. 2012 Apr 27;11:12</Citation><ArticleIdList><ArticleId IdType="pubmed">22540266</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Themes Epidemiol. 2015 Dec 23;12:20</Citation><ArticleIdList><ArticleId IdType="pubmed">26705402</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2012 Sep 05;12:741</Citation><ArticleIdList><ArticleId IdType="pubmed">22950896</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Nov 1;210 Suppl 1:S98-101</Citation><ArticleIdList><ArticleId IdType="pubmed">25316882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Feb 7;415(6872):710-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11832960</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2014 Sep 1;92(9):690-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25378761</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Health Geogr. 2009 Jul 23;8:49</Citation><ArticleIdList><ArticleId IdType="pubmed">19627614</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2009 Mar;20(2):214-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19177025</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2015 Sep 17;14:345</Citation><ArticleIdList><ArticleId IdType="pubmed">26376980</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Health Geogr. 2016 Jul 30;15(1):26</Citation><ArticleIdList><ArticleId IdType="pubmed">27473186</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2013;13 Suppl 2:S4</Citation><ArticleIdList><ArticleId IdType="pubmed">23819552</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Health Geogr. 2013 Jan 18;12:3</Citation><ArticleIdList><ArticleId IdType="pubmed">23331997</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Themes Epidemiol. 2007 Jun 01;4:8</Citation><ArticleIdList><ArticleId IdType="pubmed">17543102</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Themes Epidemiol. 2012 Sep 11;9(1):5</Citation><ArticleIdList><ArticleId IdType="pubmed">22967277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">30362295</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1051-0761</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Ecological applications : a publication of the Ecological Society of America</Title><ISOAbbreviation>Ecol Appl</ISOAbbreviation></Journal><ArticleTitle>Open science, reproducibility, and transparency in ecology.</ArticleTitle><Pagination><MedlinePgn>e01822</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eap.1822</ELocationID><Abstract><AbstractText>Reproducibility is a key tenet of the scientific process that dictates the reliability and generality of results and methods. The complexities of ecological observations and data present novel challenges in satisfying needs for reproducibility and also transparency. Ecological systems are dynamic and heterogeneous, interacting with numerous factors that sculpt natural history and that investigators cannot completely control. Observations may be highly dependent on spatial and temporal context, making them very difficult to reproduce, but computational reproducibility can still be achieved. Computational reproducibility often refers to the ability to produce equivalent analytical outcomes from the same data set using the same code and software as the original study. When coded workflows are shared, authors and editors provide transparency for readers and allow other researchers to build directly and efficiently on primary work. These qualities may be especially important in ecological applications that have important or controversial implications for science, management, and policy. Expectations for computational reproducibility and transparency are shifting rapidly in the sciences. In this work, we highlight many of the unique challenges for ecology along with practical guidelines for reproducibility and transparency, as ecologists continue to participate in the stewardship of critical environmental information and ensure that research methods demonstrate integrity.</AbstractText><CopyrightInformation>© 2018 The Authors. Ecological Applications published by Wiley Periodicals, Inc. on behalf of Ecological Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Powers</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0001-6267-2644</Identifier><AffiliationInfo><Affiliation>School of the Environment, Washington State University, Pullman, Washington, 99164, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampton</LastName><ForeName>Stephanie E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0003-2389-4249</Identifier><AffiliationInfo><Affiliation>School of the Environment, Washington State University, Pullman, Washington, 99164, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ecol Appl</MedlineTA><NlmUniqueID>9889808</NlmUniqueID><ISSNLinking>1051-0761</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004463" MajorTopicYN="Y">Ecology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">collaborative tools</Keyword><Keyword MajorTopicYN="Y">data policy</Keyword><Keyword MajorTopicYN="Y">data science</Keyword><Keyword MajorTopicYN="Y">ecoinformatics</Keyword><Keyword MajorTopicYN="Y">ecosystem</Keyword><Keyword MajorTopicYN="Y">environmental science</Keyword><Keyword MajorTopicYN="Y">open science</Keyword><Keyword MajorTopicYN="Y">repeatability</Keyword><Keyword MajorTopicYN="Y">replicability</Keyword><Keyword MajorTopicYN="Y">reproducible</Keyword><Keyword MajorTopicYN="Y">transparent</Keyword><Keyword MajorTopicYN="Y">workflows</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>07</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30362295</ArticleId><ArticleId IdType="doi">10.1002/eap.1822</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30351300</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2018</Year><Month>10</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>The Dat Project, an open and decentralized research data tool.</ArticleTitle><Pagination><MedlinePgn>180221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/sdata.2018.221</ELocationID><Abstract><AbstractText>Today's scientific data are primarily stored and accessed via centralized Web-based infrastructure. Centralization has advantages but also carries risks such as link rot and content drift, which can hinder scientific progress. It is time to ask whether traditional, centralized Web architecture aligns with scholarly priorities and values, and to collaboratively move towards new approaches that do.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Danielle C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Code for Science &amp; Society, Portland, OR 97214, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Dat Project, Portland, OR 97214, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hand</LastName><ForeName>Joe A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Code for Science &amp; Society, Portland, OR 97214, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Dat Project, Portland, OR 97214, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Mathias Buus</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>The Dat Project, Portland, OR 97214, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beaker Browser, Portland, OR 97214, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKelvey</LastName><ForeName>Karissa R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>The Dat Project, Portland, OR 97214, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Digital Democracy, Portland, OR 97214, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30351300</ArticleId><ArticleId IdType="pii">sdata2018221</ArticleId><ArticleId IdType="doi">10.1038/sdata.2018.221</ArticleId><ArticleId IdType="pmc">PMC6198755</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2014 Dec 26;9(12):e115253</Citation><ArticleIdList><ArticleId IdType="pubmed">25541969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 May 7;521(7550):111-2</Citation><ArticleIdList><ArticleId IdType="pubmed">25951286</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ Comput Sci. 2015;1:null</Citation><ArticleIdList><ArticleId IdType="pubmed">26167542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30311434</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2190-6009</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>12</Month></PubDate></JournalIssue><Title>Journal of cachexia, sarcopenia and muscle</Title><ISOAbbreviation>J Cachexia Sarcopenia Muscle</ISOAbbreviation></Journal><ArticleTitle>Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions.</ArticleTitle><Pagination><MedlinePgn>1023-1033</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcsm.12344</ELocationID><Abstract><AbstractText Label="BACKGROUND">The 'placebo effect' and 'nocebo effect' are phenomena whereby beneficial (placebo) or adverse (nocebo) effects result from the expectation that an inert substance will relieve or cause a particular symptom. These terms are often inappropriately applied to effects experienced on drug therapy. Quantifying the magnitude of placebo and nocebo effects in clinical trials is problematic because it requires a 'no treatment' arm. To overcome the difficulties associated with measuring the nocebo effect, and the fact that its definition refers to inert compounds, rather than drugs, we introduce the concept of 'drucebo' (a combination of DRUg and plaCEBO or noCEBO) to relate to beneficial or adverse effects of a drug, which result from expectation and are not pharmacologically caused by the drug. As an initial application of the concept, we have estimated the contribution of the drucebo effect to statin discontinuation and statin-induced muscle symptoms by performing a systematic review of randomized controlled trial of statin therapy.</AbstractText><AbstractText Label="METHODS">This preferred reporting items for systematic reviews and meta-analysis-compliant systematic review was prospectively registered in PROSPERO (CRD42017082700). We searched PubMed and Cochrane Central from inception until 3 January 2018 using a search strategy designed to detect studies including the concepts (Statins AND Placebo AND muscle pain). We included studies that allowed us to quantify the drucebo effect for adverse muscle symptoms of statins by (i) comparing reported rates of muscle symptoms in blinded and unblinded phases of randomized controlled trials and (ii) comparing rates of muscle symptoms at baseline and during blinded therapy in trials that included patients with objectively confirmed statin intolerance at baseline. Extraction was performed by two researchers with disagreements settled by a third reviewer.</AbstractText><AbstractText Label="RESULTS">Five studies allowed the estimation of the drucebo effect. All trials demonstrated an excess of side effects under open-label conditions. The contribution of the drucebo effect to statin-associated muscle pain ranged between 38% and 78%. The heterogeneity of study methods, outcomes, and reporting did not allow for quantitative synthesis (meta-analysis) of the results.</AbstractText><AbstractText Label="CONCLUSIONS">The drucebo effect may be useful in evaluating the safety and efficacy of medicines. Diagnosis of the drucebo effect in patients presenting with statin intolerance will allow restoration of life-prolonging lipid-lowering therapy. Our study was limited by heterogeneity of included studies and lack of access to individual patient data. Further studies are necessary to better understand risk factors for and clinical management of the drucebo effect.</AbstractText><CopyrightInformation>© 2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley &amp; Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penson</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>G B John</ForeName><Initials>GBJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Peter P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Seth S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Gerald F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahebkar</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikhailidis</LastName><ForeName>Dimitri P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banach</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6690-6874</Identifier><AffiliationInfo><Affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group &amp; International Lipid Expert Panel (ILEP)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Cachexia Sarcopenia Muscle</MedlineTA><NlmUniqueID>101552883</NlmUniqueID><ISSNLinking>2190-5991</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009135" MajorTopicYN="N">Muscular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064786" MajorTopicYN="Y">Nocebo Effect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015990" MajorTopicYN="N">Placebo Effect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Drucebo</Keyword><Keyword MajorTopicYN="Y">Nocebo</Keyword><Keyword MajorTopicYN="Y">Placebo</Keyword><Keyword MajorTopicYN="Y">Statins</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30311434</ArticleId><ArticleId IdType="doi">10.1002/jcsm.12344</ArticleId><ArticleId IdType="pmc">PMC6240752</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Cardiol. 2016 Dec 15;225:184-196</Citation><ArticleIdList><ArticleId IdType="pubmed">27728862</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Apr 7;352(14):1425-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15755765</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis. 2015 Feb;238(2):329-35</Citation><ArticleIdList><ArticleId IdType="pubmed">25545331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2017 Aug 15;167(4):281-282</Citation><ArticleIdList><ArticleId IdType="pubmed">28738422</ArticleId></ArticleIdList></Reference><Reference><Citation>Med World. 1961 Sep;95:203-5</Citation><ArticleIdList><ArticleId IdType="pubmed">13752532</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Saf. 2015 Jun;14(6):935-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25907232</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 5;361(9364):1149-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12686036</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Lipidol. 2016 Jul-Aug;10(4):739-747</Citation><ArticleIdList><ArticleId IdType="pubmed">27578103</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain Physician. 2017 Jul;20(5):363-386</Citation><ArticleIdList><ArticleId IdType="pubmed">28727700</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2017 Mar 21;69(11):1386-1395</Citation><ArticleIdList><ArticleId IdType="pubmed">28302290</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Lipidol. 2015 Nov-Dec;9(6):758-769</Citation><ArticleIdList><ArticleId IdType="pubmed">26687696</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Behav Neurosci. 2014 Nov 03;8:375</Citation><ArticleIdList><ArticleId IdType="pubmed">25404901</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Apr 2;289(13):1681-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12672737</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Cardiol. 2013 Dec;29(12):1553-68</Citation><ArticleIdList><ArticleId IdType="pubmed">24267801</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2015 May;21(5):285-94</Citation><ArticleIdList><ArticleId IdType="pubmed">25883069</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2002 Aug 7;40(3):567-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12142128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2014 Mar 4;160(5):301-10</Citation><ArticleIdList><ArticleId IdType="pubmed">24737272</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Apr 19;315(15):1580-90</Citation><ArticleIdList><ArticleId IdType="pubmed">27039291</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1023-1033</Citation><ArticleIdList><ArticleId IdType="pubmed">30311434</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):396-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27030814</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiovasc Drugs. 2018 Jun;18(3):157-173</Citation><ArticleIdList><ArticleId IdType="pubmed">29318532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2016 May 24;67(20):2395-2410</Citation><ArticleIdList><ArticleId IdType="pubmed">27199064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2017 Aug 15;167(4):221-227</Citation><ArticleIdList><ArticleId IdType="pubmed">28738423</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2014 Jul;168(1):6-15</Citation><ArticleIdList><ArticleId IdType="pubmed">24952854</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2017 Sep 5;70(10):1290-1301</Citation><ArticleIdList><ArticleId IdType="pubmed">28859793</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 1999 May;20(10):725-41</Citation><ArticleIdList><ArticleId IdType="pubmed">10329064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jun 24;389(10088):2473-2481</Citation><ArticleIdList><ArticleId IdType="pubmed">28476288</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1993 Jun 14;153(11):1321-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8507122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2004;(3):CD003974</Citation><ArticleIdList><ArticleId IdType="pubmed">15266510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083</Citation><ArticleIdList><ArticleId IdType="pubmed">29098794</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2006 Dec 19;114(25):2788-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17159064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Nov 19;388(10059):2532-2561</Citation><ArticleIdList><ArticleId IdType="pubmed">27616593</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychosom Res. 2015 Dec;79(6):519-29</Citation><ArticleIdList><ArticleId IdType="pubmed">26519128</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Prev Cardiol. 2014 Apr;21(4):464-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24623264</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Jul 21;339:b2535</Citation><ArticleIdList><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S58-71</Citation><ArticleIdList><ArticleId IdType="pubmed">24793443</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Pharmacother. 2016 Aug;17(11):1497-507</Citation><ArticleIdList><ArticleId IdType="pubmed">27254275</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Med Sci. 2015 Mar 16;11(1):1-23</Citation><ArticleIdList><ArticleId IdType="pubmed">25861286</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2017 Sep 1;120(5):774-781</Citation><ArticleIdList><ArticleId IdType="pubmed">28779871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30289930</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Design and validation of an open-source modular Microplate Photoirradiation System for high-throughput photobiology experiments.</ArticleTitle><Pagination><MedlinePgn>e0203597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0203597</ELocationID><Abstract><AbstractText>Research in photobiology is currently limited by a lack of devices capable of delivering precise and tunable irradiation to cells in a high-throughput format. This limits researchers to using expensive commercially available or custom-built light sources which make it difficult to replicate, standardize, optimize, and scale experiments. Here we present an open-source Microplate Photoirradiation System (MPS) developed to enable high-throughput light experiments in standard 96 and 24-well microplates for a variety of applications in photobiology research. This open-source system features 96 independently controlled LEDs (4 LEDs per well in 24-well), Wi-Fi connected control and programmable graphical user interface (GUI) for control and programming, automated calibration GUI, and modular control and LED boards for maximum flexibility. A web-based GUI generates light program files containing irradiation parameters for groups of LEDs. These parameters are then uploaded wirelessly, stored and used on the MPS to run photoirradiation experiments inside any incubator. A rapid and semi-quantitative porphyrin metabolism assay was also developed to validate the system in wild-type fibroblasts. Protoporphyrin IX (PpIX) fluorescence accumulation was induced by incubation with 5-aminolevulinic acid (ALA), a photosensitization method leveraged clinically to destroy malignant cell types in a process termed photodynamic therapy (PDT), and cells were irradiated with 405nm light with varying irradiance, duration and pulsation parameters. Immediately after light treatment with the MPS, subsequent photobleaching was measured in live, adherent cells in both 96-well and a 24-well microplates using a microplate reader. Results demonstrate the utility and reliability of the Microplate Photoirradiation System to irradiate cells with precise irradiance and timing parameters in order to measure PpIx photobleaching kinetics in live adherent cells and perform comparable experiments with both 24 and 96 well microplate formats. The high-throughput capability of the MPS enabled measurement of enough irradiance conditions in a single microplate to fit PpIX fluorescence to a bioexponential decay model of photobleaching, as well as reveal a dependency of photobleaching on duty-cycle-but not frequency-in a pulsed irradiance regimen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Suzanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backeris</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Sinai Biodesign, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merck</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Merck Engineering LLC, Hamburg, NJ, 07495 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suprun</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9161-4021</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Souza</LastName><ForeName>Sunita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desnick</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Kateri</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ubarretxena-Belandia</LastName><ForeName>Iban</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-4082-4349</Identifier><AffiliationInfo><Affiliation>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biofisika Institute (CSIC, UPV/EHU), University of the Basque Country, Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemischka</LastName><ForeName>Ihor R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029 United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011524">Protoporphyrins</NameOfSubstance></Chemical><Chemical><RegistryNumber>88755TAZ87</RegistryNumber><NameOfSubstance UI="D000622">Aminolevulinic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C2K325S808</RegistryNumber><NameOfSubstance UI="C028025">protoporphyrin IX</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000622" MajorTopicYN="N">Aminolevulinic Acid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003196" MajorTopicYN="N">Computer Graphics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008027" MajorTopicYN="N">Light</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018462" MajorTopicYN="N">Photobiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038761" MajorTopicYN="N">Photobleaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010778" MajorTopicYN="N">Photochemotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010787" MajorTopicYN="Y">Photosensitivity Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011524" MajorTopicYN="N">Protoporphyrins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011827" MajorTopicYN="N">Radiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059015" MajorTopicYN="N">Wireless Technology</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>We have the following interests: Chris Merck is affiliated with his own LLC (Merck Engineering LLC). Merck Engineering LLC did not contribute funding to the development of the MPS or its biological validation and has no pecuniary interest in this study. Chris Merck worked as a volunteer collaborator not representing any company or institution. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30289930</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0203597</ArticleId><ArticleId IdType="pii">PONE-D-18-08794</ArticleId><ArticleId IdType="pmc">PMC6173374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Med Chem. 2002 Jan;9(1):127-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11860353</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 1997 Mar;34(1):65-70</Citation><ArticleIdList><ArticleId IdType="pubmed">9107386</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 1997 Jan 6;70(1):90-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8985096</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Laser Med Surg. 1996 Oct;14(5):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">9612192</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol Sci. 2004 Nov-Dec;3(11-12):981-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15570383</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2000 Dec;16(4):381-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11118846</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Ther. 2008 Mar-Apr;21(2):86-95</Citation><ArticleIdList><ArticleId IdType="pubmed">18394082</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 1999 Jan;69(1):61-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10063801</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 2004 Jun;79(6):545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15291307</ArticleId></ArticleIdList></Reference><Reference><Citation>J Photochem Photobiol B. 2017 Dec;177:32-38</Citation><ArticleIdList><ArticleId IdType="pubmed">29045918</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Gastroenterol. 1999 Dec;29(4):327-31</Citation><ArticleIdList><ArticleId IdType="pubmed">10599635</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 2003 Sep;78(3):271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14556314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Clin. 2007 Jan;25(1):89-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17126746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Nov 02;6:35363</Citation><ArticleIdList><ArticleId IdType="pubmed">27805047</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Derm Venereol. 2000 Jan-Feb;80(1):26-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10721828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2016 May;12(5):317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26974814</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 1998 Jan;67(1):140-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9477772</ArticleId></ArticleIdList></Reference><Reference><Citation>Photodiagnosis Photodyn Ther. 2015 Jun;12(2):282-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25595357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatol Surg. 2010;36(1):39-48</Citation><ArticleIdList><ArticleId IdType="pubmed">20002646</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 1997 Jan;65(1):135-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9066293</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2004 Sep;151(3):616-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15377348</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol Sci. 2004 May;3(5):403-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15122355</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Spectrosc. 2003 Jun;57(6):682-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14658702</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 1998 Jun;67(6):612-25</Citation><ArticleIdList><ArticleId IdType="pubmed">9648527</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol Sci. 2004 May;3(5):436-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15122361</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2009 Sep;161(3):647-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19519826</ArticleId></ArticleIdList></Reference><Reference><Citation>Photomed Laser Surg. 2016 Mar;34(3):108-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26890993</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Sep 18;10(9):e0138754</Citation><ArticleIdList><ArticleId IdType="pubmed">26382065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Soc Rev. 2002 Mar;31(2):128-36</Citation><ArticleIdList><ArticleId IdType="pubmed">12109206</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Immunol Med Microbiol. 1997 Dec;19(4):307-14</Citation><ArticleIdList><ArticleId IdType="pubmed">9537756</ArticleId></ArticleIdList></Reference><Reference><Citation>Photochem Photobiol. 2000 Aug;72(2):186-92</Citation><ArticleIdList><ArticleId IdType="pubmed">10946571</ArticleId></ArticleIdList></Reference><Reference><Citation>J Photochem Photobiol B. 2000 Nov;58(2-3):149-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11233643</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dermatol. 2004 Jan;140(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14732659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Soc Rev. 2013 Jun 21;42(12):5323-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23450221</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2013 Jun 10;368(1622):20120262</Citation><ArticleIdList><ArticleId IdType="pubmed">23754814</ArticleId></ArticleIdList></Reference><Reference><Citation>An Bras Dermatol. 2010 Jul-Aug;85(4):501-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20944910</ArticleId></ArticleIdList></Reference><Reference><Citation>Photomed Laser Surg. 2016 Sep;34(9):400-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27500317</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem J. 1960 Jun;75(3):620-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16748818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2016 Apr 27;2(4):283-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27135540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasers Med Sci. 1997 Oct;12(3):182-99</Citation><ArticleIdList><ArticleId IdType="pubmed">20803326</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 1966 Jul;16(1):20-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5966128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2008 May-Jun;13(3):034009</Citation><ArticleIdList><ArticleId IdType="pubmed">18601554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron. 1990;55(2):159-63</Citation><ArticleIdList><ArticleId IdType="pubmed">2362629</ArticleId></ArticleIdList></Reference><Reference><Citation>J Drugs Dermatol. 2006 Jan;5(1):45-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16468292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2014 Mar 18;(85):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24686859</ArticleId></ArticleIdList></Reference><Reference><Citation>Photodiagnosis Photodyn Ther. 2006 Mar;3(1):19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25049024</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2006 Jul;1763(7):723-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16839620</ArticleId></ArticleIdList></Reference><Reference><Citation>J Photochem Photobiol B. 1997 Oct;40(3):313-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9372622</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biophotonics. 2017 Nov;10(11):1514-1525</Citation><ArticleIdList><ArticleId IdType="pubmed">28164460</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2004 Jul;151(1):196-200</Citation><ArticleIdList><ArticleId IdType="pubmed">15270891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30255541</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1462-2920</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Environmental microbiology</Title><ISOAbbreviation>Environ Microbiol</ISOAbbreviation></Journal><ArticleTitle>UCYN-A3, a newly characterized open ocean sublineage of the symbiotic N<sub>2</sub> -fixing cyanobacterium Candidatus Atelocyanobacterium thalassa.</ArticleTitle><Pagination><MedlinePgn>111-124</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1462-2920.14429</ELocationID><Abstract><AbstractText>The symbiotic unicellular cyanobacterium Candidatus Atelocyanobacterium thalassa (UCYN-A) is one of the most abundant and widespread nitrogen (N<sub>2</sub> )-fixing cyanobacteria in the ocean. Although it remains uncultivated, multiple sublineages have been detected based on partial nitrogenase (nifH) gene sequences, including the four most commonly detected sublineages UCYN-A1, UCYN-A2, UCYN-A3 and UCYN-A4. However, very little is known about UCYN-A3 beyond the nifH sequences from nifH gene diversity surveys. In this study, single cell sorting, DNA sequencing, qPCR and CARD-FISH assays revealed discrepancies involving the identification of sublineages, which led to new information on the diversity of the UCYN-A symbiosis. 16S rRNA and nifH gene sequencing on single sorted cells allowed us to identify the 16S rRNA gene of the uncharacterized UCYN-A3 sublineage. We designed new CARD-FISH probes that allowed us to distinguish and observe UCYN-A2 in a coastal location (SIO Pier; San Diego) and UCYN-A3 in an open ocean location (Station ALOHA; Hawaii). Moreover, we reconstructed about 13% of the UCYN-A3 genome from Tara Oceans metagenomic data. Finally, our findings unveil the UCYN-A3 symbiosis in open ocean waters suggesting that the different UCYN-A sublineages are distributed along different size fractions of the plankton defined by the cell-size ranges of their prymnesiophyte hosts.</AbstractText><CopyrightInformation>© 2018 Society for Applied Microbiology and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cornejo-Castillo</LastName><ForeName>Francisco M</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0001-8431-9278</Identifier><AffiliationInfo><Affiliation>Department of Ocean Sciences, University of California, Santa Cruz, CA 95064, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Marine Biology and Oceanography, Institut de Ciències del Mar (ICM), CSIC, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muñoz-Marín</LastName><ForeName>Maria Del Carmen</ForeName><Initials>MDC</Initials><Identifier Source="ORCID">0000-0001-5075-8619</Identifier><AffiliationInfo><Affiliation>Department of Ocean Sciences, University of California, Santa Cruz, CA 95064, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Bioquímica y Biología Molecular, Campus de Excelencia Internacional Agroalimentario, Universidad de Córdoba, Córdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turk-Kubo</LastName><ForeName>Kendra A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Ocean Sciences, University of California, Santa Cruz, CA 95064, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royo-Llonch</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Marine Biology and Oceanography, Institut de Ciències del Mar (ICM), CSIC, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farnelid</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ocean Sciences, University of California, Santa Cruz, CA 95064, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acinas</LastName><ForeName>Silvia G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Marine Biology and Oceanography, Institut de Ciències del Mar (ICM), CSIC, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zehr</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Ocean Sciences, University of California, Santa Cruz, CA 95064, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Biosensomics to SGA (Convocatoria 2015 de ayudas Fundación BBVA a investigadores y creadores culturales)</Agency><Country>International</Country></Grant><Grant><GrantID>FPI (BES-2014-068285)</GrantID><Agency>Consejo Superior de Investigaciones Científicas</Agency><Country>International</Country></Grant><Grant><GrantID>493.01</GrantID><Agency>Gordon and Betty Moore Foundation</Agency><Country>International</Country></Grant><Grant><Agency>Marie Curie International Outgoing Fellowship</Agency><Country>International</Country></Grant><Grant><GrantID>329108</GrantID><Agency>Simons Collaboration on Ocean Processes and Ecology (SCOPE)</Agency><Country>International</Country></Grant><Grant><GrantID>545171</GrantID><Agency>Simons Foundation</Agency><Country>International</Country></Grant><Grant><Agency>Spanish Ministry of Economy, Industry and Competitiveness</Agency><Country>International</Country></Grant><Grant><GrantID>VR 637-2013-7502</GrantID><Agency>Svenska Forskningsrådet Formas</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Environ Microbiol</MedlineTA><NlmUniqueID>100883692</NlmUniqueID><ISSNLinking>1462-2912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004269">DNA, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.18.6.1</RegistryNumber><NameOfSubstance UI="D009591">Nitrogenase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000458" MajorTopicYN="N">Cyanobacteria</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004269" MajorTopicYN="N">DNA, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058087" MajorTopicYN="N">Haptophyta</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006254" MajorTopicYN="N" Type="Geographic">Hawaii</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009586" MajorTopicYN="Y">Nitrogen Fixation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009591" MajorTopicYN="N">Nitrogenase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009792" MajorTopicYN="N">Oceans and Seas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012623" MajorTopicYN="N">Seawater</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013559" MajorTopicYN="N">Symbiosis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30255541</ArticleId><ArticleId IdType="doi">10.1111/1462-2920.14429</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30229967</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-2683</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Electrophoresis</Title><ISOAbbreviation>Electrophoresis</ISOAbbreviation></Journal><ArticleTitle>Open source capillary electrophoresis.</ArticleTitle><Pagination><MedlinePgn>65-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/elps.201800304</ELocationID><Abstract><AbstractText>Open source paradigm is becoming widely accepted in scientific communities and open source hardware is finding its steady place in chemistry research. In this review article, we provide the reader with the most up-to-date information on open source hardware and software resources enabling the construction and utilization of an "open source capillary electrophoresis instrument". While CE is still underused as a separation technique, it offers unique flexibility, low-cost, and high efficiency and is particularly suitable for open source instrumental development. We overview the major parts of CE instruments, such as high voltage power supplies, detectors, data acquisition systems, and CE software resources with emphasis on availability of the open source information on the web and in the scientific literature. This review is the first of its kind, revealing accessible blueprints of most parts from which a fully functional open source CE system can be built. By collecting the extensive information on open source capillary electrophoresis in this review article, the authors aim at facilitating the dissemination of knowledge on CE within and outside the scientific community, fosters innovation and inspire other researchers to improve the shared CE blueprints.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubáň</LastName><ForeName>Petr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4056-5570</Identifier><AffiliationInfo><Affiliation>Department of Bioanalytical Instrumentation, CEITEC Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioanalytical Instrumentation, Institute of Analytical Chemistry, Academy of Sciences of the Czech Republic, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foret</LastName><ForeName>František</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0060-7350</Identifier><AffiliationInfo><Affiliation>Department of Bioanalytical Instrumentation, CEITEC Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioanalytical Instrumentation, Institute of Analytical Chemistry, Academy of Sciences of the Czech Republic, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erny</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Chemical Engineering Department, Faculty of Engineering - University of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Ministry of Education, Youth and Sports of the Czech Republic</Agency><Country>International</Country></Grant><Grant><GrantID>17-31945A</GrantID><Agency>Grant Agency of the Czech Ministry of Health</Agency><Country>International</Country></Grant><Grant><GrantID>NV-18-08-00189</GrantID><Agency>Grant Agency of the Czech Ministry of Health</Agency><Country>International</Country></Grant><Grant><GrantID>RVO: 68081715</GrantID><Agency>Grant Agency of the Czech Ministry of Health</Agency><Country>International</Country></Grant><Grant><GrantID>POCI-01-0145-FEDER-006939</GrantID><Agency>Grant Agency of the Czech Ministry of Health</Agency><Country>International</Country></Grant><Grant><Agency>Laboratory for Process Engineering, Environment, Biotechnology and Energy</Agency><Country>International</Country></Grant><Grant><GrantID>COMPETE2020</GrantID><Agency>European Regional Development Fund</Agency><Country>International</Country></Grant><Grant><GrantID>NORTE-01-0145-FEDER-000005</GrantID><Agency>European Regional Development Fund</Agency><Country>International</Country></Grant><Grant><GrantID>IF/00528/2013</GrantID><Agency>Operational Program for Human Potential and by National Funds through FCT</Agency><Country>International</Country></Grant><Grant><GrantID>Action CA 16215</GrantID><Agency>Operational Program for Human Potential and by National Funds through FCT</Agency><Country>International</Country></Grant><Grant><Agency>European Cooperation in Science and Technology</Agency><Country>International</Country></Grant><Grant><Agency>Institute of Analytical Chemistry of the Academy of Sciences</Agency><Country>International</Country></Grant><Grant><GrantID>LQ1601</GrantID><Agency>Central European Institute of Technology</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Electrophoresis</MedlineTA><NlmUniqueID>8204476</NlmUniqueID><ISSNLinking>0173-0835</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004581" MajorTopicYN="N">Electronics</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019075" MajorTopicYN="N">Electrophoresis, Capillary</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Capillary electrophoresis</Keyword><Keyword MajorTopicYN="Y">Open source hardware</Keyword><Keyword MajorTopicYN="Y">Open source software</Keyword><Keyword MajorTopicYN="Y">Review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30229967</ArticleId><ArticleId IdType="doi">10.1002/elps.201800304</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30219628</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>10</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.</ArticleTitle><Pagination><MedlinePgn>1315-1327</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(18)30497-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(18)30497-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Encorafenib plus binimetinib and encorafenib alone improved progression-free survival compared with vemurafenib in patients with BRAF<sup>V600</sup>-mutant melanoma in the COLUMBUS trial. Here, we report the results of the secondary endpoint of overall survival.</AbstractText><AbstractText Label="METHODS">COLUMBUS was a two-part, randomised, open-label, phase 3 study done at 162 hospitals in 28 countries. Eligible patients were aged at least 18 years with histologically confirmed, locally advanced, unresectable, or metastatic cutaneous melanoma, or unknown primary melanoma, BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutation, an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and were treatment naive or had progressed on or after first-line immunotherapy. In part 1 of the study, patients were randomly assigned (1:1:1) by use of interactive response technology to receive oral encorafenib 450 mg once daily plus oral binimetinib 45 mg twice daily (encorafenib plus binimetinib group), oral encorafenib 300 mg once daily (encorafenib group), or oral vemurafenib 960 mg twice daily (vemurafenib group). Randomisation was stratified by the American Joint Committee on Cancer stage, ECOG performance status, and BRAF mutation status. The primary outcome of the trial, progression-free survival with encorafenib plus binimetinib versus vemurafenib, was reported previously. Here we present the prespecified interim overall survival analysis. Efficacy analyses were by intent to treat. Safety was analysed in patients who received at least one dose of study drug. Part 2 of the study was initiated at the request of the US Food and Drug Administration to better understand the contribution of binimetinib to the combination therapy by comparing encorafenib 300 mg once daily plus binimetinib 45 mg twice daily with encorafenib 300 mg once daily alone. Results of part 2 will be published separately. This trial is ongoing and is registered with ClinicalTrials.gov, number NCT01909453, and EudraCT, number 2013-001176-38.</AbstractText><AbstractText Label="FINDINGS">Between Dec 30, 2013, and April 10, 2015, 577 of 1345 screened patients were randomly assigned to receive encorafenib plus binimetinib (n=192), encorafenib (n=194), or vemurafenib (n=191). Median follow-up for overall survival was 36·8 months (95% CI 35·9-37·5). Median overall survival was 33·6 months (95% CI 24·4-39·2) with encorafenib plus binimetinib and 16·9 months (14·0-24·5) with vemurafenib (hazard ratio 0·61 [95% CI 0·47-0·79]; two-sided p&lt;0·0001). The most common grade 3 or 4 adverse events did not change substantially from the first report; those seen in more than 5% of patients treated with encorafenib plus binimetinib were increased γ-glutamyltransferase (18 [9%] of 192 patients), increased blood creatine phosphokinase (14 [7%]), and hypertension (12 [6%]); those seen with encorafenib alone were palmar-plantar erythrodysaesthesia syndrome (26 [14%] of 192 patients), myalgia (19 [10%]), and arthralgia (18 [9%]); and with vemurafenib the most common grade 3 or 4 adverse event was arthralgia (11 [6%] of 186 patients). One death in the combination treatment group was considered by the investigator to be possibly related to treatment.</AbstractText><AbstractText Label="INTERPRETATION">The combination of encorafenib plus binimetinib provided clinically meaningful efficacy with good tolerability as shown by improvements in both progression-free survival and overall survival compared with vemurafenib. These data suggest that the combination of encorafenib plus binimetinib is likely to become an important therapeutic option in patients with BRAF<sup>V600</sup>-mutant melanoma.</AbstractText><AbstractText Label="FUNDING">Array BioPharma, Novartis.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dummer</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: reinhard.dummer@usz.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascierto</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogas</LastName><ForeName>Helen J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arance</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandala</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liszkay</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Dermatology, National Institute of Oncology, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garbe</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schadendorf</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajsova</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutzmer</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarion Sileni</LastName><ForeName>Vanna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutriaux</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux Cédex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Jan Willem B</ForeName><Initials>JWB</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Isala, Zwolle, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamazaki</LastName><ForeName>Naoya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loquai</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Medical Center Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutouh-de Parseval</LastName><ForeName>Laure A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickard</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Array BioPharma, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandor</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Array BioPharma, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaherty</LastName><ForeName>Keith T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Cancer Center, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01909453</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001562">Benzimidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002219">Carbamates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>181R97MR71</RegistryNumber><NameOfSubstance UI="C581313">binimetinib</NameOfSubstance></Chemical><Chemical><RegistryNumber>207SMY3FQT</RegistryNumber><NameOfSubstance UI="D000077484">Vemurafenib</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L7891MRB6</RegistryNumber><NameOfSubstance UI="C000601108">encorafenib</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C482119">BRAF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 Oct;19(10):1263-1264</RefSource><PMID Version="1">30219625</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet Oncol. 2018 Oct;19(10):e509</RefSource><PMID Version="1">30303122</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001562" MajorTopicYN="N">Benzimidazoles</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002219" MajorTopicYN="N">Carbamates</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048493" MajorTopicYN="N">Proto-Oncogene Proteins B-raf</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077484" MajorTopicYN="N">Vemurafenib</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30219628</ArticleId><ArticleId IdType="pii">S1470-2045(18)30497-2</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(18)30497-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30219343</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-349X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the American College of Radiology : JACR</Title><ISOAbbreviation>J Am Coll Radiol</ISOAbbreviation></Journal><ArticleTitle>Needs Assessment Using a Structured Prioritization Schema: An Open Letter to PACS Vendors.</ArticleTitle><Pagination><MedlinePgn>170-177</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1546-1440(18)30862-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacr.2018.07.014</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this work was to prioritize in a quaternary academic environment necessary elements of a replacement PACS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This quality improvement work was conducted at one academic medical center and was "not regulated" by the institutional review board. Three workgroups (10-15 members each) with unique resident, fellow, and attending radiologists; IT specialists; and departmental leaders convened in 2018 to prioritize elements for a PACS replacement project, including integrated IT tools. Each workgroup met two or three times and represented one of three missions (clinical, research, and education). Six elements assigned the highest priority were distilled from each workgroup. The resulting 18 elements were condensed into survey format and distributed to all department residents, fellows, and faculty members for 5-point Likert-type prioritization stratified by mission. Data were collected over 2 weeks.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The survey response rate was 37% (71 of 192; 17 of 44 residents, 3 of 27 fellows, and 51 of 121 faculty members). Self-reported work effort was 63 ± 26% clinical, 14 ± 11% education, 15 ± 21% research, and 8 ± 14% administration. Aggregate priority ratings across all domains were highest for "stable system with predictable behavior" (mean, 4.51), "minimizes repetitive non-value-added work" (mean, 4.40), "interoperability" (mean, 4.12), and "near-instantaneous load times" (mean, 4.07). Clinical-specific ratings for these elements were even higher (means, 4.85-4.90). The lowest aggregate scores were mobile device compatibility (mean, 3.03), connectivity to nonaffiliated sites (mean, 3.01), and integrated instant messaging (mean, 2.87).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The department prioritized a stable and interoperable system that minimized non-value-added work. In other words, participants wanted a functioning PACS. PACS vendors should prioritize a reliable experience over niche add-ons.</AbstractText><CopyrightInformation>Copyright © 2018 American College of Radiology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roseland</LastName><ForeName>Molly E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazerooni</LastName><ForeName>Ella A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Janet E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luker</LastName><ForeName>Gary D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohan</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan. Electronic address: matdaven@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Radiol</MedlineTA><NlmUniqueID>101190326</NlmUniqueID><ISSNLinking>1546-1440</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003659" MajorTopicYN="Y">Decision Making, Organizational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007857" MajorTopicYN="N">Leadership</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020380" MajorTopicYN="Y">Needs Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011682" MajorTopicYN="N">Purchasing, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011872" MajorTopicYN="N">Radiology Department, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011873" MajorTopicYN="Y">Radiology Information Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">information technology</Keyword><Keyword MajorTopicYN="N">leadership</Keyword><Keyword MajorTopicYN="N">needs assessment</Keyword><Keyword MajorTopicYN="N">prioritization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30219343</ArticleId><ArticleId IdType="pii">S1546-1440(18)30862-7</ArticleId><ArticleId IdType="doi">10.1016/j.jacr.2018.07.014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33816817</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2376-5992</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PeerJ. Computer science</Title><ISOAbbreviation>PeerJ Comput Sci</ISOAbbreviation></Journal><ArticleTitle>20 GB in 10 minutes: a case for linking major biodiversity databases using an open socio-technical infrastructure and a pragmatic, cross-institutional collaboration.</ArticleTitle><Pagination><MedlinePgn>e164</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj-cs.164</ELocationID><Abstract><AbstractText>Biodiversity information is made available through numerous databases that each have their own data models, web services, and data types. Combining data across databases leads to new insights, but is not easy because each database uses its own system of identifiers. In the absence of stable and interoperable identifiers, databases are often linked using taxonomic names. This labor intensive, error prone, and lengthy process relies on accessible versions of nomenclatural authorities and fuzzy-matching algorithms. To approach the challenge of linking diverse data, more than technology is needed. New social collaborations like the Global Unified Open Data Architecture (GUODA) that combines skills from diverse groups of computer engineers from iDigBio, server resources from the Advanced Computing and Information Systems (ACIS) Lab, global-scale data presentation from EOL, and independent developers and researchers are what is needed to make concrete progress on finding relationships between biodiversity datasets. This paper will discuss a technical solution developed by the GUODA collaboration for faster linking across databases with a use case linking Wikidata and the Global Biotic Interactions database (GloBI). The GUODA infrastructure is a 12-node, high performance computing cluster made up of about 192 threads with 12 TB of storage and 288 GB memory. Using GUODA, 20 GB of compressed JSON from Wikidata was processed and linked to GloBI in about 10-11 min. Instead of comparing name strings or relying on a single identifier, Wikidata and GloBI were linked by comparing graphs of biodiversity identifiers external to each system. This method resulted in adding 119,957 Wikidata links in GloBI, an increase of 13.7% of all outgoing name links in GloBI. Wikidata and GloBI were compared to Open Tree of Life Reference Taxonomy to examine consistency and coverage. The process of parsing Wikidata, Open Tree of Life Reference Taxonomy and GloBI archives and calculating consistency metrics was done in minutes on the GUODA platform. As a model collaboration, GUODA has the potential to revolutionize biodiversity science by bringing diverse technically minded people together with high performance computing resources that are accessible from a laptop or desktop. However, participating in such a collaboration still requires basic programming skills.</AbstractText><CopyrightInformation>©2018 Thessen et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thessen</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Ronin Institute for Independent Scholarship, Montclair, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oregon State University, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poelen</LastName><ForeName>Jorrit H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Independent consultant, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Florida, Gainsville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammock</LastName><ForeName>Jen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Museum of Natural History, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ Comput Sci</MedlineTA><NlmUniqueID>101660598</NlmUniqueID><ISSNLinking>2376-5992</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biodiversity</Keyword><Keyword MajorTopicYN="N">Collaboration</Keyword><Keyword MajorTopicYN="N">Graph</Keyword><Keyword MajorTopicYN="N">Identifiers</Keyword><Keyword MajorTopicYN="N">Linking</Keyword><Keyword MajorTopicYN="N">Wikidata</Keyword></KeywordList><CoiStatement>The authors declare there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33816817</ArticleId><ArticleId IdType="doi">10.7717/peerj-cs.164</ArticleId><ArticleId IdType="pii">cs-164</ArticleId><ArticleId IdType="pmc">PMC7924439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biodivers Data J. 2017 May 22;(5):e12581</Citation><ArticleIdList><ArticleId IdType="pubmed">28765728</ArticleId></ArticleIdList></Reference><Reference><Citation>Biodivers Data J. 2014 Apr 29;(2):e1079</Citation><ArticleIdList><ArticleId IdType="pubmed">24891832</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2008 Sep;9(5):345-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18445641</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ. 2013 Oct 29;1:e190</Citation><ArticleIdList><ArticleId IdType="pubmed">24244913</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 May 18;8:158</Citation><ArticleIdList><ArticleId IdType="pubmed">17511869</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Ecol. 2013 Apr 15;13:16</Citation><ArticleIdList><ArticleId IdType="pubmed">23587026</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2011 Mar 31;3:RRN1228</Citation><ArticleIdList><ArticleId IdType="pubmed">21516242</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Sep 6;413(6851):21</Citation><ArticleIdList><ArticleId IdType="pubmed">11544504</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30190299</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-490X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>02</Month></PubDate></JournalIssue><Title>The oncologist</Title><ISOAbbreviation>Oncologist</ISOAbbreviation></Journal><ArticleTitle>Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.</ArticleTitle><Pagination><MedlinePgn>185-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2018-0072</ELocationID><Abstract><AbstractText Label="BACKGROUND">In the phase III CORRECT trial, regorafenib significantly improved survival in treatment-refractory metastatic colorectal cancer (mCRC). The CONSIGN study was designed to further characterize regorafenib safety and allow patients access to regorafenib before market authorization.</AbstractText><AbstractText Label="METHODS">This prospective, single-arm study enrolled patients in 25 countries at 186 sites. Patients with treatment-refractory mCRC and an Eastern Cooperative Oncology Group performance status (ECOG PS) ≤1 received regorafenib 160 mg once daily for the first 3 weeks of each 4-week cycle. The primary endpoint was safety. Progression-free survival (PFS) per investigator assessment was the only efficacy evaluation.</AbstractText><AbstractText Label="RESULTS">In total, 2,872 patients were assigned to treatment and 2,864 were treated. Median age was 62 years, ECOG PS 0/1 was 47%/53%, and 74% had received at least three prior regimens for metastatic disease. Median treatment duration was three cycles. Treatment-emergent adverse events (TEAEs) led to dose reduction in 46% of patients. Regorafenib-related TEAEs led to treatment discontinuation in 9%. Grade 5 regorafenib-related TEAEs occurred in &lt;1%. The most common grade ≥3 regorafenib-related TEAEs were hypertension (15%), hand-foot skin reaction (14%), fatigue (13%), diarrhea (5%), and hypophosphatemia (5%). Treatment-emergent grade 3-4 laboratory toxicities included alanine aminotransferase (6%), aspartate aminotransferase (7%), and bilirubin (13%). Ongoing monitoring identified one nonfatal case of regorafenib-related severe drug-induced liver injury per DILI Working Group criteria. Median PFS (95% confidence interval [CI]) was 2.7 months (2.6-2.7).</AbstractText><AbstractText Label="CONCLUSION">In CONSIGN, the frequency and severity of TEAEs were consistent with the known safety profile of regorafenib. PFS was similar to reports of phase III trials. ClinicalTrials.gov: NCT01538680.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE">Patients with metastatic colorectal cancer (mCRC) who fail treatment with standard therapies, including chemotherapy and monoclonal antibodies targeting vascular endothelial growth factor or epidermal growth factor receptor, have few treatment options. The multikinase inhibitor regorafenib was shown to improve survival in patients with treatment-refractory mCRC in the phase III CORRECT (<i>N</i> = 760) and CONCUR (<i>N</i> = 204) trials. However, safety data on regorafenib for mCRC in a larger number of patients were not available. The CONSIGN trial, carried out prospectively in more than 2,800 patients across 25 countries, confirmed the safety profile of regorafenib from the phase III trials and reinforced the importance of using treatment modifications to manage adverse events.</AbstractText><CopyrightInformation>© AlphaMed Press 2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Cutsem</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium eric.vancutsem@uzleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Università degli studi della Campania Luigi Vanvitelli, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cascinu</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinica di Oncologia Medica, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobrero</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Oncology, IRCCS Ospedale San Martino IST, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banzi</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology and Advanced Technologies, Oncology Unit, Azienda Ospedaliera S. Maria Nuova/IRCCS, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitz</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Digestive Oncology, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barone</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Oncology, University Hospital A. Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ychou</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peeters</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Oncological Research, Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenner</LastName><ForeName>Baruch</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofheinz</LastName><ForeName>Ralf Dieter</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Interdisciplinary Tumor Center, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiello</LastName><ForeName>Evaristo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>André</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Service d'Oncologie Médicale, Hôpital Saint-Antoine Paris and Sorbonne Universités, UPMC Paris 06, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spallanzani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Carbonero</LastName><ForeName>Rocio</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arriaga</LastName><ForeName>Yull E</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Udit</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grothey</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappeler</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Statistics, Global Clinical Oncology, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miriyala</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Benefit Risk Management, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalmus</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Development, Oncology, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaniboni</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, Fondazione Poliambulanza, Brescia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01538680</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oncologist</MedlineTA><NlmUniqueID>9607837</NlmUniqueID><ISSNLinking>1083-7159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010671">Phenylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>24T2A1DOYB</RegistryNumber><NameOfSubstance UI="C559147">regorafenib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010671" MajorTopicYN="N">Phenylurea Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Metastatic colorectal cancer</Keyword><Keyword MajorTopicYN="Y">Prospective studies</Keyword><Keyword MajorTopicYN="Y">Regorafenib</Keyword><Keyword MajorTopicYN="Y">Toxicities</Keyword></KeywordList><CoiStatement>Disclosures of potential conflicts of interest may be found at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30190299</ArticleId><ArticleId IdType="pii">theoncologist.2018-0072</ArticleId><ArticleId IdType="doi">10.1634/theoncologist.2018-0072</ArticleId><ArticleId IdType="pmc">PMC6369948</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Cancer. 2016 Jul 07;16:412</Citation><ArticleIdList><ArticleId IdType="pubmed">27389564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Jan 26;381(9863):303-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23177514</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Adv Hematol Oncol. 2015 Aug;13(8):514-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26351814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2015 Jun;16(6):619-29</Citation><ArticleIdList><ArticleId IdType="pubmed">25981818</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2014 Mar;22(3):837-46</Citation><ArticleIdList><ArticleId IdType="pubmed">24337717</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2011 Jul 1;129(1):245-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21170960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2015 Aug;16(8):937-48</Citation><ArticleIdList><ArticleId IdType="pubmed">26184520</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2011 Jun;89(6):806-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21544079</ArticleId></ArticleIdList></Reference><Reference><Citation>Target Oncol. 2015 Sep;10(3):445-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25548130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2016 Aug;27(8):1386-422</Citation><ArticleIdList><ArticleId IdType="pubmed">27380959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30171901</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5921</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Journal of clinical epidemiology</Title><ISOAbbreviation>J Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>SMOOTH: Self-Management of Open Online Trials in Health analysis found improvements were needed for reporting methods of internet-based trials.</ArticleTitle><Pagination><MedlinePgn>27-39</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0895-4356(17)31415-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinepi.2018.08.017</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">The growth of trials conducted over the internet has increased, but with little practical guidance for their conduct, and it is sometimes challenging for researchers to adapt the conventions used in face-to-face trials and maintain the validity of the work. The aim of the study is to systematically explore existing self-recruited online randomized trials of self-management interventions and analyze the trials to assess their strengths and weaknesses, the quality of reporting, and the involvement of lay persons as collaborators in the research process.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTINGS">The Online Randomized Controlled Trials of Health Information Database was used as the sampling frame to identify a subset of self-recruited online trials of self-management interventions. The authors cataloged what these online trials were assessing, appraised study quality, extracted information on how trials were run, and assessed the potential for bias. We searched out how public and patient participation was integrated into online trial design and how this was reported. We recorded patterns of use for registration, reporting, settings, informed consent, public involvement, supplementary materials, and dissemination planning.</AbstractText><AbstractText Label="RESULTS">The sample included 41 online trials published from 2002 to 2015. The barriers to replicability and risk of bias in online trials included inadequate reporting of blinding in 28/41 (68%) studies; high attrition rates with incomplete or unreported data in 30/41 (73%) of trials; and 26/41 (63%) of studies were at high risk for selection bias as trial registrations were unreported. The methods for (23/41, 56%) trials contained insufficient information to replicate the trial, 19/41 did not report piloting the intervention. Only 2/41 studies were cross-platform compatible. Public involvement was most common for advisory roles (n = 9, 22%), and in the design, usability testing, and piloting of user materials (n = 9, 22%).</AbstractText><AbstractText Label="CONCLUSION">This study catalogs the state of online trials of self-management in the early 21st century and provides insights for online trials development as early as the protocol planning stage. Reporting of trials was generally poor and, in addition to recommending that authors report their trials in accordance with CONSORT guidelines, we make recommendations for researchers writing protocols, reporting on and evaluating online trials. The research highlights considerable room for improvement in trial registration, reporting of methods, data management plans, and public and patient involvement in self-recruited online trials of self-management interventions.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evidence Based Heath Care, Department of Continuing Education, University of Oxford, Oxford, United Kingdom. Electronic address: healingjia@msn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasanthan</LastName><ForeName>Lenny</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>PMC Department, Christian Medical College Vellore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Northern Ireland Methodology Hub, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Su May</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Primary Care Medicine, University of Malaya, Malaya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brice</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evidence Based Heath Care, Department of Continuing Education, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burls</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Epidemiol</MedlineTA><NlmUniqueID>8801383</NlmUniqueID><ISSNLinking>0895-4356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009862" MajorTopicYN="N">Online Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073278" MajorTopicYN="Y">Self-Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Internet trials</Keyword><Keyword MajorTopicYN="Y">Online trials</Keyword><Keyword MajorTopicYN="Y">Public involvement</Keyword><Keyword MajorTopicYN="Y">Reporting guidelines</Keyword><Keyword MajorTopicYN="Y">Reporting methods</Keyword><Keyword MajorTopicYN="Y">Self-management</Keyword><Keyword MajorTopicYN="Y">Self-recruited</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30171901</ArticleId><ArticleId IdType="pii">S0895-4356(17)31415-4</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2018.08.017</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30096816</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>08</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Evolution of Landscape Ecological Risk at the Optimal Scale: A Case Study of the Open Coastal Wetlands in Jiangsu, China.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E1691</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph15081691</ELocationID><Abstract><AbstractText>Detailed analysis of the evolution characteristics of landscape ecological risk is crucial for coastal sustainable management and for understanding the potential environmental impacts of a man-made landform landscapes (MMLL). As a typical open coastal wetland, large-scale human activities (e.g., tidal reclamation, fishery activities, wind farm construction, and port construction) have substantially affected the evolution of the coastal ecological environment. Previous landscape ecological risk assessment studies have documented the effectiveness of assessing the quality of ecological environment processes. However, these studies have either focused on the noncoastal zone, or they have not considered the evolution of the spatial characteristics and ecological risk evolution of the landscape at an optimal scale. Here, we present a landscape ecological risk pattern (LERP) evolution model, based on two successive steps: first, we constructed an optimal scale method with an appropriate extent and grain using multi⁻temporal Landsat TM/OLI images acquired in the years 2000, 2004, 2008, 2013 and 2017, and then we calculated landscape ecological risk indices. Based on this model, the entire process of the spatiotemporal evolution of ecological risk patterns of the open coastal wetlands in Jiangsu, China, was determined. The principal findings are as follows: (1) The main landscape types in the study area are tidal flats and farmland, and the main features of the landscape evolution are a significant increase in aquafarming and a substantial decrease in the tidal flat area, while the landscape heterogeneity increased; (2) In the past 20 years, the areas of low and relatively low ecological risk in the study region were greatly reduced, while the areas of medium, relatively high, and high ecological risk greatly increased; the areas of high-grade ecological risk areas are mainly around Dongtai and Dafeng; (3) The area of ecological risk from low-grade to high-grade occupied 71.75% of the study area during 2000⁻2017. During the previous periods (2000⁻2004 and 2004⁻2008), the areas of low-grade ecological risk were transformed to areas of middle-grade ecological risk area, while during the later periods (2008⁻2013 and 2013⁻2017) there was a substantial increase in the proportion of areas of high-grade ecological risk. Our results complement the official database of coastal landscape planning, and provide important information for assessing the potential effects of MMLL processes on coastal environments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yongchao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geographic Information Science, Nanjing University, Nanjing 210023, China. yongchaoliu@smail.nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Coastal Zone Exploitation and Protection, Ministry of Land and Resource, Nanjing 210024, China. yongchaoliu@smail.nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of South China Sea Studies, Nanjing University, Nanjing 210093, China. yongchaoliu@smail.nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yongxue</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6837-5015</Identifier><AffiliationInfo><Affiliation>Department of Geographic Information Science, Nanjing University, Nanjing 210023, China. yongxue@nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of South China Sea Studies, Nanjing University, Nanjing 210093, China. yongxue@nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Geographic Information Science and Technology, Nanjing University, Nanjing 210023, China. yongxue@nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jialin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Geography &amp; Spatial Information Techniques, Ningbo University, Ningbo 315211, China. lijialin@nbu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for East China Sea, Ningbo University, Ningbo 315211, China. lijialin@nbu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Wanyun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Geographic Information Science, Nanjing University, Nanjing 210023, China. wanyunlu@smail.nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xianglin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Geographic Information Science, Nanjing University, Nanjing 210023, China. xianglinwei_nju@foxmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geography &amp; Spatial Information Techniques, Ningbo University, Ningbo 315211, China. sunchaonju@yeah.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003247" MajorTopicYN="N">Conservation of Natural Resources</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004463" MajorTopicYN="N">Ecology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040362" MajorTopicYN="N">Geographic Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055593" MajorTopicYN="N">Geological Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006802" MajorTopicYN="N">Human Activities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058998" MajorTopicYN="N">Remote Sensing Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053833" MajorTopicYN="Y">Wetlands</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">landscape ecological risk assessment</Keyword><Keyword MajorTopicYN="Y">landscape patterns</Keyword><Keyword MajorTopicYN="Y">open coastal wetlands</Keyword><Keyword MajorTopicYN="Y">remote sensing and GIS</Keyword><Keyword MajorTopicYN="Y">spatial heterogeneity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30096816</ArticleId><ArticleId IdType="pii">ijerph15081691</ArticleId><ArticleId IdType="doi">10.3390/ijerph15081691</ArticleId><ArticleId IdType="pmc">PMC6121314</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Environ Res Public Health. 2013 Jan 14;10(1):328-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23343986</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Monit Assess. 2012 Apr;184(4):2307-19</Citation><ArticleIdList><ArticleId IdType="pubmed">21614621</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hazard Mater. 2006 Mar 17;130(1-2):58-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16298053</ArticleId></ArticleIdList></Reference><Reference><Citation>Water Res. 2001 Apr;35(6):1489-99</Citation><ArticleIdList><ArticleId IdType="pubmed">11317896</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 Jul 6;317(5834):58-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17615333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Jan 3;415(6867):23</Citation><ArticleIdList><ArticleId IdType="pubmed">11780095</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1995 Jul 21;269(5222):331-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17841249</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Environ Res Public Health. 2018 Apr 19;15(4):null</Citation><ArticleIdList><ArticleId IdType="pubmed">29671817</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Environ Res Public Health. 2015 Nov 09;12(11):14192-215</Citation><ArticleIdList><ArticleId IdType="pubmed">26569270</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Manage. 2004 Oct;34(4):528-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15747408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2014 Aug 08;4:5995</Citation><ArticleIdList><ArticleId IdType="pubmed">25104138</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19179280</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Sep 4;513(7516):30-1</Citation><ArticleIdList><ArticleId IdType="pubmed">25186885</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30079769</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>11</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?</ArticleTitle><Pagination><MedlinePgn>1223-1226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818792577</ELocationID><Abstract><AbstractText>Biomedical outcomes for people with diabetes remain suboptimal for many. Psychosocial care in diabetes does not fare any better. "Artificial pancreas" (also known as "closed-loop" and "automated insulin delivery") systems present a promising therapeutic option for people with diabetes (PWD)-simultaneously improving glycemic outcomes, reducing the burden of self-management, and improving health-related quality of life. In recent years there has emerged a growing movement of PWD innovators rallying behind the mantra #WeAreNotWaiting, developing "do-it-yourself artificial pancreas systems (DIY APS)." Self-reported results by DIY APS users show improved metabolic outcomes such as impressive stability of glucose profiles, significant reduction of A1c, and more time within their glycemic target range. However, the benefits remain unclear for the broader population of PWD beyond these highly engaged, highly tech-savvy users willing and able to engage in the demands of building and maintaining their DIY APS. We discuss the challenges faced by key stakeholder groups in terms of potential collaboration and open debate of these challenges.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnard</LastName><ForeName>Katharine D</ForeName><Initials>KD</Initials><Identifier Source="ORCID">0000-0002-3888-3123</Identifier><AffiliationInfo><Affiliation>1 Bournemouth University, Bournemouth, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 BHR Limited, Portsmouth, Hampshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>3 Diabetes Clinic for Children and Adolescents, Münster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klonoff</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>4 Diabetes Research Institute, Mills-Peninsula Health Service, San Mateo, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braune</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6590-245X</Identifier><AffiliationInfo><Affiliation>5 Charité-Universitätsmedizin Berlin, Department of Paediatric Endocrinology and Diabetes; &amp; DIY Community, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>6 Roche Diabetes Care GmbH, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rendschmidt</LastName><ForeName>Til</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>6 Roche Diabetes Care GmbH, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finan</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>7 JDRF, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalski</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>7 JDRF, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinemann</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>8 Science &amp; Co, Dusseldorf, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004864" MajorTopicYN="N">Equipment and Supplies</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054624" MajorTopicYN="N">Health Status Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">automated insulin delivery system</Keyword><Keyword MajorTopicYN="Y">diabetes technology</Keyword><Keyword MajorTopicYN="Y">do it yourself</Keyword><Keyword MajorTopicYN="Y">inequality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30079769</ArticleId><ArticleId IdType="doi">10.1177/1932296818792577</ArticleId><ArticleId IdType="pmc">PMC6232748</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 2015 Jun;38(6):971-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25998289</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1411</Citation><ArticleIdList><ArticleId IdType="pubmed">27510442</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Jul;41(7):e115-e116</Citation><ArticleIdList><ArticleId IdType="pubmed">29712714</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30069885</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4159</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>10</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Open Science Badges in the Journal of Neurochemistry.</ArticleTitle><Pagination><MedlinePgn>132-136</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.14536</ELocationID><Abstract><AbstractText>The Open Science Framework (OSF) has the mission to increase openness, integrity, and reproducibility in research. The Journal of Neurochemistry became a signatory of their Transparency and Openness guidelines in 2016, which provides eight modular standards (Citation standards, Data Transparency, Analytic Methods/Code Transparency, Research Materials Transparency, Design and Analysis Transparency, Study Pre-registration, Analysis Plan Transparency, Replication) with increasing levels of stringency. Furthermore, OSF recommends and offers a collection of practices intended to make scientific processes and results more transparent and available in a standardized way for reuse to people outside the research team. It includes making research materials, data, and laboratory procedures freely accessible online to anyone. This editorial announces the decision of the Journal of Neurochemistry to introduce Open Science Badges, maintained by the Open Science Badges Committee and by the Center for Open Science (COS). The Open Science Badges, visual icons placed on publications, certify that an open practice was followed and signal to readers that an author has shared the corresponding research evidence, thus, allowing an independent researcher to understand how to reproduce the procedure.</AbstractText><CopyrightInformation>© 2018 International Society for Neurochemistry.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schweitzer</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3077-6817</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Jörg B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-8903-0593</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jülich Aachen Research Alliance (JARA), JARA-Institute Molecular Neuroscience and Neuroimaging, FZ Jülich and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="Y">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009448" MajorTopicYN="N">Neurochemistry</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010506" MajorTopicYN="Y">Periodicals as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">open science</Keyword><Keyword MajorTopicYN="Y">open science badges</Keyword><Keyword MajorTopicYN="Y">pre-registration</Keyword><Keyword MajorTopicYN="Y">reproducibility</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30069885</ArticleId><ArticleId IdType="doi">10.1111/jnc.14536</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30016813</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2511-705X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>S 01</Issue><PubDate><Year>2018</Year><Month>07</Month></PubDate></JournalIssue><Title>Methods of information in medicine</Title><ISOAbbreviation>Methods Inf Med</ISOAbbreviation></Journal><ArticleTitle>HiGHmed - An Open Platform Approach to Enhance Care and Research across Institutional Boundaries.</ArticleTitle><Pagination><MedlinePgn>e66-e81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3414/ME18-02-0002</ELocationID><Abstract><AbstractText Label="INTRODUCTION">This article is part of the Focus Theme of Methods of Information in Medicine on the German Medical Informatics Initiative. HiGHmed brings together 24 partners from academia and industry, aiming at improvements in care provision, biomedical research and epidemiology. By establishing a shared information governance framework, data integration centers and an open platform architecture in cooperation with independent healthcare providers, the meaningful reuse of data will be facilitated. Complementary, HiGHmed integrates a total of seven Medical Informatics curricula to develop collaborative structures and processes to train medical informatics professionals, physicians and researchers in new forms of data analytics.</AbstractText><AbstractText Label="GOVERNANCE AND POLICIES">We describe governance structures and policies that have proven effective during the conceptual phase. These were further adapted to take into account the specific needs of the development and networking phase, such as roll-out, carerelated aspects and our focus on curricula development in Medical Inform atics.</AbstractText><AbstractText Label="ARCHITECTURAL FRAMEWORK AND METHODOLOGY">To address the challenges of organizational, technical and semantic interoperability, a concept for a scalable platform architecture, the HiGHmed Platform, was developed. We outline the basic principles and design goals of the open platform approach as well as the roles of standards and specifications such as IHE XDS, openEHR, SNOMED CT and HL7 FHIR. A shared governance framework provides the semantic artifacts which are needed to establish semantic interoperability.</AbstractText><AbstractText Label="USE CASES">Three use cases in the fields of oncology, cardiology and infection control will demonstrate the capabilities of the HiGHmed approach. Each of the use cases entails diverse challenges in terms of data protection, privacy and security, including clinical use of genome sequencing data (oncology), continuous longitudinal monitoring of physical activity (cardiology) and cross-site analysis of patient movement data (infection control).</AbstractText><AbstractText Label="DISCUSSION">Besides the need for a shared governance framework and a technical infrastructure, backing from clinical leaders is a crucial factor. Moreover, firm and sustainable commitment by participating organizations to collaborate in further development of their information system architectures is needed. Other challenges including topics such as data quality, privacy regulations, and patient consent will be addressed throughout the project.</AbstractText><CopyrightInformation>Schattauer GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="N"><LastName>Haarbrandt</LastName><ForeName>Birger</ForeName><Initials>B</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Schreiweis</LastName><ForeName>Björn</ForeName><Initials>B</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Rey</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Sax</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Scheithauer</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Rienhoff</LastName><ForeName>Otto</ForeName><Initials>O</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Knaup-Gregori</LastName><ForeName>Petra</ForeName><Initials>P</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Bavendiek</LastName><ForeName>Udo</ForeName><Initials>U</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Dieterich</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Brors</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Kraus</LastName><ForeName>Inga</ForeName><Initials>I</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Thoms</LastName><ForeName>Caroline Marieken</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Jäger</LastName><ForeName>Dirk</ForeName><Initials>D</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Ellenrieder</LastName><ForeName>Volker</ForeName><Initials>V</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Bergh</LastName><ForeName>Björn</ForeName><Initials>B</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Yahyapour</LastName><ForeName>Ramin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Eils</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Consortium</LastName><ForeName>HiGHmed</ForeName><Initials>H</Initials></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Marschollek</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Methods Inf Med</MedlineTA><NlmUniqueID>0210453</NlmUniqueID><ISSNLinking>0026-1270</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000047" MajorTopicYN="Y">Academies and Institutes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054976" MajorTopicYN="N">Clinical Governance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006266" MajorTopicYN="N">Health Education</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057386" MajorTopicYN="N">Search Engine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30016813</ArticleId><ArticleId IdType="doi">10.3414/ME18-02-0002</ArticleId><ArticleId IdType="pmc">PMC6193407</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Clin North Am. 2016 Apr;63(2):251-68</Citation><ArticleIdList><ArticleId IdType="pubmed">27017033</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2016 Oct 18;13(10):e1002150</Citation><ArticleIdList><ArticleId IdType="pubmed">27755545</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2009 Nov 14;2009:391-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20351886</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2011;169:849-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21893867</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2010;49(2):173-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20177649</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2013;192:313-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23920567</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:6-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24303286</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Jan 1;20(1):172-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22733975</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2015;216:1091</Citation><ArticleIdList><ArticleId IdType="pubmed">26262390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2014 Feb;21(e1):e11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23828173</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2012 Jan;56(1):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21782758</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2015 Dec;58 Suppl:S11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26225918</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2001;84(Pt 1):246-50</Citation><ArticleIdList><ArticleId IdType="pubmed">11604742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Mar 15;3:160018</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;228:426-30</Citation><ArticleIdList><ArticleId IdType="pubmed">27577418</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2007 Jun;13(6 Part 1):277-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17567224</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2009 Sep-Oct;16(5):624-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2007;46(3):332-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17492120</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2012 Feb;271(2):111-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22142401</ArticleId></ArticleIdList></Reference><Reference><Citation>J Zhejiang Univ Sci B. 2018 Jan.;19(1):6-24</Citation><ArticleIdList><ArticleId IdType="pubmed">29308604</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;228:272-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27577386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2015 Feb;53:162-73</Citation><ArticleIdList><ArticleId IdType="pubmed">25463966</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2016 Sep;23(5):899-908</Citation><ArticleIdList><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2018;248:196-203</Citation><ArticleIdList><ArticleId IdType="pubmed">29726437</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e55811</Citation><ArticleIdList><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2013 Feb;32(2):357-67</Citation><ArticleIdList><ArticleId IdType="pubmed">23381529</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2011;2011:248-56</Citation><ArticleIdList><ArticleId IdType="pubmed">22195076</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:239-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24303274</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Mar-Apr;17(2):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20190054</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2014 Dec;52:28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24534443</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2016 Oct;63:277-294</Citation><ArticleIdList><ArticleId IdType="pubmed">27507090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2017;245:905-909</Citation><ArticleIdList><ArticleId IdType="pubmed">29295231</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;223:63-70</Citation><ArticleIdList><ArticleId IdType="pubmed">27139386</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Jul 20;355(3):251-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16855265</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Feb 9;366(6):489-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22256780</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Transl Res. 2014 Aug;7(6):607-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25070682</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2016;228:157-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27577362</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29977328</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1749-7922</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>World journal of emergency surgery : WJES</Title><ISOAbbreviation>World J Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial.</ArticleTitle><Pagination><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13017-018-0183-4</ELocationID><Abstract><AbstractText Label="Background">Severe complicated intra-abdominal sepsis (SCIAS) has an increasing incidence with mortality rates over 80% in some settings. Mortality typically results from disruption of the gastrointestinal tract, progressive and self-perpetuating bio-mediator generation, systemic inflammation, and multiple organ failure. Principles of treatment include early antibiotic administration and operative source control. A further therapeutic option may be open abdomen (OA) management with active negative peritoneal pressure therapy (ANPPT) to remove inflammatory ascites and ameliorate the systemic damage from SCIAS. Although there is now a biologic rationale for such an intervention as well as non-standardized and erratic clinical utilization, this remains a novel therapy with potential side effects and clinical equipoise.</AbstractText><AbstractText Label="Methods">The Closed Or Open after Laparotomy (COOL) study will constitute a prospective randomized controlled trial that will randomly allocate eligible surgical patients intra-operatively to either formal closure of the fascia or use of the OA with application of an ANPTT dressing. Patients will be eligible if they have free uncontained intra-peritoneal contamination and physiologic derangements exemplified by septic shock OR a Predisposition-Infection-Response-Organ Dysfunction Score ≥ 3 or a World-Society-of-Emergency-Surgery-Sepsis-Severity-Score ≥ 8. The primary outcome will be 90-day survival. Secondary outcomes will be logistical, physiologic, safety, bio-mediators, microbiological, quality of life, and health-care costs. Secondary outcomes will include days free of ICU, ventilation, renal replacement therapy, and hospital at 30 days from the index laparotomy. Physiologic secondary outcomes will include changes in intensive care unit illness severity scores after laparotomy. Bio-mediator outcomes for participating centers will involve measurement of interleukin (IL)-6 and IL-10, procalcitonin, activated protein C (APC), high-mobility group box protein-1, complement factors, and mitochondrial DNA. Economic outcomes will comprise standard costing for utilization of health-care resources.</AbstractText><AbstractText Label="Discussion">Although facial closure after SCIAS is considered the current standard of care, many reports are suggesting that OA management may improve outcomes in these patients. This trial will be powered to demonstrate a mortality difference in this highly lethal and morbid condition to ensure critically ill patients are receiving the best care possible and not being harmed by inappropriate therapies based on opinion only.</AbstractText><AbstractText Label="Trial registration">ClinicalTrials.gov, NCT03163095.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-1692-5919</Identifier><AffiliationInfo><Affiliation>1Department of Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3The Trauma Program, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coccolini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>4General, Emergency and Trauma Surgery Department, Bufalini Hospital, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansaloni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>5Unit of General and Emergency Surgery, Bufalini Hospital of Cesena, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>1Department of Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolonen</LastName><ForeName>Matti</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>6Department of Abdominal Surgery, Abdominal Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>7Regional Trauma Services, Foothills Medical Centre, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leppaniemi</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>6Department of Abdominal Surgery, Abdominal Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faris</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>8Research Facilitation Analytics (DIMR), University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>9Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catena</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>10Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabian</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>11Surgery, University of Tennessee Health Sciences Center Memphis, Memphis, TN USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenne</LastName><ForeName>Craig N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiara</LastName><ForeName>Osvaldo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>General Surgery and Trauma Team Niguarda Hospital Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubes</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>13Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>14Department of Physiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>15Department of Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manns</LastName><ForeName>Braden</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>10Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>16Department of Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>17Libin Cardiovascular Institute and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluger</LastName><ForeName>Yoram</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraga</LastName><ForeName>Gustavo P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>19Division of Trauma Surgery, University of Campinas, Campinas, SP Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Bruno M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>19Division of Trauma Surgery, University of Campinas, Campinas, SP Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Jose J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>20Department of Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School on Medicine, Baltimore, MD USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugrue</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>21Donegal Clinical Research Academy, Letterkenny University Hospital, Donegal, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Ernest E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>22Trauma and Critical Care Research, University of Colorado, Denver, CO USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jianan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>23Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Chad G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>24General, Acute Care, and Hepatobiliary Surgery, and Regional Trauma Services, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coimbra</LastName><ForeName>Raul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>25Riverside University Health System Medical Center, Loma Linda, CA USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>26Department of Surgery, Loma Linda University School of Medicine, Loma Linda, CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balogh</LastName><ForeName>Zsolt J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>27John Hunter Hospital and Hunter New England Health District, Newcastle, NSW Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>28Surgery and Traumatology, University of Newcastle, Newcastle, NSW Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Zidan</LastName><ForeName>Fikri M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>29Department of Surgery, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixon</LastName><ForeName>Elijah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>1Department of Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>10Emergency Surgery Department, Parma University Hospital, Parma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>30Surgical Oncology, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>31City Wide Section of General Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biffl</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>32Scripps Memorial Hospital La Jolla, La Jolla, California USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLean</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1Department of Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>33Department of Medicine, Western University, London, Ontario Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>34Department of Epidemiology and Biostatistics, Western University, London, Ontario Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drover</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>35Department of Critical Care Medicine, Queen's University, Kingston, Ontario Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>36Department of Surgery, Queen's University, Kingston, Ontario Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBeth</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>1Department of Surgery, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3The Trauma Program, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posadas-Calleja</LastName><ForeName>Juan G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>Neil G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>37Department of Surgery, Western University, Victoria Hospital, London Health Sciences Centre, London, Ontario Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>38Department of Critical Care, Western University, Victoria Hospital, London Health Sciences Centre, London, Ontario Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Saverio</LastName><ForeName>Salomone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>39Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordonez</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>40Department of Surgery, Fundación Valle del Lili and Universidad Del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>7Regional Trauma Services, Foothills Medical Centre, Calgary, Alberta Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Macerata Hospital, Macerata, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Closed Or Open after Laparotomy (COOL) after Source Control for Severe Complicated Intra-Abdominal Sepsis Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03163095</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Emerg Surg</MedlineTA><NlmUniqueID>101266603</NlmUniqueID><ISSNLinking>1749-7922</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011486">Protein C</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011486" MajorTopicYN="N">Protein C</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bio-mediators</Keyword><Keyword MajorTopicYN="Y">Intra-peritoneal sepsis</Keyword><Keyword MajorTopicYN="Y">Laparotomy</Keyword><Keyword MajorTopicYN="Y">Multiple organ dysfunction</Keyword><Keyword MajorTopicYN="Y">Open-abdomen</Keyword><Keyword MajorTopicYN="Y">Peritonitis</Keyword><Keyword MajorTopicYN="Y">Randomized trial</Keyword><Keyword MajorTopicYN="Y">Septic shock</Keyword></KeywordList><CoiStatement>The COOL trial has been ethically approved at the lead and pilot center by the Conjoint Health Research Ethics Board (CHREB) of the University of Calgary (REB16-1588). The study has also been registered with the National Institutes of Health (ClinicalTrials.gov, identifier: NCT03163095).Andrew W. Kirkpatrick serves in the Canadian Forces Medical Services and has consulted for the Innovative Trauma Care and Acelity Corporations. Jessica L. McKee declares that she has consulted for Innovative Trauma Care, Aceso, and the Acelity Corporations. Osvaldo Chiara reported having consulted for the Acelity Corporation. Jose J. Diaz reported having consulted for the Acelity Corporation. Michael Sugrue reported having consulted for the Smith and Nephew Corporation. Ernest E. Moore reported Research support and intellectual property related to the Haemonetics, TEM Systems, Pryor Corporations, and being a Cofounder of Thrombo Therapeutics Inc. The remaining authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29977328</ArticleId><ArticleId IdType="doi">10.1186/s13017-018-0183-4</ArticleId><ArticleId IdType="pii">183</ArticleId><ArticleId IdType="pmc">PMC6015449</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crit Care Clin. 2017 Jan;33(1):15-36</Citation><ArticleIdList><ArticleId IdType="pubmed">27894494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2017;2017:6305387</Citation><ArticleIdList><ArticleId IdType="pubmed">28286376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intensive Care Med. 2016 Oct;31(9):567-76</Citation><ArticleIdList><ArticleId IdType="pubmed">26180038</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2009 Jul 06;10:49</Citation><ArticleIdList><ArticleId IdType="pubmed">19580665</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Surg. 1991 Apr;157(4):277-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1677283</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2008 Jan;36(1):296-327</Citation><ArticleIdList><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2016 Apr;80(4):631-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26808023</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Trauma Resusc Emerg Med. 2017 Jun 9;25(1):56</Citation><ArticleIdList><ArticleId IdType="pubmed">28599661</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2013 Dec 09;17(6):R283</Citation><ArticleIdList><ArticleId IdType="pubmed">24321230</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2014 Dec;38(12):3112-24</Citation><ArticleIdList><ArticleId IdType="pubmed">25231700</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Belg. 2000 Feb;100(1):16-20</Citation><ArticleIdList><ArticleId IdType="pubmed">10776522</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2014 Feb;76(2):457-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24398772</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 1993 Sep;114(3):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7690162</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2015 Apr;39(4):912-25</Citation><ArticleIdList><ArticleId IdType="pubmed">25446477</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Gynecol Obstet. 1986 Nov;163(5):433-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3535135</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Mar 24;303(12):1180-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20332404</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2017 Aug 14;12:39</Citation><ArticleIdList><ArticleId IdType="pubmed">28814969</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Targets. 2014 Mar;18(3):243-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24479494</ArticleId></ArticleIdList></Reference><Reference><Citation>Trauma Surg Acute Care Open. 2017 Apr 13;2(1):e000083</Citation><ArticleIdList><ArticleId IdType="pubmed">29766087</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Dec 1;11(12):e0167230</Citation><ArticleIdList><ArticleId IdType="pubmed">27907062</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2013 Sep;75(3):365-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23928745</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2011 May;98(5):735-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21462176</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2014 Apr;41(4):317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24430553</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2013 May 16;14:141</Citation><ArticleIdList><ArticleId IdType="pubmed">23680127</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2014 Mar 19;18(2):124</Citation><ArticleIdList><ArticleId IdType="pubmed">25030025</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Infect (Larchmt). 2015 Dec;16(6):785-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26258265</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1997 Feb;25(2):372-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9034279</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2010;14(3):R97</Citation><ArticleIdList><ArticleId IdType="pubmed">20507557</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2009 Nov 19;4:41</Citation><ArticleIdList><ArticleId IdType="pubmed">19925649</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2002 Dec;184(6):538-43; discussion 543-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12488160</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrib Nephrol. 1995;116:76-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8529385</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Surg. 2007 Sep;73(9):865-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17939414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2017 Jun;265(6):1045-1050</Citation><ArticleIdList><ArticleId IdType="pubmed">28486288</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2008 Dec;23(4):461-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19056007</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2001 May;48(5):502-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11394523</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2013 Jan 03;8(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">23286785</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chronic Dis. 1987;40(5):373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2010 Nov;34(5):525-34</Citation><ArticleIdList><ArticleId IdType="pubmed">20823698</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2018 Apr 6;13:17</Citation><ArticleIdList><ArticleId IdType="pubmed">29636790</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2003 Aug;31(8):2228-37</Citation><ArticleIdList><ArticleId IdType="pubmed">12973184</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2013 Sep;37(9):2018-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23674252</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2008 Mar;61(3):241-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18226746</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Aug 22;298(8):865-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17712070</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Med Res. 2007 May 29;12(5):200-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17513191</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2002 Dec;89(12):1516-24</Citation><ArticleIdList><ArticleId IdType="pubmed">12445059</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2017 Apr;224(4):396-404</Citation><ArticleIdList><ArticleId IdType="pubmed">28137537</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrib Nephrol. 2010;166:73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20472994</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Clin North Am. 1994 Jun;74(3):677-92</Citation><ArticleIdList><ArticleId IdType="pubmed">8197537</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2004 May;30(5):822-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14758472</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2014 Jan;45(1):151-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23453268</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1995 Dec;130(12):1314-9; discussion 1319-20</Citation><ArticleIdList><ArticleId IdType="pubmed">7492280</ArticleId></ArticleIdList></Reference><Reference><Citation>J Glob Health. 2012 Jun;2(1):010404</Citation><ArticleIdList><ArticleId IdType="pubmed">23198133</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1999 Nov;86(11):1371-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10583280</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Clin North Am. 2017 Oct;97(5):999-1014</Citation><ArticleIdList><ArticleId IdType="pubmed">28958369</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2017 Feb;82(2):345-350</Citation><ArticleIdList><ArticleId IdType="pubmed">27787442</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72</Citation><ArticleIdList><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Clin Belg. 2007;62 Suppl 1:162-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24881714</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2012 Sep;73(3):629-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22929494</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2005 Aug;9(4):R294-302</Citation><ArticleIdList><ArticleId IdType="pubmed">16137340</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2015 Aug 12;10:35</Citation><ArticleIdList><ArticleId IdType="pubmed">26269709</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2015 Dec 16;10:61</Citation><ArticleIdList><ArticleId IdType="pubmed">26677396</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesiol Intensive Ther. 2015;47(4):400-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25973662</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2001 Jul;29(7):1303-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1982 Oct;25(7):641-3</Citation><ArticleIdList><ArticleId IdType="pubmed">7128362</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2017 Apr;23(2):159-166</Citation><ArticleIdList><ArticleId IdType="pubmed">28107224</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2017 Jan 17;317(3):290-300</Citation><ArticleIdList><ArticleId IdType="pubmed">28114553</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2015 May;41(5):909-11</Citation><ArticleIdList><ArticleId IdType="pubmed">25643905</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Infect (Larchmt). 2007 Feb;8(1):63-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17381398</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Res. 1998 May;47(5):201-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9657252</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Surg. 2016 Mar;105(1):5-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26929286</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2010 Aug;211(2):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20670866</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25432556</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2014 May 14;9:37</Citation><ArticleIdList><ArticleId IdType="pubmed">24883079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Res. 2007 Sep;142(1):59-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17716608</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2003 Feb;7(1):1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12617727</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2004 Mar;187(3):372-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15006565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2004 Aug;240(2):205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2013 Jan 08;8(1):3</Citation><ArticleIdList><ArticleId IdType="pubmed">23294512</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrib Nephrol. 2010;167:83-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20519902</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2001 Apr;181(4):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11438263</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2000 Mar;28(3):788-94</Citation><ArticleIdList><ArticleId IdType="pubmed">10752831</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2008 Jan;34(1):17-60</Citation><ArticleIdList><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2018 Feb;73(2):195-204</Citation><ArticleIdList><ArticleId IdType="pubmed">29150856</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Trauma Resusc Emerg Med. 2017 Nov 3;25(1):108</Citation><ArticleIdList><ArticleId IdType="pubmed">29100549</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Oct 08;9(10):e109350</Citation><ArticleIdList><ArticleId IdType="pubmed">25295715</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2013 Jul;39(7):1190-206</Citation><ArticleIdList><ArticleId IdType="pubmed">23673399</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2009 Dec 16;4:45</Citation><ArticleIdList><ArticleId IdType="pubmed">20015376</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Surg. 2014 Oct;57(5):314-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25265104</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2016 Apr;22(2):174-85</Citation><ArticleIdList><ArticleId IdType="pubmed">26844989</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2017 May 4;12:22</Citation><ArticleIdList><ArticleId IdType="pubmed">28484510</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2012 Jan;99 Suppl 1:10-1</Citation><ArticleIdList><ArticleId IdType="pubmed">22441850</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med. 2008 May-Jun;14(5-6):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18327291</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2015 Jul;262(1):38-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25536308</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2014 Jul;42(7):1714-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24717456</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2001 Jul;29(7 Suppl):S99-106</Citation><ArticleIdList><ArticleId IdType="pubmed">11445742</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1987 Jul 16;317(3):141-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3600702</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1998 Apr;175(4):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9568659</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2015 Jul 25;10:32</Citation><ArticleIdList><ArticleId IdType="pubmed">26213565</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2012 Aug;14(8):e429-38</Citation><ArticleIdList><ArticleId IdType="pubmed">22487141</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Clin. 2005 Apr;21(2):177-96</Citation><ArticleIdList><ArticleId IdType="pubmed">15781156</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Infect Dis Rep. 2016 Aug;18(8):23</Citation><ArticleIdList><ArticleId IdType="pubmed">27363829</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Res. 1997 Jul 1;70(2):107-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9237883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29961408</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1745-6924</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>07</Month></PubDate></JournalIssue><Title>Perspectives on psychological science : a journal of the Association for Psychological Science</Title><ISOAbbreviation>Perspect Psychol Sci</ISOAbbreviation></Journal><ArticleTitle>Open Science Is Liberating and Can Foster Creativity.</ArticleTitle><Pagination><MedlinePgn>439-447</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1745691618767878</ELocationID><Abstract><AbstractText>Some scholars think that Open Science practices constrain researchers in ways that reduce their creativity, arguing, for instance, that preregistration discourages data exploration and so stifles discovery. In this article, we argue the opposite: Open Science practices are liberating and can foster creativity. Open Science practices are liberating because they (a) enable us to explore data transparently and comfortably; (b) reward quality, which is under our control, rather than outcomes, which are not; and (c) reduce the choke hold of needing to find "positive" results for career advancement. Open Science practices can foster creativity because they cultivate an open and flexible mind-set, create a more collaborative and constructive climate, and generate more accurate information and make it more accessible. In sum, Open Science liberates researchers more than it constrains them.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frankenhuis</LastName><ForeName>Willem E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>1 Behavioural Science Institute, Radboud University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nettle</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>2 Centre for Behaviour and Evolution and Institute of Neuroscience, Newcastle University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>666669</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Perspect Psychol Sci</MedlineTA><NlmUniqueID>101274347</NlmUniqueID><ISSNLinking>1745-6916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003405" MajorTopicYN="Y">Creativity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012108" MajorTopicYN="N">Research Personnel</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073820" MajorTopicYN="Y">Scholarly Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">creativity</Keyword><Keyword MajorTopicYN="Y">doubt</Keyword><Keyword MajorTopicYN="Y">open science</Keyword><Keyword MajorTopicYN="Y">preregistration</Keyword><Keyword MajorTopicYN="Y">uncertainty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29961408</ArticleId><ArticleId IdType="doi">10.1177/1745691618767878</ArticleId><ArticleId IdType="pmc">PMC6041740</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Biol. 2016 Nov 10;14(11):e2000995</Citation><ArticleIdList><ArticleId IdType="pubmed">27832072</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Methods. 2012 Dec;17(4):551-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22924598</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Dev. 2018 Jan 16;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">29336023</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):543-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26168111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2013 May;14(5):365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23571845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Sci. 2013 Jul;16(4):584-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23786476</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2009 May;4(3):274-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26158964</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2015 Jan 2;116(1):116-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25552691</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Psychol. 2018 Jan 4;69:511-534</Citation><ArticleIdList><ArticleId IdType="pubmed">29068778</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2005 Aug;2(8):e124</Citation><ArticleIdList><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychol Personal Sci. 2017 Nov;8(8):875-881</Citation><ArticleIdList><ArticleId IdType="pubmed">29276574</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2011 Nov;22(11):1359-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22006061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortex. 2013 Mar;49(3):609-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23347556</ArticleId></ArticleIdList></Reference><Reference><Citation>R Soc Open Sci. 2018 Jan 10;5(1):171511</Citation><ArticleIdList><ArticleId IdType="pubmed">29410855</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8414-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27402744</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Apr 07;5(4):e10068</Citation><ArticleIdList><ArticleId IdType="pubmed">20383332</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2016 Dec 20;5:</Citation><ArticleIdList><ArticleId IdType="pubmed">27995896</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 2006 Oct;61(7):726-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17032082</ArticleId></ArticleIdList></Reference><Reference><Citation>R Soc Open Sci. 2016 Sep 21;3(9):160384</Citation><ArticleIdList><ArticleId IdType="pubmed">27703703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers Soc Psychol Rev. 1998;2(3):196-217</Citation><ArticleIdList><ArticleId IdType="pubmed">15647155</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):555-61</Citation><ArticleIdList><ArticleId IdType="pubmed">26168112</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):615-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26168121</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):632-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26168122</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2982-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26929364</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jun 26;348(6242):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26113702</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2012 Nov;7(6):608-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26168120</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychometrika. 2016 Mar;81(1):27-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25820979</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Aug 26;10(8):e0136088</Citation><ArticleIdList><ArticleId IdType="pubmed">26308448</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Mar 25;351(6280):1433-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26940865</ArticleId></ArticleIdList></Reference><Reference><Citation>R Soc Open Sci. 2016 Jan 13;3(1):150547</Citation><ArticleIdList><ArticleId IdType="pubmed">26909182</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Sci. 2017 Oct 25;:1-50</Citation><ArticleIdList><ArticleId IdType="pubmed">29065933</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 2012 May;138(3):389-414</Citation><ArticleIdList><ArticleId IdType="pubmed">22545686</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychon Bull Rev. 2014 Oct;21(5):1180-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24638826</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2600-2606</Citation><ArticleIdList><ArticleId IdType="pubmed">29531091</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Psychol. 2018 Jan 4;69:487-510</Citation><ArticleIdList><ArticleId IdType="pubmed">29300688</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychol Sci. 2017 Sep;12(5):762-771</Citation><ArticleIdList><ArticleId IdType="pubmed">28972841</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2018 May;48(7):1084-1091</Citation><ArticleIdList><ArticleId IdType="pubmed">29173233</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 28;349(6251):aac4716</Citation><ArticleIdList><ArticleId IdType="pubmed">26315443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29940008</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A geometric model for the human pulmonary valve in its fully open case.</ArticleTitle><Pagination><MedlinePgn>e0199390</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0199390</ELocationID><Abstract><AbstractText>The human pulmonary valve, one of the key cardiac structures, plays an important role in circulatory system. However, there are few mathematical models to accurately simulate it. In this paper, we establish a geometric model of the normal human pulmonary valve from a mathematical perspective in the fully opening case. Based on the statistical data of the human pulmonary valves, we assume that the motions of the three cusps are symmetrical in the cardiac cycle. Thus, we first propose that each cusp is a part of the cylindrical shell according to its structure and physiological feature. The parameters for the pulmonary valve cusps in three-dimensional space are obtained by the fitting functions. We verify the accuracy of our results by comparing the areas of the pulmonary valve and pulmonary valve flap.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Xiaoqin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1110-2566</Identifier><AffiliationInfo><Affiliation>School of Sciences, Xi'an University of Technology, Xi'an, 710054, P.R.China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NPU-UoG International Cooperative Lab for Computation &amp; Application in Cardiology, Northwestern Polytechnical University, Xi'an, 710072, P.R.China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Sciences, Xi'an University of Technology, Xi'an, 710054, P.R.China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>NPU-UoG International Cooperative Lab for Computation &amp; Application in Cardiology, Northwestern Polytechnical University, Xi'an, 710072, P.R.China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Xiaoshan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Sciences, Xi'an University of Technology, Xi'an, 710054, P.R.China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Transducer Technology, Chinese Academy of Sciences, Shanghai, 200050, P.R.China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008953" MajorTopicYN="Y">Models, Anatomic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011664" MajorTopicYN="N">Pulmonary Valve</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29940008</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0199390</ArticleId><ArticleId IdType="pii">PONE-D-17-38187</ArticleId><ArticleId IdType="pmc">PMC6016897</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29;362(1484):1421-36</Citation><ArticleIdList><ArticleId IdType="pubmed">17581807</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1998 May;31(6):1420-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9581744</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1931 Sep;7(5):445-474.7</Citation><ArticleIdList><ArticleId IdType="pubmed">19969978</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1974 Feb;74(2):331-44</Citation><ArticleIdList><ArticleId IdType="pubmed">4811758</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2004 Sep;26(3):634-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15302062</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiographics. 2014 Jan-Feb;34(1):51-71</Citation><ArticleIdList><ArticleId IdType="pubmed">24428282</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2013 Feb 22;46(4):662-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23294966</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Biomater. 2011 Apr;7(4):1728-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21118731</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2012 Jul;16(5):1003-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22481023</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Aug 25;12(8):e0183362</Citation><ArticleIdList><ArticleId IdType="pubmed">28841703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Oct;29(5):862-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23198423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 1997 Jun;14(2):115-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9817637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2009 Apr;87(4):1240-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19324159</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mech Behav Biomed Mater. 2014 Jan;29:557-67</Citation><ArticleIdList><ArticleId IdType="pubmed">24035437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1967 Nov 4;2(7523):956-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4167516</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Apr 13;12(4):e0174834</Citation><ArticleIdList><ArticleId IdType="pubmed">28406991</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biomed Eng. 2014 Jul 11;16:53-76</Citation><ArticleIdList><ArticleId IdType="pubmed">24819475</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29938298</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1543-0154</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cancer education : the official journal of the American Association for Cancer Education</Title><ISOAbbreviation>J Cancer Educ</ISOAbbreviation></Journal><ArticleTitle>Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in Russia.</ArticleTitle><Pagination><MedlinePgn>871-873</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13187-018-1388-7</ELocationID><Abstract><AbstractText>Radiation oncologists in Russia face a number of unique professional difficulties including lack of standardized training and continuing medical education. To combat this, under the auspices of the Russian Society of Clinical Oncology (RUSSCO), our group has developed a series of ongoing in-person interactive contouring workshops that are held during the major Russian oncology conferences in Moscow, Russia. Since November 2016 during each workshop, we utilized a web-based open-access interactive three-dimensional contouring atlas as part of our didactics. We sought to determine the impact of this resource on radiation oncology practice in Russia. We distributed an IRB-approved web-based survey to 172 practicing radiation oncologists in Russia. We inquired about practice demographics, RUSSCO contouring workshop attendance, and the clinical use of open-access English language interactive contouring atlas (eContour). The survey remained open for 2 months until November 2017. Eighty radiation oncologists completed the survey with a 46.5% response rate. Mean number of years in practice was 13.7. Sixty respondents (75%) attended at least one RUSSCO contouring workshop. Of those who were aware of eContour, 76% were introduced during a RUSSCO contouring workshop, and 81% continue to use it in their daily practice. The greatest obstacles to using the program were language barrier (51%) and internet access (38%). Nearly 90% reported their contouring practices changed since they started using the program, particularly for delineation of clinical target volumes (57%) and/or organs at risk (46%). More than 97% found the clinical pearls/links to cooperative group protocols in the software helpful in their daily practice. The majority used the contouring program several times per month (43%) or several times per week (41%). Face-to-face contouring instruction in combination with open-access web-based interactive contouring resource had a meaningful impact on perceived quality of radiation oncology contours among Russian practitioners and has the potential to have applications worldwide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McClelland</LastName><ForeName>Shearwood</ForeName><Initials>S</Initials><Suffix>3rd</Suffix><Identifier Source="ORCID">http://orcid.org/0000-0001-7951-9726</Identifier><AffiliationInfo><Affiliation>Department of Radiation Medicine, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Rd, L337, Portland, OR, 97239-3098, USA. drwood@post.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chernykh</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>N.N. Blohin National Medical Research Center of Oncology, Ministry of Healthcare of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dengina</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ulyanovsk Regional Cancer Center, Ulyanovsk Oblast, Ulyanovsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillespie</LastName><ForeName>Erin F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhacheva</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banner MD Anderson Cancer Center, Gilbert, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usychkin</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medscan Clinic, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankratov</LastName><ForeName>Alexandr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PET-Technology Balashiha, Moscow Oblast, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharitonova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Russian Society of Clinical Oncology (RUSSCO), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egorova</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Russian Society of Clinical Oncology (RUSSCO), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsimafeyeu</LastName><ForeName>Ilya</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Russian Society of Clinical Oncology (RUSSCO), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjulandin</LastName><ForeName>Sergei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Russian Society of Clinical Oncology (RUSSCO), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Radiation Medicine, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Rd, L337, Portland, OR, 97239-3098, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitin</LastName><ForeName>Timur</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiation Medicine, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Rd, L337, Portland, OR, 97239-3098, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Design and Implementation Group for Radiation Oncology Workshops (INDIGO), Trubnaya street, 25/1, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cancer Educ</MedlineTA><NlmUniqueID>8610343</NlmUniqueID><ISSNLinking>0885-8195</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000715" MajorTopicYN="N">Anatomy</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058958" MajorTopicYN="N">Organs at Risk</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072378" MajorTopicYN="N">Radiation Oncologists</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018787" MajorTopicYN="N">Radiation Oncology</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical target volume</Keyword><Keyword MajorTopicYN="N">Global oncology</Keyword><Keyword MajorTopicYN="N">Organs at risk</Keyword><Keyword MajorTopicYN="N">RUSSCO</Keyword><Keyword MajorTopicYN="N">Radiation oncology</Keyword><Keyword MajorTopicYN="N">Russia</Keyword><Keyword MajorTopicYN="N">eContour.org</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29938298</ArticleId><ArticleId IdType="doi">10.1007/s13187-018-1388-7</ArticleId><ArticleId IdType="pii">10.1007/s13187-018-1388-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Radiat Oncol. 2011 Jan 27;6:10</Citation><ArticleIdList><ArticleId IdType="pubmed">21272369</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiother Oncol. 1998 Jun;47(3):285-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9681892</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):220-224</Citation><ArticleIdList><ArticleId IdType="pubmed">28068229</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):547-554</Citation><ArticleIdList><ArticleId IdType="pubmed">28262474</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):527-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22342091</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):804-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24969794</ArticleId></ArticleIdList></Reference><Reference><Citation>Pract Radiat Oncol. 2015 Mar-Apr;5(2):e67-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25413413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1993 Nov 27;342(8883):1317-22</Citation><ArticleIdList><ArticleId IdType="pubmed">7901634</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29897443</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-2050</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title><ISOAbbreviation>Dis Esophagus</ISOAbbreviation></Journal><ArticleTitle>Single center consecutive series cohort study of minimally invasive versus open resection for cancer in the esophagus or gastroesophageal junction.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/doy027</ELocationID><Abstract><AbstractText>Minimally invasive esophagectomy (MIE) has been introduced at many centers worldwide as evidence is accumulating that it reduces the risk of postoperative morbidity and mortality and decreases the length of hospital stay compared to conventional open esophagectomy. The study is a single institution cohort study of 366 consecutive patients treated with curative intent for cancer in the esophagus or gastroesophageal junction, comparing MIE to open surgery. The outcomes studied were peroperative bleeding, operation time, lymph node yield, complications, length of stay and overall survival. The results showed that MIE was associated with reduced peroperative bleeding and operation time. The patients in the MIE group had a statistically significant reduced risk of postoperative complications, 60.2% compared to 78.8% in the open group. In the MIE group 28.4% of the patients had postoperative complications classified according to the Clavien-Dindo classification system as grade IIIb-V compared to 38.2% in the open group, P = 0.046. Median hospital stay was reduced with 10 days comparing MIE to open surgery, P &lt; 0.001. Mean number of resected lymph nodes was 31 in the MIE group and 22 in the open group (P &lt; 0.001), while the R0 resections were 91.5% versus 85% (P = 0.057). Overall long-term survival was higher in the MIE group, a difference that however did not reach statistical significance (adjusted hazard ratio for three-year survival 0.76, 95% CI 0.54-1.08). In conclusion, MIE at a high volume center with a devoted specialist team reduces the risk of peroperative bleeding, operation time, and severe postoperative complications compared to open surgery for esophageal or junctional cancer. The number of resected lymph nodes was increased and the R0 resections were similar between the groups indicating a good oncological quality of the surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klevebro</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandavini</LastName><ForeName>C M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General and Reconstructive Surgery, Department of Surgical Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamiya</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundell</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouvelas</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Upper Abdominal Surgery, Centre for Digestive Diseases, Karolinska University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Esophagus</MedlineTA><NlmUniqueID>8809160</NlmUniqueID><ISSNLinking>1120-8694</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004943" MajorTopicYN="N">Esophagogastric Junction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29897443</ArticleId><ArticleId IdType="pii">4980436</ArticleId><ArticleId IdType="doi">10.1093/dote/doy027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29876770</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1591-9528</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Clinical and experimental medicine</Title><ISOAbbreviation>Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.</ArticleTitle><Pagination><MedlinePgn>569-576</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10238-018-0510-9</ELocationID><Abstract><AbstractText>To evaluate potency and safety of 14-day bismuth-furazolidone quadruple regimens and to compare efficacies of five proton pump inhibitors (PPIs) for the initial eradication of Helicobacter pylori (H. pylori), 175 eligible patients were enrolled and randomly assigned to 14-day quadruple regimens consisting of bismuth (400 mg), amoxicillin (1 g), furazolidone (100 mg), and a PPI, twice a day. PPIs used were Group A (pantoprazole capsules, 40 mg), Group B (pantoprazole tablets, 40 mg), Group C (lansoprazole, 30 mg), Group D (esomeprazole, 20 mg), and Group E (rabeprazole, 10 mg). H. pylori status was reassessed by <sup>13</sup>C urea breath test on day 56 as the primary outcome. Gastrointestinal symptoms, parenteral side effects, compliance, and stool type were recorded simultaneously. The total eradication rates were 86.9% (152/175 [95% CI 80.9-91.5%]) and 95.6% (152/159 [91.1-98.2%]) by intention-to-treat (ITT) and per-protocol (PP) analysis. The efficacies of Group A, B, C, D, and E by ITT analysis were 91.4% (32/35 [76.9-98.2%]), 85.7% (30/35 [69.7-95.2%]), 88.6% (31/35 [73.3-96.8%]), 85.7% (30/35 [69.7-95.2%]), and 82.9% (29/35 [66.4-93.4%]) (p &gt; 0.05). In the PP analysis, the efficacies were 97.0% (32/33), 93.8% (30/32), 93.9% (31/33), 100% (30/30), and 93.5% (29/31) (p &gt; 0.05). Gastrointestinal symptoms and stool type were improved significantly (p &lt; 0.05). Total side effects rate and poor compliance rate were 15.7% (25/159) and 5.0% (8/159). Fourteen-day bismuth-furazolidone quadruple regimens are of high potency and safety for the initial eradication of H. pylori. Efficacies of different PPIs and different dosages (9-32 mg omeprazole equivalents) showed no significant difference. The appropriate PPI can thus be chosen by clinicians.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Luyi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Jiamin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Qiwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Yanqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yanyong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Huiqin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Aiqing</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China. 3310015@zju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China. 3310015@zju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shujie</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9523-0033</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang Province, China. chenshujie77@zju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, China. chenshujie77@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2013TD13</GrantID><Agency>Zhejiang Province Key Science and Technology Innovation Team</Agency><Country/></Grant><Grant><GrantID>2017ZB063</GrantID><Agency>Science Foundation of Zhejiang Traditional Medicine Bureau</Agency><Country/></Grant><Grant><GrantID>2012ZB098</GrantID><Agency>Science Foundation of Zhejiang Traditional Medicine Bureau</Agency><Country/></Grant><Grant><GrantID>LY18H160011</GrantID><Agency>Natural Science Foundation of Zhejiang Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Exp Med</MedlineTA><NlmUniqueID>100973405</NlmUniqueID><ISSNLinking>1591-8890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>5J9CPU3RE0</RegistryNumber><NameOfSubstance UI="D005664">Furazolidone</NameOfSubstance></Chemical><Chemical><RegistryNumber>804826J2HU</RegistryNumber><NameOfSubstance UI="D000658">Amoxicillin</NameOfSubstance></Chemical><Chemical><RegistryNumber>KG60484QX9</RegistryNumber><NameOfSubstance UI="D009853">Omeprazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>U015TT5I8H</RegistryNumber><NameOfSubstance UI="D001729">Bismuth</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000658" MajorTopicYN="N">Amoxicillin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001729" MajorTopicYN="N">Bismuth</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005664" MajorTopicYN="N">Furazolidone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009853" MajorTopicYN="N">Omeprazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bismuth-containing quadruple regimen</Keyword><Keyword MajorTopicYN="N">Efficacy</Keyword><Keyword MajorTopicYN="N">Furazolidone</Keyword><Keyword MajorTopicYN="N">Helicobacter pylori</Keyword><Keyword MajorTopicYN="N">Initial treatment</Keyword><Keyword MajorTopicYN="N">Proton pump inhibitors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29876770</ArticleId><ArticleId IdType="doi">10.1007/s10238-018-0510-9</ArticleId><ArticleId IdType="pii">10.1007/s10238-018-0510-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–39. https://doi.org/10.1038/ajg.2016.563 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2016.563</ArticleId><ArticleId IdType="pubmed">28071659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med. 1996;100(5A):12S–8S Discussion 7S-8S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(96)80224-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy P, Johansson S, Molloy-Bland M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog. 2016;8:8. https://doi.org/10.1186/s13099-016-0091-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0091-7</ArticleId><ArticleId IdType="pubmed">26981156</ArticleId><ArticleId IdType="pmcid">4791971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–67. https://doi.org/10.1136/gutjnl-2015-309252 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2015-309252</ArticleId><ArticleId IdType="pubmed">26187502</ArticleId><ArticleId IdType="pmcid">4552923</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. https://doi.org/10.1136/gutjnl-2016-312288 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312288</ArticleId><ArticleId IdType="pubmed">27707777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Society of G, Chinese Study Group on Helicobacter p, Peptic U, Liu G, Xie J, Lu ZR, et al. Fifth Chinese national consensus report on the management of Helicobacter pylori infection. Zhonghua Nei Ke Za Zhi. 2017;56(7):532–45. https://doi.org/10.3760/cma.j.issn.0578-1426.2017.07.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0578-1426.2017.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CH, Lu CY, Shih HY, Liu CJ, Wu MC, Hu HM, et al. CYP2C19 polymorphism influences Helicobacter pylori eradication. World J Gastroenterol. 2014;20(43):16029–36. https://doi.org/10.3748/wjg.v20.i43.16029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i43.16029</ArticleId><ArticleId IdType="pubmed">25473155</ArticleId><ArticleId IdType="pmcid">4239489</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P, Li Y, Li H, Zhang J, Lin L, Wang Q, et al. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter. 2013;18(4):274–9. https://doi.org/10.1111/hel.12046 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hel.12046</ArticleId><ArticleId IdType="pubmed">23418857</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DS, Wang YH, Zeng ZR, Zhang ZY, Lu H, Xu JM, et al. Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multi-region prospective 7-year study. Clin Microbiol Infect. 2017. https://doi.org/10.1016/j.cmi.2017.11.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.11.010</ArticleId><ArticleId IdType="pubmed">29288021</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DY, Lu H. Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread. Saudi J Gastroenterol. 2012;18(1):1–2. https://doi.org/10.4103/1319-3767.91724 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.91724</ArticleId><ArticleId IdType="pubmed">22249084</ArticleId><ArticleId IdType="pmcid">3271686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Zhang W, Graham DY. Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China. Eur J Gastroenterol Hepatol. 2013;25(10):1134–40. https://doi.org/10.1097/MEG.0b013e3283633b57 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0b013e3283633b57</ArticleId><ArticleId IdType="pubmed">23778309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi M, Attaran B, Malekzadeh R, Graham DY. Furazolidone, an underutilized drug for H. pylori eradication: lessons from Iran. Dig Dis Sci. 2017;62(8):1890–6. https://doi.org/10.1007/s10620-017-4628-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-017-4628-5</ArticleId><ArticleId IdType="pubmed">28577244</ArticleId><ArticleId IdType="pmcid">5527993</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalano F, Terminella C, Branciforte G, Bentivegna C, Brogna A, Scalia A. Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer. Digestion. 2002;66(3):154–9. https://doi.org/10.1159/000066756 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000066756</ArticleId><ArticleId IdType="pubmed">12481161</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HS, Park DI, Hwang SJ, Park JS, Kim HJ, Cho YK, et al. Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter. 2007;12(6):638–42. https://doi.org/10.1111/j.1523-5378.2007.00556.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-5378.2007.00556.x</ArticleId><ArticleId IdType="pubmed">18001407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee VW, Chau TS, Chan AK, Lee KK, Waye MM, Ling TK, et al. Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. J Clin Pharm Ther. 2010;35(3):343–50. https://doi.org/10.1111/j.1365-2710.2009.01088.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2710.2009.01088.x</ArticleId><ArticleId IdType="pubmed">20831535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X, Li Y, Qiu Y, Tang Q, Qian B, Yao L, et al. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults. Clin Ther. 2010;32(12):2003–11. https://doi.org/10.1016/j.clinthera.2010.11.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2010.11.005</ArticleId><ArticleId IdType="pubmed">21118735</ArticleId></ArticleIdList></Reference><Reference><Citation>Keum B, Lee SW, Kim SY, Kim JM, Choung RS, Yim HJ, et al. Comparison of Helicobacter pylori eradication rate according to different PPI-based triple therapy–omeprazole, rabeprazole, esomeprazole and lansoprazole. Korean J Gastroenterol = Taehan Sohwagi Hakhoe chi. 2005;46(6):433–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16371717</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2017. https://doi.org/10.1016/j.cgh.2017.09.033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2017.09.033</ArticleId><ArticleId IdType="pubmed">28964908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchheiner J, Glatt S, Fuhr U, Klotz U, Meineke I, Seufferlein T, et al. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Eur J Clin Pharmacol. 2009;65(1):19–31. https://doi.org/10.1007/s00228-008-0576-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-008-0576-5</ArticleId><ArticleId IdType="pubmed">18925391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuah YY, Wu DC, Chuah SK, Yang JC, Lee TH, Yeh HZ, et al. Real-world practice and expectation of Asia-Pacific physicians and patients in Helicobacter pylori eradication (REAP-HP survey). Helicobacter. 2017. https://doi.org/10.1111/hel.12380 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hel.12380</ArticleId><ArticleId IdType="pubmed">28244264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Lu R, Yang Y, Xu Q, Wang B, Ye G. Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients. J Clin Lab Anal. 2017. https://doi.org/10.1002/jcla.22339 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.22339</ArticleId><ArticleId IdType="pubmed">28984385</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X, Xu X, Zheng Q, Zhang W, Sun Q, Liu W, et al. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study. Clin Gastroenterol Hepatol. 2013;11(7):802–7. https://doi.org/10.1016/j.cgh.2013.01.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2013.01.008</ArticleId><ArticleId IdType="pubmed">23376004</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y, Li Y, Wu H, Sha W, Du H, Dai S, et al. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori–positive duodenal ulcer. Helicobacter. 1999;4(2):128–34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-5378.1999.98281.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Dore MP, Farina V, Cuccu M, Mameli L, Massarelli G, Graham DY. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter. 2011;16(4):295–300. https://doi.org/10.1111/j.1523-5378.2011.00857.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-5378.2011.00857.x</ArticleId><ArticleId IdType="pubmed">21762269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Xie Y, Lu N, Zhou H, Liu Z, Zhu X, et al. Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection. Zhonghua Yi Xue Za Zhi. 2014;94(8):572–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24762683</ArticleId></ArticleIdList></Reference><Reference><Citation>Labenz J. Current role of acid suppressants in Helicobacter pylori eradication therapy. Best Pract Res Clin Gastroenterol. 2001;15(3):413–31. https://doi.org/10.1053/bega.2001.0188 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/bega.2001.0188</ArticleId><ArticleId IdType="pubmed">11403536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kita T, Tanigawara Y, Aoyama N, Hohda T, Saijoh Y, Komada F, et al. CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability. Pharm Res. 2001;18(5):615–21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1011025125163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisbert JP. Potent gastric acid inhibition in Helicobacter pylori eradication. Drugs. 2005;65(Suppl 1):83–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16335862</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvet X, Gomollon F. What is potent acid inhibition, and how can it be achieved? Drugs. 2005;65(Suppl 1):13–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">16335854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahara S, Sugimoto M, Uotani T, Ichikawa H, Yamade M, Iwaizumi M, et al. Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole. Aliment Pharmacol Ther. 2013;38(9):1129–37. https://doi.org/10.1111/apt.12492 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12492</ArticleId><ArticleId IdType="pubmed">24099474</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014;12(2):177–86. https://doi.org/10.1016/j.cgh.2013.05.028 Discussion e12-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2013.05.028</ArticleId><ArticleId IdType="pubmed">23751282</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MK, Wu IC, Lu CY, Kuo CH, Yu FJ, Liu CJ, et al. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens. Kaohsiung J Med Sci. 2013;29(7):379–84. https://doi.org/10.1016/j.kjms.2012.11.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kjms.2012.11.006</ArticleId><ArticleId IdType="pubmed">23768702</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarikaya M, Dogan Z, Ergul B, Filik L. Functional dyspepsia symptom resolution after Helicobacter pylori eradication with two different regimens. Prz Gastroenterol. 2014;9(1):49–52. https://doi.org/10.5114/pg.2014.40851 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pg.2014.40851</ArticleId><ArticleId IdType="pubmed">24868299</ArticleId><ArticleId IdType="pmcid">4027843</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtare M, Hosseini V, Tirgar Fakheri H, Maleki I, Taghvaei T, Valizadeh SM, et al. Comparison of quadruple and triple Furazolidone containing regimens on eradication of Helicobacter pylori. Med J Islam Repub Iran. 2015;29:195.</Citation><ArticleIdList><ArticleId IdType="pubmed">26157713</ArticleId><ArticleId IdType="pmcid">4476222</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Zhu Y, Zhou H, Lu ZF, Yang Z, Shu X, et al. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection. World J Gastroenterol. 2014;20(32):11415–21. https://doi.org/10.3748/wjg.v20.i32.11415 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i32.11415</ArticleId><ArticleId IdType="pubmed">25170230</ArticleId><ArticleId IdType="pmcid">4145784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29795809</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2379-5077</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>3</Issue><PubDate><MedlineDate>2018 May-Jun</MedlineDate></PubDate></JournalIssue><Title>mSystems</Title><ISOAbbreviation>mSystems</ISOAbbreviation></Journal><ArticleTitle>American Gut: an Open Platform for Citizen Science Microbiome Research.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00031-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mSystems.00031-18</ELocationID><Abstract><AbstractText>Although much work has linked the human microbiome to specific phenotypes and lifestyle variables, data from different projects have been challenging to integrate and the extent of microbial and molecular diversity in human stool remains unknown. Using standardized protocols from the Earth Microbiome Project and sample contributions from over 10,000 citizen-scientists, together with an open research network, we compare human microbiome specimens primarily from the United States, United Kingdom, and Australia to one another and to environmental samples. Our results show an unexpected range of beta-diversity in human stool microbiomes compared to environmental samples; demonstrate the utility of procedures for removing the effects of overgrowth during room-temperature shipping for revealing phenotype correlations; uncover new molecules and kinds of molecular communities in the human stool metabolome; and examine emergent associations among the microbiome, metabolome, and the diversity of plants that are consumed (rather than relying on reductive categorical variables such as veganism, which have little or no explanatory power). We also demonstrate the utility of the living data resource and cross-cohort comparison to confirm existing associations between the microbiome and psychiatric illness and to reveal the extent of microbiome change within one individual during surgery, providing a paradigm for open microbiome research and education. <b>IMPORTANCE</b> We show that a citizen science, self-selected cohort shipping samples through the mail at room temperature recaptures many known microbiome results from clinically collected cohorts and reveals new ones. Of particular interest is integrating <i>n</i> = 1 study data with the population data, showing that the extent of microbiome change after events such as surgery can exceed differences between distinct environmental biomes, and the effect of diverse plants in the diet, which we confirm with untargeted metabolomics on hundreds of samples.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>McDonald</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0876-9060</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hyde</LastName><ForeName>Embriette</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debelius</LastName><ForeName>Justine W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackermann</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aksenov</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behsaz</LastName><ForeName>Bahar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Caitriona</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yingfeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology, San Diego State University, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeRight Goldasich</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorrestein</LastName><ForeName>Pieter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Robert R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Applied Ecology, North Carolina State University, Raleigh, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahimipour</LastName><ForeName>Ashkaan K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Biology and the Built Environment Center, University of Oregon, Eugene, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaffney</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Jack A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Genomic and Systems Biology, University of Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biosciences, Argonne National Laboratory, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marine Biology Laboratory, University of Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogul</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Biology and the Built Environment Center, University of Oregon, Eugene, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hugenholtz</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, the University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huttenhower</LastName><ForeName>Curtis</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0955-0589</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeste</LastName><ForeName>Dilip V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and Neurosciences, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sam and Rose Stein Institute for Research on Aging and Center for Healthy Aging, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lingjing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Scott T</ForeName><Initials>ST</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-9547-4169</Identifier><AffiliationInfo><Affiliation>Department of Biology, San Diego State University, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knights</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biotechnology Institute, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosciolek</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladau</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Gladstone Institutes, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leach</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Human Food Project, Terlingua, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marotz</LastName><ForeName>Clarisse</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meleshko</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St. Petersburg State University, Center for Algorithmic Biotechnology, Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melnik</LastName><ForeName>Alexey V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metcalf</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Animal Science, Colorado State University, Fort Collins, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohimani</LastName><ForeName>Hosein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Computational Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montassier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2313-1172</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université de Nantes, Microbiotas Hosts Antibiotics and Bacterial Resistances (MiHAR), Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navas-Molina</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tanya T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and Neurosciences, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sam and Rose Stein Institute for Research on Aging and Center for Healthy Aging, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peddada</LastName><ForeName>Shyamal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pevzner</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Collaborative Mass Spectrometry Innovation Center, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollard</LastName><ForeName>Katherine S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>The Gladstone Institutes, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahnavard</LastName><ForeName>Gholamali</ForeName><Initials>G</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9710-0248</Identifier><AffiliationInfo><Affiliation>Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robbins-Pianka</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Colorado Boulder, Boulder, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangwan</LastName><ForeName>Naseer</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biosciences, Argonne National Laboratory, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorenstein</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smarr</LastName><ForeName>Larry</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California Institute for Telecommunications and Information Technology (Calit2), University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Se Jin</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0750-5709</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spector</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swafford</LastName><ForeName>Austin D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thackray</LastName><ForeName>Varykina G</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Luke R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Ocean Chemistry and Ecosystems Division, Atlantic Oceanographic and Meteorological Laboratory, National Oceanic and Atmospheric Administration, stationed at Southwest Fisheries Science Center, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences and Northern Gulf Institute, University of Southern Mississippi, Hattiesburg, Mississippi, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Anupriya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vázquez-Baeza</LastName><ForeName>Yoshiki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrbanac</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wischmeyer</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgery, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Qiyun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>American Gut Consortium </CollectiveName></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/N01183X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 DK042086</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK043351</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/N030125/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>T32 GM007752</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mSystems</MedlineTA><NlmUniqueID>101680636</NlmUniqueID><ISSNLinking>2379-5077</ISSNLinking></MedlineJournalInfo><InvestigatorList><Investigator ValidYN="Y"><LastName>Mann</LastName><ForeName>Allison E</ForeName><Initials>AE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Amnon</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frazier</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martino</LastName><ForeName>Cameron</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lebrilla</LastName><ForeName>Carlito</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lozupone</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Cecil M</ForeName><Initials>CM</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Raison</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lauber</LastName><ForeName>Christian L</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warinner</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lowry</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Callewaert</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bloss</LastName><ForeName>Cinnamon</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willner</LastName><ForeName>Dana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galzerani</LastName><ForeName>Daniela Domingos</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chopra</LastName><ForeName>Deepak</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gevers</LastName><ForeName>Dirk</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berg-Lyons</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sears</LastName><ForeName>Dorothy D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wendel</LastName><ForeName>Doug</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lovelace</LastName><ForeName>Elijah</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierce</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>TerAvest</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolyen</LastName><ForeName>Evan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bushman</LastName><ForeName>Frederic D</ForeName><Initials>FD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Gary D</ForeName><Initials>GD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Church</LastName><ForeName>George M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saxe</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holscher</LastName><ForeName>Hanna D</ForeName><Initials>HD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ugrina</LastName><ForeName>Ivo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>German</LastName><ForeName>J Bruce</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caporaso</LastName><ForeName>J Gregory</ForeName><Initials>JG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wozniak</LastName><ForeName>Jacob M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerr</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravel</LastName><ForeName>Jacques</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>James D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suchodolski</LastName><ForeName>Jan S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jansson</LastName><ForeName>Janet K</ForeName><Initials>JK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hampton-Marcell</LastName><ForeName>Jarrad T</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bobe</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raes</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chase</LastName><ForeName>John H</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eisen</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monk</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemente</LastName><ForeName>Jose C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrosino</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodrich</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gauglitz</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Julian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zengler</LastName><ForeName>Karsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swanson</LastName><ForeName>Kelly S</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayer</LastName><ForeName>Kris</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bittinger</LastName><ForeName>Kyle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillon</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaramela</LastName><ForeName>Livia S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schriml</LastName><ForeName>Lynn M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dominguez-Bello</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jankowska</LastName><ForeName>Marta M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blaser</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pirrung</LastName><ForeName>Meg</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minson</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurisu</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajami</LastName><ForeName>Nadim</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottel</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chia</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fierer</LastName><ForeName>Noah</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Owen</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cani</LastName><ForeName>Patrice D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gajer</LastName><ForeName>Pawel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strandwitz</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Purna</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dutton</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Rachel S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Ramnik J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krajmalnik-Brown</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ley</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Owens</LastName><ForeName>Sarah M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klemmer</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matamoros</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mirarab</LastName><ForeName>Siavash</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moorman</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holmes</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Tara</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eshoo-Anton</LastName><ForeName>Tifani W</ForeName><Initials>TW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vigers</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pandey</LastName><ForeName>Vineet</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treuren</LastName><ForeName>Will Van</ForeName><Initials>WV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fang</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zech Xu</LastName><ForeName>Zhenjiang</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarmusch</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geier</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reeve</LastName><ForeName>Nicolai</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silva</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kopylova</LastName><ForeName>Evguenia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Dominic</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanders</LastName><ForeName>Karenina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salido Benitez</LastName><ForeName>Rodolfo Antonio</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heale</LastName><ForeName>Arthur Cole</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abramson</LastName><ForeName>Max</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waldispühl</LastName><ForeName>Jérôme</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butyaev</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drogaris</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nazarova</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ball</LastName><ForeName>Madeleine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gunderson</LastName><ForeName>Beau</ForeName><Initials>B</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29795809</ArticleId><ArticleId IdType="doi">10.1128/mSystems.00031-18</ArticleId><ArticleId IdType="pii">mSystems00031-18</ArticleId><ArticleId IdType="pmc">PMC5954204</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Med Res Methodol. 2008 Jun 05;8:37</Citation><ArticleIdList><ArticleId IdType="pubmed">18644098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Feb 15;32(4):605-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26515820</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2016 May 3;1(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">27822526</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2013 Apr 16;2:e00458</Citation><ArticleIdList><ArticleId IdType="pubmed">23599893</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17808-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24127592</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2012;:247-58</Citation><ArticleIdList><ArticleId IdType="pubmed">22174280</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2016 Aug 30;13(9):741-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27575624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2017 Dec;16(12 ):829-842</Citation><ArticleIdList><ArticleId IdType="pubmed">29075003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 1967 Feb;27(2):209-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6018555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Oct 5;550(7674):61-66</Citation><ArticleIdList><ArticleId IdType="pubmed">28953883</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Mar 04;9(4):357-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2011 Feb;5(2):169-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20827291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Adv. 2015 Apr 3;1(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">26229982</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes. 2016 Jan;8(1):8-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27144261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Jul 15;30(14):2068-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24642063</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Bacteriol. 1991 Jun;70(6):443-59</Citation><ArticleIdList><ArticleId IdType="pubmed">1938669</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 1992 Jul;112(1):155-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19565683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Endocrinol. 2014 Aug;28(8):1221-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24892638</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2013 Nov 26;2(1):16</Citation><ArticleIdList><ArticleId IdType="pubmed">24280061</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2017 Feb 13;2:17004</Citation><ArticleIdList><ArticleId IdType="pubmed">28191884</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1743-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22586093</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jun 13;486(7402):207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22699609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Metab. 2016 May 27;5(9):743-52</Citation><ArticleIdList><ArticleId IdType="pubmed">27617197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Nov;38(20):e191</Citation><ArticleIdList><ArticleId IdType="pubmed">20805240</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 May 09;486(7402):222-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22699611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Oct 09;5:14567</Citation><ArticleIdList><ArticleId IdType="pubmed">26449758</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Mar 7;2(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28289731</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ. 2017 Aug 30;5:e3720</Citation><ArticleIdList><ArticleId IdType="pubmed">28875074</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4825-34</Citation><ArticleIdList><ArticleId IdType="pubmed">26283367</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiome. 2015 Mar 30;3:10</Citation><ArticleIdList><ArticleId IdType="pubmed">25825673</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Microbiol. 2003;94(1):138-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12492934</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2012 Aug;6(8):1621-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22402401</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Aug 25;357(6353):802-806</Citation><ArticleIdList><ArticleId IdType="pubmed">28839072</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2010 Jun;66(2):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19645703</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2018 Mar;3(3):319-327</Citation><ArticleIdList><ArticleId IdType="pubmed">29358742</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2016 Oct 31;2:16197</Citation><ArticleIdList><ArticleId IdType="pubmed">27798598</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2015 Jan;9(1):207-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25003965</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4578-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20668239</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2015 Nov;9(11):2423-34</Citation><ArticleIdList><ArticleId IdType="pubmed">26023870</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2017;1520:307-329</Citation><ArticleIdList><ArticleId IdType="pubmed">27873261</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2007 Aug;73(16):5261-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17586664</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Apr 29;352(6285):565-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27126040</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Psichiatr Soc. 2002 Apr-Jun;11(2):83-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12212469</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014 Dec 03;15(12):531</Citation><ArticleIdList><ArticleId IdType="pubmed">25517225</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Jan 08;10:11</Citation><ArticleIdList><ArticleId IdType="pubmed">19133141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2016 Jun;21(6):786-96</Citation><ArticleIdList><ArticleId IdType="pubmed">27067014</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Bioinformatics. 2016 Sep 07;55:14.10.1-14.10.91</Citation><ArticleIdList><ArticleId IdType="pubmed">27603023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jul;39(Web Server issue):W29-37</Citation><ArticleIdList><ArticleId IdType="pubmed">21593126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D490-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24270786</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jun 19;324(5934):1561-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19541996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2010 May;7(5):335-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Biol. 2016 Jun 15;219(Pt 12):1903-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27307545</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Microbiol. 2017 Mar;19(3):835-841</Citation><ArticleIdList><ArticleId IdType="pubmed">28028921</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12580-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26392543</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Aug 11;313(5788):848-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16902142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2017 Jan 11;21(1):7-10</Citation><ArticleIdList><ArticleId IdType="pubmed">28081445</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiome. 2017 Mar 3;5(1):27</Citation><ArticleIdList><ArticleId IdType="pubmed">28253908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Mar 4;464(7285):59-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Jan 23;505(7484):559-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24336217</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Nov 21;2(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">29181446</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2011 Oct;7(10):e1002195</Citation><ArticleIdList><ArticleId IdType="pubmed">22039361</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2015 Aug;48:186-94</Citation><ArticleIdList><ArticleId IdType="pubmed">25882912</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2005 Dec;71(12):8228-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16332807</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 08;8(10):e77157</Citation><ArticleIdList><ArticleId IdType="pubmed">24116215</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Sep 7;549(7670):48-53</Citation><ArticleIdList><ArticleId IdType="pubmed">28854168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Nov 23;551(7681):457-463</Citation><ArticleIdList><ArticleId IdType="pubmed">29088705</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nat Prod. 2013 Sep 27;76(9):1686-99</Citation><ArticleIdList><ArticleId IdType="pubmed">24025162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2013 Jul;11(7):497-504</Citation><ArticleIdList><ArticleId IdType="pubmed">23748339</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2009 Nov;77(11):4696-703</Citation><ArticleIdList><ArticleId IdType="pubmed">19720753</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiologyopen. 2017 Oct;6(5):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28834331</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Mar 7;2(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28289733</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014 Mar 03;15(3):R46</Citation><ArticleIdList><ArticleId IdType="pubmed">24580807</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2013 Sep;7(9):1669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23514781</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Jan 1;207 :300-304</Citation><ArticleIdList><ArticleId IdType="pubmed">27741466</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrika. 1950 Jun;37(1-2):17-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15420245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2016 Aug 9;34(8):828-837</Citation><ArticleIdList><ArticleId IdType="pubmed">27504778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Biol. 2012 May;19(5):455-77</Citation><ArticleIdList><ArticleId IdType="pubmed">22506599</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2012 Mar;6(3):610-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22134646</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolomics. 2007 Sep;3(3):211-221</Citation><ArticleIdList><ArticleId IdType="pubmed">24039616</ArticleId></ArticleIdList></Reference><Reference><Citation>OMICS. 2013 Sep;17(9):473-85</Citation><ArticleIdList><ArticleId IdType="pubmed">23808607</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2007 Mar;73(5):1576-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17220268</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Apr 29;352(6285):560-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27126039</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Jan 17;2(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">28144630</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2017 May;27(5):824-834</Citation><ArticleIdList><ArticleId IdType="pubmed">28298430</ArticleId></ArticleIdList></Reference><Reference><Citation>mSphere. 2016 Aug 31;1(4):null</Citation><ArticleIdList><ArticleId IdType="pubmed">27602409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1985 Oct;131(10):2673-86</Citation><ArticleIdList><ArticleId IdType="pubmed">3934329</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2008 Oct;6(10 ):776-88</Citation><ArticleIdList><ArticleId IdType="pubmed">18794915</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Jul 23;11:395</Citation><ArticleIdList><ArticleId IdType="pubmed">20650010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Mar 25;6:6505</Citation><ArticleIdList><ArticleId IdType="pubmed">25807110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29792414</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-510X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>Inorganic chemistry</Title><ISOAbbreviation>Inorg Chem</ISOAbbreviation></Journal><ArticleTitle>Hybrid Assembly of Different-Sized Supertetrahedral Clusters into a Unique Non-Interpenetrated Mn-In-S Open Framework with Large Cavity.</ArticleTitle><Pagination><MedlinePgn>6710-6715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.inorgchem.8b00907</ELocationID><Abstract><AbstractText>Reported here is a unique crystalline semiconductor open-framework material built from the large-sized supertetrahedral T4 and T5 clusters with the Mn-In-S compositions. The hybrid assembly between T4 and T5 clusters by sharing terminal μ<sub>2</sub>-S<sup>2-</sup> is for the first time observed among the cluster-based chalcogenide open frameworks. Such three-dimensional structure displays non-interpenetrated diamond-type topology with extra-large nonframework volume of 82%. Moreover, ion exchange, CO<sub>2</sub> adsorption, as well as photoluminescence properties of the title compound are also investigated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongxiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Min</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8080-0881</Identifier><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Chaozhuang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1283-6334</Identifier><AffiliationInfo><Affiliation>College of Materials and Chemical Engineering, Hubei Provincial Collaborative Innovation Center for New Energy Microgrid, Key Laboratory of Inorganic Nonmetallic Crystalline and Energy Conversion Materials , China Three Gorges University , Yichang , Hubei 443002 , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4443-1227</Identifier><AffiliationInfo><Affiliation>College of Chemistry, Chemical Engineering and Materials Science , Soochow University , Suzhou , Jiangsu 215123 , China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Inorg Chem</MedlineTA><NlmUniqueID>0366543</NlmUniqueID><ISSNLinking>0020-1669</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29792414</ArticleId><ArticleId IdType="doi">10.1021/acs.inorgchem.8b00907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29790950</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-217X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>07</Month><Day>01</Day></PubDate></JournalIssue><Title>GigaScience</Title><ISOAbbreviation>Gigascience</ISOAbbreviation></Journal><ArticleTitle>The research data management platform (RDMP): A novel, process driven, open-source tool for the management of longitudinal cohorts of clinical data.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/gigascience/giy060</ELocationID><Abstract><AbstractText Label="Background">The Health Informatics Centre at the University of Dundee provides a service to securely host clinical datasets and extract relevant data for anonymized cohorts to researchers to enable them to answer key research questions. As is common in research using routine healthcare data, the service was historically delivered using ad-hoc processes resulting in the slow provision of data whose provenance was often hidden to the researchers using it. This paper describes the development and evaluation of the Research Data Management Platform (RDMP): an open source tool to load, manage, clean, and curate longitudinal healthcare data for research and provide reproducible and updateable datasets for defined cohorts to researchers.</AbstractText><AbstractText Label="Results">Between 2013 and 2017, RDMP tool implementation tripled the productivity of data analysts producing data releases for researchers from 7.1 to 25.3 per month and reduced the error rate from 12.7% to 3.1%. The effort on data management reduced from a mean of 24.6 to 3.0 hours per data release. The waiting time for researchers to receive data after agreeing a specification reduced from approximately 6 months to less than 1 week. The software is scalable and currently manages 163 datasets. A total 1,321 data extracts for research have been produced, with the largest extract linking data from 70 different datasets.</AbstractText><AbstractText Label="Conclusions">The tools and processes that encompass the RDMP not only fulfil the research data management requirements of researchers but also support the seamless collaboration of data cleaning, data transformation, data summarization and data quality assessment activities by different research groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nind</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galloway</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAllister</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scobbie</LastName><ForeName>Donald</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Edinburgh Parallel Computing Centre, James Clerk Maxwell Building, Peter Guthrie Tait Road, Edinburgh, EH9 3FD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonney</LastName><ForeName>Wilfred</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tramma</LastName><ForeName>Leandro</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reel</LastName><ForeName>Parminder</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groves</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appleby</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doney</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guthrie</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Mail Box 15, Ninewells Hospital &amp; Medical School, Dundee, DD1 9SY, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M501633/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gigascience</MedlineTA><NlmUniqueID>101596872</NlmUniqueID><ISSNLinking>2047-217X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003199" MajorTopicYN="Y">Computer Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="Y">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011381" MajorTopicYN="N">Programming Languages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012606" MajorTopicYN="N">Scotland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014495" MajorTopicYN="N">Universities</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29790950</ArticleId><ArticleId IdType="pii">5001426</ArticleId><ArticleId IdType="doi">10.1093/gigascience/giy060</ArticleId><ArticleId IdType="pmc">PMC6041881</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Biomed Inform. 2009 Apr;42(2):377-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Aug 4;536(7614):41-47</Citation><ArticleIdList><ArticleId IdType="pubmed">27398621</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2000 Jun 15;69(11):2449-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10868658</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Bot. 2000 Jun;87(6):769-73</Citation><ArticleIdList><ArticleId IdType="pubmed">10860907</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2014 Apr 07;2014:96-101</Citation><ArticleIdList><ArticleId IdType="pubmed">25717408</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2002 Nov 12;65(3):225-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12414020</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2017;234:29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">28186011</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Dec;47(12):1415-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26551672</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Mar-Apr;17(2):124-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2018 Apr 1;47(2):380-381j</Citation><ArticleIdList><ArticleId IdType="pubmed">29025058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2018 Jul 1;7(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">29790950</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Mar 24;374(12):1134-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26934567</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2012;2012:552-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23304327</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:6-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24303286</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2009 Nov 14;2009:391-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20351886</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Mar 17;374(11):1053-64</Citation><ArticleIdList><ArticleId IdType="pubmed">26981935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29773698</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Protocol for the validation of sensitivity and specificity of the Cow's Milk-related Symptom Score (CoMiSS) against open food challenge in a single-blinded, prospective, multicentre trial in infants.</ArticleTitle><Pagination><MedlinePgn>e019968</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2017-019968</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The symptoms of cow's milk protein allergy (CMPA) in infancy can be non-specific which may delay a correct diagnosis and cause adverse clinical outcomes. The diagnosis of non-IgE-mediated CMPA is particularly complex as it involves a 2 to 4 week elimination diet followed by oral food challenge (OFC). The Cow's Milk-related Symptom Score (CoMiSS) is a clinical resource for primary healthcare providers which aims to increase awareness of CMPA symptoms to facilitate an earlier diagnosis. The aim of the present study is to assess if the CoMiSS can be used as a potential diagnostic tool in infants with suspected CMPA.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">Exclusively formula-fed infants aged 0-6 months presenting with symptoms suggestive of CMPA will be included in this prospective, multicentre trial which will be conducted in 10 centres in China. All infants will commence a 2-week trial of an amino acid-based formula (AAF) while eliminating all cow milk protein from their diets. After the AAF treatment period, infants will undergo an open OFC in hospital with standard cow's milk formula, followed by an open home challenge for another 2 weeks. Clinical symptoms will be documented on standardised symptom scorecards. The CoMiSS will be determined at study entry (CoMiSS 1, before the start of the AAF), after 2 weeks (CoMiSS 2, before the OFC) and after a further period of 2 weeks or when symptoms suggestive of CMPA reappear (CoMiSS 3). Weight and length will be measured at each visit. The difference between CoMiSS 1 and 2 as a predictor of the OFC outcome will also be assessed. The diagnostic accuracy of the baseline CoMiSS will be calculated.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">The study was approved by the Hunan Children's Hospital Medical Ethics Committee, Hunan, China. The findings of this trial will be submitted for publication in a peer-reviewed journal in paediatric nutrition or gastroenterology. Abstracts will be submitted to the relevant national and international conferences.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT03004729; Pre-results.</AbstractText><CopyrightInformation>© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vandenplas</LastName><ForeName>Yvan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Kidz Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Rajat</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cytel Software Corp, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hôpital Necker-Enfants Malades, Université de Paris Descartes, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinique Pédiatrique Saint Antoine, Hôpital Saint Vincent de Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eigenmann</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Paediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Høst</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuitunen</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribes-Koninkx</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paediatric Gastroenterology and Hepatology Unit, La Fe University Hospital, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Great Ormond Street Hospital for Children, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szajewska</LastName><ForeName>Hania</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Berg</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Research Institute, Marien-Hospital, Wezel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heine</LastName><ForeName>Ralf G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Nestle Health Science, Vevey, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zheng-Yan</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Children's Hospital Zhejiang, University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>on behalf the Chinese CoMiSS Investigator Team.</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03004729</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000485">Allergens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000485" MajorTopicYN="N">Allergens</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016269" MajorTopicYN="N">Milk Hypersensitivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054928" MajorTopicYN="N">Validation Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">cow’s milk protein allergy</Keyword><Keyword MajorTopicYN="Y">diagnosis</Keyword><Keyword MajorTopicYN="Y">infant</Keyword><Keyword MajorTopicYN="Y">study design</Keyword><Keyword MajorTopicYN="Y">symptom score</Keyword><Keyword MajorTopicYN="Y">validation</Keyword></KeywordList><CoiStatement>Competing interests: PE has received lecture honoraria from Danone and Sodilac and research grants from Nestlé. AH has received honoraria for lectures for Danone and Nestlé. CR-K has participated as consultant and/or speaker for Mead Johnson International, Hero Institute, Alter-Nutriben, Danone and Nestlé. NS is a member of the medical advisory board for Mead Johnson in the UK. HS has participated as a clinical investigator and/or speaker for Arla, Biogaia, Biocodex, Danone, Dicofarm, HiPP, Nestlé, Nestlé Nutrition Institute, Nutricia, Mead Johnson, Merck and Sequoia. YV has participated as a clinical investigator, and/or advisory board member, and/or consultant and/or speaker for Abbott Nutrition, Biocodex, Danone, Mead Johnson, Merck, Menarini, Nestlé Health Science, Nestlé Nutrition Institute, Nutricia, Phacobel, Sari Husada, Sucampo, United Pharmaceuticals and Yakult. RGH is an employee of Nestlé Health Science.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Tong</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liyan</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Jieling</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Shufen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao Qin</ForeName><Initials>XQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Jinjin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhenyang</ForeName><Initials>Z</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29773698</ArticleId><ArticleId IdType="pii">bmjopen-2017-019968</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2017-019968</ArticleId><ArticleId IdType="pmc">PMC5961578</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Dis Child. 2007 Oct;92(10):902-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17895338</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2013 Oct;102(10):990-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23837862</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr. 2009 Aug;168(8):891-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19271238</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2015 Dec;70(12):1679-80</Citation><ArticleIdList><ArticleId IdType="pubmed">26769086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):221-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22569527</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2016 Mar;105(3):253-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26666845</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2014 Apr;48:193-204</Citation><ArticleIdList><ArticleId IdType="pubmed">24582925</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2015 Apr;104(4):334-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25557474</ArticleId></ArticleIdList></Reference><Reference><Citation>World Allergy Organ J. 2010 Apr;3(4):57-161</Citation><ArticleIdList><ArticleId IdType="pubmed">23268426</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr. 1994 Jun;153(6):419-23</Citation><ArticleIdList><ArticleId IdType="pubmed">8088297</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):22-26</Citation><ArticleIdList><ArticleId IdType="pubmed">28401052</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Gastroenterol. 1997 Sep;32(9):920-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9299672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29752199</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3026</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Lancet. Haematology</Title><ISOAbbreviation>Lancet Haematol</ISOAbbreviation></Journal><ArticleTitle>Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial.</ArticleTitle><Pagination><MedlinePgn>e261-e269</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2352-3026(18)30054-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-3026(18)30054-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The combination of rituximab, gemcitabine, and oxaliplatin (R-GemOx) has shown high efficacy with a low toxicity profile in elderly patients with relapsed and refractory diffuse large B-cell lymphoma. We aimed to evaluate the efficacy, safety, and feasibility of the R-GemOx regimen as a first-line treatment in elderly patients with diffuse large B-cell lymphoma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this single-arm, open-label, phase 2 clinical trial, we enrolled patients with previously untreated, histologically confirmed, CD20-positive diffuse large B-cell lymphoma, aged 70 years or older, or aged 60-69 years with an Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or greater. Patients were recruited from Jiangsu Province Hospital (Jiangsu Sheng, China). The R-GemOx regimen was administered intravenously: rituximab 375 mg/m<sup>2</sup> on day 0; gemcitabine 1 g/m<sup>2</sup> on day 1; and oxaliplatin 100 mg/m<sup>2</sup> on day 1. The cycle was repeated every 14 days. Six cycles were planned if the patient achieved at least partial remission after the interim assessment. The primary endpoint was the proportion of patients who achieved an overall response at the end of treatment (defined as complete response plus partial response). Analyses were done by intention to treat. The trial is ongoing but no longer recruiting patients. This study is registered with ClinicalTrials.gov, number NCT01670370.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Between Aug 22, 2012, and Dec 31, 2015, 60 patients were enrolled and included in the study. The median age of the patients was 75 years (IQR 70-80) and 27 (45%) patients had a poor performance status with an ECOG score of 2 or greater. 45 (75%) patients achieved an overall response at the end of the treatment, with 28 (47%) achieving a complete response. Common grade 3-4 adverse events were haematological toxicities (thrombocytopenia in five [8%] patients, anaemia in four [7%], and neutropenia in nine [15%]) and gastrointestinal complications (nausea in five [8%] patients, vomiting in three [5%], and diarrhoea in one [2%]). No treatment-related deaths were reported.</AbstractText><AbstractText Label="INTERPRETATIONS" NlmCategory="CONCLUSIONS">The R-GemOx regimen shows high efficacy and safety as a front-line treatment in an elderly patient subpopulation and might be a therapeutic option for management of diffuse large B-cell lymphoma in elderly patients.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">National Natural Science Foundation of China, Jiangsu Province's Medical Elite Programme, Project of National Key Clinical Specialty, National Science &amp; Technology Pillar Program, Jiangsu Provincial Special Program of Medical, and National Science and Technology Major Project.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Qiu-Dan</ForeName><Initials>QD</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hua-Yuan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jin-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian-Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China; Key Laboratory of Haematology of Nanjing Medical University, Nanjing, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China. Electronic address: xuwei10000@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01670370</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Haematol</MedlineTA><NlmUniqueID>101643584</NlmUniqueID><ISSNLinking>2352-3026</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018951">Antigens, CD20</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009944">Organoplatinum Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>04ZR38536J</RegistryNumber><NameOfSubstance UI="D000077150">Oxaliplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W860991D6</RegistryNumber><NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>4F4X42SYQ6</RegistryNumber><NameOfSubstance UI="D000069283">Rituximab</NameOfSubstance></Chemical><Chemical><RegistryNumber>B76N6SBZ8R</RegistryNumber><NameOfSubstance UI="C056507">gemcitabine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018951" MajorTopicYN="N">Antigens, CD20</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016403" MajorTopicYN="N">Lymphoma, Large B-Cell, Diffuse</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009944" MajorTopicYN="N">Organoplatinum Compounds</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077150" MajorTopicYN="N">Oxaliplatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069283" MajorTopicYN="N">Rituximab</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29752199</ArticleId><ArticleId IdType="pii">S2352-3026(18)30054-1</ArticleId><ArticleId IdType="doi">10.1016/S2352-3026(18)30054-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29750858</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-3773</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>30</Issue><PubDate><Year>2018</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>Angewandte Chemie (International ed. in English)</Title><ISOAbbreviation>Angew Chem Int Ed Engl</ISOAbbreviation></Journal><ArticleTitle>A Metal-Organic Framework with Cooperative Phosphines That Permit Post-Synthetic Installation of Open Metal Sites.</ArticleTitle><Pagination><MedlinePgn>9295-9299</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201802402</ELocationID><Abstract><AbstractText>PCM-101 is a phosphine coordination material comprised of tris(p-carboxylato)triphenylphosphine and secondary pillaring groups coordinated to [M<sub>3</sub> (OH)]<sup>5+</sup> nodes (M=Co, Ni). PCM-101 has a unique topology in which R<sub>3</sub> P: sites are arranged directly trans to one another, with a P⋅⋅⋅P separation distance dictated by the pillars. Post-synthetic coordination of soft metals to the P: sites proceeds at room temperature to provide X-ray quality crystals that permit full structural resolution. Addition of AuCl groups forces a large distortion of the parent framework. In contrast, CuBr undergoes insertion directly between the trans-P sites to form dimers that mimic solution-phase complexes, but that are geometrically strained due to steric pressure exerted by the MOF scaffold. The metalated materials are active in heterogeneous hydroaddition catalysis under mild conditions, yielding different major products compared to their molecular counterparts.</AbstractText><CopyrightInformation>© 2018 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dunning</LastName><ForeName>Samuel G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nandra</LastName><ForeName>Gianne</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conn</LastName><ForeName>Adam D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Wenrui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikma</LastName><ForeName>R Eric</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji Sun</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Research Center for Nanocatalysts, Korea Research Institute of Chemical Technology, P.O. Box 107, Yusung, Daejeon, 305-600, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunal</LastName><ForeName>Pranaw</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jong-San</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Research Center for Nanocatalysts, Korea Research Institute of Chemical Technology, P.O. Box 107, Yusung, Daejeon, 305-600, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Sungkyunkwan University, Suwon, 440-476, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Liverpool, Crown St., Liverpool, L69 7ZD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henkelman</LastName><ForeName>Graeme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Simon M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5379-4623</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, The University of Texas at Austin, 105 E 24th Street A5300, Welch Hall 2.204, Austin, TX, 78712-1224, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angew Chem Int Ed Engl</MedlineTA><NlmUniqueID>0370543</NlmUniqueID><ISSNLinking>1433-7851</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">copper</Keyword><Keyword MajorTopicYN="N">gold</Keyword><Keyword MajorTopicYN="N">heterogeneous catalysis</Keyword><Keyword MajorTopicYN="N">metal-organic frameworks</Keyword><Keyword MajorTopicYN="N">phosphorus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29750858</ArticleId><ArticleId IdType="doi">10.1002/anie.201802402</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29745059</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>10</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial.</ArticleTitle><Pagination><MedlinePgn>1557-1564</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.40546</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate, from a societal perspective, the incremental cost-effectiveness of withdrawing tumor necrosis factor inhibitor (TNFi) treatment compared to continuation of these drugs within a 1-year, randomized trial among rheumatoid arthritis patients with longstanding, stable disease activity or remission.</AbstractText><AbstractText Label="METHODS">Data were collected from a pragmatic, open-label trial. Cost-utility analysis was performed using the nonparametric bootstrapping method, and a cost-effectiveness acceptability curve was constructed using the net-monetary benefit framework, where a willingness-to-accept threshold (WTA) was defined as the minimal cost saved that a patient accepted for each quality-adjusted life year (QALY) lost.</AbstractText><AbstractText Label="RESULTS">A total of 531 patients were randomized to the stop group and 286 patients to the continuation group. Withdrawal of TNFi treatment resulted in a &gt;60% reduction of the total drug cost, but led to an increase of ∼30% in other health care expenditures. Compared to continuation, stopping TNFi resulted in a mean yearly cost saving of €7,133 (95% confidence interval [95% CI] €6,071, €8,234]) and was associated with a mean loss of QALYs of 0.02 (95% CI 0.002, 0.040). Mean saved cost per QALY lost and per extra flare incurred in the stop group compared to the continuation group was €368,269 (95% CI €155,132, €1,675,909) and €17,670 (95% CI €13,650, €22,721), respectively. At a WTA of €98,438 per QALY lost, the probability that stopping TNFi treatment is cost-effective was 100%.</AbstractText><AbstractText Label="CONCLUSION">Although an official WTA is not defined, the mean saved cost of €368,269 per QALY lost seems acceptable in The Netherlands, given existing data on willingness to pay.</AbstractText><CopyrightInformation>© 2018, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran-Duy</LastName><ForeName>An</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiti Moghadam</LastName><ForeName>Marjan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oude Voshaar</LastName><ForeName>Martijn A H</ForeName><Initials>MAH</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonkeman</LastName><ForeName>Harald E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonen</LastName><ForeName>Annelies</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center and Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McColl</LastName><ForeName>Geoff</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ten Klooster</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijlstra</LastName><ForeName>T R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Isala Medical Center, Zwolle, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lems</LastName><ForeName>Willem F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>VU University Medical Center and Reade Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riyazi</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Haga Medical Center, The Hague, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griep</LastName><ForeName>E N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Antonius Medical Center, Sneek, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hazes</LastName><ForeName>J M W</ForeName><Initials>JMW</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landewé</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>AMC Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernelot Moens</LastName><ForeName>Hein J</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-6190-3196</Identifier><AffiliationInfo><Affiliation>Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Riel</LastName><ForeName>Piet L C M</ForeName><Initials>PLCM</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Laar</LastName><ForeName>Mart A F J</ForeName><Initials>MAFJ</Initials><AffiliationInfo><Affiliation>Arthritis Center Twente, Medisch Spectrum Twente, and University of Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>T L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Viecurie Medical Center, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch National POET Collaboration</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>NTR</DataBankName><AccessionNumberList><AccessionNumber>NTR3112</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016527" MajorTopicYN="N">Drug Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064792" MajorTopicYN="N">Pragmatic Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028761" MajorTopicYN="N">Withholding Treatment</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29745059</ArticleId><ArticleId IdType="doi">10.1002/art.40546</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29740681</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>09</Month></PubDate></JournalIssue><Title>Environmental management</Title><ISOAbbreviation>Environ Manage</ISOAbbreviation></Journal><ArticleTitle>Mitigating Undesignated Trail Use: The Efficacy of Messaging and Direct Site Management Actions in an Urban-Proximate Open Space Context.</ArticleTitle><Pagination><MedlinePgn>458-473</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00267-018-1054-1</ELocationID><Abstract><AbstractText>The use and creation of undesignated recreational trails can lead to erosion, vegetation damage, unsafe trail conditions, and impacts to local wildlife. The mitigation of undesignated trail use is typically addressed indirectly through minimum-impact visitor education programs such as Leave No Trace, or directly through closures or sanctions. In this study, researchers collaborated with City of Boulder, Colorado Open Space and Mountain Parks (OSMP) staff to develop a quasi-experimental field study that examined the effectiveness of indirect (messaging) and direct (barriers) management approaches to mitigating undesignated trail use. The study applied a Theory of Planned Behavior framework, utilized Leave No Trace messaging, and employed a method to pair survey and direct observation data. A total of 2232 visitor parties were observed, and 147 surveys were collected. The combined direct (barrier) and indirect (messaging) intervention was the most effective at mitigating undesignated trail use. Implications for management and future research are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1554-8733</Identifier><AffiliationInfo><Affiliation>Postdoctoral Scholar, Recreation, Park, and Tourism Management Department, Pennsylvania State University, 801 Ford Building, University Park, State College, PA, 16802, USA. fgs117@psu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taff</LastName><ForeName>B D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Assistant Professor, Recreation, Park, and Tourism Management Department, Pennsylvania State University, 801 Ford Building, University Park, State College, PA, 16802, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawhon</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Education Director, Leave No Trace Center for Outdoor Ethics, 1000 North St, Boulder, CO, 80306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanderWoude</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Human Dimensions Program Supervisor, City of Boulder Open Space and Mountain Parks, 66S. Cherryvale Road, Boulder, CO, 80303, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Environ Manage</MedlineTA><NlmUniqueID>7703893</NlmUniqueID><ISSNLinking>0364-152X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003120" MajorTopicYN="N" Type="Geographic">Colorado</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003247" MajorTopicYN="Y">Conservation of Natural Resources</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068316" MajorTopicYN="Y">Parks, Recreational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011998" MajorTopicYN="Y">Recreation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">environmental communication</Keyword><Keyword MajorTopicYN="Y">leave no trace</Keyword><Keyword MajorTopicYN="Y">park management</Keyword><Keyword MajorTopicYN="Y">recreational impact</Keyword><Keyword MajorTopicYN="Y">theory of planned behavior</Keyword><Keyword MajorTopicYN="Y">visitor education</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29740681</ArticleId><ArticleId IdType="doi">10.1007/s00267-018-1054-1</ArticleId><ArticleId IdType="pii">10.1007/s00267-018-1054-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annu Rev Psychol. 1980;31:457-501</Citation><ArticleIdList><ArticleId IdType="pubmed">20809783</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Manage. 2015 Sep;56(3):765-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25900602</ArticleId></ArticleIdList></Reference><Reference><Citation>J Environ Manage. 2017 Mar 15;189:46-57</Citation><ArticleIdList><ArticleId IdType="pubmed">28006733</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Soc Psychol. 2001 Dec;40(Pt 4):471-99</Citation><ArticleIdList><ArticleId IdType="pubmed">11795063</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Manage. 2000 Dec;26(6):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11029110</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Manage. 2011 Jan;47(1):93-106</Citation><ArticleIdList><ArticleId IdType="pubmed">21103872</ArticleId></ArticleIdList></Reference><Reference><Citation>J Environ Manage. 2015 Oct 1;162:53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26225933</ArticleId></ArticleIdList></Reference><Reference><Citation>J Environ Manage. 2003 Jun;68(2):207-18</Citation><ArticleIdList><ArticleId IdType="pubmed">12781760</ArticleId></ArticleIdList></Reference><Reference><Citation>J Environ Manage. 2011 Mar;92(3):1012-22</Citation><ArticleIdList><ArticleId IdType="pubmed">21129844</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Soc Psychol. 2002 Mar;41(Pt 1):101-21</Citation><ArticleIdList><ArticleId IdType="pubmed">11970777</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Health. 2011 Sep;26(9):1113-27</Citation><ArticleIdList><ArticleId IdType="pubmed">21929476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29739427</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>05</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Open innovation and external sources of innovation. An opportunity to fuel the R&amp;D pipeline and enhance decision making?</ArticleTitle><Pagination><MedlinePgn>119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-018-1499-2</ELocationID><Abstract><AbstractText>Historically, research and development (R&amp;D) in the pharmaceutical sector has predominantly been an in-house activity. To enable investments for game changing late-stage assets and to enable better and less costly go/no-go decisions, most companies have employed a fail early paradigm through the implementation of clinical proof-of-concept organizations. To fuel their pipelines, some pioneers started to complement their internal R&amp;D efforts through collaborations as early as the 1990s. In recent years, multiple extrinsic and intrinsic factors induced an opening for external sources of innovation and resulted in new models for open innovation, such as open sourcing, crowdsourcing, public-private partnerships, innovations centres, and the virtualization of R&amp;D. Three factors seem to determine the breadth and depth regarding how companies approach external innovation: (1) the company's legacy, (2) the company's willingness and ability to take risks and (3) the company's need to control IP and competitors. In addition, these factors often constitute the major hurdles to effectively leveraging external opportunities and assets. Conscious and differential choices of the R&amp;D and business models for different companies and different divisions in the same company seem to best allow a company to fully exploit the potential of both internal and external innovations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuhmacher</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7884-5757</Identifier><AffiliationInfo><Affiliation>Reutlingen University, Alteburgstrasse 150, 72762, Reutlingen, Germany. alexander.schuhmacher@reutlingen-university.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gassmann</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute for Technology Management, University of St. Gallen, Dufourstrasse 40a, 9000, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCracken</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Debiopharm International S.A., Chemin Messidor 5-7, 1002, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinder</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Novartis Institutes for BioMedical Research, Postfach, Forum 1, 4002, Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D063045" MajorTopicYN="N">Crowdsourcing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062069" MajorTopicYN="Y">Inventions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019359" MajorTopicYN="N">Knowledge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="Y">Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Crowdsourcing</Keyword><Keyword MajorTopicYN="Y">Knowledge leverager</Keyword><Keyword MajorTopicYN="Y">Open innovation</Keyword><Keyword MajorTopicYN="Y">Pharmaceutical industry</Keyword><Keyword MajorTopicYN="Y">Public–private partnerships</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29739427</ArticleId><ArticleId IdType="doi">10.1186/s12967-018-1499-2</ArticleId><ArticleId IdType="pii">10.1186/s12967-018-1499-2</ArticleId><ArticleId IdType="pmc">PMC5941640</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drug Discov Today. 2011 Apr;16(7-8):288-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21129498</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):545-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23136843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2009 Dec;8(12 ):959-68</Citation><ArticleIdList><ArticleId IdType="pubmed">19949401</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2014 Mar;19(3):348-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24291787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 11;533(7602):S62-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27167394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2011 Apr;10(4):241-2</Citation><ArticleIdList><ArticleId IdType="pubmed">21455221</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2013 Dec;18(23-24):1133-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23892183</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Med. 2008;59:1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">18186700</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2004 Dec;1(3):e56</Citation><ArticleIdList><ArticleId IdType="pubmed">15630466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 Jul;28(7):631-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20622810</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2016 Jul 15;17 (8):470-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27418159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Nov;31(11):979-85</Citation><ArticleIdList><ArticleId IdType="pubmed">24213770</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2008 May;31(5):924-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18448501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2006 Sep;5(9):723-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16915233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Jan;14(1):74-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25430867</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2012;6(9):e1827</Citation><ArticleIdList><ArticleId IdType="pubmed">23029588</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Jan;14 (1):1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">25503331</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2016 Apr 27;14 (1):105</Citation><ArticleIdList><ArticleId IdType="pubmed">27118048</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Med Chem. 2014;14(3):294-303</Citation><ArticleIdList><ArticleId IdType="pubmed">24283973</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Parasitol. 2006 Jul;22(7):301-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16757213</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Apr 11;300(5617):286-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12690187</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2012 Nov;17(21-22):1188-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22683805</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2017 Feb 15;15(2):e2001387</Citation><ArticleIdList><ArticleId IdType="pubmed">28199324</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2008 May;13(9-10):371-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18468553</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2011 Oct;66(10):910-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21106547</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3355</Citation><ArticleIdList><ArticleId IdType="pubmed">25569251</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2010 Sep;15(17-18):693-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20685343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2017 May;16(5):367</Citation><ArticleIdList><ArticleId IdType="pubmed">28417984</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2013 Nov 27;6:e201303017</Citation><ArticleIdList><ArticleId IdType="pubmed">24688725</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Jan;14(1):17-28</Citation><ArticleIdList><ArticleId IdType="pubmed">25503514</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2010 Mar;9(3):203-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20168317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 May 2;373(9674):1507-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19410700</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2012 Mar 06;18(3):341</Citation><ArticleIdList><ArticleId IdType="pubmed">22395691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Feb;14 (2):75-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25633780</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2016 Jan;17 (1):23-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25888696</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Med. 2013 Jan 15;2(1):2</Citation><ArticleIdList><ArticleId IdType="pubmed">23369569</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 11;533(7602):S54-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27167390</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2017 Apr 18;14 (4):e1002276</Citation><ArticleIdList><ArticleId IdType="pubmed">28419094</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2015 Nov;20(11):1310-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26429298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29720113</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment.</ArticleTitle><Pagination><MedlinePgn>510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4404-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge of emetic pathways. High rates of N/V control have been reported using both etiology-based guideline-driven antiemetic regimens and an empiric approach using single agents in uncontrolled studies. These different approaches had never been formally compared.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This randomized, prospective, open label, dose-escalating study used readily available antiemetics in accordance with etiology-based guidelines or single agent therapy with haloperidol. Participants had a baseline average nausea score of ≥3/10. Response was defined as a ≥ 2/10 point reduction on a numerical rating scale of average nausea score with a final score &lt; 3/10 at 72 h.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nausea scores and distress from nausea improved over time in the majority of the 185 patients randomized. For those who completed each treatment day, a greater response rate was seen in the guideline arm than the single agent arm at 24 h (49% vs 32%; p = 0.02), but not at 48 or 72 h. Response rates at 72 h in the intention to treat analysis were 49 and 53% respectively, with no significant difference between arms (0·04; 95% CI: -0·11, 0·19; p = 0·59). Over 80% of all participants reported an improved global impression of change. There were few adverse events worse than baseline in either arm.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An etiology-based, guideline-directed approach to antiemetic therapy may offer more rapid benefit, but is no better than single agent treatment with haloperidol at 72 h.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">Australian New Zealand Clinical Trials Registry: ANZCTRN12610000481077 .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mater Misericordiae Limited, Mater Research - University of Queensland, Raymond Terrace, Brisbane, QLD, 4101, Australia. Janet.Hardy@mater.org.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Palliative and Supportive Care, Mater Health Services, Raymond Terrace, South Brisbane, QLD, 4101, Australia. Janet.Hardy@mater.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skerman</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Health and Biomedical Innovation (IHBI), Faculty of Health, Queensland University of Technology, Level 7, Q Block, Kelvin Grove Campus, Brisbane, QLD, 4059, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glare</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pain Management Research Institute, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Vincent's Hospital and the University of Melbourne, Fitzroy, VIC, 3065, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudson</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Vincent's Hospital &amp; Collaborative Centre of The University of Melbourne, PO Box 2900, Fitzroy, VIC, 3065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Barwon Health McKellar Centre, 45-95 Ballarat Rd, North Geelong, VIC, 3215, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spruyt</LastName><ForeName>Odette</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Currow</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Health, University of Technology, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yates</LastName><ForeName>Patsy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Queensland University of Technology, VIC Park Rd, Kelvin Grove, QLD, 4059, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>614247</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="N">Antiemetics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiemetic</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Nausea</Keyword><Keyword MajorTopicYN="N">Palliative care</Keyword><Keyword MajorTopicYN="N">Vomiting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29720113</ArticleId><ArticleId IdType="doi">10.1186/s12885-018-4404-8</ArticleId><ArticleId IdType="pii">10.1186/s12885-018-4404-8</ArticleId><ArticleId IdType="pmc">PMC5932901</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Support Care Cancer. 2006 Apr;14 (4):348-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16228185</ArticleId></ArticleIdList></Reference><Reference><Citation>J Support Oncol. 2013 Mar;11(1):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23137588</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 14;375(2):134-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27410922</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2000 Aug;20(2):104-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10989248</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Palliat Care. 2005 Nov 12;4:7</Citation><ArticleIdList><ArticleId IdType="pubmed">16283937</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2003 Mar;56(3):221-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12725876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2006 Jan;31(1):58-69</Citation><ArticleIdList><ArticleId IdType="pubmed">16442483</ArticleId></ArticleIdList></Reference><Reference><Citation>Palliat Med. 2001 May;15(3):247-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11407196</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8433390</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Care. 2000 Autumn;16(3):16-21</Citation><ArticleIdList><ArticleId IdType="pubmed">11019503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2010 May;21 Suppl 5:v232-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20555089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Care. 1993 Summer;9(2):19-21</Citation><ArticleIdList><ArticleId IdType="pubmed">8397302</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 2010;96:175-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20884654</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2004 Jun;12(6):432-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15108099</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2005 Sep;13(9):715-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15700129</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2005 Jul 15;76(2-3):247-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15949657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain Symptom Manage. 2010 Jul;40(1):111-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20619214</ArticleId></ArticleIdList></Reference><Reference><Citation>J Palliat Med. 2013 Nov;16(11):1335-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24138282</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2017 Jan;25(1):333-340</Citation><ArticleIdList><ArticleId IdType="pubmed">27534961</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain. 2001 Nov;94(2):149-58</Citation><ArticleIdList><ArticleId IdType="pubmed">11690728</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2013 Mar;21(3):735-48</Citation><ArticleIdList><ArticleId IdType="pubmed">22976921</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 1998 Nov;6(6):539-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9833305</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29712627</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>04</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>A Remote Collaborative Care Program for Patients with Depression Living in Rural Areas: Open-Label Trial.</ArticleTitle><Pagination><MedlinePgn>e158</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/jmir.8803</ELocationID><Abstract><AbstractText Label="BACKGROUND">In the treatment of depression, primary care teams have an essential role, but they are most effective when inserted into a collaborative care model for disease management. In rural areas, the shortage of specialized mental health resources may hamper management of depressed patients.</AbstractText><AbstractText Label="OBJECTIVE">The aim was to test the feasibility, acceptability, and effectiveness of a remote collaborative care program for patients with depression living in rural areas.</AbstractText><AbstractText Label="METHODS">In a nonrandomized, open-label (blinded outcome assessor), two-arm clinical trial, physicians from 15 rural community hospitals recruited 250 patients aged 18 to 70 years with a major depressive episode (DSM-IV criteria). Patients were assigned to the remote collaborative care program (n=111) or to usual care (n=139). The remote collaborative care program used Web-based shared clinical records between rural primary care teams and a specialized/centralized mental health team, telephone monitoring of patients, and remote supervision by psychiatrists through the Web-based shared clinical records and/or telephone. Depressive symptoms, health-related quality of life, service use, and patient satisfaction were measured 3 and 6 months after baseline assessment.</AbstractText><AbstractText Label="RESULTS">Six-month follow-up assessments were completed by 84.4% (221/250) of patients. The remote collaborative care program achieved higher user satisfaction (odds ratio [OR] 1.94, 95% CI 1.25-3.00) and better treatment adherence rates (OR 1.81, 95% CI 1.02-3.19) at 6 months compared to usual care. There were no statically significant differences in depressive symptoms between the remote collaborative care program and usual care. Significant differences between groups in favor of remote collaborative care program were observed at 3 months for mental health-related quality of life (beta 3.11, 95% CI 0.19-6.02).</AbstractText><AbstractText Label="CONCLUSIONS">Higher rates of treatment adherence in the remote collaborative care program suggest that technology-assisted interventions may help rural primary care teams in the management of depressive patients. Future cost-effectiveness studies are needed.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Clinicaltrials.gov NCT02200367; https://clinicaltrials.gov/ct2/show/NCT02200367 (Archived by WebCite at http://www.webcitation.org/6xtZ7OijZ).</AbstractText><CopyrightInformation>©Graciela Rojas, Viviana Guajardo, Pablo Martínez, Ariel Castro, Rosemarie Fritsch, Markus Moessner, Stephanie Bauer. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 30.04.2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Graciela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9577-7415</Identifier><AffiliationInfo><Affiliation>Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Milenio para la Investigación en Depresión y Personalidad (MIDAP), Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guajardo</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3906-5584</Identifier><AffiliationInfo><Affiliation>Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Milenio para la Investigación en Depresión y Personalidad (MIDAP), Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4482-7993</Identifier><AffiliationInfo><Affiliation>Instituto Milenio para la Investigación en Depresión y Personalidad (MIDAP), Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela de Psicología, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Innovación en Tecnologías de la Información para Aplicaciones Sociales (CITIAPS), Universidad de Santiago de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4729-4889</Identifier><AffiliationInfo><Affiliation>Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritsch</LastName><ForeName>Rosemarie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7694-1470</Identifier><AffiliationInfo><Affiliation>Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moessner</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1215-1055</Identifier><AffiliationInfo><Affiliation>Center for Psychotherapy Research, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7508-6521</Identifier><AffiliationInfo><Affiliation>Center for Psychotherapy Research, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02200367</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073919" MajorTopicYN="N">Interdisciplinary Placement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">depression</Keyword><Keyword MajorTopicYN="Y">medically underserved area</Keyword><Keyword MajorTopicYN="Y">primary health care</Keyword><Keyword MajorTopicYN="Y">rural health care</Keyword><Keyword MajorTopicYN="Y">telemedicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29712627</ArticleId><ArticleId IdType="pii">v20i4e158</ArticleId><ArticleId IdType="doi">10.2196/jmir.8803</ArticleId><ArticleId IdType="pmc">PMC5952120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Screen. 2013;20(3):118-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24080916</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2012 Aug;169(8):790-804</Citation><ArticleIdList><ArticleId IdType="pubmed">22772364</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2002 Mar 8;16(4):605-13</Citation><ArticleIdList><ArticleId IdType="pubmed">11873004</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2001 Mar;178:228-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11230033</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rural Health. 2018 Dec;34(1):48-62</Citation><ArticleIdList><ArticleId IdType="pubmed">28084667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Chil. 2007 May;135(5):587-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17657327</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Aug;163(8):1379-87</Citation><ArticleIdList><ArticleId IdType="pubmed">16877650</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Chil. 2002 May;130(5):527-36</Citation><ArticleIdList><ArticleId IdType="pubmed">12143273</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2017 Apr;32(4):404-410</Citation><ArticleIdList><ArticleId IdType="pubmed">28243873</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation><ArticleIdList><ArticleId IdType="pubmed">9881538</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Sep 29;9(9):e108114</Citation><ArticleIdList><ArticleId IdType="pubmed">25264616</ArticleId></ArticleIdList></Reference><Reference><Citation>Implement Sci. 2013 Nov 16;8:135</Citation><ArticleIdList><ArticleId IdType="pubmed">24238225</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1961 Jun;4:561-71</Citation><ArticleIdList><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Apr;170(4):414-25</Citation><ArticleIdList><ArticleId IdType="pubmed">23429924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Mar 22;361(9362):995-1000</Citation><ArticleIdList><ArticleId IdType="pubmed">12660056</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2007 Aug;22(8):1086-93</Citation><ArticleIdList><ArticleId IdType="pubmed">17492326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Panam Salud Publica. 2005 Oct-Nov;18(4-5):229-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16354419</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29698120</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8100</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>Omics : a journal of integrative biology</Title><ISOAbbreviation>OMICS</ISOAbbreviation></Journal><ArticleTitle>Use of Free/Libre Open Source Software in Sepsis "-Omics" Research: A Bibliometric, Comparative Analysis Among the United States, EU-28 Member States, and China.</ArticleTitle><Pagination><MedlinePgn>365-372</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/omi.2018.0032</ELocationID><Abstract><AbstractText>"-Omics" systems sciences are at the epicenter of personalized medicine and public health, and drivers of knowledge-based biotechnology innovation. Bioinformatics, a core component of omics research, is one of the disciplines that first employed Free/Libre Open Source Software (FLOSS), and thus provided a fertile ground for its further development. Understanding the use and characteristics of FLOSS deployed in the omics field is valuable for future innovation strategies, policy and funding priorities. We conducted a bibliometric, longitudinal study of the use of FLOSS in sepsis omics research from 2011 to 2015 in the United States, EU-28 and China. Because sepsis is an interdisciplinary field at the intersection of multiple omics technologies and medical specialties, it was chosen as a model innovation ecosystem for this empirical analysis, which used publicly available data. Despite development of and competition from proprietary commercial software, scholars in omics continue to employ FLOSS routinely, and independent of the type of omics technology they work with. The number of articles using FLOSS increased significantly over time in the EU-28, as opposed to the United States and China (R = 0.96, p = 0.004). Furthermore, in an era where sharing of knowledge is being strongly advocated and promoted by public agencies and social institutions, we discuss possible correlations between the use of FLOSS and various funding sources in omics research. These observations and analyses provide new insights into the use of FLOSS in sepsis omics research across three (supra)national regions. Further benchmarking studies are warranted for FLOSS trends in other omics fields and geographical settings. These could, in time, lead to the development of new composite innovation and technology use metrics in omics systems sciences and bioinformatics communities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evangelatos</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>1 Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), Maastricht University , Maastricht, The Netherlands .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Intensive Care Medicine Unit, Department of Respiratory Medicine, Allergology and Sleep Medicine, Paracelsus Medical University , Nuremberg, Germany .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 Dr. TMA Pai Endowment Chair in Research Policy, Research Policy in Biomedical Sciences and Public Health, Prasanna School of Public Health (PSPH), Manipal University , Manipal, India .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satyamourthy</LastName><ForeName>Kapaettu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>4 Department of Biotechnology, School of Life Sciences, Manipal University , Manipal, India .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levidou</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>5 Department of Pathology, Klinikum Nuremberg, Paracelsus Medical University , Nuremberg, Germany .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Helmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>6 Department of International Health, Faculty of Health, Medicine and Life Sciences, Department of International Health, Maastricht University , Maastricht, The Netherlands .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Pia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>2 Intensive Care Medicine Unit, Department of Respiratory Medicine, Allergology and Sleep Medicine, Paracelsus Medical University , Nuremberg, Germany .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouskouti</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>7 Department of Obstetrics and Perinatal Medicine, Klinik Hallerwiese , Nuremberg, Germany .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT), Maastricht University , Maastricht, The Netherlands .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>8 Health Genomics, Manipal University , Manipal, India .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>OMICS</MedlineTA><NlmUniqueID>101131135</NlmUniqueID><ISSNLinking>1536-2310</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D022126" MajorTopicYN="N">Access to Information</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="N">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001709" MajorTopicYN="N">Biotechnology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">commons</Keyword><Keyword MajorTopicYN="Y">innovation and technology policy</Keyword><Keyword MajorTopicYN="Y">omics research trends</Keyword><Keyword MajorTopicYN="Y">open source software</Keyword><Keyword MajorTopicYN="Y">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29698120</ArticleId><ArticleId IdType="doi">10.1089/omi.2018.0032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29685678</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>07</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Prophylactic Mesh Reinforcement versus Sutured Closure to Prevent Incisional Hernias after Open Abdominal Aortic Aneurysm Repair via Midline Laparotomy: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><MedlinePgn>120-128</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(18)30162-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2018.03.021</ELocationID><Abstract><AbstractText Label="OBJECTIVE/BACKGROUND">Incisional hernia is a frequent late complication after open abdominal aortic aneurysm (AAA) repair. We aimed to determine whether prophylactic mesh reinforcement of the abdominal wall at open AAA repair via midline laparotomy reduces the rate of incisional hernia compared to standard sutured closure.</AbstractText><AbstractText Label="METHODS">A systematic review and meta-analysis was carried out in accordance with the PRISMA statement (PROSPERO registration CRD42017072508). Randomised controlled trials (RCTs) comparing prophylactic mesh reinforcement with standard sutured closure were eligible for inclusion. MEDLINE, Embase, and the Cochrane Library were searched. A meta-analysis with a random effects model was carried out to estimate pooled risk ratios (RR) with 95% confidence intervals (CIs) for the incidence of, and re-operation rate for, incisional hernias. Assessments of methodological quality, quality of evidence, and strength of recommendations were done with the Cochrane Collaboration's tool for assessing risk of bias and the GRADE approach.</AbstractText><AbstractText Label="RESULTS">Four RCTs with a total of 388 patients were included in the meta-analysis. Pooled analysis showed that mesh reinforcement significantly reduced the risk of incisional hernia after AAA repair compared with standard sutured closure (RR 0.27, 95% CI 0.11-0.66). The pooled rate of re-operations was not different between groups (RR 0.23, 95% CI 0.11-1.05). Mesh reinforcement did not cause more intra-operative or post-operative complications than sutured closure. The risk of bias in studies was low and the quality of evidence was rated as moderate.</AbstractText><AbstractText Label="CONCLUSION">Prophylactic mesh reinforcement of the abdominal wall after open AAA repair via midline laparotomy significantly reduces the risk of incisional hernia. However, no significant difference in re-operation for incisional hernia was found.</AbstractText><CopyrightInformation>Copyright © 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Indrakusuma</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. Electronic address: r.indrakusuma@amc.uva.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jalalzadeh</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Meij</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balm</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koelemay</LastName><ForeName>Mark J W</ForeName><Initials>MJW</Initials><AffiliationInfo><Affiliation>Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2018 Jul;56(1):129</RefSource><PMID Version="1">29739690</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2018 Sep;56(3):455</RefSource><PMID Version="1">30030053</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058107" MajorTopicYN="N">Abdominal Wound Closure Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046449" MajorTopicYN="N">Hernia, Abdominal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069290" MajorTopicYN="N">Incisional Hernia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013526" MajorTopicYN="Y">Surgical Mesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013536" MajorTopicYN="Y">Suture Techniques</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Abdominal aortic aneurysm</Keyword><Keyword MajorTopicYN="Y">Incisional hernia</Keyword><Keyword MajorTopicYN="Y">Operative surgical procedures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29685678</ArticleId><ArticleId IdType="pii">S1078-5884(18)30162-X</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2018.03.021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29684092</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.</ArticleTitle><Pagination><MedlinePgn>e0196239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0196239</ELocationID><Abstract><AbstractText Label="BACKGROUND">Weekends off antiretroviral therapy (ART) may help engage HIV-1-infected young people facing lifelong treatment. BREATHER showed short cycle therapy (SCT; 5 days on, 2 days off ART) was non-inferior to continuous therapy (CT) over 48 weeks. Planned follow-up was extended to 144 weeks, maintaining original randomisation.</AbstractText><AbstractText Label="METHODS">BREATHER was an open-label, non-inferiority trial. Participants aged 8-24yrs with virological suppression on efavirenz-based first-line ART were randomised 1:1, stratified by age and African/non-African sites, to remain on CT or change to SCT. The Kaplan-Meier method was used to estimate the proportion of participants with viral rebound (confirmed VL≥50 copies/mL) under intent-to-treat at 48 weeks (primary outcome), and in extended follow-up at 96, 144, and 192 weeks. SCT participants returned to CT following viral rebound, 3 VL blips or discontinuation of efavirenz.</AbstractText><AbstractText Label="FINDINGS">Of 199 participants (99 SCT, 100 CT), 97 per arm consented to extended follow-up. Median follow-up was 185.3 weeks (IQR 160.9-216.1). 69 (70%) SCT participants remained on SCT at last follow-up. 105 (53%) were male, baseline median age 14 years (IQR 12-18), median CD4 count 735 cells/μL (IQR 576-968). 16 SCT and 16 CT participants had confirmed VL≥50 copies/mL by the end of extended follow-up (HR 1.00, 95% CI 0.50-2.00). Estimated difference in percentage with viral rebound (SCT minus CT) by week 144 was 1.9% (90% CI -6.6-10.4; p = 0.72) and was similar in a per-protocol analysis. There were no significant differences between arms in proportions of participants with grade 3/4 adverse events (18 SCT vs 16 CT participants; p = 0.71) or ART-related adverse events (10 vs 12; p = 0.82). 20 versus 8 serious adverse events (SAEs) were reported in 16 SCT versus 4 CT participants, respectively (p = 0.005 comparing proportions between groups; incidence rate ratio 2.49, 95%CI 0.71-8.66, p = 0.15). 75% of SAEs (15 SCT, 6 CT) were hospitalisations for a wide range of conditions. 3 SCT and 6 CT participants switched to second-line ART following viral failure (p = 0.50).</AbstractText><AbstractText Label="CONCLUSIONS">Sustainable non-inferiority of virological suppression in young people was shown for SCT versus CT over median 3.6 years. Standard-dose efavirenz-based SCT is a viable option for virologically suppressed HIV-1 infected young people on first-line ART with 3-monthly VL monitoring.</AbstractText><AbstractText Label="TRIAL REGISTRATION">EudraCT 2009-012947-40 ISRCTN 97755073 ClinicalTrials.gov NCT01641016.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turkova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7008-4145</Identifier><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric infectious Diseases Department, Great Ormond Street Hospital, London United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Cecilia L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Paediatric Department, Our Lady's Children's Hospital, Crumlin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Compagnucci</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Trials and Infectious Diseases, INSERM/ANRS SC10-US19, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saïdi</LastName><ForeName>Yacine</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Trials and Infectious Diseases, INSERM/ANRS SC10-US19, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musiime</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Department, Joint Clinical Research Center, Kampala, Uganda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Department, Makerere University, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanduudu</LastName><ForeName>Annet</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5922-8152</Identifier><AffiliationInfo><Affiliation>Research Department, Joint Clinical Research Center, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaudha</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research Department, Joint Clinical Research Center, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cressey</LastName><ForeName>Tim R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>PHPT-IRD UMI 174, Faculty of Associated Medical Sciences, Department of Medical Technology, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology &amp; Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular &amp; Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalermpantmetagul</LastName><ForeName>Suwalai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>PHPT-IRD UMI 174, Faculty of Associated Medical Sciences, Department of Medical Technology, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6459-8468</Identifier><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harper</LastName><ForeName>Lynda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3430-0127</Identifier><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riault</LastName><ForeName>Yoann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Trials and Infectious Diseases, INSERM/ANRS SC10-US19, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunupuradah</LastName><ForeName>Torsak</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Center, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volokha</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyiv City Centre for Prevention and Control of AIDS, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Patricia M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Saint Jude Children's Research Hospital, Memphis, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bologna</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiology and Infectious Diseases Department, Hospital de Pediatría Dr JP Garrahan, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos Amador</LastName><ForeName>Jose T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Hospital Clinico Universitario San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Steven B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-6923-3502</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Birmingham Heartlands Hospital, Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nastouli</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Virology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3925-9258</Identifier><AffiliationInfo><Affiliation>Infection, Immunity and Inflammation Programme, University College London Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giaquinto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1713-6302</Identifier><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babiker</LastName><ForeName>Abdel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibb</LastName><ForeName>Diana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>MRC CTU, University College London Institute of Clinical Trials and Methodology, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BREATHER (PENTA 16) trial Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01641016</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000480">Alkynes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048588">Benzoxazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003521">Cyclopropanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018894">Reverse Transcriptase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>JE6H2O27P8</RegistryNumber><NameOfSubstance UI="C098320">efavirenz</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000480" MajorTopicYN="N">Alkynes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048588" MajorTopicYN="N">Benzoxazines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003521" MajorTopicYN="N">Cyclopropanes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018894" MajorTopicYN="N">Reverse Transcriptase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29684092</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0196239</ArticleId><ArticleId IdType="pii">PONE-D-17-38586</ArticleId><ArticleId IdType="pmc">PMC5912750</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet HIV. 2016 Aug;3(8):e351-e360</Citation><ArticleIdList><ArticleId IdType="pubmed">27470027</ArticleId></ArticleIdList></Reference><Reference><Citation>Afr J AIDS Res. 2014;13(2):189-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25174636</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Apr 22;5(4):e10307</Citation><ArticleIdList><ArticleId IdType="pubmed">20442758</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin HIV AIDS. 2016 Sep;11(5):477-486</Citation><ArticleIdList><ArticleId IdType="pubmed">27272537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet HIV. 2016 Sep;3(9):e421-e430</Citation><ArticleIdList><ArticleId IdType="pubmed">27562743</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2014 Nov 02;17(4 Suppl 3):19523</Citation><ArticleIdList><ArticleId IdType="pubmed">25394032</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Feb 05;11(2):e0148231</Citation><ArticleIdList><ArticleId IdType="pubmed">26849060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Jul;14(7):627-39</Citation><ArticleIdList><ArticleId IdType="pubmed">24406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet HIV. 2016 Sep;3(9):e399-e400</Citation><ArticleIdList><ArticleId IdType="pubmed">27562734</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2017 Feb 17;7(2):e012934</Citation><ArticleIdList><ArticleId IdType="pubmed">28213595</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2014 Feb 20;28(4):559-68</Citation><ArticleIdList><ArticleId IdType="pubmed">24076661</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19282780</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1097-103</Citation><ArticleIdList><ArticleId IdType="pubmed">25426651</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Res Hum Retroviruses. 2013 Jun;29(6):892-900</Citation><ArticleIdList><ArticleId IdType="pubmed">23373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2018 Feb;97(5):e9698</Citation><ArticleIdList><ArticleId IdType="pubmed">29384848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29681042</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-0502</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Yearbook of medical informatics</Title><ISOAbbreviation>Yearb Med Inform</ISOAbbreviation></Journal><ArticleTitle>The Privacy and Security Implications of Open Data in Healthcare.</ArticleTitle><Pagination><MedlinePgn>41-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0038-1641201</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE"> The International Medical Informatics Association (IMIA) Open Source Working Group (OSWG) initiated a group discussion to discuss current privacy and security issues in the open data movement in the healthcare domain from the perspective of the OSWG membership.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS"> Working group members independently reviewed the recent academic and grey literature and sampled a number of current large-scale open data projects to inform the working group discussion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS"> This paper presents an overview of open data repositories and a series of short case reports to highlight relevant issues present in the recent literature concerning the adoption of open approaches to sharing healthcare datasets. Important themes that emerged included data standardisation, the inter-connected nature of the open source and open data movements, and how publishing open data can impact on the ethics, security, and privacy of informatics projects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS"> The open data and open source movements in healthcare share many common philosophies and approaches including developing international collaborations across multiple organisations and domains of expertise. Both movements aim to reduce the costs of advancing scientific research and improving healthcare provision for people around the world by adopting open intellectual property licence agreements and codes of practice. Implications of the increased adoption of open data in healthcare include the need to balance the security and privacy challenges of opening data sources with the potential benefits of open data for improving research and healthcare delivery.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="N"><LastName>Kobayashi</LastName><ForeName>Shinji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chair of IMIA OSWG, EHR Department of Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Kane</LastName><ForeName>Thomas B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Centre for Algorithms, Visualisation and Evolving Systems, School of Computing, Edinburgh Napier University, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="N"><LastName>Paton</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Co-Chair of IMIA OSWG, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/N005600/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Yearb Med Inform</MedlineTA><NlmUniqueID>9312666</NlmUniqueID><ISSNLinking>0943-4747</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016494" MajorTopicYN="N">Computer Security</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003219" MajorTopicYN="Y">Confidentiality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29681042</ArticleId><ArticleId IdType="doi">10.1055/s-0038-1641201</ArticleId><ArticleId IdType="pmc">PMC6115211</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Coll Radiol. 2005 Nov;2(11):927-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17411967</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Derecho Genoma Hum. 2011 Jul-Dec;(35):225-38</Citation><ArticleIdList><ArticleId IdType="pubmed">22984755</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2014;1107:51-71</Citation><ArticleIdList><ArticleId IdType="pubmed">24272431</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Jun 25;311(24):2481-2</Citation><ArticleIdList><ArticleId IdType="pubmed">25058079</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurse Educ Today. 2015 Dec;35(12):e1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">26427668</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods. 2016 Sep;48(3):1062-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26428912</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Public Health. 2016 Feb 17;4:7</Citation><ArticleIdList><ArticleId IdType="pubmed">26925395</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2016 Apr;38(4):688-701</Citation><ArticleIdList><ArticleId IdType="pubmed">27130797</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Aug 4;375(5):405-7</Citation><ArticleIdList><ArticleId IdType="pubmed">27518658</ArticleId></ArticleIdList></Reference><Reference><Citation>Yearb Med Inform. 2017 Aug;26(1):53-58</Citation><ArticleIdList><ArticleId IdType="pubmed">28480476</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2017 May 18;357:j2439</Citation><ArticleIdList><ArticleId IdType="pubmed">28522583</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Technol (Berl). 2017;7(4):441-451</Citation><ArticleIdList><ArticleId IdType="pubmed">29308346</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29676732</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2018</Year><Month>04</Month><Day>20</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Donated chemical probes for open science.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.34311</ELocationID><ELocationID EIdType="pii" ValidYN="Y">e34311</ELocationID><Abstract><AbstractText>Potent, selective and broadly characterized small molecule modulators of protein function (chemical probes) are powerful research reagents. The pharmaceutical industry has generated many high-quality chemical probes and several of these have been made available to academia. However, probe-associated data and control compounds, such as inactive structurally related molecules and their associated data, are generally not accessible. The lack of data and guidance makes it difficult for researchers to decide which chemical tools to choose. Several pharmaceutical companies (AbbVie, Bayer, Boehringer Ingelheim, Janssen, MSD, Pfizer, and Takeda) have therefore entered into a pre-competitive collaboration to make available a large number of innovative high-quality probes, including all probe-associated data, control compounds and recommendations on use (&lt;ext-link ext-link-type="uri" xlink:href="https://openscienceprobes.sgc-frankfurt.de"&gt;https://openscienceprobes.sgc-frankfurt.de&lt;/ext-link&gt;&lt;ext-link ext-link-type="uri" xlink:href="https://openscienceprobes.sgc-frankfurt.de/"&gt;/&lt;/ext-link&gt;). Here we describe the chemical tools and target-related knowledge that have been made available, and encourage others to join the project.</AbstractText><CopyrightInformation>© 2018, Müller et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2402-4157</Identifier><AffiliationInfo><Affiliation>Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackloo</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrowsmith</LastName><ForeName>Cheryl H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauser</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryza</LastName><ForeName>Jeremy L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Vertex Pharmaceuticals, Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blagg</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Böttcher</LastName><ForeName>Jark</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Discovery Research, Boehringer Ingelheim, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bountra</LastName><ForeName>Chas</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunnage</LastName><ForeName>Mark E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vertex Pharmaceuticals, Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Adrian J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Discovery Research, Boehringer Ingelheim, Ingelheim am Rhein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damerell</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dötsch</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5720-212X</Identifier><AffiliationInfo><Affiliation>Institute of Biophysical Chemistry, Goethe-University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drewry</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Aled M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Spring House, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkins</LastName><ForeName>Jon M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-2858-8929</Identifier><AffiliationInfo><Affiliation>Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Merck &amp; Co., Inc., Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frye</LastName><ForeName>Stephen V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gollner</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Discovery Research, Boehringer Ingelheim, Biberach an der Riss, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimshaw</LastName><ForeName>Charles E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-2897-3483</Identifier><AffiliationInfo><Affiliation>Ched Grimshaw Consulting, LLC, Poway, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>IJzerman</LastName><ForeName>Adriaan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Medicinal Chemistry, Leiden University, Leiden, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7202-9468</Identifier><AffiliationInfo><Affiliation>Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartung</LastName><ForeName>Ingo V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hitchcock</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Takeda California Inc., San Diego, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>J&amp;J Innovation Centre, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Terry V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>J&amp;J Innovation Centre, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laufer</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, Eberhard Karls Universität Tübingen, Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Volkhart Mj</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Drug Discovery Pharmaceuticals, Bayer AG, Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liras</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsden</LastName><ForeName>Brian D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Hisanori</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Takeda Pharmaceutical Company Ltd, Fujisawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathias</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hagan</LastName><ForeName>Ronan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Merck &amp; Co., Inc., Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Dafydd R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pande</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Janssen-Pharmaceutical Companies of Johnson &amp; Johnson, Beerse, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauh</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Saul H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>AbbVie, North Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Bryan L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>The National Institute of Mental Health Psychoactive Active Drug Screening Program, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Natalie S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scholten</LastName><ForeName>Cora</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh Saikatendu</LastName><ForeName>Kumar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Takeda California Inc., San Diego, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simeonov</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takizawa</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Takeda Pharmaceutical Company Ltd., Fujisawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AbbVie, North Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, University of Massachusetts Medical School, Worcester, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treiber</LastName><ForeName>Daniel K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Eurofins DiscoverX, Sane Diego, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Amélia Yi</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Discovery Research, Boehringer Ingelheim, Ingelheim am Rhein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Carrow I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willson</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuercher</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knapp</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller-Fahrnow</LastName><ForeName>Anke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>11566</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>106169/ZZ14/Z</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015335">Molecular Probes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015335" MajorTopicYN="N">Molecular Probes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010600" MajorTopicYN="N">Pharmacology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013678" MajorTopicYN="N">Technology, Pharmaceutical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chemical probes</Keyword><Keyword MajorTopicYN="Y">Open Science</Keyword><Keyword MajorTopicYN="Y">Target validation</Keyword><Keyword MajorTopicYN="Y">biochemistry</Keyword><Keyword MajorTopicYN="Y">chemical biology</Keyword></KeywordList><CoiStatement>SM, SA, CA, JB, CB, PB, DD, DD, AE, JE, SF, AI, TH, SL, BM, BR, NS, AS, PT, CW, TW, WZ, SK No competing interests declared, MB employee of Bayer AG, JB employee of Vertex Pharmaceuticals, JB employee of Boehringer Ingelheim, MB Mark E Bunnage: employee of Vertex Pharmaceuticals, AC Adrian J Carter: employee of Boehringer Ingelheim, VD Reviewing editor, eLife, JE employee of Janssen Pharmaceutical Research and Development LLC, CF employee of Merck &amp;amp; Co., Inc. AG Andreas Gollner: employee of Boehringer Ingelheim, CG employee of Ched Grimshaw Consulting, LLC, IH Ingo V Hartung: employee of Bayer AG, SH employee of Takeda California Inc. TH employee of J&amp;amp;J Innovation Centre, TH Terry V Hughes: employee of J&amp;amp;J Innovation Centre, VL Volkhart MJ Li: employee of Bayer AG, SL employee of Pfizer, HM employee of Takeda Pharmaceutical Company Ltd, JM John Mathias: employee of Pfizer, RO Ronan C O'Hagan: employee of Merck &amp;amp; Co., Inc.,, DO Dafydd R Owen: employee of Pfizer, VP employee of Janssen-Pharmaceutical Companies of Johnson &amp;amp; Johnson, DR Daniel Rauh received consulting and lecture fees (Sanofi-Aventis, Takeda, Novartis, Pfizer, LDC) as well as research support (Novartis, J&amp;amp;J, Bayer, Merck, MSD). SR employee of AbbVie, CS Cora Scholten: employee of Bayer AG, KS Kumar Singh Saikatendu: employee of Takeda California Inc, MT Masayuki Takizawa: employee of Takeda Pharmaceutical Company Ltd. CT Chris Tse: employee of AbbVie, DT employee of Eurofins DiscoverX, AV Amélia YI Viana: employee of Boehringer Ingelheim, AM Anke Mueller-Fahrnow: employee of Bayer AG</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29676732</ArticleId><ArticleId IdType="doi">10.7554/eLife.34311</ArticleId><ArticleId IdType="pii">34311</ArticleId><ArticleId IdType="pmc">PMC5910019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swiss Med Wkly. 2015 Feb 06;145:w14086</Citation><ArticleIdList><ArticleId IdType="pubmed">25658854</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2015 Feb 26;58(4):1669-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25671290</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2011 Mar;162(6):1239-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21091654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Sep 25;513(7519):481-3</Citation><ArticleIdList><ArticleId IdType="pubmed">25254460</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1999 Feb 5;366(2-3):189-201</Citation><ArticleIdList><ArticleId IdType="pubmed">10082200</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2015 Jun 04;13(6):e1002164</Citation><ArticleIdList><ArticleId IdType="pubmed">26042736</ArticleId></ArticleIdList></Reference><Reference><Citation>Angew Chem Int Ed Engl. 2016 Feb 5;55(6):1966-73</Citation><ArticleIdList><ArticleId IdType="pubmed">26756721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2017 Jul 10;32(1):9-25</Citation><ArticleIdList><ArticleId IdType="pubmed">28697345</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2014 Nov 13;57(21):8886-902</Citation><ArticleIdList><ArticleId IdType="pubmed">25264600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2015 Aug;11(8):536-41</Citation><ArticleIdList><ArticleId IdType="pubmed">26196764</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2012 Jan;17(1-2):56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21963616</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2009 Jul;5(7):436-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19536100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Oct 5;550(7674):128-132</Citation><ArticleIdList><ArticleId IdType="pubmed">28953875</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Chem Biol. 2016 Jan 21;23 (1):10-17</Citation><ArticleIdList><ArticleId IdType="pubmed">26933732</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Mar;14(3):149-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25722227</ArticleId></ArticleIdList></Reference><Reference><Citation>ChemMedChem. 2016 Oct 19;11(20):2261-2271</Citation><ArticleIdList><ArticleId IdType="pubmed">27552707</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2015;7(14):1853-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26393392</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2014 Jul;6(11):1265-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25163000</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Feb 15;339(6121):823-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Chem Biol. 2013 Apr;9(4):195-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23508172</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29673085</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-3768</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Acta ophthalmologica</Title><ISOAbbreviation>Acta Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Association of serum uric acid levels with primary open-angle glaucoma: a 5-year case-control study.</ArticleTitle><Pagination><MedlinePgn>e356-e363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aos.13789</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">It has been hypothesised that uric acid (UA) has a protective effect against oxidative damage in the central nervous system. Therefore, we investigated serum UA concentrations in patients with primary open-angle glaucoma (POAG) and explored the relationship between serum UA concentration and glaucoma severity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective, cross-sectional, case-control study was conducted in 163 POAG patients and 103 normal controls. Clinical and demographic information was obtained from the medical data platform of the Eye &amp; ENT Hospital of Fudan University, Shanghai, China. The POAG patients were categorised into mild [median deviation (MD) ≤ 6.00 dB], moderate (MD &gt; 6 Db-≥12 dB) and severe (MD &gt; 12 dB) subgroups, based on their visual field MD results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The level of serum UA in the POAG group (0.321 ± 0.084 mmol/l) was approximately 12.77% lower (p &lt; 0.001) than that of the control group (0.362 ± 0.053 mmol/l). The UA/creatinine (Cr) ratio was approximately 14.99% lower (p &lt; 0.001) in patients with POAG (4.47 ± 1.15), compared with the control group (5.14 ± 1.05). The mean level of UA was lowest in the severe POAG group, followed by the moderate POAG group, and the mild POAG group (p &lt; 0.001). A similar trend was observed when UA levels were compared between the POAG and control groups in males. Multivariate regression analyses showed a significant negative correlation between UA and vertical cup-disc ratio (B = -0.320, p = 0.034), and UA and MD (B = -0.441, p = 0.031) in males.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Primary open-angle glaucoma patients have lower UA levels; however, a negative association between UA levels and disease severity was evident in male patients.</AbstractText><CopyrightInformation>© 2018 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shengjie</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6443-740X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Mingxi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Danhui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Medical School, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Binghua</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xinghuai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology &amp; Visual Science, Eye &amp; ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Ministry of Health (Fudan University), Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81790641</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2013SY058</GrantID><Agency>New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning</Agency><Country/></Grant><Grant><GrantID>201302015</GrantID><Agency>National Health and Family Planning Commission, China</Agency><Country/></Grant><Grant><GrantID>81430007</GrantID><Agency>State Key Program of National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Ophthalmol</MedlineTA><NlmUniqueID>101468102</NlmUniqueID><ISSNLinking>1755-375X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>268B43MJ25</RegistryNumber><NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005902" MajorTopicYN="N">Glaucoma, Open-Angle</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033401" MajorTopicYN="N">Microscopy, Acoustic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009898" MajorTopicYN="N">Optic Disk</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014527" MajorTopicYN="N">Uric Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">primary open-angle glaucoma</Keyword><Keyword MajorTopicYN="N">uric acid</Keyword><Keyword MajorTopicYN="N">uric acid/creatinine ratio</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29673085</ArticleId><ArticleId IdType="doi">10.1111/aos.13789</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35415404</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2509-4971</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>1-2</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of healthcare informatics research</Title><ISOAbbreviation>J Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>Building an Open Health Data Analytics Platform: a Case Study Examining Relationships and Trends in Seniority and Performance in Healthcare Providers.</ArticleTitle><Pagination><MedlinePgn>44-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s41666-018-0014-0</ELocationID><Abstract><AbstractText>With a movement toward an open data-driven approach, governments worldwide are releasing public data in an effort to increase transparency. Despite the availability of this data, many factors make it difficult for anyone to extract knowledge from it. The relationship between seniority and performance is a controversial issue in many fields; using an open and reproducible framework, we investigate the relationship in open healthcare data. Using data from the Center for Medicare and Medicaid Services covering 895,000 practitioners and 3000 hospitals, weak but statistically significant correlations between graduation year, a proxy for seniority, and the hospital value-based performance score were found in 29 of 74 specialties (Spearman rank correlation values &lt; 0.164, <i>p</i> value &lt; 0.05). This result represents 7% of US healthcare practitioners and over 75% of medical practitioners in several specialties. With 5 years of data (2009-2014) from the New York Statewide Planning and Research Cooperative System (SPARCS), we found weak but statistically significant correlations between graduation year and cardiac surgery outcome measures (Spearman rank correlation value - 0.096, <i>p</i> value &lt; 0.0005). An unsupervised clustering <i>K</i>-means-based algorithm for finding outliers was also applied to these datasets. It captured a unique trend in the number of nurse practitioners which was increasing rapidly since 2010. It also revealed consistencies in practitioner placement throughout hospitals. Our findings suggest that the training of healthcare professionals appears to be robust and positions them for long-lasting and consistent careers across the majority of specialties.</AbstractText><CopyrightInformation>© Springer International Publishing AG, part of Springer Nature 2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravishankar Rao</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7483-0678</Identifier><AffiliationInfo><Affiliation>Gildart Haase School of Computer Sciences and Engineering, Fairleigh Dickinson University, Teaneck, NJ USA.</Affiliation><Identifier Source="ISNI">0000 0004 0472 3804</Identifier><Identifier Source="GRID">grid.255802.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gildart Haase School of Computer Sciences and Engineering, Fairleigh Dickinson University, Teaneck, NJ USA.</Affiliation><Identifier Source="ISNI">0000 0004 0472 3804</Identifier><Identifier Source="GRID">grid.255802.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Maryelena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Henry P. Becton School of Nursing &amp; Allied Health, Fairleigh Dickinson University, Teaneck, NJ USA.</Affiliation><Identifier Source="ISNI">0000 0004 0472 3804</Identifier><Identifier Source="GRID">grid.255802.8</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Healthc Inform Res</MedlineTA><NlmUniqueID>101707451</NlmUniqueID><ISSNLinking>2509-498X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hospitals</Keyword><Keyword MajorTopicYN="N">Information dissemination</Keyword><Keyword MajorTopicYN="N">Medicare</Keyword><Keyword MajorTopicYN="N">Nurse practitioners</Keyword><Keyword MajorTopicYN="N">Surgeons</Keyword></KeywordList><CoiStatement>Conflict of InterestThe authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>16</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>16</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35415404</ArticleId><ArticleId IdType="doi">10.1007/s41666-018-0014-0</ArticleId><ArticleId IdType="pii">14</ArticleId><ArticleId IdType="pmc">PMC8982821</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 2010 Nov 5;330(6005):759-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21051617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2006 Sep;244(3):353-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16926561</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Sci. 2016 Jun;351(6):582-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27238920</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2017 May 1;177(5):675-682</Citation><ArticleIdList><ArticleId IdType="pubmed">28288254</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Aging. 2009 Apr;30(4):507-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19231028</ArticleId></ArticleIdList></Reference><Reference><Citation>Inquiry. 2004-2005 Winter;41(4):435-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15835601</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2014 Jan;104(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24228646</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jan 2;370(1):6-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24304001</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2004 Mar-Apr;23(2):116-26</Citation><ArticleIdList><ArticleId IdType="pubmed">15046136</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Manag Health Care. 2004 Oct-Dec;13(4):202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15532513</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Med. 2002 Aug;77(8):776-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12176690</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Rev Musculoskelet Med. 2014 Sep;7(3):189-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24903374</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 12;283(14):1866-74</Citation><ArticleIdList><ArticleId IdType="pubmed">10770149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2007 Jan-Feb;14(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Imaging. 2016 May-Jun;40(3):531-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27133699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2005 Feb 15;142(4):260-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15710959</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2015 Aug;175(8):1420-1</Citation><ArticleIdList><ArticleId IdType="pubmed">26236973</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">28710297</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 25;533(7604):452-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy. 2012 May;105(2-3):165-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22440194</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2006 May-Jun;25(3):844-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16684751</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2011 Apr;30(4):569-73</Citation><ArticleIdList><ArticleId IdType="pubmed">21471474</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Jan 26;315(4):341-2</Citation><ArticleIdList><ArticleId IdType="pubmed">26720141</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2017 May 16;357:j1797</Citation><ArticleIdList><ArticleId IdType="pubmed">28512089</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2014 Jul;33(7):1163-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25006142</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Sep 6;296(9):1094-102</Citation><ArticleIdList><ArticleId IdType="pubmed">16954489</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2014 Jul;174(7):1067-76</Citation><ArticleIdList><ArticleId IdType="pubmed">24819824</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jun 5;370(23):2161-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24897079</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2015 Oct 6;187(14):1041-1048</Citation><ArticleIdList><ArticleId IdType="pubmed">26283716</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Jan 5;283(1):59-68</Citation><ArticleIdList><ArticleId IdType="pubmed">10632281</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care Res Rev. 2014 Oct;71(5 Suppl):5S-16S</Citation><ArticleIdList><ArticleId IdType="pubmed">24871273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2008 Jan 15;148(2):111-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18195336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2005 Sep;242(3):344-8; discussion 348-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16135920</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Med. 2016 Jun;91(6):833-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26606721</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Apr 1;301(13):1341-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19336709</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2018 Jan 1;25(1):32-39</Citation><ArticleIdList><ArticleId IdType="pubmed">29036464</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Neurosurg. 2003 Apr;17(2):124-8; discussion 129</Citation><ArticleIdList><ArticleId IdType="pubmed">12820753</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Clin North Am. 2016 Feb;96(1):129-38</Citation><ArticleIdList><ArticleId IdType="pubmed">26612025</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2007 Sep;142(9):863-8; discussion 868-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17875841</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Educ. 2000 Jul;34(7):551-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10886638</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2016 Feb;22(2):126-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26885672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29653352</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2018</Year><Month>05</Month><Day>01</Day></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Online molecular image repository and analysis system: A multicenter collaborative open-source infrastructure for molecular imaging research and application.</ArticleTitle><Pagination><MedlinePgn>233-240</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(18)30076-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2018.04.001</ELocationID><Abstract><AbstractText>Molecular imaging serves as an important tool for researchers and clinicians to visualize and investigate complex biochemical phenomena using specialized instruments; these instruments are either used individually or in combination with targeted imaging agents to obtain images related to specific diseases with high sensitivity, specificity, and signal-to-noise ratios. However, molecular imaging, which is a multidisciplinary research field, faces several challenges, including the integration of imaging informatics with bioinformatics and medical informatics, requirement of reliable and robust image analysis algorithms, effective quality control of imaging facilities, and those related to individualized disease mapping, data sharing, software architecture, and knowledge management. As a cost-effective and open-source approach to address these challenges related to molecular imaging, we develop a flexible, transparent, and secure infrastructure, named MIRA, which stands for Molecular Imaging Repository and Analysis, primarily using the Python programming language, and a MySQL relational database system deployed on a Linux server. MIRA is designed with a centralized image archiving infrastructure and information database so that a multicenter collaborative informatics platform can be built. The capability of dealing with metadata, image file format normalization, and storing and viewing different types of documents and multimedia files make MIRA considerably flexible. With features like logging, auditing, commenting, sharing, and searching, MIRA is useful as an Electronic Laboratory Notebook for effective knowledge management. In addition, the centralized approach for MIRA facilitates on-the-fly access to all its features remotely through any web browser. Furthermore, the open-source approach provides the opportunity for sustainable continued development. MIRA offers an infrastructure that can be used as cross-boundary collaborative MI research platform for the rapid achievement in cancer diagnosis and therapeutics.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Mahabubur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Radiation Protection and Safety Control, Cyclotron and Radioisotope Center, Graduate School of Biomedical Engineering, Tohoku University, Aoba-6-3 Aramaki, Aoba-ku, Sendai-shi, Miyagi-ken, 980-0845, Japan; Bangladesh Atomic Energy Commission, E-12/A, Shahid Shahabuddin Shorok, Dhaka 1207, Bangladesh. Electronic address: tstariq2007@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watabe</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Radiation Protection and Safety Control, Cyclotron and Radioisotope Center, Graduate School of Biomedical Engineering, Tohoku University, Aoba-6-3 Aramaki, Aoba-ku, Sendai-shi, Miyagi-ken, 980-0845, Japan. Electronic address: watabe@cyric.tohoku.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003628" MajorTopicYN="Y">Database Management Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057054" MajorTopicYN="Y">Molecular Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Electronic laboratory notebook (ELN)</Keyword><Keyword MajorTopicYN="Y">Image analysis</Keyword><Keyword MajorTopicYN="Y">Knowledge management</Keyword><Keyword MajorTopicYN="Y">Molecular imaging</Keyword><Keyword MajorTopicYN="Y">Open source</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>04</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29653352</ArticleId><ArticleId IdType="pii">S0010-4825(18)30076-3</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2018.04.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29606364</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>391</Volume><Issue>10128</Issue><PubDate><Year>2018</Year><Month>04</Month><Day>07</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.</ArticleTitle><Pagination><MedlinePgn>1378-1390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(18)30291-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(18)30291-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Artemether-lumefantrine and artesunate-amodiaquine are used as first-line artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine-artesunate and dihydroartemisinin-piperaquine are potentially useful for diversification of ACTs in this region, but further safety and efficacy data are required on malaria retreatment.</AbstractText><AbstractText Label="METHODS">We did a randomised, multicentre, open-label, longitudinal, controlled phase 3b/4 clinical trial at seven tertiary centres in Burkina Faso, Guinea, and Mali. Eligible participants for first malaria episode and all retreatment episodes were adults and children aged 6 months and older with microscopically confirmed Plasmodium spp malaria (&gt;0 to &lt;200 000 parasites per μL of blood) and fever or history of fever in the previous 24 h. Individuals with severe or complicated malaria, an alanine aminotransferase concentration of more than twice the upper limit of normal, or a QTc greater than 450 ms were excluded. Using a randomisation list for each site, masked using sealed envelopes, participants were assigned to either pyronaridine-artesunate or dihydroartemisinin-piperaquine versus either artesunate-amodiaquine or artemether-lumefantrine. Block sizes were two or four if two treatments were allocated, and three or six if three treatments were allocated. Microscopists doing the parasitological assessments were masked to treatment allocation. All treatments were once-daily or twice-daily tablets or granules given orally and dosed by bodyweight over 3 days at the study centre. Patients were followed up as outpatients up to day 42, receiving clinical assessments on days 0, 1, 2, 3, 7, 14, 21, 28, 35, and 42. Two primary outcomes were compared for non-inferiority: the 2-year incidence rate of all microscopically confirmed, complicated and uncomplicated malaria episodes in patients in the intention-to-treat population (ITT; non-inferiority margin 20%); and adequate clinical and parasitological response (ACPR) in uncomplicated malaria across all episodes (unadjusted and PCR-adjusted for Plasmodium falciparum and unadjusted for other Plasmodium spp) in the per-protocol population on days 28 and 42 (non-inferiority margin 5%). Safety was assessed in all participants who received one dose of study drug. This study is registered at the Pan African Clinical Trials Registry (PACTR201105000286876).</AbstractText><AbstractText Label="FINDINGS">Between Oct 24, 2011, and Feb 1, 2016, we assigned 4710 eligible participants to the different treatment strategies: 1342 to pyronaridine-artesunate, 967 to artemether-lumefantrine, 1061 to artesunate-amodiaquine, and 1340 to dihydroartemisinin-piperaquine. The 2-year malaria incidence rate in the ITT population was non-inferior for pyronaridine-artesunate versus artemether-lumefantrine (1·77, 95% CI 1·63-1·93 vs 1·87, 1·72-2·03; rate ratio [RR] 1·05, 95% CI 0·94-1·17); and versus artesunate-amodiaquine (1·39, 95% CI 1·22-1·59 vs 1·35, 1·18-1·54; RR 0·97, 0·87-1·07). Similarly, this endpoint was non-inferior for dihydroartemisinin-piperaquine versus artemether-lumefantrine (1·16, 95% CI 1·01-1·34 vs 1·42 1·25-1·62; RR 1·22, 95% CI 1·06-1·41) and versus artesunate-amodiaquine (1·35, 1·21-1·51 vs 1·68, 1·51-1·88; RR 1·25, 1·02-1·50). For uncomplicated P falciparum malaria, PCR-adjusted ACPR was greater than 99·5% at day 28 and greater than 98·6% at day 42 for all ACTs; unadjusted ACPR was higher for pyronaridine-artesunate versus comparators at day 28 (96·9% vs 82·3% for artemether-lumefantrine and 95·6% vs 89·0% for artesunate-amodiaquine) and for dihydroartemisinin-piperaquine versus comparators (99·5% vs 81·6% for artemether-lumefantrine and 99·0% vs 89·0% for artesunate-amodiaquine). For non-falciparum species, unadjusted ACPR was greater than 98% for all study drugs at day 28 and at day 42 was greater than 83% except for artemether-lumefantrine against Plasmodium ovale (in ten [62·5%] of 16 patients) and against Plasmodium malariae (in nine [75·0%] of 12 patients). Nine deaths occurred during the study, none of which were related to the study treatment. Mostly mild transient elevations in transaminases occurred with pyronaridine-artesunate versus comparators, and mild QTcF prolongation with dihydroartemisinin-piperaquine versus comparators.</AbstractText><AbstractText Label="INTERPRETATION">Pyronaridine-artesunate and dihydroartemisinin-piperaquine treatment and retreatment of malaria were well tolerated with efficacy that was non-inferior to first-line ACTs. Greater access to these efficacious treatments in west Africa is justified.</AbstractText><AbstractText Label="FUNDING">The European and Developing Countries Clinical Trial Partnership, Medicines for Malaria Venture (Geneva, Switzerland), the UK Medical Research Council, the Swedish International Development Cooperation Agency, German Ministry for Education and Research, University Claude Bernard (Lyon, France), University of Science, Techniques and Technologies of Bamako (Bamako, Mali), the Centre National de Recherche et de Formation sur le Paludisme (Burkina Faso), Institut de Recherche en Sciences de la Santé (Bobo-Dioulasso, Burkina Faso), and Centre National de Formation et de Recherche en Santé Rurale (Republic of Guinea).</AbstractText><CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D017429">Clinical Trial, Phase IV</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077611">Artemether, Lumefantrine Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037621">Artemisinins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004983">Ethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005449">Fluorenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009287">Naphthyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C515299">amodiaquine, artesunate drug combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>220236ED28</RegistryNumber><NameOfSubstance UI="D000655">Amodiaquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>60W3249T9M</RegistryNumber><NameOfSubstance UI="D000077332">Artesunate</NameOfSubstance></Chemical><Chemical><RegistryNumber>6A9O50735X</RegistryNumber><NameOfSubstance UI="C039060">artenimol</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0HV2Q956Y</RegistryNumber><NameOfSubstance UI="C034759">piperaquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TD3P7Q3SG6</RegistryNumber><NameOfSubstance UI="C027871">pyronaridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Apr 7;391(10128):1336-1338</RefSource><PMID Version="1">29606365</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000655" MajorTopicYN="N">Amodiaquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077611" MajorTopicYN="N">Artemether, Lumefantrine Drug Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037621" MajorTopicYN="N">Artemisinins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077332" MajorTopicYN="N">Artesunate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004983" MajorTopicYN="N">Ethanolamines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005449" MajorTopicYN="N">Fluorenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009287" MajorTopicYN="N">Naphthyridines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Sagara</LastName><ForeName>Issaka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beavogui</LastName><ForeName>Abdoul Habib</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Centre de Formation et de Recherche en Santé Rurale de Mafèrinyah, Conakry, Guinea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zongo</LastName><ForeName>Issaka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Science de la Santé, Bobo Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soulama</LastName><ForeName>Issiaka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Borghini-Fuhrer</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medicines for Malaria Venture, Geneva, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fofana</LastName><ForeName>Bakary</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Traore</LastName><ForeName>Aliou</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Nouhoum</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diakite</LastName><ForeName>Hamadoun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Togo</LastName><ForeName>Amadou H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koumare</LastName><ForeName>Sekou</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Keita</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Camara</LastName><ForeName>Daouda</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre de Formation et de Recherche en Santé Rurale de Mafèrinyah, Conakry, Guinea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Somé</LastName><ForeName>Anyirékun F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Science de la Santé, Bobo Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coulibaly</LastName><ForeName>Aboubacar S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Traore</LastName><ForeName>Oumar B</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dama</LastName><ForeName>Souleymane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goita</LastName><ForeName>Siaka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Djimde</LastName><ForeName>Moussa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bamadio</LastName><ForeName>Amadou</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dara</LastName><ForeName>Niawanlou</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maiga</LastName><ForeName>Hamma</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sidibe</LastName><ForeName>Bouran</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dao</LastName><ForeName>Francois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coulibaly</LastName><ForeName>Moctar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alhousseini</LastName><ForeName>Mohamed Lamine</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Niangaly</LastName><ForeName>Hamidou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sangare</LastName><ForeName>Boubou</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diarra</LastName><ForeName>Modibo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coumare</LastName><ForeName>Samba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kabore</LastName><ForeName>Moïse J T</ForeName><Initials>MJT</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ouattara</LastName><ForeName>San Maurice</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barry</LastName><ForeName>Aissata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kargougou</LastName><ForeName>Désiré</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diarra</LastName><ForeName>Amidou</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Henry</LastName><ForeName>Noelie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soré</LastName><ForeName>Harouna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bougouma</LastName><ForeName>Edith C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thera</LastName><ForeName>Ismaila</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Compaore</LastName><ForeName>Yves D</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Science de la Santé, Bobo Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sutherland</LastName><ForeName>Colin J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sylla</LastName><ForeName>Malick Minkael</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Centre de Formation et de Recherche en Santé Rurale de Mafèrinyah, Conakry, Guinea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nikiema</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Science de la Santé, Bobo Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Mamadou Saliou</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Centre de Formation et de Recherche en Santé Rurale de Mafèrinyah, Conakry, Guinea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dicko</LastName><ForeName>Alassane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Picot</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Malaria Research Unit, UMR 5246, University of Lyon, and Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Borrmann</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany; German Centre for Infection Research, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Duparc</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicines for Malaria Venture, Geneva, Switzerland.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Artemida Pharma, Stevenage, UK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Doumbo</LastName><ForeName>Ogobara K</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shin</LastName><ForeName>Jangsik</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shin Poong Pharmaceutical Company, Seoul, South Korea.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gil</LastName><ForeName>Jose Pedro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Björkman</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ouedraogo</LastName><ForeName>Jean-Bosco</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Science de la Santé, Bobo Dioulasso, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sirima</LastName><ForeName>Sodiomon B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Djimde</LastName><ForeName>Abdoulaye A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Science, Techniques and Technologies of Bamako, Mali. Electronic address: adjimde@icermali.org.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29606364</ArticleId><ArticleId IdType="pii">S0140-6736(18)30291-5</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(18)30291-5</ArticleId><ArticleId IdType="pmc">PMC5889791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trans R Soc Trop Med Hyg. 2013 Feb;107(2):65-73</Citation><ArticleIdList><ArticleId IdType="pubmed">23222952</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2012 Oct 31;11:364</Citation><ArticleIdList><ArticleId IdType="pubmed">23113947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Oct;10(10):673-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20832366</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2017 Feb 2;16(1):62</Citation><ArticleIdList><ArticleId IdType="pubmed">28153004</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007 Oct 31;2(10):e1101</Citation><ArticleIdList><ArticleId IdType="pubmed">17971864</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar Res Treat. 2014;2014:263674</Citation><ArticleIdList><ArticleId IdType="pubmed">25045575</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Trop Med Hyg. 2016 Dec 7;95(6):1228-1238</Citation><ArticleIdList><ArticleId IdType="pubmed">27928074</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2014 Jan 20;(1):CD010927</Citation><ArticleIdList><ArticleId IdType="pubmed">24443033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2017 Jan;5(1):e60-e68</Citation><ArticleIdList><ArticleId IdType="pubmed">27840069</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Trop Med Hyg. 2012 Jul;87(1):50-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22764291</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2015 Jan;59(1):437-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25367912</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2008 Feb;48(2):166-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18199893</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2015 Jul 31;14:292</Citation><ArticleIdList><ArticleId IdType="pubmed">26228915</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2017 Jan 13;16(1):27</Citation><ArticleIdList><ArticleId IdType="pubmed">28086775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Mar 3;369(9563):757-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17336652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2016 Feb;16(2):189-98</Citation><ArticleIdList><ArticleId IdType="pubmed">26601738</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2008 Jul 11;7:127</Citation><ArticleIdList><ArticleId IdType="pubmed">18620577</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Dec 1;45(11):1453-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17990228</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2017 Feb 2;16(1):59</Citation><ArticleIdList><ArticleId IdType="pubmed">28148267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 Jun 24;367(9528):2075-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16798391</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2011 Aug 12;10:237</Citation><ArticleIdList><ArticleId IdType="pubmed">21838909</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jul 30;5(7):e11880</Citation><ArticleIdList><ArticleId IdType="pubmed">20689583</ArticleId></ArticleIdList></Reference><Reference><Citation>Malar J. 2013 Feb 21;12 :70</Citation><ArticleIdList><ArticleId IdType="pubmed">23433102</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Nov;8(11):e1001119</Citation><ArticleIdList><ArticleId IdType="pubmed">22087077</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Apr 1;52(7):873-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21427394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Apr 24;375(9724):1457-67</Citation><ArticleIdList><ArticleId IdType="pubmed">20417857</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Oct 20;11(10 ):e0164851</Citation><ArticleIdList><ArticleId IdType="pubmed">27764178</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2014 Mar 04;(3):CD006404</Citation><ArticleIdList><ArticleId IdType="pubmed">24596021</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Nov 17;4(11):e7871</Citation><ArticleIdList><ArticleId IdType="pubmed">19936217</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Jan 18;6(1):e14501</Citation><ArticleIdList><ArticleId IdType="pubmed">21267072</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Apr 5;366(14 ):1298-309</Citation><ArticleIdList><ArticleId IdType="pubmed">22475593</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2016 Jun 20;60(7):3884-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26926629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2017 Feb;17 (2):164-173</Citation><ArticleIdList><ArticleId IdType="pubmed">27818095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29596782</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2405-4712</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>03</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell systems</Title><ISOAbbreviation>Cell Syst</ISOAbbreviation></Journal><ArticleTitle>Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.</ArticleTitle><Pagination><MedlinePgn>271-281.e7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2405-4712(18)30096-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cels.2018.03.002</ELocationID><Abstract><AbstractText>The Cancer Genome Atlas (TCGA) cancer genomics dataset includes over 10,000 tumor-normal exome pairs across 33 different cancer types, in total &gt;400 TB of raw data files requiring analysis. Here we describe the Multi-Center Mutation Calling in Multiple Cancers project, our effort to generate a comprehensive encyclopedia of somatic mutation calls for the TCGA data to enable robust cross-tumor-type analyses. Our approach accounts for variance and batch effects introduced by the rapid advancement of DNA extraction, hybridization-capture, sequencing, and analysis methods over time. We present best practices for applying an ensemble of seven mutation-calling algorithms with scoring and artifact filtering. The dataset created by this analysis includes 3.5 million somatic variants and forms the basis for PanCan Atlas papers. The results have been made available to the research community along with the methods used to generate them. This project is the result of collaboration from a number of institutes and demonstrates how team science drives extremely large genomics projects.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ellrott</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: ellrott@ohsu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Matthew H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Medicine, McDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saksena</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covington</LastName><ForeName>Kyle R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine Human Genome Sequencing Center, 1 Baylor Plaza, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandoth</LastName><ForeName>Cyriac</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Chip</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Singer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>DNAnexus, 1975 W EL Camino Real, Suite 204, Mountain View, CA 94040, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiotti</LastName><ForeName>Kami E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLellan</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, McDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sofia</LastName><ForeName>Heidi J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutter</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute (NHGRI), NIH, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Getz</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine Human Genome Sequencing Center, 1 Baylor Plaza, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, McDonnell Genome Institute, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MC3 Working Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Cancer Genome Atlas Research Network</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143882</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143866</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG003273</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143840</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143843</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143858</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143848</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA180778</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA210949</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA163722</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143867</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA210990</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG003067</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143835</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006517</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA210950</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143845</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143799</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA144025</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA183793</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN261201400007C</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA210957</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG003079</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA210969</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG007990</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA143883</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA211006</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Syst</MedlineTA><NlmUniqueID>101656080</NlmUniqueID><ISSNLinking>2405-4712</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Whole Exome Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">PanCanAtlas project</Keyword><Keyword MajorTopicYN="Y">TCGA</Keyword><Keyword MajorTopicYN="Y">large-scale</Keyword><Keyword MajorTopicYN="Y">open science</Keyword><Keyword MajorTopicYN="Y">pan-cancer</Keyword><Keyword MajorTopicYN="Y">reproducible computing</Keyword><Keyword MajorTopicYN="Y">somatic mutation calling</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Caesar-Johnson</LastName><ForeName>Samantha J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Demchok</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felau</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasapi</LastName><ForeName>Melpomeni</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Martin L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hutter</LastName><ForeName>Carolyn M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sofia</LastName><ForeName>Heidi J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tarnuzzer</LastName><ForeName>Roy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhining</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Liming</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zenklusen</LastName><ForeName>Jean C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiashan Julia</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chudamani</LastName><ForeName>Sudha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lolla</LastName><ForeName>Laxmi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naresh</LastName><ForeName>Rashi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pihl</LastName><ForeName>Todd</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wan</LastName><ForeName>Yunhu</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Ye</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cho</LastName><ForeName>Juok</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeFreitas</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frazer</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gehlenborg</LastName><ForeName>Nils</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Getz</LastName><ForeName>Gad</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heiman</LastName><ForeName>David I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Jaegil</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Pei</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meier</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noble</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saksena</LastName><ForeName>Gordon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voet</LastName><ForeName>Doug</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hailei</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Brady</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chambwe</LastName><ForeName>Nyasha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhankani</LastName><ForeName>Varsha</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knijnenburg</LastName><ForeName>Theo</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kramer</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leinonen</LastName><ForeName>Kalle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuexin</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Sheila</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shmulevich</LastName><ForeName>Ilya</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thorsson</LastName><ForeName>Vesteinn</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akbani</LastName><ForeName>Rehan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broom</LastName><ForeName>Bradley M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hegde</LastName><ForeName>Apurva M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ju</LastName><ForeName>Zhenlin</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kanchi</LastName><ForeName>Rupa S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korkut</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liang</LastName><ForeName>Han</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ling</LastName><ForeName>Shiyun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenbin</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Yiling</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>Gordon B</ForeName><Initials>GB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Kwok-Shing</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Arvind</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weinstein</LastName><ForeName>John N</ForeName><Initials>JN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiexin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abeshouse</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Armenia</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chakravarty</LastName><ForeName>Debyani</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chatila</LastName><ForeName>Walid K</ForeName><Initials>WK</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Bruijn</LastName><ForeName>Ino</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Jianjiong</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heins</LastName><ForeName>Zachary J</ForeName><Initials>ZJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kundra</LastName><ForeName>Ritika</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>La</LastName><ForeName>Konnor</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ladanyi</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luna</LastName><ForeName>Augustin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nissan</LastName><ForeName>Moriah G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ochoa</LastName><ForeName>Angelica</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips</LastName><ForeName>Sarah M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reznik</LastName><ForeName>Ed</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez-Vega</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sander</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheridan</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sumer</LastName><ForeName>S Onur</ForeName><Initials>SO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>Yichao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Barry S</ForeName><Initials>BS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Jioajiao</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongxin</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anur</LastName><ForeName>Pavana</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peto</LastName><ForeName>Myron</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spellman</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benz</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stuart</LastName><ForeName>Joshua M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yau</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayes</LastName><ForeName>D Neil</ForeName><Initials>DN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName></Investigator><Investigator ValidYN="Y"><LastName>Wilkerson</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ally</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasundaram</LastName><ForeName>Miruna</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowlby</LastName><ForeName>Reanne</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carlsen</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chuah</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhalla</LastName><ForeName>Noreen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holt</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Steven J M</ForeName><Initials>SJM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasaian</LastName><ForeName>Katayoon</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Darlene</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Yussanne</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marra</LastName><ForeName>Marco A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayo</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungall</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mungall</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robertson</LastName><ForeName>A Gordon</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadeghi</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schein</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sipahimalani</LastName><ForeName>Payal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tam</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiessen</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tse</LastName><ForeName>Kane</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berger</LastName><ForeName>Ashton C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beroukhim</LastName><ForeName>Rameen</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherniack</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cibulskis</LastName><ForeName>Carrie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Stacey B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Galen F</ForeName><Initials>GF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ha</LastName><ForeName>Gavin</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyerson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schumacher</LastName><ForeName>Steven E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shih</LastName><ForeName>Juliann</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kucherlapati</LastName><ForeName>Melanie H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kucherlapati</LastName><ForeName>Raju S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baylin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cope</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danilova</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bootwalla</LastName><ForeName>Moiz S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Phillip H</ForeName><Initials>PH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maglinte</LastName><ForeName>Dennis T</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Den Berg</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weisenberger</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Auman</LastName><ForeName>J Todd</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balu</LastName><ForeName>Saianand</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodenheimer</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fan</LastName><ForeName>Cheng</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoadley</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoyle</LastName><ForeName>Alan P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jefferys</LastName><ForeName>Stuart R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Corbin D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meng</LastName><ForeName>Shaowu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mieczkowski</LastName><ForeName>Piotr A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mose</LastName><ForeName>Lisle E</ForeName><Initials>LE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perou</LastName><ForeName>Amy H</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perou</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roach</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shi</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simons</LastName><ForeName>Janae V</ForeName><Initials>JV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skelly</LastName><ForeName>Tara</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soloway</LastName><ForeName>Matthew G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tan</LastName><ForeName>Donghui</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veluvolu</LastName><ForeName>Umadevi</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fan</LastName><ForeName>Huihui</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hinoue</LastName><ForeName>Toshinori</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laird</LastName><ForeName>Peter W</ForeName><Initials>PW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shen</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wanding</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellair</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>Kyle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Covington</LastName><ForeName>Kyle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creighton</LastName><ForeName>Chad J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinh</LastName><ForeName>Huyen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doddapaneni</LastName><ForeName>HarshaVardhan</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donehower</LastName><ForeName>Lawrence A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drummond</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gibbs</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glenn</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hale</LastName><ForeName>Walker</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Han</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Jianhong</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korchina</LastName><ForeName>Viktoriya</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Lora</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiuping</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morton</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muzny</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santibanez</LastName><ForeName>Jireh</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheth</LastName><ForeName>Margi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shinbrot</LastName><ForeName>Eve</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Linghua</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wheeler</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xi</LastName><ForeName>Liu</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fengmei</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hess</LastName><ForeName>Julian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Appelbaum</LastName><ForeName>Elizabeth L</ForeName><Initials>EL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bailey</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cordes</LastName><ForeName>Matthew G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ding</LastName><ForeName>Li</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fronick</LastName><ForeName>Catrina C</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fulton</LastName><ForeName>Lucinda A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fulton</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kandoth</LastName><ForeName>Cyriac</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mardis</LastName><ForeName>Elaine R</ForeName><Initials>ER</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLellan</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Heather K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crain</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curley</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gardner</LastName><ForeName>Johanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lau</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mallery</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paulauskis</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Penny</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelton</LastName><ForeName>Candace</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelton</LastName><ForeName>Troy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yena</LastName><ForeName>Peggy</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowen</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gastier-Foster</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerken</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leraas</LastName><ForeName>Kristen M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lichtenberg</LastName><ForeName>Tara M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Nilsa C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wise</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zmuda</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Niall</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costello</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hovens</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Andre L</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Ana C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fregnani</LastName><ForeName>José H</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Longatto-Filho</LastName><ForeName>Adhemar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reis</LastName><ForeName>Rui M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scapulatempo-Neto</LastName><ForeName>Cristovam</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silveira</LastName><ForeName>Henrique C S</ForeName><Initials>HCS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>Daniel O</ForeName><Initials>DO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burnette</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eschbacher</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermes</LastName><ForeName>Beth</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noss</LastName><ForeName>Ardene</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Rosy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Patricia D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ittmann</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huntsman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kohl</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Le</LastName><ForeName>Xuan</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thorp</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andry</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duffy</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyadov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paklina</LastName><ForeName>Oxana</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Setdikova</LastName><ForeName>Galiya</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shabunin</LastName><ForeName>Alexey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tavobilov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>McPherson</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warnick</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berkowitz</LastName><ForeName>Ross</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cramer</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feltmate</LastName><ForeName>Colleen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horowitz</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kibel</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muto</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raut</LastName><ForeName>Chandrajit P</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malykh</LastName><ForeName>Andrei</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barnholtz-Sloan</LastName><ForeName>Jill S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barrett</LastName><ForeName>Wendi</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devine</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fulop</LastName><ForeName>Jordonna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostrom</LastName><ForeName>Quinn T</ForeName><Initials>QT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shimmel</LastName><ForeName>Kristen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolinsky</LastName><ForeName>Yingli</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sloan</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Rose</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giuliante</LastName><ForeName>Felice</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodman</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karlan</LastName><ForeName>Beth Y</ForeName><Initials>BY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hagedorn</LastName><ForeName>Curt H</ForeName><Initials>CH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckman</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harr</LastName><ForeName>Jodi</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myers</LastName><ForeName>Jerome</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tucker</LastName><ForeName>Kelinda</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zach</LastName><ForeName>Leigh Anne</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deyarmin</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Hai</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kvecher</LastName><ForeName>Leonid</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larson</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mural</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Somiari</LastName><ForeName>Stella</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vicha</LastName><ForeName>Ales</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zelinka</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennett</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iacocca</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rabeno</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swanson</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Latour</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Têtu</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergeron</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGraw</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staugaitis</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chabot</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hibshoosh</LastName><ForeName>Hanina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sepulveda</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Su</LastName><ForeName>Tao</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potapova</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voronina</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desjardins</LastName><ForeName>Laurence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mariani</LastName><ForeName>Odette</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roman-Roman</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sastre</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stern</LastName><ForeName>Marc-Henri</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheng</LastName><ForeName>Feixiong</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Signoretti</LastName><ForeName>Sabina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berchuck</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bigner</LastName><ForeName>Darell</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipp</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marks</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCall</LastName><ForeName>Shannon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McLendon</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Secord</LastName><ForeName>Angeles</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharp</LastName><ForeName>Alexis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Behera</LastName><ForeName>Madhusmita</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brat</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delman</LastName><ForeName>Keith</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Force</LastName><ForeName>Seth</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khuri</LastName><ForeName>Fadlo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magliocca</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maithel</LastName><ForeName>Shishir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olson</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Owonikoko</LastName><ForeName>Taofeek</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pickens</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramalingam</LastName><ForeName>Suresh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shin</LastName><ForeName>Dong M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sica</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Meir</LastName><ForeName>Erwin G</ForeName><Initials>EG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongzheng</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eijckenboom</LastName><ForeName>Wil</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gillis</LastName><ForeName>Ad</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korpershoek</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Looijenga</LastName><ForeName>Leendert</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oosterhuis</LastName><ForeName>Wolter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoop</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Kessel</LastName><ForeName>Kim E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zwarthoff</LastName><ForeName>Ellen C</ForeName><Initials>EC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calatozzolo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuppini</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuzzubbo</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>DiMeco</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finocchiaro</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mattei</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perin</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollo</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Chu</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houck</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lohavanichbutr</LastName><ForeName>Pawadee</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Arndt</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoehr</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoehr</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taubert</LastName><ForeName>Helge</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wach</LastName><ForeName>Sven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wullich</LastName><ForeName>Bernd</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kycler</LastName><ForeName>Witold</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murawa</LastName><ForeName>Dawid</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wiznerowicz</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chung</LastName><ForeName>Ki</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edenfield</LastName><ForeName>W Jeffrey</ForeName><Initials>WJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baudin</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bubley</LastName><ForeName>Glenn</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bueno</LastName><ForeName>Raphael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Rienzo</LastName><ForeName>Assunta</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalkanis</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikkelsen</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noushmehr</LastName><ForeName>Houtan</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarpace</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girard</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aymerich</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campo</LastName><ForeName>Elias</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giné</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guillermo</LastName><ForeName>Armando López</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Bang</LastName><ForeName>Nguyen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hanh</LastName><ForeName>Phan Thi</ForeName><Initials>PT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phu</LastName><ForeName>Bui Duc</ForeName><Initials>BD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tang</LastName><ForeName>Yufang</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colman</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evason</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dottino</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martignetti</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabra</LastName><ForeName>Hani</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Juhl</LastName><ForeName>Hartmut</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akeredolu</LastName><ForeName>Teniola</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stepa</LastName><ForeName>Serghei</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoon</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahn</LastName><ForeName>Keunsoo</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kang</LastName><ForeName>Koo Jeong</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beuschlein</LastName><ForeName>Felix</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breggia</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birrer</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Debra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borad</LastName><ForeName>Mitesh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bryce</LastName><ForeName>Alan H</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castle</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chandan</LastName><ForeName>Vishal</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheville</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Copland</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farnell</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flotte</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giama</LastName><ForeName>Nasra</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Thai</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kendrick</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kocher</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kopp</LastName><ForeName>Karla</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moser</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagorney</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Brian Patrick</ForeName><Initials>BP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Tushar</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petersen</LastName><ForeName>Gloria</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Que</LastName><ForeName>Florencia</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivera</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roberts</LastName><ForeName>Lewis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smallridge</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smyrk</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stanton</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>R Houston</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torbenson</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Ju Dong</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lizhi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brimo</LastName><ForeName>Fadi</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajani</LastName><ForeName>Jaffer A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angulo Gonzalez</LastName><ForeName>Ana Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Behrens</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bondaruk</LastName><ForeName>Jolanta</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broaddus</LastName><ForeName>Russell</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Czerniak</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esmaeli</LastName><ForeName>Bita</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fujimoto</LastName><ForeName>Junya</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gershenwald</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazar</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Logothetis</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meric-Bernstam</LastName><ForeName>Funda</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moran</LastName><ForeName>Cesar</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramondetta</LastName><ForeName>Lois</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rice</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sood</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tamboli</LastName><ForeName>Pheroze</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Troncoso</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsao</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wistuba</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carter</LastName><ForeName>Candace</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haydu</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hersey</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jakrot</LastName><ForeName>Valerie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kakavand</LastName><ForeName>Hojabr</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kefford</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Long</LastName><ForeName>Georgina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mann</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saw</LastName><ForeName>Robyn</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scolyer</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shannon</LastName><ForeName>Kerwin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spillane</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stretch</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Synott</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilmott</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Al-Ahmadie</LastName><ForeName>Hikmat</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Timothy A</ForeName><Initials>TA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghossein</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gopalan</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levine</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reuter</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Bhuvanesh</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tien</LastName><ForeName>Nguyen Viet</ForeName><Initials>NV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broudy</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mirsaidi</LastName><ForeName>Cyrus</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nair</LastName><ForeName>Praveen</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drwiega</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Judy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaren</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Joong-Won</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hung</LastName><ForeName>Nguyen Phi</ForeName><Initials>NP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kebebew</LastName><ForeName>Electron</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linehan</LastName><ForeName>W Marston</ForeName><Initials>WM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Metwalli</LastName><ForeName>Adam R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pacak</LastName><ForeName>Karel</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiffman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Laura S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vocke</LastName><ForeName>Cathy D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wentzensen</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worrell</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Hannah</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moncrieff</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goparaju</LastName><ForeName>Chandra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melamed</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pass</LastName><ForeName>Harvey</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Botnariuc</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caraman</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cernat</LastName><ForeName>Mircea</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chemencedji</LastName><ForeName>Inga</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clipca</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doruc</LastName><ForeName>Serghei</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorincioi</LastName><ForeName>Ghenadie</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mura</LastName><ForeName>Sergiu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pirtac</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stancul</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tcaciuc</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albert</LastName><ForeName>Monique</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alexopoulou</LastName><ForeName>Iakovina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnaout</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartlett</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engel</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parfitt</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sekhon</LastName><ForeName>Harman</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rassl</LastName><ForeName>Doris M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rintoul</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bifulco</LastName><ForeName>Carlo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tamakawa</LastName><ForeName>Raina</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Urba</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayward</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Timmers</LastName><ForeName>Henri</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antenucci</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Facciolo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grazi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marino</LastName><ForeName>Mirella</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merola</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Krijger</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gimenez-Roqueplo</LastName><ForeName>Anne-Paule</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piché</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKercher</LastName><ForeName>Ginette</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birsoy</LastName><ForeName>Kivanc</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barnett</LastName><ForeName>Gene</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brewer</LastName><ForeName>Cathy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farver</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naska</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pennell</LastName><ForeName>Nathan A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raymond</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schilero</LastName><ForeName>Cathy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smolenski</LastName><ForeName>Kathy</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Felicia</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morrison</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borgia</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liptay</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pool</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seder</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Junker</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Omberg</LastName><ForeName>Larsson</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinkin</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manikhas</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvaro</LastName><ForeName>Domenico</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bragazzi</LastName><ForeName>Maria Consiglia</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardinale</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carpino</LastName><ForeName>Guido</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaudio</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chesla</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cottingham</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubina</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moiseenko</LastName><ForeName>Fedor</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhanasekaran</LastName><ForeName>Renumathy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becker</LastName><ForeName>Karl-Friedrich</ForeName><Initials>KF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janssen</LastName><ForeName>Klaus-Peter</ForeName><Initials>KP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slotta-Huspenina</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdel-Rahman</LastName><ForeName>Mohamed H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aziz</LastName><ForeName>Dina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cebulla</LastName><ForeName>Colleen M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duell</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elder</LastName><ForeName>J Bradley</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hilty</LastName><ForeName>Joe</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kumar</LastName><ForeName>Bahavna</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lang</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lehman</LastName><ForeName>Norman L</ForeName><Initials>NL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mandt</LastName><ForeName>Randy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phuong</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pilarski</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rai</LastName><ForeName>Karan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schoenfield</LastName><ForeName>Lynn</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senecal</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wakely</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hansen</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lechan</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Powers</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tischler</LastName><ForeName>Arthur</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grizzle</LastName><ForeName>William E</ForeName><Initials>WE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sexton</LastName><ForeName>Katherine C</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kastl</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henderson</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porten</LastName><ForeName>Sima</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waldmann</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fassnacht</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asa</LastName><ForeName>Sylvia L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schadendorf</LastName><ForeName>Dirk</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couce</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graefen</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huland</LastName><ForeName>Hartwig</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sauter</LastName><ForeName>Guido</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlomm</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simon</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tennstedt</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olabode</LastName><ForeName>Oluwole</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bathe</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>June M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Disaia</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glenn</LastName><ForeName>Pat</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kelley</LastName><ForeName>Robin K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landen</LastName><ForeName>Charles N</ForeName><Initials>CN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prados</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simko</LastName><ForeName>Jeffry</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith-McCune</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>VandenBerg</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roggin</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fehrenbach</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kendler</LastName><ForeName>Ady</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sifri</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steele</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jimeno</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carey</LastName><ForeName>Francis</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forgie</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carney</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campos</LastName><ForeName>Benito</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herold-Mende</LastName><ForeName>Christel</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jungk</LastName><ForeName>Christin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unterberg</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Deimling</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bossler</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbraith</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacobus</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knudson</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knutson</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Deqin</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milhem</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sigmund</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godwin</LastName><ForeName>Andrew K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madan</LastName><ForeName>Rashna</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Howard G</ForeName><Initials>HG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adebamowo</LastName><ForeName>Clement</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adebamowo</LastName><ForeName>Sally N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boussioutas</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beer</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giordano</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mes-Masson</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saad</LastName><ForeName>Fred</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bocklage</LastName><ForeName>Therese</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landrum</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannel</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moxley</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postier</LastName><ForeName>Russel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zuna</LastName><ForeName>Rosemary</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feldman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valdivieso</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhir</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luketich</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mora Pinero</LastName><ForeName>Edna M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quintero-Aguilo</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carlotti</LastName><ForeName>Carlos Gilberto</ForeName><Initials>CG</Initials><Suffix>Jr.</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Jose Sebastião</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemp</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sankarankuty</LastName><ForeName>Ajith</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tirapelli</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catto</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agnew</LastName><ForeName>Kathy</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swisher</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creaney</LastName><ForeName>Jenette</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shelley</LastName><ForeName>Carl Simon</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godwin</LastName><ForeName>Eryn M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kendall</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shipman</LastName><ForeName>Cassaundra</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradford</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carey</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haddad</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moyer</LastName><ForeName>Jeffey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peterson</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prince</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozek</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolf</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowman</LastName><ForeName>Rayleen</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fong</LastName><ForeName>Kwun M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korst</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rathmell</LastName><ForeName>W Kimryn</ForeName><Initials>WK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fantacone-Campbell</LastName><ForeName>J Leigh</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hooke</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kovatich</LastName><ForeName>Albert J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shriver</LastName><ForeName>Craig D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>DiPersio</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drake</LastName><ForeName>Bettina</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Govindan</LastName><ForeName>Ramaswamy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heath</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ley</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Tine</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westervelt</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rubin</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Jung Il</ForeName><Initials>JI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aredes</LastName><ForeName>Natália D</ForeName><Initials>ND</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mariamidze</LastName><ForeName>Armaz</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29596782</ArticleId><ArticleId IdType="pii">S2405-4712(18)30096-6</ArticleId><ArticleId IdType="doi">10.1016/j.cels.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC6075717</ArticleId><ArticleId IdType="mid">NIHMS954142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Med. 2016 Jan;22(1):97-104</Citation><ArticleIdList><ArticleId IdType="pubmed">26657142</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2001 Jan 1;29(1):308-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11125122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Apr 1;29(4):784-787</Citation><ArticleIdList><ArticleId IdType="pubmed">29462260</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2013 May;93(5):396-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23549146</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Apr 1;41(6):e67</Citation><ArticleIdList><ArticleId IdType="pubmed">23303777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2017 Feb;7(2):118</Citation><ArticleIdList><ArticleId IdType="pubmed">28077436</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013 Jun 10;14:189</Citation><ArticleIdList><ArticleId IdType="pubmed">23758877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Nov 1;25(21):2865-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19561018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Jul;12(7):623-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25984700</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Oct 17;502(7471):333-339</Citation><ArticleIdList><ArticleId IdType="pubmed">24132290</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Sep 15;33(18):2938-2940</Citation><ArticleIdList><ArticleId IdType="pubmed">28645171</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2012 Mar;22(3):568-76</Citation><ArticleIdList><ArticleId IdType="pubmed">22300766</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2012 Aug;22(8):1589-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22759861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Feb 1;28(3):311-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22155872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jul 11;499(7457):214-218</Citation><ArticleIdList><ArticleId IdType="pubmed">23770567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Mar 28;483(7391):603-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22460905</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11</Citation><ArticleIdList><ArticleId IdType="pubmed">25355519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2018 Jan 9;24(1):7-9</Citation><ArticleIdList><ArticleId IdType="pubmed">29315296</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Mar;31(3):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23396013</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 Jun 06;17(1):122</Citation><ArticleIdList><ArticleId IdType="pubmed">27268795</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2010 Sep;20(9):1297-303</Citation><ArticleIdList><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Aug 17;536(7616):285-91</Citation><ArticleIdList><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2016 Aug 24;17(1):178</Citation><ArticleIdList><ArticleId IdType="pubmed">27557938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2017 May 1;77(9):2464-2475</Citation><ArticleIdList><ArticleId IdType="pubmed">28235761</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2010;11(5):207</Citation><ArticleIdList><ArticleId IdType="pubmed">20441614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 24;471(7339):467-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21430775</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2016 Jun 23;2016:</Citation><ArticleIdList><ArticleId IdType="pubmed">27337980</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Nov 18;9(11):e111516</Citation><ArticleIdList><ArticleId IdType="pubmed">25405470</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2013 Sep 30;5(9):90</Citation><ArticleIdList><ArticleId IdType="pubmed">24073752</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29576963</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2167-8359</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>Electroencephalographic modulations during an open- or closed-eyes motor task.</ArticleTitle><Pagination><MedlinePgn>e4492</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.4492</ELocationID><Abstract><AbstractText>There is fundamental knowledge that during the resting state cerebral activity recorded by electroencephalography (EEG) is strongly modulated by the eyes-closed condition compared to the eyes-open condition, especially in the occipital lobe. However, little research has demonstrated the influence of the eyes-closed condition on the motor cortex, particularly during a self-paced movement. This prompted the question: How does the motor cortex activity change between the eyes-closed and eyes-open conditions? To answer this question, we recorded EEG signals from 15 voluntary healthy subjects who performed a simple motor task (i.e., a voluntary isometric flexion of the right-hand index) under two conditions: eyes-closed and eyes-open. Our results confirmed strong modulation in the mu rhythm (7-13 Hz) with a large event-related desynchronisation. However, no significant differences have been observed in the beta band (15-30 Hz). Furthermore, evidence suggests that the eyes-closed condition influences the behaviour of subjects. This study gives us greater insight into the motor cortex and could also be useful in the brain-computer interface (BCI) domain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rimbert</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurosys team, Inria, Villers-lès-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Artificial Intelligence and Complex Systems, Université de Lorraine, LORIA, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosys team, CNRS, LORIA, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chwa</LastName><ForeName>Rahaf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurosys team, Inria, Villers-lès-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Artificial Intelligence and Complex Systems, Université de Lorraine, LORIA, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaepffel</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unaffiliated, Dambach-la-ville, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bougrain</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurosys team, Inria, Villers-lès-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Artificial Intelligence and Complex Systems, Université de Lorraine, LORIA, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosys team, CNRS, LORIA, Vandœuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electroencephalography</Keyword><Keyword MajorTopicYN="N">Event-related desynchronization (ERD)</Keyword><Keyword MajorTopicYN="N">Event-relatedsynchronization (ERS)</Keyword><Keyword MajorTopicYN="N">Eyes-closed</Keyword><Keyword MajorTopicYN="N">Eyes-open</Keyword><Keyword MajorTopicYN="N">Motor cortex</Keyword><Keyword MajorTopicYN="N">Real movement</Keyword><Keyword MajorTopicYN="N">Voluntary movement</Keyword></KeywordList><CoiStatement>The authors declare there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29576963</ArticleId><ArticleId IdType="doi">10.7717/peerj.4492</ArticleId><ArticleId IdType="pii">4492</ArticleId><ArticleId IdType="pmc">PMC5857351</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hum Brain Mapp. 2012 Aug;33(8):1834-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21618665</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2016 Feb;127(2):1261-1268</Citation><ArticleIdList><ArticleId IdType="pubmed">26603651</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 1999 Nov;110(11):1842-57</Citation><ArticleIdList><ArticleId IdType="pubmed">10576479</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Ital Biol. 1993 Jan;131(1):25-35</Citation><ArticleIdList><ArticleId IdType="pubmed">8481083</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2007 Dec;118(12):2765-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17911042</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2009 Oct;120(10):1806-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19748828</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychophysiol. 2006 Nov;62(2):321-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16904786</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2009 Jan;120(1):24-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19028138</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 1997 Apr;5(3):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9345551</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1977 Jun;42(6):817-26</Citation><ArticleIdList><ArticleId IdType="pubmed">67933</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 2001;41(10-11):1257-60</Citation><ArticleIdList><ArticleId IdType="pubmed">11322970</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1979 Feb;46(2):138-46</Citation><ArticleIdList><ArticleId IdType="pubmed">86421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2008 Jan 15;167(1):43-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17399797</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroeng Rehabil. 2013 Feb 26;10:24</Citation><ArticleIdList><ArticleId IdType="pubmed">23442349</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1962 Dec;14:858-68</Citation><ArticleIdList><ArticleId IdType="pubmed">14020161</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 1997 Dec 19;239(2-3):65-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9469657</ArticleId></ArticleIdList></Reference><Reference><Citation>Pflugers Arch Gesamte Physiol Menschen Tiere. 1965 May 10;284:1-17</Citation><ArticleIdList><ArticleId IdType="pubmed">14341490</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychologia. 1995 Nov;33(11):1419-32</Citation><ArticleIdList><ArticleId IdType="pubmed">8584178</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Tech (Berl). 2013 Sep 7;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">24042816</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2004 Apr;21(4):1818-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15050602</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Brain Res. 2006 Jun;172(1):94-102</Citation><ArticleIdList><ArticleId IdType="pubmed">16369787</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1967 Feb;22(2):174-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4163688</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1969 Nov;27(5):470-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4187033</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2013 Jul;245:15-26</Citation><ArticleIdList><ArticleId IdType="pubmed">23022918</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2006 Nov;117(11):2341-56</Citation><ArticleIdList><ArticleId IdType="pubmed">16876476</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2004 Mar 15;134(1):9-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15102499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Postgrad Med. 2002 Jul-Sep;48(3):206-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12432198</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 1998 Oct;22(6):761-88</Citation><ArticleIdList><ArticleId IdType="pubmed">9809311</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Psychol. 1997;48:269-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9046562</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(5):e37534</Citation><ArticleIdList><ArticleId IdType="pubmed">22624046</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Integr Neurosci. 2012 Aug 14;6:59</Citation><ArticleIdList><ArticleId IdType="pubmed">22912607</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2005 May;116(5):1213-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15826864</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2003 Feb;114(2):376-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12559247</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychophysiol. 2001 Dec;43(1):41-58</Citation><ArticleIdList><ArticleId IdType="pubmed">11742684</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1936 Mar 13;83(2150):259-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17757098</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1989 Feb;72(2):184-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2464490</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:4112-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23366832</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscientist. 2008 Aug;14(4):319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">18660462</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1993 Dec;116 ( Pt 6):1387-98</Citation><ArticleIdList><ArticleId IdType="pubmed">8293277</ArticleId></ArticleIdList></Reference><Reference><Citation>Epilepsia. 2003;44 Suppl 12:2-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14641556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2013 Mar;23(3):520-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22414772</ArticleId></ArticleIdList></Reference><Reference><Citation>Electroencephalogr Clin Neurophysiol. 1996 Apr;98(4):281-93</Citation><ArticleIdList><ArticleId IdType="pubmed">8641150</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Brain Res. 2017 Jul;235(7):2059-2067</Citation><ArticleIdList><ArticleId IdType="pubmed">28365800</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6277-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22255773</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2013 Jul;245:27-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22981841</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2014 Aug 20;8:645</Citation><ArticleIdList><ArticleId IdType="pubmed">25191258</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2003 Apr 10;340(2):143-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12668257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29573941</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.</ArticleTitle><Pagination><MedlinePgn>603-615</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(18)30142-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(18)30142-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Combined BRAF-MEK inhibitor therapy is the standard of care for BRAF<sup>V600</sup>-mutant advanced melanoma. We investigated encorafenib, a BRAF inhibitor with unique target-binding properties, alone or in combination with the MEK inhibitor binimetinib, versus vemurafenib in patients with advanced BRAF<sup>V600</sup>-mutant melanoma.</AbstractText><AbstractText Label="METHODS">COLUMBUS was conducted as a two-part, randomised, open-label phase 3 study at 162 hospitals in 28 countries. Eligible patients were aged 18 years or older and had histologically confirmed locally advanced (American Joint Committee on Cancer [AJCC] stage IIIB, IIIC, or IV), unresectable or metastatic cutaneous melanoma, or unknown primary melanoma; a BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutation; an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; and were treatment naive or had progressed on or after previous first-line immunotherapy. In part 1 of the study, patients were randomly assigned (1:1:1) via interactive response technology to receive either oral encorafenib 450 mg once daily plus oral binimetinib 45 mg twice daily (encorafenib plus binimetinib group), oral encorafenib 300 mg once daily (encorafenib group), or oral vemurafenib 960 mg twice daily (vemurafenib group). The primary endpoint was progression-free survival by blinded independent central review for encorafenib plus binimetinib versus vemurafenib. Efficacy analyses were by intention-to-treat. Safety was analysed in patients who received at least one dose of study drug and one postbaseline safety assessment. The results of part 2 will be published separately. This study is registered with ClinicalTrials.gov, number NCT01909453, and EudraCT, number 2013-001176-38.</AbstractText><AbstractText Label="FINDINGS">Between Dec 30, 2013, and April 10, 2015, 577 of 1345 screened patients were randomly assigned to either the encorafenib plus binimetinib group (n=192), the encorafenib group (n=194), or the vemurafenib group (n=191). With a median follow-up of 16·6 months (95% CI 14·8-16·9), median progression-free survival was 14·9 months (95% CI 11·0-18·5) in the encorafenib plus binimetinib group and 7·3 months (5·6-8·2) in the vemurafenib group (hazard ratio [HR] 0·54, 95% CI 0·41-0·71; two-sided p&lt;0·0001). The most common grade 3-4 adverse events seen in more than 5% of patients in the encorafenib plus binimetinib group were increased γ-glutamyltransferase (18 [9%] of 192 patients), increased creatine phosphokinase (13 [7%]), and hypertension (11 [6%]); in the encorafenib group they were palmoplantar erythrodysaesthesia syndrome (26 [14%] of 192 patients), myalgia (19 [10%]), and arthralgia (18 [9%]); and in the vemurafenib group it was arthralgia (11 [6%] of 186 patients). There were no treatment-related deaths except for one death in the combination group, which was considered possibly related to treatment by the investigator.</AbstractText><AbstractText Label="INTERPRETATION">Encorafenib plus binimetinib and encorafenib monotherapy showed favourable efficacy compared with vemurafenib. Overall, encorafenib plus binimetinib appears to have an improved tolerability profile compared with encorafenib or vemurafenib. Encorafenib plus binimetinib could represent a new treatment option for patients with BRAF-mutant melanoma.</AbstractText><AbstractText Label="FUNDING">Array BioPharma, Novartis.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dummer</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: reinhard.dummer@usz.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascierto</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogas</LastName><ForeName>Helen J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arance</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandala</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liszkay</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Dermatology, National Institute of Oncology, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garbe</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Tüebingen, Tüebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schadendorf</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajsova</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Dermato-oncology, University Hospital Prague, Charles University First Medical Faculty, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutzmer</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarion-Sileni</LastName><ForeName>Vanna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutriaux</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Jan Willem B</ForeName><Initials>JWB</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Isala, Zwolle, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamazaki</LastName><ForeName>Naoya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loquai</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Medical Center Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutouh-de Parseval</LastName><ForeName>Laure A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickard</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Array BioPharma, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandor</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Array BioPharma, Boulder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service of Dermatology, Department of Medicine, Paris-Sud University, Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaherty</LastName><ForeName>Keith T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Cancer Center, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01909453</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001562">Benzimidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002219">Carbamates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>181R97MR71</RegistryNumber><NameOfSubstance UI="C581313">binimetinib</NameOfSubstance></Chemical><Chemical><RegistryNumber>207SMY3FQT</RegistryNumber><NameOfSubstance UI="D000077484">Vemurafenib</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L7891MRB6</RegistryNumber><NameOfSubstance UI="C000601108">encorafenib</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C482119">BRAF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 May;19(5):580-581</RefSource><PMID Version="1">29573940</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Clin Oncol. 2018 Jun;15(6):344-345</RefSource><PMID Version="1">29651128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001562" MajorTopicYN="N">Benzimidazoles</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002219" MajorTopicYN="N">Carbamates</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048493" MajorTopicYN="N">Proto-Oncogene Proteins B-raf</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077484" MajorTopicYN="N">Vemurafenib</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29573941</ArticleId><ArticleId IdType="pii">S1470-2045(18)30142-6</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(18)30142-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29556187</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5196</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in neuroinformatics</Title><ISOAbbreviation>Front Neuroinform</ISOAbbreviation></Journal><ArticleTitle>Arkheia: Data Management and Communication for Open Computational Neuroscience.</ArticleTitle><Pagination><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fninf.2018.00006</ELocationID><Abstract><AbstractText>Two trends have been unfolding in computational neuroscience during the last decade. First, a shift of focus to increasingly complex and heterogeneous neural network models, with a concomitant increase in the level of collaboration within the field (whether direct or in the form of building on top of existing tools and results). Second, a general trend in science toward more open communication, both internally, with other potential scientific collaborators, and externally, with the wider public. This multi-faceted development toward more integrative approaches and more intense communication within and outside of the field poses major new challenges for modelers, as currently there is a severe lack of tools to help with automatic communication and sharing of all aspects of a simulation workflow to the rest of the community. To address this important gap in the current computational modeling software infrastructure, here we introduce Arkheia. Arkheia is a web-based open science platform for computational models in systems neuroscience. It provides an automatic, interactive, graphical presentation of simulation results, experimental protocols, and interactive exploration of parameter searches, in a web browser-based application. Arkheia is focused on automatic presentation of these resources with minimal manual input from users. Arkheia is written in a modular fashion with a focus on future development of the platform. The platform is designed in an open manner, with a clearly defined and separated API for database access, so that any project can write its own backend translating its data into the Arkheia database format. Arkheia is not a centralized platform, but allows any user (or group of users) to set up their own repository, either for public access by the general population, or locally for internal use. Overall, Arkheia provides users with an automatic means to communicate information about not only their models but also individual simulation results and the entire experimental context in an approachable graphical manner, thus facilitating the user's ability to collaborate in the field and outreach to a wider audience.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antolík</LastName><ForeName>Ján</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut National de la Santé et de la Recherche Médicale UMRI S 968; Sorbonne Universits, UPMC Univ Paris 06, UMR S 968; Centre National de la Recherche Scientifique, UMR 7210, Institut de la Vision, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unité de Neurosciences, Information et Complexité, Centre National de la Recherche Scientifique UPR 3293, Gif-sur-Yvette, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Unité de Neurosciences, Information et Complexité, Centre National de la Recherche Scientifique UPR 3293, Gif-sur-Yvette, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neuroinform</MedlineTA><NlmUniqueID>101477957</NlmUniqueID><ISSNLinking>1662-5196</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">computational modeling</Keyword><Keyword MajorTopicYN="N">neuroscience</Keyword><Keyword MajorTopicYN="N">publish</Keyword><Keyword MajorTopicYN="N">tool</Keyword><Keyword MajorTopicYN="N">workflow</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29556187</ArticleId><ArticleId IdType="doi">10.3389/fninf.2018.00006</ArticleId><ArticleId IdType="pmc">PMC5845131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Rev Neurosci. 2006 Feb;7(2):153-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16429124</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2016 Nov 2;92 (3):628-631</Citation><ArticleIdList><ArticleId IdType="pubmed">27810006</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Feb 20;8:10</Citation><ArticleIdList><ArticleId IdType="pubmed">24600386</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Eng Med Biol Mag. 2009 May-Jun;28(3):19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19457730</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Mar 05;8:17</Citation><ArticleIdList><ArticleId IdType="pubmed">24634655</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2016 Aug 25;10:38</Citation><ArticleIdList><ArticleId IdType="pubmed">27610080</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2009 Jan 27;2:11</Citation><ArticleIdList><ArticleId IdType="pubmed">19194529</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">27382147</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Jan 17;7:52</Citation><ArticleIdList><ArticleId IdType="pubmed">24478691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Mar 1;19(4):524-31</Citation><ArticleIdList><ArticleId IdType="pubmed">12611808</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Dec 10;7:34</Citation><ArticleIdList><ArticleId IdType="pubmed">24368902</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Nov 11;7:26</Citation><ArticleIdList><ArticleId IdType="pubmed">24273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Jan 06;7:48</Citation><ArticleIdList><ArticleId IdType="pubmed">24431999</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2017 May 25;20(6):770-773</Citation><ArticleIdList><ArticleId IdType="pubmed">28542156</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Apr 22;8:36</Citation><ArticleIdList><ArticleId IdType="pubmed">24795617</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Feb 04;8:6</Citation><ArticleIdList><ArticleId IdType="pubmed">24550820</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Comput Neurosci. 2014 Nov 03;8:137</Citation><ArticleIdList><ArticleId IdType="pubmed">25404913</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Dec 30;7:44</Citation><ArticleIdList><ArticleId IdType="pubmed">24416014</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Mar 05;8:15</Citation><ArticleIdList><ArticleId IdType="pubmed">24634654</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Jul 10;8:63</Citation><ArticleIdList><ArticleId IdType="pubmed">25071540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Mar 21;483(7390):397-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22437592</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29555258</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.</ArticleTitle><Pagination><MedlinePgn>660-671</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(18)30140-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(18)30140-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Studies of a modified XELIRI (mXELIRI; capecitabine plus irinotecan) regimen suggest promising efficacy and tolerability profiles in the first-line and second-line settings. Therefore, we aimed to compare the efficacy and safety of the mXELIRI regimen with that of standard FOLFIRI (leucovorin, fluorouracil, and irinotecan), with or without bevacizumab in both regimens, as a second-line therapy for metastatic colorectal cancer.</AbstractText><AbstractText Label="METHODS">We did a multicentre, open-label, randomised, non-inferiority, phase 3 trial. We enrolled patients from 98 hospitals in Japan, China, and South Korea who were aged 20 years or older with histologically confirmed and unresectable colorectal adenocarcinoma, and who had withdrawn from first-line chemotherapy for metastatic colorectal cancer. We randomly assigned patients (1:1) to receive either mXELIRI with or without bevacizumab (irinotecan 200 mg/m<sup>2</sup> intravenously on day 1 plus oral capecitabine 800 mg/m<sup>2</sup> twice daily on days 1-14, repeated every 21 days, with or without bevacizumab 7·5 mg/kg intravenously on day 1) or FOLFIRI with or without bevacizumab (irinotecan 180 mg/m<sup>2</sup> intravenously on day 1, leucovorin 200 mg/m<sup>2</sup> intravenously on day 1, fluorouracil 400 mg/m<sup>2</sup> intravenously on day 1, and a 46-h continuous intravenous infusion of fluorouracil [2400 mg/m<sup>2</sup>], repeated every 14 days, with or without the addition of bevacizumab 5 mg/kg intravenously on day 1) via a centralised electronic system. We used the minimisation method to stratify randomisation by country, Eastern Cooperative Oncology Group performance status, number of metastatic sites, previous oxaliplatin treatment, and concomitant bevacizumab treatment. Patients and clinicians were not masked to the allocated treatment. The primary endpoint was overall survival analysed on an intention-to-treat basis with a non-inferiority upper margin of 1·30 for the hazard ratio (HR). This study is registered with ClinicalTrials.gov, number NCT01996306, and is ongoing but no longer recruiting participants.</AbstractText><AbstractText Label="FINDINGS">Between Dec 2, 2013, and Aug 13, 2015, 650 patients were enrolled and randomly assigned to receive mXELIRI with or without bevacizumab (n=326) or FOLFIRI with or without bevacizumab (n=324). After a median follow-up of 15·8 months (IQR 8·7-24·9), a total of 490 patients had died (242 in the mXELIRI with or without bevacizumab group and 248 in the FOLFIRI with or without bevacizumab group) and the median overall survival was 16·8 months (95% CI 15·3-19·1) in the mXELIRI group and 15·4 months (13·0-17·7) in the FOLFIRI group (HR 0·85, 95% CI 0·71-1·02; p<sub>non-inferiority</sub>&lt;0·0001). In the per-protocol safety population, the most common grade 3-4 adverse event was neutropenia (affecting 52 [17%] of 310 patients in the mXELIRI group and 133 [43%] of 310 in the FOLFIRI group). Incidences of grade 3-4 diarrhoea were higher in the mXELIRI group (22 [7%]) than in the FOLFIRI group (ten [3%]). Serious adverse events were reported in 46 (15%) of 310 patients in the mXELIRI group and 63 (20%) of 310 in the FOLFIRI group. Two treatment-related deaths (one pneumonitis and one lung infection) were observed in the mXELIRI group and there was one treatment-related death (lung infection) in the FOLFIRI group.</AbstractText><AbstractText Label="INTERPRETATION">mXELIRI with or without bevacizumab is well tolerated and non-inferior to FOLFIRI with or without bevacizumab in terms of overall survival. mXELIRI could be an alternative to FOLFIRI as a standard second-line backbone treatment for metastatic colorectal cancer, at least for Asian patient populations.</AbstractText><AbstractText Label="FUNDING">Chugai Pharmaceutical and F Hoffmann-La Roche.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Rui-Hua</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muro</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasa</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Sae Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Oncology, The First People's Hospital of Foshan, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotaka</LastName><ForeName>Masahito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Joong Bae</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Severance Hospital, Yonsei University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yan-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sang-Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Hematology-Oncology, Chonnam National University Hospital, Hwasun, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Digestive Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Fujita Health University School of Medicine, Toyoake, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Keun-Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Yasuhide</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Oncology, National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tokai Central Hospital, Kakamigahara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Young Suk</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Won</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: twkimmd@amc.seoul.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01996306</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020533">Angiogenesis Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074322">Antineoplastic Agents, Immunological</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W860991D6</RegistryNumber><NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S9ZZM9Q9V</RegistryNumber><NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q573I9DVLP</RegistryNumber><NameOfSubstance UI="D002955">Leucovorin</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical><Chemical><RegistryNumber>XT3Z54Z28A</RegistryNumber><NameOfSubstance UI="D002166">Camptothecin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C480833">IFL protocol</SupplMeshName><SupplMeshName Type="Protocol" UI="C520768">capecitabine-irinotecan combination</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 May;19(5):587-589</RefSource><PMID Version="1">29555259</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020533" MajorTopicYN="N">Angiogenesis Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074322" MajorTopicYN="N">Antineoplastic Agents, Immunological</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068258" MajorTopicYN="N">Bevacizumab</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002166" MajorTopicYN="N">Camptothecin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002955" MajorTopicYN="N">Leucovorin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29555258</ArticleId><ArticleId IdType="pii">S1470-2045(18)30140-2</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(18)30140-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29553146</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2515-5059</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>MNI open research</Title><ISOAbbreviation>MNI Open Res</ISOAbbreviation></Journal><ArticleTitle>Defining Success in Open Science.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12688/mniopenres.12780.1</ELocationID><Abstract><AbstractText>Mounting evidence indicates that worldwide, innovation systems are increasing unsustainable. Equally, concerns about inequities in the science and innovation process, and in access to its benefits, continue. Against a backdrop of growing health, economic and scientific challenges global stakeholders are urgently seeking to spur innovation and maximize the just distribution of benefits for all. Open Science collaboration (OS) - comprising a variety of approaches to increase open, public, and rapid mobilization of scientific knowledge - is seen to be one of the most promising ways forward. Yet, many decision-makers hesitate to construct policy to support the adoption and implementation of OS without access to substantive, clear and reliable evidence. In October 2017, international thought-leaders gathered at an Open Science Leadership Forum in the Washington DC offices of the Bill and Melinda Gates Foundation to share their views on what successful Open Science looks like. Delegates from developed and developing nations, national governments, science agencies and funding bodies, philanthropy, researchers, patient organizations and the biotechnology, pharma and artificial intelligence (AI) industries discussed the outcomes that would rally them to invest in OS, as well as wider issues of policy and implementation. This first of two reports, summarizes delegates' views on what they believe OS will deliver in terms of research, innovation and social impact in the life sciences. Through open and collaborative process over the next months, we will translate these success outcomes into a toolkit of quantitative and qualitative indicators to assess when, where and how open science collaborations best advance research, innovation and social benefit. Ultimately, this work aims to develop and openly share tools to allow stakeholders to evaluate and re-invent their innovation ecosystems, to maximize value for the global public and patients, and address long-standing questions about the mechanics of innovation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali-Khan</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, 3801 University, Montreal, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>E Richard</ForeName><Initials>ER</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3789-9238</Identifier><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Stewart Biology Building, 1205 Avenue Dr. Penfield, Montreal, H3A 1B1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>MNI Open Res</MedlineTA><NlmUniqueID>101718757</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evaluation</Keyword><Keyword MajorTopicYN="N">Open Science</Keyword><Keyword MajorTopicYN="N">indicators</Keyword><Keyword MajorTopicYN="N">innovation</Keyword><Keyword MajorTopicYN="N">intellectual property</Keyword><Keyword MajorTopicYN="N">open access</Keyword><Keyword MajorTopicYN="N">policy</Keyword><Keyword MajorTopicYN="N">social and economic benefits</Keyword></KeywordList><CoiStatement>Competing interests: The authors received financial support from the Tannenbaum Open Science Institute, where ERG heads the Monitoring and Evaluation Committee.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29553146</ArticleId><ArticleId IdType="doi">10.12688/mniopenres.12780.1</ArticleId><ArticleId IdType="pmc">PMC5852639</ArticleId></ArticleIdList><?nihms ?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29536282</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2197-1153</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of experimental orthopaedics</Title><ISOAbbreviation>J Exp Orthop</ISOAbbreviation></Journal><ArticleTitle>Open versus arthroscopic repair of the triangular fibrocartilage complex: a systematic review.</ArticleTitle><Pagination><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40634-018-0120-1</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">To investigate the outcome of open versus arthroscopic repair of injuries of the triangular fibrocartilage complex (TFCC).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An electronic literature search of articles published between January 1, 1985, and May 26, 2016, in PubMed, Embase, and the Cochrane Library was carried out in May 2016 and updated in March and December 2017. Studies comparing open and arthroscopic repair of TFCC injury with a mean follow up of more than 1 year were eligible for inclusion. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist guided the extraction and reporting of data. The methodological quality of the included articles was assessed with the Cochrane Collaboration's tool for assessing risk of bias. The primary outcome measure was the rate of postoperative distal radioulnar joint (DRUJ) re-instability. Secondary outcome measures were range of motion (ROM), grip strength, residual pain, functional wrist scores and the rates of complications and re-operations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 868 articles were identified by the electronic search. After duplicate removal and subsequent study selection, a total of two studies were included in this systematic review. The methodological quality of the included articles displayed risks of bias. There was no difference in DRUJ re-instability between open and arthroscopic repair of the TFCC. There were no differences in obtained postoperative ROM, grip strength or values in functional outcome scores, between open and arthroscopic TFCC repair in the two included studies, except for the Disability of the Arm Shoulder and Hand (DASH) questionnaire - in favor of arthroscopic surgery - in one of the included studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This systematic review shows comparable results between open and arthroscopic repair of the TFCC, in terms of DRUJ re-instability and functional outcome scores. There is insufficient evidence to recommend one technique over the other in clinical practice. There is an immense lack of comparison studies with high level of evidence in the area of wrist ligament repair and reconstruction, including TFCC-injuries and DRUJ-instability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Jonny K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Hand Surgery, Sahlgrenska University Hospital, SE-413 45, Göteborg, Sweden. jonny_a@telia.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. jonny_a@telia.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Åhlén</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hand Surgery, Sahlgrenska University Hospital, SE-413 45, Göteborg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andernord</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vårdcentralen Gripen, Karlstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, County Council of Värmland, Karlstad, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Exp Orthop</MedlineTA><NlmUniqueID>101653750</NlmUniqueID><ISSNLinking>2197-1153</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthroscopic repair, Systematic review</Keyword><Keyword MajorTopicYN="N">Open repair</Keyword><Keyword MajorTopicYN="N">Triangular fibrocartilage complex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29536282</ArticleId><ArticleId IdType="doi">10.1186/s40634-018-0120-1</ArticleId><ArticleId IdType="pii">10.1186/s40634-018-0120-1</ArticleId><ArticleId IdType="pmc">PMC5849747</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Hand Surg Am. 2013 Feb;38(2):271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23351910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tech Hand Up Extrem Surg. 2003 Dec;7(4):134-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16518212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand Surg. 2013;18(1):21-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23413845</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Trauma. 1998 Nov-Dec;12(8):577-86</Citation><ArticleIdList><ArticleId IdType="pubmed">9840793</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2008 Nov;24(11):1244-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18971054</ArticleId></ArticleIdList></Reference><Reference><Citation>J Wrist Surg. 2015 Feb;4(1):22-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25709875</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 1990;6(2):120-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2363779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand Clin. 2011 Aug;27(3):263-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21871349</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2008 May-Jun;33(5):675-82</Citation><ArticleIdList><ArticleId IdType="pubmed">18590850</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Oct;62(10):1006-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 1994 Jan;19(1):143-54</Citation><ArticleIdList><ArticleId IdType="pubmed">8169359</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2011 Jun;82(3):360-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21504313</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 1987 Jan;(214):136-47</Citation><ArticleIdList><ArticleId IdType="pubmed">3791735</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2011 Oct;27(10 ):1371-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21868189</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2013 Nov;29(11):1762-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24209673</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 1990;6(2):125-32</Citation><ArticleIdList><ArticleId IdType="pubmed">2363780</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2005 Sep;30(5):1074.e1-1074.e10</Citation><ArticleIdList><ArticleId IdType="pubmed">16182070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Eur Vol. 2015 Oct;40(8):783-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26037650</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Sports Med. 2015 Jan;43(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25325560</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 1996 Oct;12(5):588-97</Citation><ArticleIdList><ArticleId IdType="pubmed">8902134</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Orthop. 2008 Feb;32(1):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17534619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tech Hand Up Extrem Surg. 2008 Dec;12(4):226-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19060683</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 1996 Jun;12(3):339-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8783830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Eur Vol. 2014 Oct;39(8):845-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23962870</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthroscopy. 2005 Sep;21(9):1126-30</Citation><ArticleIdList><ArticleId IdType="pubmed">16171639</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand Clin. 2011 Aug;27(3):281-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21871351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 1997 Sep;22(5):772-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9330132</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2016 May;41(5):615-23</Citation><ArticleIdList><ArticleId IdType="pubmed">27039349</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand Clin. 1994 Nov;10(4):605-14</Citation><ArticleIdList><ArticleId IdType="pubmed">7868628</ArticleId></ArticleIdList></Reference><Reference><Citation>Tech Hand Up Extrem Surg. 2000 Sep;4(3):154-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16609384</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Br. 1997 Oct;22(5):638-43</Citation><ArticleIdList><ArticleId IdType="pubmed">9752922</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2012 Aug;37(8):1555-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22835585</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 1996 Mar;78(3):357-65</Citation><ArticleIdList><ArticleId IdType="pubmed">8613442</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Ind Med. 1996 Jun;29(6):602-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8773720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 1989 Jul;14(4):594-606</Citation><ArticleIdList><ArticleId IdType="pubmed">2666492</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 2000 Jul;(376):229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10906880</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Br. 1994 Aug;19(4):505-12</Citation><ArticleIdList><ArticleId IdType="pubmed">7964104</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Orthop. 2001;25(6):392-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11820450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2010 Oct;35(10):1607-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20888497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakartidningen. 2011 Oct 19-25;108(42):2096-101</Citation><ArticleIdList><ArticleId IdType="pubmed">22165536</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hand Surg Am. 2006 Mar;31(3):445-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16516740</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29534069</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>PRISM: An open source framework for the interactive design of GPU volume rendering shaders.</ArticleTitle><Pagination><MedlinePgn>e0193636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0193636</ELocationID><Abstract><AbstractText>Direct volume rendering has become an essential tool to explore and analyse 3D medical images. Despite several advances in the field, it remains a challenge to produce an image that highlights the anatomy of interest, avoids occlusion of important structures, provides an intuitive perception of shape and depth while retaining sufficient contextual information. Although the computer graphics community has proposed several solutions to address specific visualization problems, the medical imaging community still lacks a general volume rendering implementation that can address a wide variety of visualization use cases while avoiding complexity. In this paper, we propose a new open source framework called the Programmable Ray Integration Shading Model, or PRISM, that implements a complete GPU ray-casting solution where critical parts of the ray integration algorithm can be replaced to produce new volume rendering effects. A graphical user interface allows clinical users to easily experiment with pre-existing rendering effect building blocks drawn from an open database. For programmers, the interface enables real-time editing of the code inside the blocks. We show that in its default mode, the PRISM framework produces images very similar to those produced by a widely-adopted direct volume rendering implementation in VTK at comparable frame rates. More importantly, we demonstrate the flexibility of the framework by showing how several volume rendering techniques can be implemented in PRISM with no more than a few lines of code. Finally, we demonstrate the simplicity of our system in a usability study with 5 medical imaging expert subjects who have none or little experience with volume rendering. The PRISM framework has the potential to greatly accelerate development of volume rendering for medical applications by promoting sharing and enabling faster development iterations and easier collaboration between engineers and clinical personnel.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drouin</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7265-8747</Identifier><AffiliationInfo><Affiliation>McConnell Brain Imaging Center, Montreal Neurological Institute and Hospital McGill University, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>D Louis</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>McConnell Brain Imaging Center, Montreal Neurological Institute and Hospital McGill University, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003196" MajorTopicYN="Y">Computer Graphics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29534069</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0193636</ArticleId><ArticleId IdType="pii">PONE-D-17-16488</ArticleId><ArticleId IdType="pmc">PMC5849289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Comput Assist Radiol Surg. 2017 Mar;12 (3):363-378</Citation><ArticleIdList><ArticleId IdType="pubmed">27581336</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2006 Nov-Dec;12(6):1559-69</Citation><ArticleIdList><ArticleId IdType="pubmed">17073377</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Comput Graph Appl. 2014 Nov-Dec;34(6):16-23</Citation><ArticleIdList><ArticleId IdType="pubmed">25388232</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2005 Jul-Aug;11(4):408-18</Citation><ArticleIdList><ArticleId IdType="pubmed">16138551</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2013 Dec;19(12):2936-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24051861</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2007 Nov-Dec;13(6):1344-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17968083</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Comput Assist Radiol Surg. 2016 Apr;11(4):505-19</Citation><ArticleIdList><ArticleId IdType="pubmed">26410841</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Comput Assist Radiol Surg. 2015 Mar;10(3):293-300</Citation><ArticleIdList><ArticleId IdType="pubmed">24841148</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Comput Assist Radiol Surg. 2013 Jul;8(4):607-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23588509</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2013 Jan;19(1):67-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22431550</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2006 Sep-Oct;12(5):941-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17080820</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2008 Nov-Dec;14(6):1587-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18989014</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2007 Nov-Dec;13(6):1696-703</Citation><ArticleIdList><ArticleId IdType="pubmed">17968127</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2006 Jul 1;31(3):1116-28</Citation><ArticleIdList><ArticleId IdType="pubmed">16545965</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2014 Mar;20(3):391-403</Citation><ArticleIdList><ArticleId IdType="pubmed">24434220</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Nov 27;310(20):2191-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging. 2012 Nov;30(9):1323-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22770690</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Med Imaging Graph. 2014 Dec;38(8):744-52</Citation><ArticleIdList><ArticleId IdType="pubmed">25066009</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2014 Dec;20(12):2437-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26356957</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2016 Jan;22(1):1015-24</Citation><ArticleIdList><ArticleId IdType="pubmed">26529745</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Comput Graph Appl. 2009 Nov-Dec;29(6):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24806774</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Vis Comput Graph. 2010 Jul-Aug;16(4):548-59</Citation><ArticleIdList><ArticleId IdType="pubmed">20467054</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1994 Jun;34(12):1595-604</Citation><ArticleIdList><ArticleId IdType="pubmed">7941367</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29501366</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>04</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.</ArticleTitle><Pagination><MedlinePgn>461-473</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(18)30104-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(18)30104-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cisplatin-based concurrent chemoradiotherapy is currently considered to be the standard treatment regimen for patients with advanced nasopharyngeal carcinoma, but has well known side-effects such as gastrointestinal reactions, nephrotoxicity, and ototoxicity. Nedaplatin was developed to decrease the toxic effects induced by cisplatin, and in this trial we assessed whether a nedaplatin-based concurrent chemoradiotherapy regimen was non-inferior to a cisplatin-based regimen in patients with locoregional, stage II-IVB nasopharyngeal carcinoma.</AbstractText><AbstractText Label="METHODS">We did an open-label, non-inferiority, phase 3, randomised, controlled trial at two centres in China. Patients aged 18-65 years with non-keratinising stage II-IVB (T1-4N1-3 or T3-4N0) nasopharyngeal carcinoma, a Karnofsky score of at least 70, and adequate haematological, renal, and hepatic function were randomly assigned (1:1) to receive intravenously either nedaplatin 100 mg/m<sup>2</sup> or cisplatin 100 mg/m<sup>2</sup> on days 1, 22, and 43 for three cycles concurrently with intensity-modulated radiotherapy. Randomisation was done manually using a computer-generated random number code and patients were stratified by treatment centre and clinical stage. Patients and clinicians were not masked to treatment allocation. The primary endpoint was progression-free survival at 2 years; non-inferiority was shown if the upper limit of the 95% CI for the difference in 2-year progression-free survival between the two groups did not exceed 10%. Analyses were by both intention to treat and per protocol, including all patients who received at least one complete cycle of chemotherapy. This trial is registered with ClinicalTrials.gov, number NCT01540136, and is currently in follow-up.</AbstractText><AbstractText Label="FINDINGS">Between Jan 16, 2012, and July 16, 2014, we randomly assigned 402 patients to nedaplatin-based (n=201) or cisplatin-based (n=201) concurrent chemoradiotherapy. In the intention-to-treat population, 2-year progression-free survival was 89·9% (95% CI 85·8-94·0) in the cisplatin group and 88·0% (83·5-94·5) in the nedaplatin group, with a difference of 1·9% (95% CI -4·2 to 8·0; p<sub>non-inferiority</sub>=0·0048). In the per-protocol analysis (cisplatin group, n=197; nedaplatin group, n=196), 2-year progression-free survival was 89·7% (95% CI 85·4-94·0) in the cisplatin group and 88·7% (84·2-94·5) in the nedaplatin group, with a difference of 1·0% (95% CI -5·2 to 7·0; p<sub>non-inferiority</sub>=0·0020). A significantly higher frequency of grade 3 or 4 vomiting (35 [18%] of 198 in the cisplatin group vs 12 [6%] of 200 in the nedaplatin group, p&lt;0·0001), nausea (18 [9%] vs four [2%], p=0·0021), and anorexia (53 [27%] vs 26 [13%], p=0·00070) was observed in the cisplatin group compared with the nedaplatin group. 11 (6%) patients in the nedaplatin group had grade 3 or 4 thrombocytopenia compared with four (2%) in the cisplatin group (p=0·065). Patients in the cisplatin group had a higher frequency of any grade or grade 3 or 4 late auditory or hearing toxicities than did patients in the nedaplatin group (grade 3 or 4: three [2%] in the nedaplatin group vs 11 [6%] in the cisplatin group, p=0·030). No patients died from treatment-related causes.</AbstractText><AbstractText Label="INTERPRETATION">Our findings show that nedaplatin-based concurrent chemoradiotherapy represents an alternative doublet treatment strategy to cisplatin-based concurrent chemoradiotherapy for patients with locoregional, advanced nasopharyngeal carcinoma. Further investigations are needed to explore the potential use of this treatment as induction or adjuvant chemotherapy or in combination with other agents.</AbstractText><AbstractText Label="FUNDING">National Key R&amp;D Program of China, National Natural Science Foundation of China, Sun Yat-sen University Clinical Research 5010 Program, Sci-Tech Project Foundation of Guangzhou City, National Key Basic Research Program of China, Special Support Plan of Guangdong Province, Sci-Tech Project Foundation of Guangdong Province, Health &amp; Medical Collaborative Innovation Project of Guangzhou City, National Science &amp; Technology Pillar Program during the Twelfth Five-year Plan Period, PhD Start-up Fund of Natural Science Foundation of Guangdong Province, Cultivation Foundation for the Junior Teachers in Sun Yat-sen University, and Fundamental Research Funds for the Central Universities.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lin-Quan</ForeName><Initials>LQ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dong-Ping</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Hao-Yuan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Shan-Shan</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qing-Nan</ForeName><Initials>QN</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Yun</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ji-Bin</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Clinical Trials Centre, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Medical Statistics and Epidemiology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuan-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Fang-Yun</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li-Ting</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sai-Lan</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Hao-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yu-Jing</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xue-Song</ForeName><Initials>XS</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jin-Jie</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yi-Shan</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Dong-Hua</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Pei-Yu</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yan-Qun</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ming-Yuan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wei-Xiong</ForeName><Initials>WX</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Ka-Jia</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Chao-Nan</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Ming-Huang</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Clinical Trials Centre, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Zhi-Qiang</ForeName><Initials>ZQ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiu-Yan</ForeName><Initials>QY</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Hai-Qiang</ForeName><Initials>HQ</Initials><AffiliationInfo><Affiliation>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China. Electronic address: maihq@sysucc.org.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01540136</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009944">Organoplatinum Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>8UQ3W6JXAN</RegistryNumber><NameOfSubstance UI="C053989">nedaplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 Apr;19(4):429-431</RefSource><PMID Version="1">29501364</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000855" MajorTopicYN="N">Anorexia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059248" MajorTopicYN="Y">Chemoradiotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006311" MajorTopicYN="N">Hearing Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009303" MajorTopicYN="N">Nasopharyngeal Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009944" MajorTopicYN="N">Organoplatinum Compounds</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29501366</ArticleId><ArticleId IdType="pii">S1470-2045(18)30104-9</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(18)30104-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29483069</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Open Availability of Patient Medical Photographs in Google Images Search Results: Cross-Sectional Study of Transgender Research.</ArticleTitle><Pagination><MedlinePgn>e70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/jmir.8787</ELocationID><Abstract><AbstractText Label="BACKGROUND">This paper focuses on the collision of three factors: a growing emphasis on sharing research through open access publication, an increasing awareness of big data and its potential uses, and an engaged public interested in the privacy and confidentiality of their personal health information. One conceptual space where this collision is brought into sharp relief is with the open availability of patient medical photographs from peer-reviewed journal articles in the search results of online image databases such as Google Images.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to assess the availability of patient medical photographs from published journal articles in Google Images search results and the factors impacting this availability.</AbstractText><AbstractText Label="METHODS">We conducted a cross-sectional study using data from an evidence map of research with transgender, gender non-binary, and other gender diverse (trans) participants. For the original evidence map, a comprehensive search of 15 academic databases was developed in collaboration with a health sciences librarian. Initial search results produced 25,230 references after duplicates were removed. Eligibility criteria were established to include empirical research of any design that included trans participants or their personal information and that was published in English in peer-reviewed journals. We identified all articles published between 2008 and 2015 with medical photographs of trans participants. For each reference, images were individually numbered in order to track the total number of medical photographs. We used odds ratios (OR) to assess the association between availability of the clinical photograph on Google Images and the following factors: whether the article was openly available online (open access, Researchgate.net, or Academia.edu), whether the article included genital images, if the photographs were published in color, and whether the photographs were located on the journal article landing page.</AbstractText><AbstractText Label="RESULTS">We identified 94 articles with medical photographs of trans participants, including a total of 605 photographs. Of the 94 publications, 35 (37%) included at least one medical photograph that was found on Google Images. The ability to locate the article freely online contributes to the availability of at least one image from the article on Google Images (OR 2.99, 95% CI 1.20-7.45).</AbstractText><AbstractText Label="CONCLUSIONS">This is the first study to document the existence of medical photographs from peer-reviewed journals appearing in Google Images search results. Almost all of the images we searched for included sensitive photographs of patient genitals, chests, or breasts. Given that it is unlikely that patients consented to sharing their personal health information in these ways, this constitutes a risk to patient privacy. Based on the impact of current practices, revisions to informed consent policies and guidelines are required.</AbstractText><CopyrightInformation>©Zack Marshall, Fern Brunger, Vivian Welch, Shabnam Asghari, Chris Kaposy. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 26.02.2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Zack</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-2315-3512</Identifier><AffiliationInfo><Affiliation>School of Social Work, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Community Health &amp; Humanities, Memorial University of Newfoundland, St John's, NL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunger</LastName><ForeName>Fern</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8367-610X</Identifier><AffiliationInfo><Affiliation>Division of Community Health &amp; Humanities, Memorial University of Newfoundland, St John's, NL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5238-7097</Identifier><AffiliationInfo><Affiliation>Bruyere Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghari</LastName><ForeName>Shabnam</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4970-0978</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Memorial University of Newfoundland, St John's, NL, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Rural Health Studies, Faculty of Medicine, Memorial University of Newfoundland, St John's, NL, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaposy</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9689-2052</Identifier><AffiliationInfo><Affiliation>Division of Community Health &amp; Humanities, Memorial University of Newfoundland, St John's, NL, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003219" MajorTopicYN="N">Confidentiality</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010781" MajorTopicYN="N">Photography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063106" MajorTopicYN="N">Transgender Persons</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">big data</Keyword><Keyword MajorTopicYN="Y">confidentiality</Keyword><Keyword MajorTopicYN="Y">image repositories</Keyword><Keyword MajorTopicYN="Y">informed consent</Keyword><Keyword MajorTopicYN="Y">open access publishing</Keyword><Keyword MajorTopicYN="Y">photography</Keyword><Keyword MajorTopicYN="Y">publication ethics</Keyword><Keyword MajorTopicYN="Y">transgender persons</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29483069</ArticleId><ArticleId IdType="pii">v20i2e70</ArticleId><ArticleId IdType="doi">10.2196/jmir.8787</ArticleId><ArticleId IdType="pmc">PMC5847816</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Br J Dermatol. 2013 Aug;169(2):298-305</Citation><ArticleIdList><ArticleId IdType="pubmed">23551168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interpers Violence. 2017 Jun 1;:886260517715026</Citation><ArticleIdList><ArticleId IdType="pubmed">29294810</ArticleId></ArticleIdList></Reference><Reference><Citation>SADJ. 2009 Oct;64(9):404, 406</Citation><ArticleIdList><ArticleId IdType="pubmed">20411835</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2000 Nov-Dec;2(6):353-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11339658</ArticleId></ArticleIdList></Reference><Reference><Citation>Plast Reconstr Surg. 2017 Jul 17;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28753143</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Oct 15;51(8):929-30, 980-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20858072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Eng Ethics. 2017 Feb;23 (1):1-19</Citation><ArticleIdList><ArticleId IdType="pubmed">27090147</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1998 Mar 28;316(7136):1009-11</Citation><ArticleIdList><ArticleId IdType="pubmed">9550967</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg Case Rep. 2012;3(7):266-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22504480</ArticleId></ArticleIdList></Reference><Reference><Citation>Issues Med Ethics. 2003 Jul-Sep;11(3):83-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16335510</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2011 Nov;9(11):e1001210</Citation><ArticleIdList><ArticleId IdType="pubmed">22140361</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Forensic Med Pathol. 2013 Mar;34(1):29-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23361077</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Rev. 2017 Feb 20;6(1):35</Citation><ArticleIdList><ArticleId IdType="pubmed">28219417</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2011 Jun 17;11:92</Citation><ArticleIdList><ArticleId IdType="pubmed">21682870</ArticleId></ArticleIdList></Reference><Reference><Citation>J Craniomaxillofac Surg. 2010 Sep;38(6):416-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20036572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent Educ. 2015 Apr;79(4):432-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25838015</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29473705</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>08</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.</ArticleTitle><Pagination><MedlinePgn>945-954</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.12660</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the safety and pharmacokinetics of alpha-1 antitrypsin (AAT) in adults and children.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">Short-term AAT treatment restores euglycemia in the non-obese mouse model of type 1 diabetes. A phase I multicenter study in 16 subjects with new-onset type 1 diabetes studied the safety and pharmacokinetics of Aralast NP (AAT). This open-label, dose-escalation study enrolled 8 adults aged 16 to 35 years and 8 children aged 8 to 15 years within 100 days of diagnosis, to receive 12 infusions of AAT: a low dose of 45 mg/kg weekly for 6 weeks, followed by a higher dose of 90 mg/kg for 6 weeks.</AbstractText><AbstractText Label="RESULTS">C-peptide secretion during a mixed meal, hemoglobin A1c (HbA1c), and insulin usage remained relatively stable during the treatment period. At 72 hours after infusion of 90 mg/kg, mean levels of AAT fell below 2.0 g/L for 7 of 15 subjects. To identify a plasma level of AAT likely to be therapeutic, pharmacodynamic ex vivo assays were performed on fresh whole blood from adult subjects. Polymerase chain reaction (PCR) analyses were performed on inhibitor of IKBKE, NOD1, TLR1, and TRAD gene expression, which are important for activation of nuclear factor-κB (NF-κB) and apoptosis pathways. AAT suppressed expression dose-dependently; 50% inhibition was achieved in the 2.5 to 5.0 mg/mL range.</AbstractText><AbstractText Label="CONCLUSIONS">AAT was well tolerated and safe in subjects with new-onset type 1 diabetes. Weekly doses of AAT greater than 90 mg/kg may be necessary for an optimal therapeutic effect.</AbstractText><CopyrightInformation>© 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weir</LastName><ForeName>Gordon C</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0003-1456-0546</Identifier><AffiliationInfo><Affiliation>Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehlers</LastName><ForeName>Mario R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Immune Tolerance Network, Clinical Trials Group, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Kristina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Immune Tolerance Network, Biomarker &amp; Discovery Research, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaparthi</LastName><ForeName>Sai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immune Tolerance Network, Biomarker &amp; Discovery Research, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute at Virginia Mason, Translational Research Program, Seattle, Western Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phippard</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Immune Tolerance Network, Biomarker &amp; Discovery Research, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Lia J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Rho Federal Systems Division, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jepson</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Rho Federal Systems Division, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>James G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>National Institute of Allergy and Infectious Diseases, Division of Allergy, Immunology and Transplant, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koulmanda</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strom</LastName><ForeName>Terry B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ITN RETAIN Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN272200800029C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK036836</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI109565</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM2 AI117870</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017426">Clinical Trial, Phase I</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002096">C-Peptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000515">alpha 1-Antitrypsin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517652">hemoglobin A1c protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002096" MajorTopicYN="N">C-Peptide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000515" MajorTopicYN="N">alpha 1-Antitrypsin</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">C-peptide</Keyword><Keyword MajorTopicYN="Y">autoimmune diseases</Keyword><Keyword MajorTopicYN="Y">diabetes mellitus</Keyword><Keyword MajorTopicYN="Y">pharmacokinetics</Keyword><Keyword MajorTopicYN="Y">serine proteinase inhibitors</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29473705</ArticleId><ArticleId IdType="doi">10.1111/pedi.12660</ArticleId><ArticleId IdType="pmc">PMC6030471</ArticleId><ArticleId IdType="mid">NIHMS946829</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2012;7(5):e33254</Citation><ArticleIdList><ArticleId IdType="pubmed">22606220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Jun 1;381(9881):1905-15</Citation><ArticleIdList><ArticleId IdType="pubmed">23562090</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12153-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16093309</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2001 Dec;25(4):383-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11846607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1995 May 19;81(4):495-504</Citation><ArticleIdList><ArticleId IdType="pubmed">7758105</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15443-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22949661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2006 May 11;441(7090):235-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16648838</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 1992 Mar 23;300(1):21-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1312485</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2009 May;85(5):886-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19197072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2011 Mar;11(3):221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21350581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2013 Dec;1(4):284-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24622414</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1984 Mar 30;223(4643):1362-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6367043</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Sep;60(9):2206-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21715553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2011 Dec;1243:119-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22211897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1998 Apr 1;128(7):517-23</Citation><ArticleIdList><ArticleId IdType="pubmed">9518395</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2007 Mar;50(3):596-601</Citation><ArticleIdList><ArticleId IdType="pubmed">17221211</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2009 Jul;32(7):1244-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19366957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Jul 30;378(9789):412-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21719096</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):271-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24983393</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Nutr. 2012 Jul;7(3):427-35</Citation><ArticleIdList><ArticleId IdType="pubmed">22367890</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2005 Jun;54(6):1763-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15919798</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2013 Oct;170(3):475-85</Citation><ArticleIdList><ArticleId IdType="pubmed">23848281</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Aug;61(8):2066-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22688329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2016 Aug;17(5):351-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26073583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Sep 15;179(6):3896-903</Citation><ArticleIdList><ArticleId IdType="pubmed">17785827</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Chem. 2014 Oct;395(10):1187-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24854541</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Rev. 2002 Dec;102(12):4751-804</Citation><ArticleIdList><ArticleId IdType="pubmed">12475206</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16242-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18852471</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2014 Aug;99(8):E1418-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24527714</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1997 Oct 1;159(7):3555-64</Citation><ArticleIdList><ArticleId IdType="pubmed">9317155</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Sci (Lond). 2014 Dec;127(12):665-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24934088</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 26;361(22):2143-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19940299</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Jun 23;352(25):2598-608</Citation><ArticleIdList><ArticleId IdType="pubmed">15972866</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Aug 27;321(3):592-600</Citation><ArticleIdList><ArticleId IdType="pubmed">15358147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29452685</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-4465</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>The Lancet. Neurology</Title><ISOAbbreviation>Lancet Neurol</ISOAbbreviation></Journal><ArticleTitle>Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.</ArticleTitle><Pagination><MedlinePgn>223-231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1474-4422(18)30035-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1474-4422(18)30035-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although subthalamic stimulation is a recognised treatment for motor complications in Parkinson's disease, reports on behavioural outcomes are controversial, which represents a major challenge when counselling candidates for subthalamic stimulation. We aimed to assess changes in behaviour in patients with Parkinson's disease receiving combined treatment with subthalamic stimulation and medical therapy over a 2-year follow-up period as compared with the behavioural evolution under medical therapy alone.</AbstractText><AbstractText Label="METHODS">We did a parallel, open-label study (EARLYSTIM) at 17 surgical centres in France (n=8) and Germany (n=9). We recruited patients with Parkinson's disease who were disabled by early motor complications. Participants were randomly allocated (1:1) to either medical therapy alone or bilateral subthalamic stimulation plus medical therapy. The primary outcome was mean change in quality of life from baseline to 2 years. A secondary analysis was also done to assess behavioural outcomes. We used the Ardouin Scale of Behavior in Parkinson's Disease to assess changes in behaviour between baseline and 2-year follow-up. Apathy was also measured using the Starkstein Apathy Scale, and depression was assessed with the Beck Depression Inventory. The secondary analysis was done in all patients recruited. We used a generalised estimating equations (GEE) regression model for individual items and mixed model regression for subscores of the Ardouin scale and the apathy and depression scales. This trial is registered with ClinicalTrials.gov, number NCT00354133. The primary analysis has been reported elsewhere; this report presents the secondary analysis only.</AbstractText><AbstractText Label="FINDINGS">Between July, 2006, and November, 2009, 251 participants were recruited, of whom 127 were allocated medical therapy alone and 124 were assigned bilateral subthalamic stimulation plus medical therapy. At 2-year follow-up, the levodopa-equivalent dose was reduced by 39% (-363·3 mg/day [SE 41·8]) in individuals allocated bilateral subthalamic stimulation plus medical therapy and was increased by 21% (245·8 mg/day [40·4]) in those assigned medical therapy alone (p&lt;0·0001). Neuropsychiatric fluctuations decreased with bilateral subthalamic stimulation plus medical therapy during 2-year follow-up (mean change -0·65 points [SE 0·15]) and did not change with medical therapy alone (-0·02 points [0·15]); the between-group difference in change from baseline was significant (p=0·0028). At 2 years, the Ardouin scale subscore for hyperdopaminergic behavioural disorders had decreased with bilateral subthalamic stimulation plus medical therapy (mean change -1·26 points [SE 0·35]) and had increased with medical therapy alone (1·12 points [0·35]); the between-group difference was significant (p&lt;0·0001). Mean change from baseline at 2 years in the Ardouin scale subscore for hypodopaminergic behavioural disorders, the Starkstein Apathy Scale score, and the Beck Depression Inventory score did not differ between treatment groups. Antidepressants were stopped in 12 patients assigned bilateral subthalamic stimulation plus medical therapy versus four patients allocated medical therapy alone. Neuroleptics were started in nine patients assigned medical therapy alone versus one patient allocated bilateral subthalamic stimulation plus medical therapy. During the 2-year follow-up, two individuals assigned bilateral subthalamic stimulation plus medical therapy and one patient allocated medical therapy alone died by suicide.</AbstractText><AbstractText Label="INTERPRETATION">In a large cohort with Parkinson's disease and early motor complications, better overall behavioural outcomes were noted with bilateral subthalamic stimulation plus medical therapy compared with medical therapy alone. The presence of hyperdopaminergic behaviours and neuropsychiatric fluctuations can be judged additional arguments in favour of subthalamic stimulation if surgery is considered for disabling motor complications.</AbstractText><AbstractText Label="FUNDING">German Federal Ministry of Education and Research, French Programme Hospitalier de Recherche Clinique National, and Medtronic.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lhommée</LastName><ForeName>Eugénie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Movement Disorder Unit, Neurology Department, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, University Grenoble Alpes, Grenoble Institut des Neurosciences (GIN), and Institut National de Santé et en Recherche Médicale (INSERM) U1216, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojtecki</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czernecki</LastName><ForeName>Virginie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sorbonne University, Pierre and Marie Curie University Paris 6, Paris, France; Brain and Spine Institute, Paris, France; Neurology Department, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris (APHP), INSERM, Institut du Cerveau et de la Moelle Epinière, and Centre d'Investigation Clinique (CIC) 1422, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witt</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonder</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medtronic, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timmermann</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Cologne, Cologne, Germany; Department of Neurology, Philipps University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hälbig</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>NeuroCure Clinical Research Center (NCRC), Charité University Medical Center, Charité (Campus Mitte), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pineau</LastName><ForeName>Fanny</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne University, Pierre and Marie Curie University Paris 6, Paris, France; Brain and Spine Institute, Paris, France; Neurology Department, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris (APHP), INSERM, Institut du Cerveau et de la Moelle Epinière, and Centre d'Investigation Clinique (CIC) 1422, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durif</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de Neurologie, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witjas</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurology, Assistance Publique Hôpitaux de Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsker</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehdorn</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Universitätsklinikum Schlsewig-Holstein, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sixel-Döring</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Philipps University of Marburg, Marburg, Germany; Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kupsch</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Stereotactic Neurosurgery, University of Magdeburg, and Neurology Moves, Medical Center Bismarck Karrée, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krüger</LastName><ForeName>Rejko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center of Neurology, and Hertie Institute for Clinical Brain Research, University Hospital, Tübingen, Germany; Luxembourg Centre for Systems Biology, University of Luxembourg, Luxembourg City, Luxembourg; Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elben</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chabardès</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, University Grenoble Alpes, Grenoble Institut des Neurosciences (GIN), and Institut National de Santé et en Recherche Médicale (INSERM) U1216, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thobois</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Movement Disorder Unit, Neurologie C, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France; Centre National de la Recherche Scientifique (CNRS), Institut des Sciences Cognitives, Centre de Neurosciences Cognitives, Bron, France; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brefel-Courbon</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurology Department and Centre Expert Parkinson, University Hospital Toulouse, Toulouse France; INSERM Toulouse NeuroImaging Centre, Toulouse France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ory-Magne</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Department and Centre Expert Parkinson, University Hospital Toulouse, Toulouse France; INSERM Toulouse NeuroImaging Centre, Toulouse France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regis</LastName><ForeName>Jean-Marie</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Functional Neurosurgery, Assistance Publique Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maltête</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Rouen University Hospital, INSERM U1073, Rouen Faculty of Medicine, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauvaget</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Addictology and Liaison-Psychiatry Department, CIC 0004, CHU de Nantes, Hôtel Dieu, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rau</LastName><ForeName>Jörn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Clinical Trials of the Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnitzler</LastName><ForeName>Alfons</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schüpbach</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Department, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris (APHP), INSERM, Institut du Cerveau et de la Moelle Epinière, and Centre d'Investigation Clinique (CIC) 1422, Paris, France; Department of Neurology, University Hospital Bern, Bern, Switzerland; University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schade-Brittinger</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Clinical Trials of the Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deuschl</LastName><ForeName>Gunther</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houeto</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neurology, CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers, Poitiers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krack</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Movement Disorder Unit, Neurology Department, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, University Grenoble Alpes, Grenoble Institut des Neurosciences (GIN), and Institut National de Santé et en Recherche Médicale (INSERM) U1216, Grenoble, France; Department of Clinical Neurosciences (Neurology), Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: Paul.krack@hcuge.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EARLYSTIM study group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00354133</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Neurol</MedlineTA><NlmUniqueID>101139309</NlmUniqueID><ISSNLinking>1474-4422</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Neurol. 2018 Mar;17(3):195-197</RefSource><PMID Version="1">29452675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046690" MajorTopicYN="N">Deep Brain Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020531" MajorTopicYN="N">Subthalamic Nucleus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Negovanska</LastName><ForeName>Velina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welter</LastName><ForeName>Marie-Laure</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corvol</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agid</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navarro</LastName><ForeName>Soledad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meier</LastName><ForeName>Niklaus</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hesekamp</LastName><ForeName>Helke</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cornu</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Möller</LastName><ForeName>Bettina</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nebel</LastName><ForeName>Adelheid</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raethjen</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knudsen</LastName><ForeName>Karina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volkmann</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falk</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paschen</LastName><ForeName>Steffen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meister</LastName><ForeName>Ingo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donner</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kessler</LastName><ForeName>Josef</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbe</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fink</LastName><ForeName>Gereon</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maarouf</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kühn</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Müller</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faust</LastName><ForeName>Katharina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gruber</LastName><ForeName>Doreen</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Gerd-H</ForeName><Initials>GH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seigneuret</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollak</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraix</LastName><ForeName>Valerie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kistner</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rascol</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arbus</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danet</LastName><ForeName>Lola</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaynes</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Groiss</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Südmeyer</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Partowinia-Peters</LastName><ForeName>Mahnaz</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vesper</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ledily</LastName><ForeName>Severine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raoul</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trenkwalder</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richter-Dreske</LastName><ForeName>Wenke</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wächter</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weiss</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eusebio</LastName><ForeName>Alexandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azulay</LastName><ForeName>Jean Philippe</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polo</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levin</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dornier</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pene</LastName><ForeName>Fredy</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hourton</LastName><ForeName>Delphine</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quintin</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoffart-Jourdain</LastName><ForeName>Cecile</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brocvielle</LastName><ForeName>Helene</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balthasar</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>Meryem</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harnisch</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reuss</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aminossadati</LastName><ForeName>Behnaz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nasemann</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oertel</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bataille</LastName><ForeName>Benoit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hellwig</LastName><ForeName>Dieter</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gharabaghi</LastName><ForeName>Alireza</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amtage</LastName><ForeName>Florian</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mertens</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kloss</LastName><ForeName>Manja</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Post</LastName><ForeName>Bart</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Speelman</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29452685</ArticleId><ArticleId IdType="pii">S1474-4422(18)30035-8</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(18)30035-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29433430</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.</ArticleTitle><Pagination><MedlinePgn>76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-018-2979-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">The World Health Organization (WHO) recommends viral load (VL) measurement as the preferred monitoring strategy for HIV-infected individuals on antiretroviral therapy (ART) in resource-limited settings. The new WHO guidelines 2016 continue to define virologic failure as two consecutive VL ≥1000 copies/mL (at least 3 months apart) despite good adherence, triggering switch to second-line therapy. However, the threshold of 1000 copies/mL for defining virologic failure is based on low-quality evidence. Observational studies have shown that individuals with low-level viremia (measurable but below 1000 copies/mL) are at increased risk for accumulation of resistance mutations and subsequent virologic failure. The SESOTHO trial assesses a lower threshold for switch to second-line ART in patients with sustained unsuppressed VL.</AbstractText><AbstractText Label="METHODS">In this multicenter, parallel-group, open-label, randomized controlled trial conducted in Lesotho, patients on first-line ART with two consecutive unsuppressed VL measurements ≥100 copies/mL, where the second VL is between 100 and 999 copies/mL, will either be switched to second-line ART immediately (intervention group) or not be switched (standard of care, according to WHO guidelines). The primary endpoint is viral resuppression (VL &lt; 50 copies/mL) 9 months after randomization. We will enrol 80 patients, giving us 90% power to detect a difference of 35% in viral resuppression between the groups (assuming two-sided 5% alpha error). For our primary analysis, we will use a modified intention-to-treat set, with those lost to care, death, or crossed over considered failure to resuppress, and using logistic regression models adjusted for the prespecified stratification variables.</AbstractText><AbstractText Label="DISCUSSION">The SESOTHO trial challenges the current WHO guidelines, assessing an alternative, lower VL threshold for patients with unsuppressed VL on first-line ART. This trial will provide data to inform future WHO guidelines on VL thresholds to recommend switch to second-line ART.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov ( NCT03088241 ), registered May 05, 2017.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amstutz</LastName><ForeName>Alain</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1716-993X</Identifier><AffiliationInfo><Affiliation>Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland. alain.amstutz@swisstph.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland. alain.amstutz@swisstph.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4051, Basel, Switzerland. alain.amstutz@swisstph.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsakala</LastName><ForeName>Bienvenu Lengo</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>SolidarMed, Swiss Organization for Health in Africa, Maseru/Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanobberghen</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhairwe</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SolidarMed, Swiss Organization for Health in Africa, Maseru/Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glass</LastName><ForeName>Tracy Renée</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achieng</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>SolidarMed, Swiss Organization for Health in Africa, Maseru/Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Butha-Buthe Government Hospital, Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepeka</LastName><ForeName>Mamorena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Butha-Buthe Government Hospital, Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tlali</LastName><ForeName>Katleho</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>SolidarMed, Swiss Organization for Health in Africa, Maseru/Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Butha-Buthe Government Hospital, Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sao</LastName><ForeName>Lebohang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Butha-Buthe Government Hospital, Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>District Health Management Team Butha-Buthe, Butha-Buthe, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thin</LastName><ForeName>Kyaw</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research Coordination Unit, Ministry of Health of Lesotho, Maseru, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klimkait</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Virology, Department of Biomedicine, University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battegay</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labhardt</LastName><ForeName>Niklaus Daniel</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4051, Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03088241</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>IZ07Z0_160876/1</GrantID><Agency>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000353" MajorTopicYN="N">Africa, Southern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059039" MajorTopicYN="N">Standard of Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">First-line antiretroviral therapy failure</Keyword><Keyword MajorTopicYN="Y">HIV</Keyword><Keyword MajorTopicYN="Y">Lesotho</Keyword><Keyword MajorTopicYN="Y">Low-level viremia</Keyword><Keyword MajorTopicYN="Y">Randomized controlled trial</Keyword><Keyword MajorTopicYN="Y">Southern Africa</Keyword><Keyword MajorTopicYN="Y">Switch to second-line antiretroviral therapy</Keyword><Keyword MajorTopicYN="Y">Treatment failure</Keyword><Keyword MajorTopicYN="Y">Viral suppression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29433430</ArticleId><ArticleId IdType="doi">10.1186/s12879-018-2979-y</ArticleId><ArticleId IdType="pii">10.1186/s12879-018-2979-y</ArticleId><ArticleId IdType="pmc">PMC5810070</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2006 Aug 5;368(9534):505-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16890837</ArticleId></ArticleIdList></Reference><Reference><Citation>JAAPA. 2016 Nov;29(11):16-17</Citation><ArticleIdList><ArticleId IdType="pubmed">27787272</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Jul;58(7):3585-98</Citation><ArticleIdList><ArticleId IdType="pubmed">24733471</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Sep 1;51(5):611-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20645862</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 Aug 15;204(4):515-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21791652</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 Nov;57(10):1489-96</Citation><ArticleIdList><ArticleId IdType="pubmed">23946221</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Res Ther. 2014 Jul 07;11:18</Citation><ArticleIdList><ArticleId IdType="pubmed">25035708</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2012 Nov;56(11):5998-6000</Citation><ArticleIdList><ArticleId IdType="pubmed">22890763</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(2):e55747</Citation><ArticleIdList><ArticleId IdType="pubmed">23418455</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Oct 15;21(19):2917-30</Citation><ArticleIdList><ArticleId IdType="pubmed">12325108</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2015 Aug 07;18:20061</Citation><ArticleIdList><ArticleId IdType="pubmed">26257204</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2016 Jul;95(28):e3985</Citation><ArticleIdList><ArticleId IdType="pubmed">27428189</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Mar 23;340:c332</Citation><ArticleIdList><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2012 May 15;26(8):929-38</Citation><ArticleIdList><ArticleId IdType="pubmed">22313953</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2008 Mar;61(3):699-704</Citation><ArticleIdList><ArticleId IdType="pubmed">18192682</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2014 May 15;28(8):1125-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24451160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2018 Feb;18(2):188-197</Citation><ArticleIdList><ArticleId IdType="pubmed">29158101</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Mar 13;9(3):e90772</Citation><ArticleIdList><ArticleId IdType="pubmed">24625508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Mar 1;209(5):711-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23943851</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2008;13(7):927-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19043927</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2015 Jan 28;29(3):373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">25686685</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2017 Nov;20 Suppl 7:</Citation><ArticleIdList><ArticleId IdType="pubmed">29171192</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Jul 12;316(2):191-210</Citation><ArticleIdList><ArticleId IdType="pubmed">27404187</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2017 Jul 19;20(1):21803</Citation><ArticleIdList><ArticleId IdType="pubmed">28777506</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Sep 15;214(6):873-83</Citation><ArticleIdList><ArticleId IdType="pubmed">27402780</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2002 Sep 27;16(14):1967-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12351960</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29414697</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1542-0086</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>06</Day></PubDate></JournalIssue><Title>Biophysical journal</Title><ISOAbbreviation>Biophys J</ISOAbbreviation></Journal><ArticleTitle>PyFolding: Open-Source Graphing, Simulation, and Analysis of the Biophysical Properties of Proteins.</ArticleTitle><Pagination><MedlinePgn>516-521</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0006-3495(17)35041-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpj.2017.11.3779</ELocationID><Abstract><AbstractText>For many years, curve-fitting software has been heavily utilized to fit simple models to various types of biophysical data. Although such software packages are easy to use for simple functions, they are often expensive and present substantial impediments to applying more complex models or for the analysis of large data sets. One field that is reliant on such data analysis is the thermodynamics and kinetics of protein folding. Over the past decade, increasingly sophisticated analytical models have been generated, but without simple tools to enable routine analysis. Consequently, users have needed to generate their own tools or otherwise find willing collaborators. Here we present PyFolding, a free, open-source, and extensible Python framework for graphing, analysis, and simulation of the biophysical properties of proteins. To demonstrate the utility of PyFolding, we have used it to analyze and model experimental protein folding and thermodynamic data. Examples include: 1) multiphase kinetic folding fitted to linked equations, 2) global fitting of multiple data sets, and 3) analysis of repeat protein thermodynamics with Ising model variants. Moreover, we demonstrate how PyFolding is easily extensible to novel functionality beyond applications in protein folding via the addition of new models. Example scripts to perform these and other operations are supplied with the software, and we encourage users to contribute notebooks and models to create a community resource. Finally, we show that PyFolding can be used in conjunction with Jupyter notebooks as an easy way to share methods and analysis for publication and among research teams.</AbstractText><CopyrightInformation>Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Alan R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>London Centre for Nanotechnology, University College London, London, United Kingdom; Department of Structural and Molecular Biology, University College London, London, United Kingdom; Department of Biological Sciences, Birkbeck College, University of London, London, United Kingdom. Electronic address: a.lowe@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Riba</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itzhaki</LastName><ForeName>Laura S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Main</LastName><ForeName>Ewan R G</ForeName><Initials>ERG</Initials><AffiliationInfo><Affiliation>School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom. Electronic address: e.main@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MRF_C0385</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biophys J</MedlineTA><NlmUniqueID>0370626</NlmUniqueID><ISSNLinking>0006-3495</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001703" MajorTopicYN="N">Biophysics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003196" MajorTopicYN="N">Computer Graphics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29414697</ArticleId><ArticleId IdType="pii">S0006-3495(17)35041-5</ArticleId><ArticleId IdType="doi">10.1016/j.bpj.2017.11.3779</ArticleId><ArticleId IdType="pmc">PMC5985001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ACS Chem Biol. 2008 Mar 20;3(3):161-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18355005</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 2009;455:95-125</Citation><ArticleIdList><ArticleId IdType="pubmed">19289204</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18655-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19033473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2014 Apr 23;136(16):6037-48</Citation><ArticleIdList><ArticleId IdType="pubmed">24684597</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Struct Biol. 2014 Aug;27:102-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25033247</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2004 Nov 12;344(1):207-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15504412</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 1991 Oct 29;30(43):10428-35</Citation><ArticleIdList><ArticleId IdType="pubmed">1931967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2006 Mar 24;357(2):655-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16442561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Feb 4;463(7281):685-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20130652</ArticleId></ArticleIdList></Reference><Reference><Citation>Biopolymers. 2012 Jul;97(7):508-17</Citation><ArticleIdList><ArticleId IdType="pubmed">22328209</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2015 Nov 25;137(46):14610-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26561984</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1992 Apr 5;224(3):771-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1569556</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2017;23 (11):1610-1615</Citation><ArticleIdList><ArticleId IdType="pubmed">27928961</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2014 Jul 1;107(1):220-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24988356</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 2013 Nov 5;21(11):1954-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24120762</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Soc Trans. 2013 Oct;41(5):1131-1136</Citation><ArticleIdList><ArticleId IdType="pubmed">24059497</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Struct Biol. 2012 Aug;22(4):451-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22832173</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2016 May 8;428(9 Pt A):1804-17</Citation><ArticleIdList><ArticleId IdType="pubmed">26947150</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Chem Soc. 2005 Jul 27;127(29):10188-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16028928</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9853-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18632565</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2008 Feb 8;376(1):241-57</Citation><ArticleIdList><ArticleId IdType="pubmed">18164721</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Sci. 2005 Mar;14(3):602-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15689503</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2011 Apr 22;408(1):163-76</Citation><ArticleIdList><ArticleId IdType="pubmed">21329696</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1992 Apr 5;224(3):805-18</Citation><ArticleIdList><ArticleId IdType="pubmed">1569558</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2007 Feb 16;366(2):650-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17169371</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Soc Trans. 2013 Oct;41(5):1152-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24059501</ArticleId></ArticleIdList></Reference><Reference><Citation>J Phys Chem B. 2014 Jul 31;118(30):8982-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24988372</ArticleId></ArticleIdList></Reference><Reference><Citation>Angew Chem Int Ed Engl. 2012 Dec 21;51(52):13132-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23150207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Nov 13;390(6656):196-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9367160</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Dec 13;298(5601):2191-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12481137</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10500173</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2007 Jan 26;365(4):1245-55</Citation><ArticleIdList><ArticleId IdType="pubmed">17113103</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9890-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26216963</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17383-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19805120</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1999 Aug 13;291(2):429-44</Citation><ArticleIdList><ArticleId IdType="pubmed">10438630</ArticleId></ArticleIdList></Reference><Reference><Citation>J Phys Chem B. 2012 Jun 14;116(23):7014-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22475221</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2013 Apr 17;10(83):20130051</Citation><ArticleIdList><ArticleId IdType="pubmed">23594813</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Chem. 2017 Jan 1;398(1):23-29</Citation><ArticleIdList><ArticleId IdType="pubmed">27636831</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Struct Biol. 2008 Feb;18(1):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18243686</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3779-84</Citation><ArticleIdList><ArticleId IdType="pubmed">18305166</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 2011 Mar 9;19(3):349-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21397186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29405475</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1051-0761</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>04</Month></PubDate></JournalIssue><Title>Ecological applications : a publication of the Ecological Society of America</Title><ISOAbbreviation>Ecol Appl</ISOAbbreviation></Journal><ArticleTitle>Estimating abundance of an open population with an N-mixture model using auxiliary data on animal movements.</ArticleTitle><Pagination><MedlinePgn>816-825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eap.1692</ELocationID><Abstract><AbstractText>Accurate assessment of abundance forms a central challenge in population ecology and wildlife management. Many statistical techniques have been developed to estimate population sizes because populations change over time and space and to correct for the bias resulting from animals that are present in a study area but not observed. The mobility of individuals makes it difficult to design sampling procedures that account for movement into and out of areas with fixed jurisdictional boundaries. Aerial surveys are the gold standard used to obtain data of large mobile species in geographic regions with harsh terrain, but these surveys can be prohibitively expensive and dangerous. Estimating abundance with ground-based census methods have practical advantages, but it can be difficult to simultaneously account for temporary emigration and observer error to avoid biased results. Contemporary research in population ecology increasingly relies on telemetry observations of the states and locations of individuals to gain insight on vital rates, animal movements, and population abundance. Analytical models that use observations of movements to improve estimates of abundance have not been developed. Here we build upon existing multi-state mark-recapture methods using a hierarchical N-mixture model with multiple sources of data, including telemetry data on locations of individuals, to improve estimates of population sizes. We used a state-space approach to model animal movements to approximate the number of marked animals present within the study area at any observation period, thereby accounting for a frequently changing number of marked individuals. We illustrate the approach using data on a population of elk (Cervus elaphus nelsoni) in Northern Colorado, USA. We demonstrate substantial improvement compared to existing abundance estimation methods and corroborate our results from the ground based surveys with estimates from aerial surveys during the same seasons. We develop a hierarchical Bayesian N-mixture model using multiple sources of data on abundance, movement and survival to estimate the population size of a mobile species that uses remote conservation areas. The model improves accuracy of inference relative to previous methods for estimating abundance of open populations.</AbstractText><CopyrightInformation>© 2018 by the Ecological Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ketz</LastName><ForeName>Alison C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Natural Resource Ecology Lab, Department of Ecosystem Science and Sustainability, Graduate Degree Program in Ecology, Colorado State University, Fort Collins, Colorado, 80523, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Therese L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Rocky Mountain National Park, National Park Service, 1000 West Highway 36, Estes Park, Colorado, 80517, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monello</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Biological Resources Division, National Park Service, 1201 Oakridge Drive, Suite 200, Fort Collins, Colorado, 80525, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Rocky Mountain National Park, National Park Service, 1000 West Highway 36, Estes Park, Colorado, 80517, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Janet L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Colorado Parks and Wildlife, 6060 Broadway, Denver, Colorado, 80216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Benjamin R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Colorado Parks and Wildlife, 6060 Broadway, Denver, Colorado, 80216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Biological Resources Division, National Park Service, 1201 Oakridge Drive, Suite 200, Fort Collins, Colorado, 80525, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooten</LastName><ForeName>Mevin B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Colorado Cooperative Fish and Wildlife Research Unit, U.S. Geological Survey, Departments of Fish, Wildlife &amp; Conservation Biology and Statistics, Colorado State University, Fort Collins, Colorado, 80523, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobbs</LastName><ForeName>N Thompson</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Natural Resource Ecology Lab, Department of Ecosystem Science and Sustainability, Graduate Degree Program in Ecology, Colorado State University, Fort Collins, Colorado, 80523, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ecol Appl</MedlineTA><NlmUniqueID>9889808</NlmUniqueID><ISSNLinking>1051-0761</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D063147" MajorTopicYN="Y">Animal Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003670" MajorTopicYN="Y">Deer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004463" MajorTopicYN="N">Ecology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009068" MajorTopicYN="N">Movement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011157" MajorTopicYN="N">Population Dynamics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">
Cervus elaphus nelsoni
</Keyword><Keyword MajorTopicYN="Y">N-mixture model</Keyword><Keyword MajorTopicYN="Y">abundance</Keyword><Keyword MajorTopicYN="Y">elk</Keyword><Keyword MajorTopicYN="Y">hierarchical Bayesian statistics</Keyword><Keyword MajorTopicYN="Y">multi-state mark-recapture</Keyword><Keyword MajorTopicYN="Y">population size</Keyword><Keyword MajorTopicYN="Y">wildlife</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29405475</ArticleId><ArticleId IdType="doi">10.1002/eap.1692</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" VersionDate="2018/01/30" Owner="NLM"><PMID Version="2">29355231</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2572-4754</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Gates open research</Title><ISOAbbreviation>Gates Open Res</ISOAbbreviation></Journal><ArticleTitle>Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.</ArticleTitle><Pagination><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12688/gatesopenres.12752.2</ELocationID><Abstract><AbstractText><b>Background</b>: Pre-exposure prophylaxis (PrEP) can provide high protection against HIV infection and is a recommended intervention for HIV-negative persons with substantial HIV risk.  Demonstration projects conducted in diverse settings worldwide illustrate practical examples of how PrEP can be delivered. This manuscript presents estimates of effectiveness and patterns of PrEP use within a two-year demonstration project of PrEP for HIV-negative members of heterosexual HIV serodiscordant couples in East Africa. <b>Methods</b>: The PrEP delivery model integrated PrEP into HIV treatment services, prioritizing PrEP use for HIV-negative partners within serodiscordant couples before and during the first 6 months after the partner living with HIV initiated antiretroviral therapy (ART).  We measured PrEP uptake through pharmacy records and adherence to PrEP through medication event monitoring system (MEMS) bottle caps and quantification of tenofovir in plasma among a random sample of participants. We estimated HIV infections prevented using a counterfactual cohort simulated from the placebo arm of a previous PrEP clinical trial. <b>Results</b>: We enrolled 1,010 HIV serodiscordant couples that were naïve to ART and PrEP.  Ninety-seven percent of HIV-negative partners initiated PrEP. Objective measures suggest high adherence: 71% of HIV-negative participants took ≥80% of expected doses, as recorded via MEMS, and 81% of plasma samples had tenofovir detected.  Four incident HIV infections were observed (incidence rate=0.24 per 100 person-years), a 95% reduction (95% CI 86-98%, p&lt;0.0001) in HIV incidence, relative to estimated HIV incidence for the population in the absence of PrEP integrated into HIV treatment services.   <b>Conclusions</b>: PrEP uptake and adherence were high and incident HIV was rare in this PrEP demonstration project for African HIV-negative individuals whose partners were known to be living with HIV.  Delivery of PrEP to HIV-negative partners within HIV serodiscordant couples was feasible and should be prioritized for wide-scale implementation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heffron</LastName><ForeName>Renee</ForeName><Initials>R</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-6039-0352</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngure</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odoyo</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centres for Microbiology Research , Kenya Medical Research Institute, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulya</LastName><ForeName>Nulu</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Infectious Diseases Institute, Makerere University, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tindimwebwa</LastName><ForeName>Edna</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4255-2818</Identifier><AffiliationInfo><Affiliation>Kabwohe Clinical Research Center, Kabwohe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kidoguchi</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnell</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0587-7480</Identifier><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mugo</LastName><ForeName>Nelly R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centres for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukusi</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centres for Microbiology Research , Kenya Medical Research Institute, Nairobi, Kenya.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katabira</LastName><ForeName>Elly</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Institute, Makerere University, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiimwe</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kabwohe Clinical Research Center, Kabwohe, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haugen</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mujugira</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Institute, Makerere University, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haberer</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Harvard Medical School - Massachusetts General Hospital, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ware</LastName><ForeName>Norma C</ForeName><Initials>NC</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-5039-9991</Identifier><AffiliationInfo><Affiliation>Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyatt</LastName><ForeName>Monique A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Global, Cambridge, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzinke</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenkel</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Seattle Children's Research Center, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celum</LastName><ForeName>Connie</ForeName><Initials>C</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-8813-3419</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baeten</LastName><ForeName>Jared M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Partners Demonstration Project Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AI027757</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH095507</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gates Open Res</MedlineTA><NlmUniqueID>101717821</NlmUniqueID><ISSNLinking>2572-4754</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ART</Keyword><Keyword MajorTopicYN="N">HIV prevention</Keyword><Keyword MajorTopicYN="N">HIV serodiscordant couples</Keyword><Keyword MajorTopicYN="N">PrEP</Keyword></KeywordList><CoiStatement>Competing interests: Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The authors disclosed no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29355231</ArticleId><ArticleId IdType="doi">10.12688/gatesopenres.12752.2</ArticleId><ArticleId IdType="pmc">PMC5757790</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2012 Aug 2;367(5):423-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22784038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):488-492</Citation><ArticleIdList><ArticleId IdType="pubmed">28961676</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2018 May;21(5):e25113</Citation><ArticleIdList><ArticleId IdType="pubmed">29851436</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Dec 30;363(27):2587-99</Citation><ArticleIdList><ArticleId IdType="pubmed">21091279</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Res Hum Retroviruses. 2017 Sep 13;34(2):140-147</Citation><ArticleIdList><ArticleId IdType="pubmed">28899162</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Patient Care STDS. 2016 Feb;30(2):78-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26836236</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20013</Citation><ArticleIdList><ArticleId IdType="pubmed">26198348</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2016 Aug 23;13(8):e1002099</Citation><ArticleIdList><ArticleId IdType="pubmed">27552090</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int AIDS Soc. 2017 Feb 8;20(1):21234</Citation><ArticleIdList><ArticleId IdType="pubmed">28362073</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Aug 2;367(5):399-410</Citation><ArticleIdList><ArticleId IdType="pubmed">22784037</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Care. 2012;24(4):509-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22085306</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Behav. 2018 Jun;22(6):1758-1765</Citation><ArticleIdList><ArticleId IdType="pubmed">28894986</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S15-S22</Citation><ArticleIdList><ArticleId IdType="pubmed">27930607</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2016 Oct 17;16(1):571</Citation><ArticleIdList><ArticleId IdType="pubmed">27751179</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Aug 11;365(6):493-505</Citation><ArticleIdList><ArticleId IdType="pubmed">21767103</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23764623</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(1):e55013</Citation><ArticleIdList><ArticleId IdType="pubmed">23383037</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):339-47</Citation><ArticleIdList><ArticleId IdType="pubmed">23187945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):206-211</Citation><ArticleIdList><ArticleId IdType="pubmed">29135656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29326079</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5832</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>04</Month></PubDate></JournalIssue><Title>Drug discovery today</Title><ISOAbbreviation>Drug Discov Today</ISOAbbreviation></Journal><ArticleTitle>Unlocking the full potential of open innovation in the life sciences through a classification system.</ArticleTitle><Pagination><MedlinePgn>771-775</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1359-6446(17)30345-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drudis.2018.01.002</ELocationID><Abstract><AbstractText>A common understanding of expectations and requirements is critical for boosting research-driven business opportunities in open innovation (OI) settings. Transparent communication requires common definitions and standards for OI to align the expectations of both parties. Here, we suggest a five-level classification system for OI models, reflecting the degree of openness. The aim of this classification system is to reduce contract negotiation complexity and times between two parties looking to engage in OI. Systematizing definitions and contractual terms for OI in the life sciences helps to reduce entry barriers and boosts collaborative value generation. By providing a contractual framework with predefined rules, science will be allowed to move more freely, thus maximizing the potential of OI.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Niclas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>LEO Pharma, Industriparken 55, 2750 Ballerup, Denmark. Electronic address: nnidk@leo-pharma.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minssen</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Drug Discov Today</MedlineTA><NlmUniqueID>9604391</NlmUniqueID><ISSNLinking>1359-6446</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001690" MajorTopicYN="N">Biological Science Disciplines</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29326079</ArticleId><ArticleId IdType="pii">S1359-6446(17)30345-8</ArticleId><ArticleId IdType="doi">10.1016/j.drudis.2018.01.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33937622</PMID><DateRevised><Year>2021</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2515-5059</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>MNI open research</Title><ISOAbbreviation>MNI Open Res</ISOAbbreviation></Journal><ArticleTitle>Defining Success in Open Science [version 2; peer review:2 approved].</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12688/mniopenres.12780.2</ELocationID><Abstract><AbstractText>Mounting evidence indicates that worldwide, innovation systems are increasing unsustainable. Equally, concerns about inequities in the science and innovation process, and in access to its benefits, continue. Against a backdrop of growing health, economic and scientific challenges global stakeholders are urgently seeking to spur innovation and maximize the just distribution of benefits for all. Open Science collaboration (OS) - comprising a variety of approaches to increase open, public, and rapid mobilization of scientific knowledge - is seen to be one of the most promising ways forward. Yet, many decision-makers hesitate to construct policy to support the adoption and implementation of OS without access to substantive, clear and reliable evidence. In October 2017, international thought-leaders gathered at an Open Science Leadership Forum in the Washington DC offices of the Bill and Melinda Gates Foundation to share their views on what successful Open Science looks like. Delegates from developed and developing nations, national governments, science agencies and funding bodies, philanthropy, researchers, patient organizations and the biotechnology, pharma and artificial intelligence (AI) industries discussed the outcomes that would rally them to invest in OS, as well as wider issues of policy and implementation. This first of two reports, summarizes delegates' views on what they believe OS will deliver in terms of research, innovation and social impact in the life sciences. Through open and collaborative process over the next months, we will translate these success outcomes into a toolkit of quantitative and qualitative indicators to assess when, where and how open science collaborations best advance research, innovation and social benefit. Ultimately, this work aims to develop and openly share tools to allow stakeholders to evaluate and re-invent their innovation ecosystems, to maximize value for the global public and patients, and address long-standing questions about the mechanics of innovation.</AbstractText><CopyrightInformation>© 2018 Ali-Khan SE et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali-Khan</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9453-5086</Identifier><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, 3801 University, Montreal, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>E Richard</ForeName><Initials>ER</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-3789-9238</Identifier><AffiliationInfo><Affiliation>Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Stewart Biology Building, 1205 Avenue Dr. Penfield, Montreal, H3A 1B1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>MNI Open Res</MedlineTA><NlmUniqueID>101718757</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evaluation</Keyword><Keyword MajorTopicYN="N">Open Science</Keyword><Keyword MajorTopicYN="N">indicators</Keyword><Keyword MajorTopicYN="N">innovation</Keyword><Keyword MajorTopicYN="N">intellectual property</Keyword><Keyword MajorTopicYN="N">open access</Keyword><Keyword MajorTopicYN="N">policy</Keyword><Keyword MajorTopicYN="N">social and economic benefits</Keyword></KeywordList><CoiStatement>The authors received financial support from the Tanenbaum Open Science Institute, where ERG heads the Monitoring and Evaluation Committee.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33937622</ArticleId><ArticleId IdType="doi">10.12688/mniopenres.12780.2</ArticleId><ArticleId IdType="pii">MNIOR-02-02</ArticleId><ArticleId IdType="pmc">PMC7839829</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Nat Rev Drug Discov. 2009 Dec;8(12):959-68</Citation><ArticleIdList><ArticleId IdType="pubmed">19949401</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2016 May;47:20-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 May 11;533(7602):S70</Citation><ArticleIdList><ArticleId IdType="pubmed">27167397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jan 28;389(10067):339-341</Citation><ArticleIdList><ArticleId IdType="pubmed">27832876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32704456</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2167-9843</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PeerJ preprints</Title><ISOAbbreviation>PeerJ Prepr</ISOAbbreviation></Journal><ArticleTitle>Journal of Open Source Software (JOSS): design and first-year review.</ArticleTitle><Pagination><MedlinePgn>e147</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj-cs.147</ELocationID><Abstract><AbstractText>This article describes the motivation, design, and progress of the Journal of Open Source Software (JOSS). JOSS is a free and open-access journal that publishes articles describing research software. It has the dual goals of improving the quality of the software submitted and providing a mechanism for research software developers to receive credit. While designed to work within the current merit system of science, JOSS addresses the dearth of rewards for key contributions to science made in the form of software. JOSS publishes articles that encapsulate scholarship contained in the software itself, and its rigorous peer review targets the software components: functionality, documentation, tests, continuous integration, and the license. A JOSS article contains an abstract describing the purpose and functionality of the software, references, and a link to the software archive. The article is the entry point of a JOSS submission, which encompasses the full set of software artifacts. Submission and review proceed in the open, on GitHub. Editors, reviewers, and authors work collaboratively and openly. Unlike other journals, JOSS does not reject articles requiring major revision; while not yet accepted, articles remain visible and under review until the authors make adequate changes (or withdraw, if unable to meet requirements). Once an article is accepted, JOSS gives it a digital object identifier (DOI), deposits its metadata in Crossref, and the article can begin collecting citations on indexers like Google Scholar and other services. Authors retain copyright of their JOSS article, releasing it under a Creative Commons Attribution 4.0 International License. In its first year, starting in May 2016, JOSS published 111 articles, with more than 40 additional articles under review. JOSS is a sponsored project of the nonprofit organization NumFOCUS and is an affiliate of the Open Source Initiative (OSI).</AbstractText><CopyrightInformation>© Copyright 2018 Smith et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Arfon M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Data Science Mission Office, Space Telescope Science Institute, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niemeyer</LastName><ForeName>Kyle E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>School of Mechanical, Industrial, and Manufacturing Engineering, Oregon State University, Corvallis, OR, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>National Center for Supercomputing Applications &amp; Department of Computer Science &amp; Department of Electrical and Computer Engineering &amp; School of Information Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barba</LastName><ForeName>Lorena A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Mechanical &amp; Aerospace Engineering, The George Washington University, Washington, D.C., United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Githinji</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gymrek</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Medicine &amp; Computer Science and Engineering, University of California, San Diego, La Jolla, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huff</LastName><ForeName>Kathryn D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Nuclear, Plasma, and Radiological Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>School of Psychology, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayes</LastName><ForeName>Abigail Cabunoc</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Mozilla Foundation, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moerman</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trinity Centre for Bioengineering, Trinity College, The University of Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Pjotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Berkeley Institute for Data Science, University of California, Berkeley, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rokem</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>eScience Institute, University of Washington, Seattle, WA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teal</LastName><ForeName>Tracy K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Data Carpentry, Davis, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimera</LastName><ForeName>Roman Valls</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>University of Melbourne Centre for Cancer Research, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderplas</LastName><ForeName>Jacob T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>eScience Institute, University of Washington, Seattle, WA, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.5147722</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM123489</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 MH112480</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ Prepr</MedlineTA><NlmUniqueID>101680891</NlmUniqueID><ISSNLinking>2167-9843</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Code review</Keyword><Keyword MajorTopicYN="N">Computational research</Keyword><Keyword MajorTopicYN="N">Data Science</Keyword><Keyword MajorTopicYN="N">Digital Libraries</Keyword><Keyword MajorTopicYN="N">Open-source software</Keyword><Keyword MajorTopicYN="N">Research software</Keyword><Keyword MajorTopicYN="N">Scholarly publishing</Keyword><Keyword MajorTopicYN="N">Scientific Computing and Simulation</Keyword><Keyword MajorTopicYN="N">Software Engineering</Keyword><Keyword MajorTopicYN="N">Software citation</Keyword></KeywordList><CoiStatement>Daniel S. Katz is an Academic Editor for PeerJ CS. Abigail Cabunoc Mayes is an employee of Mozilla Foundation. Tracy K. Teal is an employee of Data Carpentry.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32704456</ArticleId><ArticleId IdType="doi">10.7717/peerj-cs.147</ArticleId><ArticleId IdType="pii">PJCS-2018-PEERJ-CS-147</ArticleId><ArticleId IdType="pmc">PMC7340488</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Nat Biotechnol. 2015 Jul;33(7):686-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26154002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2014 Mar;11(3):211</Citation><ArticleIdList><ArticleId IdType="pubmed">24724161</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Apr 13;336(6078):159-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22499926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Feb 22;482(7386):485-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22358837</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2017 Jul 20;6:1151</Citation><ArticleIdList><ArticleId IdType="pubmed">29188015</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ Comput Sci. 2015;1:</Citation><ArticleIdList><ArticleId IdType="pubmed">26167542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Oct 14;467(7317):753</Citation><ArticleIdList><ArticleId IdType="pubmed">20944687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29205686</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>02</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Ultrasound-guided lower forearm median nerve block in open surgery for trigger thumb in 1- to 3-year-old children: A randomized trial.</ArticleTitle><Pagination><MedlinePgn>134-141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.13296</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM">Trigger thumb is a common hand disability in children and is primarily treated with open surgery. A conscious median nerve block can usually meet the requirements for trigger thumb-releasing surgery in adults; however, its effectiveness in children requires further clarification. The present study aims to demonstrate whether ultrasound-guided lower forearm median nerve blockade is a viable option for children undergoing open surgery for trigger thumb.</AbstractText><AbstractText Label="METHODS">A prospective randomized study was designed to compare median nerve blocks guided by ultrasonography with those guided by anatomic landmarks. Following induction of general anesthesia, the children received a median nerve block performed either by ultrasound-guided block of the lower forearm (group U) or landmark-based blocking at the proximal wrist crease level (group T) with a 0.2% ropivacaine injection. The success rates were compared between groups as the primary endpoint; additional sufentanil and propofol administration, anesthesia recovery time, and other secondary endpoints were also compared.</AbstractText><AbstractText Label="RESULTS">A total of 100 children (age 1-3 years) with ASA status I who were scheduled for open surgery for trigger thumb were included in this study (n = 50 per group). Thirty-seven children in group T and 50 children in group U underwent successful blocks. The rate of unsuccessful blockade was significantly lower in group U than group T (0% and 26%, respectively), and rate of additional sufentanil and propofol administration was also lower in group U than in group T.</AbstractText><AbstractText Label="CONCLUSION">Ultrasound-guided lower forearm median nerve block can provide more effective analgesia, a higher success rate, and lower general and local anesthetic dosages than the anatomic landmark-based blocking method in children undergoing open surgery for trigger thumb.</AbstractText><CopyrightInformation>© 2017 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianxia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xingqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shouyong</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9525-6150</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000577">Amides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>7IO5LYA57N</RegistryNumber><NameOfSubstance UI="D000077212">Ropivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005542" MajorTopicYN="N">Forearm</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008475" MajorTopicYN="Y">Median Nerve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009407" MajorTopicYN="N">Nerve Block</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077212" MajorTopicYN="N">Ropivacaine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052582" MajorTopicYN="N">Trigger Finger Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">children</Keyword><Keyword MajorTopicYN="Y">median nerve</Keyword><Keyword MajorTopicYN="Y">nerve block</Keyword><Keyword MajorTopicYN="Y">trigger finger disorder</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29205686</ArticleId><ArticleId IdType="doi">10.1111/pan.13296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29181549</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-9941</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of trauma and emergency surgery : official publication of the European Trauma Society</Title><ISOAbbreviation>Eur J Trauma Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Treating open lower limb fractures successfully; thoughts and current practice on therapy and centralization in The Netherlands.</ArticleTitle><Pagination><MedlinePgn>99-106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00068-017-0874-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The British Orthopedic Association (BOA) and British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) updated the evidence-based guidelines for the treatment and care of open lower limb fractures (BOAST 4). Following this, a Dutch version has been developed. The main points are multidisciplinary care, planning, and treatment of these injuries. Early osteosynthesis (within 7-14 days) combined with soft-tissue coverage results in more efficient care and less complications.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To study the variation in treatment and thoughts among trauma, orthopedic, and plastic surgeons.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In this cross-sectional study 94 surgeons (57 trauma, 23 plastic, and 14 orthopedic surgeons) working at 46 centers completed an online questionnaire, consisting of 5 demographic, 14 hospital-related, 8 BOAST 4-related, and 2 centralization-related questions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a strong agreement among surgeons about the best moment for multidisciplinary consultation, which was before initial debridement, while in practice, this often does not occur. All surgeons agreed that the initial debridement should be performed immediately by any surgeon, but not solely by trainees. Plastic surgeons responded that the definitive stabilization and wound cover should not exceed 7 days, while half of the trauma and orthopedic surgeons agreed that it should not exceed 14 days. Finally, most surgeons agreed that Gustilo 3 fractures should be centralized. However, there was disagreement on the need for centralization of Gustilo 2 fractures.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Surgeons agree on better and earlier multidisciplinary treatment of open lower limb fractures and the centralization of Gustilo 3 fractures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oflazoglu</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7527-1110</Identifier><AffiliationInfo><Affiliation>Research fellow Orthopedic Hand Service, Orthopedic Surgery, Harvard Medical School, Massachusetts General Hospital, Yawkey Center, 55 Fruit Street, Boston, MA, 02114, USA. k.oflazoglu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogendoorn</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, Haaglanden Medical Center, The Hague, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Zwaal</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Orthopedic and Trauma Surgery, Haaglanden Medisch Centrum, The Hague, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walbeehm</LastName><ForeName>E T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Enst</LastName><ForeName>W A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Kennisinstituut van de Federatie Medisch Specialisten, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtslag</LastName><ForeName>H R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofstee</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Noordwest Ziekenhuis Groep, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plantinga</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emergency Department, Rijnstate Hospital, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elzinga</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, VU Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rakhorst</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Trauma Emerg Surg</MedlineTA><NlmUniqueID>101313350</NlmUniqueID><ISSNLinking>1863-9933</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005597" MajorTopicYN="N">Fractures, Open</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="N">Patient Care Planning</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="N">Reconstructive Surgical Procedures</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013978" MajorTopicYN="N">Tibial Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Multidisciplinary treatment</Keyword><Keyword MajorTopicYN="N">National survey</Keyword><Keyword MajorTopicYN="N">Open lower limb fractures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29181549</ArticleId><ArticleId IdType="doi">10.1007/s00068-017-0874-7</ArticleId><ArticleId IdType="pii">10.1007/s00068-017-0874-7</ArticleId><ArticleId IdType="pmc">PMC6394538</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Injury. 2001 May;32(4):329-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11325370</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Sci Monit. 2007 May;13(5):SR9-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17476202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Feb;251(2):339-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20010086</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2010 Sep;34(9):2069-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20414777</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2010 Dec;145(12):1171-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21173291</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2012 Jun;43(6):891-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22204774</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Surg. 2012 Feb;55(1):8-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22269307</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery. 2013 Oct;154(4):875-82; discussion 882-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24074427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2015 May;97(4):287-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26263937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2015 Sep;97(6):469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26274742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Joint J. 2016 Mar;98-B(3):420-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26920970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Bras Ortop. 2016 Jan 29;51(2):143-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27069881</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 1976 Jun;58(4):453-8</Citation><ArticleIdList><ArticleId IdType="pubmed">773941</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29158011</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>01</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol</ISOAbbreviation></Journal><ArticleTitle>Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.</ArticleTitle><Pagination><MedlinePgn>127-138</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(17)30715-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(17)30715-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">In animal models of breast cancer, resistance to continuous use of letrozole can be reversed by withdrawal and reintroduction of letrozole. We therefore hypothesised that extended intermittent use of adjuvant letrozole would improve breast cancer outcome compared with continuous use of letrozole in postmenopausal women.</AbstractText><AbstractText Label="METHODS">We did the multicentre, open-label, randomised, parallel, phase 3 SOLE trial in 240 centres (academic, primary, secondary, and tertiary care centres) in 22 countries. We enrolled postmenopausal women of any age with hormone receptor-positive, lymph node-positive, and operable breast cancer for which they had undergone local treatment (surgery with or without radiotherapy) and had completed 4-6 years of adjuvant endocrine therapy. They had to be clinically free of breast cancer at enrolment and without evidence of recurrent disease at any time before randomisation. We randomly assigned women (1:1) to treatment groups of either continuous use of letrozole (2·5 mg/day orally for 5 years) or intermittent use of letrozole (2·5 mg/day orally for 9 months followed by a 3-month break in years 1-4 and then 2·5 mg/day during all 12 months of year 5). Randomisation was done by principal investigators or designee at respective centres through the internet-based system of the International Breast Cancer Study Group, was stratified by type of previous endocrine therapy (aromatase inhibitors only vs selective oestrogen receptor modulators only vs both therapies), and used permuted block sizes of four and institutional balancing. No one was masked to treatment assignment. The primary endpoint was disease-free survival, analysed by the intention-to-treat principle using a stratified log-rank test. All patients in the intention-to-treat population who initiated protocol treatment during their period of trial participation were included in the safety analyses. This study is registered with ClinicalTrials.gov, number NCT00553410, and EudraCT, number 2007-001370-88; and long-term follow-up of patients is ongoing.</AbstractText><AbstractText Label="FINDINGS">Between Dec 5, 2007, and Oct 8, 2012, 4884 women were enrolled and randomised after exclusion of patients at a non-adherent centre, found to have inadequate documentation of informed consent, immediately withdrew consent, or randomly assigned to intervention groups in error. 4851 women comprised the intention-to-treat population that compared extended intermittent letrozole use (n=2425) with continuous letrozole use (n=2426). After a median follow-up of 60 months (IQR 53-72), disease-free survival was 85·8% (95% CI 84·2-87·2) in the intermittent letrozole group compared with 87·5% (86·0-88·8) in the continuous letrozole group (hazard ratio 1·08, 95% CI 0·93-1·26; p=0·31). Adverse events were reported as expected and were similar between the two groups. The most common grade 3-5 adverse events were hypertension (584 [24%] of 2417 in the intermittent letrozole group vs 517 [21%] of 2411 in the continuous letrozole group) and arthralgia (136 [6%] vs 151 [6%]). 54 patients (24 [1%] in the intermittent letrozole group and 30 [1%] in the continuous letrozole group) had grade 3-5 CNS cerebrovascular ischaemia, 16 (nine [&lt;1%] vs seven [&lt;1%]) had grade 3-5 CNS haemorrhage, and 40 (19 [1%] vs 21 [1%]) had grade 3-5 cardiac ischaemia. In total, 23 (&lt;1%) of 4851 patients died while on trial treatment (13 [&lt;1%] of 2417 patients in the intermittent letrozole group vs ten [&lt;1%] of 2411 in the continuous letrozole group).</AbstractText><AbstractText Label="INTERPRETATION">In postmenopausal women with hormone receptor-positive breast cancer, extended use of intermittent letrozole did not improve disease-free survival compared with continuous use of letrozole. An alternative schedule of extended adjuvant endocrine therapy with letrozole, including intermittent administration, might be feasible and the results of the SOLE trial support the safety of temporary treatment breaks in selected patients who might require them.</AbstractText><AbstractText Label="FUNDING">Novartis and the International Breast Cancer Study Group.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colleoni</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: marco.colleoni@ieo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Weixiu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsson</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirgwin</LastName><ForeName>Jacquie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aebi</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerusalem</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neven</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hitre</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graas</LastName><ForeName>Marie-Pascale</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simoncini</LastName><ForeName>Edda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamby</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Alastair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loibl</LastName><ForeName>Sibylle</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Breast Group, Neu-Isenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavilá</LastName><ForeName>Joaquín</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuroi</LastName><ForeName>Katsumasa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marth</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Austrian Breast &amp; Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>Seamus</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cancer Trials Ireland and Cork University Hospital, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lauro</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gombos</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruhstaller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burstein</LastName><ForeName>Harold</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribi</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernhard</LastName><ForeName>Jürg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viale</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maibach</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabaglio-Poretti</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelber</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science &amp; Technology Research Foundation, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coates</LastName><ForeName>Alan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Leo</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regan</LastName><ForeName>Meredith M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldhirsch</LastName><ForeName>Aron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SOLE Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00553410</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047072">Aromatase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009570">Nitriles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011980">Receptors, Progesterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014230">Triazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>7LKK855W8I</RegistryNumber><NameOfSubstance UI="D000077289">Letrozole</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 Jan;19(1):13-15</RefSource><PMID Version="1">29158010</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2018 Feb;19(2):e77</RefSource><PMID Version="1">29413478</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047072" MajorTopicYN="N">Aromatase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077289" MajorTopicYN="N">Letrozole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009570" MajorTopicYN="N">Nitriles</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="Y">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018719" MajorTopicYN="N">Receptor, ErbB-2</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011980" MajorTopicYN="N">Receptors, Progesterone</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014230" MajorTopicYN="N">Triazoles</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Vandebroek</LastName><ForeName>An</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berliere</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitine</LastName><ForeName>Carine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vuylsteke</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borms</LastName><ForeName>Marleen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Hondt</LastName><ForeName>Randal</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glorieux</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mebis</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhoeven</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coibion</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forget</LastName><ForeName>Frederic</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duck</LastName><ForeName>Lionel</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhoeven</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wyendaele</LastName><ForeName>Wim</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbeaux</LastName><ForeName>Annelore</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salmon</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berteloot</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vermeij</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richard</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cinieri</LastName><ForeName>Saverio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gianni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clerico</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinotti</LastName><ForeName>Graziella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernardo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biganzoli</LastName><ForeName>Leo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gennari</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graiff</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amadori</LastName><ForeName>Dino</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Passalacqua</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francis</LastName><ForeName>Prudence</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foo</LastName><ForeName>Serene</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boyle</LastName><ForeName>Frances</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Redfern</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Westhuizen</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Sharad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beale</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Byard</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Begbie</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sardelic</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abdi</LastName><ForeName>Ehtesham</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chindewere</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Della-Fiorentina</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asghari</LastName><ForeName>Ray</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Islam</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Na Teo</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Shane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gardner</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uhlmann</LastName><ForeName>Catarina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rauch</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannhart</LastName><ForeName>Meinrad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buser</LastName><ForeName>Katharina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dedes</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mueller</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rageth</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Von Orelli</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senn</LastName><ForeName>Hans Joerg</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pagani</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedrazzini</LastName><ForeName>Augusto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rochlitz</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodmer</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anchisi</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaman</LastName><ForeName>Khalil</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Moos</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Betticher</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kralidas</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Popescu</LastName><ForeName>Razven</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fehr</LastName><ForeName>Mathias</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyman</LastName><ForeName>Per</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jungquist</LastName><ForeName>Anja</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chamalidou</LastName><ForeName>Chaido</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foukakis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabrosin</LastName><ForeName>Charlotta</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valachis</LastName><ForeName>Antonis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lang</LastName><ForeName>Istvan</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kahan</LastName><ForeName>Zsuzsanna</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Retamales</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>Ulloa Roberto</ForeName><Initials>UR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fritis</LastName><ForeName>Marcela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sole</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>Soledad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Letzkus</LastName><ForeName>Jaime</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Escobar</LastName><ForeName>Paula</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vigneaux</LastName><ForeName>Ines</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arancibia</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cardemil</LastName><ForeName>Juana Bernardita</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huidobro</LastName><ForeName>Patricio</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gomez</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wetter</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vorobiof</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMichael</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Apffelstaedt</LastName><ForeName>Justus</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vorotnikov</LastName><ForeName>Igor</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Openshaw</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonnefoi</LastName><ForeName>Herve</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacquin</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonichon-Lamichhane</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borstner</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Budrukkar</LastName><ForeName>Ashwini</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ewertz</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quispe</LastName><ForeName>Oscar Zambrano</ForeName><Initials>OZ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vestlev</LastName><ForeName>Peter Michael</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danø</LastName><ForeName>Hella</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Ditte</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jakobsen</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoejris</LastName><ForeName>Inger</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bogovic</LastName><ForeName>Jurij Antonovic</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Britta Bjerregaard</ForeName><Initials>BB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aage Møller</LastName><ForeName>Knud</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stenbygaard</LastName><ForeName>Eric Lars</ForeName><Initials>EL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ravi</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bedi</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bews-Hair</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neades</LastName><ForeName>Glyn</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKirdy</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barber</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alhasso</LastName><ForeName>Abdulla</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraser</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuille</LastName><ForeName>Frances</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lannigan</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Dermot</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shere</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackisch</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomé</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steer</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Augustin</LastName><ForeName>Doris</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lübbe</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackisch</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Köcker-Korus</LastName><ForeName>Heike</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deuker</LastName><ForeName>Jörg-Uwe</ForeName><Initials>JU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefek</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Just</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rhein</LastName><ForeName>Uwe</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bechtner</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baerens</LastName><ForeName>Dirk-Toralf</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schrader</LastName><ForeName>Iris</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grischke</LastName><ForeName>Eva-Maria</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorenz</LastName><ForeName>Ralf</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dietz</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomalla</LastName><ForeName>Jörg</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schilling</LastName><ForeName>Jörg</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rempen</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graf</LastName><ForeName>Heiko</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doering</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Busch</LastName><ForeName>Steffi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heinrich</LastName><ForeName>Georg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tesch</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uleer</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krabisch</LastName><ForeName>Petra</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rösel</LastName><ForeName>Siegfried</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostertag</LastName><ForeName>Horst</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Josten</LastName><ForeName>Klaus-M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hielscher</LastName><ForeName>Carsten</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gröll</LastName><ForeName>Isolde</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mattner</LastName><ForeName>Ute Marie</ForeName><Initials>UM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prechtl</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lantzsch</LastName><ForeName>Tilmann</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciruelos</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garau</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellet</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Climent</LastName><ForeName>Miguel Angel</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>López</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Virizuela</LastName><ForeName>Juan Antonio</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bermejo</LastName><ForeName>Begoña</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janez</LastName><ForeName>Noelia Martinez</ForeName><Initials>NM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amillano</LastName><ForeName>Kepa</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Márquez</LastName><ForeName>Raúl</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dorca</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godes</LastName><ForeName>Maria Jose</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Santiago</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ohno</LastName><ForeName>Shinji</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aruga</LastName><ForeName>Tomoyuki</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yotsumoto</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aihara</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bando</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masuda</LastName><ForeName>Norikazu</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toi</LastName><ForeName>Masakazu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aogi</LastName><ForeName>Kenjiro</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sato</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okada</LastName><ForeName>Morihito</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Masato</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tokunaga</LastName><ForeName>Eriko</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iwata</LastName><ForeName>Hiroji</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fujita</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fridrik</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pristauz</LastName><ForeName>Gunda</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hackl</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wette</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gnant</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thaler</LastName><ForeName>Josef</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greil</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abendstein</LastName><ForeName>Burghard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heck</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manfreda</LastName><ForeName>Diether</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sevelda</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiel</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tuttlies</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stöger</LastName><ForeName>Herbert</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neunteufel</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crown</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kennedy</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hill</LastName><ForeName>Arnold</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCaffrey</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Conleth</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coate</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keane</LastName><ForeName>Maccon</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duffy</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruepp</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piccart</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zardavas</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29158011</ArticleId><ArticleId IdType="pii">S1470-2045(17)30715-5</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(17)30715-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28719988</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2684</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Dementia (London, England)</Title><ISOAbbreviation>Dementia (London)</ISOAbbreviation></Journal><ArticleTitle>Experiences of Integrated Care for Dementia from Family and Carer Perspectives: A Framework Analysis of Massive Open Online Course Discussion Board Posts.</ArticleTitle><Pagination><MedlinePgn>1492-1506</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1471301217719991</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Integrated Care for dementia is an increasingly popular approach to supporting people with dementia, bringing services together to form a single cohesive provision for service users. This approach is still in its infancy but has the potential to improve the management of dementia, social care and to enhance the patient experience.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To understand views and experiences of integrated health and social care for dementia from the perspective of carers, families, healthcare professionals and researchers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Crowdsourcing views and experiences from 'Bridging the Dementia Divide', a massive open online course at the University of Derby, provide a rich source of qualitative data from carers, families and healthcare professionals. We analysed 847 massive open online course discussion board posts using a Framework Analysis approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants described how Integrated Care for dementia should be person-centred and holistic, involving a multidisciplinary team of health and social care practitioners, as well as the patient, the family and the wider community. The establishment of Integrated Care for dementia was viewed positively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robertshaw</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Health and Social Care, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Ainslea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dementia (London)</MedlineTA><NlmUniqueID>101128698</NlmUniqueID><ISSNLinking>1471-3012</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019033" MajorTopicYN="Y">Delivery of Health Care, Integrated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020375" MajorTopicYN="Y">Education, Distance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">internet-mediated research</Keyword><Keyword MajorTopicYN="N">massive open online course</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28719988</ArticleId><ArticleId IdType="doi">10.1177/1471301217719991</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28419324</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1477-4054</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>09</Month><Day>28</Day></PubDate></JournalIssue><Title>Briefings in bioinformatics</Title><ISOAbbreviation>Brief Bioinform</ISOAbbreviation></Journal><ArticleTitle>Improving data workflow systems with cloud services and use of open data for bioinformatics research.</ArticleTitle><Pagination><MedlinePgn>1035-1050</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bib/bbx039</ELocationID><Abstract><AbstractText>Data workflow systems (DWFSs) enable bioinformatics researchers to combine components for data access and data analytics, and to share the final data analytics approach with their collaborators. Increasingly, such systems have to cope with large-scale data, such as full genomes (about 200 GB each), public fact repositories (about 100 TB of data) and 3D imaging data at even larger scales. As moving the data becomes cumbersome, the DWFS needs to embed its processes into a cloud infrastructure, where the data are already hosted. As the standardized public data play an increasingly important role, the DWFS needs to comply with Semantic Web technologies. This advancement to DWFS would reduce overhead costs and accelerate the progress in bioinformatics research based on large-scale data and public resources, as researchers would require less specialized IT knowledge for the implementation. Furthermore, the high data growth rates in bioinformatics research drive the demand for parallel and distributed computing, which then imposes a need for scalability and high-throughput capabilities onto the DWFS. As a result, requirements for data sharing and access to public knowledge bases suggest that compliance of the DWFS with Semantic Web standards is necessary. In this article, we will analyze the existing DWFS with regard to their capabilities toward public open data use as well as large-scale computational and human interface requirements. We untangle the parameters for selecting a preferable solution for bioinformatics research with particular consideration to using cloud services and Semantic Web technologies. Our analysis leads to research guidelines and recommendations toward the development of future DWFS for the bioinformatics research community.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Md Rezaul</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Semantics in eHealth and Life Sciences (SeLS), Insight Centre for Data Analytics, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Biochemistry and Cell Biology, University College Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zappa</LastName><ForeName>Achille</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Insight Centre for Data Analytics, National University of Ireland Galway, Dangan, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranov</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Biochemistry and Cell Biology, University College Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahay</LastName><ForeName>Ratnesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Semantics in eHealth and Life Sciences (SeLS), Insight Centre for Data Analytics, National University of Ireland, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebholz-Schuhmann</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Insight Centre for Data Analytics, National University of Ireland Galway, Dangan, Galway, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brief Bioinform</MedlineTA><NlmUniqueID>100912837</NlmUniqueID><ISSNLinking>1467-5463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="Y">Cloud Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003628" MajorTopicYN="N">Database Management Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051188" MajorTopicYN="N">Knowledge Bases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075403" MajorTopicYN="N">Semantic Web</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="Y">Workflow</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28419324</ArticleId><ArticleId IdType="pii">3737318</ArticleId><ArticleId IdType="doi">10.1093/bib/bbx039</ArticleId><ArticleId IdType="pmc">PMC6169675</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Bioinforma. 2012 Jan 13;2(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">22239822</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Chem. 2007 Oct;31(5-6):305-19</Citation><ArticleIdList><ArticleId IdType="pubmed">17931570</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2015 Feb 22;15:12</Citation><ArticleIdList><ArticleId IdType="pubmed">25880555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2009 Jan;37(Database issue):D674-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18832364</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2012 May 04;13:77</Citation><ArticleIdList><ArticleId IdType="pubmed">22559942</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 May 08;10:136</Citation><ArticleIdList><ArticleId IdType="pubmed">19426475</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2010;11(8):R86</Citation><ArticleIdList><ArticleId IdType="pubmed">20738864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Sep 15;30(18):2652-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24845651</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Semantics. 2011 Oct 24;2(1):8</Citation><ArticleIdList><ArticleId IdType="pubmed">22024447</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Med Chem. 2012;12(18):1965-79</Citation><ArticleIdList><ArticleId IdType="pubmed">23110532</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2009 Mar;10(2):111-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19304871</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes (Basel). 2012 Aug 30;3(3):545-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23139896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23640334</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2009 Jul 20;3:22</Citation><ArticleIdList><ArticleId IdType="pubmed">19649168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Mar 15;30(6):893-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24177720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Semantics. 2015 Jan 07;6:3</Citation><ArticleIdList><ArticleId IdType="pubmed">25973165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigascience. 2015 Dec 03;4:59</Citation><ArticleIdList><ArticleId IdType="pubmed">26640691</ArticleId></ArticleIdList></Reference><Reference><Citation>Procedia Comput Sci. 2014;29:1745-1755</Citation><ArticleIdList><ArticleId IdType="pubmed">29399238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jul;38(Web Server issue):W677-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20501605</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ. 2014 Nov 04;2:e644</Citation><ArticleIdList><ArticleId IdType="pubmed">25392756</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D8-D20</Citation><ArticleIdList><ArticleId IdType="pubmed">23193264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Jan 1;31(1):13-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12519938</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Jan 1;33(Database issue):D514-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15608251</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 Sep 03;16:284</Citation><ArticleIdList><ArticleId IdType="pubmed">26335531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2012 Dec;13(12):829-39</Citation><ArticleIdList><ArticleId IdType="pubmed">23150036</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2008 Oct;41(5):706-16</Citation><ArticleIdList><ArticleId IdType="pubmed">18472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Biotechnol. 2012 Feb;23(1):9-15</Citation><ArticleIdList><ArticleId IdType="pubmed">22154470</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2016 Mar;17(2):213-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26108229</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Semantics. 2014 Sep 22;5(1):42</Citation><ArticleIdList><ArticleId IdType="pubmed">25309716</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2010 Sep 07;2(9):65</Citation><ArticleIdList><ArticleId IdType="pubmed">20822536</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comb Chem. 2008 May-Jun;10(3):345-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18220367</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Jul 26;12:304</Citation><ArticleIdList><ArticleId IdType="pubmed">21791102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2011 Sep 23;11(10):726-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21941284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Jan 1;33(Database issue):D428-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15608231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2000 Jan 1;28(1):352-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10592272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 May 1;30(9):1338-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24413672</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2006 Dec;11(23-24):1085-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17129827</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2015 Apr;20(4):399-405</Citation><ArticleIdList><ArticleId IdType="pubmed">25463038</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2010;160(Pt 2):1304-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20841895</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6958-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19964717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2002 Jan 1;30(1):52-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11752252</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Life Sci Lett. 2015 Aug;1(2):22-25</Citation><ArticleIdList><ArticleId IdType="pubmed">29270443</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2015 Aug 19;10:43</Citation><ArticleIdList><ArticleId IdType="pubmed">26282399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Divers. 2006 Aug;10(3):283-99</Citation><ArticleIdList><ArticleId IdType="pubmed">17031533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Jan 1;31(1):10-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25189778</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Drug Discov Devel. 2008 May;11(3):381-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18428092</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 1999 Aug;9(8):677-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10447503</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D44-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24194602</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2005;44(1):80-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15778798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Nov 22;20(17):3045-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15201187</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteomics. 2009 Apr 13;72(3):567-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19084081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Oct 15;27(20):2907-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21873641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Aided Mol Des. 2012 Jul;26(7):801-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22644661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>
